pmid,year,mesh,meshTreeNumber
22125116,2012-01-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22125116,2012-01-03T00:00:00,Membrane Glycoproteins,D12.776.395.550
22125116,2012-01-03T00:00:00,Membrane Glycoproteins,D12.776.543.550
22125116,2012-01-03T00:00:00,Mutation,G05.365.590
22125116,2012-01-03T00:00:00,"Protein Structure, Secondary",G02.111.570.790.709.600
22201111,2012-01-03T00:00:00,Aged,M01.060.116.100
22201111,2012-01-03T00:00:00,Hippocampus,A08.186.211.464.405
22201111,2012-01-03T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
22201111,2012-01-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22201111,2012-01-03T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
22201111,2012-01-03T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
22201111,2012-01-03T00:00:00,Stroke,C10.228.140.300.775
22201111,2012-01-03T00:00:00,Stroke,C14.907.253.855
22214176,2012-01-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22214176,2012-01-03T00:00:00,Nanocapsules,D26.255.260.575
22214176,2012-01-03T00:00:00,Nanocapsules,D27.720.280.260.575
22214176,2012-01-03T00:00:00,Nanocapsules,E02.319.300.380.575
22214176,2012-01-03T00:00:00,Nanocapsules,J01.637.512.600.575
22214176,2012-01-03T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
22214176,2012-01-03T00:00:00,Prostatic Neoplasms,C12.294.260.750
22214176,2012-01-03T00:00:00,Prostatic Neoplasms,C12.294.565.625
22214176,2012-01-03T00:00:00,Prostatic Neoplasms,C12.758.409.750
22214176,2012-01-03T00:00:00,Treatment Outcome,E01.789.800
22214176,2012-01-03T00:00:00,Treatment Outcome,N04.761.559.590.800
22214176,2012-01-03T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22215894,2012-01-03T00:00:00,Adolescent,M01.060.057
22215894,2012-01-03T00:00:00,Adult,M01.060.116
22215894,2012-01-03T00:00:00,Aged,M01.060.116.100
22215894,2012-01-03T00:00:00,Child,M01.060.406
22215894,2012-01-03T00:00:00,"Child, Preschool",M01.060.406.448
22215894,2012-01-03T00:00:00,Heart Diseases,C14.280
22215894,2012-01-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22215894,2012-01-03T00:00:00,Middle Aged,M01.060.116.630
22215894,2012-01-03T00:00:00,Stroke,C10.228.140.300.775
22215894,2012-01-03T00:00:00,Stroke,C14.907.253.855
22215894,2012-01-03T00:00:00,United States,Z01.107.567.875
22215894,2012-01-03T00:00:00,Young Adult,M01.060.116.815
22218426,2012-01-03T00:00:00,Adolescent,M01.060.057
22218426,2012-01-03T00:00:00,Adult,M01.060.116
22218426,2012-01-03T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
22218426,2012-01-03T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
22218426,2012-01-03T00:00:00,Health Surveys,E05.318.308.250
22218426,2012-01-03T00:00:00,Health Surveys,N05.715.360.300.375
22218426,2012-01-03T00:00:00,Health Surveys,N06.850.520.308.250
22218426,2012-01-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22218426,2012-01-03T00:00:00,Middle Aged,M01.060.116.630
22218426,2012-01-03T00:00:00,Motivation,F01.658
22218426,2012-01-03T00:00:00,Motivation,F01.752.543.500.750
22218426,2012-01-03T00:00:00,Smoking,F01.145.466.753
22218426,2012-01-03T00:00:00,Smoking Cessation,F01.145.940.700
22218426,2012-01-03T00:00:00,United States,Z01.107.567.875
22218426,2012-01-03T00:00:00,Young Adult,M01.060.116.815
22215244,2012-01-04T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.350.700.715.200.200
22215244,2012-01-04T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.200.200
22215244,2012-01-04T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.250.200
22215244,2012-01-04T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.388.250.250.160
22215244,2012-01-04T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.210.240.160
22215244,2012-01-04T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.800.250.250.160
22215244,2012-01-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22215244,2012-01-04T00:00:00,Intraoperative Complications,C23.550.505
22223641,2012-01-05T00:00:00,Adenosine Triphosphate,D03.438.759.646.138.236
22223641,2012-01-05T00:00:00,Adenosine Triphosphate,D13.695.667.138.236
22223641,2012-01-05T00:00:00,Adenosine Triphosphate,D13.695.827.068.236
22223641,2012-01-05T00:00:00,Animals,B01.050
22223641,2012-01-05T00:00:00,Cell Line,A11.251.210
22223641,2012-01-05T00:00:00,Endoplasmic Reticulum,A11.284.430.214.190.875.248
22223641,2012-01-05T00:00:00,Gene Deletion,G05.355.600.800.320
22223641,2012-01-05T00:00:00,Gene Deletion,G05.365.590.762.320
22223641,2012-01-05T00:00:00,HSP90 Heat-Shock Proteins,D12.776.580.216.380
22223641,2012-01-05T00:00:00,"Immunity, Innate",G12.450.575
22223641,2012-01-05T00:00:00,Integrins,D12.776.543.750.705.408
22223641,2012-01-05T00:00:00,Molecular Chaperones,D12.776.580
22223641,2012-01-05T00:00:00,"Mutagenesis, Site-Directed",E05.393.420.601.575
22223641,2012-01-05T00:00:00,Toll-Like Receptors,D12.776.543.750.705.910.500
22223751,2012-01-05T00:00:00,Adenosine Triphosphate,D03.438.759.646.138.236
22223751,2012-01-05T00:00:00,Adenosine Triphosphate,D13.695.667.138.236
22223751,2012-01-05T00:00:00,Adenosine Triphosphate,D13.695.827.068.236
22223751,2012-01-05T00:00:00,Animals,B01.050
22223751,2012-01-05T00:00:00,Calcium,D01.268.552.100
22223751,2012-01-05T00:00:00,Calcium,D01.552.539.288
22223751,2012-01-05T00:00:00,Calcium,D23.119.100
22223751,2012-01-05T00:00:00,Calcium Signaling,G02.111.087.800.800.100
22223751,2012-01-05T00:00:00,Calcium Signaling,G02.149.115.800.800.100
22223751,2012-01-05T00:00:00,Calcium Signaling,G03.495.166.500.100
22223751,2012-01-05T00:00:00,Calcium Signaling,G04.299.880.800.100
22223751,2012-01-05T00:00:00,Chondrocytes,A11.329.171
22223751,2012-01-05T00:00:00,Cilia,A11.284.180.165
22223751,2012-01-05T00:00:00,Compressive Strength,G01.374.180
22223751,2012-01-05T00:00:00,Extracellular Matrix,A11.284.295.310
22223751,2012-01-05T00:00:00,"Mechanotransduction, Cellular",G01.154.100.440
22223751,2012-01-05T00:00:00,"Mechanotransduction, Cellular",G01.595.100.440
22223751,2012-01-05T00:00:00,"Mechanotransduction, Cellular",G02.111.087.800.580
22223751,2012-01-05T00:00:00,"Mechanotransduction, Cellular",G02.149.115.800.580
22223751,2012-01-05T00:00:00,"Mechanotransduction, Cellular",G04.299.880.580
22223751,2012-01-05T00:00:00,"Stress, Mechanical",G01.374.676.830
22223751,2012-01-05T00:00:00,"Stress, Mechanical",G01.595.540.830
22225726,2012-01-05T00:00:00,Adult,M01.060.116
22225726,2012-01-05T00:00:00,Aged,M01.060.116.100
22225726,2012-01-05T00:00:00,Artifacts,E05.047
22225726,2012-01-05T00:00:00,Cardiac Output,E01.370.370.380.150
22225726,2012-01-05T00:00:00,Cardiac Output,G09.330.380.124
22225726,2012-01-05T00:00:00,Contrast Media,D27.720.259
22225726,2012-01-05T00:00:00,Coronary Angiography,E01.370.350.700.060.200
22225726,2012-01-05T00:00:00,Coronary Angiography,E01.370.370.050.200
22225726,2012-01-05T00:00:00,Coronary Angiography,E01.370.370.380.200
22225726,2012-01-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22225726,2012-01-05T00:00:00,Magnetic Resonance Angiography,E01.370.350.500.500
22225726,2012-01-05T00:00:00,Magnetic Resonance Angiography,E01.370.350.825.500.500
22225726,2012-01-05T00:00:00,Magnetic Resonance Angiography,E01.370.370.050.500
22225726,2012-01-05T00:00:00,Middle Aged,M01.060.116.630
22225726,2012-01-05T00:00:00,Stroke Volume,E01.370.370.380.150.700
22225726,2012-01-05T00:00:00,Stroke Volume,G09.330.380.124.882
22225726,2012-01-05T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
22225726,2012-01-05T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
22225726,2012-01-05T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
22225726,2012-01-05T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
22225726,2012-01-05T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
22225726,2012-01-05T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
22225726,2012-01-05T00:00:00,"Ventricular Dysfunction, Right",C14.280.945.910
22225858,2012-01-05T00:00:00,Aged,M01.060.116.100
22225858,2012-01-05T00:00:00,Anticoagulants,D27.505.954.502.119
22225858,2012-01-05T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
22225858,2012-01-05T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
22225858,2012-01-05T00:00:00,Drug Interactions,G07.690.812.240
22225858,2012-01-05T00:00:00,Drug Interactions,G07.700.680.240
22225858,2012-01-05T00:00:00,Enoxaparin,D09.698.373.400.300.200
22225858,2012-01-05T00:00:00,Hemorrhage,C23.550.414
22225858,2012-01-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22225858,2012-01-05T00:00:00,Middle Aged,M01.060.116.630
22225858,2012-01-05T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
22225858,2012-01-05T00:00:00,Thiophenes,D02.886.778
22225858,2012-01-05T00:00:00,Thiophenes,D03.383.903
22225858,2012-01-05T00:00:00,Venous Thromboembolism,C14.907.355.590.700
22225858,2012-01-05T00:00:00,Venous Thromboembolism,C14.907.355.830.850.700
22224593,2012-01-06T00:00:00,Adult,M01.060.116
22224593,2012-01-06T00:00:00,African Americans,M01.686.508.100.100
22224593,2012-01-06T00:00:00,African Americans,M01.686.754.100
22224593,2012-01-06T00:00:00,Attitude to Health,F01.100.150
22224593,2012-01-06T00:00:00,Attitude to Health,N05.300.150
22224593,2012-01-06T00:00:00,Cultural Characteristics,I01.076.201.450.324
22224593,2012-01-06T00:00:00,Cultural Characteristics,I01.880.143.329
22224593,2012-01-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22224593,2012-01-06T00:00:00,Interviews as Topic,E05.318.308.420
22224593,2012-01-06T00:00:00,Interviews as Topic,L01.280.520
22224593,2012-01-06T00:00:00,Interviews as Topic,N05.715.360.300.400
22224593,2012-01-06T00:00:00,Interviews as Topic,N06.850.520.308.420
22224593,2012-01-06T00:00:00,Neoplasms,C04
22224593,2012-01-06T00:00:00,Saliva,A12.200.666
22224593,2012-01-06T00:00:00,Tissue Donors,M01.898
22228763,2012-01-06T00:00:00,Animals,B01.050
22228763,2012-01-06T00:00:00,Central Nervous System Depressants,D27.505.696.277
22228763,2012-01-06T00:00:00,Central Nervous System Depressants,D27.505.954.427.210
22228763,2012-01-06T00:00:00,Ethanol,D02.033.375
22228763,2012-01-06T00:00:00,Hepatocytes,A11.436.348
22228763,2012-01-06T00:00:00,"Mitochondria, Liver",A11.284.430.214.190.875.564.461
22228763,2012-01-06T00:00:00,"Mitochondria, Liver",A11.284.835.626.461
22228763,2012-01-06T00:00:00,Oxygen Consumption,G03.730
22228763,2012-01-06T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22228763,2012-01-06T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
22228763,2012-01-06T00:00:00,Voltage-Dependent Anion Channels,D12.776.157.530.400.500.520
22228763,2012-01-06T00:00:00,Voltage-Dependent Anion Channels,D12.776.543.550.425.730.520
22228763,2012-01-06T00:00:00,Voltage-Dependent Anion Channels,D12.776.543.585.400.730.520
22228809,2012-01-06T00:00:00,Animals,B01.050
22228809,2012-01-06T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22228809,2012-01-06T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
22228809,2012-01-06T00:00:00,Recovery of Function,G16.757
22248731,2012-01-08T00:00:00,Alternative Splicing,G02.111.087.750.700.100
22248731,2012-01-08T00:00:00,Alternative Splicing,G02.149.115.750.700.100
22248731,2012-01-08T00:00:00,Alternative Splicing,G03.495.839.700.100
22248731,2012-01-08T00:00:00,Alternative Splicing,G05.355.315.700.700.100
22248731,2012-01-08T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
22248731,2012-01-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22248731,2012-01-08T00:00:00,Neoplasms,C04
22248731,2012-01-08T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
22248731,2012-01-08T00:00:00,RNA-Binding Proteins,D12.776.157.725
22248731,2012-01-08T00:00:00,RNA-Binding Proteins,D12.776.664.962
22248731,2012-01-08T00:00:00,"Receptors, Androgen",D12.776.260.698.750.150
22248731,2012-01-08T00:00:00,"Receptors, Androgen",D12.776.826.750.150
22248731,2012-01-08T00:00:00,"Receptors, Androgen",D12.776.930.669.750.150
22230476,2012-01-09T00:00:00,Adolescent,M01.060.057
22230476,2012-01-09T00:00:00,Case-Control Studies,E05.318.760.500.500
22230476,2012-01-09T00:00:00,Case-Control Studies,N05.715.360.775.175.200
22230476,2012-01-09T00:00:00,Case-Control Studies,N06.850.520.450.500.500
22230476,2012-01-09T00:00:00,Child,M01.060.406
22230476,2012-01-09T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
22230476,2012-01-09T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
22230476,2012-01-09T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
22230476,2012-01-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22230476,2012-01-09T00:00:00,South Carolina,Z01.107.567.875.075.662
22230476,2012-01-09T00:00:00,South Carolina,Z01.107.567.875.750.700
22230476,2012-01-09T00:00:00,Young Adult,M01.060.116.815
22231377,2012-01-09T00:00:00,"Anemia, Sickle Cell",C15.378.071.141.150.150
22231377,2012-01-09T00:00:00,"Anemia, Sickle Cell",C15.378.420.155
22231377,2012-01-09T00:00:00,"Anemia, Sickle Cell",C16.320.070.150
22231377,2012-01-09T00:00:00,"Anemia, Sickle Cell",C16.320.365.155
22231377,2012-01-09T00:00:00,Autoantibodies,D12.776.124.486.485.114.323
22231377,2012-01-09T00:00:00,Autoantibodies,D12.776.124.790.651.114.323
22231377,2012-01-09T00:00:00,Autoantibodies,D12.776.377.715.548.114.323
22231377,2012-01-09T00:00:00,Child,M01.060.406
22231377,2012-01-09T00:00:00,"Child, Preschool",M01.060.406.448
22231377,2012-01-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22231377,2012-01-09T00:00:00,Stroke,C10.228.140.300.775
22231377,2012-01-09T00:00:00,Stroke,C14.907.253.855
22231377,2012-01-09T00:00:00,Time Factors,G01.910.857
22231377,2012-01-09T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.700.560.260.850
22231377,2012-01-09T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.850.260.850
22231377,2012-01-09T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.850.850.870
22231377,2012-01-09T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.376.560.260.850
22231568,2012-01-09T00:00:00,Alleles,G05.360.340.024.340.030
22231568,2012-01-09T00:00:00,Case-Control Studies,E05.318.760.500.500
22231568,2012-01-09T00:00:00,Case-Control Studies,N05.715.360.775.175.200
22231568,2012-01-09T00:00:00,Case-Control Studies,N06.850.520.450.500.500
22231568,2012-01-09T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
22231568,2012-01-09T00:00:00,Genetic Predisposition to Disease,G05.380.355
22231568,2012-01-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22231568,2012-01-09T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
22231568,2012-01-09T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
22231568,2012-01-09T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
22232738,2012-01-09T00:00:00,Androgens,D27.505.696.399.472.161
22232738,2012-01-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22232738,2012-01-09T00:00:00,Phenotype,G05.695
22232738,2012-01-09T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
22232738,2012-01-09T00:00:00,Prostatic Neoplasms,C12.294.260.750
22232738,2012-01-09T00:00:00,Prostatic Neoplasms,C12.294.565.625
22232738,2012-01-09T00:00:00,Prostatic Neoplasms,C12.758.409.750
22232738,2012-01-09T00:00:00,Proto-Oncogene Protein c-ets-1,D12.776.260.665.100
22232738,2012-01-09T00:00:00,Proto-Oncogene Protein c-ets-1,D12.776.624.664.700.175.100
22232738,2012-01-09T00:00:00,Proto-Oncogene Protein c-ets-1,D12.776.930.635.100
22232738,2012-01-09T00:00:00,"Receptors, Androgen",D12.776.260.698.750.150
22232738,2012-01-09T00:00:00,"Receptors, Androgen",D12.776.826.750.150
22232738,2012-01-09T00:00:00,"Receptors, Androgen",D12.776.930.669.750.150
22232738,2012-01-09T00:00:00,Signal Transduction,G02.111.087.800
22232738,2012-01-09T00:00:00,Signal Transduction,G02.149.115.800
22232738,2012-01-09T00:00:00,Signal Transduction,G04.299.880
22232738,2012-01-09T00:00:00,"Transcription, Genetic",G02.111.087.847
22232738,2012-01-09T00:00:00,"Transcription, Genetic",G02.149.115.847
22232738,2012-01-09T00:00:00,"Transcription, Genetic",G05.355.310.700
22249026,2012-01-09T00:00:00,Animals,B01.050
22249026,2012-01-09T00:00:00,Cell Adhesion,G04.299.117
22249026,2012-01-09T00:00:00,Cytokines,D12.644.276.374
22249026,2012-01-09T00:00:00,Cytokines,D12.776.467.374
22249026,2012-01-09T00:00:00,Cytokines,D23.529.374
22249026,2012-01-09T00:00:00,Extracellular Matrix Proteins,D12.776.860.300
22249026,2012-01-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22249026,2012-01-09T00:00:00,Intercellular Signaling Peptides and Proteins,D12.644.276
22249026,2012-01-09T00:00:00,Intercellular Signaling Peptides and Proteins,D12.776.467
22249026,2012-01-09T00:00:00,Intercellular Signaling Peptides and Proteins,D23.529
22249026,2012-01-09T00:00:00,Neoplasms,C04
22249026,2012-01-09T00:00:00,"Neovascularization, Pathologic",C23.550.589.500
22249026,2012-01-09T00:00:00,Osteonectin,D12.776.157.125.715
22249026,2012-01-09T00:00:00,Osteonectin,D12.776.395.600
22249026,2012-01-09T00:00:00,Protein Folding,G01.154.100.640
22249026,2012-01-09T00:00:00,Protein Folding,G01.595.100.640
22249026,2012-01-09T00:00:00,Protein Folding,G02.111.087.690
22249026,2012-01-09T00:00:00,Protein Folding,G02.149.115.690
22284622,2012-01-09T00:00:00,Animals,B01.050
22284622,2012-01-09T00:00:00,Brain Injuries,C10.228.140.199
22284622,2012-01-09T00:00:00,Brain Injuries,C10.900.300.087
22284622,2012-01-09T00:00:00,Brain Injuries,C21.866.260.118
22284622,2012-01-09T00:00:00,Brain Injuries,C21.866.915.300.200
22284622,2012-01-09T00:00:00,Brain Ischemia,C10.228.140.300.150
22284622,2012-01-09T00:00:00,Brain Ischemia,C14.907.253.092
22284622,2012-01-09T00:00:00,NF-kappa B,D12.776.260.600
22284622,2012-01-09T00:00:00,NF-kappa B,D12.776.660.600
22284622,2012-01-09T00:00:00,NF-kappa B,D12.776.930.600
22284622,2012-01-09T00:00:00,Neuroprotective Agents,D27.505.696.706.548
22284622,2012-01-09T00:00:00,Neuroprotective Agents,D27.505.954.427.575
22110009,2012-01-10T00:00:00,Aged,M01.060.116.100
22110009,2012-01-10T00:00:00,Coronary Artery Disease,C14.280.647.250.260
22110009,2012-01-10T00:00:00,Coronary Artery Disease,C14.907.137.126.339
22110009,2012-01-10T00:00:00,Coronary Artery Disease,C14.907.585.250.260
22110009,2012-01-10T00:00:00,Coronary Vessels,A07.231.114.269
22110009,2012-01-10T00:00:00,Coronary Vessels,A07.231.908.194
22110009,2012-01-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22110009,2012-01-10T00:00:00,Lipids,D10
22110009,2012-01-10T00:00:00,Middle Aged,M01.060.116.630
22110009,2012-01-10T00:00:00,"Spectroscopy, Near-Infrared",E01.370.350.750
22110009,2012-01-10T00:00:00,"Spectroscopy, Near-Infrared",E05.196.867.851
22110009,2012-01-10T00:00:00,"Ultrasonography, Interventional",E01.370.350.850.855
22228201,2012-01-10T00:00:00,ATP-Binding Cassette Transporters,D12.776.157.530.100
22228201,2012-01-10T00:00:00,ATP-Binding Cassette Transporters,D12.776.395.550.020
22228201,2012-01-10T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.550.192
22228201,2012-01-10T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.585.100
22228201,2012-01-10T00:00:00,Angiogenesis Inhibitors,D27.505.696.377.077.099
22228201,2012-01-10T00:00:00,Angiogenesis Inhibitors,D27.505.696.377.450.100
22228201,2012-01-10T00:00:00,Angiogenesis Inhibitors,D27.505.954.248.025
22228201,2012-01-10T00:00:00,Brain Neoplasms,C04.588.614.250.195
22228201,2012-01-10T00:00:00,Brain Neoplasms,C10.228.140.211
22228201,2012-01-10T00:00:00,Brain Neoplasms,C10.551.240.250
22228201,2012-01-10T00:00:00,Combined Modality Therapy,E02.186
22228201,2012-01-10T00:00:00,DNA Repair,G02.111.087.219
22228201,2012-01-10T00:00:00,DNA Repair,G02.149.115.219
22228201,2012-01-10T00:00:00,DNA Repair,G05.355.195
22228201,2012-01-10T00:00:00,DNA Repair Enzymes,D08.811.074
22228201,2012-01-10T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
22228201,2012-01-10T00:00:00,Glioblastoma,C04.557.465.625.600.380.080.335
22228201,2012-01-10T00:00:00,Glioblastoma,C04.557.470.670.380.080.335
22228201,2012-01-10T00:00:00,Glioblastoma,C04.557.580.625.600.380.080.335
22228201,2012-01-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22228201,2012-01-10T00:00:00,MicroRNAs,D13.150.650.319
22228201,2012-01-10T00:00:00,MicroRNAs,D13.444.735.150.319
22228201,2012-01-10T00:00:00,MicroRNAs,D13.444.735.790.099
22228201,2012-01-10T00:00:00,Neoplastic Stem Cells,A11.872.650
22228201,2012-01-10T00:00:00,P-Glycoprotein,D12.776.157.530.100.652.500
22228201,2012-01-10T00:00:00,P-Glycoprotein,D12.776.157.530.450.074.500.500.750
22228201,2012-01-10T00:00:00,P-Glycoprotein,D12.776.395.550.020.610.610
22228201,2012-01-10T00:00:00,P-Glycoprotein,D12.776.543.550.192.610.610
22228201,2012-01-10T00:00:00,P-Glycoprotein,D12.776.543.585.100.610.500
22228201,2012-01-10T00:00:00,P-Glycoprotein,D12.776.543.585.450.074.500.500.750
22228201,2012-01-10T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.644.360.075.718
22228201,2012-01-10T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.476.075.718
22228201,2012-01-10T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.624.664.700.169
22228201,2012-01-10T00:00:00,Retinoids,D02.455.326.271.665.202.495
22228201,2012-01-10T00:00:00,Retinoids,D02.455.426.392.368.367.379.249.700
22228201,2012-01-10T00:00:00,Retinoids,D02.455.849.131.495
22228201,2012-01-10T00:00:00,Retinoids,D23.767.261.700
22228201,2012-01-10T00:00:00,Tumor Suppressor Proteins,D12.776.624.776
22231541,2012-01-10T00:00:00,Alcohol Drinking,F01.145.317.269
22231541,2012-01-10T00:00:00,Depressive Disorder,F03.600.300
22231541,2012-01-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22231541,2012-01-10T00:00:00,Middle Aged,M01.060.116.630
22231541,2012-01-10T00:00:00,Pressure Ulcer,C17.800.893.665
22231541,2012-01-10T00:00:00,Spinal Cord Injuries,C10.228.854.770
22231541,2012-01-10T00:00:00,Spinal Cord Injuries,C10.900.850
22231541,2012-01-10T00:00:00,Spinal Cord Injuries,C21.866.819
22234947,2012-01-10T00:00:00,Aged,M01.060.116.100
22234947,2012-01-10T00:00:00,Catheterization,E02.148
22234947,2012-01-10T00:00:00,Catheterization,E05.157
22234947,2012-01-10T00:00:00,Extravasation of Diagnostic and Therapeutic Materials,C21.866.371
22234947,2012-01-10T00:00:00,Extravasation of Diagnostic and Therapeutic Materials,C23.550.340
22234947,2012-01-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22234947,2012-01-10T00:00:00,Stroke,C10.228.140.300.775
22234947,2012-01-10T00:00:00,Stroke,C14.907.253.855
22234947,2012-01-10T00:00:00,Thrombectomy,E04.100.814.842
22240084,2012-01-10T00:00:00,Adult,M01.060.116
22240084,2012-01-10T00:00:00,Bipolar Disorder,F03.600.150.150
22240084,2012-01-10T00:00:00,Dibenzothiazepines,D02.886.680.702.500
22240084,2012-01-10T00:00:00,Dibenzothiazepines,D03.494.276
22240084,2012-01-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22240084,2012-01-10T00:00:00,Middle Aged,M01.060.116.630
22240084,2012-01-10T00:00:00,Triazines,D03.383.931
22234379,2012-01-11T00:00:00,Adult,M01.060.116
22234379,2012-01-11T00:00:00,Cocaine-Related Disorders,C21.739.300
22234379,2012-01-11T00:00:00,Cocaine-Related Disorders,F03.900.300
22234379,2012-01-11T00:00:00,Cues,F02.463.425.234
22234379,2012-01-11T00:00:00,Cycloserine,D03.383.129.385.162
22234379,2012-01-11T00:00:00,Cycloserine,D03.383.129.462.600.162
22234379,2012-01-11T00:00:00,Cycloserine,D12.125.837.150
22234379,2012-01-11T00:00:00,Double-Blind Method,E05.318.780.300
22234379,2012-01-11T00:00:00,Double-Blind Method,E05.581.500.300
22234379,2012-01-11T00:00:00,Double-Blind Method,N05.715.360.780.320
22234379,2012-01-11T00:00:00,Double-Blind Method,N06.850.520.445.300
22234379,2012-01-11T00:00:00,Fear,F01.470.361
22234379,2012-01-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22234379,2012-01-11T00:00:00,Middle Aged,M01.060.116.630
22234379,2012-01-11T00:00:00,Treatment Outcome,E01.789.800
22234379,2012-01-11T00:00:00,Treatment Outcome,N04.761.559.590.800
22234379,2012-01-11T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22237021,2012-01-11T00:00:00,Space Flight,J01.937.285.850
22237296,2012-01-11T00:00:00,Adolescent,M01.060.057
22237296,2012-01-11T00:00:00,Adult,M01.060.116
22237296,2012-01-11T00:00:00,Age Factors,N05.715.350.075
22237296,2012-01-11T00:00:00,Age Factors,N06.850.490.250
22237296,2012-01-11T00:00:00,Aged,M01.060.116.100
22237296,2012-01-11T00:00:00,Child,M01.060.406
22237296,2012-01-11T00:00:00,"Child, Preschool",M01.060.406.448
22237296,2012-01-11T00:00:00,Head and Neck Neoplasms,C04.588.443
22237296,2012-01-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22237296,2012-01-11T00:00:00,Lymph Node Excision,E04.446
22237296,2012-01-11T00:00:00,Melanoma,C04.557.465.625.650.510
22237296,2012-01-11T00:00:00,Melanoma,C04.557.580.625.650.510
22237296,2012-01-11T00:00:00,Melanoma,C04.557.665.510
22237296,2012-01-11T00:00:00,Middle Aged,M01.060.116.630
22237296,2012-01-11T00:00:00,Neoplasm Staging,E01.370.550
22237296,2012-01-11T00:00:00,SEER Program,E05.318.308.970.725
22237296,2012-01-11T00:00:00,SEER Program,L01.280.950.725
22237296,2012-01-11T00:00:00,SEER Program,N04.452.859.819.725
22237296,2012-01-11T00:00:00,SEER Program,N05.715.360.300.715.700.725
22237296,2012-01-11T00:00:00,SEER Program,N06.850.520.308.970.725
22237301,2012-01-11T00:00:00,Adenoidectomy,E04.580.068
22237301,2012-01-11T00:00:00,"Child, Preschool",M01.060.406.448
22237301,2012-01-11T00:00:00,Cilia,A11.284.180.165
22237301,2012-01-11T00:00:00,Hair,A17.360
22237301,2012-01-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22237301,2012-01-11T00:00:00,Nicotine,D03.132.760.570
22237301,2012-01-11T00:00:00,Nicotine,D03.383.725.518
22237301,2012-01-11T00:00:00,"Sleep Apnea, Obstructive",C08.618.085.852.850
22237301,2012-01-11T00:00:00,"Sleep Apnea, Obstructive",C10.886.425.800.750.850
22237301,2012-01-11T00:00:00,Tobacco Smoke Pollution,D20.633.937.680
22237301,2012-01-11T00:00:00,Tobacco Smoke Pollution,N06.850.460.100.555
22238268,2012-01-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22238268,2012-01-11T00:00:00,"Mutation, Missense",G05.365.590.650
22238268,2012-01-11T00:00:00,Point Mutation,G05.365.590.675
22238268,2012-01-11T00:00:00,Protein Folding,G01.154.100.640
22238268,2012-01-11T00:00:00,Protein Folding,G01.595.100.640
22238268,2012-01-11T00:00:00,Protein Folding,G02.111.087.690
22238268,2012-01-11T00:00:00,Protein Folding,G02.149.115.690
22238268,2012-01-11T00:00:00,Protein Stability,G02.111.700
22238268,2012-01-11T00:00:00,Proteins,D12.776
22238268,2012-01-11T00:00:00,Software,L01.224.900
22243973,2012-01-11T00:00:00,"Biofeedback, Psychology",E02.190.525.123
22243973,2012-01-11T00:00:00,"Biofeedback, Psychology",F02.830.131
22243973,2012-01-11T00:00:00,"Biofeedback, Psychology",F04.754.137.301
22243973,2012-01-11T00:00:00,"Biofeedback, Psychology",F04.754.308.500
22243973,2012-01-11T00:00:00,"Biofeedback, Psychology",L01.143.283.425.624.500
22243973,2012-01-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22243973,2012-01-11T00:00:00,Medical Records,E05.318.308.940.968
22243973,2012-01-11T00:00:00,Medical Records,L01.280.900.968
22243973,2012-01-11T00:00:00,Medical Records,N04.452.859.564
22243973,2012-01-11T00:00:00,Medical Records,N05.715.360.300.715.500
22243973,2012-01-11T00:00:00,Medical Records,N06.850.520.308.940.968
22243973,2012-01-11T00:00:00,Patient Compliance,F01.145.488.500
22243973,2012-01-11T00:00:00,Patient Compliance,N05.300.150.600.600
22243973,2012-01-11T00:00:00,Phonation,G09.772.770.680
22243973,2012-01-11T00:00:00,Self Efficacy,F01.752.747.792.700
22243973,2012-01-11T00:00:00,Treatment Outcome,E01.789.800
22243973,2012-01-11T00:00:00,Treatment Outcome,N04.761.559.590.800
22243973,2012-01-11T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22243973,2012-01-11T00:00:00,Voice Disorders,C08.360.940
22243973,2012-01-11T00:00:00,Voice Disorders,C09.400.940
22243973,2012-01-11T00:00:00,Voice Disorders,C10.597.975
22243973,2012-01-11T00:00:00,Voice Disorders,C23.888.592.979
22236222,2012-01-12T00:00:00,Aged,M01.060.116.100
22236222,2012-01-12T00:00:00,Atrial Fibrillation,C14.280.067.198
22236222,2012-01-12T00:00:00,Atrial Fibrillation,C23.550.073.198
22236222,2012-01-12T00:00:00,"Cardiac Pacing, Artificial",E02.145
22236222,2012-01-12T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
22236222,2012-01-12T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
22236222,2012-01-12T00:00:00,"Defibrillators, Implantable",E07.695.175
22236222,2012-01-12T00:00:00,Embolism,C14.907.355.350
22236222,2012-01-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22236222,2012-01-12T00:00:00,Hypertension,C14.907.489
22236222,2012-01-12T00:00:00,"Pacemaker, Artificial",E07.858.082.748
22236222,2012-01-12T00:00:00,Stroke,C10.228.140.300.775
22236222,2012-01-12T00:00:00,Stroke,C14.907.253.855
22237686,2012-01-12T00:00:00,Adolescent,M01.060.057
22237686,2012-01-12T00:00:00,Adult,M01.060.116
22237686,2012-01-12T00:00:00,African Americans,M01.686.508.100.100
22237686,2012-01-12T00:00:00,African Americans,M01.686.754.100
22237686,2012-01-12T00:00:00,Birth Weight,C23.888.144.186
22237686,2012-01-12T00:00:00,Birth Weight,E01.370.600.115.100.160.120.186
22237686,2012-01-12T00:00:00,Birth Weight,E05.041.124.160.750.149
22237686,2012-01-12T00:00:00,Birth Weight,G07.100.100.160.120.186
22237686,2012-01-12T00:00:00,Birth Weight,G07.700.320.249.314.120.186
22237686,2012-01-12T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
22237686,2012-01-12T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
22237686,2012-01-12T00:00:00,"Diabetes, Gestational",C13.703.170
22237686,2012-01-12T00:00:00,"Diabetes, Gestational",C18.452.394.750.448
22237686,2012-01-12T00:00:00,"Diabetes, Gestational",C19.246.200
22237686,2012-01-12T00:00:00,European Continental Ancestry Group,M01.686.508.400
22237686,2012-01-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22237686,2012-01-12T00:00:00,"Infant, Newborn",M01.060.703.520
22237686,2012-01-12T00:00:00,Obesity,C18.654.726.500
22237686,2012-01-12T00:00:00,Obesity,C23.888.144.699.500
22237686,2012-01-12T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
22237686,2012-01-12T00:00:00,Obesity,G07.100.100.160.120.699.500
22237686,2012-01-12T00:00:00,Pregnancy,G08.686.785.760.769
22237686,2012-01-12T00:00:00,South Carolina,Z01.107.567.875.075.662
22237686,2012-01-12T00:00:00,South Carolina,Z01.107.567.875.750.700
22241863,2012-01-12T00:00:00,Animals,B01.050
22241863,2012-01-12T00:00:00,Apoptosis,G04.299.139.160
22241863,2012-01-12T00:00:00,Calcium,D01.268.552.100
22241863,2012-01-12T00:00:00,Calcium,D01.552.539.288
22241863,2012-01-12T00:00:00,Calcium,D23.119.100
22241863,2012-01-12T00:00:00,Calcium Signaling,G02.111.087.800.800.100
22241863,2012-01-12T00:00:00,Calcium Signaling,G02.149.115.800.800.100
22241863,2012-01-12T00:00:00,Calcium Signaling,G03.495.166.500.100
22241863,2012-01-12T00:00:00,Calcium Signaling,G04.299.880.800.100
22241863,2012-01-12T00:00:00,Hepatocytes,A11.436.348
22241863,2012-01-12T00:00:00,Intracellular Membranes,A11.284.149.450
22241863,2012-01-12T00:00:00,Intracellular Membranes,A11.284.835.514
22241863,2012-01-12T00:00:00,"Mitochondria, Liver",A11.284.430.214.190.875.564.461
22241863,2012-01-12T00:00:00,"Mitochondria, Liver",A11.284.835.626.461
22241863,2012-01-12T00:00:00,Oxygen,D01.268.185.550
22241863,2012-01-12T00:00:00,Oxygen,D01.362.670
22241863,2012-01-12T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22241863,2012-01-12T00:00:00,Reactive Oxygen Species,D01.339.431
22241863,2012-01-12T00:00:00,Reactive Oxygen Species,D01.650.775
22265892,2012-01-12T00:00:00,ADAM Proteins,D08.811.277.656.675.374.102
22265892,2012-01-12T00:00:00,ADAM Proteins,D09.400.430.500
22265892,2012-01-12T00:00:00,ADAM Proteins,D12.776.395.033
22265892,2012-01-12T00:00:00,Animals,B01.050
22265892,2012-01-12T00:00:00,Aortic Diseases,C14.907.109
22265892,2012-01-12T00:00:00,Aortic Valve,A07.541.510.110
22265892,2012-01-12T00:00:00,"Disease Models, Animal",C22.232
22265892,2012-01-12T00:00:00,"Disease Models, Animal",E05.598.500
22265892,2012-01-12T00:00:00,"Disease Models, Animal",E05.599.395.080
22265892,2012-01-12T00:00:00,Elastin,D05.750.078.421
22265892,2012-01-12T00:00:00,Elastin,D12.776.860.300.350
22265892,2012-01-12T00:00:00,Extracellular Matrix,A11.284.295.310
22265892,2012-01-12T00:00:00,Heart Valve Diseases,C14.280.484
22265892,2012-01-12T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.205.360
22265892,2012-01-12T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.252.445
22265892,2012-01-12T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.525.700.350
22265892,2012-01-12T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.205.360
22265892,2012-01-12T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.252.445
22265892,2012-01-12T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.525.700.350
22265892,2012-01-12T00:00:00,Versicans,D09.698.735.830.750
22265892,2012-01-12T00:00:00,Versicans,D12.776.395.650.750.750
22265892,2012-01-12T00:00:00,Versicans,D12.776.503.280.625
22306134,2012-01-12T00:00:00,Adult,M01.060.116
22306134,2012-01-12T00:00:00,Aged,M01.060.116.100
22306134,2012-01-12T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
22306134,2012-01-12T00:00:00,Emotions,F01.470
22306134,2012-01-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22306134,2012-01-12T00:00:00,Life Change Events,F01.829.458.410
22306134,2012-01-12T00:00:00,Middle Aged,M01.060.116.630
22306134,2012-01-12T00:00:00,"Models, Psychological",E05.599.695
22306134,2012-01-12T00:00:00,Primary Health Care,N04.590.233.727
22306134,2012-01-12T00:00:00,Psychometrics,F04.711.780
22306134,2012-01-12T00:00:00,Questionnaires,E05.318.308.750
22306134,2012-01-12T00:00:00,Questionnaires,L01.280.800
22306134,2012-01-12T00:00:00,Questionnaires,N05.715.360.300.695
22306134,2012-01-12T00:00:00,Questionnaires,N06.850.520.308.750
22306134,2012-01-12T00:00:00,Sex Factors,N05.715.350.675
22306134,2012-01-12T00:00:00,Sex Factors,N06.850.490.875
22306134,2012-01-12T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
22306134,2012-01-12T00:00:00,Veterans,M01.930
22103793,2012-01-13T00:00:00,Optical Fibers,E07.632.750
22103793,2012-01-13T00:00:00,"Spectroscopy, Fourier Transform Infrared",E05.196.712.726.676.700
22103793,2012-01-13T00:00:00,"Spectroscopy, Fourier Transform Infrared",E05.196.867.826.676.700
22103793,2012-01-13T00:00:00,Water,D01.455.900
22103793,2012-01-13T00:00:00,Water,D01.650.550.925
22242716,2012-01-13T00:00:00,Adult,M01.060.116
22242716,2012-01-13T00:00:00,Clinical Competence,I02.399.630.210
22242716,2012-01-13T00:00:00,Clinical Competence,N04.761.210
22242716,2012-01-13T00:00:00,Communication,F01.145.209
22242716,2012-01-13T00:00:00,Communication,L01.143
22242716,2012-01-13T00:00:00,"Hospitals, University",N02.278.020.300.310
22242716,2012-01-13T00:00:00,"Hospitals, University",N02.278.421.639.725
22242716,2012-01-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22242716,2012-01-13T00:00:00,Physician-Patient Relations,F01.829.401.650.675
22242716,2012-01-13T00:00:00,Physician-Patient Relations,N05.300.660.625
22242716,2012-01-13T00:00:00,Questionnaires,E05.318.308.750
22242716,2012-01-13T00:00:00,Questionnaires,L01.280.800
22242716,2012-01-13T00:00:00,Questionnaires,N05.715.360.300.695
22242716,2012-01-13T00:00:00,Questionnaires,N06.850.520.308.750
22243631,2012-01-13T00:00:00,Cough,C08.618.248
22243631,2012-01-13T00:00:00,Cough,C23.888.852.293
22243631,2012-01-13T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
22243631,2012-01-13T00:00:00,Heartburn,C23.888.821.525
22243631,2012-01-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22243631,2012-01-13T00:00:00,Proton Pump Inhibitors,D27.505.519.389.848
22245304,2012-01-13T00:00:00,Child,M01.060.406
22245304,2012-01-13T00:00:00,"Child, Preschool",M01.060.406.448
22245304,2012-01-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22245304,2012-01-13T00:00:00,Infant,M01.060.703
22245304,2012-01-13T00:00:00,Treatment Outcome,E01.789.800
22245304,2012-01-13T00:00:00,Treatment Outcome,N04.761.559.590.800
22245304,2012-01-13T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22245304,2012-01-13T00:00:00,Urologic Surgical Procedures,E04.950.774
22245304,2012-01-13T00:00:00,Vesico-Ureteral Reflux,C12.777.829.920
22245304,2012-01-13T00:00:00,Vesico-Ureteral Reflux,C13.351.968.829.920
22249024,2012-01-13T00:00:00,Acetylglucosamine,D09.067.342.531.050
22249024,2012-01-13T00:00:00,Fatty Acids,D10.251
22249024,2012-01-13T00:00:00,Heat-Shock Proteins,D12.776.580.216
22249024,2012-01-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22249024,2012-01-13T00:00:00,Mitochondria,A11.284.430.214.190.875.564
22249024,2012-01-13T00:00:00,Mitochondria,A11.284.835.626
22249024,2012-01-13T00:00:00,Protein Kinases,D08.811.913.696.620.682
22249024,2012-01-13T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
22249024,2012-01-13T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
22249024,2012-01-13T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
22249024,2012-01-13T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
22249024,2012-01-13T00:00:00,Transcription Factors,D12.776.930
22244866,2012-01-14T00:00:00,Adult,M01.060.116
22244866,2012-01-14T00:00:00,Aged,M01.060.116.100
22244866,2012-01-14T00:00:00,Colonic Polyps,C23.300.825.411.235
22244866,2012-01-14T00:00:00,Colonoscopy,E01.370.372.250.250.200
22244866,2012-01-14T00:00:00,Colonoscopy,E01.370.388.250.250.250.160
22244866,2012-01-14T00:00:00,Colonoscopy,E04.210.240.250.160
22244866,2012-01-14T00:00:00,Colonoscopy,E04.800.250.250.250.160
22244866,2012-01-14T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
22244866,2012-01-14T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
22244866,2012-01-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22244866,2012-01-14T00:00:00,Middle Aged,M01.060.116.630
22244866,2012-01-14T00:00:00,Pilot Projects,E05.318.760.750
22244866,2012-01-14T00:00:00,Pilot Projects,E05.337.737
22244866,2012-01-14T00:00:00,Pilot Projects,N05.715.360.775.625
22244866,2012-01-14T00:00:00,Pilot Projects,N06.850.520.450.720
22245405,2012-01-14T00:00:00,Anticoagulants,D27.505.954.502.119
22245405,2012-01-14T00:00:00,Cardiology,H02.403.429.163
22245405,2012-01-14T00:00:00,Clinical Competence,I02.399.630.210
22245405,2012-01-14T00:00:00,Clinical Competence,N04.761.210
22245405,2012-01-14T00:00:00,Fellowships and Scholarships,N03.219.483.838.276
22245405,2012-01-14T00:00:00,Heparin,D09.698.373.400
22245405,2012-01-14T00:00:00,"Hospitals, Teaching",N02.278.020.300
22245405,2012-01-14T00:00:00,"Hospitals, Teaching",N02.278.421.639
22245405,2012-01-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22245405,2012-01-14T00:00:00,Length of Stay,E02.760.400.480
22245405,2012-01-14T00:00:00,Length of Stay,N02.421.585.400.480
22245405,2012-01-14T00:00:00,Middle Aged,M01.060.116.630
22245405,2012-01-14T00:00:00,Peptide Fragments,D12.644.541
22245405,2012-01-14T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
22245405,2012-01-14T00:00:00,Recombinant Proteins,D12.776.828
22245405,2012-01-14T00:00:00,South Carolina,Z01.107.567.875.075.662
22245405,2012-01-14T00:00:00,South Carolina,Z01.107.567.875.750.700
22191731,2012-01-17T00:00:00,Adsorption,G02.149.047
22191731,2012-01-17T00:00:00,Adsorption,G02.149.767.029
22191731,2012-01-17T00:00:00,Adsorption,G02.842.750.029
22191731,2012-01-17T00:00:00,Albumins,D12.776.034
22191731,2012-01-17T00:00:00,Blood Platelets,A11.118.188
22191731,2012-01-17T00:00:00,Blood Platelets,A15.145.229.188
22191731,2012-01-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22191731,2012-01-17T00:00:00,Protein Conformation,G02.111.570.790.709
22191731,2012-01-17T00:00:00,Surface Properties,G02.842.850
22191731,2012-01-17T00:00:00,Time Factors,G01.910.857
22249361,2012-01-17T00:00:00,Animals,B01.050
22249361,2012-01-17T00:00:00,"Behavior, Animal",F01.145.113
22249361,2012-01-17T00:00:00,Cocaine,D02.145.074.722.388
22249361,2012-01-17T00:00:00,Cocaine,D03.132.889.354
22249361,2012-01-17T00:00:00,Cocaine,D03.605.869.388
22249361,2012-01-17T00:00:00,Cocaine,D04.075.080.875.099.722.388
22249361,2012-01-17T00:00:00,Cocaine-Related Disorders,C21.739.300
22249361,2012-01-17T00:00:00,Cocaine-Related Disorders,F03.900.300
22249361,2012-01-17T00:00:00,Discrimination Learning,F02.463.425.280
22249361,2012-01-17T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22249361,2012-01-17T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
22249361,2012-01-17T00:00:00,Self Administration,E02.319.890
22249361,2012-01-17T00:00:00,Self Administration,E02.900.890
22249361,2012-01-17T00:00:00,Time Factors,G01.910.857
22249497,2012-01-17T00:00:00,Attitude of Health Personnel,F01.100.050
22249497,2012-01-17T00:00:00,Attitude of Health Personnel,N05.300.100
22249497,2012-01-17T00:00:00,Military Medicine,H02.403.500
22249497,2012-01-17T00:00:00,Physicians,M01.526.485.810
22249497,2012-01-17T00:00:00,Physicians,N02.360.810
22249497,2012-01-17T00:00:00,United States,Z01.107.567.875
22261484,2012-01-18T00:00:00,Child,M01.060.406
22261484,2012-01-18T00:00:00,"Child, Preschool",M01.060.406.448
22261484,2012-01-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22261484,2012-01-18T00:00:00,Incidence,E05.318.308.985.525.375
22261484,2012-01-18T00:00:00,Incidence,L01.280.975.525.375
22261484,2012-01-18T00:00:00,Incidence,N01.224.935.597.500
22261484,2012-01-18T00:00:00,Incidence,N06.850.505.400.975.525.375
22261484,2012-01-18T00:00:00,Incidence,N06.850.520.308.985.525.375
22261484,2012-01-18T00:00:00,Postoperative Complications,C23.550.767
22261484,2012-01-18T00:00:00,Time Factors,G01.910.857
22261484,2012-01-18T00:00:00,Vesico-Ureteral Reflux,C12.777.829.920
22261484,2012-01-18T00:00:00,Vesico-Ureteral Reflux,C13.351.968.829.920
22257306,2012-01-19T00:00:00,Adolescent,M01.060.057
22257306,2012-01-19T00:00:00,Adult,M01.060.116
22257306,2012-01-19T00:00:00,Amphetamine-Related Disorders,C21.739.225
22257306,2012-01-19T00:00:00,Amphetamine-Related Disorders,F03.900.225
22257306,2012-01-19T00:00:00,"Behavior, Addictive",F01.145.527.100.120
22257306,2012-01-19T00:00:00,Cognition Disorders,F03.087.250
22257306,2012-01-19T00:00:00,Cues,F02.463.425.234
22257306,2012-01-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22257306,2012-01-19T00:00:00,Inhibition (Psychology),F01.145.544
22257306,2012-01-19T00:00:00,Inhibition (Psychology),F02.463.425.475
22257306,2012-01-19T00:00:00,Inhibition (Psychology),F02.739.794.405
22257306,2012-01-19T00:00:00,Middle Aged,M01.060.116.630
22257306,2012-01-19T00:00:00,Neuropsychological Tests,F04.711.513
22257306,2012-01-19T00:00:00,Photic Stimulation,E05.723.729
22257306,2012-01-19T00:00:00,Psychomotor Performance,F02.808
22257306,2012-01-19T00:00:00,Psychomotor Performance,G11.427.700
22257306,2012-01-19T00:00:00,Psychomotor Performance,G11.561.623
22257306,2012-01-19T00:00:00,Reaction Time,F02.830.650
22257306,2012-01-19T00:00:00,Reaction Time,F04.669.817
22257306,2012-01-19T00:00:00,Reaction Time,G11.561.677
22261850,2012-01-19T00:00:00,Endoscopy,E01.370.388.250
22261850,2012-01-19T00:00:00,Endoscopy,E04.800.250
22261850,2012-01-19T00:00:00,Face,A01.456.505
22261850,2012-01-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22261850,2012-01-19T00:00:00,Nasal Cavity,A04.531.449
22261850,2012-01-19T00:00:00,Neoplasm Staging,E01.370.550
22261850,2012-01-19T00:00:00,Treatment Outcome,E01.789.800
22261850,2012-01-19T00:00:00,Treatment Outcome,N04.761.559.590.800
22261850,2012-01-19T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22372779,2012-01-19T00:00:00,Antihypertensive Agents,D27.505.954.411.162
22372779,2012-01-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22372779,2012-01-19T00:00:00,Hypertension,C14.907.489
22390523,2012-01-19T00:00:00,Diffusion of Innovation,L01.143.320
22390523,2012-01-19T00:00:00,Electronic Health Records,E05.318.308.940.968.625.500
22390523,2012-01-19T00:00:00,Information Dissemination,F01.145.209.364
22390523,2012-01-19T00:00:00,Information Dissemination,L01.143.443
22390523,2012-01-19T00:00:00,Information Management,L01.399
22390523,2012-01-19T00:00:00,Information Systems,L01.700.508.300
22390523,2012-01-19T00:00:00,Medical Record Linkage,E05.318.308.940.968.500
22390523,2012-01-19T00:00:00,Medical Record Linkage,L01.280.900.968.500
22390523,2012-01-19T00:00:00,Medical Record Linkage,N04.452.859.564.550
22390523,2012-01-19T00:00:00,Medical Record Linkage,N05.715.360.300.715.500.500
22390523,2012-01-19T00:00:00,Medical Record Linkage,N06.850.520.308.940.968.500
22390523,2012-01-19T00:00:00,Population Surveillance,E05.318.308.250.700
22390523,2012-01-19T00:00:00,Population Surveillance,N05.715.360.300.375.625
22390523,2012-01-19T00:00:00,Population Surveillance,N06.850.520.308.250.700
22390523,2012-01-19T00:00:00,Population Surveillance,N06.850.780.675
22390523,2012-01-19T00:00:00,Systems Integration,H01.770.787
22390523,2012-01-19T00:00:00,Systems Integration,L01.906.787
22390523,2012-01-19T00:00:00,United States,Z01.107.567.875
22267220,2012-01-20T00:00:00,Animals,B01.050
22267220,2012-01-20T00:00:00,Apoptosis,G04.299.139.160
22267220,2012-01-20T00:00:00,Fas Ligand Protein,D12.644.276.374.750.249
22267220,2012-01-20T00:00:00,Fas Ligand Protein,D12.644.276.972.249
22267220,2012-01-20T00:00:00,Fas Ligand Protein,D12.776.395.550.312
22267220,2012-01-20T00:00:00,Fas Ligand Protein,D12.776.467.374.750.249
22267220,2012-01-20T00:00:00,Fas Ligand Protein,D12.776.467.972.249
22267220,2012-01-20T00:00:00,Fas Ligand Protein,D12.776.543.550.312
22267220,2012-01-20T00:00:00,Fas Ligand Protein,D23.050.301.264.035.283
22267220,2012-01-20T00:00:00,Fas Ligand Protein,D23.101.100.110.282
22267220,2012-01-20T00:00:00,Fas Ligand Protein,D23.529.374.750.249
22267220,2012-01-20T00:00:00,Fas Ligand Protein,D23.529.972.249
22267220,2012-01-20T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
22267220,2012-01-20T00:00:00,Flow Cytometry,E05.200.500.386.350
22267220,2012-01-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22267734,2012-01-20T00:00:00,Alzheimer Disease,C10.228.140.380.100
22267734,2012-01-20T00:00:00,Alzheimer Disease,C10.574.945.249
22267734,2012-01-20T00:00:00,Alzheimer Disease,F03.087.400.100
22267734,2012-01-20T00:00:00,Amyloid Precursor Protein Secretases,D08.811.277.656.300.032
22267734,2012-01-20T00:00:00,Animals,B01.050
22267734,2012-01-20T00:00:00,Aspartic Acid Endopeptidases,D08.811.277.656.074.500
22267734,2012-01-20T00:00:00,Aspartic Acid Endopeptidases,D08.811.277.656.300.048
22267734,2012-01-20T00:00:00,CHO Cells,A11.251.210.200
22267734,2012-01-20T00:00:00,CHO Cells,A11.436.155
22267734,2012-01-20T00:00:00,Cricetinae,B01.050.150.900.649.865.635.150
22267734,2012-01-20T00:00:00,Enzyme Inhibitors,D27.505.519.389
22267734,2012-01-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22267734,2012-01-20T00:00:00,Neuroglia,A08.637
22267734,2012-01-20T00:00:00,Neuroglia,A11.650
22267734,2012-01-20T00:00:00,Neurons,A08.663
22267734,2012-01-20T00:00:00,Neurons,A11.671
22267734,2012-01-20T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22267751,2012-01-20T00:00:00,Aged,M01.060.116.100
22267751,2012-01-20T00:00:00,Angiotensin II,D06.472.699.094.078
22267751,2012-01-20T00:00:00,Angiotensin II,D12.644.400.070.078
22267751,2012-01-20T00:00:00,Angiotensin II,D12.644.456.073.041
22267751,2012-01-20T00:00:00,Angiotensin II,D12.644.548.058.078
22267751,2012-01-20T00:00:00,Angiotensin II,D12.776.641.650.070.078
22267751,2012-01-20T00:00:00,Angiotensin II,D23.469.050.050.050
22267751,2012-01-20T00:00:00,Biphenyl Compounds,D02.455.426.559.389.185
22267751,2012-01-20T00:00:00,Heart Failure,C14.280.434
22267751,2012-01-20T00:00:00,Hospital Mortality,E05.318.308.985.550.400
22267751,2012-01-20T00:00:00,Hospital Mortality,L01.280.975.550.400
22267751,2012-01-20T00:00:00,Hospital Mortality,N01.224.935.698.400
22267751,2012-01-20T00:00:00,Hospital Mortality,N06.850.505.400.975.550.400
22267751,2012-01-20T00:00:00,Hospital Mortality,N06.850.520.308.985.550.400
22267751,2012-01-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22267751,2012-01-20T00:00:00,Questionnaires,E05.318.308.750
22267751,2012-01-20T00:00:00,Questionnaires,L01.280.800
22267751,2012-01-20T00:00:00,Questionnaires,N05.715.360.300.695
22267751,2012-01-20T00:00:00,Questionnaires,N06.850.520.308.750
22267751,2012-01-20T00:00:00,Stroke Volume,E01.370.370.380.150.700
22267751,2012-01-20T00:00:00,Stroke Volume,G09.330.380.124.882
22267751,2012-01-20T00:00:00,Time Factors,G01.910.857
22267751,2012-01-20T00:00:00,Treatment Outcome,E01.789.800
22267751,2012-01-20T00:00:00,Treatment Outcome,N04.761.559.590.800
22267751,2012-01-20T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22267751,2012-01-20T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
22267855,2012-01-20T00:00:00,Adolescent,M01.060.057
22267855,2012-01-20T00:00:00,Age Factors,N05.715.350.075
22267855,2012-01-20T00:00:00,Age Factors,N06.850.490.250
22267855,2012-01-20T00:00:00,Child,M01.060.406
22267855,2012-01-20T00:00:00,"Child, Preschool",M01.060.406.448
22267855,2012-01-20T00:00:00,Hospitalization,E02.760.400
22267855,2012-01-20T00:00:00,Hospitalization,N02.421.585.400
22267855,2012-01-20T00:00:00,"Hospitals, Pediatric",N02.278.421.556.437
22267855,2012-01-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22267855,2012-01-20T00:00:00,Infant,M01.060.703
22267855,2012-01-20T00:00:00,"Infant, Newborn",M01.060.703.520
22267855,2012-01-20T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
22267855,2012-01-20T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
22267855,2012-01-20T00:00:00,Time Factors,G01.910.857
22268218,2012-01-21T00:00:00,Community Networks,I01.880.656.300
22268218,2012-01-21T00:00:00,Community Networks,L01.700.508.300.184
22268218,2012-01-21T00:00:00,Community Networks,N02.421.143.202
22268218,2012-01-21T00:00:00,Health Policy,I01.880.604.825.608.400
22268218,2012-01-21T00:00:00,Health Policy,N03.706.825.608.428
22268218,2012-01-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22268218,2012-01-21T00:00:00,"Models, Organizational",E05.599.670
22268218,2012-01-21T00:00:00,"Models, Organizational",N04.452.534
22268218,2012-01-21T00:00:00,Private Sector,I01.791
22268218,2012-01-21T00:00:00,Private Sector,N04.452.633.390
22268218,2012-01-21T00:00:00,Systems Integration,H01.770.787
22268218,2012-01-21T00:00:00,Systems Integration,L01.906.787
22268218,2012-01-21T00:00:00,United States,Z01.107.567.875
22266543,2012-01-22T00:00:00,Animals,B01.050
22266543,2012-01-22T00:00:00,Brain,A08.186.211
22266543,2012-01-22T00:00:00,Fluorescent Dyes,D27.720.233.348
22266543,2012-01-22T00:00:00,Fluorescent Dyes,D27.720.470.330.348
22266543,2012-01-22T00:00:00,Fluorescent Dyes,D27.720.470.410.505.500
22266543,2012-01-22T00:00:00,"Microscopy, Fluorescence, Multiphoton",E01.370.350.515.458.500
22266543,2012-01-22T00:00:00,"Microscopy, Fluorescence, Multiphoton",E05.595.458.500
22266543,2012-01-22T00:00:00,Neurons,A08.663
22266543,2012-01-22T00:00:00,Neurons,A11.671
22266543,2012-01-22T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22296815,2012-01-24T00:00:00,Alcoholism,C21.739.100.250
22296815,2012-01-24T00:00:00,Alcoholism,F03.900.100.350
22296815,2012-01-24T00:00:00,Amygdala,A08.186.211.464.090
22296815,2012-01-24T00:00:00,Amygdala,A08.186.211.730.885.287.249.152
22296815,2012-01-24T00:00:00,Animals,B01.050
22296815,2012-01-24T00:00:00,"Behavior, Animal",F01.145.113
22296815,2012-01-24T00:00:00,Cues,F02.463.425.234
22296815,2012-01-24T00:00:00,"Disease Models, Animal",C22.232
22296815,2012-01-24T00:00:00,"Disease Models, Animal",E05.598.500
22296815,2012-01-24T00:00:00,"Disease Models, Animal",E05.599.395.080
22296815,2012-01-24T00:00:00,Ethanol,D02.033.375
22296815,2012-01-24T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
22296815,2012-01-24T00:00:00,Pyridines,D03.383.725
22296815,2012-01-24T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22296815,2012-01-24T00:00:00,"Receptors, Metabotropic Glutamate",D12.776.543.750.100.450
22296815,2012-01-24T00:00:00,"Receptors, Metabotropic Glutamate",D12.776.543.750.720.200.450.500
22296815,2012-01-24T00:00:00,Self Administration,E02.319.890
22296815,2012-01-24T00:00:00,Self Administration,E02.900.890
22296815,2012-01-24T00:00:00,Thiazoles,D02.886.675
22296815,2012-01-24T00:00:00,Thiazoles,D03.383.129.708
22220628,2012-01-25T00:00:00,Apoptosis,G04.299.139.160
22220628,2012-01-25T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
22220628,2012-01-25T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
22220628,2012-01-25T00:00:00,Cell Survival,G04.299.316
22220628,2012-01-25T00:00:00,Enzyme Inhibitors,D27.505.519.389
22220628,2012-01-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22220628,2012-01-25T00:00:00,Iron,D01.268.556.412
22220628,2012-01-25T00:00:00,Iron,D01.268.956.287
22220628,2012-01-25T00:00:00,Iron,D01.552.544.412
22220628,2012-01-25T00:00:00,Light,G01.201.875.770.578
22220628,2012-01-25T00:00:00,Light,G01.590.540
22220628,2012-01-25T00:00:00,Lysosomes,A11.284.430.214.190.875.190.550
22220628,2012-01-25T00:00:00,Macrolides,D02.540.505
22220628,2012-01-25T00:00:00,Macrolides,D04.345.349
22220628,2012-01-25T00:00:00,Macrolides,D09.408.477
22220628,2012-01-25T00:00:00,Mitochondria,A11.284.430.214.190.875.564
22220628,2012-01-25T00:00:00,Mitochondria,A11.284.835.626
22220628,2012-01-25T00:00:00,Photochemotherapy,E02.186.500
22220628,2012-01-25T00:00:00,Photochemotherapy,E02.319.685
22220628,2012-01-25T00:00:00,Photochemotherapy,E02.774.722
22220628,2012-01-25T00:00:00,Photosensitizing Agents,D27.505.696.750.710
22220628,2012-01-25T00:00:00,Photosensitizing Agents,D27.505.954.444.600
22220628,2012-01-25T00:00:00,Signal Transduction,G02.111.087.800
22220628,2012-01-25T00:00:00,Signal Transduction,G02.149.115.800
22220628,2012-01-25T00:00:00,Signal Transduction,G04.299.880
22277656,2012-01-25T00:00:00,"Feedback, Physiological",G07.700.360.732
22277656,2012-01-25T00:00:00,"Feedback, Physiological",L01.143.283.425.311
22277656,2012-01-25T00:00:00,Saccharomyces cerevisiae,B01.300.107.795.785.800
22277656,2012-01-25T00:00:00,Saccharomyces cerevisiae,B01.300.930.705.655
22277656,2012-01-25T00:00:00,Saccharomyces cerevisiae Proteins,D12.776.354.750
22277656,2012-01-25T00:00:00,Serine,D12.125.154.800
22277656,2012-01-25T00:00:00,Serine,D12.125.837
22277656,2012-01-25T00:00:00,Sphingolipids,D10.570.877
22277656,2012-01-25T00:00:00,Sphingolipids,D10.808
22282541,2012-01-25T00:00:00,African Americans,M01.686.508.100.100
22282541,2012-01-25T00:00:00,African Americans,M01.686.754.100
22282541,2012-01-25T00:00:00,Counseling,F02.784.176
22282541,2012-01-25T00:00:00,Counseling,F04.408.413
22282541,2012-01-25T00:00:00,Counseling,N02.421.143.303
22282541,2012-01-25T00:00:00,Counseling,N02.421.461.363
22282541,2012-01-25T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.150.800
22282541,2012-01-25T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.600.220
22282541,2012-01-25T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.150.800
22282541,2012-01-25T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.600.220
22282541,2012-01-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22282541,2012-01-25T00:00:00,Smoking,F01.145.466.753
22282541,2012-01-25T00:00:00,Smoking Cessation,F01.145.940.700
22386053,2012-01-25T00:00:00,Adult,M01.060.116
22386053,2012-01-25T00:00:00,Body Mass Index,E01.370.600.115.100.125
22386053,2012-01-25T00:00:00,Body Mass Index,E05.041.124.125
22386053,2012-01-25T00:00:00,Body Mass Index,G07.100.100.125
22386053,2012-01-25T00:00:00,Body Mass Index,N06.850.505.200.100.175
22386053,2012-01-25T00:00:00,Case-Control Studies,E05.318.760.500.500
22386053,2012-01-25T00:00:00,Case-Control Studies,N05.715.360.775.175.200
22386053,2012-01-25T00:00:00,Case-Control Studies,N06.850.520.450.500.500
22386053,2012-01-25T00:00:00,Gastric Bypass,E02.065.062.249
22386053,2012-01-25T00:00:00,Gastric Bypass,E04.035.398.385
22386053,2012-01-25T00:00:00,Gastric Bypass,E04.062.249
22386053,2012-01-25T00:00:00,Gastric Bypass,E04.210.457.430
22386053,2012-01-25T00:00:00,Health Status,I01.240.425
22386053,2012-01-25T00:00:00,Health Status,N01.224.425
22386053,2012-01-25T00:00:00,Health Status,N06.850.505.400.425
22386053,2012-01-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22386053,2012-01-25T00:00:00,"Obesity, Morbid",C18.654.726.500.700
22386053,2012-01-25T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
22386053,2012-01-25T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
22386053,2012-01-25T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
22386053,2012-01-25T00:00:00,Quality of Life,I01.800
22386053,2012-01-25T00:00:00,Quality of Life,K01.752.400.750
22386053,2012-01-25T00:00:00,Questionnaires,E05.318.308.750
22386053,2012-01-25T00:00:00,Questionnaires,L01.280.800
22386053,2012-01-25T00:00:00,Questionnaires,N05.715.360.300.695
22386053,2012-01-25T00:00:00,Questionnaires,N06.850.520.308.750
22386053,2012-01-25T00:00:00,Time Factors,G01.910.857
22386053,2012-01-25T00:00:00,Weight Loss,C23.888.144.243.963
22386053,2012-01-25T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
22390584,2012-01-25T00:00:00,Adult,M01.060.116
22390584,2012-01-25T00:00:00,Aged,M01.060.116.100
22390584,2012-01-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22390584,2012-01-25T00:00:00,Mental Disorders,F03
22390584,2012-01-25T00:00:00,Middle Aged,M01.060.116.630
22390584,2012-01-25T00:00:00,Pain,C10.597.617
22390584,2012-01-25T00:00:00,Pain,C23.888.592.612
22390584,2012-01-25T00:00:00,Pain,C23.888.646
22390584,2012-01-25T00:00:00,Pain,F02.830.816.444
22390584,2012-01-25T00:00:00,Pain,G11.561.600.810.444
22390584,2012-01-25T00:00:00,Pain Measurement,E01.370.376.550.600
22390584,2012-01-25T00:00:00,Primary Health Care,N04.590.233.727
22390584,2012-01-25T00:00:00,Psychometrics,F04.711.780
22390584,2012-01-25T00:00:00,Risk Factors,E05.318.740.600.800.725
22390584,2012-01-25T00:00:00,Risk Factors,N05.715.350.200.700
22390584,2012-01-25T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22390584,2012-01-25T00:00:00,Risk Factors,N06.850.490.625.750
22390584,2012-01-25T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22390584,2012-01-25T00:00:00,Veterans,M01.930
22282888,2012-01-26T00:00:00,Aged,M01.060.116.100
22282888,2012-01-26T00:00:00,"Databases, Factual",L01.470.750.750
22282888,2012-01-26T00:00:00,"Databases, Factual",L01.700.508.300.188.400
22282888,2012-01-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22282888,2012-01-26T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
22282888,2012-01-26T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
22282888,2012-01-26T00:00:00,Middle Aged,M01.060.116.630
22282888,2012-01-26T00:00:00,Regression Analysis,E05.318.740.750
22282888,2012-01-26T00:00:00,Regression Analysis,N05.715.360.750.695
22282888,2012-01-26T00:00:00,Regression Analysis,N06.850.520.830.750
22282888,2012-01-26T00:00:00,Thrombectomy,E04.100.814.842
22282888,2012-01-26T00:00:00,Thrombosis,C14.907.355.830
22282888,2012-01-26T00:00:00,Treatment Outcome,E01.789.800
22282888,2012-01-26T00:00:00,Treatment Outcome,N04.761.559.590.800
22282888,2012-01-26T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22285578,2012-01-26T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
22285578,2012-01-26T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
22285578,2012-01-26T00:00:00,"Defibrillators, Implantable",E07.695.175
22285578,2012-01-26T00:00:00,Double-Blind Method,E05.318.780.300
22285578,2012-01-26T00:00:00,Double-Blind Method,E05.581.500.300
22285578,2012-01-26T00:00:00,Double-Blind Method,N05.715.360.780.320
22285578,2012-01-26T00:00:00,Double-Blind Method,N06.850.520.445.300
22285578,2012-01-26T00:00:00,Heart Failure,C14.280.434
22285578,2012-01-26T00:00:00,Heart Ventricles,A07.541.560
22285578,2012-01-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22285578,2012-01-26T00:00:00,Middle Aged,M01.060.116.630
22285578,2012-01-26T00:00:00,Prosthesis Implantation,E04.650
22285578,2012-01-26T00:00:00,Treatment Outcome,E01.789.800
22285578,2012-01-26T00:00:00,Treatment Outcome,N04.761.559.590.800
22285578,2012-01-26T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22281865,2012-01-27T00:00:00,Adolescent,M01.060.057
22281865,2012-01-27T00:00:00,Adult,M01.060.116
22281865,2012-01-27T00:00:00,Aged,M01.060.116.100
22281865,2012-01-27T00:00:00,Antiviral Agents,D27.505.954.122.388
22281865,2012-01-27T00:00:00,Child,M01.060.406
22281865,2012-01-27T00:00:00,Herpes Simplex,C02.256.466.382
22281865,2012-01-27T00:00:00,Herpes Simplex,C02.825.320
22281865,2012-01-27T00:00:00,Herpes Simplex,C17.800.838.790.320
22281865,2012-01-27T00:00:00,Herpes Zoster,C02.256.466.423
22281865,2012-01-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22281865,2012-01-27T00:00:00,Incidence,E05.318.308.985.525.375
22281865,2012-01-27T00:00:00,Incidence,L01.280.975.525.375
22281865,2012-01-27T00:00:00,Incidence,N01.224.935.597.500
22281865,2012-01-27T00:00:00,Incidence,N06.850.505.400.975.525.375
22281865,2012-01-27T00:00:00,Incidence,N06.850.520.308.985.525.375
22281865,2012-01-27T00:00:00,Middle Aged,M01.060.116.630
22281865,2012-01-27T00:00:00,Population Surveillance,E05.318.308.250.700
22281865,2012-01-27T00:00:00,Population Surveillance,N05.715.360.300.375.625
22281865,2012-01-27T00:00:00,Population Surveillance,N06.850.520.308.250.700
22281865,2012-01-27T00:00:00,Population Surveillance,N06.850.780.675
22281865,2012-01-27T00:00:00,Visual Acuity,E01.370.380.850.950
22281865,2012-01-27T00:00:00,Visual Acuity,F02.463.593.932.901
22281865,2012-01-27T00:00:00,Visual Acuity,G14.940
22281865,2012-01-27T00:00:00,Young Adult,M01.060.116.815
22287584,2012-01-27T00:00:00,Animals,B01.050
22287584,2012-01-27T00:00:00,Aortic Diseases,C14.907.109
22287584,2012-01-27T00:00:00,Blood Pressure,E01.370.600.875.249
22287584,2012-01-27T00:00:00,Blood Pressure,G09.330.380.076
22287584,2012-01-27T00:00:00,Collagen,D05.750.078.280
22287584,2012-01-27T00:00:00,Collagen,D12.776.860.300.250
22287584,2012-01-27T00:00:00,Echocardiography,E01.370.350.850.220
22287584,2012-01-27T00:00:00,Echocardiography,E01.370.370.380.220
22287584,2012-01-27T00:00:00,Extracellular Matrix,A11.284.295.310
22287584,2012-01-27T00:00:00,Fibrosis,C23.550.355
22287584,2012-01-27T00:00:00,Hemodynamics,G09.330.190.400
22287584,2012-01-27T00:00:00,Hemodynamics,G09.330.380
22287584,2012-01-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22287584,2012-01-27T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.300.480.205.351
22287584,2012-01-27T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.300.480.525.700.100
22287584,2012-01-27T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.675.374.205.351
22287584,2012-01-27T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.675.374.525.700.100
22287584,2012-01-27T00:00:00,Myocardium,A02.633.580
22287584,2012-01-27T00:00:00,Myocardium,A07.541.704
22287584,2012-01-27T00:00:00,Myocardium,A10.690.552.750
22287584,2012-01-27T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
22287584,2012-01-27T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
22287584,2012-01-27T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
22287584,2012-01-27T00:00:00,RNA,D13.444.735
22287584,2012-01-27T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
22287584,2012-01-27T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
22287584,2012-01-27T00:00:00,Ventricular Remodeling,C23.300.985
22287584,2012-01-27T00:00:00,Ventricular Remodeling,G09.330.190.962.975
22287723,2012-01-27T00:00:00,Catheterization,E02.148
22287723,2012-01-27T00:00:00,Catheterization,E05.157
22287723,2012-01-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22287723,2012-01-27T00:00:00,Intracranial Aneurysm,C10.228.140.300.510.600
22287723,2012-01-27T00:00:00,Intracranial Aneurysm,C14.907.055.635
22287723,2012-01-27T00:00:00,Intracranial Aneurysm,C14.907.253.560.300
22287723,2012-01-27T00:00:00,Stents,E07.695.750
22287723,2012-01-27T00:00:00,Treatment Outcome,E01.789.800
22287723,2012-01-27T00:00:00,Treatment Outcome,N04.761.559.590.800
22287723,2012-01-27T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22286530,2012-01-28T00:00:00,Adolescent,M01.060.057
22286530,2012-01-28T00:00:00,Adult,M01.060.116
22286530,2012-01-28T00:00:00,European Continental Ancestry Group,M01.686.508.400
22286530,2012-01-28T00:00:00,Health Behavior,F01.145.488
22286530,2012-01-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22286530,2012-01-28T00:00:00,Mental Disorders,F03
22286530,2012-01-28T00:00:00,Middle Aged,M01.060.116.630
22286530,2012-01-28T00:00:00,Obesity,C18.654.726.500
22286530,2012-01-28T00:00:00,Obesity,C23.888.144.699.500
22286530,2012-01-28T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
22286530,2012-01-28T00:00:00,Obesity,G07.100.100.160.120.699.500
22286530,2012-01-28T00:00:00,Population Surveillance,E05.318.308.250.700
22286530,2012-01-28T00:00:00,Population Surveillance,N05.715.360.300.375.625
22286530,2012-01-28T00:00:00,Population Surveillance,N06.850.520.308.250.700
22286530,2012-01-28T00:00:00,Population Surveillance,N06.850.780.675
22286530,2012-01-28T00:00:00,Rural Population,N01.600.725
22286530,2012-01-28T00:00:00,Substance-Related Disorders,C21.739
22286530,2012-01-28T00:00:00,Substance-Related Disorders,F03.900
22286530,2012-01-28T00:00:00,Young Adult,M01.060.116.815
22290860,2012-01-30T00:00:00,Adolescent,M01.060.057
22290860,2012-01-30T00:00:00,Aging,G07.700.320.124
22290860,2012-01-30T00:00:00,Attitude to Health,F01.100.150
22290860,2012-01-30T00:00:00,Attitude to Health,N05.300.150
22290860,2012-01-30T00:00:00,Child,M01.060.406
22290860,2012-01-30T00:00:00,Depression,F01.145.126.350
22290860,2012-01-30T00:00:00,Epilepsy,C10.228.140.490
22290860,2012-01-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22290860,2012-01-30T00:00:00,Psychiatric Status Rating Scales,F04.586
22290860,2012-01-30T00:00:00,Questionnaires,E05.318.308.750
22290860,2012-01-30T00:00:00,Questionnaires,L01.280.800
22290860,2012-01-30T00:00:00,Questionnaires,N05.715.360.300.695
22290860,2012-01-30T00:00:00,Questionnaires,N06.850.520.308.750
22290860,2012-01-30T00:00:00,Rheumatic Diseases,C05.799
22290860,2012-01-30T00:00:00,Rheumatic Diseases,C17.300.775
22290860,2012-01-30T00:00:00,Young Adult,M01.060.116.815
22292567,2012-01-31T00:00:00,Adolescent,M01.060.057
22292567,2012-01-31T00:00:00,Adult,M01.060.116
22292567,2012-01-31T00:00:00,Aged,M01.060.116.100
22292567,2012-01-31T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
22292567,2012-01-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22292567,2012-01-31T00:00:00,Middle Aged,M01.060.116.630
22292567,2012-01-31T00:00:00,Posture,G11.427.695
22292567,2012-01-31T00:00:00,Proton Pump Inhibitors,D27.505.519.389.848
22292567,2012-01-31T00:00:00,Young Adult,M01.060.116.815
22293439,2012-01-31T00:00:00,Alligators and Crocodiles,B01.050.150.900.833.100
22293439,2012-01-31T00:00:00,Animals,B01.050
22293439,2012-01-31T00:00:00,Genome,G05.360.340
22293439,2012-01-31T00:00:00,"Sequence Analysis, DNA",E05.393.760.700
22294294,2012-01-31T00:00:00,African Continental Ancestry Group,M01.686.508.100
22294294,2012-01-31T00:00:00,Ethnic Groups,M01.686.754
22294294,2012-01-31T00:00:00,Ethnic Groups,N01.224.317
22294294,2012-01-31T00:00:00,European Continental Ancestry Group,M01.686.508.400
22294294,2012-01-31T00:00:00,Health Services Accessibility,N04.590.374.350
22294294,2012-01-31T00:00:00,Health Services Accessibility,N05.300.430
22294294,2012-01-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22294294,2012-01-31T00:00:00,Incidence,E05.318.308.985.525.375
22294294,2012-01-31T00:00:00,Incidence,L01.280.975.525.375
22294294,2012-01-31T00:00:00,Incidence,N01.224.935.597.500
22294294,2012-01-31T00:00:00,Incidence,N06.850.505.400.975.525.375
22294294,2012-01-31T00:00:00,Incidence,N06.850.520.308.985.525.375
22294294,2012-01-31T00:00:00,Neoplasms,C04
22294688,2012-01-31T00:00:00,Animals,B01.050
22294688,2012-01-31T00:00:00,Cell Cycle Proteins,D12.776.167
22294688,2012-01-31T00:00:00,Down-Regulation,G02.111.087.225
22294688,2012-01-31T00:00:00,Down-Regulation,G02.149.115.225
22294688,2012-01-31T00:00:00,Down-Regulation,G05.355.315.200
22294688,2012-01-31T00:00:00,Down-Regulation,G07.690.812.230
22294688,2012-01-31T00:00:00,Down-Regulation,G07.700.680.230
22294688,2012-01-31T00:00:00,Endothelial Cells,A11.436.275
22294688,2012-01-31T00:00:00,Endothelin-1,D12.644.276.400.225
22294688,2012-01-31T00:00:00,Endothelin-1,D12.776.467.400.225
22294688,2012-01-31T00:00:00,Endothelin-1,D23.529.400.225
22294688,2012-01-31T00:00:00,Gene Expression,G05.355.310
22294688,2012-01-31T00:00:00,Hepatic Veins,A07.231.908.380
22294688,2012-01-31T00:00:00,Homeostasis,G07.700.360
22294688,2012-01-31T00:00:00,"Hypertension, Portal",C06.552.494
22294688,2012-01-31T00:00:00,Liver,A03.620
22294688,2012-01-31T00:00:00,Nitric Oxide,D01.339.387
22294688,2012-01-31T00:00:00,Nitric Oxide,D01.625.550.500
22294688,2012-01-31T00:00:00,Nitric Oxide,D01.625.700.500
22294688,2012-01-31T00:00:00,Nitric Oxide,D01.650.550.587.600
22294688,2012-01-31T00:00:00,Nitric Oxide Synthase Type III,D08.811.682.664.500.772.750
22294688,2012-01-31T00:00:00,Phosphoproteins,D12.776.744
22294688,2012-01-31T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
22294688,2012-01-31T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
22294688,2012-01-31T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
22294688,2012-01-31T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22294688,2012-01-31T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
22294688,2012-01-31T00:00:00,Signal Transduction,G02.111.087.800
22294688,2012-01-31T00:00:00,Signal Transduction,G02.149.115.800
22294688,2012-01-31T00:00:00,Signal Transduction,G04.299.880
22297151,2012-01-31T00:00:00,Antisocial Personality Disorder,F03.675.050
22297151,2012-01-31T00:00:00,Case-Control Studies,E05.318.760.500.500
22297151,2012-01-31T00:00:00,Case-Control Studies,N05.715.360.775.175.200
22297151,2012-01-31T00:00:00,Case-Control Studies,N06.850.520.450.500.500
22297151,2012-01-31T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
22297151,2012-01-31T00:00:00,Genetic Predisposition to Disease,G05.380.355
22297151,2012-01-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22297151,2012-01-31T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
22297151,2012-01-31T00:00:00,Substance-Related Disorders,C21.739
22297151,2012-01-31T00:00:00,Substance-Related Disorders,F03.900
21274742,2012-02-01T00:00:00,Animals,B01.050
21274742,2012-02-01T00:00:00,"Disease Models, Animal",C22.232
21274742,2012-02-01T00:00:00,"Disease Models, Animal",E05.598.500
21274742,2012-02-01T00:00:00,"Disease Models, Animal",E05.599.395.080
21274742,2012-02-01T00:00:00,Endotoxemia,C01.539.757.100.275
21274742,2012-02-01T00:00:00,Endotoxemia,C01.539.861.375
21274742,2012-02-01T00:00:00,Endotoxemia,C23.550.470.790.500.100.275
21274742,2012-02-01T00:00:00,Interleukin-10,D12.644.276.374.465.510
21274742,2012-02-01T00:00:00,Interleukin-10,D12.776.467.374.465.510
21274742,2012-02-01T00:00:00,Interleukin-10,D23.529.374.465.510
21274742,2012-02-01T00:00:00,Interleukin-6,D12.644.276.374.465.506
21274742,2012-02-01T00:00:00,Interleukin-6,D12.776.467.374.465.506
21274742,2012-02-01T00:00:00,Interleukin-6,D23.529.374.465.506
21274742,2012-02-01T00:00:00,Lipopolysaccharides,D09.400.500
21274742,2012-02-01T00:00:00,Lipopolysaccharides,D09.698.718.450
21274742,2012-02-01T00:00:00,Lipopolysaccharides,D10.494
21274742,2012-02-01T00:00:00,Lipopolysaccharides,D23.050.161.616.525
21274742,2012-02-01T00:00:00,Lipopolysaccharides,D23.946.123.329.500
21274742,2012-02-01T00:00:00,Macrophages,A11.329.372
21274742,2012-02-01T00:00:00,Macrophages,A11.627.482
21274742,2012-02-01T00:00:00,Macrophages,A11.733.397
21274742,2012-02-01T00:00:00,Macrophages,A15.382.680.397
21274742,2012-02-01T00:00:00,Macrophages,A15.382.812.522
21274742,2012-02-01T00:00:00,Multiple Organ Failure,C23.550.835.525
21274742,2012-02-01T00:00:00,Sepsis,C01.539.757
21274742,2012-02-01T00:00:00,Sepsis,C23.550.470.790.500
21274742,2012-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
21274742,2012-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
21274742,2012-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
21274742,2012-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
21274742,2012-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
21274742,2012-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
21274742,2012-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
21274742,2012-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
21274742,2012-02-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
21274742,2012-02-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
21274742,2012-02-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
21430548,2012-02-01T00:00:00,Adult,M01.060.116
21430548,2012-02-01T00:00:00,Coronary Angiography,E01.370.350.700.060.200
21430548,2012-02-01T00:00:00,Coronary Angiography,E01.370.370.050.200
21430548,2012-02-01T00:00:00,Coronary Angiography,E01.370.370.380.200
21430548,2012-02-01T00:00:00,Coronary Vessel Anomalies,C14.240.400.210
21430548,2012-02-01T00:00:00,Coronary Vessel Anomalies,C14.280.400.210
21430548,2012-02-01T00:00:00,Coronary Vessel Anomalies,C16.131.240.400.210
21430548,2012-02-01T00:00:00,Echocardiography,E01.370.350.850.220
21430548,2012-02-01T00:00:00,Echocardiography,E01.370.370.380.220
21430548,2012-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21430548,2012-02-01T00:00:00,Pulmonary Artery,A07.231.114.715
21430548,2012-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
21430548,2012-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
21430548,2012-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
21430548,2012-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
21430548,2012-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
21643822,2012-02-01T00:00:00,Diet,E05.272
21643822,2012-02-01T00:00:00,Diet,G07.610.240
21643822,2012-02-01T00:00:00,Health Promotion,N02.370
21643822,2012-02-01T00:00:00,Health Promotion,N02.421.726.507
21643822,2012-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21643822,2012-02-01T00:00:00,South Carolina,Z01.107.567.875.075.662
21643822,2012-02-01T00:00:00,South Carolina,Z01.107.567.875.750.700
21792753,2012-02-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
21792753,2012-02-01T00:00:00,Clinical Trials as Topic,E05.337.250
21792753,2012-02-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
21792753,2012-02-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
21792753,2012-02-01T00:00:00,Critical Care,E02.760.190
21792753,2012-02-01T00:00:00,Critical Care,N02.421.585.190
21792753,2012-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21792753,2012-02-01T00:00:00,Research Design,E05.581.500
21792753,2012-02-01T00:00:00,Research Design,H01.770.644.728
21841517,2012-02-01T00:00:00,Aged,M01.060.116.100
21841517,2012-02-01T00:00:00,Brain Ischemia,C10.228.140.300.150
21841517,2012-02-01T00:00:00,Brain Ischemia,C14.907.253.092
21841517,2012-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21841517,2012-02-01T00:00:00,Middle Aged,M01.060.116.630
21841517,2012-02-01T00:00:00,Stroke,C10.228.140.300.775
21841517,2012-02-01T00:00:00,Stroke,C14.907.253.855
21841517,2012-02-01T00:00:00,Thrombectomy,E04.100.814.842
21845451,2012-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21845451,2012-02-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
21845451,2012-02-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
21845451,2012-02-01T00:00:00,Polyneuropathies,C10.668.829.800
21845451,2012-02-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
21845451,2012-02-01T00:00:00,Risk Assessment,N04.452.871.715
21845451,2012-02-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
21845451,2012-02-01T00:00:00,Risk Assessment,N06.850.505.715
21845451,2012-02-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
21845451,2012-02-01T00:00:00,Risk Factors,E05.318.740.600.800.725
21845451,2012-02-01T00:00:00,Risk Factors,N05.715.350.200.700
21845451,2012-02-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
21845451,2012-02-01T00:00:00,Risk Factors,N06.850.490.625.750
21845451,2012-02-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
21845451,2012-02-01T00:00:00,Ventilator Weaning,E02.880.820.950
21952918,2012-02-01T00:00:00,Adult,M01.060.116
21952918,2012-02-01T00:00:00,Alleles,G05.360.340.024.340.030
21952918,2012-02-01T00:00:00,"Epistasis, Genetic",G05.355.315.207
21952918,2012-02-01T00:00:00,Genetic Loci,G05.360.340.024.380
21952918,2012-02-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
21952918,2012-02-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
21952918,2012-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21952918,2012-02-01T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
21952918,2012-02-01T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
21952918,2012-02-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
22002804,2012-02-01T00:00:00,Anxiety,F01.470.132
22002804,2012-02-01T00:00:00,Depression,F01.145.126.350
22002804,2012-02-01T00:00:00,Diabetes Mellitus,C18.452.394.750
22002804,2012-02-01T00:00:00,Diabetes Mellitus,C19.246
22002804,2012-02-01T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
22002804,2012-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22002804,2012-02-01T00:00:00,Incidence,E05.318.308.985.525.375
22002804,2012-02-01T00:00:00,Incidence,L01.280.975.525.375
22002804,2012-02-01T00:00:00,Incidence,N01.224.935.597.500
22002804,2012-02-01T00:00:00,Incidence,N06.850.505.400.975.525.375
22002804,2012-02-01T00:00:00,Incidence,N06.850.520.308.985.525.375
22002804,2012-02-01T00:00:00,International Classification of Diseases,L01.453.245.945.400
22002804,2012-02-01T00:00:00,Mental Disorders,F03
22002804,2012-02-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
22002804,2012-02-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
22002804,2012-02-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
22002804,2012-02-01T00:00:00,"Stress, Psychological",F01.145.126.990
22002804,2012-02-01T00:00:00,"Stress, Psychological",F02.830.900
22006725,2012-02-01T00:00:00,Diphosphonates,D02.705.206
22006725,2012-02-01T00:00:00,"Fractures, Bone",C21.866.404
22006725,2012-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22006725,2012-02-01T00:00:00,Middle Aged,M01.060.116.630
22038571,2012-02-01T00:00:00,Adult,M01.060.116
22038571,2012-02-01T00:00:00,Bariatric Surgery,E02.065.062
22038571,2012-02-01T00:00:00,Bariatric Surgery,E04.062
22038571,2012-02-01T00:00:00,Evidence-Based Medicine,H02.249.750
22038571,2012-02-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
22038571,2012-02-01T00:00:00,Exercise,G11.427.590.237
22038571,2012-02-01T00:00:00,Exercise,I03.350
22038571,2012-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22038571,2012-02-01T00:00:00,Middle Aged,M01.060.116.630
22038571,2012-02-01T00:00:00,"Obesity, Morbid",C18.654.726.500.700
22038571,2012-02-01T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
22038571,2012-02-01T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
22038571,2012-02-01T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
22038571,2012-02-01T00:00:00,Questionnaires,E05.318.308.750
22038571,2012-02-01T00:00:00,Questionnaires,L01.280.800
22038571,2012-02-01T00:00:00,Questionnaires,N05.715.360.300.695
22038571,2012-02-01T00:00:00,Questionnaires,N06.850.520.308.750
22038571,2012-02-01T00:00:00,Treatment Outcome,E01.789.800
22038571,2012-02-01T00:00:00,Treatment Outcome,N04.761.559.590.800
22038571,2012-02-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22038571,2012-02-01T00:00:00,Weight Loss,C23.888.144.243.963
22038571,2012-02-01T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
22104428,2012-02-01T00:00:00,Aged,M01.060.116.100
22104428,2012-02-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
22104428,2012-02-01T00:00:00,Autoimmune Diseases,C20.111
22104428,2012-02-01T00:00:00,Extravasation of Diagnostic and Therapeutic Materials,C21.866.371
22104428,2012-02-01T00:00:00,Extravasation of Diagnostic and Therapeutic Materials,C23.550.340
22104428,2012-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22104428,2012-02-01T00:00:00,"Skin Diseases, Vesiculobullous",C17.800.865
22104428,2012-02-01T00:00:00,South Carolina,Z01.107.567.875.075.662
22104428,2012-02-01T00:00:00,South Carolina,Z01.107.567.875.750.700
22104428,2012-02-01T00:00:00,Treatment Outcome,E01.789.800
22104428,2012-02-01T00:00:00,Treatment Outcome,N04.761.559.590.800
22104428,2012-02-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22104428,2012-02-01T00:00:00,Vancomycin,D09.400.420.925
22104428,2012-02-01T00:00:00,Vancomycin,D12.644.233.925
22113462,2012-02-01T00:00:00,Animals,B01.050
22113462,2012-02-01T00:00:00,Cell Differentiation,G04.299.151
22113462,2012-02-01T00:00:00,Cell Lineage,G04.172
22113462,2012-02-01T00:00:00,Cell Lineage,G07.700.320.500.325.180.500
22113462,2012-02-01T00:00:00,Cell Lineage,G08.686.155
22113462,2012-02-01T00:00:00,Cell Lineage,G08.686.785.760.170.104.249
22113462,2012-02-01T00:00:00,Cell Proliferation,G04.299.233.750
22113462,2012-02-01T00:00:00,Cell Proliferation,G07.700.320.249.410.750
22113462,2012-02-01T00:00:00,Green Fluorescent Proteins,D12.776.532.265
22113462,2012-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22113462,2012-02-01T00:00:00,Larva,B05.500.500
22113462,2012-02-01T00:00:00,Larva,G07.700.320.500.550.500.500
22113462,2012-02-01T00:00:00,Neuroglia,A08.637
22113462,2012-02-01T00:00:00,Neuroglia,A11.650
22113462,2012-02-01T00:00:00,Neurons,A08.663
22113462,2012-02-01T00:00:00,Neurons,A11.671
22113462,2012-02-01T00:00:00,SOXB1 Transcription Factors,D12.776.260.719.100
22113462,2012-02-01T00:00:00,SOXB1 Transcription Factors,D12.776.660.235.400.750.100
22113462,2012-02-01T00:00:00,SOXB1 Transcription Factors,D12.776.664.235.400.750.100
22113462,2012-02-01T00:00:00,SOXB1 Transcription Factors,D12.776.930.823.100
22113462,2012-02-01T00:00:00,Stem Cells,A11.872
22113462,2012-02-01T00:00:00,Superior Colliculi,A08.186.211.132.659.727.816
22113462,2012-02-01T00:00:00,Superior Colliculi,A08.186.211.653.727.500
22113462,2012-02-01T00:00:00,Xenopus Proteins,D12.776.045.500
22113462,2012-02-01T00:00:00,Xenopus laevis,B01.050.150.900.090.180.610.500.562
22127151,2012-02-01T00:00:00,Central Nervous System Diseases,C10.228
22127151,2012-02-01T00:00:00,Eye Diseases,C11
22127151,2012-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22127151,2012-02-01T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
22127151,2012-02-01T00:00:00,Methanol,D02.033.623
22127151,2012-02-01T00:00:00,Middle Aged,M01.060.116.630
22127151,2012-02-01T00:00:00,Neuroprotective Agents,D27.505.696.706.548
22127151,2012-02-01T00:00:00,Neuroprotective Agents,D27.505.954.427.575
22127151,2012-02-01T00:00:00,Renal Dialysis,E02.870.300
22127151,2012-02-01T00:00:00,Renal Dialysis,E02.912.800
22127151,2012-02-01T00:00:00,Solvents,D27.720.844
22127151,2012-02-01T00:00:00,Visual Acuity,E01.370.380.850.950
22127151,2012-02-01T00:00:00,Visual Acuity,F02.463.593.932.901
22127151,2012-02-01T00:00:00,Visual Acuity,G14.940
22189877,2012-02-01T00:00:00,Clinical Competence,I02.399.630.210
22189877,2012-02-01T00:00:00,Clinical Competence,N04.761.210
22189877,2012-02-01T00:00:00,Competency-Based Education,I02.158.210
22189877,2012-02-01T00:00:00,Fatigue,C23.888.369
22189877,2012-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22189877,2012-02-01T00:00:00,Internship and Residency,I02.358.399.644
22189877,2012-02-01T00:00:00,United States,Z01.107.567.875
22189877,2012-02-01T00:00:00,Workload,N04.452.677.950
22237260,2012-02-01T00:00:00,Adenocarcinoma,C04.557.470.200.025
22237260,2012-02-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
22237260,2012-02-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
22237260,2012-02-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
22237260,2012-02-01T00:00:00,"Chemotherapy, Adjuvant",E02.186.170
22237260,2012-02-01T00:00:00,"Chemotherapy, Adjuvant",E02.319.170
22237260,2012-02-01T00:00:00,Combined Modality Therapy,E02.186
22237260,2012-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22237260,2012-02-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
22237260,2012-02-01T00:00:00,Lung Neoplasms,C08.381.540
22237260,2012-02-01T00:00:00,Lung Neoplasms,C08.785.520
22237260,2012-02-01T00:00:00,Neoplasm Staging,E01.370.550
22237260,2012-02-01T00:00:00,Physician's Practice Patterns,N04.590.748
22237260,2012-02-01T00:00:00,Physician's Practice Patterns,N05.300.625
22237260,2012-02-01T00:00:00,Pneumonectomy,E04.928.600.600
22237260,2012-02-01T00:00:00,Treatment Outcome,E01.789.800
22237260,2012-02-01T00:00:00,Treatment Outcome,N04.761.559.590.800
22237260,2012-02-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22251008,2012-02-01T00:00:00,Adrenal Cortex Hormones,D06.472.040
22251008,2012-02-01T00:00:00,Animals,B01.050
22251008,2012-02-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
22251008,2012-02-01T00:00:00,Clinical Trials as Topic,E05.337.250
22251008,2012-02-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
22251008,2012-02-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
22251008,2012-02-01T00:00:00,Complementary Therapies,E02.190
22251008,2012-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22251008,2012-02-01T00:00:00,Stilbenes,D02.455.426.559.389.150.700
22258720,2012-02-01T00:00:00,Cardiovascular Diseases,C14
22258720,2012-02-01T00:00:00,Extracellular Matrix,A11.284.295.310
22258720,2012-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22288674,2012-02-01T00:00:00,Activities of Daily Living,E02.831.067
22288674,2012-02-01T00:00:00,Activities of Daily Living,I03.050
22288674,2012-02-01T00:00:00,Activities of Daily Living,N02.421.784.110
22288674,2012-02-01T00:00:00,Exercise Therapy,E02.779.483
22288674,2012-02-01T00:00:00,Exercise Therapy,E02.831.387
22288674,2012-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22288674,2012-02-01T00:00:00,Movement,G07.700.560
22288674,2012-02-01T00:00:00,Movement,G11.427.590.530
22288674,2012-02-01T00:00:00,Stroke,C10.228.140.300.775
22288674,2012-02-01T00:00:00,Stroke,C14.907.253.855
22288674,2012-02-01T00:00:00,Upper Extremity,A01.378.800
22289243,2012-02-01T00:00:00,Adult,M01.060.116
22289243,2012-02-01T00:00:00,Alcohol Drinking,F01.145.317.269
22289243,2012-02-01T00:00:00,Analgesics,D27.505.696.663.850.014
22289243,2012-02-01T00:00:00,Analgesics,D27.505.954.427.040
22289243,2012-02-01T00:00:00,Diet,E05.272
22289243,2012-02-01T00:00:00,Diet,G07.610.240
22289243,2012-02-01T00:00:00,Exercise,G11.427.590.237
22289243,2012-02-01T00:00:00,Exercise,I03.350
22289243,2012-02-01T00:00:00,Fatigue,C23.888.369
22289243,2012-02-01T00:00:00,Health Behavior,F01.145.488
22289243,2012-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22289243,2012-02-01T00:00:00,Middle Aged,M01.060.116.630
22289243,2012-02-01T00:00:00,Questionnaires,E05.318.308.750
22289243,2012-02-01T00:00:00,Questionnaires,L01.280.800
22289243,2012-02-01T00:00:00,Questionnaires,N05.715.360.300.695
22289243,2012-02-01T00:00:00,Questionnaires,N06.850.520.308.750
22289243,2012-02-01T00:00:00,Risk Factors,E05.318.740.600.800.725
22289243,2012-02-01T00:00:00,Risk Factors,N05.715.350.200.700
22289243,2012-02-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22289243,2012-02-01T00:00:00,Risk Factors,N06.850.490.625.750
22289243,2012-02-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22289243,2012-02-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
22289243,2012-02-01T00:00:00,Spinal Cord Injuries,C10.900.850
22289243,2012-02-01T00:00:00,Spinal Cord Injuries,C21.866.819
22289243,2012-02-01T00:00:00,"Stress, Psychological",F01.145.126.990
22289243,2012-02-01T00:00:00,"Stress, Psychological",F02.830.900
22289252,2012-02-01T00:00:00,Adult,M01.060.116
22289252,2012-02-01T00:00:00,Employment,N01.824.245
22289252,2012-02-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
22289252,2012-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22289252,2012-02-01T00:00:00,Questionnaires,E05.318.308.750
22289252,2012-02-01T00:00:00,Questionnaires,L01.280.800
22289252,2012-02-01T00:00:00,Questionnaires,N05.715.360.300.695
22289252,2012-02-01T00:00:00,Questionnaires,N06.850.520.308.750
22289252,2012-02-01T00:00:00,Sex Factors,N05.715.350.675
22289252,2012-02-01T00:00:00,Sex Factors,N06.850.490.875
22289252,2012-02-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
22289252,2012-02-01T00:00:00,Spinal Cord Injuries,C10.900.850
22289252,2012-02-01T00:00:00,Spinal Cord Injuries,C21.866.819
22289252,2012-02-01T00:00:00,Time Factors,G01.910.857
22299805,2012-02-01T00:00:00,Adolescent,M01.060.057
22299805,2012-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22299805,2012-02-01T00:00:00,Substance Abuse Detection,E05.885
22299805,2012-02-01T00:00:00,Substance Abuse Detection,N06.850.780.500.765
22299805,2012-02-01T00:00:00,Substance-Related Disorders,C21.739
22299805,2012-02-01T00:00:00,Substance-Related Disorders,F03.900
22300775,2012-02-01T00:00:00,Cardiology,H02.403.429.163
22300775,2012-02-01T00:00:00,Forecasting,I01.320
22300775,2012-02-01T00:00:00,Heart Failure,C14.280.434
22300775,2012-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22300775,2012-02-01T00:00:00,United States,Z01.107.567.875
22301195,2012-02-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
22301195,2012-02-01T00:00:00,Alzheimer Disease,C10.574.945.249
22301195,2012-02-01T00:00:00,Alzheimer Disease,F03.087.400.100
22301195,2012-02-01T00:00:00,Cognitive Therapy,F04.754.137.428
22301195,2012-02-01T00:00:00,Double-Blind Method,E05.318.780.300
22301195,2012-02-01T00:00:00,Double-Blind Method,E05.581.500.300
22301195,2012-02-01T00:00:00,Double-Blind Method,N05.715.360.780.320
22301195,2012-02-01T00:00:00,Double-Blind Method,N06.850.520.445.300
22301195,2012-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22301195,2012-02-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
22301195,2012-02-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
22301195,2012-02-01T00:00:00,Psychiatric Status Rating Scales,F04.586
22301195,2012-02-01T00:00:00,Psychomotor Agitation,C10.597.350.600
22301195,2012-02-01T00:00:00,Psychomotor Agitation,C10.597.606.881.700
22301195,2012-02-01T00:00:00,Psychomotor Agitation,C23.888.592.350.600
22301195,2012-02-01T00:00:00,Psychomotor Agitation,C23.888.592.604.882.700
22301195,2012-02-01T00:00:00,Psychomotor Agitation,F01.700.875.700
22301195,2012-02-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.519.625.600.850
22301195,2012-02-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.519.625.850.900
22301195,2012-02-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.696.577.600.850
22301195,2012-02-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.696.577.850.900
22302110,2012-02-01T00:00:00,Blood Pressure,E01.370.600.875.249
22302110,2012-02-01T00:00:00,Blood Pressure,G09.330.380.076
22302110,2012-02-01T00:00:00,Cardiovascular Diseases,C14
22302110,2012-02-01T00:00:00,Centers for Disease Control and Prevention (U.S.),I01.409.137.500.600.650.225
22302110,2012-02-01T00:00:00,Centers for Disease Control and Prevention (U.S.),N03.540.348.500.500.600.650.225
22302110,2012-02-01T00:00:00,Cholesterol,D04.808.247.222.284
22302110,2012-02-01T00:00:00,Cholesterol,D04.808.247.808.197
22302110,2012-02-01T00:00:00,Cholesterol,D10.570.938.208
22302110,2012-02-01T00:00:00,Cholesterol,D10.851.208
22302110,2012-02-01T00:00:00,Ethnic Groups,M01.686.754
22302110,2012-02-01T00:00:00,Ethnic Groups,N01.224.317
22302110,2012-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22302110,2012-02-01T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
22302110,2012-02-01T00:00:00,Smoking Cessation,F01.145.940.700
22302110,2012-02-01T00:00:00,Stroke,C10.228.140.300.775
22302110,2012-02-01T00:00:00,Stroke,C14.907.253.855
22302110,2012-02-01T00:00:00,United States,Z01.107.567.875
22302144,2012-02-01T00:00:00,3' Untranslated Regions,D13.444.735.544.875.880
22302144,2012-02-01T00:00:00,3' Untranslated Regions,D13.444.735.790.878.880
22302144,2012-02-01T00:00:00,3' Untranslated Regions,G05.360.340.024.220.880.880
22302144,2012-02-01T00:00:00,3' Untranslated Regions,G05.360.340.024.340.137.910.880
22302144,2012-02-01T00:00:00,Cyclooxygenase 2,D08.811.600.720.750
22302144,2012-02-01T00:00:00,Cytokines,D12.644.276.374
22302144,2012-02-01T00:00:00,Cytokines,D12.776.467.374
22302144,2012-02-01T00:00:00,Cytokines,D23.529.374
22302144,2012-02-01T00:00:00,Gene Expression Regulation,G05.355.315
22302144,2012-02-01T00:00:00,Inflammation,C23.550.470
22302144,2012-02-01T00:00:00,Interleukin-6,D12.644.276.374.465.506
22302144,2012-02-01T00:00:00,Interleukin-6,D12.776.467.374.465.506
22302144,2012-02-01T00:00:00,Interleukin-6,D23.529.374.465.506
22302144,2012-02-01T00:00:00,MicroRNAs,D13.150.650.319
22302144,2012-02-01T00:00:00,MicroRNAs,D13.444.735.150.319
22302144,2012-02-01T00:00:00,MicroRNAs,D13.444.735.790.099
22302144,2012-02-01T00:00:00,Molecular Sequence Data,L01.453.245.667
22302144,2012-02-01T00:00:00,"RNA Processing, Post-Transcriptional",G02.111.087.750
22302144,2012-02-01T00:00:00,"RNA Processing, Post-Transcriptional",G02.149.115.750
22302144,2012-02-01T00:00:00,"RNA Processing, Post-Transcriptional",G03.495.839
22302144,2012-02-01T00:00:00,"RNA Processing, Post-Transcriptional",G05.355.315.700
22302144,2012-02-01T00:00:00,RNA Stability,G02.111.780
22302144,2012-02-01T00:00:00,"RNA, Messenger",D13.444.735.544
22302144,2012-02-01T00:00:00,RNA-Binding Proteins,D12.776.157.725
22302144,2012-02-01T00:00:00,RNA-Binding Proteins,D12.776.664.962
22302144,2012-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
22302144,2012-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
22302144,2012-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
22302144,2012-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
22302144,2012-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
22302144,2012-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
22302144,2012-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
22302144,2012-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
22302144,2012-02-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
22302144,2012-02-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
22302144,2012-02-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
22302144,2012-02-01T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
22302144,2012-02-01T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
22302144,2012-02-01T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
22315117,2012-02-01T00:00:00,"Biopsy, Needle",E01.370.388.100.100
22315117,2012-02-01T00:00:00,"Biopsy, Needle",E01.450.230.100.100
22315117,2012-02-01T00:00:00,"Biopsy, Needle",E01.450.865.100.100
22315117,2012-02-01T00:00:00,"Biopsy, Needle",E01.450.865.632.100
22315117,2012-02-01T00:00:00,"Biopsy, Needle",E04.074.119
22315117,2012-02-01T00:00:00,Bronchoscopy,E01.370.386.105
22315117,2012-02-01T00:00:00,Bronchoscopy,E01.370.388.250.100
22315117,2012-02-01T00:00:00,Bronchoscopy,E04.800.250.100
22315117,2012-02-01T00:00:00,Bronchoscopy,E04.928.600.080
22315117,2012-02-01T00:00:00,Endosonography,E01.370.350.850.280
22315117,2012-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22315117,2012-02-01T00:00:00,Lung Diseases,C08.381
22315117,2012-02-01T00:00:00,Lymph Nodes,A10.549.400
22315117,2012-02-01T00:00:00,Lymph Nodes,A15.382.520.604.412
22315117,2012-02-01T00:00:00,Middle Aged,M01.060.116.630
22315117,2012-02-01T00:00:00,South Carolina,Z01.107.567.875.075.662
22315117,2012-02-01T00:00:00,South Carolina,Z01.107.567.875.750.700
22315117,2012-02-01T00:00:00,United States,Z01.107.567.875
22329472,2012-02-01T00:00:00,Adult,M01.060.116
22329472,2012-02-01T00:00:00,Alcohol Deterrents,D27.505.954.427.020
22329472,2012-02-01T00:00:00,Alcoholism,C21.739.100.250
22329472,2012-02-01T00:00:00,Alcoholism,F03.900.100.350
22329472,2012-02-01T00:00:00,Bipolar Disorder,F03.600.150.150
22329472,2012-02-01T00:00:00,Double-Blind Method,E05.318.780.300
22329472,2012-02-01T00:00:00,Double-Blind Method,E05.581.500.300
22329472,2012-02-01T00:00:00,Double-Blind Method,N05.715.360.780.320
22329472,2012-02-01T00:00:00,Double-Blind Method,N06.850.520.445.300
22329472,2012-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22329472,2012-02-01T00:00:00,Middle Aged,M01.060.116.630
22329472,2012-02-01T00:00:00,Taurine,D02.455.326.146.100.850
22329472,2012-02-01T00:00:00,Taurine,D02.886.645.600.055.850
22354506,2012-02-01T00:00:00,Adolescent,M01.060.057
22354506,2012-02-01T00:00:00,Adolescent Behavior,F01.145.022
22354506,2012-02-01T00:00:00,Alcoholism,C21.739.100.250
22354506,2012-02-01T00:00:00,Alcoholism,F03.900.100.350
22354506,2012-02-01T00:00:00,Child,M01.060.406
22354506,2012-02-01T00:00:00,Data Collection,E05.318.308
22354506,2012-02-01T00:00:00,Data Collection,L01.280
22354506,2012-02-01T00:00:00,Data Collection,N05.715.360.300
22354506,2012-02-01T00:00:00,Data Collection,N06.850.520.308
22354506,2012-02-01T00:00:00,Depression,F01.145.126.350
22354506,2012-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22354506,2012-02-01T00:00:00,Interpersonal Relations,F01.829.401
22354506,2012-02-01T00:00:00,Interviews as Topic,E05.318.308.420
22354506,2012-02-01T00:00:00,Interviews as Topic,L01.280.520
22354506,2012-02-01T00:00:00,Interviews as Topic,N05.715.360.300.400
22354506,2012-02-01T00:00:00,Interviews as Topic,N06.850.520.308.420
22354506,2012-02-01T00:00:00,Juvenile Delinquency,I01.880.735.479
22354506,2012-02-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
22354506,2012-02-01T00:00:00,Risk Assessment,N04.452.871.715
22354506,2012-02-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
22354506,2012-02-01T00:00:00,Risk Assessment,N06.850.505.715
22354506,2012-02-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
22354506,2012-02-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
22354506,2012-02-01T00:00:00,United States,Z01.107.567.875
22354506,2012-02-01T00:00:00,Violence,I01.198.240.856
22354506,2012-02-01T00:00:00,Violence,I01.880.735.900
22369705,2012-02-01T00:00:00,Bayes Theorem,E05.318.740.600.200
22369705,2012-02-01T00:00:00,Bayes Theorem,N05.715.360.750.625.150
22369705,2012-02-01T00:00:00,Bayes Theorem,N06.850.520.830.600.200
22369705,2012-02-01T00:00:00,Bias (Epidemiology),N05.715.350.150
22369705,2012-02-01T00:00:00,Bias (Epidemiology),N06.850.490.500
22369705,2012-02-01T00:00:00,Dental Research,H02.163.090
22369705,2012-02-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
22369705,2012-02-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
22369705,2012-02-01T00:00:00,"Hemoglobin A, Glycosylated",D09.408.375
22369705,2012-02-01T00:00:00,"Hemoglobin A, Glycosylated",D12.776.124.400.405.440
22369705,2012-02-01T00:00:00,"Hemoglobin A, Glycosylated",D12.776.422.316.762.380.440
22369705,2012-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22369705,2012-02-01T00:00:00,Periodontal Pocket,C07.465.714.533.750
22369705,2012-02-01T00:00:00,Pilot Projects,E05.318.760.750
22369705,2012-02-01T00:00:00,Pilot Projects,E05.337.737
22369705,2012-02-01T00:00:00,Pilot Projects,N05.715.360.775.625
22369705,2012-02-01T00:00:00,Pilot Projects,N06.850.520.450.720
22369705,2012-02-01T00:00:00,Research Design,E05.581.500
22369705,2012-02-01T00:00:00,Research Design,H01.770.644.728
22369705,2012-02-01T00:00:00,South Carolina,Z01.107.567.875.075.662
22369705,2012-02-01T00:00:00,South Carolina,Z01.107.567.875.750.700
22369821,2012-02-01T00:00:00,General Surgery,H02.403.810.300
22369821,2012-02-01T00:00:00,"History, 19th Century",K01.400.504.937
22369821,2012-02-01T00:00:00,"History, 20th Century",K01.400.504.968
22369821,2012-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22369821,2012-02-01T00:00:00,United States,Z01.107.567.875
22389410,2012-02-01T00:00:00,"Antigens, CD147",D12.776.395.550.045
22389410,2012-02-01T00:00:00,"Antigens, CD147",D12.776.543.550.188
22389410,2012-02-01T00:00:00,"Antigens, CD147",D23.050.285.040
22389410,2012-02-01T00:00:00,"Antigens, CD147",D23.050.301.264.035.247
22389410,2012-02-01T00:00:00,"Antigens, CD147",D23.101.100.110.247
22389410,2012-02-01T00:00:00,Breast Neoplasms,C04.588.180
22389410,2012-02-01T00:00:00,Breast Neoplasms,C17.800.090.500
22389410,2012-02-01T00:00:00,Cell Line,A11.251.210
22389410,2012-02-01T00:00:00,Epithelial Cells,A11.436
22389410,2012-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22389410,2012-02-01T00:00:00,Matrix Metalloproteinase 14,D08.811.277.656.300.480.525.300.500
22389410,2012-02-01T00:00:00,Matrix Metalloproteinase 14,D08.811.277.656.675.374.525.300.500
22389410,2012-02-01T00:00:00,Neoplasm Invasiveness,C04.697.645
22389410,2012-02-01T00:00:00,Neoplasm Invasiveness,C23.550.727.645
22449084,2012-02-01T00:00:00,Adult,M01.060.116
22449084,2012-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22449084,2012-02-01T00:00:00,Implosive Therapy,F04.754.137.506.325
22449084,2012-02-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
22449084,2012-02-01T00:00:00,Treatment Outcome,E01.789.800
22449084,2012-02-01T00:00:00,Treatment Outcome,N04.761.559.590.800
22449084,2012-02-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22449084,2012-02-01T00:00:00,Veterans,M01.930
22464075,2012-02-01T00:00:00,Adult,M01.060.116
22464075,2012-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22464075,2012-02-01T00:00:00,"Infant, Newborn",M01.060.703.520
22464075,2012-02-01T00:00:00,"Infant, Premature",M01.060.703.520.520
22464075,2012-02-01T00:00:00,"Infectious Disease Transmission, Vertical",N06.850.310.425
22464075,2012-02-01T00:00:00,"Intensive Care Units, Neonatal",N02.278.388.493.390.380
22464075,2012-02-01T00:00:00,Methicillin-Resistant Staphylococcus aureus,B03.300.390.400.800.750.100.500
22464075,2012-02-01T00:00:00,Methicillin-Resistant Staphylococcus aureus,B03.510.100.750.750.100.500
22464075,2012-02-01T00:00:00,Methicillin-Resistant Staphylococcus aureus,B03.510.400.790.750.100.500
22464075,2012-02-01T00:00:00,"Obstetric Labor, Premature",C13.703.420.491
22464075,2012-02-01T00:00:00,Pregnancy,G08.686.785.760.769
22464075,2012-02-01T00:00:00,"Pregnancy Complications, Infectious",C01.539.674
22464075,2012-02-01T00:00:00,"Pregnancy Complications, Infectious",C13.703.700
22464075,2012-02-01T00:00:00,Staphylococcal Infections,C01.252.410.868
22464075,2012-02-01T00:00:00,Young Adult,M01.060.116.815
22489353,2012-02-01T00:00:00,Cost-Benefit Analysis,N03.219.151.125
22489353,2012-02-01T00:00:00,Early Detection of Cancer,E01.390.500
22489353,2012-02-01T00:00:00,Endoscopy,E01.370.388.250
22489353,2012-02-01T00:00:00,Endoscopy,E04.800.250
22489353,2012-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22489353,2012-02-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
22489353,2012-02-01T00:00:00,Lung Neoplasms,C08.381.540
22489353,2012-02-01T00:00:00,Lung Neoplasms,C08.785.520
22489353,2012-02-01T00:00:00,"Radiography, Thoracic",E01.370.350.700.730
22489353,2012-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
22489353,2012-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
22489353,2012-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
22489353,2012-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
22489353,2012-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
22489353,2012-02-01T00:00:00,"Tumor Markers, Biological",D23.101.840
23270079,2012-02-01T00:00:00,AIDS-Related Opportunistic Infections,C01.539.597.050
23270079,2012-02-01T00:00:00,AIDS-Related Opportunistic Infections,C02.597.050
23270079,2012-02-01T00:00:00,AIDS-Related Opportunistic Infections,C02.782.815.616.400.100
23270079,2012-02-01T00:00:00,AIDS-Related Opportunistic Infections,C03.684.050
23270079,2012-02-01T00:00:00,AIDS-Related Opportunistic Infections,C20.673.480.100
23270079,2012-02-01T00:00:00,Cough,C08.618.248
23270079,2012-02-01T00:00:00,Cough,C23.888.852.293
23270079,2012-02-01T00:00:00,HIV Infections,C02.782.815.616.400
23270079,2012-02-01T00:00:00,HIV Infections,C02.800.801.400
23270079,2012-02-01T00:00:00,HIV Infections,C20.673.480
23270079,2012-02-01T00:00:00,Hospital Costs,N03.219.151.400.687
23270079,2012-02-01T00:00:00,Hospital Costs,N03.219.262.500
23270079,2012-02-01T00:00:00,Hospital Costs,N05.300.375.500
23270079,2012-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23270079,2012-02-01T00:00:00,Infant,M01.060.703
23270079,2012-02-01T00:00:00,"Infectious Disease Transmission, Vertical",N06.850.310.425
23270079,2012-02-01T00:00:00,Respiratory Insufficiency,C08.618.846
23270079,2012-02-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23270079,2012-02-01T00:00:00,South Carolina,Z01.107.567.875.750.700
22301113,2012-02-02T00:00:00,Animals,B01.050
22301113,2012-02-02T00:00:00,Down-Regulation,G02.111.087.225
22301113,2012-02-02T00:00:00,Down-Regulation,G02.149.115.225
22301113,2012-02-02T00:00:00,Down-Regulation,G05.355.315.200
22301113,2012-02-02T00:00:00,Down-Regulation,G07.690.812.230
22301113,2012-02-02T00:00:00,Down-Regulation,G07.700.680.230
22301113,2012-02-02T00:00:00,Endothelin-1,D12.644.276.400.225
22301113,2012-02-02T00:00:00,Endothelin-1,D12.776.467.400.225
22301113,2012-02-02T00:00:00,Endothelin-1,D23.529.400.225
22301113,2012-02-02T00:00:00,Interferon-gamma,D12.644.276.374.440.893
22301113,2012-02-02T00:00:00,Interferon-gamma,D12.644.276.374.480.350
22301113,2012-02-02T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
22301113,2012-02-02T00:00:00,Interferon-gamma,D12.644.276.718.550
22301113,2012-02-02T00:00:00,Interferon-gamma,D12.776.467.374.440.893
22301113,2012-02-02T00:00:00,Interferon-gamma,D12.776.467.374.480.350
22301113,2012-02-02T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
22301113,2012-02-02T00:00:00,Interferon-gamma,D12.776.467.718.550
22301113,2012-02-02T00:00:00,Interferon-gamma,D23.529.374.440.893
22301113,2012-02-02T00:00:00,Interferon-gamma,D23.529.374.480.350
22301113,2012-02-02T00:00:00,Interferon-gamma,D23.529.374.480.615.350
22301113,2012-02-02T00:00:00,Interferon-gamma,D23.529.718.550
22301113,2012-02-02T00:00:00,Molecular Sequence Data,L01.453.245.667
22301113,2012-02-02T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22301113,2012-02-02T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
22301323,2012-02-02T00:00:00,Cross Infection,C01.539.248
22301323,2012-02-02T00:00:00,Dietary Fats,D10.212.302
22301323,2012-02-02T00:00:00,Dietary Fats,J02.500.375
22301323,2012-02-02T00:00:00,Drug Compounding,E05.916.270
22301323,2012-02-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22301323,2012-02-02T00:00:00,Immunity,G12.450
22301323,2012-02-02T00:00:00,Medication Errors,E02.319.529
22301323,2012-02-02T00:00:00,Medication Errors,N02.421.450.500
22301323,2012-02-02T00:00:00,Parenteral Nutrition,E02.421.505
22301323,2012-02-02T00:00:00,Parenteral Nutrition,E02.642.500.505
22304960,2012-02-03T00:00:00,Adult,M01.060.116
22304960,2012-02-03T00:00:00,African Continental Ancestry Group,M01.686.508.100
22304960,2012-02-03T00:00:00,European Continental Ancestry Group,M01.686.508.400
22304960,2012-02-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22304960,2012-02-03T00:00:00,Questionnaires,E05.318.308.750
22304960,2012-02-03T00:00:00,Questionnaires,L01.280.800
22304960,2012-02-03T00:00:00,Questionnaires,N05.715.360.300.695
22304960,2012-02-03T00:00:00,Questionnaires,N06.850.520.308.750
22304960,2012-02-03T00:00:00,Sex Factors,N05.715.350.675
22304960,2012-02-03T00:00:00,Sex Factors,N06.850.490.875
22304960,2012-02-03T00:00:00,Spinal Cord Injuries,C10.228.854.770
22304960,2012-02-03T00:00:00,Spinal Cord Injuries,C10.900.850
22304960,2012-02-03T00:00:00,Spinal Cord Injuries,C21.866.819
22307665,2012-02-03T00:00:00,Action Potentials,G04.580.100
22307665,2012-02-03T00:00:00,Action Potentials,G07.265.750.100
22307665,2012-02-03T00:00:00,Action Potentials,G11.561.570.100
22307665,2012-02-03T00:00:00,Animals,B01.050
22307665,2012-02-03T00:00:00,Cardiomegaly,C14.280.195
22307665,2012-02-03T00:00:00,Cardiomegaly,C23.300.775.250
22307665,2012-02-03T00:00:00,Cell Size,G04.190
22307665,2012-02-03T00:00:00,Echocardiography,E01.370.350.850.220
22307665,2012-02-03T00:00:00,Echocardiography,E01.370.370.380.220
22307665,2012-02-03T00:00:00,Heart Conduction System,A07.541.409
22307665,2012-02-03T00:00:00,Hemodynamics,G09.330.190.400
22307665,2012-02-03T00:00:00,Hemodynamics,G09.330.380
22307665,2012-02-03T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
22307665,2012-02-03T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
22307665,2012-02-03T00:00:00,"Microscopy, Confocal",E05.595.395
22307665,2012-02-03T00:00:00,"Myocytes, Cardiac",A07.541.704.570
22307665,2012-02-03T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
22307665,2012-02-03T00:00:00,"Myocytes, Cardiac",A11.620.500
22307665,2012-02-03T00:00:00,Pressure,G01.374.715
22307665,2012-02-03T00:00:00,"Receptor, Epidermal Growth Factor",D08.811.913.696.620.682.725.400.100
22307665,2012-02-03T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.060.249
22307665,2012-02-03T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.360.300
22307665,2012-02-03T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.400.340
22307665,2012-02-03T00:00:00,Ventricular Remodeling,C23.300.985
22307665,2012-02-03T00:00:00,Ventricular Remodeling,G09.330.190.962.975
22306221,2012-02-04T00:00:00,Aged,M01.060.116.100
22306221,2012-02-04T00:00:00,Device Removal,E04.199
22306221,2012-02-04T00:00:00,"Embolization, Therapeutic",E02.520.360
22306221,2012-02-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22306221,2012-02-04T00:00:00,Iatrogenic Disease,C23.550.291.875
22306221,2012-02-04T00:00:00,"Lasers, Excimer",E07.632.490.244
22306221,2012-02-04T00:00:00,"Lasers, Excimer",E07.710.520.244
22306221,2012-02-04T00:00:00,"Pacemaker, Artificial",E07.858.082.748
22306221,2012-02-04T00:00:00,Subclavian Vein,A07.231.908.877
22306221,2012-02-04T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
22306221,2012-02-04T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
22306221,2012-02-04T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
22306221,2012-02-04T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
22306221,2012-02-04T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
22306221,2012-02-04T00:00:00,Treatment Outcome,E01.789.800
22306221,2012-02-04T00:00:00,Treatment Outcome,N04.761.559.590.800
22306221,2012-02-04T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22309159,2012-02-06T00:00:00,Alcohol Drinking,F01.145.317.269
22309159,2012-02-06T00:00:00,Animals,B01.050
22309159,2012-02-06T00:00:00,Avoidance Learning,F02.463.425.097
22309159,2012-02-06T00:00:00,Drug Tolerance,G07.690.812.260
22309159,2012-02-06T00:00:00,Drug Tolerance,G07.700.680.260
22309159,2012-02-06T00:00:00,Ethanol,D02.033.375
22309159,2012-02-06T00:00:00,Time Factors,G01.910.857
22309197,2012-02-06T00:00:00,Angiogenesis Inhibitors,D27.505.696.377.077.099
22309197,2012-02-06T00:00:00,Angiogenesis Inhibitors,D27.505.696.377.450.100
22309197,2012-02-06T00:00:00,Angiogenesis Inhibitors,D27.505.954.248.025
22309197,2012-02-06T00:00:00,Animals,B01.050
22309197,2012-02-06T00:00:00,Biological Markers,D23.101
22309197,2012-02-06T00:00:00,Choroidal Neovascularization,C11.941.160.244
22309197,2012-02-06T00:00:00,Choroidal Neovascularization,C23.550.589.500.145
22309197,2012-02-06T00:00:00,"Complement Pathway, Alternative",G12.425.255.695
22309197,2012-02-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22309197,2012-02-06T00:00:00,Plasmids,G05.360.600
22309197,2012-02-06T00:00:00,"RNA, Messenger",D13.444.735.544
22309197,2012-02-06T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
22309197,2012-02-06T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
22309197,2012-02-06T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
22309197,2012-02-06T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
22309470,2012-02-06T00:00:00,Adolescent,M01.060.057
22309470,2012-02-06T00:00:00,Behavior Therapy,F04.754.137
22309470,2012-02-06T00:00:00,Crime,I01.198.240
22309470,2012-02-06T00:00:00,Crime,I01.880.735.191
22309470,2012-02-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22309470,2012-02-06T00:00:00,Juvenile Delinquency,I01.880.735.479
22309470,2012-02-06T00:00:00,Mental Disorders,F03
22309470,2012-02-06T00:00:00,Substance-Related Disorders,C21.739
22309470,2012-02-06T00:00:00,Substance-Related Disorders,F03.900
22309470,2012-02-06T00:00:00,Treatment Outcome,E01.789.800
22309470,2012-02-06T00:00:00,Treatment Outcome,N04.761.559.590.800
22309470,2012-02-06T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22341203,2012-02-06T00:00:00,China,Z01.252.474.164
22341203,2012-02-06T00:00:00,Health Status,I01.240.425
22341203,2012-02-06T00:00:00,Health Status,N01.224.425
22341203,2012-02-06T00:00:00,Health Status,N06.850.505.400.425
22341203,2012-02-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22341203,2012-02-06T00:00:00,Population Dynamics,I01.240.600
22341203,2012-02-06T00:00:00,Population Dynamics,N01.224.625
22341203,2012-02-06T00:00:00,Population Dynamics,N06.850.505.400.700
22341203,2012-02-06T00:00:00,Power Plants,E07.305.437
22341203,2012-02-06T00:00:00,Power Plants,J01.780
22341203,2012-02-06T00:00:00,Rivers,G01.311.750
22341203,2012-02-06T00:00:00,Rivers,G16.500.275.280.500
22341203,2012-02-06T00:00:00,Rivers,N06.230.232.500
22341203,2012-02-06T00:00:00,Rural Population,N01.600.725
22341203,2012-02-06T00:00:00,"Stress, Psychological",F01.145.126.990
22341203,2012-02-06T00:00:00,"Stress, Psychological",F02.830.900
22313281,2012-02-07T00:00:00,"Dental Restoration, Permanent",E06.323.428
22313281,2012-02-07T00:00:00,"Dental Restoration, Permanent",E06.780.345.737
22313281,2012-02-07T00:00:00,"Dental Restoration, Permanent",E07.695.190.190
22313281,2012-02-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22316644,2012-02-07T00:00:00,Aged,M01.060.116.100
22316644,2012-02-07T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
22316644,2012-02-07T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
22316644,2012-02-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22316644,2012-02-07T00:00:00,Internal-External Control,F01.829.379
22316644,2012-02-07T00:00:00,Medication Adherence,F01.145.488.500.500
22316644,2012-02-07T00:00:00,Medication Adherence,N05.300.150.600.600.500
22316644,2012-02-07T00:00:00,Middle Aged,M01.060.116.630
22316644,2012-02-07T00:00:00,Perception,F02.463.593
22316644,2012-02-07T00:00:00,Quality of Life,I01.800
22316644,2012-02-07T00:00:00,Quality of Life,K01.752.400.750
22316644,2012-02-07T00:00:00,Questionnaires,E05.318.308.750
22316644,2012-02-07T00:00:00,Questionnaires,L01.280.800
22316644,2012-02-07T00:00:00,Questionnaires,N05.715.360.300.695
22316644,2012-02-07T00:00:00,Questionnaires,N06.850.520.308.750
22316644,2012-02-07T00:00:00,South Carolina,Z01.107.567.875.075.662
22316644,2012-02-07T00:00:00,South Carolina,Z01.107.567.875.750.700
22317913,2012-02-07T00:00:00,Adolescent,M01.060.057
22317913,2012-02-07T00:00:00,Adult,M01.060.116
22317913,2012-02-07T00:00:00,Aged,M01.060.116.100
22317913,2012-02-07T00:00:00,Cataract,C11.510.245
22317913,2012-02-07T00:00:00,Cataract Extraction,E04.540.825.249
22317913,2012-02-07T00:00:00,Child,M01.060.406
22317913,2012-02-07T00:00:00,"Child, Preschool",M01.060.406.448
22317913,2012-02-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22317913,2012-02-07T00:00:00,"Lens Implantation, Intraocular",E04.540.825.600
22317913,2012-02-07T00:00:00,"Lenses, Intraocular",E07.632.500.460
22317913,2012-02-07T00:00:00,"Lenses, Intraocular",E07.695.460
22317913,2012-02-07T00:00:00,Middle Aged,M01.060.116.630
22317913,2012-02-07T00:00:00,Prostheses and Implants,E07.695
22317913,2012-02-07T00:00:00,Treatment Outcome,E01.789.800
22317913,2012-02-07T00:00:00,Treatment Outcome,N04.761.559.590.800
22317913,2012-02-07T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22317913,2012-02-07T00:00:00,Visual Acuity,E01.370.380.850.950
22317913,2012-02-07T00:00:00,Visual Acuity,F02.463.593.932.901
22317913,2012-02-07T00:00:00,Visual Acuity,G14.940
22317913,2012-02-07T00:00:00,Young Adult,M01.060.116.815
22318689,2012-02-07T00:00:00,Adult,M01.060.116
22318689,2012-02-07T00:00:00,Bias (Epidemiology),N05.715.350.150
22318689,2012-02-07T00:00:00,Bias (Epidemiology),N06.850.490.500
22318689,2012-02-07T00:00:00,Data Collection,E05.318.308
22318689,2012-02-07T00:00:00,Data Collection,L01.280
22318689,2012-02-07T00:00:00,Data Collection,N05.715.360.300
22318689,2012-02-07T00:00:00,Data Collection,N06.850.520.308
22318689,2012-02-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22318689,2012-02-07T00:00:00,Interviews as Topic,E05.318.308.420
22318689,2012-02-07T00:00:00,Interviews as Topic,L01.280.520
22318689,2012-02-07T00:00:00,Interviews as Topic,N05.715.360.300.400
22318689,2012-02-07T00:00:00,Interviews as Topic,N06.850.520.308.420
22318689,2012-02-07T00:00:00,Middle Aged,M01.060.116.630
22318689,2012-02-07T00:00:00,Nicotinic Agonists,D27.505.519.625.120.140.700
22318689,2012-02-07T00:00:00,Nicotinic Agonists,D27.505.696.577.120.140.700
22318689,2012-02-07T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
22318689,2012-02-07T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
22318689,2012-02-07T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
22318689,2012-02-07T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
22318689,2012-02-07T00:00:00,Smoking,F01.145.466.753
22318689,2012-02-07T00:00:00,Smoking Cessation,F01.145.940.700
22318929,2012-02-07T00:00:00,Health Personnel,M01.526.485
22318929,2012-02-07T00:00:00,Health Personnel,N02.360
22318929,2012-02-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22318929,2012-02-07T00:00:00,Patient Compliance,F01.145.488.500
22318929,2012-02-07T00:00:00,Patient Compliance,N05.300.150.600.600
22318929,2012-02-07T00:00:00,Physician's Practice Patterns,N04.590.748
22318929,2012-02-07T00:00:00,Physician's Practice Patterns,N05.300.625
22318929,2012-02-07T00:00:00,Prescription Drugs,D26.670
22315182,2012-02-08T00:00:00,Animals,B01.050
22315182,2012-02-08T00:00:00,Cytokines,D12.644.276.374
22315182,2012-02-08T00:00:00,Cytokines,D12.776.467.374
22315182,2012-02-08T00:00:00,Cytokines,D23.529.374
22315182,2012-02-08T00:00:00,"Disease Models, Animal",C22.232
22315182,2012-02-08T00:00:00,"Disease Models, Animal",E05.598.500
22315182,2012-02-08T00:00:00,"Disease Models, Animal",E05.599.395.080
22315182,2012-02-08T00:00:00,"Epilepsy, Temporal Lobe",C10.228.140.490.360.290
22315182,2012-02-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22315182,2012-02-08T00:00:00,Seizures,C10.228.140.490.631
22315182,2012-02-08T00:00:00,Seizures,C10.597.742
22315182,2012-02-08T00:00:00,Seizures,C23.888.592.742
22323433,2012-02-08T00:00:00,Adult,M01.060.116
22323433,2012-02-08T00:00:00,Aged,M01.060.116.100
22323433,2012-02-08T00:00:00,Body Mass Index,E01.370.600.115.100.125
22323433,2012-02-08T00:00:00,Body Mass Index,E05.041.124.125
22323433,2012-02-08T00:00:00,Body Mass Index,G07.100.100.125
22323433,2012-02-08T00:00:00,Body Mass Index,N06.850.505.200.100.175
22323433,2012-02-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22323433,2012-02-08T00:00:00,Middle Aged,M01.060.116.630
22323433,2012-02-08T00:00:00,Treatment Outcome,E01.789.800
22323433,2012-02-08T00:00:00,Treatment Outcome,N04.761.559.590.800
22323433,2012-02-08T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22323433,2012-02-08T00:00:00,Young Adult,M01.060.116.815
22377486,2012-02-08T00:00:00,"Abnormalities, Multiple",C16.131.077
22377486,2012-02-08T00:00:00,Brain,A08.186.211
22377486,2012-02-08T00:00:00,Epilepsy,C10.228.140.490
22377486,2012-02-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22377486,2012-02-08T00:00:00,Phenotype,G05.695
22377486,2012-02-08T00:00:00,Syndrome,C23.550.288.500
22313320,2012-02-09T00:00:00,Fluorenes,D02.455.426.559.847.389
22313320,2012-02-09T00:00:00,Fluorenes,D04.615.389
22313320,2012-02-09T00:00:00,Materials Testing,E05.570
22313320,2012-02-09T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
22313320,2012-02-09T00:00:00,"Microscopy, Fluorescence",E05.595.458
22313320,2012-02-09T00:00:00,Nanostructures,J01.637.512
22313320,2012-02-09T00:00:00,Polymers,D05.750
22313320,2012-02-09T00:00:00,Polymers,D25.720
22313320,2012-02-09T00:00:00,Polymers,J01.637.051.720
22313320,2012-02-09T00:00:00,Radiation Dosage,E05.799.513
22313320,2012-02-09T00:00:00,Radiation Dosage,G01.201.875.740
22313320,2012-02-09T00:00:00,Radiation Dosage,N06.850.810.250
22313320,2012-02-09T00:00:00,Radiometry,E05.799
22313320,2012-02-09T00:00:00,Static Electricity,G01.201.249.820
22321070,2012-02-09T00:00:00,Animals,B01.050
22321070,2012-02-09T00:00:00,"Behavior, Addictive",F01.145.527.100.120
22321070,2012-02-09T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
22321070,2012-02-09T00:00:00,Cocaine,D02.145.074.722.388
22321070,2012-02-09T00:00:00,Cocaine,D03.132.889.354
22321070,2012-02-09T00:00:00,Cocaine,D03.605.869.388
22321070,2012-02-09T00:00:00,Cocaine,D04.075.080.875.099.722.388
22321070,2012-02-09T00:00:00,"Conditioning, Operant",F02.463.425.179.509
22321070,2012-02-09T00:00:00,Cues,F02.463.425.234
22321070,2012-02-09T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.150.800
22321070,2012-02-09T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.600.220
22321070,2012-02-09T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.150.800
22321070,2012-02-09T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.600.220
22321070,2012-02-09T00:00:00,Motor Activity,F01.145.632
22321070,2012-02-09T00:00:00,Motor Activity,G11.427.590.530.698
22321070,2012-02-09T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
22321070,2012-02-09T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22321070,2012-02-09T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
22321070,2012-02-09T00:00:00,Self Administration,E02.319.890
22321070,2012-02-09T00:00:00,Self Administration,E02.900.890
22322338,2012-02-09T00:00:00,Bacterial Proteins,D12.776.097
22322338,2012-02-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22322338,2012-02-09T00:00:00,"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",E05.196.566.755
22322338,2012-02-09T00:00:00,Staphylococcus aureus,B03.300.390.400.800.750.100
22322338,2012-02-09T00:00:00,Staphylococcus aureus,B03.510.100.750.750.100
22322338,2012-02-09T00:00:00,Staphylococcus aureus,B03.510.400.790.750.100
22342406,2012-02-09T00:00:00,Animals,B01.050
22342406,2012-02-09T00:00:00,"Diabetes Mellitus, Experimental",C18.452.394.750.074
22342406,2012-02-09T00:00:00,"Diabetes Mellitus, Experimental",C19.246.240
22342406,2012-02-09T00:00:00,"Diabetes Mellitus, Experimental",E05.598.500.374
22342406,2012-02-09T00:00:00,Heart,A07.541
22342406,2012-02-09T00:00:00,Insulin,D06.472.699.587.740.625
22342406,2012-02-09T00:00:00,Insulin,D12.644.548.586.740.625
22342406,2012-02-09T00:00:00,"Mitochondria, Heart",A11.284.430.214.190.875.564.627.603
22342406,2012-02-09T00:00:00,"Mitochondria, Heart",A11.284.835.626.627.603
22342406,2012-02-09T00:00:00,Mitochondrial Proteins,D12.776.575
22342406,2012-02-09T00:00:00,Myocardium,A02.633.580
22342406,2012-02-09T00:00:00,Myocardium,A07.541.704
22342406,2012-02-09T00:00:00,Myocardium,A10.690.552.750
22342406,2012-02-09T00:00:00,Oxidative Stress,G03.495.710
22342406,2012-02-09T00:00:00,Oxidative Stress,G07.700.830.750
22342406,2012-02-09T00:00:00,Oxygen Consumption,G03.730
22342406,2012-02-09T00:00:00,Reactive Oxygen Species,D01.339.431
22342406,2012-02-09T00:00:00,Reactive Oxygen Species,D01.650.775
22347450,2012-02-09T00:00:00,Animals,B01.050
22347450,2012-02-09T00:00:00,Cell Proliferation,G04.299.233.750
22347450,2012-02-09T00:00:00,Cell Proliferation,G07.700.320.249.410.750
22347450,2012-02-09T00:00:00,Down-Regulation,G02.111.087.225
22347450,2012-02-09T00:00:00,Down-Regulation,G02.149.115.225
22347450,2012-02-09T00:00:00,Down-Regulation,G05.355.315.200
22347450,2012-02-09T00:00:00,Down-Regulation,G07.690.812.230
22347450,2012-02-09T00:00:00,Down-Regulation,G07.700.680.230
22347450,2012-02-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22347450,2012-02-09T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
22347450,2012-02-09T00:00:00,Prostatic Neoplasms,C12.294.260.750
22347450,2012-02-09T00:00:00,Prostatic Neoplasms,C12.294.565.625
22347450,2012-02-09T00:00:00,Prostatic Neoplasms,C12.758.409.750
22347450,2012-02-09T00:00:00,Protein Isoforms,D12.776.800
22347450,2012-02-09T00:00:00,"Receptors, Androgen",D12.776.260.698.750.150
22347450,2012-02-09T00:00:00,"Receptors, Androgen",D12.776.826.750.150
22347450,2012-02-09T00:00:00,"Receptors, Androgen",D12.776.930.669.750.150
22325835,2012-02-10T00:00:00,"Abnormalities, Multiple",C16.131.077
22325835,2012-02-10T00:00:00,Adult,M01.060.116
22325835,2012-02-10T00:00:00,Analgesics,D27.505.696.663.850.014
22325835,2012-02-10T00:00:00,Analgesics,D27.505.954.427.040
22325835,2012-02-10T00:00:00,"Anesthesia, General",E03.155.197
22325835,2012-02-10T00:00:00,"Anesthetics, Inhalation",D27.505.696.277.100.035.060
22325835,2012-02-10T00:00:00,"Anesthetics, Inhalation",D27.505.954.427.210.100.035.060
22325835,2012-02-10T00:00:00,Cesarean Section,E04.520.252.500
22325835,2012-02-10T00:00:00,Fiber Optic Technology,H01.671.617.249
22325835,2012-02-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22325835,2012-02-10T00:00:00,Ketamine,D02.455.426.392.368.367.652
22325835,2012-02-10T00:00:00,Laryngoscopy,E01.370.386.460
22325835,2012-02-10T00:00:00,Laryngoscopy,E01.370.388.250.525
22325835,2012-02-10T00:00:00,Laryngoscopy,E04.580.373
22325835,2012-02-10T00:00:00,Laryngoscopy,E04.800.250.525
22325835,2012-02-10T00:00:00,Posture,G11.427.695
22325835,2012-02-10T00:00:00,Pregnancy,G08.686.785.760.769
22325835,2012-02-10T00:00:00,Pregnancy Complications,C13.703
22325835,2012-02-10T00:00:00,Propofol,D02.755.773
22325835,2012-02-10T00:00:00,Young Adult,M01.060.116.815
22334024,2012-02-10T00:00:00,Adult,M01.060.116
22334024,2012-02-10T00:00:00,Automobile Driving,I03.125
22334024,2012-02-10T00:00:00,Behavior,F01.145
22334024,2012-02-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22386866,2012-02-10T00:00:00,Fibroblasts,A11.329.228
22386866,2012-02-10T00:00:00,Fibroblasts,A11.872.228
22386866,2012-02-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22386866,2012-02-10T00:00:00,Interleukin-6,D12.644.276.374.465.506
22386866,2012-02-10T00:00:00,Interleukin-6,D12.776.467.374.465.506
22386866,2012-02-10T00:00:00,Interleukin-6,D23.529.374.465.506
22386866,2012-02-10T00:00:00,Lipopolysaccharides,D09.400.500
22386866,2012-02-10T00:00:00,Lipopolysaccharides,D09.698.718.450
22386866,2012-02-10T00:00:00,Lipopolysaccharides,D10.494
22386866,2012-02-10T00:00:00,Lipopolysaccharides,D23.050.161.616.525
22386866,2012-02-10T00:00:00,Lipopolysaccharides,D23.946.123.329.500
22386866,2012-02-10T00:00:00,Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567
22386866,2012-02-10T00:00:00,Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750
22386866,2012-02-10T00:00:00,Mitogen-Activated Protein Kinases,D12.644.360.450
22386866,2012-02-10T00:00:00,Mitogen-Activated Protein Kinases,D12.776.476.450
22386866,2012-02-10T00:00:00,Monocytes,A11.118.637.555.652
22386866,2012-02-10T00:00:00,Monocytes,A11.148.580
22386866,2012-02-10T00:00:00,Monocytes,A11.627.624
22386866,2012-02-10T00:00:00,Monocytes,A11.733.547
22386866,2012-02-10T00:00:00,Monocytes,A15.145.229.637.555.652
22386866,2012-02-10T00:00:00,Monocytes,A15.378.316.580
22386866,2012-02-10T00:00:00,Monocytes,A15.382.490.555.652
22386866,2012-02-10T00:00:00,Monocytes,A15.382.680.547
22386866,2012-02-10T00:00:00,Monocytes,A15.382.812.547
22386866,2012-02-10T00:00:00,NF-kappa B,D12.776.260.600
22386866,2012-02-10T00:00:00,NF-kappa B,D12.776.660.600
22386866,2012-02-10T00:00:00,NF-kappa B,D12.776.930.600
22386866,2012-02-10T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
22386866,2012-02-10T00:00:00,"RNA, Messenger",D13.444.735.544
22412206,2012-02-10T00:00:00,"Education, Pharmacy",I02.358.525
22412206,2012-02-10T00:00:00,Faculty,I02.463
22412206,2012-02-10T00:00:00,Faculty,M01.526.339
22412206,2012-02-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22412206,2012-02-10T00:00:00,Minority Groups,I01.880.371
22412206,2012-02-10T00:00:00,Questionnaires,E05.318.308.750
22412206,2012-02-10T00:00:00,Questionnaires,L01.280.800
22412206,2012-02-10T00:00:00,Questionnaires,N05.715.360.300.695
22412206,2012-02-10T00:00:00,Questionnaires,N06.850.520.308.750
22412206,2012-02-10T00:00:00,"Schools, Pharmacy",I02.783.660.694
22500925,2012-02-10T00:00:00,Adult,M01.060.116
22500925,2012-02-10T00:00:00,Aged,M01.060.116.100
22500925,2012-02-10T00:00:00,Algorithms,G17.035
22500925,2012-02-10T00:00:00,Algorithms,L01.224.050
22500925,2012-02-10T00:00:00,Artifacts,E05.047
22500925,2012-02-10T00:00:00,Brain,A08.186.211
22500925,2012-02-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22500925,2012-02-10T00:00:00,Image Enhancement,E01.370.350.600.350
22500925,2012-02-10T00:00:00,Image Enhancement,L01.224.308.380
22500925,2012-02-10T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
22500925,2012-02-10T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
22500925,2012-02-10T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
22500925,2012-02-10T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
22500925,2012-02-10T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
22500925,2012-02-10T00:00:00,Middle Aged,M01.060.116.630
22500925,2012-02-10T00:00:00,"Pattern Recognition, Physiological",F02.463.593.524
22500925,2012-02-10T00:00:00,Young Adult,M01.060.116.815
22330985,2012-02-11T00:00:00,Brachytherapy,E02.815.150
22330985,2012-02-11T00:00:00,Carcinoma,C04.557.470.200
22330985,2012-02-11T00:00:00,Endometrial Neoplasms,C04.588.945.418.948.585
22330985,2012-02-11T00:00:00,Endometrial Neoplasms,C13.351.500.852.762.200
22330985,2012-02-11T00:00:00,Endometrial Neoplasms,C13.351.937.418.875.200
22330985,2012-02-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22330985,2012-02-11T00:00:00,Postoperative Care,E02.760.722.700
22330985,2012-02-11T00:00:00,Postoperative Care,E04.624
22330985,2012-02-11T00:00:00,Postoperative Care,N02.421.585.722.700
22330985,2012-02-11T00:00:00,Urinary Bladder,A05.810.890
22333221,2012-02-12T00:00:00,Complement Activation,G12.425.255
22333221,2012-02-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22333221,2012-02-12T00:00:00,Mass Spectrometry,E05.196.566
22333221,2012-02-12T00:00:00,Staphylococcal Infections,C01.252.410.868
22333221,2012-02-12T00:00:00,Staphylococcus aureus,B03.300.390.400.800.750.100
22333221,2012-02-12T00:00:00,Staphylococcus aureus,B03.510.100.750.750.100
22333221,2012-02-12T00:00:00,Staphylococcus aureus,B03.510.400.790.750.100
22330139,2012-02-13T00:00:00,Bone and Bones,A02.835.232
22330139,2012-02-13T00:00:00,Bone and Bones,A10.165.265
22330139,2012-02-13T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
22330139,2012-02-13T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
22330139,2012-02-13T00:00:00,Chemokine CXCL13,D12.644.276.374.200.120.650
22330139,2012-02-13T00:00:00,Chemokine CXCL13,D12.776.467.374.200.120.650
22330139,2012-02-13T00:00:00,Chemokine CXCL13,D23.125.300.120.650
22330139,2012-02-13T00:00:00,Chemokine CXCL13,D23.469.200.120.650
22330139,2012-02-13T00:00:00,Chemokine CXCL13,D23.529.374.200.120.650
22330139,2012-02-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22330139,2012-02-13T00:00:00,Mouth Neoplasms,C04.588.443.591
22330139,2012-02-13T00:00:00,Mouth Neoplasms,C07.465.565
22330139,2012-02-13T00:00:00,Osteoblasts,A11.329.629
22330139,2012-02-13T00:00:00,Proto-Oncogene Proteins c-myc,D12.776.260.676
22330139,2012-02-13T00:00:00,Proto-Oncogene Proteins c-myc,D12.776.624.664.700.189
22330139,2012-02-13T00:00:00,Proto-Oncogene Proteins c-myc,D12.776.660.765
22330139,2012-02-13T00:00:00,RANK Ligand,D12.644.276.374.750.562
22330139,2012-02-13T00:00:00,RANK Ligand,D12.644.276.972.562
22330139,2012-02-13T00:00:00,RANK Ligand,D12.776.467.374.750.562
22330139,2012-02-13T00:00:00,RANK Ligand,D12.776.467.972.562
22330139,2012-02-13T00:00:00,RANK Ligand,D23.529.374.750.562
22330139,2012-02-13T00:00:00,RANK Ligand,D23.529.972.562
22330139,2012-02-13T00:00:00,Stromal Cells,A11.329.830
22341724,2012-02-14T00:00:00,Aged,M01.060.116.100
22341724,2012-02-14T00:00:00,Cardiac Surgical Procedures,E04.100.376
22341724,2012-02-14T00:00:00,Cardiac Surgical Procedures,E04.928.220
22341724,2012-02-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22341724,2012-02-14T00:00:00,Incidence,E05.318.308.985.525.375
22341724,2012-02-14T00:00:00,Incidence,L01.280.975.525.375
22341724,2012-02-14T00:00:00,Incidence,N01.224.935.597.500
22341724,2012-02-14T00:00:00,Incidence,N06.850.505.400.975.525.375
22341724,2012-02-14T00:00:00,Incidence,N06.850.520.308.985.525.375
22341724,2012-02-14T00:00:00,Middle Aged,M01.060.116.630
22341724,2012-02-14T00:00:00,Vasoconstrictor Agents,D27.505.954.411.793
22348081,2012-02-14T00:00:00,Animals,B01.050
22348081,2012-02-14T00:00:00,Disease Progression,C23.550.291.656
22348081,2012-02-14T00:00:00,Extracellular Matrix,A11.284.295.310
22348081,2012-02-14T00:00:00,Neoplasm Invasiveness,C04.697.645
22348081,2012-02-14T00:00:00,Neoplasm Invasiveness,C23.550.727.645
22348081,2012-02-14T00:00:00,Osteonectin,D12.776.157.125.715
22348081,2012-02-14T00:00:00,Osteonectin,D12.776.395.600
22348081,2012-02-14T00:00:00,Pancreatic Neoplasms,C04.588.274.761
22348081,2012-02-14T00:00:00,Pancreatic Neoplasms,C04.588.322.421
22348081,2012-02-14T00:00:00,Pancreatic Neoplasms,C06.301.761
22348081,2012-02-14T00:00:00,Pancreatic Neoplasms,C06.689.667
22348081,2012-02-14T00:00:00,Pancreatic Neoplasms,C19.344.421
22348081,2012-02-14T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
22348081,2012-02-14T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
22348081,2012-02-14T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
22348081,2012-02-14T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
22348081,2012-02-14T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
22348081,2012-02-14T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
22348081,2012-02-14T00:00:00,Transforming Growth Factor beta,D23.529.374.687
22348081,2012-02-14T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
22348081,2012-02-14T00:00:00,Transforming Growth Factor beta,D23.529.960.720
22348081,2012-02-14T00:00:00,Treatment Outcome,E01.789.800
22348081,2012-02-14T00:00:00,Treatment Outcome,N04.761.559.590.800
22348081,2012-02-14T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22296270,2012-02-15T00:00:00,Adsorption,G02.149.047
22296270,2012-02-15T00:00:00,Adsorption,G02.149.767.029
22296270,2012-02-15T00:00:00,Adsorption,G02.842.750.029
22296270,2012-02-15T00:00:00,Plutonium,D01.268.033.700
22296270,2012-02-15T00:00:00,Plutonium,D01.268.271.100.700
22296270,2012-02-15T00:00:00,Plutonium,D01.268.556.700
22296270,2012-02-15T00:00:00,Plutonium,D01.552.020.734
22296270,2012-02-15T00:00:00,Plutonium,D01.552.544.700
22296270,2012-02-15T00:00:00,Surface Properties,G02.842.850
22296270,2012-02-15T00:00:00,Time Factors,G01.910.857
22335237,2012-02-15T00:00:00,Adolescent,M01.060.057
22335237,2012-02-15T00:00:00,Anxiety,F01.470.132
22335237,2012-02-15T00:00:00,Attention,F02.830.104.214
22335237,2012-02-15T00:00:00,Cognition,F02.463.188
22335237,2012-02-15T00:00:00,Depression,F01.145.126.350
22335237,2012-02-15T00:00:00,Executive Function,F02.463.217
22335237,2012-02-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22335237,2012-02-15T00:00:00,Neuropsychological Tests,F04.711.513
22335237,2012-02-15T00:00:00,Personality Inventory,F04.711.647.513
22335237,2012-02-15T00:00:00,Questionnaires,E05.318.308.750
22335237,2012-02-15T00:00:00,Questionnaires,L01.280.800
22335237,2012-02-15T00:00:00,Questionnaires,N05.715.360.300.695
22335237,2012-02-15T00:00:00,Questionnaires,N06.850.520.308.750
22335237,2012-02-15T00:00:00,Sleep,F02.830.855
22335237,2012-02-15T00:00:00,Sleep,G11.561.600.815
22335237,2012-02-15T00:00:00,Sleep Disorders,C10.886
22335237,2012-02-15T00:00:00,Sleep Disorders,C23.888.592.796
22335237,2012-02-15T00:00:00,Sleep Disorders,F03.870
22335237,2012-02-15T00:00:00,Young Adult,M01.060.116.815
22335823,2012-02-15T00:00:00,Adult,M01.060.116
22335823,2012-02-15T00:00:00,Aged,M01.060.116.100
22335823,2012-02-15T00:00:00,Cardiovascular Diseases,C14
22335823,2012-02-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22335823,2012-02-15T00:00:00,Middle Aged,M01.060.116.630
22335823,2012-02-15T00:00:00,Nutrition Surveys,E05.318.308.250.600
22335823,2012-02-15T00:00:00,Nutrition Surveys,E05.318.308.585.550
22335823,2012-02-15T00:00:00,Nutrition Surveys,N05.715.360.300.375.560
22335823,2012-02-15T00:00:00,Nutrition Surveys,N05.715.360.300.560.565
22335823,2012-02-15T00:00:00,Nutrition Surveys,N06.850.520.308.250.600
22335823,2012-02-15T00:00:00,Nutrition Surveys,N06.850.520.308.585.550
22335823,2012-02-15T00:00:00,Risk Factors,E05.318.740.600.800.725
22335823,2012-02-15T00:00:00,Risk Factors,N05.715.350.200.700
22335823,2012-02-15T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22335823,2012-02-15T00:00:00,Risk Factors,N06.850.490.625.750
22335823,2012-02-15T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22335823,2012-02-15T00:00:00,Stroke,C10.228.140.300.775
22335823,2012-02-15T00:00:00,Stroke,C14.907.253.855
22335823,2012-02-15T00:00:00,Time Factors,G01.910.857
22335823,2012-02-15T00:00:00,United States,Z01.107.567.875
22341415,2012-02-15T00:00:00,Accidental Falls,N06.850.135.122
22341415,2012-02-15T00:00:00,Hepatectomy,E04.210.556
22341415,2012-02-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22341415,2012-02-15T00:00:00,Suture Techniques,E04.901
22341415,2012-02-15T00:00:00,Thoracic Surgical Procedures,E04.928
22341415,2012-02-15T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
22341415,2012-02-15T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
22341415,2012-02-15T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
22341415,2012-02-15T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
22341415,2012-02-15T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
22341415,2012-02-15T00:00:00,Treatment Outcome,E01.789.800
22341415,2012-02-15T00:00:00,Treatment Outcome,N04.761.559.590.800
22341415,2012-02-15T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22341415,2012-02-15T00:00:00,"Wounds, Nonpenetrating",C21.866.974
22341415,2012-02-15T00:00:00,Young Adult,M01.060.116.815
22341427,2012-02-15T00:00:00,Algorithms,G17.035
22341427,2012-02-15T00:00:00,Algorithms,L01.224.050
22341427,2012-02-15T00:00:00,"Child, Preschool",M01.060.406.448
22341427,2012-02-15T00:00:00,Heart Transplantation,E04.100.376.475
22341427,2012-02-15T00:00:00,Heart Transplantation,E04.928.220.390
22341427,2012-02-15T00:00:00,Heart Transplantation,E04.936.450.475
22341427,2012-02-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22341427,2012-02-15T00:00:00,Hypoplastic Left Heart Syndrome,C14.240.400.625
22341427,2012-02-15T00:00:00,Hypoplastic Left Heart Syndrome,C14.280.400.625
22341427,2012-02-15T00:00:00,Hypoplastic Left Heart Syndrome,C16.131.240.400.625
22341427,2012-02-15T00:00:00,Infant,M01.060.703
22341427,2012-02-15T00:00:00,"Infant, Newborn",M01.060.703.520
22341427,2012-02-15T00:00:00,"Infant, Premature",M01.060.703.520.520
22341427,2012-02-15T00:00:00,Risk Factors,E05.318.740.600.800.725
22341427,2012-02-15T00:00:00,Risk Factors,N05.715.350.200.700
22341427,2012-02-15T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22341427,2012-02-15T00:00:00,Risk Factors,N06.850.490.625.750
22341427,2012-02-15T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22341427,2012-02-15T00:00:00,Treatment Outcome,E01.789.800
22341427,2012-02-15T00:00:00,Treatment Outcome,N04.761.559.590.800
22341427,2012-02-15T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22349666,2012-02-15T00:00:00,"Cardiac Output, Low",C14.280.148
22349666,2012-02-15T00:00:00,"Cardiac Output, Low",C23.888.192
22349666,2012-02-15T00:00:00,Cardiac Surgical Procedures,E04.100.376
22349666,2012-02-15T00:00:00,Cardiac Surgical Procedures,E04.928.220
22349666,2012-02-15T00:00:00,Glucocorticoids,D06.472.040.543
22349666,2012-02-15T00:00:00,Glucocorticoids,D27.505.696.399.472.488
22349666,2012-02-15T00:00:00,"Heart Defects, Congenital",C14.240.400
22349666,2012-02-15T00:00:00,"Heart Defects, Congenital",C14.280.400
22349666,2012-02-15T00:00:00,"Heart Defects, Congenital",C16.131.240.400
22349666,2012-02-15T00:00:00,Hospital Mortality,E05.318.308.985.550.400
22349666,2012-02-15T00:00:00,Hospital Mortality,L01.280.975.550.400
22349666,2012-02-15T00:00:00,Hospital Mortality,N01.224.935.698.400
22349666,2012-02-15T00:00:00,Hospital Mortality,N06.850.505.400.975.550.400
22349666,2012-02-15T00:00:00,Hospital Mortality,N06.850.520.308.985.550.400
22349666,2012-02-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22349666,2012-02-15T00:00:00,Incidence,E05.318.308.985.525.375
22349666,2012-02-15T00:00:00,Incidence,L01.280.975.525.375
22349666,2012-02-15T00:00:00,Incidence,N01.224.935.597.500
22349666,2012-02-15T00:00:00,Incidence,N06.850.505.400.975.525.375
22349666,2012-02-15T00:00:00,Incidence,N06.850.520.308.985.525.375
22349666,2012-02-15T00:00:00,"Infant, Newborn",M01.060.703.520
22349666,2012-02-15T00:00:00,"Intensive Care Units, Pediatric",N02.278.388.493.390
22349666,2012-02-15T00:00:00,Length of Stay,E02.760.400.480
22349666,2012-02-15T00:00:00,Length of Stay,N02.421.585.400.480
22349666,2012-02-15T00:00:00,Myocardial Contraction,G09.330.190.541
22349666,2012-02-15T00:00:00,Myocardial Contraction,G11.427.590.540.570
22349666,2012-02-15T00:00:00,Postoperative Complications,C23.550.767
22349666,2012-02-15T00:00:00,United States,Z01.107.567.875
22365970,2012-02-15T00:00:00,Animals,B01.050
22365970,2012-02-15T00:00:00,Ceramides,D02.065.313
22365970,2012-02-15T00:00:00,Ceramides,D09.400.410.420.525.200
22365970,2012-02-15T00:00:00,Ceramides,D10.390.470.675.200
22365970,2012-02-15T00:00:00,Ceramides,D10.570.877.360.612.200
22365970,2012-02-15T00:00:00,"Mitochondria, Liver",A11.284.430.214.190.875.564.461
22365970,2012-02-15T00:00:00,"Mitochondria, Liver",A11.284.835.626.461
22365970,2012-02-15T00:00:00,"Models, Molecular",E05.599.595
22365970,2012-02-15T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22365970,2012-02-15T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
22335736,2012-02-16T00:00:00,Adolescent,M01.060.057
22335736,2012-02-16T00:00:00,Adult,M01.060.116
22335736,2012-02-16T00:00:00,Anticonvulsants,D27.505.954.427.080
22335736,2012-02-16T00:00:00,Child,M01.060.406
22335736,2012-02-16T00:00:00,"Child, Preschool",M01.060.406.448
22335736,2012-02-16T00:00:00,Double-Blind Method,E05.318.780.300
22335736,2012-02-16T00:00:00,Double-Blind Method,E05.581.500.300
22335736,2012-02-16T00:00:00,Double-Blind Method,N05.715.360.780.320
22335736,2012-02-16T00:00:00,Double-Blind Method,N06.850.520.445.300
22335736,2012-02-16T00:00:00,Emergency Medical Services,N02.421.297
22335736,2012-02-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22335736,2012-02-16T00:00:00,Infant,M01.060.703
22335736,2012-02-16T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
22335736,2012-02-16T00:00:00,Middle Aged,M01.060.116.630
22335736,2012-02-16T00:00:00,Status Epilepticus,C10.228.140.490.690
22335736,2012-02-16T00:00:00,Time Factors,G01.910.857
22335736,2012-02-16T00:00:00,Treatment Outcome,E01.789.800
22335736,2012-02-16T00:00:00,Treatment Outcome,N04.761.559.590.800
22335736,2012-02-16T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22336945,2012-02-16T00:00:00,Adult,M01.060.116
22336945,2012-02-16T00:00:00,Aged,M01.060.116.100
22336945,2012-02-16T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
22336945,2012-02-16T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
22336945,2012-02-16T00:00:00,Case-Control Studies,E05.318.760.500.500
22336945,2012-02-16T00:00:00,Case-Control Studies,N05.715.360.775.175.200
22336945,2012-02-16T00:00:00,Case-Control Studies,N06.850.520.450.500.500
22336945,2012-02-16T00:00:00,DNA Helicases,D08.811.277.040.025.159
22336945,2012-02-16T00:00:00,DNA Helicases,D08.811.399.340
22336945,2012-02-16T00:00:00,DNA Repair,G02.111.087.219
22336945,2012-02-16T00:00:00,DNA Repair,G02.149.115.219
22336945,2012-02-16T00:00:00,DNA Repair,G05.355.195
22336945,2012-02-16T00:00:00,DNA Repair Enzymes,D08.811.074
22336945,2012-02-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22336945,2012-02-16T00:00:00,Middle Aged,M01.060.116.630
22336945,2012-02-16T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
22336945,2012-02-16T00:00:00,Skin Neoplasms,C04.588.805
22336945,2012-02-16T00:00:00,Skin Neoplasms,C17.800.882
22343285,2012-02-16T00:00:00,Adolescent,M01.060.057
22343285,2012-02-16T00:00:00,Adult,M01.060.116
22343285,2012-02-16T00:00:00,Aged,M01.060.116.100
22343285,2012-02-16T00:00:00,Brain,A08.186.211
22343285,2012-02-16T00:00:00,Brain Mapping,E01.370.350.086
22343285,2012-02-16T00:00:00,Brain Mapping,E01.370.376.149
22343285,2012-02-16T00:00:00,Brain Mapping,E05.132
22343285,2012-02-16T00:00:00,Diagnostic Imaging,E01.370.350
22343285,2012-02-16T00:00:00,Genetic Variation,G05.365
22343285,2012-02-16T00:00:00,Genome-Wide Association Study,E05.318.416.249
22343285,2012-02-16T00:00:00,Genome-Wide Association Study,E05.318.780.392
22343285,2012-02-16T00:00:00,Genome-Wide Association Study,E05.393.385.500
22343285,2012-02-16T00:00:00,Genome-Wide Association Study,E05.393.522.500
22343285,2012-02-16T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
22343285,2012-02-16T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
22343285,2012-02-16T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
22343285,2012-02-16T00:00:00,Genomics,H01.158.273.180.350
22343285,2012-02-16T00:00:00,Genomics,H01.158.273.343.350
22343285,2012-02-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22343285,2012-02-16T00:00:00,Middle Aged,M01.060.116.630
22343285,2012-02-16T00:00:00,"Models, Genetic",E05.599.395.397
22343285,2012-02-16T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
22343285,2012-02-16T00:00:00,Saccharomyces cerevisiae,B01.300.107.795.785.800
22343285,2012-02-16T00:00:00,Saccharomyces cerevisiae,B01.300.930.705.655
22343285,2012-02-16T00:00:00,Visual Cortex,A08.186.211.730.885.287.500.571.735
22343643,2012-02-16T00:00:00,Health Care Costs,N03.219.151.400
22343643,2012-02-16T00:00:00,Health Care Costs,N05.300.375
22343643,2012-02-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22343643,2012-02-16T00:00:00,Medicare,N03.219.521.346.506.564.663
22343643,2012-02-16T00:00:00,Medicare,N03.219.521.576.343.840
22343643,2012-02-16T00:00:00,Medicare,N03.706.615.696
22343643,2012-02-16T00:00:00,South Carolina,Z01.107.567.875.075.662
22343643,2012-02-16T00:00:00,South Carolina,Z01.107.567.875.750.700
22343643,2012-02-16T00:00:00,Stroke,C10.228.140.300.775
22343643,2012-02-16T00:00:00,Stroke,C14.907.253.855
22343643,2012-02-16T00:00:00,United States,Z01.107.567.875
22343650,2012-02-16T00:00:00,"Data Interpretation, Statistical",E05.245.380
22343650,2012-02-16T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
22343650,2012-02-16T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
22343650,2012-02-16T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
22343650,2012-02-16T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
22343650,2012-02-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22343650,2012-02-16T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
22343650,2012-02-16T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
22343650,2012-02-16T00:00:00,Probability,E05.318.740.600
22343650,2012-02-16T00:00:00,Probability,G17.680
22343650,2012-02-16T00:00:00,Probability,N05.715.360.750.625
22343650,2012-02-16T00:00:00,Probability,N06.850.520.830.600
22343650,2012-02-16T00:00:00,Research Design,E05.581.500
22343650,2012-02-16T00:00:00,Research Design,H01.770.644.728
22343650,2012-02-16T00:00:00,Stroke,C10.228.140.300.775
22343650,2012-02-16T00:00:00,Stroke,C14.907.253.855
22343650,2012-02-16T00:00:00,Treatment Outcome,E01.789.800
22343650,2012-02-16T00:00:00,Treatment Outcome,N04.761.559.590.800
22343650,2012-02-16T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22344711,2012-02-16T00:00:00,Disease Progression,C23.550.291.656
22344711,2012-02-16T00:00:00,Hearing,F02.830.816.263
22344711,2012-02-16T00:00:00,Hearing,G11.561.600.810.263
22344711,2012-02-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22344711,2012-02-16T00:00:00,Incidence,E05.318.308.985.525.375
22344711,2012-02-16T00:00:00,Incidence,L01.280.975.525.375
22344711,2012-02-16T00:00:00,Incidence,N01.224.935.597.500
22344711,2012-02-16T00:00:00,Incidence,N06.850.505.400.975.525.375
22344711,2012-02-16T00:00:00,Incidence,N06.850.520.308.985.525.375
22344711,2012-02-16T00:00:00,Infant,M01.060.703
22344711,2012-02-16T00:00:00,Otitis Media,C09.218.705.663
22344711,2012-02-16T00:00:00,Risk Factors,E05.318.740.600.800.725
22344711,2012-02-16T00:00:00,Risk Factors,N05.715.350.200.700
22344711,2012-02-16T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22344711,2012-02-16T00:00:00,Risk Factors,N06.850.490.625.750
22344711,2012-02-16T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22344711,2012-02-16T00:00:00,"Sleep Apnea, Obstructive",C08.618.085.852.850
22344711,2012-02-16T00:00:00,"Sleep Apnea, Obstructive",C10.886.425.800.750.850
22340009,2012-02-17T00:00:00,Animals,B01.050
22340009,2012-02-17T00:00:00,Carrier Proteins,D12.776.157
22340009,2012-02-17T00:00:00,Cocaine,D02.145.074.722.388
22340009,2012-02-17T00:00:00,Cocaine,D03.132.889.354
22340009,2012-02-17T00:00:00,Cocaine,D03.605.869.388
22340009,2012-02-17T00:00:00,Cocaine,D04.075.080.875.099.722.388
22340009,2012-02-17T00:00:00,Cocaine-Related Disorders,C21.739.300
22340009,2012-02-17T00:00:00,Cocaine-Related Disorders,F03.900.300
22340009,2012-02-17T00:00:00,Cues,F02.463.425.234
22340009,2012-02-17T00:00:00,"Disease Models, Animal",C22.232
22340009,2012-02-17T00:00:00,"Disease Models, Animal",E05.598.500
22340009,2012-02-17T00:00:00,"Disease Models, Animal",E05.599.395.080
22340009,2012-02-17T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.150.800
22340009,2012-02-17T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.600.220
22340009,2012-02-17T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.150.800
22340009,2012-02-17T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.600.220
22340009,2012-02-17T00:00:00,Glycine,D12.125.481
22340009,2012-02-17T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
22340009,2012-02-17T00:00:00,Protein Transport,G03.495.166.700
22340009,2012-02-17T00:00:00,Pyridines,D03.383.725
22340009,2012-02-17T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
22340009,2012-02-17T00:00:00,"Receptors, Metabotropic Glutamate",D12.776.543.750.100.450
22340009,2012-02-17T00:00:00,"Receptors, Metabotropic Glutamate",D12.776.543.750.720.200.450.500
22340009,2012-02-17T00:00:00,Self Administration,E02.319.890
22340009,2012-02-17T00:00:00,Self Administration,E02.900.890
22340009,2012-02-17T00:00:00,Synaptic Transmission,G02.111.087.800.850
22340009,2012-02-17T00:00:00,Synaptic Transmission,G02.149.115.800.850
22340009,2012-02-17T00:00:00,Synaptic Transmission,G04.299.880.850
22340009,2012-02-17T00:00:00,Synaptic Transmission,G07.265.337.900
22340009,2012-02-17T00:00:00,Synaptic Transmission,G07.700.240.900
22340009,2012-02-17T00:00:00,Synaptic Transmission,G11.561.600.835
22340009,2012-02-17T00:00:00,Thiazoles,D02.886.675
22340009,2012-02-17T00:00:00,Thiazoles,D03.383.129.708
22345109,2012-02-18T00:00:00,Aged,M01.060.116.100
22345109,2012-02-18T00:00:00,"Aneurysm, Dissecting",C14.907.055.050
22345109,2012-02-18T00:00:00,Catheterization,E02.148
22345109,2012-02-18T00:00:00,Catheterization,E05.157
22345109,2012-02-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22345109,2012-02-18T00:00:00,Intracranial Aneurysm,C10.228.140.300.510.600
22345109,2012-02-18T00:00:00,Intracranial Aneurysm,C14.907.055.635
22345109,2012-02-18T00:00:00,Intracranial Aneurysm,C14.907.253.560.300
22345109,2012-02-18T00:00:00,Middle Aged,M01.060.116.630
22345109,2012-02-18T00:00:00,Stents,E07.695.750
22345109,2012-02-18T00:00:00,Treatment Outcome,E01.789.800
22345109,2012-02-18T00:00:00,Treatment Outcome,N04.761.559.590.800
22345109,2012-02-18T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22345109,2012-02-18T00:00:00,United States,Z01.107.567.875
22709994,2012-02-18T00:00:00,"Accidents, Traffic",N06.850.135.392
22709994,2012-02-18T00:00:00,Adult,M01.060.116
22709994,2012-02-18T00:00:00,Automobile Driving,I03.125
22709994,2012-02-18T00:00:00,Awareness,F02.463.188.150
22709994,2012-02-18T00:00:00,Color,G01.201.875.770.578.199
22709994,2012-02-18T00:00:00,Color,G01.590.540.199
22709994,2012-02-18T00:00:00,Computer Simulation,L01.224.160
22709994,2012-02-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22709994,2012-02-18T00:00:00,Middle Aged,M01.060.116.630
22709994,2012-02-18T00:00:00,Students,I02.233.748
22709994,2012-02-18T00:00:00,Students,I02.851
22709994,2012-02-18T00:00:00,Students,M01.848
22709994,2012-02-18T00:00:00,Walking,G11.427.590.530.568.900
22709994,2012-02-18T00:00:00,Walking,G11.427.590.530.698.940
22709994,2012-02-18T00:00:00,Walking,I03.450.642.845.940
22709994,2012-02-18T00:00:00,Young Adult,M01.060.116.815
22361278,2012-02-20T00:00:00,"Diagnosis, Differential",E01.171
22361278,2012-02-20T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
22361278,2012-02-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22361278,2012-02-20T00:00:00,Manometry,E05.559
22363735,2012-02-20T00:00:00,Animals,B01.050
22363735,2012-02-20T00:00:00,Biological Transport,G03.495.166
22363735,2012-02-20T00:00:00,Golgi Apparatus,A11.284.430.214.190.875.336
22363735,2012-02-20T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
22363735,2012-02-20T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
22363735,2012-02-20T00:00:00,"Models, Biological",E05.599.395
22363735,2012-02-20T00:00:00,Rabbits,B01.050.150.900.649.521.700
22363735,2012-02-20T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
22363735,2012-02-20T00:00:00,rab GTP-Binding Proteins,D08.811.277.040.330.300.400.400
22363735,2012-02-20T00:00:00,rab GTP-Binding Proteins,D12.644.360.525.400
22363735,2012-02-20T00:00:00,rab GTP-Binding Proteins,D12.776.157.325.515.400
22363735,2012-02-20T00:00:00,rab GTP-Binding Proteins,D12.776.476.525.400
22356621,2012-02-22T00:00:00,Animals,B01.050
22356621,2012-02-22T00:00:00,"Behavior, Addictive",F01.145.527.100.120
22356621,2012-02-22T00:00:00,"Conditioning, Operant",F02.463.425.179.509
22356621,2012-02-22T00:00:00,Cues,F02.463.425.234
22356621,2012-02-22T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22356621,2012-02-22T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
22356621,2012-02-22T00:00:00,"Receptors, G-Protein-Coupled",D12.776.543.750.100
22356621,2012-02-22T00:00:00,"Receptors, Neuropeptide",D12.776.543.750.720.600
22356621,2012-02-22T00:00:00,"Receptors, Neuropeptide",D12.776.543.750.750.555
22356621,2012-02-22T00:00:00,Self Administration,E02.319.890
22356621,2012-02-22T00:00:00,Self Administration,E02.900.890
22360982,2012-02-22T00:00:00,Animals,B01.050
22360982,2012-02-22T00:00:00,CD8-Positive T-Lymphocytes,A11.118.637.555.567.569.220
22360982,2012-02-22T00:00:00,CD8-Positive T-Lymphocytes,A15.145.229.637.555.567.569.220
22360982,2012-02-22T00:00:00,CD8-Positive T-Lymphocytes,A15.382.490.555.567.569.220
22360982,2012-02-22T00:00:00,Cyclophosphamide,D02.455.526.728.650.730.243
22360982,2012-02-22T00:00:00,Cyclophosphamide,D02.705.670.243
22360982,2012-02-22T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
22360982,2012-02-22T00:00:00,Flow Cytometry,E05.200.500.386.350
22360982,2012-02-22T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
22360982,2012-02-22T00:00:00,"Immunotherapy, Adoptive",E02.095.465.425.400.330.050.400
22360982,2012-02-22T00:00:00,"Immunotherapy, Adoptive",E05.478.550.520.050.400
22360982,2012-02-22T00:00:00,Interleukin-12,D12.644.276.374.465.512
22360982,2012-02-22T00:00:00,Interleukin-12,D12.776.467.374.465.512
22360982,2012-02-22T00:00:00,Interleukin-12,D23.529.374.465.512
22360982,2012-02-22T00:00:00,Lymphocyte Activation,E01.450.495.482
22360982,2012-02-22T00:00:00,Lymphocyte Activation,E05.478.594.530
22360982,2012-02-22T00:00:00,Lymphocyte Activation,G12.425.747
22360982,2012-02-22T00:00:00,Lymphocyte Activation,G12.450.050.400.545
22360982,2012-02-22T00:00:00,Melanoma,C04.557.465.625.650.510
22360982,2012-02-22T00:00:00,Melanoma,C04.557.580.625.650.510
22360982,2012-02-22T00:00:00,Melanoma,C04.557.665.510
22360982,2012-02-22T00:00:00,Treatment Outcome,E01.789.800
22360982,2012-02-22T00:00:00,Treatment Outcome,N04.761.559.590.800
22360982,2012-02-22T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22361357,2012-02-22T00:00:00,Bacteria,B03
22361357,2012-02-22T00:00:00,Bacterial Infections,C01.252
22361357,2012-02-22T00:00:00,Beds,E07.325.220
22361357,2012-02-22T00:00:00,Disinfection,N06.850.780.200.450.850.375
22361357,2012-02-22T00:00:00,Hospitals,N02.278.421
22361357,2012-02-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22361357,2012-02-22T00:00:00,Intensive Care Units,N02.278.388.493
22360739,2012-02-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22360739,2012-02-23T00:00:00,"Infant, Newborn",M01.060.703.520
22360739,2012-02-23T00:00:00,Treatment Outcome,E01.789.800
22360739,2012-02-23T00:00:00,Treatment Outcome,N04.761.559.590.800
22360739,2012-02-23T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22363054,2012-02-23T00:00:00,Aged,M01.060.116.100
22363054,2012-02-23T00:00:00,Brain Ischemia,C10.228.140.300.150
22363054,2012-02-23T00:00:00,Brain Ischemia,C14.907.253.092
22363054,2012-02-23T00:00:00,"Constriction, Pathologic",C23.300.287
22363054,2012-02-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22363054,2012-02-23T00:00:00,Incidence,E05.318.308.985.525.375
22363054,2012-02-23T00:00:00,Incidence,L01.280.975.525.375
22363054,2012-02-23T00:00:00,Incidence,N01.224.935.597.500
22363054,2012-02-23T00:00:00,Incidence,N06.850.505.400.975.525.375
22363054,2012-02-23T00:00:00,Incidence,N06.850.520.308.985.525.375
22363054,2012-02-23T00:00:00,Middle Aged,M01.060.116.630
22363054,2012-02-23T00:00:00,Risk Factors,E05.318.740.600.800.725
22363054,2012-02-23T00:00:00,Risk Factors,N05.715.350.200.700
22363054,2012-02-23T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22363054,2012-02-23T00:00:00,Risk Factors,N06.850.490.625.750
22363054,2012-02-23T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22363054,2012-02-23T00:00:00,United States,Z01.107.567.875
22365933,2012-02-23T00:00:00,Binding Sites,G02.111.570.120
22365933,2012-02-23T00:00:00,Catalytic Domain,G02.111.570.120.704
22365933,2012-02-23T00:00:00,Catalytic Domain,G02.111.570.790.709.610.189
22365933,2012-02-23T00:00:00,"Crystallography, X-Ray",E05.196.309.742.225
22365933,2012-02-23T00:00:00,"Models, Molecular",E05.599.595
22365933,2012-02-23T00:00:00,Mycobacterium tuberculosis,B03.510.024.049.525.500.702
22365933,2012-02-23T00:00:00,Mycobacterium tuberculosis,B03.510.460.400.410.552.552.702
22365933,2012-02-23T00:00:00,Penicillin-Binding Proteins,D08.811.710
22365933,2012-02-23T00:00:00,Penicillin-Binding Proteins,D12.776.097.545
22365933,2012-02-23T00:00:00,Protein Conformation,G02.111.570.790.709
22365286,2012-02-24T00:00:00,Adolescent,M01.060.057
22365286,2012-02-24T00:00:00,Adult,M01.060.116
22365286,2012-02-24T00:00:00,Aged,M01.060.116.100
22365286,2012-02-24T00:00:00,Case-Control Studies,E05.318.760.500.500
22365286,2012-02-24T00:00:00,Case-Control Studies,N05.715.360.775.175.200
22365286,2012-02-24T00:00:00,Case-Control Studies,N06.850.520.450.500.500
22365286,2012-02-24T00:00:00,Gene Expression,G05.355.310
22365286,2012-02-24T00:00:00,Gene Expression Profiling,E05.393.332
22365286,2012-02-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22365286,2012-02-24T00:00:00,Middle Aged,M01.060.116.630
22365286,2012-02-24T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
22365286,2012-02-24T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
22365286,2012-02-24T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
22365286,2012-02-24T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
22365286,2012-02-24T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
22365286,2012-02-24T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
22365286,2012-02-24T00:00:00,Risk Factors,E05.318.740.600.800.725
22365286,2012-02-24T00:00:00,Risk Factors,N05.715.350.200.700
22365286,2012-02-24T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22365286,2012-02-24T00:00:00,Risk Factors,N06.850.490.625.750
22365286,2012-02-24T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22365286,2012-02-24T00:00:00,Stroke,C10.228.140.300.775
22365286,2012-02-24T00:00:00,Stroke,C14.907.253.855
22365286,2012-02-24T00:00:00,Young Adult,M01.060.116.815
22365973,2012-02-24T00:00:00,Adolescent,M01.060.057
22365973,2012-02-24T00:00:00,Bladder Exstrophy,C12.706.132
22365973,2012-02-24T00:00:00,Bladder Exstrophy,C12.777.829.132
22365973,2012-02-24T00:00:00,Bladder Exstrophy,C13.351.875.132
22365973,2012-02-24T00:00:00,Bladder Exstrophy,C13.351.968.829.132
22365973,2012-02-24T00:00:00,Bladder Exstrophy,C16.131.939.132
22365973,2012-02-24T00:00:00,Child,M01.060.406
22365973,2012-02-24T00:00:00,"Child, Preschool",M01.060.406.448
22365973,2012-02-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22365973,2012-02-24T00:00:00,Infant,M01.060.703
22365973,2012-02-24T00:00:00,"Infant, Newborn",M01.060.703.520
22365973,2012-02-24T00:00:00,"Models, Biological",E05.599.395
22365973,2012-02-24T00:00:00,Postoperative Complications,C23.550.767
22365973,2012-02-24T00:00:00,Reconstructive Surgical Procedures,E04.680
22365973,2012-02-24T00:00:00,Urethra,A05.360.444.492.726
22365973,2012-02-24T00:00:00,Urethra,A05.810.876
22365973,2012-02-24T00:00:00,Urinary Bladder,A05.810.890
22365973,2012-02-24T00:00:00,Urologic Surgical Procedures,E04.950.774
22365895,2012-02-25T00:00:00,Behavior,F01.145
22365895,2012-02-25T00:00:00,Cues,F02.463.425.234
22365895,2012-02-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22365895,2012-02-25T00:00:00,Nicotine,D03.132.760.570
22365895,2012-02-25T00:00:00,Nicotine,D03.383.725.518
22365895,2012-02-25T00:00:00,Smoking,F01.145.466.753
22365895,2012-02-25T00:00:00,Tobacco Industry,J01.576.919
22365895,2012-02-25T00:00:00,Tobacco Use Disorder,C21.739.912
22365895,2012-02-25T00:00:00,Tobacco Use Disorder,F03.900.912
22320890,2012-02-27T00:00:00,Adsorption,G02.149.047
22320890,2012-02-27T00:00:00,Adsorption,G02.149.767.029
22320890,2012-02-27T00:00:00,Adsorption,G02.842.750.029
22320890,2012-02-27T00:00:00,"Biodegradation, Environmental",N06.850.460.375.500
22320890,2012-02-27T00:00:00,"Biodegradation, Environmental",N06.850.860.510.900.299
22320890,2012-02-27T00:00:00,Nanostructures,J01.637.512
22320890,2012-02-27T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
22320890,2012-02-27T00:00:00,Water Purification,N06.850.780.200.800.800.900.900
22320890,2012-02-27T00:00:00,Water Purification,N06.850.860.510.900.900
22320890,2012-02-27T00:00:00,Water Purification,N06.850.860.510.915.900
22464158,2012-02-27T00:00:00,Adolescent,M01.060.057
22464158,2012-02-27T00:00:00,Child,M01.060.406
22464158,2012-02-27T00:00:00,"Child, Preschool",M01.060.406.448
22464158,2012-02-27T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
22464158,2012-02-27T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
22464158,2012-02-27T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
22464158,2012-02-27T00:00:00,Geographic Information Systems,L01.470.750.750.462
22464158,2012-02-27T00:00:00,Geographic Information Systems,L01.700.508.300.314
22464158,2012-02-27T00:00:00,Health Surveys,E05.318.308.250
22464158,2012-02-27T00:00:00,Health Surveys,N05.715.360.300.375
22464158,2012-02-27T00:00:00,Health Surveys,N06.850.520.308.250
22464158,2012-02-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22464158,2012-02-27T00:00:00,Incidence,E05.318.308.985.525.375
22464158,2012-02-27T00:00:00,Incidence,L01.280.975.525.375
22464158,2012-02-27T00:00:00,Incidence,N01.224.935.597.500
22464158,2012-02-27T00:00:00,Incidence,N06.850.505.400.975.525.375
22464158,2012-02-27T00:00:00,Incidence,N06.850.520.308.985.525.375
22464158,2012-02-27T00:00:00,Infant,M01.060.703
22464158,2012-02-27T00:00:00,Risk Factors,E05.318.740.600.800.725
22464158,2012-02-27T00:00:00,Risk Factors,N05.715.350.200.700
22464158,2012-02-27T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22464158,2012-02-27T00:00:00,Risk Factors,N06.850.490.625.750
22464158,2012-02-27T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22464158,2012-02-27T00:00:00,United States,Z01.107.567.875
22464158,2012-02-27T00:00:00,Young Adult,M01.060.116.815
22371128,2012-02-28T00:00:00,Conservation of Natural Resources,J01.256
22371128,2012-02-28T00:00:00,Conservation of Natural Resources,N06.230.080
22371128,2012-02-28T00:00:00,Data Collection,E05.318.308
22371128,2012-02-28T00:00:00,Data Collection,L01.280
22371128,2012-02-28T00:00:00,Data Collection,N05.715.360.300
22371128,2012-02-28T00:00:00,Data Collection,N06.850.520.308
22371128,2012-02-28T00:00:00,Geographic Information Systems,L01.470.750.750.462
22371128,2012-02-28T00:00:00,Geographic Information Systems,L01.700.508.300.314
22371128,2012-02-28T00:00:00,Internet,L01.224.230.110.500
22371128,2012-02-28T00:00:00,Pilot Projects,E05.318.760.750
22371128,2012-02-28T00:00:00,Pilot Projects,E05.337.737
22371128,2012-02-28T00:00:00,Pilot Projects,N05.715.360.775.625
22371128,2012-02-28T00:00:00,Pilot Projects,N06.850.520.450.720
22371128,2012-02-28T00:00:00,Software,L01.224.900
22371128,2012-02-28T00:00:00,South Carolina,Z01.107.567.875.075.662
22371128,2012-02-28T00:00:00,South Carolina,Z01.107.567.875.750.700
22371128,2012-02-28T00:00:00,Water,D01.455.900
22371128,2012-02-28T00:00:00,Water,D01.650.550.925
22425402,2012-02-28T00:00:00,Adolescent,M01.060.057
22425402,2012-02-28T00:00:00,Adult,M01.060.116
22425402,2012-02-28T00:00:00,Contraception,E02.875.194
22425402,2012-02-28T00:00:00,"Contraceptive Agents, Female",D27.505.696.875.360.276
22425402,2012-02-28T00:00:00,"Contraceptive Agents, Female",D27.505.954.705.360.276
22425402,2012-02-28T00:00:00,Drug Implants,D26.255.210.315
22425402,2012-02-28T00:00:00,Drug Implants,D27.720.280.210.315
22425402,2012-02-28T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
22425402,2012-02-28T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
22425402,2012-02-28T00:00:00,Health Surveys,E05.318.308.250
22425402,2012-02-28T00:00:00,Health Surveys,N05.715.360.300.375
22425402,2012-02-28T00:00:00,Health Surveys,N06.850.520.308.250
22425402,2012-02-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22425402,2012-02-28T00:00:00,Young Adult,M01.060.116.815
22339264,2012-02-29T00:00:00,Case-Control Studies,E05.318.760.500.500
22339264,2012-02-29T00:00:00,Case-Control Studies,N05.715.360.775.175.200
22339264,2012-02-29T00:00:00,Case-Control Studies,N06.850.520.450.500.500
22339264,2012-02-29T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
22339264,2012-02-29T00:00:00,Gene Expression Profiling,E05.393.332
22339264,2012-02-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22339264,2012-02-29T00:00:00,Mass Spectrometry,E05.196.566
22339264,2012-02-29T00:00:00,Prostatic Diseases,C12.294.565
22339264,2012-02-29T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
22339264,2012-02-29T00:00:00,Prostatic Neoplasms,C12.294.260.750
22339264,2012-02-29T00:00:00,Prostatic Neoplasms,C12.294.565.625
22339264,2012-02-29T00:00:00,Prostatic Neoplasms,C12.758.409.750
22339264,2012-02-29T00:00:00,Proteomics,H01.158.201.843
22339264,2012-02-29T00:00:00,Proteomics,H01.158.273.180.350.700
22339264,2012-02-29T00:00:00,Proteomics,H01.158.273.343.350.700
22339264,2012-02-29T00:00:00,Proteomics,H01.181.122.738
22377532,2012-02-29T00:00:00,Ceramides,D02.065.313
22377532,2012-02-29T00:00:00,Ceramides,D09.400.410.420.525.200
22377532,2012-02-29T00:00:00,Ceramides,D10.390.470.675.200
22377532,2012-02-29T00:00:00,Ceramides,D10.570.877.360.612.200
22377532,2012-02-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22377532,2012-02-29T00:00:00,Neuroblastoma,C04.557.465.625.600.590.650.550
22377532,2012-02-29T00:00:00,Neuroblastoma,C04.557.470.670.590.650.550
22377532,2012-02-29T00:00:00,Neuroblastoma,C04.557.580.625.600.590.650.550
22377532,2012-02-29T00:00:00,Oxidoreductases,D08.811.682
21904257,2012-03-01T00:00:00,Adult,M01.060.116
21904257,2012-03-01T00:00:00,Brain Ischemia,C10.228.140.300.150
21904257,2012-03-01T00:00:00,Brain Ischemia,C14.907.253.092
21904257,2012-03-01T00:00:00,Case-Control Studies,E05.318.760.500.500
21904257,2012-03-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
21904257,2012-03-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
21904257,2012-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21904257,2012-03-01T00:00:00,Middle Aged,M01.060.116.630
21904257,2012-03-01T00:00:00,Risk Factors,E05.318.740.600.800.725
21904257,2012-03-01T00:00:00,Risk Factors,N05.715.350.200.700
21904257,2012-03-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
21904257,2012-03-01T00:00:00,Risk Factors,N06.850.490.625.750
21904257,2012-03-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
21904257,2012-03-01T00:00:00,Subarachnoid Hemorrhage,C10.228.140.300.535.800
21904257,2012-03-01T00:00:00,Subarachnoid Hemorrhage,C14.907.253.573.800
21904257,2012-03-01T00:00:00,Subarachnoid Hemorrhage,C23.550.414.913.850
21904257,2012-03-01T00:00:00,Treatment Outcome,E01.789.800
21904257,2012-03-01T00:00:00,Treatment Outcome,N04.761.559.590.800
21904257,2012-03-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21932143,2012-03-01T00:00:00,Cooperative Behavior,F01.145.813.115
21932143,2012-03-01T00:00:00,Delivery of Health Care,N04.590.374
21932143,2012-03-01T00:00:00,Delivery of Health Care,N05.300
21932143,2012-03-01T00:00:00,Evidence-Based Medicine,H02.249.750
21932143,2012-03-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
21932143,2012-03-01T00:00:00,Health Services Accessibility,N04.590.374.350
21932143,2012-03-01T00:00:00,Health Services Accessibility,N05.300.430
21932143,2012-03-01T00:00:00,Healthcare Disparities,N04.590.374.380
21932143,2012-03-01T00:00:00,Healthcare Disparities,N05.300.493
21932143,2012-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21932143,2012-03-01T00:00:00,Neoplasms,C04
21932143,2012-03-01T00:00:00,Primary Health Care,N04.590.233.727
21932143,2012-03-01T00:00:00,South Carolina,Z01.107.567.875.075.662
21932143,2012-03-01T00:00:00,South Carolina,Z01.107.567.875.750.700
21992709,2012-03-01T00:00:00,Adolescent,M01.060.057
21992709,2012-03-01T00:00:00,Adult,M01.060.116
21992709,2012-03-01T00:00:00,Aged,M01.060.116.100
21992709,2012-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21992709,2012-03-01T00:00:00,Middle Aged,M01.060.116.630
21992709,2012-03-01T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
21992709,2012-03-01T00:00:00,Smoking,F01.145.466.753
21992709,2012-03-01T00:00:00,Smoking Cessation,F01.145.940.700
21992709,2012-03-01T00:00:00,Time Factors,G01.910.857
21992709,2012-03-01T00:00:00,United States,Z01.107.567.875
21992709,2012-03-01T00:00:00,Young Adult,M01.060.116.815
22052558,2012-03-01T00:00:00,Delphi Technique,L01.280.800.310
22052558,2012-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22052558,2012-03-01T00:00:00,"Scleroderma, Systemic",C17.300.799
22052558,2012-03-01T00:00:00,"Scleroderma, Systemic",C17.800.784
22072425,2012-03-01T00:00:00,3T3 Cells,A11.251.210.700
22072425,2012-03-01T00:00:00,3T3 Cells,A11.329.228.900
22072425,2012-03-01T00:00:00,Amino Acid Sequence,G02.111.570.060
22072425,2012-03-01T00:00:00,Amino Acid Sequence,L01.453.245.667.060
22072425,2012-03-01T00:00:00,Animals,B01.050
22072425,2012-03-01T00:00:00,Bone Morphogenetic Proteins,D12.644.276.954.200
22072425,2012-03-01T00:00:00,Bone Morphogenetic Proteins,D12.776.467.942.200
22072425,2012-03-01T00:00:00,Bone Morphogenetic Proteins,D23.529.942.200
22072425,2012-03-01T00:00:00,Cell Differentiation,G04.299.151
22072425,2012-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22072425,2012-03-01T00:00:00,MAP Kinase Signaling System,G02.111.087.800.560
22072425,2012-03-01T00:00:00,MAP Kinase Signaling System,G02.149.115.800.560
22072425,2012-03-01T00:00:00,MAP Kinase Signaling System,G03.495.553.560
22072425,2012-03-01T00:00:00,MAP Kinase Signaling System,G04.299.880.560
22072425,2012-03-01T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
22072425,2012-03-01T00:00:00,"Microscopy, Fluorescence",E05.595.458
22072425,2012-03-01T00:00:00,Molecular Sequence Data,L01.453.245.667
22072425,2012-03-01T00:00:00,Osteoblasts,A11.329.629
22072425,2012-03-01T00:00:00,Phosphorylation,G02.111.087.677
22072425,2012-03-01T00:00:00,Phosphorylation,G02.149.115.677
22072425,2012-03-01T00:00:00,Phosphorylation,G02.149.465.700
22072425,2012-03-01T00:00:00,Phosphorylation,G02.607.750.700
22072425,2012-03-01T00:00:00,Phosphorylation,G03.495.790
22072425,2012-03-01T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
22072425,2012-03-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22072425,2012-03-01T00:00:00,"Sequence Homology, Amino Acid",G02.111.810.200
22072425,2012-03-01T00:00:00,"Sequence Homology, Amino Acid",G05.810.200
22072425,2012-03-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567.878
22072425,2012-03-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750.843
22072425,2012-03-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.644.360.450.835
22072425,2012-03-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.776.476.450.835
22162255,2012-03-01T00:00:00,Child,M01.060.406
22162255,2012-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22162255,2012-03-01T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
22162255,2012-03-01T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
22162255,2012-03-01T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
22162255,2012-03-01T00:00:00,Lupus Nephritis,C12.777.419.570.363.680
22162255,2012-03-01T00:00:00,Lupus Nephritis,C13.351.968.419.570.363.680
22162255,2012-03-01T00:00:00,Lupus Nephritis,C17.300.480.680
22162255,2012-03-01T00:00:00,Lupus Nephritis,C20.111.590.560
22162255,2012-03-01T00:00:00,Remission Induction,E02.860
22215326,2012-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22215326,2012-03-01T00:00:00,Neoplasm Invasiveness,C04.697.645
22215326,2012-03-01T00:00:00,Neoplasm Invasiveness,C23.550.727.645
22215326,2012-03-01T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
22215326,2012-03-01T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
22215326,2012-03-01T00:00:00,Palliative Care,E02.760.666
22215326,2012-03-01T00:00:00,Palliative Care,N02.421.585.666
22215326,2012-03-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
22215326,2012-03-01T00:00:00,Risk Assessment,N04.452.871.715
22215326,2012-03-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
22215326,2012-03-01T00:00:00,Risk Assessment,N06.850.505.715
22215326,2012-03-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
22234582,2012-03-01T00:00:00,Carcinoma,C04.557.470.200
22234582,2012-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22234582,2012-03-01T00:00:00,Thyroid Neoplasms,C04.588.322.894
22234582,2012-03-01T00:00:00,Thyroid Neoplasms,C04.588.443.915
22234582,2012-03-01T00:00:00,Thyroid Neoplasms,C19.344.894
22234582,2012-03-01T00:00:00,Thyroid Neoplasms,C19.874.788
22234582,2012-03-01T00:00:00,United States,Z01.107.567.875
22282394,2012-03-01T00:00:00,Antineoplastic Agents,D27.505.954.248
22282394,2012-03-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
22282394,2012-03-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
22282394,2012-03-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
22282394,2012-03-01T00:00:00,Clinical Trials as Topic,E05.337.250
22282394,2012-03-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
22282394,2012-03-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
22282394,2012-03-01T00:00:00,Head and Neck Neoplasms,C04.588.443
22282394,2012-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22282394,2012-03-01T00:00:00,Signal Transduction,G02.111.087.800
22282394,2012-03-01T00:00:00,Signal Transduction,G02.149.115.800
22282394,2012-03-01T00:00:00,Signal Transduction,G04.299.880
22282394,2012-03-01T00:00:00,United States,Z01.107.567.875
22285001,2012-03-01T00:00:00,"Carcinoma, Hepatocellular",C04.557.470.200.025.255
22285001,2012-03-01T00:00:00,"Carcinoma, Hepatocellular",C04.588.274.623.160
22285001,2012-03-01T00:00:00,"Carcinoma, Hepatocellular",C06.301.623.160
22285001,2012-03-01T00:00:00,"Carcinoma, Hepatocellular",C06.552.697.160
22285001,2012-03-01T00:00:00,Chronic Disease,C23.550.291.500
22285001,2012-03-01T00:00:00,Disease Progression,C23.550.291.656
22285001,2012-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22285001,2012-03-01T00:00:00,Liver Cirrhosis,C06.552.630
22285001,2012-03-01T00:00:00,Liver Neoplasms,C04.588.274.623
22285001,2012-03-01T00:00:00,Liver Neoplasms,C06.301.623
22285001,2012-03-01T00:00:00,Liver Neoplasms,C06.552.697
22285001,2012-03-01T00:00:00,Mass Screening,E01.370.500
22285001,2012-03-01T00:00:00,Mass Screening,E05.318.308.250.580
22285001,2012-03-01T00:00:00,Mass Screening,N02.421.143.827.233.443
22285001,2012-03-01T00:00:00,Mass Screening,N02.421.726.233.443
22285001,2012-03-01T00:00:00,Mass Screening,N05.715.360.300.375.500
22285001,2012-03-01T00:00:00,Mass Screening,N06.850.520.308.250.580
22285001,2012-03-01T00:00:00,Mass Screening,N06.850.780.500
22299123,2012-03-01T00:00:00,Adult,M01.060.116
22299123,2012-03-01T00:00:00,Amphetamine-Related Disorders,C21.739.225
22299123,2012-03-01T00:00:00,Amphetamine-Related Disorders,F03.900.225
22299123,2012-03-01T00:00:00,Central Nervous System Stimulants,D27.505.696.282
22299123,2012-03-01T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
22299123,2012-03-01T00:00:00,Cocaine-Related Disorders,C21.739.300
22299123,2012-03-01T00:00:00,Cocaine-Related Disorders,F03.900.300
22299123,2012-03-01T00:00:00,Dental Care,E06.170
22299123,2012-03-01T00:00:00,Dental Care,N02.421.240.190
22299123,2012-03-01T00:00:00,Dental Plaque,C07.793.208.377
22299123,2012-03-01T00:00:00,Gingival Diseases,C07.465.714.258
22299123,2012-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22299123,2012-03-01T00:00:00,Marijuana Abuse,C21.739.635
22299123,2012-03-01T00:00:00,Marijuana Abuse,F03.900.635
22299123,2012-03-01T00:00:00,Methamphetamine,D02.092.471.683.152.619
22299123,2012-03-01T00:00:00,Middle Aged,M01.060.116.630
22299123,2012-03-01T00:00:00,Mouth Diseases,C07.465
22299123,2012-03-01T00:00:00,Pilot Projects,E05.318.760.750
22299123,2012-03-01T00:00:00,Pilot Projects,E05.337.737
22299123,2012-03-01T00:00:00,Pilot Projects,N05.715.360.775.625
22299123,2012-03-01T00:00:00,Pilot Projects,N06.850.520.450.720
22299123,2012-03-01T00:00:00,Saliva,A12.200.666
22299123,2012-03-01T00:00:00,Tooth Diseases,C07.793
22299123,2012-03-01T00:00:00,Young Adult,M01.060.116.815
22332856,2012-03-01T00:00:00,Adolescent,M01.060.057
22332856,2012-03-01T00:00:00,Adult,M01.060.116
22332856,2012-03-01T00:00:00,Affective Symptoms,F01.145.126.100
22332856,2012-03-01T00:00:00,Amphetamine-Related Disorders,C21.739.225
22332856,2012-03-01T00:00:00,Amphetamine-Related Disorders,F03.900.225
22332856,2012-03-01T00:00:00,Cues,F02.463.425.234
22332856,2012-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22332856,2012-03-01T00:00:00,Middle Aged,M01.060.116.630
22332856,2012-03-01T00:00:00,Motivation,F01.658
22332856,2012-03-01T00:00:00,Motivation,F01.752.543.500.750
22332856,2012-03-01T00:00:00,Personality Inventory,F04.711.647.513
22333921,2012-03-01T00:00:00,"Adaptation, Physiological",G07.700.062
22333921,2012-03-01T00:00:00,"Adaptation, Physiological",G16.100.057.500
22333921,2012-03-01T00:00:00,Disability Evaluation,E01.370.400
22333921,2012-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22333921,2012-03-01T00:00:00,Movement Disorders,C10.228.662
22333921,2012-03-01T00:00:00,Physical Therapy Modalities,E02.779
22333921,2012-03-01T00:00:00,Recovery of Function,G16.757
22333921,2012-03-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
22333921,2012-03-01T00:00:00,Risk Assessment,N04.452.871.715
22333921,2012-03-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
22333921,2012-03-01T00:00:00,Risk Assessment,N06.850.505.715
22333921,2012-03-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
22333921,2012-03-01T00:00:00,Treatment Outcome,E01.789.800
22333921,2012-03-01T00:00:00,Treatment Outcome,N04.761.559.590.800
22333921,2012-03-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22339573,2012-03-01T00:00:00,Aged,M01.060.116.100
22339573,2012-03-01T00:00:00,Heart Failure,C14.280.434
22339573,2012-03-01T00:00:00,Hospitalization,E02.760.400
22339573,2012-03-01T00:00:00,Hospitalization,N02.421.585.400
22339573,2012-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22339573,2012-03-01T00:00:00,Middle Aged,M01.060.116.630
22339573,2012-03-01T00:00:00,Renal Insufficiency,C12.777.419.780
22339573,2012-03-01T00:00:00,Renal Insufficiency,C13.351.968.419.780
22339573,2012-03-01T00:00:00,Risk Factors,E05.318.740.600.800.725
22339573,2012-03-01T00:00:00,Risk Factors,N05.715.350.200.700
22339573,2012-03-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22339573,2012-03-01T00:00:00,Risk Factors,N06.850.490.625.750
22339573,2012-03-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22339573,2012-03-01T00:00:00,Stroke,C10.228.140.300.775
22339573,2012-03-01T00:00:00,Stroke,C14.907.253.855
22339573,2012-03-01T00:00:00,Time Factors,G01.910.857
22372911,2012-03-01T00:00:00,Aged,M01.060.116.100
22372911,2012-03-01T00:00:00,Central Nervous System,A08.186
22372911,2012-03-01T00:00:00,"Diagnosis, Differential",E01.171
22372911,2012-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22372911,2012-03-01T00:00:00,"Lymphoma, Large B-Cell, Diffuse",C04.557.386.480.150.585
22372911,2012-03-01T00:00:00,"Lymphoma, Large B-Cell, Diffuse",C15.604.515.569.480.150.585
22372911,2012-03-01T00:00:00,"Lymphoma, Large B-Cell, Diffuse",C20.683.515.761.480.150.585
22372911,2012-03-01T00:00:00,Skin,A17.815
22372911,2012-03-01T00:00:00,Vascular Neoplasms,C04.588.839.750
22372911,2012-03-01T00:00:00,Vascular Neoplasms,C14.907.936
22378042,2012-03-01T00:00:00,Amino Acid Sequence,G02.111.570.060
22378042,2012-03-01T00:00:00,Amino Acid Sequence,L01.453.245.667.060
22378042,2012-03-01T00:00:00,"Antigens, Bacterial",D23.050.161
22378042,2012-03-01T00:00:00,Bacterial Proteins,D12.776.097
22378042,2012-03-01T00:00:00,Cell Line,A11.251.210
22378042,2012-03-01T00:00:00,Helicobacter Infections,C01.252.400.466
22378042,2012-03-01T00:00:00,Helicobacter pylori,B03.440.500.550
22378042,2012-03-01T00:00:00,Helicobacter pylori,B03.660.150.280.550
22378042,2012-03-01T00:00:00,Host-Pathogen Interactions,G06.590.470
22378042,2012-03-01T00:00:00,Host-Pathogen Interactions,G16.100.380
22378042,2012-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22378042,2012-03-01T00:00:00,Molecular Sequence Data,L01.453.245.667
22378042,2012-03-01T00:00:00,"Mutagenesis, Site-Directed",E05.393.420.601.575
22378042,2012-03-01T00:00:00,Phosphorylation,G02.111.087.677
22378042,2012-03-01T00:00:00,Phosphorylation,G02.149.115.677
22378042,2012-03-01T00:00:00,Phosphorylation,G02.149.465.700
22378042,2012-03-01T00:00:00,Phosphorylation,G02.607.750.700
22378042,2012-03-01T00:00:00,Phosphorylation,G03.495.790
22378042,2012-03-01T00:00:00,Phosphotyrosine,D12.125.072.050.875.750
22378042,2012-03-01T00:00:00,Phosphotyrosine,D12.125.740.740
22378042,2012-03-01T00:00:00,"Protein Processing, Post-Translational",G02.111.087.675.871.790.600
22378042,2012-03-01T00:00:00,"Protein Processing, Post-Translational",G02.111.087.693.600
22378042,2012-03-01T00:00:00,"Protein Processing, Post-Translational",G02.149.115.675.871.790.600
22378042,2012-03-01T00:00:00,"Protein Processing, Post-Translational",G02.149.115.693.600
22378042,2012-03-01T00:00:00,"Protein Processing, Post-Translational",G03.495.770.871.790.600
22378042,2012-03-01T00:00:00,"Protein Processing, Post-Translational",G05.355.315.670.600
22378042,2012-03-01T00:00:00,Protein-Tyrosine Kinases,D08.811.913.696.620.682.725
22378042,2012-03-01T00:00:00,Recombinant Proteins,D12.776.828
22378042,2012-03-01T00:00:00,"Sequence Homology, Amino Acid",G02.111.810.200
22378042,2012-03-01T00:00:00,"Sequence Homology, Amino Acid",G05.810.200
22378042,2012-03-01T00:00:00,src-Family Kinases,D08.811.913.696.620.682.725.800
22382307,2012-03-01T00:00:00,Antioxidants,D27.505.519.217
22382307,2012-03-01T00:00:00,Antioxidants,D27.505.696.706.125
22382307,2012-03-01T00:00:00,Antioxidants,D27.720.799.047
22382307,2012-03-01T00:00:00,Copper,D01.268.556.195
22382307,2012-03-01T00:00:00,Copper,D01.268.956.170
22382307,2012-03-01T00:00:00,Copper,D01.552.544.195
22382307,2012-03-01T00:00:00,Organometallic Compounds,D01.632
22382307,2012-03-01T00:00:00,Organometallic Compounds,D02.691
22382307,2012-03-01T00:00:00,Selenium,D01.268.185.850
22382307,2012-03-01T00:00:00,Selenium,D01.578.700
22382307,2012-03-01T00:00:00,Sulfur,D01.268.185.900
22382997,2012-03-01T00:00:00,Animals,B01.050
22382997,2012-03-01T00:00:00,Apoptosis,G04.299.139.160
22382997,2012-03-01T00:00:00,Biological Assay,E05.091
22382997,2012-03-01T00:00:00,Biological Markers,D23.101
22382997,2012-03-01T00:00:00,Cell Death,G04.299.139
22382997,2012-03-01T00:00:00,Cell Membrane,A11.284.149
22382997,2012-03-01T00:00:00,Cell Survival,G04.299.316
22382997,2012-03-01T00:00:00,Coloring Agents,D27.720.233
22382997,2012-03-01T00:00:00,Coloring Agents,D27.720.470.330
22382997,2012-03-01T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
22382997,2012-03-01T00:00:00,Flow Cytometry,E05.200.500.386.350
22382997,2012-03-01T00:00:00,Fluorescent Dyes,D27.720.233.348
22382997,2012-03-01T00:00:00,Fluorescent Dyes,D27.720.470.330.348
22382997,2012-03-01T00:00:00,Fluorescent Dyes,D27.720.470.410.505.500
22382997,2012-03-01T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
22382997,2012-03-01T00:00:00,"Microscopy, Fluorescence",E05.595.458
22382997,2012-03-01T00:00:00,Toxicity Tests,E05.940
22385990,2012-03-01T00:00:00,Environmental Exposure,N06.850.460.350
22385990,2012-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22385990,2012-03-01T00:00:00,Occupational Exposure,N06.850.460.350.600
22385990,2012-03-01T00:00:00,Risk Factors,E05.318.740.600.800.725
22385990,2012-03-01T00:00:00,Risk Factors,N05.715.350.200.700
22385990,2012-03-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22385990,2012-03-01T00:00:00,Risk Factors,N06.850.490.625.750
22385990,2012-03-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22385990,2012-03-01T00:00:00,Urinary Bladder Neoplasms,C04.588.945.947.960
22385990,2012-03-01T00:00:00,Urinary Bladder Neoplasms,C12.758.820.968
22385990,2012-03-01T00:00:00,Urinary Bladder Neoplasms,C12.777.829.813
22385990,2012-03-01T00:00:00,Urinary Bladder Neoplasms,C13.351.937.820.945
22385990,2012-03-01T00:00:00,Urinary Bladder Neoplasms,C13.351.968.829.707
22386161,2012-03-01T00:00:00,Diagnostic Imaging,E01.370.350
22386161,2012-03-01T00:00:00,Evidence-Based Medicine,H02.249.750
22386161,2012-03-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
22386161,2012-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22386161,2012-03-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
22386161,2012-03-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
22386161,2012-03-01T00:00:00,"Radiography, Thoracic",E01.370.350.700.730
22386161,2012-03-01T00:00:00,Radiology,H02.403.740
22386161,2012-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
22386161,2012-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
22386161,2012-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
22386161,2012-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
22386161,2012-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
22386161,2012-03-01T00:00:00,United States,Z01.107.567.875
22394533,2012-03-01T00:00:00,Aged,M01.060.116.100
22394533,2012-03-01T00:00:00,Automobile Driving,I03.125
22394533,2012-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22394533,2012-03-01T00:00:00,Psychometrics,F04.711.780
22399588,2012-03-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
22399588,2012-03-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
22399588,2012-03-01T00:00:00,Head and Neck Neoplasms,C04.588.443
22399588,2012-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22399588,2012-03-01T00:00:00,Membrane Proteins,D12.776.543
22399588,2012-03-01T00:00:00,Photochemotherapy,E02.186.500
22399588,2012-03-01T00:00:00,Photochemotherapy,E02.319.685
22399588,2012-03-01T00:00:00,Photochemotherapy,E02.774.722
22399588,2012-03-01T00:00:00,Sphingosine N-Acyltransferase,D08.811.913.050.712
22402430,2012-03-01T00:00:00,Adult,M01.060.116
22402430,2012-03-01T00:00:00,Central Nervous System Diseases,C10.228
22402430,2012-03-01T00:00:00,"Histiocytosis, Sinus",C15.604.250.410.450
22402430,2012-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22402430,2012-03-01T00:00:00,Middle Aged,M01.060.116.630
22402430,2012-03-01T00:00:00,Young Adult,M01.060.116.815
22412001,2012-03-01T00:00:00,Adult,M01.060.116
22412001,2012-03-01T00:00:00,Attitude of Health Personnel,F01.100.050
22412001,2012-03-01T00:00:00,Attitude of Health Personnel,N05.300.100
22412001,2012-03-01T00:00:00,Clinical Competence,I02.399.630.210
22412001,2012-03-01T00:00:00,Clinical Competence,N04.761.210
22412001,2012-03-01T00:00:00,Early Detection of Cancer,E01.390.500
22412001,2012-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22412001,2012-03-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
22412001,2012-03-01T00:00:00,Lung Neoplasms,C08.381.540
22412001,2012-03-01T00:00:00,Lung Neoplasms,C08.785.520
22412001,2012-03-01T00:00:00,Middle Aged,M01.060.116.630
22412001,2012-03-01T00:00:00,Physician's Practice Patterns,N04.590.748
22412001,2012-03-01T00:00:00,Physician's Practice Patterns,N05.300.625
22412001,2012-03-01T00:00:00,Questionnaires,E05.318.308.750
22412001,2012-03-01T00:00:00,Questionnaires,L01.280.800
22412001,2012-03-01T00:00:00,Questionnaires,N05.715.360.300.695
22412001,2012-03-01T00:00:00,Questionnaires,N06.850.520.308.750
22412001,2012-03-01T00:00:00,United States,Z01.107.567.875
22425169,2012-03-01T00:00:00,Aged,M01.060.116.100
22425169,2012-03-01T00:00:00,Binding Sites,G02.111.570.120
22425169,2012-03-01T00:00:00,"Cholesterol, HDL",D10.532.432.400
22425169,2012-03-01T00:00:00,"Cholesterol, HDL",D10.570.938.208.270
22425169,2012-03-01T00:00:00,"Cholesterol, HDL",D12.776.521.479.470
22425169,2012-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22425169,2012-03-01T00:00:00,Middle Aged,M01.060.116.630
22425169,2012-03-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
22425169,2012-03-01T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
22425169,2012-03-01T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
22425169,2012-03-01T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
22425169,2012-03-01T00:00:00,Vitamin D,D04.808.812.768
22431871,2012-03-01T00:00:00,Adult,M01.060.116
22431871,2012-03-01T00:00:00,Aged,M01.060.116.100
22431871,2012-03-01T00:00:00,Alcohol Drinking,F01.145.317.269
22431871,2012-03-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
22431871,2012-03-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
22431871,2012-03-01T00:00:00,Delirium,C10.597.606.337.500
22431871,2012-03-01T00:00:00,Delirium,C23.888.592.604.339.500
22431871,2012-03-01T00:00:00,Delirium,F01.700.250.500
22431871,2012-03-01T00:00:00,Delirium,F03.087.350
22431871,2012-03-01T00:00:00,Head and Neck Neoplasms,C04.588.443
22431871,2012-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22431871,2012-03-01T00:00:00,Middle Aged,M01.060.116.630
22431871,2012-03-01T00:00:00,Postoperative Complications,C23.550.767
22431871,2012-03-01T00:00:00,Risk Factors,E05.318.740.600.800.725
22431871,2012-03-01T00:00:00,Risk Factors,N05.715.350.200.700
22431871,2012-03-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22431871,2012-03-01T00:00:00,Risk Factors,N06.850.490.625.750
22431871,2012-03-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22469599,2012-03-01T00:00:00,Adult,M01.060.116
22469599,2012-03-01T00:00:00,Child,M01.060.406
22469599,2012-03-01T00:00:00,Chronic Disease,C23.550.291.500
22469599,2012-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22469599,2012-03-01T00:00:00,Nasal Polyps,C08.460.572
22469599,2012-03-01T00:00:00,Nasal Polyps,C09.603.557
22469599,2012-03-01T00:00:00,Nasal Polyps,C23.300.825.557
22469599,2012-03-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
22469599,2012-03-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
22469599,2012-03-01T00:00:00,Rhinitis,C08.460.799
22469599,2012-03-01T00:00:00,Rhinitis,C08.730.674
22469599,2012-03-01T00:00:00,Rhinitis,C09.603.799
22469599,2012-03-01T00:00:00,Sinusitis,C08.460.692.752
22469599,2012-03-01T00:00:00,Sinusitis,C08.730.749
22469599,2012-03-01T00:00:00,Sinusitis,C09.603.692.752
22487286,2012-03-01T00:00:00,Adult,M01.060.116
22487286,2012-03-01T00:00:00,Chronic Disease,C23.550.291.500
22487286,2012-03-01T00:00:00,Endoscopy,E01.370.388.250
22487286,2012-03-01T00:00:00,Endoscopy,E04.800.250
22487286,2012-03-01T00:00:00,Ethnic Groups,M01.686.754
22487286,2012-03-01T00:00:00,Ethnic Groups,N01.224.317
22487286,2012-03-01T00:00:00,Healthcare Disparities,N04.590.374.380
22487286,2012-03-01T00:00:00,Healthcare Disparities,N05.300.493
22487286,2012-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22487286,2012-03-01T00:00:00,Paranasal Sinuses,A04.531.621
22487286,2012-03-01T00:00:00,Rhinitis,C08.460.799
22487286,2012-03-01T00:00:00,Rhinitis,C08.730.674
22487286,2012-03-01T00:00:00,Rhinitis,C09.603.799
22487286,2012-03-01T00:00:00,Sinusitis,C08.460.692.752
22487286,2012-03-01T00:00:00,Sinusitis,C08.730.749
22487286,2012-03-01T00:00:00,Sinusitis,C09.603.692.752
22487286,2012-03-01T00:00:00,Treatment Outcome,E01.789.800
22487286,2012-03-01T00:00:00,Treatment Outcome,N04.761.559.590.800
22487286,2012-03-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22487286,2012-03-01T00:00:00,United States,Z01.107.567.875
22490934,2012-03-01T00:00:00,"Adaptation, Psychological",F01.058
22490934,2012-03-01T00:00:00,Adult,M01.060.116
22490934,2012-03-01T00:00:00,Age Factors,N05.715.350.075
22490934,2012-03-01T00:00:00,Age Factors,N06.850.490.250
22490934,2012-03-01T00:00:00,Anxiety Disorders,F03.080
22490934,2012-03-01T00:00:00,Cyclonic Storms,G16.500.240.135.500
22490934,2012-03-01T00:00:00,"Depressive Disorder, Major",F03.600.300.375
22490934,2012-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22490934,2012-03-01T00:00:00,"Interview, Psychological",F04.669.599
22490934,2012-03-01T00:00:00,Mental Disorders,F03
22490934,2012-03-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
22490934,2012-03-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
22490934,2012-03-01T00:00:00,Psychometrics,F04.711.780
22490934,2012-03-01T00:00:00,Relief Work,I01.880.787.839
22490934,2012-03-01T00:00:00,Relief Work,N06.230.100.300
22490934,2012-03-01T00:00:00,Risk Factors,E05.318.740.600.800.725
22490934,2012-03-01T00:00:00,Risk Factors,N05.715.350.200.700
22490934,2012-03-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22490934,2012-03-01T00:00:00,Risk Factors,N06.850.490.625.750
22490934,2012-03-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22490934,2012-03-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
22490934,2012-03-01T00:00:00,"Stress, Psychological",F01.145.126.990
22490934,2012-03-01T00:00:00,"Stress, Psychological",F02.830.900
22491547,2012-03-01T00:00:00,"Accidents, Traffic",N06.850.135.392
22491547,2012-03-01T00:00:00,Adult,M01.060.116
22491547,2012-03-01T00:00:00,Cervical Vertebrae,A02.835.232.834.151
22491547,2012-03-01T00:00:00,Head Protective Devices,E07.700.380
22491547,2012-03-01T00:00:00,Head Protective Devices,J01.637.708.380
22491547,2012-03-01T00:00:00,Hospital Mortality,E05.318.308.985.550.400
22491547,2012-03-01T00:00:00,Hospital Mortality,L01.280.975.550.400
22491547,2012-03-01T00:00:00,Hospital Mortality,N01.224.935.698.400
22491547,2012-03-01T00:00:00,Hospital Mortality,N06.850.505.400.975.550.400
22491547,2012-03-01T00:00:00,Hospital Mortality,N06.850.520.308.985.550.400
22491547,2012-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22491547,2012-03-01T00:00:00,Incidence,E05.318.308.985.525.375
22491547,2012-03-01T00:00:00,Incidence,L01.280.975.525.375
22491547,2012-03-01T00:00:00,Incidence,N01.224.935.597.500
22491547,2012-03-01T00:00:00,Incidence,N06.850.505.400.975.525.375
22491547,2012-03-01T00:00:00,Incidence,N06.850.520.308.985.525.375
22491547,2012-03-01T00:00:00,Length of Stay,E02.760.400.480
22491547,2012-03-01T00:00:00,Length of Stay,N02.421.585.400.480
22491547,2012-03-01T00:00:00,Middle Aged,M01.060.116.630
22491547,2012-03-01T00:00:00,Population Surveillance,E05.318.308.250.700
22491547,2012-03-01T00:00:00,Population Surveillance,N05.715.360.300.375.625
22491547,2012-03-01T00:00:00,Population Surveillance,N06.850.520.308.250.700
22491547,2012-03-01T00:00:00,Population Surveillance,N06.850.780.675
22491547,2012-03-01T00:00:00,Risk Factors,E05.318.740.600.800.725
22491547,2012-03-01T00:00:00,Risk Factors,N05.715.350.200.700
22491547,2012-03-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22491547,2012-03-01T00:00:00,Risk Factors,N06.850.490.625.750
22491547,2012-03-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22491547,2012-03-01T00:00:00,United States,Z01.107.567.875
22524763,2012-03-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
22524763,2012-03-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
22524763,2012-03-01T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
22524763,2012-03-01T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
22524763,2012-03-01T00:00:00,General Surgery,H02.403.810.300
22524763,2012-03-01T00:00:00,"History, 19th Century",K01.400.504.937
22528411,2012-03-01T00:00:00,Electromagnetic Fields,G01.201.260
22528411,2012-03-01T00:00:00,Electromagnetic Fields,G01.201.875.240
22528411,2012-03-01T00:00:00,Electrophoresis,E05.196.401
22528411,2012-03-01T00:00:00,Electrophoresis,E05.301.300
22528411,2012-03-01T00:00:00,Electrophoresis,G02.149.767.570
22528411,2012-03-01T00:00:00,Electrophoresis,G02.842.750.570
22528411,2012-03-01T00:00:00,Microfluidic Analytical Techniques,E05.196.630.465
22528411,2012-03-01T00:00:00,Microfluidic Analytical Techniques,E05.588.465
22528411,2012-03-01T00:00:00,"Models, Theoretical",E05.599
22584310,2012-03-01T00:00:00,Child,M01.060.406
22584310,2012-03-01T00:00:00,Child Health Services,N02.421.143.130
22584310,2012-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22584310,2012-03-01T00:00:00,Palliative Care,E02.760.666
22584310,2012-03-01T00:00:00,Palliative Care,N02.421.585.666
22589067,2012-03-01T00:00:00,Adsorption,G02.149.047
22589067,2012-03-01T00:00:00,Adsorption,G02.149.767.029
22589067,2012-03-01T00:00:00,Adsorption,G02.842.750.029
22589067,2012-03-01T00:00:00,Molecular Dynamics Simulation,E05.599.595.500
22589067,2012-03-01T00:00:00,Molecular Dynamics Simulation,G02.575.750
22589067,2012-03-01T00:00:00,Molecular Dynamics Simulation,L01.224.160.500
22589067,2012-03-01T00:00:00,Proteins,D12.776
22589067,2012-03-01T00:00:00,Surface Properties,G02.842.850
22626724,2012-03-01T00:00:00,Cervical Vertebrae,A02.835.232.834.151
22626724,2012-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22626724,2012-03-01T00:00:00,Meningocele,C10.500.680.598
22626724,2012-03-01T00:00:00,Meningocele,C16.131.666.680.598
22626724,2012-03-01T00:00:00,Middle Aged,M01.060.116.630
22626724,2012-03-01T00:00:00,Postoperative Complications,C23.550.767
22626724,2012-03-01T00:00:00,Quadriplegia,C10.597.622.760
22626724,2012-03-01T00:00:00,Quadriplegia,C23.888.592.636.786
22626724,2012-03-01T00:00:00,Spinal Cord Compression,C10.228.854.761
22626724,2012-03-01T00:00:00,Spinal Cord Compression,C21.866.819.678
22730858,2012-03-01T00:00:00,Cardiopulmonary Bypass,E04.292.413
22730858,2012-03-01T00:00:00,Extracorporeal Circulation,E04.292
22730858,2012-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22730858,2012-03-01T00:00:00,Kidney Diseases,C12.777.419
22730858,2012-03-01T00:00:00,Kidney Diseases,C13.351.968.419
22730858,2012-03-01T00:00:00,Postoperative Complications,C23.550.767
22730858,2012-03-01T00:00:00,Treatment Outcome,E01.789.800
22730858,2012-03-01T00:00:00,Treatment Outcome,N04.761.559.590.800
22730858,2012-03-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22734270,2012-03-01T00:00:00,"Aorta, Thoracic",A07.231.114.056.372
22734270,2012-03-01T00:00:00,Emergency Medical Services,N02.421.297
22734270,2012-03-01T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
22734270,2012-03-01T00:00:00,"Emergency Service, Hospital",N02.421.297.195
22734270,2012-03-01T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
22734270,2012-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22734270,2012-03-01T00:00:00,Patient Care Team,N04.590.715
22734270,2012-03-01T00:00:00,Thoracic Injuries,C21.866.891
22734270,2012-03-01T00:00:00,Triage,N02.421.297.900
22764607,2012-03-01T00:00:00,Adult,M01.060.116
22764607,2012-03-01T00:00:00,Child,M01.060.406
22764607,2012-03-01T00:00:00,Cost of Illness,I01.137
22764607,2012-03-01T00:00:00,Cost of Illness,N03.219.151.165
22764607,2012-03-01T00:00:00,"Diagnosis, Differential",E01.171
22764607,2012-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22764607,2012-03-01T00:00:00,Nasal Polyps,C08.460.572
22764607,2012-03-01T00:00:00,Nasal Polyps,C09.603.557
22764607,2012-03-01T00:00:00,Nasal Polyps,C23.300.825.557
22764607,2012-03-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
22764607,2012-03-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
22764607,2012-03-01T00:00:00,Rhinitis,C08.460.799
22764607,2012-03-01T00:00:00,Rhinitis,C08.730.674
22764607,2012-03-01T00:00:00,Rhinitis,C09.603.799
22764607,2012-03-01T00:00:00,Risk Factors,E05.318.740.600.800.725
22764607,2012-03-01T00:00:00,Risk Factors,N05.715.350.200.700
22764607,2012-03-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22764607,2012-03-01T00:00:00,Risk Factors,N06.850.490.625.750
22764607,2012-03-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22764607,2012-03-01T00:00:00,Sinusitis,C08.460.692.752
22764607,2012-03-01T00:00:00,Sinusitis,C08.730.749
22764607,2012-03-01T00:00:00,Sinusitis,C09.603.692.752
22386902,2012-03-02T00:00:00,Adult,M01.060.116
22386902,2012-03-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22386902,2012-03-02T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
22386902,2012-03-02T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
22386902,2012-03-02T00:00:00,Stroke,C10.228.140.300.775
22386902,2012-03-02T00:00:00,Stroke,C14.907.253.855
22386902,2012-03-02T00:00:00,Subarachnoid Hemorrhage,C10.228.140.300.535.800
22386902,2012-03-02T00:00:00,Subarachnoid Hemorrhage,C14.907.253.573.800
22386902,2012-03-02T00:00:00,Subarachnoid Hemorrhage,C23.550.414.913.850
22386902,2012-03-02T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
22386902,2012-03-02T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
22386902,2012-03-02T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
22386902,2012-03-02T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
22386902,2012-03-02T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
22386903,2012-03-02T00:00:00,Adult,M01.060.116
22386903,2012-03-02T00:00:00,Aged,M01.060.116.100
22386903,2012-03-02T00:00:00,"Data Interpretation, Statistical",E05.245.380
22386903,2012-03-02T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
22386903,2012-03-02T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
22386903,2012-03-02T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
22386903,2012-03-02T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
22386903,2012-03-02T00:00:00,Functional Laterality,F02.830.297.425
22386903,2012-03-02T00:00:00,Functional Laterality,G11.561.225.425
22386903,2012-03-02T00:00:00,Hand,A01.378.800.667
22386903,2012-03-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22386903,2012-03-02T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
22386903,2012-03-02T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
22386903,2012-03-02T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
22386903,2012-03-02T00:00:00,Middle Aged,M01.060.116.630
22386903,2012-03-02T00:00:00,Movement,G07.700.560
22386903,2012-03-02T00:00:00,Movement,G11.427.590.530
22386903,2012-03-02T00:00:00,Parietal Lobe,A08.186.211.730.885.287.500.670
22386903,2012-03-02T00:00:00,Psychomotor Performance,F02.808
22386903,2012-03-02T00:00:00,Psychomotor Performance,G11.427.700
22386903,2012-03-02T00:00:00,Psychomotor Performance,G11.561.623
22386903,2012-03-02T00:00:00,Torticollis,C10.228.662.300.750
22386903,2012-03-02T00:00:00,Torticollis,C10.597.350.300.800
22386903,2012-03-02T00:00:00,Torticollis,C23.888.592.350.300.800
22386903,2012-03-02T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
22386903,2012-03-02T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
22381450,2012-03-03T00:00:00,Blood Vessel Prosthesis,E07.695.110
22381450,2012-03-03T00:00:00,Child,M01.060.406
22381450,2012-03-03T00:00:00,"Child, Preschool",M01.060.406.448
22381450,2012-03-03T00:00:00,Echocardiography,E01.370.350.850.220
22381450,2012-03-03T00:00:00,Echocardiography,E01.370.370.380.220
22381450,2012-03-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22381450,2012-03-03T00:00:00,Infant,M01.060.703
22381450,2012-03-03T00:00:00,Treatment Outcome,E01.789.800
22381450,2012-03-03T00:00:00,Treatment Outcome,N04.761.559.590.800
22381450,2012-03-03T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22385731,2012-03-03T00:00:00,Dietary Proteins,D12.776.256
22385731,2012-03-03T00:00:00,Dietary Proteins,J02.500.428
22385731,2012-03-03T00:00:00,Energy Intake,G07.610.240.340
22385731,2012-03-03T00:00:00,Energy Metabolism,G03.495.335
22385731,2012-03-03T00:00:00,Guidelines as Topic,N04.761.700.350
22385731,2012-03-03T00:00:00,Guidelines as Topic,N05.700.350
22385731,2012-03-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22385731,2012-03-03T00:00:00,Nitrogen,D01.268.604
22385731,2012-03-03T00:00:00,Nitrogen,D01.362.625
22385731,2012-03-03T00:00:00,Parenteral Nutrition,E02.421.505
22385731,2012-03-03T00:00:00,Parenteral Nutrition,E02.642.500.505
22386220,2012-03-03T00:00:00,"Depressive Disorder, Major",F03.600.300.375
22386220,2012-03-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22386220,2012-03-03T00:00:00,Psychiatric Status Rating Scales,F04.586
22386220,2012-03-03T00:00:00,Questionnaires,E05.318.308.750
22386220,2012-03-03T00:00:00,Questionnaires,L01.280.800
22386220,2012-03-03T00:00:00,Questionnaires,N05.715.360.300.695
22386220,2012-03-03T00:00:00,Questionnaires,N06.850.520.308.750
22386220,2012-03-03T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
22386932,2012-03-03T00:00:00,African Americans,M01.686.508.100.100
22386932,2012-03-03T00:00:00,African Americans,M01.686.754.100
22386932,2012-03-03T00:00:00,Aged,M01.060.116.100
22386932,2012-03-03T00:00:00,Animals,B01.050
22386932,2012-03-03T00:00:00,Blood Glucose,D09.546.359.448.500
22386932,2012-03-03T00:00:00,"Chromosomes, Human, Pair 3",A11.284.187.520.300.235.250
22386932,2012-03-03T00:00:00,"Chromosomes, Human, Pair 3",G05.360.162.520.300.235.250
22386932,2012-03-03T00:00:00,European Continental Ancestry Group,M01.686.508.400
22386932,2012-03-03T00:00:00,Gene Expression Profiling,E05.393.332
22386932,2012-03-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22386932,2012-03-03T00:00:00,Insulin,D06.472.699.587.740.625
22386932,2012-03-03T00:00:00,Insulin,D12.644.548.586.740.625
22386932,2012-03-03T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
22386932,2012-03-03T00:00:00,Metabolic Syndrome X,C18.452.625
22386932,2012-03-03T00:00:00,Middle Aged,M01.060.116.630
22386932,2012-03-03T00:00:00,Obesity,C18.654.726.500
22386932,2012-03-03T00:00:00,Obesity,C23.888.144.699.500
22386932,2012-03-03T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
22386932,2012-03-03T00:00:00,Obesity,G07.100.100.160.120.699.500
22386932,2012-03-03T00:00:00,Phenotype,G05.695
22386932,2012-03-03T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
22386932,2012-03-03T00:00:00,Quantitative Trait Loci,G05.360.340.024.380.937
22392846,2012-03-05T00:00:00,Adolescent,M01.060.057
22392846,2012-03-05T00:00:00,Adult,M01.060.116
22392846,2012-03-05T00:00:00,Aging,G07.700.320.124
22392846,2012-03-05T00:00:00,Algorithms,G17.035
22392846,2012-03-05T00:00:00,Algorithms,L01.224.050
22392846,2012-03-05T00:00:00,Brain,A08.186.211
22392846,2012-03-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22392846,2012-03-05T00:00:00,Image Enhancement,E01.370.350.600.350
22392846,2012-03-05T00:00:00,Image Enhancement,L01.224.308.380
22392846,2012-03-05T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
22392846,2012-03-05T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
22392846,2012-03-05T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
22392846,2012-03-05T00:00:00,Iron,D01.268.556.412
22392846,2012-03-05T00:00:00,Iron,D01.268.956.287
22392846,2012-03-05T00:00:00,Iron,D01.552.544.412
22392846,2012-03-05T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
22392846,2012-03-05T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
22392846,2012-03-05T00:00:00,Magnetic Resonance Spectroscopy,E05.196.867.519
22392846,2012-03-05T00:00:00,Young Adult,M01.060.116.815
22392908,2012-03-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22392908,2012-03-05T00:00:00,Physician's Practice Patterns,N04.590.748
22392908,2012-03-05T00:00:00,Physician's Practice Patterns,N05.300.625
22392921,2012-03-05T00:00:00,Adult,M01.060.116
22392921,2012-03-05T00:00:00,Age Factors,N05.715.350.075
22392921,2012-03-05T00:00:00,Age Factors,N06.850.490.250
22392921,2012-03-05T00:00:00,Aged,M01.060.116.100
22392921,2012-03-05T00:00:00,Carcinoma,C04.557.470.200
22392921,2012-03-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22392921,2012-03-05T00:00:00,Middle Aged,M01.060.116.630
22392921,2012-03-05T00:00:00,Neoplasm Staging,E01.370.550
22392921,2012-03-05T00:00:00,SEER Program,E05.318.308.970.725
22392921,2012-03-05T00:00:00,SEER Program,L01.280.950.725
22392921,2012-03-05T00:00:00,SEER Program,N04.452.859.819.725
22392921,2012-03-05T00:00:00,SEER Program,N05.715.360.300.715.700.725
22392921,2012-03-05T00:00:00,SEER Program,N06.850.520.308.970.725
22392921,2012-03-05T00:00:00,Thyroid Neoplasms,C04.588.322.894
22392921,2012-03-05T00:00:00,Thyroid Neoplasms,C04.588.443.915
22392921,2012-03-05T00:00:00,Thyroid Neoplasms,C19.344.894
22392921,2012-03-05T00:00:00,Thyroid Neoplasms,C19.874.788
22381426,2012-03-06T00:00:00,Autonomic Nervous System,A08.800.050
22381426,2012-03-06T00:00:00,Blood Pressure,E01.370.600.875.249
22381426,2012-03-06T00:00:00,Blood Pressure,G09.330.380.076
22381426,2012-03-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22381426,2012-03-06T00:00:00,Hypertension,C14.907.489
22381426,2012-03-06T00:00:00,"Hypertrophy, Left Ventricular",C14.280.195.400
22381426,2012-03-06T00:00:00,"Hypertrophy, Left Ventricular",C23.300.775.250.400
22381426,2012-03-06T00:00:00,Kidney,A05.810.453
22381426,2012-03-06T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
22390304,2012-03-06T00:00:00,Animals,B01.050
22390304,2012-03-06T00:00:00,Culicidae,B01.050.500.131.617.289.275
22390304,2012-03-06T00:00:00,Feeding Behavior,F01.145.113.547
22390304,2012-03-06T00:00:00,Feeding Behavior,F01.145.407
22390304,2012-03-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22390304,2012-03-06T00:00:00,Insect Proteins,D12.776.466
22390304,2012-03-06T00:00:00,Mitochondria,A11.284.430.214.190.875.564
22390304,2012-03-06T00:00:00,Mitochondria,A11.284.835.626
22390304,2012-03-06T00:00:00,Polymerase Chain Reaction,E05.393.620.500
22390304,2012-03-06T00:00:00,"Sequence Analysis, DNA",E05.393.760.700
22390304,2012-03-06T00:00:00,South Carolina,Z01.107.567.875.075.662
22390304,2012-03-06T00:00:00,South Carolina,Z01.107.567.875.750.700
22390304,2012-03-06T00:00:00,Time Factors,G01.910.857
22395923,2012-03-06T00:00:00,"Adaptation, Psychological",F01.058
22395923,2012-03-06T00:00:00,Aged,M01.060.116.100
22395923,2012-03-06T00:00:00,Case Management,N04.590.233.624.250
22395923,2012-03-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22395923,2012-03-06T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
22395923,2012-03-06T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
22395923,2012-03-06T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
22395923,2012-03-06T00:00:00,Patient Education as Topic,I02.233.332.500
22395923,2012-03-06T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
22395923,2012-03-06T00:00:00,Patient Education as Topic,N02.421.726.407.680
22395923,2012-03-06T00:00:00,"Pulmonary Disease, Chronic Obstructive",C08.381.495.389
22395923,2012-03-06T00:00:00,Quality of Life,I01.800
22395923,2012-03-06T00:00:00,Quality of Life,K01.752.400.750
22395923,2012-03-06T00:00:00,Self Care,E02.900
22395923,2012-03-06T00:00:00,Self Care,N02.421.784.680
22395923,2012-03-06T00:00:00,Self Efficacy,F01.752.747.792.700
22401705,2012-03-07T00:00:00,Aged,M01.060.116.100
22401705,2012-03-07T00:00:00,"Depressive Disorder, Major",F03.600.300.375
22401705,2012-03-07T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
22401705,2012-03-07T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
22401705,2012-03-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22401705,2012-03-07T00:00:00,Medication Adherence,F01.145.488.500.500
22401705,2012-03-07T00:00:00,Medication Adherence,N05.300.150.600.600.500
22401705,2012-03-07T00:00:00,Middle Aged,M01.060.116.630
22401705,2012-03-07T00:00:00,Questionnaires,E05.318.308.750
22401705,2012-03-07T00:00:00,Questionnaires,L01.280.800
22401705,2012-03-07T00:00:00,Questionnaires,N05.715.360.300.695
22401705,2012-03-07T00:00:00,Questionnaires,N06.850.520.308.750
22401705,2012-03-07T00:00:00,Social Support,I01.880.656.600
22401705,2012-03-07T00:00:00,United States,Z01.107.567.875
22406086,2012-03-07T00:00:00,Antiviral Agents,D27.505.954.122.388
22406086,2012-03-07T00:00:00,BK Virus,B04.280.640.615.100
22406086,2012-03-07T00:00:00,BK Virus,B04.909.204.210.620.615.100
22406086,2012-03-07T00:00:00,BK Virus,B04.909.574.204.670.615.100
22406086,2012-03-07T00:00:00,BK Virus,B04.909.675.615.100
22406086,2012-03-07T00:00:00,Child,M01.060.406
22406086,2012-03-07T00:00:00,Graft Rejection,G12.425.901.545.328
22406086,2012-03-07T00:00:00,Heart Transplantation,E04.100.376.475
22406086,2012-03-07T00:00:00,Heart Transplantation,E04.928.220.390
22406086,2012-03-07T00:00:00,Heart Transplantation,E04.936.450.475
22406086,2012-03-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22406086,2012-03-07T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
22406086,2012-03-07T00:00:00,Isoxazoles,D03.383.129.385
22406086,2012-03-07T00:00:00,Kidney,A05.810.453
22406086,2012-03-07T00:00:00,Kidney Diseases,C12.777.419
22406086,2012-03-07T00:00:00,Kidney Diseases,C13.351.968.419
22406086,2012-03-07T00:00:00,Opportunistic Infections,C01.539.597
22406086,2012-03-07T00:00:00,Opportunistic Infections,C02.597
22406086,2012-03-07T00:00:00,Opportunistic Infections,C03.684
22406086,2012-03-07T00:00:00,Treatment Outcome,E01.789.800
22406086,2012-03-07T00:00:00,Treatment Outcome,N04.761.559.590.800
22406086,2012-03-07T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22406086,2012-03-07T00:00:00,Viremia,C02.937
22406086,2012-03-07T00:00:00,Viremia,C23.550.470.790.500.900
22402483,2012-03-08T00:00:00,Adolescent,M01.060.057
22402483,2012-03-08T00:00:00,Adult,M01.060.116
22402483,2012-03-08T00:00:00,African Americans,M01.686.508.100.100
22402483,2012-03-08T00:00:00,African Americans,M01.686.754.100
22402483,2012-03-08T00:00:00,Employment,N01.824.245
22402483,2012-03-08T00:00:00,Environmental Pollutants,D27.888.284
22402483,2012-03-08T00:00:00,European Continental Ancestry Group,M01.686.508.400
22402483,2012-03-08T00:00:00,Fetal Blood,A12.207.152.200
22402483,2012-03-08T00:00:00,Fetal Blood,A15.145.300
22402483,2012-03-08T00:00:00,Fetal Blood,A16.378.200
22402483,2012-03-08T00:00:00,Gas Chromatography-Mass Spectrometry,E05.196.181.349.500
22402483,2012-03-08T00:00:00,Gas Chromatography-Mass Spectrometry,E05.196.566.500
22402483,2012-03-08T00:00:00,Hispanic Americans,M01.686.754.441
22402483,2012-03-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22402483,2012-03-08T00:00:00,Maternal-Fetal Exchange,G08.686.785.760.769.455
22402483,2012-03-08T00:00:00,Pregnancy,G08.686.785.760.769
22402483,2012-03-08T00:00:00,Tandem Mass Spectrometry,E05.196.566.880
22402483,2012-03-08T00:00:00,Young Adult,M01.060.116.815
22404694,2012-03-08T00:00:00,Adult,M01.060.116
22404694,2012-03-08T00:00:00,Aged,M01.060.116.100
22404694,2012-03-08T00:00:00,Anti-HIV Agents,D27.505.954.122.388.077.088
22404694,2012-03-08T00:00:00,Cost-Benefit Analysis,N03.219.151.125
22404694,2012-03-08T00:00:00,Granulocyte Colony-Stimulating Factor,D12.644.276.374.410.240.350
22404694,2012-03-08T00:00:00,Granulocyte Colony-Stimulating Factor,D12.776.395.240.200
22404694,2012-03-08T00:00:00,Granulocyte Colony-Stimulating Factor,D12.776.467.374.410.240.350
22404694,2012-03-08T00:00:00,Granulocyte Colony-Stimulating Factor,D23.529.374.410.240.350
22404694,2012-03-08T00:00:00,Hematopoietic Stem Cell Mobilization,E02.095.410
22404694,2012-03-08T00:00:00,Heterocyclic Compounds,D03
22404694,2012-03-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22404694,2012-03-08T00:00:00,Middle Aged,M01.060.116.630
22404694,2012-03-08T00:00:00,Multiple Myeloma,C04.557.595.500
22404694,2012-03-08T00:00:00,Multiple Myeloma,C14.907.454.460
22404694,2012-03-08T00:00:00,Multiple Myeloma,C15.378.147.780.650
22404694,2012-03-08T00:00:00,Multiple Myeloma,C15.378.463.835.460
22404694,2012-03-08T00:00:00,Multiple Myeloma,C20.683.515.845
22404694,2012-03-08T00:00:00,Multiple Myeloma,C20.683.780.650
22404694,2012-03-08T00:00:00,Recombinant Proteins,D12.776.828
22404694,2012-03-08T00:00:00,Treatment Outcome,E01.789.800
22404694,2012-03-08T00:00:00,Treatment Outcome,N04.761.559.590.800
22404694,2012-03-08T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22406622,2012-03-08T00:00:00,Animals,B01.050
22406622,2012-03-08T00:00:00,Cisplatin,D01.210.375
22406622,2012-03-08T00:00:00,Cisplatin,D01.625.125
22406622,2012-03-08T00:00:00,Cisplatin,D01.710.100
22406622,2012-03-08T00:00:00,Glutathione,D12.644.456.448
22406622,2012-03-08T00:00:00,Glutathione Disulfide,D12.644.456.448.500
22406622,2012-03-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22406622,2012-03-08T00:00:00,Neoplasms,C04
22406622,2012-03-08T00:00:00,Serpins,D12.644.822.750
22406622,2012-03-08T00:00:00,Serpins,D12.644.861
22406622,2012-03-08T00:00:00,Serpins,D12.776.645.750
22406622,2012-03-08T00:00:00,Serpins,D12.776.872
22406622,2012-03-08T00:00:00,"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",E05.196.566.755
22406622,2012-03-08T00:00:00,Tandem Mass Spectrometry,E05.196.566.880
22406622,2012-03-08T00:00:00,"Tumor Markers, Biological",D23.101.840
22413019,2012-03-08T00:00:00,ADAM Proteins,D08.811.277.656.675.374.102
22413019,2012-03-08T00:00:00,ADAM Proteins,D09.400.430.500
22413019,2012-03-08T00:00:00,ADAM Proteins,D12.776.395.033
22413019,2012-03-08T00:00:00,Animals,B01.050
22413019,2012-03-08T00:00:00,"Antigens, CD29",D12.776.543.750.705.408.200.500
22413019,2012-03-08T00:00:00,"Antigens, CD29",D23.050.301.264.035.129
22413019,2012-03-08T00:00:00,"Antigens, CD29",D23.050.301.264.129
22413019,2012-03-08T00:00:00,"Antigens, CD29",D23.101.100.110.129
22413019,2012-03-08T00:00:00,"Antigens, CD29",D23.101.100.129
22413019,2012-03-08T00:00:00,Integrin alpha5beta1,D12.776.395.550.625.379
22413019,2012-03-08T00:00:00,Integrin alpha5beta1,D12.776.543.550.625.379
22413019,2012-03-08T00:00:00,Integrin alpha5beta1,D12.776.543.750.705.408.530.750
22413019,2012-03-08T00:00:00,Integrin alpha5beta1,D12.776.543.750.705.408.850.349
22413019,2012-03-08T00:00:00,Integrin alpha5beta1,D12.776.543.750.705.675.460
22413019,2012-03-08T00:00:00,Integrin alpha5beta1,D12.776.543.750.705.876.374
22413019,2012-03-08T00:00:00,Intercellular Signaling Peptides and Proteins,D12.644.276
22413019,2012-03-08T00:00:00,Intercellular Signaling Peptides and Proteins,D12.776.467
22413019,2012-03-08T00:00:00,Intercellular Signaling Peptides and Proteins,D23.529
22413019,2012-03-08T00:00:00,Mesangial Cells,A05.810.453.324.359.620
22413019,2012-03-08T00:00:00,Mesangial Cells,A05.810.453.736.520.620
22413019,2012-03-08T00:00:00,Mesangial Cells,A11.329.228.950
22413019,2012-03-08T00:00:00,Multiprotein Complexes,D05.500
22413019,2012-03-08T00:00:00,Protein Transport,G03.495.166.700
22413019,2012-03-08T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22413019,2012-03-08T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
22413019,2012-03-08T00:00:00,"Receptors, G-Protein-Coupled",D12.776.543.750.100
22413019,2012-03-08T00:00:00,Thiophenes,D02.886.778
22413019,2012-03-08T00:00:00,Thiophenes,D03.383.903
22404640,2012-03-09T00:00:00,Adolescent,M01.060.057
22404640,2012-03-09T00:00:00,Adult,M01.060.116
22404640,2012-03-09T00:00:00,Health Surveys,E05.318.308.250
22404640,2012-03-09T00:00:00,Health Surveys,N05.715.360.300.375
22404640,2012-03-09T00:00:00,Health Surveys,N06.850.520.308.250
22404640,2012-03-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22404640,2012-03-09T00:00:00,Income,N01.824.417
22404640,2012-03-09T00:00:00,Middle Aged,M01.060.116.630
22404640,2012-03-09T00:00:00,Smoking,F01.145.466.753
22404640,2012-03-09T00:00:00,Smoking Cessation,F01.145.940.700
22404640,2012-03-09T00:00:00,"Stress, Psychological",F01.145.126.990
22404640,2012-03-09T00:00:00,"Stress, Psychological",F02.830.900
22404640,2012-03-09T00:00:00,United States,Z01.107.567.875
22404640,2012-03-09T00:00:00,Young Adult,M01.060.116.815
22406747,2012-03-11T00:00:00,Animals,B01.050
22406747,2012-03-11T00:00:00,Apoptosis,G04.299.139.160
22406747,2012-03-11T00:00:00,Cell Differentiation,G04.299.151
22406747,2012-03-11T00:00:00,Cytokines,D12.644.276.374
22406747,2012-03-11T00:00:00,Cytokines,D12.776.467.374
22406747,2012-03-11T00:00:00,Cytokines,D23.529.374
22406747,2012-03-11T00:00:00,"Disease Models, Animal",C22.232
22406747,2012-03-11T00:00:00,"Disease Models, Animal",E05.598.500
22406747,2012-03-11T00:00:00,"Disease Models, Animal",E05.599.395.080
22406747,2012-03-11T00:00:00,Drug Interactions,G07.690.812.240
22406747,2012-03-11T00:00:00,Drug Interactions,G07.700.680.240
22406747,2012-03-11T00:00:00,Enzyme Inhibitors,D27.505.519.389
22406747,2012-03-11T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
22406747,2012-03-11T00:00:00,Flow Cytometry,E05.200.500.386.350
22406747,2012-03-11T00:00:00,Gene Expression Regulation,G05.355.315
22406747,2012-03-11T00:00:00,Histone Demethylases,D08.811.682.662.582.475
22406747,2012-03-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22406747,2012-03-11T00:00:00,"Leukemia, Myeloid, Acute",C04.557.337.539.550
22406747,2012-03-11T00:00:00,Lysine,D12.125.068.555
22406747,2012-03-11T00:00:00,Lysine,D12.125.095.647
22406747,2012-03-11T00:00:00,Lysine,D12.125.142.497
22406747,2012-03-11T00:00:00,Time Factors,G01.910.857
22410935,2012-03-12T00:00:00,Adrenal Cortex Hormones,D06.472.040
22410935,2012-03-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22410935,2012-03-12T00:00:00,Nasal Polyps,C08.460.572
22410935,2012-03-12T00:00:00,Nasal Polyps,C09.603.557
22410935,2012-03-12T00:00:00,Nasal Polyps,C23.300.825.557
22411746,2012-03-12T00:00:00,Cadaver,C23.550.260.224
22411746,2012-03-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22411746,2012-03-12T00:00:00,Luminescent Measurements,E05.196.712.516
22411746,2012-03-12T00:00:00,Paranasal Sinuses,A04.531.621
22418553,2012-03-12T00:00:00,Algorithms,G17.035
22418553,2012-03-12T00:00:00,Algorithms,L01.224.050
22418553,2012-03-12T00:00:00,Image Enhancement,E01.370.350.600.350
22418553,2012-03-12T00:00:00,Image Enhancement,L01.224.308.380
22418553,2012-03-12T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
22418553,2012-03-12T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
22418553,2012-03-12T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
22418553,2012-03-12T00:00:00,Lighting,N06.230.150.410
22410844,2012-03-13T00:00:00,Adolescent,M01.060.057
22410844,2012-03-13T00:00:00,Adult,M01.060.116
22410844,2012-03-13T00:00:00,Age Factors,N05.715.350.075
22410844,2012-03-13T00:00:00,Age Factors,N06.850.490.250
22410844,2012-03-13T00:00:00,Aged,M01.060.116.100
22410844,2012-03-13T00:00:00,Health Behavior,F01.145.488
22410844,2012-03-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22410844,2012-03-13T00:00:00,Incidence,E05.318.308.985.525.375
22410844,2012-03-13T00:00:00,Incidence,L01.280.975.525.375
22410844,2012-03-13T00:00:00,Incidence,N01.224.935.597.500
22410844,2012-03-13T00:00:00,Incidence,N06.850.505.400.975.525.375
22410844,2012-03-13T00:00:00,Incidence,N06.850.520.308.985.525.375
22410844,2012-03-13T00:00:00,Middle Aged,M01.060.116.630
22410844,2012-03-13T00:00:00,Risk Factors,E05.318.740.600.800.725
22410844,2012-03-13T00:00:00,Risk Factors,N05.715.350.200.700
22410844,2012-03-13T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22410844,2012-03-13T00:00:00,Risk Factors,N06.850.490.625.750
22410844,2012-03-13T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22410844,2012-03-13T00:00:00,Spinal Cord Injuries,C10.228.854.770
22410844,2012-03-13T00:00:00,Spinal Cord Injuries,C10.900.850
22410844,2012-03-13T00:00:00,Spinal Cord Injuries,C21.866.819
22410844,2012-03-13T00:00:00,Young Adult,M01.060.116.815
22411428,2012-03-13T00:00:00,Animals,B01.050
22411428,2012-03-13T00:00:00,Cocaine,D02.145.074.722.388
22411428,2012-03-13T00:00:00,Cocaine,D03.132.889.354
22411428,2012-03-13T00:00:00,Cocaine,D03.605.869.388
22411428,2012-03-13T00:00:00,Cocaine,D04.075.080.875.099.722.388
22411428,2012-03-13T00:00:00,Cues,F02.463.425.234
22411428,2012-03-13T00:00:00,Glutamic Acid,D12.125.067.750
22411428,2012-03-13T00:00:00,Glutamic Acid,D12.125.119.450
22411428,2012-03-13T00:00:00,Glutamic Acid,D12.125.427.300
22411428,2012-03-13T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
22411428,2012-03-13T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
22411428,2012-03-13T00:00:00,Neuropeptides,D12.644.400
22411428,2012-03-13T00:00:00,Neuropeptides,D12.776.641.650
22411428,2012-03-13T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22411428,2012-03-13T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
22411428,2012-03-13T00:00:00,"Receptors, AMPA",D12.776.543.750.720.200.450.200
22411428,2012-03-13T00:00:00,"Receptors, G-Protein-Coupled",D12.776.543.750.100
22411428,2012-03-13T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
22411428,2012-03-13T00:00:00,"Receptors, Neuropeptide",D12.776.543.750.720.600
22411428,2012-03-13T00:00:00,"Receptors, Neuropeptide",D12.776.543.750.750.555
22411428,2012-03-13T00:00:00,Self Administration,E02.319.890
22411428,2012-03-13T00:00:00,Self Administration,E02.900.890
22411428,2012-03-13T00:00:00,Signal Transduction,G02.111.087.800
22411428,2012-03-13T00:00:00,Signal Transduction,G02.149.115.800
22411428,2012-03-13T00:00:00,Signal Transduction,G04.299.880
22411428,2012-03-13T00:00:00,Ventral Tegmental Area,A08.186.211.132.659.822.820
22411428,2012-03-13T00:00:00,Ventral Tegmental Area,A08.186.211.653.822.820
22411599,2012-03-13T00:00:00,Adult,M01.060.116
22411599,2012-03-13T00:00:00,Aged,M01.060.116.100
22411599,2012-03-13T00:00:00,Data Collection,E05.318.308
22411599,2012-03-13T00:00:00,Data Collection,L01.280
22411599,2012-03-13T00:00:00,Data Collection,N05.715.360.300
22411599,2012-03-13T00:00:00,Data Collection,N06.850.520.308
22411599,2012-03-13T00:00:00,Ferritins,D12.776.157.427.249
22411599,2012-03-13T00:00:00,Ferritins,D12.776.556.579.249
22411599,2012-03-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22411599,2012-03-13T00:00:00,Hypertension,C14.907.489
22411599,2012-03-13T00:00:00,Middle Aged,M01.060.116.630
22411702,2012-03-13T00:00:00,Animals,B01.050
22411702,2012-03-13T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
22411702,2012-03-13T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
22411702,2012-03-13T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
22411702,2012-03-13T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
22411702,2012-03-13T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
22411702,2012-03-13T00:00:00,"Microscopy, Fluorescence",E05.595.458
22411702,2012-03-13T00:00:00,Nanoparticles,J01.637.512.600
22411702,2012-03-13T00:00:00,Polymers,D05.750
22411702,2012-03-13T00:00:00,Polymers,D25.720
22411702,2012-03-13T00:00:00,Polymers,J01.637.051.720
22411702,2012-03-13T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22411702,2012-03-13T00:00:00,Retina,A09.371.729
22411702,2012-03-13T00:00:00,Time Factors,G01.910.857
22411716,2012-03-13T00:00:00,Cardiopulmonary Bypass,E04.292.413
22411716,2012-03-13T00:00:00,Child,M01.060.406
22411716,2012-03-13T00:00:00,"Child, Preschool",M01.060.406.448
22411716,2012-03-13T00:00:00,"Cholesterol, HDL",D10.532.432.400
22411716,2012-03-13T00:00:00,"Cholesterol, HDL",D10.570.938.208.270
22411716,2012-03-13T00:00:00,"Cholesterol, HDL",D12.776.521.479.470
22411716,2012-03-13T00:00:00,Fontan Procedure,E04.035.410.295
22411716,2012-03-13T00:00:00,Fontan Procedure,E04.100.376.410.295
22411716,2012-03-13T00:00:00,Fontan Procedure,E04.928.220.370.295
22411716,2012-03-13T00:00:00,"Heart Defects, Congenital",C14.240.400
22411716,2012-03-13T00:00:00,"Heart Defects, Congenital",C14.280.400
22411716,2012-03-13T00:00:00,"Heart Defects, Congenital",C16.131.240.400
22411716,2012-03-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22411716,2012-03-13T00:00:00,Infant,M01.060.703
22411716,2012-03-13T00:00:00,Pleural Effusion,C08.528.652
22411716,2012-03-13T00:00:00,Postoperative Complications,C23.550.767
22411716,2012-03-13T00:00:00,Treatment Outcome,E01.789.800
22411716,2012-03-13T00:00:00,Treatment Outcome,N04.761.559.590.800
22411716,2012-03-13T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22415768,2012-03-13T00:00:00,Biostatistics,E05.318.740.237
22415768,2012-03-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22415768,2012-03-13T00:00:00,Internal Medicine,H02.403.429
22415768,2012-03-13T00:00:00,Publishing,L01.737
22418612,2012-03-13T00:00:00,Aged,M01.060.116.100
22418612,2012-03-13T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
22418612,2012-03-13T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
22418612,2012-03-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22418612,2012-03-13T00:00:00,Influenza Vaccines,D20.215.894.899.302
22418612,2012-03-13T00:00:00,"Influenza, Human",C02.782.620.365
22418612,2012-03-13T00:00:00,"Influenza, Human",C08.730.310
22418612,2012-03-13T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
22418612,2012-03-13T00:00:00,Pneumococcal Infections,C01.252.410.890.670
22418612,2012-03-13T00:00:00,Pneumococcal Vaccines,D20.215.894.135.750.600
22440645,2012-03-13T00:00:00,Algorithms,G17.035
22440645,2012-03-13T00:00:00,Algorithms,L01.224.050
22440645,2012-03-13T00:00:00,Brain,A08.186.211
22440645,2012-03-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22440645,2012-03-13T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
22440645,2012-03-13T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
22440645,2012-03-13T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
22440645,2012-03-13T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
22440645,2012-03-13T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
22440645,2012-03-13T00:00:00,Middle Aged,M01.060.116.630
22440645,2012-03-13T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
22440645,2012-03-13T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
22440645,2012-03-13T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
22440645,2012-03-13T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
22440645,2012-03-13T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
22498172,2012-03-13T00:00:00,Antineoplastic Agents,D27.505.954.248
22498172,2012-03-13T00:00:00,Apoptosis,G04.299.139.160
22498172,2012-03-13T00:00:00,Cell Survival,G04.299.316
22498172,2012-03-13T00:00:00,Fenretinide,D02.455.326.271.665.202.495.270
22498172,2012-03-13T00:00:00,Fenretinide,D02.455.426.392.368.367.379.249.700.270
22498172,2012-03-13T00:00:00,Fenretinide,D02.455.849.131.495.270
22498172,2012-03-13T00:00:00,Fenretinide,D23.767.261.700.270
22498172,2012-03-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22498172,2012-03-13T00:00:00,MicroRNAs,D13.150.650.319
22498172,2012-03-13T00:00:00,MicroRNAs,D13.444.735.150.319
22498172,2012-03-13T00:00:00,MicroRNAs,D13.444.735.790.099
22498172,2012-03-13T00:00:00,Neuroblastoma,C04.557.465.625.600.590.650.550
22498172,2012-03-13T00:00:00,Neuroblastoma,C04.557.470.670.590.650.550
22498172,2012-03-13T00:00:00,Neuroblastoma,C04.557.580.625.600.590.650.550
22415798,2012-03-14T00:00:00,Aged,M01.060.116.100
22415798,2012-03-14T00:00:00,Antineoplastic Agents,D27.505.954.248
22415798,2012-03-14T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
22415798,2012-03-14T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
22415798,2012-03-14T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
22415798,2012-03-14T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
22415798,2012-03-14T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
22415798,2012-03-14T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
22415798,2012-03-14T00:00:00,"Carcinoma, Renal Cell",C04.557.470.200.025.390
22415798,2012-03-14T00:00:00,"Carcinoma, Renal Cell",C04.588.945.947.535.160
22415798,2012-03-14T00:00:00,"Carcinoma, Renal Cell",C12.758.820.750.160
22415798,2012-03-14T00:00:00,"Carcinoma, Renal Cell",C12.777.419.473.160
22415798,2012-03-14T00:00:00,"Carcinoma, Renal Cell",C13.351.937.820.535.160
22415798,2012-03-14T00:00:00,"Carcinoma, Renal Cell",C13.351.968.419.473.160
22415798,2012-03-14T00:00:00,Histone Deacetylase Inhibitors,D27.505.519.389.360
22415798,2012-03-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22415798,2012-03-14T00:00:00,Kidney Neoplasms,C04.588.945.947.535
22415798,2012-03-14T00:00:00,Kidney Neoplasms,C12.758.820.750
22415798,2012-03-14T00:00:00,Kidney Neoplasms,C12.777.419.473
22415798,2012-03-14T00:00:00,Kidney Neoplasms,C13.351.937.820.535
22415798,2012-03-14T00:00:00,Kidney Neoplasms,C13.351.968.419.473
22415798,2012-03-14T00:00:00,Lung Neoplasms,C04.588.894.797.520
22415798,2012-03-14T00:00:00,Lung Neoplasms,C08.381.540
22415798,2012-03-14T00:00:00,Lung Neoplasms,C08.785.520
22415798,2012-03-14T00:00:00,Middle Aged,M01.060.116.630
22415798,2012-03-14T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
22415867,2012-03-14T00:00:00,Adult,M01.060.116
22415867,2012-03-14T00:00:00,African Americans,M01.686.508.100.100
22415867,2012-03-14T00:00:00,African Americans,M01.686.754.100
22415867,2012-03-14T00:00:00,Aged,M01.060.116.100
22415867,2012-03-14T00:00:00,Blood Glucose,D09.546.359.448.500
22415867,2012-03-14T00:00:00,Blood Pressure,E01.370.600.875.249
22415867,2012-03-14T00:00:00,Blood Pressure,G09.330.380.076
22415867,2012-03-14T00:00:00,Diabetes Mellitus,C18.452.394.750
22415867,2012-03-14T00:00:00,Diabetes Mellitus,C19.246
22415867,2012-03-14T00:00:00,Ethnic Groups,M01.686.754
22415867,2012-03-14T00:00:00,Ethnic Groups,N01.224.317
22415867,2012-03-14T00:00:00,European Continental Ancestry Group,M01.686.508.400
22415867,2012-03-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22415867,2012-03-14T00:00:00,Hypertension,C14.907.489
22415867,2012-03-14T00:00:00,Mexican Americans,M01.686.754.441.500
22415867,2012-03-14T00:00:00,Middle Aged,M01.060.116.630
22415867,2012-03-14T00:00:00,Nutrition Surveys,E05.318.308.250.600
22415867,2012-03-14T00:00:00,Nutrition Surveys,E05.318.308.585.550
22415867,2012-03-14T00:00:00,Nutrition Surveys,N05.715.360.300.375.560
22415867,2012-03-14T00:00:00,Nutrition Surveys,N05.715.360.300.560.565
22415867,2012-03-14T00:00:00,Nutrition Surveys,N06.850.520.308.250.600
22415867,2012-03-14T00:00:00,Nutrition Surveys,N06.850.520.308.585.550
22415867,2012-03-14T00:00:00,Risk Factors,E05.318.740.600.800.725
22415867,2012-03-14T00:00:00,Risk Factors,N05.715.350.200.700
22415867,2012-03-14T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22415867,2012-03-14T00:00:00,Risk Factors,N06.850.490.625.750
22415867,2012-03-14T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22420516,2012-03-14T00:00:00,Aged,M01.060.116.100
22420516,2012-03-14T00:00:00,Chronic Disease,C23.550.291.500
22420516,2012-03-14T00:00:00,Constipation,C23.888.821.150
22420516,2012-03-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22420516,2012-03-14T00:00:00,Nursing Assessment,N04.590.233.508.480
22420516,2012-03-14T00:00:00,Risk Factors,E05.318.740.600.800.725
22420516,2012-03-14T00:00:00,Risk Factors,N05.715.350.200.700
22420516,2012-03-14T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22420516,2012-03-14T00:00:00,Risk Factors,N06.850.490.625.750
22420516,2012-03-14T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22422395,2012-03-14T00:00:00,Adult,M01.060.116
22422395,2012-03-14T00:00:00,Aged,M01.060.116.100
22422395,2012-03-14T00:00:00,Electric Stimulation,E05.723.402
22422395,2012-03-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22422395,2012-03-14T00:00:00,Middle Aged,M01.060.116.630
22422395,2012-03-14T00:00:00,Muscle Contraction,G11.427.590.540
22422395,2012-03-14T00:00:00,"Muscle, Smooth",A02.633.570
22422395,2012-03-14T00:00:00,"Muscle, Smooth",A10.690.467
22422395,2012-03-14T00:00:00,"Myocytes, Smooth Muscle",A11.620.520
22422395,2012-03-14T00:00:00,Peptides,D12.644
22422395,2012-03-14T00:00:00,"RNA, Messenger",D13.444.735.544
22422395,2012-03-14T00:00:00,Spider Venoms,D20.888.065.870
22422395,2012-03-14T00:00:00,Spider Venoms,D23.946.833.065.870
22422395,2012-03-14T00:00:00,Urinary Bladder,A05.810.890
22422395,2012-03-14T00:00:00,Young Adult,M01.060.116.815
22422396,2012-03-14T00:00:00,Aged,M01.060.116.100
22422396,2012-03-14T00:00:00,Calcium,D01.268.552.100
22422396,2012-03-14T00:00:00,Calcium,D01.552.539.288
22422396,2012-03-14T00:00:00,Calcium,D23.119.100
22422396,2012-03-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22422396,2012-03-14T00:00:00,Middle Aged,M01.060.116.630
22422396,2012-03-14T00:00:00,Muscle Contraction,G11.427.590.540
22422396,2012-03-14T00:00:00,"Muscle, Smooth",A02.633.570
22422396,2012-03-14T00:00:00,"Muscle, Smooth",A10.690.467
22422396,2012-03-14T00:00:00,"Myocytes, Smooth Muscle",A11.620.520
22422396,2012-03-14T00:00:00,Peptides,D12.644
22422396,2012-03-14T00:00:00,"Urinary Bladder, Overactive",C12.777.829.866
22422396,2012-03-14T00:00:00,"Urinary Bladder, Overactive",C13.351.968.829.813
22422396,2012-03-14T00:00:00,"Urinary Bladder, Overactive",C23.888.942.775
22422845,2012-03-14T00:00:00,Communicable Diseases,C01.539.221
22422845,2012-03-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22422845,2012-03-14T00:00:00,Molecular Diagnostic Techniques,E05.200.880
22422845,2012-03-14T00:00:00,Molecular Diagnostic Techniques,E05.393.520
22465743,2012-03-14T00:00:00,Adult,M01.060.116
22465743,2012-03-14T00:00:00,Aged,M01.060.116.100
22465743,2012-03-14T00:00:00,Depression,F01.145.126.350
22465743,2012-03-14T00:00:00,Depressive Disorder,F03.600.300
22465743,2012-03-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22465743,2012-03-14T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
22465743,2012-03-14T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
22465743,2012-03-14T00:00:00,Middle Aged,M01.060.116.630
22465743,2012-03-14T00:00:00,Motor Cortex,A08.186.211.730.885.287.500.270.548
22465743,2012-03-14T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
22465743,2012-03-14T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
22465743,2012-03-14T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
22465743,2012-03-14T00:00:00,Treatment Outcome,E01.789.800
22465743,2012-03-14T00:00:00,Treatment Outcome,N04.761.559.590.800
22465743,2012-03-14T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22422617,2012-03-15T00:00:00,Animals,B01.050
22422617,2012-03-15T00:00:00,Cell Membrane,A11.284.149
22422617,2012-03-15T00:00:00,Connective Tissue Growth Factor,D12.644.276.200.100
22422617,2012-03-15T00:00:00,Connective Tissue Growth Factor,D12.776.467.200.100
22422617,2012-03-15T00:00:00,Connective Tissue Growth Factor,D12.776.860.300.200.100
22422617,2012-03-15T00:00:00,Connective Tissue Growth Factor,D23.529.237.100
22422617,2012-03-15T00:00:00,Diabetic Nephropathies,C12.777.419.192
22422617,2012-03-15T00:00:00,Diabetic Nephropathies,C13.351.968.419.192
22422617,2012-03-15T00:00:00,Diabetic Nephropathies,C19.246.099.875
22422617,2012-03-15T00:00:00,Gene Silencing,G05.355.315.203.374
22422617,2012-03-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22422617,2012-03-15T00:00:00,"Lipoproteins, LDL",D10.532.515
22422617,2012-03-15T00:00:00,"Lipoproteins, LDL",D12.776.521.550
22422617,2012-03-15T00:00:00,Lysophospholipids,D10.570.755.375.760.550
22422617,2012-03-15T00:00:00,MAP Kinase Signaling System,G02.111.087.800.560
22422617,2012-03-15T00:00:00,MAP Kinase Signaling System,G02.149.115.800.560
22422617,2012-03-15T00:00:00,MAP Kinase Signaling System,G03.495.553.560
22422617,2012-03-15T00:00:00,MAP Kinase Signaling System,G04.299.880.560
22422617,2012-03-15T00:00:00,Mesangial Cells,A05.810.453.324.359.620
22422617,2012-03-15T00:00:00,Mesangial Cells,A05.810.453.736.520.620
22422617,2012-03-15T00:00:00,Mesangial Cells,A11.329.228.950
22422617,2012-03-15T00:00:00,Phosphotransferases (Alcohol Group Acceptor),D08.811.913.696.620
22422617,2012-03-15T00:00:00,Protein Isoforms,D12.776.800
22422617,2012-03-15T00:00:00,Protein Transport,G03.495.166.700
22422617,2012-03-15T00:00:00,"RNA, Messenger",D13.444.735.544
22422617,2012-03-15T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22422617,2012-03-15T00:00:00,"Receptors, Lysosphingolipid",D12.776.543.750.100.420.500
22422617,2012-03-15T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
22422617,2012-03-15T00:00:00,Sphingosine,D02.033.100.700
22422617,2012-03-15T00:00:00,Sphingosine,D02.033.455.843
22422617,2012-03-15T00:00:00,Sphingosine,D02.092.063.700
22422867,2012-03-15T00:00:00,Adolescent,M01.060.057
22422867,2012-03-15T00:00:00,Adult,M01.060.116
22422867,2012-03-15T00:00:00,Aged,M01.060.116.100
22422867,2012-03-15T00:00:00,Health Services Accessibility,N04.590.374.350
22422867,2012-03-15T00:00:00,Health Services Accessibility,N05.300.430
22422867,2012-03-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22422867,2012-03-15T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
22422867,2012-03-15T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
22422867,2012-03-15T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
22422867,2012-03-15T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
22422867,2012-03-15T00:00:00,Kidney Transplantation,E02.870.500
22422867,2012-03-15T00:00:00,Kidney Transplantation,E04.936.450.485
22422867,2012-03-15T00:00:00,Kidney Transplantation,E04.950.774.400
22422867,2012-03-15T00:00:00,Middle Aged,M01.060.116.630
22422867,2012-03-15T00:00:00,United States,Z01.107.567.875
22422867,2012-03-15T00:00:00,Waiting Lists,N04.452.095.738
22422867,2012-03-15T00:00:00,Young Adult,M01.060.116.815
22424650,2012-03-15T00:00:00,"Clinical Trials, Phase II as Topic",E05.318.760.535.210
22424650,2012-03-15T00:00:00,"Clinical Trials, Phase II as Topic",E05.337.250.210
22424650,2012-03-15T00:00:00,"Clinical Trials, Phase II as Topic",N05.715.360.775.235.210
22424650,2012-03-15T00:00:00,"Clinical Trials, Phase II as Topic",N06.850.520.450.535.210
22424650,2012-03-15T00:00:00,"Data Interpretation, Statistical",E05.245.380
22424650,2012-03-15T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
22424650,2012-03-15T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
22424650,2012-03-15T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
22424650,2012-03-15T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
22424650,2012-03-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22424650,2012-03-15T00:00:00,Interdisciplinary Communication,F01.145.209.381
22424650,2012-03-15T00:00:00,Interdisciplinary Communication,F01.829.401.205.249
22424650,2012-03-15T00:00:00,Interdisciplinary Communication,L01.143.474
22424650,2012-03-15T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
22424650,2012-03-15T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
22424650,2012-03-15T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
22424650,2012-03-15T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
22424650,2012-03-15T00:00:00,Research Design,E05.581.500
22424650,2012-03-15T00:00:00,Research Design,H01.770.644.728
22424914,2012-03-15T00:00:00,Adolescent,M01.060.057
22424914,2012-03-15T00:00:00,Adult,M01.060.116
22424914,2012-03-15T00:00:00,Fear,F01.470.361
22424914,2012-03-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22424914,2012-03-15T00:00:00,Young Adult,M01.060.116.815
22425424,2012-03-15T00:00:00,Adolescent,M01.060.057
22425424,2012-03-15T00:00:00,Caregivers,M01.085
22425424,2012-03-15T00:00:00,Caregivers,M01.526.485.200
22425424,2012-03-15T00:00:00,Caregivers,N02.360.200
22425424,2012-03-15T00:00:00,Child,M01.060.406
22425424,2012-03-15T00:00:00,Depression,F01.145.126.350
22425424,2012-03-15T00:00:00,Epilepsy,C10.228.140.490
22425424,2012-03-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22425424,2012-03-15T00:00:00,Psychiatric Status Rating Scales,F04.586
22425424,2012-03-15T00:00:00,Questionnaires,E05.318.308.750
22425424,2012-03-15T00:00:00,Questionnaires,L01.280.800
22425424,2012-03-15T00:00:00,Questionnaires,N05.715.360.300.695
22425424,2012-03-15T00:00:00,Questionnaires,N06.850.520.308.750
22425424,2012-03-15T00:00:00,Seizures,C10.228.140.490.631
22425424,2012-03-15T00:00:00,Seizures,C10.597.742
22425424,2012-03-15T00:00:00,Seizures,C23.888.592.742
22425424,2012-03-15T00:00:00,Self Efficacy,F01.752.747.792.700
22421927,2012-03-16T00:00:00,Adult,M01.060.116
22421927,2012-03-16T00:00:00,Aged,M01.060.116.100
22421927,2012-03-16T00:00:00,Anti-Obesity Agents,D27.505.954.427.140
22421927,2012-03-16T00:00:00,Benzazepines,D03.438.079
22421927,2012-03-16T00:00:00,Blood Glucose,D09.546.359.448.500
22421927,2012-03-16T00:00:00,Body Mass Index,E01.370.600.115.100.125
22421927,2012-03-16T00:00:00,Body Mass Index,E05.041.124.125
22421927,2012-03-16T00:00:00,Body Mass Index,G07.100.100.125
22421927,2012-03-16T00:00:00,Body Mass Index,N06.850.505.200.100.175
22421927,2012-03-16T00:00:00,Counseling,F02.784.176
22421927,2012-03-16T00:00:00,Counseling,F04.408.413
22421927,2012-03-16T00:00:00,Counseling,N02.421.143.303
22421927,2012-03-16T00:00:00,Counseling,N02.421.461.363
22421927,2012-03-16T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
22421927,2012-03-16T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
22421927,2012-03-16T00:00:00,Double-Blind Method,E05.318.780.300
22421927,2012-03-16T00:00:00,Double-Blind Method,E05.581.500.300
22421927,2012-03-16T00:00:00,Double-Blind Method,N05.715.360.780.320
22421927,2012-03-16T00:00:00,Double-Blind Method,N06.850.520.445.300
22421927,2012-03-16T00:00:00,Echocardiography,E01.370.350.850.220
22421927,2012-03-16T00:00:00,Echocardiography,E01.370.370.380.220
22421927,2012-03-16T00:00:00,"Hemoglobin A, Glycosylated",D09.408.375
22421927,2012-03-16T00:00:00,"Hemoglobin A, Glycosylated",D12.776.124.400.405.440
22421927,2012-03-16T00:00:00,"Hemoglobin A, Glycosylated",D12.776.422.316.762.380.440
22421927,2012-03-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22421927,2012-03-16T00:00:00,Hypoglycemic Agents,D27.505.696.422
22421927,2012-03-16T00:00:00,Middle Aged,M01.060.116.630
22421927,2012-03-16T00:00:00,Obesity,C18.654.726.500
22421927,2012-03-16T00:00:00,Obesity,C23.888.144.699.500
22421927,2012-03-16T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
22421927,2012-03-16T00:00:00,Obesity,G07.100.100.160.120.699.500
22421927,2012-03-16T00:00:00,Quality of Life,I01.800
22421927,2012-03-16T00:00:00,Quality of Life,K01.752.400.750
22421927,2012-03-16T00:00:00,Risk Reduction Behavior,F01.145.699
22421927,2012-03-16T00:00:00,Weight Loss,C23.888.144.243.963
22421927,2012-03-16T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
22422059,2012-03-16T00:00:00,Animals,B01.050
22422059,2012-03-16T00:00:00,Cattle,B01.050.150.900.649.077.380.271
22422059,2012-03-16T00:00:00,Lactose,D09.698.629.305.340
22422059,2012-03-16T00:00:00,Microarray Analysis,E05.196.630.570
22422059,2012-03-16T00:00:00,Microarray Analysis,E05.588.570
22422059,2012-03-16T00:00:00,Muramidase,D08.811.277.450.642
22422059,2012-03-16T00:00:00,Polymers,D05.750
22422059,2012-03-16T00:00:00,Polymers,D25.720
22422059,2012-03-16T00:00:00,Polymers,J01.637.051.720
22422059,2012-03-16T00:00:00,"Serum Albumin, Bovine",D12.776.034.841.540
22422059,2012-03-16T00:00:00,"Serum Albumin, Bovine",D12.776.124.727.540
22422059,2012-03-16T00:00:00,"Spectrometry, Fluorescence",E05.196.712.516.600.676
22422059,2012-03-16T00:00:00,"Spectrometry, Fluorescence",E05.196.867.726
22425165,2012-03-16T00:00:00,"Adaptation, Psychological",F01.058
22425165,2012-03-16T00:00:00,Adult,M01.060.116
22425165,2012-03-16T00:00:00,Attention Deficit and Disruptive Behavior Disorders,F03.550.150
22425165,2012-03-16T00:00:00,Child,M01.060.406
22425165,2012-03-16T00:00:00,Child Abuse,I01.198.240.856.350.250
22425165,2012-03-16T00:00:00,Child Abuse,I01.880.735.900.350.250
22425165,2012-03-16T00:00:00,Child Abuse,I01.880.787.293.292
22425165,2012-03-16T00:00:00,"Child, Preschool",M01.060.406.448
22425165,2012-03-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22425165,2012-03-16T00:00:00,Parent-Child Relations,F01.829.263.370.290
22425165,2012-03-16T00:00:00,Parents,F01.829.263.500.320
22425165,2012-03-16T00:00:00,Parents,I01.880.225.500.340
22425165,2012-03-16T00:00:00,Parents,M01.620
22425165,2012-03-16T00:00:00,Sex Factors,N05.715.350.675
22425165,2012-03-16T00:00:00,Sex Factors,N06.850.490.875
22427366,2012-03-16T00:00:00,Adolescent,M01.060.057
22427366,2012-03-16T00:00:00,Antipsychotic Agents,D27.505.696.277.950.040
22427366,2012-03-16T00:00:00,Antipsychotic Agents,D27.505.954.427.210.950.040
22427366,2012-03-16T00:00:00,Antipsychotic Agents,D27.505.954.427.700.872.331
22427366,2012-03-16T00:00:00,Caregivers,M01.085
22427366,2012-03-16T00:00:00,Caregivers,M01.526.485.200
22427366,2012-03-16T00:00:00,Caregivers,N02.360.200
22427366,2012-03-16T00:00:00,Child,M01.060.406
22427366,2012-03-16T00:00:00,"Child Development Disorders, Pervasive",F03.550.325
22427366,2012-03-16T00:00:00,"Child, Preschool",M01.060.406.448
22427366,2012-03-16T00:00:00,Delivery of Health Care,N04.590.374
22427366,2012-03-16T00:00:00,Delivery of Health Care,N05.300
22427366,2012-03-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22427366,2012-03-16T00:00:00,Infant,M01.060.703
22427366,2012-03-16T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
22427366,2012-03-16T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
22427366,2012-03-16T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
22427366,2012-03-16T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
22427366,2012-03-16T00:00:00,Risperidone,D03.383.742.698.685
22427366,2012-03-16T00:00:00,Sex Factors,N05.715.350.675
22427366,2012-03-16T00:00:00,Sex Factors,N06.850.490.875
22427491,2012-03-16T00:00:00,Bacteriophages,B04.123
22427491,2012-03-16T00:00:00,Luminescence,G01.201.875.770.578.665
22427491,2012-03-16T00:00:00,Luminescence,G01.590.540.665
22427491,2012-03-16T00:00:00,Molecular Sequence Data,L01.453.245.667
22427491,2012-03-16T00:00:00,Pseudomonas,B03.440.400.425.625.625
22427491,2012-03-16T00:00:00,Pseudomonas,B03.660.250.580.590
22427491,2012-03-16T00:00:00,"Sequence Analysis, DNA",E05.393.760.700
22453577,2012-03-16T00:00:00,3T3 Cells,A11.251.210.700
22453577,2012-03-16T00:00:00,3T3 Cells,A11.329.228.900
22453577,2012-03-16T00:00:00,Animals,B01.050
22453577,2012-03-16T00:00:00,Cell Membrane,A11.284.149
22453577,2012-03-16T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
22453577,2012-03-16T00:00:00,"Microscopy, Fluorescence",E05.595.458
22453577,2012-03-16T00:00:00,Printing,L01.737.787
22433464,2012-03-17T00:00:00,Adolescent,M01.060.057
22433464,2012-03-17T00:00:00,Adult,M01.060.116
22433464,2012-03-17T00:00:00,Aged,M01.060.116.100
22433464,2012-03-17T00:00:00,Child,M01.060.406
22433464,2012-03-17T00:00:00,Gynecologic Surgical Procedures,E04.950.300
22433464,2012-03-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22433464,2012-03-17T00:00:00,Laparoscopy,E01.370.388.250.520
22433464,2012-03-17T00:00:00,Laparoscopy,E04.800.250.520
22433464,2012-03-17T00:00:00,Lung Diseases,C08.381
22433464,2012-03-17T00:00:00,Middle Aged,M01.060.116.630
22433464,2012-03-17T00:00:00,Postoperative Complications,C23.550.767
22433464,2012-03-17T00:00:00,Smoking,F01.145.466.753
22433464,2012-03-17T00:00:00,Young Adult,M01.060.116.815
22472524,2012-03-17T00:00:00,Adult,M01.060.116
22472524,2012-03-17T00:00:00,Alcohol Drinking,F01.145.317.269
22472524,2012-03-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22472524,2012-03-17T00:00:00,Impulsive Behavior,F01.145.527
22472524,2012-03-17T00:00:00,Motivation,F01.658
22472524,2012-03-17T00:00:00,Motivation,F01.752.543.500.750
22472524,2012-03-17T00:00:00,Risk Factors,E05.318.740.600.800.725
22472524,2012-03-17T00:00:00,Risk Factors,N05.715.350.200.700
22472524,2012-03-17T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22472524,2012-03-17T00:00:00,Risk Factors,N06.850.490.625.750
22472524,2012-03-17T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22472524,2012-03-17T00:00:00,Risk-Taking,F01.145.722
22472524,2012-03-17T00:00:00,Students,I02.233.748
22472524,2012-03-17T00:00:00,Students,I02.851
22472524,2012-03-17T00:00:00,Students,M01.848
22472524,2012-03-17T00:00:00,Young Adult,M01.060.116.815
22510352,2012-03-17T00:00:00,Adolescent,M01.060.057
22510352,2012-03-17T00:00:00,Adult,M01.060.116
22510352,2012-03-17T00:00:00,Aged,M01.060.116.100
22510352,2012-03-17T00:00:00,Case-Control Studies,E05.318.760.500.500
22510352,2012-03-17T00:00:00,Case-Control Studies,N05.715.360.775.175.200
22510352,2012-03-17T00:00:00,Case-Control Studies,N06.850.520.450.500.500
22510352,2012-03-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22510352,2012-03-17T00:00:00,Laryngoscopy,E01.370.386.460
22510352,2012-03-17T00:00:00,Laryngoscopy,E01.370.388.250.525
22510352,2012-03-17T00:00:00,Laryngoscopy,E04.580.373
22510352,2012-03-17T00:00:00,Laryngoscopy,E04.800.250.525
22510352,2012-03-17T00:00:00,Middle Aged,M01.060.116.630
22510352,2012-03-17T00:00:00,Stroboscopy,E01.370.350.755
22510352,2012-03-17T00:00:00,Vocal Cords,A04.329.364.737
22510352,2012-03-17T00:00:00,Voice Disorders,C08.360.940
22510352,2012-03-17T00:00:00,Voice Disorders,C09.400.940
22510352,2012-03-17T00:00:00,Voice Disorders,C10.597.975
22510352,2012-03-17T00:00:00,Voice Disorders,C23.888.592.979
22510352,2012-03-17T00:00:00,Young Adult,M01.060.116.815
22428941,2012-03-19T00:00:00,Aggression,F01.145.126.125
22428941,2012-03-19T00:00:00,Aggression,F01.145.813.045
22428941,2012-03-19T00:00:00,Child,M01.060.406
22428941,2012-03-19T00:00:00,Faculty,I02.463
22428941,2012-03-19T00:00:00,Faculty,M01.526.339
22428941,2012-03-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22428941,2012-03-19T00:00:00,Mental Health Services,F04.408
22428941,2012-03-19T00:00:00,Mental Health Services,N02.421.461
22428941,2012-03-19T00:00:00,Peer Group,F01.829.316.483
22428941,2012-03-19T00:00:00,School Health Services,N02.421.143.827.809
22428941,2012-03-19T00:00:00,School Health Services,N02.421.726.809
22428941,2012-03-19T00:00:00,Schools,I02.233.659
22428941,2012-03-19T00:00:00,Schools,I02.783
22428941,2012-03-19T00:00:00,Urban Population,N01.600.900
22429093,2012-03-19T00:00:00,Aged,M01.060.116.100
22429093,2012-03-19T00:00:00,Case-Control Studies,E05.318.760.500.500
22429093,2012-03-19T00:00:00,Case-Control Studies,N05.715.360.775.175.200
22429093,2012-03-19T00:00:00,Case-Control Studies,N06.850.520.450.500.500
22429093,2012-03-19T00:00:00,Education,I02
22429093,2012-03-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22429093,2012-03-19T00:00:00,Lung,A04.411
22429093,2012-03-19T00:00:00,Middle Aged,M01.060.116.630
22429093,2012-03-19T00:00:00,"Pulmonary Disease, Chronic Obstructive",C08.381.495.389
22429093,2012-03-19T00:00:00,Research Design,E05.581.500
22429093,2012-03-19T00:00:00,Research Design,H01.770.644.728
22429093,2012-03-19T00:00:00,Smoking,F01.145.466.753
22429093,2012-03-19T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
22429093,2012-03-19T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
22429093,2012-03-19T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
22429093,2012-03-19T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
22429093,2012-03-19T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
22430740,2012-03-19T00:00:00,Animals,B01.050
22430740,2012-03-19T00:00:00,CD8-Positive T-Lymphocytes,A11.118.637.555.567.569.220
22430740,2012-03-19T00:00:00,CD8-Positive T-Lymphocytes,A15.145.229.637.555.567.569.220
22430740,2012-03-19T00:00:00,CD8-Positive T-Lymphocytes,A15.382.490.555.567.569.220
22430740,2012-03-19T00:00:00,Cell Differentiation,G04.299.151
22430740,2012-03-19T00:00:00,Dendritic Cells,A11.066.270
22430740,2012-03-19T00:00:00,Dendritic Cells,A11.436.270
22430740,2012-03-19T00:00:00,Dendritic Cells,A15.382.066.270
22430740,2012-03-19T00:00:00,Dendritic Cells,A15.382.812.260
22430740,2012-03-19T00:00:00,Gene Expression Regulation,G05.355.315
22430740,2012-03-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22430740,2012-03-19T00:00:00,Interferon-gamma,D12.644.276.374.440.893
22430740,2012-03-19T00:00:00,Interferon-gamma,D12.644.276.374.480.350
22430740,2012-03-19T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
22430740,2012-03-19T00:00:00,Interferon-gamma,D12.644.276.718.550
22430740,2012-03-19T00:00:00,Interferon-gamma,D12.776.467.374.440.893
22430740,2012-03-19T00:00:00,Interferon-gamma,D12.776.467.374.480.350
22430740,2012-03-19T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
22430740,2012-03-19T00:00:00,Interferon-gamma,D12.776.467.718.550
22430740,2012-03-19T00:00:00,Interferon-gamma,D23.529.374.440.893
22430740,2012-03-19T00:00:00,Interferon-gamma,D23.529.374.480.350
22430740,2012-03-19T00:00:00,Interferon-gamma,D23.529.374.480.615.350
22430740,2012-03-19T00:00:00,Interferon-gamma,D23.529.718.550
22430740,2012-03-19T00:00:00,Interleukin-12,D12.644.276.374.465.512
22430740,2012-03-19T00:00:00,Interleukin-12,D12.776.467.374.465.512
22430740,2012-03-19T00:00:00,Interleukin-12,D23.529.374.465.512
22430740,2012-03-19T00:00:00,Interleukin-15,D12.644.276.374.465.515
22430740,2012-03-19T00:00:00,Interleukin-15,D12.776.467.374.465.515
22430740,2012-03-19T00:00:00,Interleukin-15,D23.529.374.465.515
22430740,2012-03-19T00:00:00,Lymphocyte Activation,E01.450.495.482
22430740,2012-03-19T00:00:00,Lymphocyte Activation,E05.478.594.530
22430740,2012-03-19T00:00:00,Lymphocyte Activation,G12.425.747
22430740,2012-03-19T00:00:00,Lymphocyte Activation,G12.450.050.400.545
22430740,2012-03-19T00:00:00,Signal Transduction,G02.111.087.800
22430740,2012-03-19T00:00:00,Signal Transduction,G02.149.115.800
22430740,2012-03-19T00:00:00,Signal Transduction,G04.299.880
22430740,2012-03-19T00:00:00,Vaccination,E02.095.465.425.400.530.890
22430740,2012-03-19T00:00:00,Vaccination,E05.478.550.600.890
22430740,2012-03-19T00:00:00,Vaccination,N02.421.726.758.310.890
22430740,2012-03-19T00:00:00,Vaccination,N06.850.780.200.425.900
22430740,2012-03-19T00:00:00,Vaccination,N06.850.780.680.310.890
22431517,2012-03-19T00:00:00,Animals,B01.050
22431517,2012-03-19T00:00:00,Cell Line,A11.251.210
22431517,2012-03-19T00:00:00,Gene Expression Regulation,G05.355.315
22431517,2012-03-19T00:00:00,Heart,A07.541
22431517,2012-03-19T00:00:00,Heart Diseases,C14.280
22431517,2012-03-19T00:00:00,Myocardium,A02.633.580
22431517,2012-03-19T00:00:00,Myocardium,A07.541.704
22431517,2012-03-19T00:00:00,Myocardium,A10.690.552.750
22431517,2012-03-19T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22431517,2012-03-19T00:00:00,Serum Response Factor,D12.776.260.400.249.875
22431517,2012-03-19T00:00:00,Serum Response Factor,D12.776.930.397.875
22431517,2012-03-19T00:00:00,Signal Transduction,G02.111.087.800
22431517,2012-03-19T00:00:00,Signal Transduction,G02.149.115.800
22431517,2012-03-19T00:00:00,Signal Transduction,G04.299.880
22431517,2012-03-19T00:00:00,Trans-Activators,D12.776.260.755
22431517,2012-03-19T00:00:00,Trans-Activators,D12.776.930.900
22431517,2012-03-19T00:00:00,Trans-Activators,D12.776.964.925.984
22397583,2012-03-20T00:00:00,Adsorption,G02.149.047
22397583,2012-03-20T00:00:00,Adsorption,G02.149.767.029
22397583,2012-03-20T00:00:00,Adsorption,G02.842.750.029
22397583,2012-03-20T00:00:00,Peptides,D12.644
22397583,2012-03-20T00:00:00,Surface Plasmon Resonance,E05.196.890
22397583,2012-03-20T00:00:00,Surface Plasmon Resonance,E05.601.123.700
22397583,2012-03-20T00:00:00,Surface Properties,G02.842.850
22438283,2012-03-20T00:00:00,Adult,M01.060.116
22438283,2012-03-20T00:00:00,Aged,M01.060.116.100
22438283,2012-03-20T00:00:00,Attitude to Health,F01.100.150
22438283,2012-03-20T00:00:00,Attitude to Health,N05.300.150
22438283,2012-03-20T00:00:00,Depression,F01.145.126.350
22438283,2012-03-20T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
22438283,2012-03-20T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
22438283,2012-03-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22438283,2012-03-20T00:00:00,Middle Aged,M01.060.116.630
22438283,2012-03-20T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
22438283,2012-03-20T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
22438283,2012-03-20T00:00:00,Questionnaires,E05.318.308.750
22438283,2012-03-20T00:00:00,Questionnaires,L01.280.800
22438283,2012-03-20T00:00:00,Questionnaires,N05.715.360.300.695
22438283,2012-03-20T00:00:00,Questionnaires,N06.850.520.308.750
22438283,2012-03-20T00:00:00,Self Care,E02.900
22438283,2012-03-20T00:00:00,Self Care,N02.421.784.680
22438226,2012-03-21T00:00:00,Adult,M01.060.116
22438226,2012-03-21T00:00:00,Cholesterol,D04.808.247.222.284
22438226,2012-03-21T00:00:00,Cholesterol,D04.808.247.808.197
22438226,2012-03-21T00:00:00,Cholesterol,D10.570.938.208
22438226,2012-03-21T00:00:00,Cholesterol,D10.851.208
22438226,2012-03-21T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
22438226,2012-03-21T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
22438226,2012-03-21T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
22438226,2012-03-21T00:00:00,"Hemoglobin A, Glycosylated",D09.408.375
22438226,2012-03-21T00:00:00,"Hemoglobin A, Glycosylated",D12.776.124.400.405.440
22438226,2012-03-21T00:00:00,"Hemoglobin A, Glycosylated",D12.776.422.316.762.380.440
22438226,2012-03-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22438226,2012-03-21T00:00:00,Lipoproteins,D10.532
22438226,2012-03-21T00:00:00,Lipoproteins,D12.776.521
22438226,2012-03-21T00:00:00,Pre-Eclampsia,C13.703.395.249
22438226,2012-03-21T00:00:00,Pregnancy,G08.686.785.760.769
22442211,2012-03-21T00:00:00,Animals,B01.050
22442211,2012-03-21T00:00:00,Ganglionic Stimulants,D27.505.696.663.050.400
22442211,2012-03-21T00:00:00,Kidney,A05.810.453
22442211,2012-03-21T00:00:00,Nicotine,D03.132.760.570
22442211,2012-03-21T00:00:00,Nicotine,D03.383.725.518
22442211,2012-03-21T00:00:00,Proteinuria,C12.777.934.734
22442211,2012-03-21T00:00:00,Proteinuria,C13.351.968.934.734
22442211,2012-03-21T00:00:00,Proteinuria,C23.888.942.750
22442211,2012-03-21T00:00:00,Renal Insufficiency,C12.777.419.780
22442211,2012-03-21T00:00:00,Renal Insufficiency,C13.351.968.419.780
22521363,2012-03-21T00:00:00,Adolescent,M01.060.057
22521363,2012-03-21T00:00:00,Alcohol Drinking,F01.145.317.269
22521363,2012-03-21T00:00:00,Alcohol-Related Disorders,C21.739.100
22521363,2012-03-21T00:00:00,Alcohol-Related Disorders,F03.900.100
22521363,2012-03-21T00:00:00,Crime Victims,M01.135
22521363,2012-03-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22521363,2012-03-21T00:00:00,Marijuana Abuse,C21.739.635
22521363,2012-03-21T00:00:00,Marijuana Abuse,F03.900.635
22521363,2012-03-21T00:00:00,Rape,I01.198.240.748.640
22521363,2012-03-21T00:00:00,Risk Factors,E05.318.740.600.800.725
22521363,2012-03-21T00:00:00,Risk Factors,N05.715.350.200.700
22521363,2012-03-21T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22521363,2012-03-21T00:00:00,Risk Factors,N06.850.490.625.750
22521363,2012-03-21T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22521363,2012-03-21T00:00:00,Time Factors,G01.910.857
22521363,2012-03-21T00:00:00,United States,Z01.107.567.875
22666547,2012-03-21T00:00:00,Clinical Trials as Topic,E05.318.760.535
22666547,2012-03-21T00:00:00,Clinical Trials as Topic,E05.337.250
22666547,2012-03-21T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
22666547,2012-03-21T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
22666547,2012-03-21T00:00:00,Dietary Supplements,J02.500.456
22666547,2012-03-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22666547,2012-03-21T00:00:00,Immune System,A15.382
22666547,2012-03-21T00:00:00,Parathyroid Hormone,D06.472.699.590
22666547,2012-03-21T00:00:00,Parathyroid Hormone,D12.644.548.587
22666547,2012-03-21T00:00:00,Pregnancy,G08.686.785.760.769
22666547,2012-03-21T00:00:00,Pregnancy Complications,C13.703
22666547,2012-03-21T00:00:00,Treatment Outcome,E01.789.800
22666547,2012-03-21T00:00:00,Treatment Outcome,N04.761.559.590.800
22666547,2012-03-21T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22666547,2012-03-21T00:00:00,United States,Z01.107.567.875
22666547,2012-03-21T00:00:00,Vitamin D,D04.808.812.768
22666547,2012-03-21T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
22397678,2012-03-22T00:00:00,Catalytic Domain,G02.111.570.120.704
22397678,2012-03-22T00:00:00,Catalytic Domain,G02.111.570.790.709.610.189
22397678,2012-03-22T00:00:00,"Models, Molecular",E05.599.595
22397678,2012-03-22T00:00:00,Mutation,G05.365.590
22397678,2012-03-22T00:00:00,Neisseria gonorrhoeae,B03.440.400.425.550.550.474
22397678,2012-03-22T00:00:00,Neisseria gonorrhoeae,B03.660.075.525.520.400
22397678,2012-03-22T00:00:00,Penicillin-Binding Proteins,D08.811.710
22397678,2012-03-22T00:00:00,Penicillin-Binding Proteins,D12.776.097.545
22442351,2012-03-22T00:00:00,Animals,B01.050
22442351,2012-03-22T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
22442351,2012-03-22T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
22442351,2012-03-22T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
22442351,2012-03-22T00:00:00,Complement System Proteins,D12.776.124.486.274
22442351,2012-03-22T00:00:00,"Disease Models, Animal",C22.232
22442351,2012-03-22T00:00:00,"Disease Models, Animal",E05.598.500
22442351,2012-03-22T00:00:00,"Disease Models, Animal",E05.599.395.080
22442351,2012-03-22T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
22442351,2012-03-22T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
22442351,2012-03-22T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
22442351,2012-03-22T00:00:00,Neoplasms,C04
22442351,2012-03-22T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
22442351,2012-03-22T00:00:00,Signal Transduction,G02.111.087.800
22442351,2012-03-22T00:00:00,Signal Transduction,G02.149.115.800
22442351,2012-03-22T00:00:00,Signal Transduction,G04.299.880
22442351,2012-03-22T00:00:00,Treatment Outcome,E01.789.800
22442351,2012-03-22T00:00:00,Treatment Outcome,N04.761.559.590.800
22442351,2012-03-22T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22444187,2012-03-22T00:00:00,Adult,M01.060.116
22444187,2012-03-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22444187,2012-03-22T00:00:00,Pain,C10.597.617
22444187,2012-03-22T00:00:00,Pain,C23.888.592.612
22444187,2012-03-22T00:00:00,Pain,C23.888.646
22444187,2012-03-22T00:00:00,Pain,F02.830.816.444
22444187,2012-03-22T00:00:00,Pain,G11.561.600.810.444
22444187,2012-03-22T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
22444187,2012-03-22T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
22444187,2012-03-22T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
22444187,2012-03-22T00:00:00,Young Adult,M01.060.116.815
22445605,2012-03-23T00:00:00,"Anesthesia, General",E03.155.197
22445605,2012-03-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22445605,2012-03-23T00:00:00,Middle Aged,M01.060.116.630
22445605,2012-03-23T00:00:00,Operating Rooms,N02.278.388.700
22445605,2012-03-23T00:00:00,Pleura,A04.716
22445605,2012-03-23T00:00:00,Pleura,A10.615.789.736
22447526,2012-03-23T00:00:00,Chronic Disease,C23.550.291.500
22447526,2012-03-23T00:00:00,Endoscopy,E01.370.388.250
22447526,2012-03-23T00:00:00,Endoscopy,E04.800.250
22447526,2012-03-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22447526,2012-03-23T00:00:00,Nasal Septum,A04.531.591
22447526,2012-03-23T00:00:00,Paranasal Sinuses,A04.531.621
22447526,2012-03-23T00:00:00,Rhinitis,C08.460.799
22447526,2012-03-23T00:00:00,Rhinitis,C08.730.674
22447526,2012-03-23T00:00:00,Rhinitis,C09.603.799
22447526,2012-03-23T00:00:00,Sinusitis,C08.460.692.752
22447526,2012-03-23T00:00:00,Sinusitis,C08.730.749
22447526,2012-03-23T00:00:00,Sinusitis,C09.603.692.752
22447526,2012-03-23T00:00:00,United States,Z01.107.567.875
22447665,2012-03-23T00:00:00,"Cell Transformation, Neoplastic",C04.697.152
22447665,2012-03-23T00:00:00,"Cell Transformation, Neoplastic",C23.550.727.152
22447665,2012-03-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22447665,2012-03-23T00:00:00,Middle Aged,M01.060.116.630
22447665,2012-03-23T00:00:00,Neoplasm Invasiveness,C04.697.645
22447665,2012-03-23T00:00:00,Neoplasm Invasiveness,C23.550.727.645
22447665,2012-03-23T00:00:00,Temporal Bone,A02.835.232.781.885
22469467,2012-03-24T00:00:00,Antimalarials,D27.505.954.122.250.100.085
22469467,2012-03-24T00:00:00,"Crystallography, X-Ray",E05.196.309.742.225
22469467,2012-03-24T00:00:00,HIV Protease,D08.811.277.656.074.500.340
22469467,2012-03-24T00:00:00,HIV Protease,D08.811.277.656.300.048.340
22469467,2012-03-24T00:00:00,HIV Protease,D12.776.964.775.375.545.750
22469467,2012-03-24T00:00:00,HIV Protease Inhibitors,D27.505.519.389.745.420
22469467,2012-03-24T00:00:00,HIV Protease Inhibitors,D27.505.954.122.388.077.088.420
22469467,2012-03-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22469467,2012-03-24T00:00:00,Oligopeptides,D12.644.456
22469467,2012-03-24T00:00:00,Protein Conformation,G02.111.570.790.709
22469467,2012-03-24T00:00:00,Pyridines,D03.383.725
22450660,2012-03-26T00:00:00,Antioxidants,D27.505.519.217
22450660,2012-03-26T00:00:00,Antioxidants,D27.505.696.706.125
22450660,2012-03-26T00:00:00,Antioxidants,D27.720.799.047
22450660,2012-03-26T00:00:00,Catecholamines,D02.092.211.215.311
22450660,2012-03-26T00:00:00,Catecholamines,D02.092.311
22450660,2012-03-26T00:00:00,Copper,D01.268.556.195
22450660,2012-03-26T00:00:00,Copper,D01.268.956.170
22450660,2012-03-26T00:00:00,Copper,D01.552.544.195
22450660,2012-03-26T00:00:00,DNA Damage,C21.111
22450660,2012-03-26T00:00:00,DNA Damage,G05.355.180
22450660,2012-03-26T00:00:00,Iron,D01.268.556.412
22450660,2012-03-26T00:00:00,Iron,D01.268.956.287
22450660,2012-03-26T00:00:00,Iron,D01.552.544.412
22322590,2012-03-27T00:00:00,Acid Ceramidase,D08.811.277.087.250.100
22322590,2012-03-27T00:00:00,Cathepsin B,D08.811.277.656.224.125
22322590,2012-03-27T00:00:00,Cathepsin B,D08.811.277.656.262.500.133
22322590,2012-03-27T00:00:00,Cathepsin B,D08.811.277.656.300.200.133
22322590,2012-03-27T00:00:00,Cell Membrane,A11.284.149
22322590,2012-03-27T00:00:00,Cell Movement,G04.299.283
22322590,2012-03-27T00:00:00,Cell Movement,G07.700.560.500.180
22322590,2012-03-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22322590,2012-03-27T00:00:00,Lysophospholipids,D10.570.755.375.760.550
22322590,2012-03-27T00:00:00,Neoplasm Invasiveness,C04.697.645
22322590,2012-03-27T00:00:00,Neoplasm Invasiveness,C23.550.727.645
22322590,2012-03-27T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
22322590,2012-03-27T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
22322590,2012-03-27T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
22322590,2012-03-27T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
22322590,2012-03-27T00:00:00,Prostatic Neoplasms,C12.294.260.750
22322590,2012-03-27T00:00:00,Prostatic Neoplasms,C12.294.565.625
22322590,2012-03-27T00:00:00,Prostatic Neoplasms,C12.758.409.750
22322590,2012-03-27T00:00:00,Proto-Oncogene Protein c-ets-1,D12.776.260.665.100
22322590,2012-03-27T00:00:00,Proto-Oncogene Protein c-ets-1,D12.776.624.664.700.175.100
22322590,2012-03-27T00:00:00,Proto-Oncogene Protein c-ets-1,D12.776.930.635.100
22322590,2012-03-27T00:00:00,Sphingosine,D02.033.100.700
22322590,2012-03-27T00:00:00,Sphingosine,D02.033.455.843
22322590,2012-03-27T00:00:00,Sphingosine,D02.092.063.700
22451118,2012-03-27T00:00:00,Adolescent,M01.060.057
22451118,2012-03-27T00:00:00,Adult,M01.060.116
22451118,2012-03-27T00:00:00,Aged,M01.060.116.100
22451118,2012-03-27T00:00:00,Body Mass Index,E01.370.600.115.100.125
22451118,2012-03-27T00:00:00,Body Mass Index,E05.041.124.125
22451118,2012-03-27T00:00:00,Body Mass Index,G07.100.100.125
22451118,2012-03-27T00:00:00,Body Mass Index,N06.850.505.200.100.175
22451118,2012-03-27T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
22451118,2012-03-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22451118,2012-03-27T00:00:00,Middle Aged,M01.060.116.630
22451118,2012-03-27T00:00:00,Obesity,C18.654.726.500
22451118,2012-03-27T00:00:00,Obesity,C23.888.144.699.500
22451118,2012-03-27T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
22451118,2012-03-27T00:00:00,Obesity,G07.100.100.160.120.699.500
22451118,2012-03-27T00:00:00,Overweight,C23.888.144.699
22451118,2012-03-27T00:00:00,Overweight,E01.370.600.115.100.160.120.699
22451118,2012-03-27T00:00:00,Overweight,G07.100.100.160.120.699
22451118,2012-03-27T00:00:00,Proton Pump Inhibitors,D27.505.519.389.848
22451118,2012-03-27T00:00:00,Risk Factors,E05.318.740.600.800.725
22451118,2012-03-27T00:00:00,Risk Factors,N05.715.350.200.700
22451118,2012-03-27T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22451118,2012-03-27T00:00:00,Risk Factors,N06.850.490.625.750
22451118,2012-03-27T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22451118,2012-03-27T00:00:00,Young Adult,M01.060.116.815
22452670,2012-03-27T00:00:00,Artifacts,E05.047
22452670,2012-03-27T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
22452670,2012-03-27T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
22452670,2012-03-27T00:00:00,"Defibrillators, Implantable",E07.695.175
22452670,2012-03-27T00:00:00,Heart-Assist Devices,E04.050.430
22452670,2012-03-27T00:00:00,Heart-Assist Devices,E07.695.300.300
22452670,2012-03-27T00:00:00,Heart-Assist Devices,E07.858.082.374.300
22452670,2012-03-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22452670,2012-03-27T00:00:00,Middle Aged,M01.060.116.630
22452947,2012-03-27T00:00:00,Animals,B01.050
22452947,2012-03-27T00:00:00,Apoptosis,G04.299.139.160
22452947,2012-03-27T00:00:00,Ceramides,D02.065.313
22452947,2012-03-27T00:00:00,Ceramides,D09.400.410.420.525.200
22452947,2012-03-27T00:00:00,Ceramides,D10.390.470.675.200
22452947,2012-03-27T00:00:00,Ceramides,D10.570.877.360.612.200
22452947,2012-03-27T00:00:00,Down-Regulation,G02.111.087.225
22452947,2012-03-27T00:00:00,Down-Regulation,G02.149.115.225
22452947,2012-03-27T00:00:00,Down-Regulation,G05.355.315.200
22452947,2012-03-27T00:00:00,Down-Regulation,G07.690.812.230
22452947,2012-03-27T00:00:00,Down-Regulation,G07.700.680.230
22452947,2012-03-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22452947,2012-03-27T00:00:00,Nitric Oxide,D01.339.387
22452947,2012-03-27T00:00:00,Nitric Oxide,D01.625.550.500
22452947,2012-03-27T00:00:00,Nitric Oxide,D01.625.700.500
22452947,2012-03-27T00:00:00,Nitric Oxide,D01.650.550.587.600
22452947,2012-03-27T00:00:00,Oxidative Stress,G03.495.710
22452947,2012-03-27T00:00:00,Oxidative Stress,G07.700.830.750
22452947,2012-03-27T00:00:00,"Receptors, G-Protein-Coupled",D12.776.543.750.100
22452947,2012-03-27T00:00:00,Sphingomyelin Phosphodiesterase,D08.811.277.352.640.750
22459871,2012-03-27T00:00:00,Alcohol-Related Disorders,C21.739.100
22459871,2012-03-27T00:00:00,Alcohol-Related Disorders,F03.900.100
22459871,2012-03-27T00:00:00,Alcoholism,C21.739.100.250
22459871,2012-03-27T00:00:00,Alcoholism,F03.900.100.350
22459871,2012-03-27T00:00:00,Animals,B01.050
22459871,2012-03-27T00:00:00,Cannabinoids,D02.455.849.090
22459871,2012-03-27T00:00:00,Drug Tolerance,G07.690.812.260
22459871,2012-03-27T00:00:00,Drug Tolerance,G07.700.680.260
22459871,2012-03-27T00:00:00,Endocannabinoids,D27.505.519.625.170
22459871,2012-03-27T00:00:00,Endocannabinoids,D27.505.696.399.472.215
22459871,2012-03-27T00:00:00,Ethanol,D02.033.375
22459871,2012-03-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22459871,2012-03-27T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22459871,2012-03-27T00:00:00,"Receptor, Cannabinoid, CB1",D12.776.543.750.100.125.100
22459871,2012-03-27T00:00:00,"Stress, Psychological",F01.145.126.990
22459871,2012-03-27T00:00:00,"Stress, Psychological",F02.830.900
22459871,2012-03-27T00:00:00,Substance Withdrawal Syndrome,C21.739.835
22459871,2012-03-27T00:00:00,Substance Withdrawal Syndrome,F03.900.825
22460547,2012-03-27T00:00:00,Brain,A08.186.211
22460547,2012-03-27T00:00:00,Computer Simulation,L01.224.160
22460547,2012-03-27T00:00:00,Diffusion,G01.595.200
22460547,2012-03-27T00:00:00,Diffusion,G02.149.767.560
22460547,2012-03-27T00:00:00,Diffusion,G02.842.750.560
22460547,2012-03-27T00:00:00,Homeostasis,G07.700.360
22460547,2012-03-27T00:00:00,"Models, Neurological",E05.599.395.642
22460547,2012-03-27T00:00:00,Neuroglia,A08.637
22460547,2012-03-27T00:00:00,Neuroglia,A11.650
22460547,2012-03-27T00:00:00,Synapses,A08.850
22460547,2012-03-27T00:00:00,Synapses,A11.284.149.165.420.780
22460547,2012-03-27T00:00:00,Synaptic Transmission,G02.111.087.800.850
22460547,2012-03-27T00:00:00,Synaptic Transmission,G02.149.115.800.850
22460547,2012-03-27T00:00:00,Synaptic Transmission,G04.299.880.850
22460547,2012-03-27T00:00:00,Synaptic Transmission,G07.265.337.900
22460547,2012-03-27T00:00:00,Synaptic Transmission,G07.700.240.900
22460547,2012-03-27T00:00:00,Synaptic Transmission,G11.561.600.835
22507116,2012-03-27T00:00:00,Animals,B01.050
22507116,2012-03-27T00:00:00,Cooperative Behavior,F01.145.813.115
22507116,2012-03-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22507116,2012-03-27T00:00:00,National Institutes of Health (U.S.),I01.409.137.500.600.480
22507116,2012-03-27T00:00:00,National Institutes of Health (U.S.),N03.540.348.500.500.600.480
22507116,2012-03-27T00:00:00,Pilot Projects,E05.318.760.750
22507116,2012-03-27T00:00:00,Pilot Projects,E05.337.737
22507116,2012-03-27T00:00:00,Pilot Projects,N05.715.360.775.625
22507116,2012-03-27T00:00:00,Pilot Projects,N06.850.520.450.720
22507116,2012-03-27T00:00:00,United States,Z01.107.567.875
22417141,2012-03-28T00:00:00,Aging,G07.700.320.124
22417141,2012-03-28T00:00:00,Animals,B01.050
22417141,2012-03-28T00:00:00,Eye Proteins,D12.776.306
22417141,2012-03-28T00:00:00,Pyridinium Compounds,D03.383.725.762
22417141,2012-03-28T00:00:00,Retinal Pigment Epithelium,A09.371.670.500
22417141,2012-03-28T00:00:00,Retinal Pigment Epithelium,A09.371.729.887
22417141,2012-03-28T00:00:00,Retinoids,D02.455.326.271.665.202.495
22417141,2012-03-28T00:00:00,Retinoids,D02.455.426.392.368.367.379.249.700
22417141,2012-03-28T00:00:00,Retinoids,D02.455.849.131.495
22417141,2012-03-28T00:00:00,Retinoids,D23.767.261.700
22453194,2012-03-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22453194,2012-03-28T00:00:00,Middle Aged,M01.060.116.630
22453194,2012-03-28T00:00:00,Piperazines,D03.383.606
22453194,2012-03-28T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
22453194,2012-03-28T00:00:00,Probability,E05.318.740.600
22453194,2012-03-28T00:00:00,Probability,G17.680
22453194,2012-03-28T00:00:00,Probability,N05.715.360.750.625
22453194,2012-03-28T00:00:00,Probability,N06.850.520.830.600
22453194,2012-03-28T00:00:00,Risk Assessment,E05.318.740.600.800.715
22453194,2012-03-28T00:00:00,Risk Assessment,N04.452.871.715
22453194,2012-03-28T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
22453194,2012-03-28T00:00:00,Risk Assessment,N06.850.505.715
22453194,2012-03-28T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
22453194,2012-03-28T00:00:00,Thiophenes,D02.886.778
22453194,2012-03-28T00:00:00,Thiophenes,D03.383.903
22453194,2012-03-28T00:00:00,Ticlopidine,D02.886.778.834
22453194,2012-03-28T00:00:00,Ticlopidine,D03.383.903.834
22456491,2012-03-28T00:00:00,African Continental Ancestry Group,M01.686.508.100
22456491,2012-03-28T00:00:00,Aged,M01.060.116.100
22456491,2012-03-28T00:00:00,Brain Ischemia,C10.228.140.300.150
22456491,2012-03-28T00:00:00,Brain Ischemia,C14.907.253.092
22456491,2012-03-28T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
22456491,2012-03-28T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
22456491,2012-03-28T00:00:00,Ethnic Groups,M01.686.754
22456491,2012-03-28T00:00:00,Ethnic Groups,N01.224.317
22456491,2012-03-28T00:00:00,European Continental Ancestry Group,M01.686.508.400
22456491,2012-03-28T00:00:00,Hospitalization,E02.760.400
22456491,2012-03-28T00:00:00,Hospitalization,N02.421.585.400
22456491,2012-03-28T00:00:00,Hospitals,N02.278.421
22456491,2012-03-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22456491,2012-03-28T00:00:00,International Classification of Diseases,L01.453.245.945.400
22456491,2012-03-28T00:00:00,Middle Aged,M01.060.116.630
22456491,2012-03-28T00:00:00,Sex Factors,N05.715.350.675
22456491,2012-03-28T00:00:00,Sex Factors,N06.850.490.875
22456491,2012-03-28T00:00:00,Stroke,C10.228.140.300.775
22456491,2012-03-28T00:00:00,Stroke,C14.907.253.855
22456491,2012-03-28T00:00:00,United States,Z01.107.567.875
22458676,2012-03-28T00:00:00,Adult,M01.060.116
22458676,2012-03-28T00:00:00,Cues,F02.463.425.234
22458676,2012-03-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22458676,2012-03-28T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
22458676,2012-03-28T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
22458676,2012-03-28T00:00:00,Middle Aged,M01.060.116.630
22458676,2012-03-28T00:00:00,Oxygen,D01.268.185.550
22458676,2012-03-28T00:00:00,Oxygen,D01.362.670
22458676,2012-03-28T00:00:00,Photic Stimulation,E05.723.729
22458676,2012-03-28T00:00:00,Pilot Projects,E05.318.760.750
22458676,2012-03-28T00:00:00,Pilot Projects,E05.337.737
22458676,2012-03-28T00:00:00,Pilot Projects,N05.715.360.775.625
22458676,2012-03-28T00:00:00,Pilot Projects,N06.850.520.450.720
22458676,2012-03-28T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
22458676,2012-03-28T00:00:00,Smoking,F01.145.466.753
22458676,2012-03-28T00:00:00,Smoking Cessation,F01.145.940.700
22458676,2012-03-28T00:00:00,Substance Withdrawal Syndrome,C21.739.835
22458676,2012-03-28T00:00:00,Substance Withdrawal Syndrome,F03.900.825
22458676,2012-03-28T00:00:00,Tobacco Use Disorder,C21.739.912
22458676,2012-03-28T00:00:00,Tobacco Use Disorder,F03.900.912
22458676,2012-03-28T00:00:00,Young Adult,M01.060.116.815
22459362,2012-03-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22459362,2012-03-28T00:00:00,Melanoma,C04.557.465.625.650.510
22459362,2012-03-28T00:00:00,Melanoma,C04.557.580.625.650.510
22459362,2012-03-28T00:00:00,Melanoma,C04.557.665.510
22459362,2012-03-28T00:00:00,Skin Neoplasms,C04.588.805
22459362,2012-03-28T00:00:00,Skin Neoplasms,C17.800.882
22459915,2012-03-28T00:00:00,Adult,M01.060.116
22459915,2012-03-28T00:00:00,Brain,A08.186.211
22459915,2012-03-28T00:00:00,Brain Mapping,E01.370.350.086
22459915,2012-03-28T00:00:00,Brain Mapping,E01.370.376.149
22459915,2012-03-28T00:00:00,Brain Mapping,E05.132
22459915,2012-03-28T00:00:00,Cues,F02.463.425.234
22459915,2012-03-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22459915,2012-03-28T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
22459915,2012-03-28T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
22459915,2012-03-28T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
22459915,2012-03-28T00:00:00,Middle Aged,M01.060.116.630
22459915,2012-03-28T00:00:00,Oxygen,D01.268.185.550
22459915,2012-03-28T00:00:00,Oxygen,D01.362.670
22459915,2012-03-28T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
22459915,2012-03-28T00:00:00,Tobacco Use Disorder,C21.739.912
22459915,2012-03-28T00:00:00,Tobacco Use Disorder,F03.900.912
22459915,2012-03-28T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
22459915,2012-03-28T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
22461301,2012-03-28T00:00:00,Angiotensin I,D06.472.699.094.075
22461301,2012-03-28T00:00:00,Angiotensin I,D12.644.400.070.075
22461301,2012-03-28T00:00:00,Angiotensin I,D12.644.456.073.021
22461301,2012-03-28T00:00:00,Angiotensin I,D12.644.548.058.075
22461301,2012-03-28T00:00:00,Angiotensin I,D12.776.641.650.070.075
22461301,2012-03-28T00:00:00,Angiotensin I,D23.469.050.050.025
22461301,2012-03-28T00:00:00,Angiotensin II,D06.472.699.094.078
22461301,2012-03-28T00:00:00,Angiotensin II,D12.644.400.070.078
22461301,2012-03-28T00:00:00,Angiotensin II,D12.644.456.073.041
22461301,2012-03-28T00:00:00,Angiotensin II,D12.644.548.058.078
22461301,2012-03-28T00:00:00,Angiotensin II,D12.776.641.650.070.078
22461301,2012-03-28T00:00:00,Angiotensin II,D23.469.050.050.050
22461301,2012-03-28T00:00:00,Endothelial Cells,A11.436.275
22461301,2012-03-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22461301,2012-03-28T00:00:00,Kidney Glomerulus,A05.810.453.324.359
22461301,2012-03-28T00:00:00,Kidney Glomerulus,A05.810.453.736.520
22461301,2012-03-28T00:00:00,Podocytes,A05.810.453.324.359.720
22461301,2012-03-28T00:00:00,Podocytes,A05.810.453.736.520.720
22461301,2012-03-28T00:00:00,Podocytes,A11.436.720
22461301,2012-03-28T00:00:00,Renin-Angiotensin System,G03.495.805
22461301,2012-03-28T00:00:00,Renin-Angiotensin System,G09.330.190.400.750
22469179,2012-03-28T00:00:00,Animals,B01.050
22469179,2012-03-28T00:00:00,Apoptosis,G04.299.139.160
22469179,2012-03-28T00:00:00,Carbon Monoxide,D01.200.250
22469179,2012-03-28T00:00:00,Carbon Monoxide,D01.362.200
22469179,2012-03-28T00:00:00,Carbon Monoxide,D01.650.550.250
22469179,2012-03-28T00:00:00,Graft Survival,G12.425.901.545.340
22469179,2012-03-28T00:00:00,Islets of Langerhans,A03.734.414
22469179,2012-03-28T00:00:00,Islets of Langerhans,A06.407.414
22469179,2012-03-28T00:00:00,Islets of Langerhans Transplantation,E04.270.550
22469179,2012-03-28T00:00:00,Islets of Langerhans Transplantation,E04.936.225.375
22469179,2012-03-28T00:00:00,Nitric Oxide Synthase Type II,D08.811.682.664.500.772.500
22469179,2012-03-28T00:00:00,Treatment Outcome,E01.789.800
22469179,2012-03-28T00:00:00,Treatment Outcome,N04.761.559.590.800
22469179,2012-03-28T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22469179,2012-03-28T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
22469179,2012-03-28T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
22469179,2012-03-28T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
22469179,2012-03-28T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
22469179,2012-03-28T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
22469179,2012-03-28T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
22469179,2012-03-28T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
22469179,2012-03-28T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
22469179,2012-03-28T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
22469179,2012-03-28T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
22469179,2012-03-28T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
22487383,2012-03-28T00:00:00,Adult,M01.060.116
22487383,2012-03-28T00:00:00,Aged,M01.060.116.100
22487383,2012-03-28T00:00:00,Amputation,E04.555.080
22487383,2012-03-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22487383,2012-03-28T00:00:00,Middle Aged,M01.060.116.630
22491073,2012-03-28T00:00:00,Adenoviridae,B04.280.030
22491073,2012-03-28T00:00:00,Adenoviridae,B04.909.204.097
22491073,2012-03-28T00:00:00,Animals,B01.050
22491073,2012-03-28T00:00:00,Gene Transfer Techniques,E05.393.350
22491073,2012-03-28T00:00:00,"Hair Cells, Auditory",A08.663.650.250
22491073,2012-03-28T00:00:00,"Hair Cells, Auditory",A08.663.650.915.750.600.350
22491073,2012-03-28T00:00:00,"Hair Cells, Auditory",A08.800.950.750.600.350
22491073,2012-03-28T00:00:00,"Hair Cells, Auditory",A09.246.631.246.577.325
22491073,2012-03-28T00:00:00,"Hair Cells, Auditory",A11.671.650.250
22491073,2012-03-28T00:00:00,"Hair Cells, Auditory",A11.671.650.915.750.600.350
22497709,2012-03-28T00:00:00,Bioreactors,E07.115
22497709,2012-03-28T00:00:00,Bioreactors,J01.897.120.115
22497709,2012-03-28T00:00:00,Chlorella,B01.040.080.469
22497709,2012-03-28T00:00:00,"Chromatography, Supercritical Fluid",E05.196.181.750
22497709,2012-03-28T00:00:00,Lipid Metabolism,G03.495.520
22497709,2012-03-28T00:00:00,Lipids,D10
22459147,2012-03-29T00:00:00,Animals,B01.050
22459147,2012-03-29T00:00:00,Apoptosis,G04.299.139.160
22459147,2012-03-29T00:00:00,Brain Ischemia,C10.228.140.300.150
22459147,2012-03-29T00:00:00,Brain Ischemia,C14.907.253.092
22459147,2012-03-29T00:00:00,"Disease Models, Animal",C22.232
22459147,2012-03-29T00:00:00,"Disease Models, Animal",E05.598.500
22459147,2012-03-29T00:00:00,"Disease Models, Animal",E05.599.395.080
22459147,2012-03-29T00:00:00,"Hypothermia, Induced",E02.258.750
22459147,2012-03-29T00:00:00,Neuroprotective Agents,D27.505.696.706.548
22459147,2012-03-29T00:00:00,Neuroprotective Agents,D27.505.954.427.575
22459147,2012-03-29T00:00:00,Neurotensin,D12.644.400.550
22459147,2012-03-29T00:00:00,Neurotensin,D12.776.641.650.550
22459147,2012-03-29T00:00:00,Oligopeptides,D12.644.456
22459147,2012-03-29T00:00:00,"Receptors, Neurotensin",D12.776.543.750.100.550
22459147,2012-03-29T00:00:00,"Receptors, Neurotensin",D12.776.543.750.720.600.560
22459147,2012-03-29T00:00:00,"Receptors, Neurotensin",D12.776.543.750.750.555.560
22459153,2012-03-29T00:00:00,Alzheimer Disease,C10.228.140.380.100
22459153,2012-03-29T00:00:00,Alzheimer Disease,C10.574.945.249
22459153,2012-03-29T00:00:00,Alzheimer Disease,F03.087.400.100
22459153,2012-03-29T00:00:00,Amyloid beta-Protein Precursor,D12.776.049.025.150
22459153,2012-03-29T00:00:00,Amyloid beta-Protein Precursor,D12.776.811.050
22459153,2012-03-29T00:00:00,Animals,B01.050
22459153,2012-03-29T00:00:00,Brain,A08.186.211
22459153,2012-03-29T00:00:00,"Disease Models, Animal",C22.232
22459153,2012-03-29T00:00:00,"Disease Models, Animal",E05.598.500
22459153,2012-03-29T00:00:00,"Disease Models, Animal",E05.599.395.080
22459153,2012-03-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22459153,2012-03-29T00:00:00,Recombinant Proteins,D12.776.828
22461534,2012-03-29T00:00:00,Adult,M01.060.116
22461534,2012-03-29T00:00:00,Antiviral Agents,D27.505.954.122.388
22461534,2012-03-29T00:00:00,BK Virus,B04.280.640.615.100
22461534,2012-03-29T00:00:00,BK Virus,B04.909.204.210.620.615.100
22461534,2012-03-29T00:00:00,BK Virus,B04.909.574.204.670.615.100
22461534,2012-03-29T00:00:00,BK Virus,B04.909.675.615.100
22461534,2012-03-29T00:00:00,Drug Monitoring,E01.370.520.200
22461534,2012-03-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22461534,2012-03-29T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
22461534,2012-03-29T00:00:00,Isoxazoles,D03.383.129.385
22461534,2012-03-29T00:00:00,Kidney Transplantation,E02.870.500
22461534,2012-03-29T00:00:00,Kidney Transplantation,E04.936.450.485
22461534,2012-03-29T00:00:00,Kidney Transplantation,E04.950.774.400
22461534,2012-03-29T00:00:00,Middle Aged,M01.060.116.630
22461534,2012-03-29T00:00:00,Polymerase Chain Reaction,E05.393.620.500
22461534,2012-03-29T00:00:00,South Carolina,Z01.107.567.875.075.662
22461534,2012-03-29T00:00:00,South Carolina,Z01.107.567.875.750.700
22461534,2012-03-29T00:00:00,Treatment Outcome,E01.789.800
22461534,2012-03-29T00:00:00,Treatment Outcome,N04.761.559.590.800
22461534,2012-03-29T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22464253,2012-03-29T00:00:00,African Continental Ancestry Group,M01.686.508.100
22464253,2012-03-29T00:00:00,European Continental Ancestry Group,M01.686.508.400
22464253,2012-03-29T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
22464253,2012-03-29T00:00:00,Genetic Predisposition to Disease,G05.380.355
22464253,2012-03-29T00:00:00,Hispanic Americans,M01.686.754.441
22464253,2012-03-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22464253,2012-03-29T00:00:00,Interferon Regulatory Factors,D12.644.360.024.302
22464253,2012-03-29T00:00:00,Interferon Regulatory Factors,D12.776.157.057.050
22464253,2012-03-29T00:00:00,Interferon Regulatory Factors,D12.776.260.504
22464253,2012-03-29T00:00:00,Interferon Regulatory Factors,D12.776.476.024.385
22464253,2012-03-29T00:00:00,Interferon Regulatory Factors,D12.776.930.332
22464253,2012-03-29T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
22464253,2012-03-29T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
22464253,2012-03-29T00:00:00,Membrane Proteins,D12.776.543
22464253,2012-03-29T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
22464253,2012-03-29T00:00:00,"Sequence Analysis, DNA",E05.393.760.700
22479593,2012-03-29T00:00:00,Animals,B01.050
22479593,2012-03-29T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
22479593,2012-03-29T00:00:00,Cognition,F02.463.188
22479593,2012-03-29T00:00:00,Corpus Striatum,A08.186.211.730.885.287.249.487
22479593,2012-03-29T00:00:00,Gene Expression Regulation,G05.355.315
22479593,2012-03-29T00:00:00,Methamphetamine,D02.092.471.683.152.619
22479593,2012-03-29T00:00:00,Motivation,F01.658
22479593,2012-03-29T00:00:00,Motivation,F01.752.543.500.750
22479593,2012-03-29T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
22479593,2012-03-29T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22479593,2012-03-29T00:00:00,"Receptors, Metabotropic Glutamate",D12.776.543.750.100.450
22479593,2012-03-29T00:00:00,"Receptors, Metabotropic Glutamate",D12.776.543.750.720.200.450.500
22479593,2012-03-29T00:00:00,Self Administration,E02.319.890
22479593,2012-03-29T00:00:00,Self Administration,E02.900.890
22507871,2012-03-29T00:00:00,Animals,B01.050
22507871,2012-03-29T00:00:00,B-Lymphocytes,A11.063.438
22507871,2012-03-29T00:00:00,B-Lymphocytes,A11.118.637.555.567.562
22507871,2012-03-29T00:00:00,B-Lymphocytes,A15.145.229.637.555.567.562
22507871,2012-03-29T00:00:00,B-Lymphocytes,A15.382.032.438
22507871,2012-03-29T00:00:00,B-Lymphocytes,A15.382.490.555.567.562
22507871,2012-03-29T00:00:00,Cell Adhesion,G04.299.117
22507871,2012-03-29T00:00:00,Cell Line,A11.251.210
22507871,2012-03-29T00:00:00,Chemokine CXCL13,D12.644.276.374.200.120.650
22507871,2012-03-29T00:00:00,Chemokine CXCL13,D12.776.467.374.200.120.650
22507871,2012-03-29T00:00:00,Chemokine CXCL13,D23.125.300.120.650
22507871,2012-03-29T00:00:00,Chemokine CXCL13,D23.469.200.120.650
22507871,2012-03-29T00:00:00,Chemokine CXCL13,D23.529.374.200.120.650
22507871,2012-03-29T00:00:00,Lysophospholipids,D10.570.755.375.760.550
22507871,2012-03-29T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
22507871,2012-03-29T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
22507871,2012-03-29T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
22507871,2012-03-29T00:00:00,Pyrimidines,D03.383.742
22507871,2012-03-29T00:00:00,Quinolones,D03.438.810.835
22507871,2012-03-29T00:00:00,Sphingosine,D02.033.100.700
22507871,2012-03-29T00:00:00,Sphingosine,D02.033.455.843
22507871,2012-03-29T00:00:00,Sphingosine,D02.092.063.700
22372381,2012-03-30T00:00:00,Carcinoma,C04.557.470.200
22372381,2012-03-30T00:00:00,Diet,E05.272
22372381,2012-03-30T00:00:00,Diet,G07.610.240
22372381,2012-03-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22372381,2012-03-30T00:00:00,"Immunity, Innate",G12.450.575
22372381,2012-03-30T00:00:00,Lymphocytes,A11.118.637.555.567
22372381,2012-03-30T00:00:00,Lymphocytes,A15.145.229.637.555.567
22372381,2012-03-30T00:00:00,Lymphocytes,A15.382.490.555.567
22372381,2012-03-30T00:00:00,Melanoma,C04.557.465.625.650.510
22372381,2012-03-30T00:00:00,Melanoma,C04.557.580.625.650.510
22372381,2012-03-30T00:00:00,Melanoma,C04.557.665.510
22372381,2012-03-30T00:00:00,Skin,A17.815
22372381,2012-03-30T00:00:00,Skin Neoplasms,C04.588.805
22372381,2012-03-30T00:00:00,Skin Neoplasms,C17.800.882
22372381,2012-03-30T00:00:00,Stilbenes,D02.455.426.559.389.150.700
22464787,2012-03-30T00:00:00,Alcohol Drinking,F01.145.317.269
22464787,2012-03-30T00:00:00,Alcoholism,C21.739.100.250
22464787,2012-03-30T00:00:00,Alcoholism,F03.900.100.350
22464787,2012-03-30T00:00:00,Animals,B01.050
22464787,2012-03-30T00:00:00,Ethanol,D02.033.375
22464787,2012-03-30T00:00:00,Neuronal Plasticity,G11.561.600.635
22464787,2012-03-30T00:00:00,Neurons,A08.663
22464787,2012-03-30T00:00:00,Neurons,A11.671
22464787,2012-03-30T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22464787,2012-03-30T00:00:00,Substance Withdrawal Syndrome,C21.739.835
22464787,2012-03-30T00:00:00,Substance Withdrawal Syndrome,F03.900.825
22466031,2012-03-30T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
22466031,2012-03-30T00:00:00,China,Z01.252.474.164
22466031,2012-03-30T00:00:00,Disease Outbreaks,N06.850.290
22466031,2012-03-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22466031,2012-03-30T00:00:00,"Infant, Newborn",M01.060.703.520
22466031,2012-03-30T00:00:00,"Intensive Care, Neonatal",E02.760.190.400.405
22466031,2012-03-30T00:00:00,"Intensive Care, Neonatal",N02.421.088.120.120
22466031,2012-03-30T00:00:00,"Intensive Care, Neonatal",N02.421.585.190.400.405
22466031,2012-03-30T00:00:00,Plasmids,G05.360.600
22467286,2012-03-30T00:00:00,Adolescent,M01.060.057
22467286,2012-03-30T00:00:00,Adult,M01.060.116
22467286,2012-03-30T00:00:00,Age Factors,N05.715.350.075
22467286,2012-03-30T00:00:00,Age Factors,N06.850.490.250
22467286,2012-03-30T00:00:00,Aged,M01.060.116.100
22467286,2012-03-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22467286,2012-03-30T00:00:00,Middle Aged,M01.060.116.630
22467286,2012-03-30T00:00:00,Thyroid Neoplasms,C04.588.322.894
22467286,2012-03-30T00:00:00,Thyroid Neoplasms,C04.588.443.915
22467286,2012-03-30T00:00:00,Thyroid Neoplasms,C19.344.894
22467286,2012-03-30T00:00:00,Thyroid Neoplasms,C19.874.788
22467286,2012-03-30T00:00:00,Young Adult,M01.060.116.815
21407047,2012-04-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
21407047,2012-04-01T00:00:00,Alzheimer Disease,C10.574.945.249
21407047,2012-04-01T00:00:00,Alzheimer Disease,F03.087.400.100
21407047,2012-04-01T00:00:00,Antipsychotic Agents,D27.505.696.277.950.040
21407047,2012-04-01T00:00:00,Antipsychotic Agents,D27.505.954.427.210.950.040
21407047,2012-04-01T00:00:00,Antipsychotic Agents,D27.505.954.427.700.872.331
21407047,2012-04-01T00:00:00,Double-Blind Method,E05.318.780.300
21407047,2012-04-01T00:00:00,Double-Blind Method,E05.581.500.300
21407047,2012-04-01T00:00:00,Double-Blind Method,N05.715.360.780.320
21407047,2012-04-01T00:00:00,Double-Blind Method,N06.850.520.445.300
21407047,2012-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21407047,2012-04-01T00:00:00,Psychomotor Agitation,C10.597.350.600
21407047,2012-04-01T00:00:00,Psychomotor Agitation,C10.597.606.881.700
21407047,2012-04-01T00:00:00,Psychomotor Agitation,C23.888.592.350.600
21407047,2012-04-01T00:00:00,Psychomotor Agitation,C23.888.592.604.882.700
21407047,2012-04-01T00:00:00,Psychomotor Agitation,F01.700.875.700
21407047,2012-04-01T00:00:00,Psychotic Disorders,F03.700.675
21407047,2012-04-01T00:00:00,Research Design,E05.581.500
21407047,2012-04-01T00:00:00,Research Design,H01.770.644.728
21407047,2012-04-01T00:00:00,Risperidone,D03.383.742.698.685
21431972,2012-04-01T00:00:00,"Aorta, Thoracic",A07.231.114.056.372
21431972,2012-04-01T00:00:00,Device Removal,E04.199
21431972,2012-04-01T00:00:00,Foreign-Body Migration,C21.866.392.500
21431972,2012-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21431972,2012-04-01T00:00:00,Middle Aged,M01.060.116.630
21431972,2012-04-01T00:00:00,Septal Occluder Device,E07.695.715
22105856,2012-04-01T00:00:00,Animals,B01.050
22105856,2012-04-01T00:00:00,Cell Differentiation,G04.299.151
22105856,2012-04-01T00:00:00,Down-Regulation,G02.111.087.225
22105856,2012-04-01T00:00:00,Down-Regulation,G02.149.115.225
22105856,2012-04-01T00:00:00,Down-Regulation,G05.355.315.200
22105856,2012-04-01T00:00:00,Down-Regulation,G07.690.812.230
22105856,2012-04-01T00:00:00,Down-Regulation,G07.700.680.230
22105856,2012-04-01T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
22105856,2012-04-01T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
22105856,2012-04-01T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
22105856,2012-04-01T00:00:00,"Microscopy, Confocal",E05.595.395
22105856,2012-04-01T00:00:00,Nuclear Proteins,D12.776.660
22105856,2012-04-01T00:00:00,Osteoclasts,A11.329.372.700
22105856,2012-04-01T00:00:00,Osteoclasts,A11.627.482.700
22105856,2012-04-01T00:00:00,RANK Ligand,D12.644.276.374.750.562
22105856,2012-04-01T00:00:00,RANK Ligand,D12.644.276.972.562
22105856,2012-04-01T00:00:00,RANK Ligand,D12.776.467.374.750.562
22105856,2012-04-01T00:00:00,RANK Ligand,D12.776.467.972.562
22105856,2012-04-01T00:00:00,RANK Ligand,D23.529.374.750.562
22105856,2012-04-01T00:00:00,RANK Ligand,D23.529.972.562
22105856,2012-04-01T00:00:00,Signal Transduction,G02.111.087.800
22105856,2012-04-01T00:00:00,Signal Transduction,G02.149.115.800
22105856,2012-04-01T00:00:00,Signal Transduction,G04.299.880
22134610,2012-04-01T00:00:00,Adolescent,M01.060.057
22134610,2012-04-01T00:00:00,Antineoplastic Agents,D27.505.954.248
22134610,2012-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22134610,2012-04-01T00:00:00,"Tumor Markers, Biological",D23.101.840
22227838,2012-04-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
22227838,2012-04-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
22227838,2012-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22227838,2012-04-01T00:00:00,Hysterectomy,E04.950.300.399
22227838,2012-04-01T00:00:00,Lymph Nodes,A10.549.400
22227838,2012-04-01T00:00:00,Lymph Nodes,A15.382.520.604.412
22227838,2012-04-01T00:00:00,Uterine Cervical Neoplasms,C04.588.945.418.948.850
22227838,2012-04-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.593.131
22227838,2012-04-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.762.850
22227838,2012-04-01T00:00:00,Uterine Cervical Neoplasms,C13.351.937.418.875.850
22227838,2012-04-01T00:00:00,Young Adult,M01.060.116.815
22336593,2012-04-01T00:00:00,Animals,B01.050
22336593,2012-04-01T00:00:00,"Conditioning, Operant",F02.463.425.179.509
22336593,2012-04-01T00:00:00,Discrimination (Psychology),F02.463.593.257
22336593,2012-04-01T00:00:00,Enzyme Inhibitors,D27.505.519.389
22336593,2012-04-01T00:00:00,Ethanol,D02.033.375
22336593,2012-04-01T00:00:00,Motor Activity,F01.145.632
22336593,2012-04-01T00:00:00,Motor Activity,G11.427.590.530.698
22336593,2012-04-01T00:00:00,Self Administration,E02.319.890
22336593,2012-04-01T00:00:00,Self Administration,E02.900.890
22343483,2012-04-01T00:00:00,Adolescent,M01.060.057
22343483,2012-04-01T00:00:00,"Anemia, Sickle Cell",C15.378.071.141.150.150
22343483,2012-04-01T00:00:00,"Anemia, Sickle Cell",C15.378.420.155
22343483,2012-04-01T00:00:00,"Anemia, Sickle Cell",C16.320.070.150
22343483,2012-04-01T00:00:00,"Anemia, Sickle Cell",C16.320.365.155
22343483,2012-04-01T00:00:00,Attention,F02.830.104.214
22343483,2012-04-01T00:00:00,Central Nervous System Stimulants,D27.505.696.282
22343483,2012-04-01T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
22343483,2012-04-01T00:00:00,Child,M01.060.406
22343483,2012-04-01T00:00:00,Cognition,F02.463.188
22343483,2012-04-01T00:00:00,Double-Blind Method,E05.318.780.300
22343483,2012-04-01T00:00:00,Double-Blind Method,E05.581.500.300
22343483,2012-04-01T00:00:00,Double-Blind Method,N05.715.360.780.320
22343483,2012-04-01T00:00:00,Double-Blind Method,N06.850.520.445.300
22343483,2012-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22343483,2012-04-01T00:00:00,Methylphenidate,D02.241.223.601.600
22343483,2012-04-01T00:00:00,Methylphenidate,D03.383.621.460
22343483,2012-04-01T00:00:00,Pilot Projects,E05.318.760.750
22343483,2012-04-01T00:00:00,Pilot Projects,E05.337.737
22343483,2012-04-01T00:00:00,Pilot Projects,N05.715.360.775.625
22343483,2012-04-01T00:00:00,Pilot Projects,N06.850.520.450.720
22343483,2012-04-01T00:00:00,Reaction Time,F02.830.650
22343483,2012-04-01T00:00:00,Reaction Time,F04.669.817
22343483,2012-04-01T00:00:00,Reaction Time,G11.561.677
22343483,2012-04-01T00:00:00,Treatment Outcome,E01.789.800
22343483,2012-04-01T00:00:00,Treatment Outcome,N04.761.559.590.800
22343483,2012-04-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22424515,2012-04-01T00:00:00,Aortic Valve Stenosis,C14.280.484.150
22424515,2012-04-01T00:00:00,Aortic Valve Stenosis,C14.280.955.249
22424515,2012-04-01T00:00:00,Health Services Accessibility,N04.590.374.350
22424515,2012-04-01T00:00:00,Health Services Accessibility,N05.300.430
22424515,2012-04-01T00:00:00,Heart Valve Prosthesis Implantation,E04.100.376.485
22424515,2012-04-01T00:00:00,Heart Valve Prosthesis Implantation,E04.650.410
22424515,2012-04-01T00:00:00,Heart Valve Prosthesis Implantation,E04.928.220.410
22424515,2012-04-01T00:00:00,Hemodynamics,G09.330.190.400
22424515,2012-04-01T00:00:00,Hemodynamics,G09.330.380
22424515,2012-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22424515,2012-04-01T00:00:00,Outcome and Process Assessment (Health Care),N04.761.559
22424515,2012-04-01T00:00:00,Outcome and Process Assessment (Health Care),N05.715.360.575
22424515,2012-04-01T00:00:00,"Quality Indicators, Health Care",N04.761.789
22469575,2012-04-01T00:00:00,Clinical Competence,I02.399.630.210
22469575,2012-04-01T00:00:00,Clinical Competence,N04.761.210
22469575,2012-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22469575,2012-04-01T00:00:00,Intraoperative Complications,C23.550.505
22469575,2012-04-01T00:00:00,Prostatectomy,E04.950.774.860.625
22469575,2012-04-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
22469575,2012-04-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
22469575,2012-04-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
22469575,2012-04-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
22472392,2012-04-01T00:00:00,"Education, Medical",I02.358.399
22472392,2012-04-01T00:00:00,"History, 19th Century",K01.400.504.937
22472392,2012-04-01T00:00:00,"History, 20th Century",K01.400.504.968
22472392,2012-04-01T00:00:00,United States,Z01.107.567.875
22496398,2012-04-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
22496398,2012-04-01T00:00:00,Clinical Trials as Topic,E05.337.250
22496398,2012-04-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
22496398,2012-04-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
22496398,2012-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22496398,2012-04-01T00:00:00,Interviews as Topic,E05.318.308.420
22496398,2012-04-01T00:00:00,Interviews as Topic,L01.280.520
22496398,2012-04-01T00:00:00,Interviews as Topic,N05.715.360.300.400
22496398,2012-04-01T00:00:00,Interviews as Topic,N06.850.520.308.420
22496398,2012-04-01T00:00:00,Middle Aged,M01.060.116.630
22496398,2012-04-01T00:00:00,Parkinson Disease,C10.228.140.079.862.500
22496398,2012-04-01T00:00:00,Parkinson Disease,C10.228.662.600.400
22496398,2012-04-01T00:00:00,Parkinson Disease,C10.574.812
22496398,2012-04-01T00:00:00,Patient Selection,E05.581.500.653
22496398,2012-04-01T00:00:00,Patient Selection,N04.590.731
22496398,2012-04-01T00:00:00,United States,Z01.107.567.875
22502488,2012-04-01T00:00:00,Acoustic Stimulation,E02.037
22502488,2012-04-01T00:00:00,Acoustic Stimulation,E02.190.888.030
22502488,2012-04-01T00:00:00,Acoustic Stimulation,E05.723.136
22502488,2012-04-01T00:00:00,Adult,M01.060.116
22502488,2012-04-01T00:00:00,Aged,M01.060.116.100
22502488,2012-04-01T00:00:00,Auditory Threshold,F02.463.593.071.173
22502488,2012-04-01T00:00:00,Auditory Threshold,F02.463.593.710.190
22502488,2012-04-01T00:00:00,Case-Control Studies,E05.318.760.500.500
22502488,2012-04-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
22502488,2012-04-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
22502488,2012-04-01T00:00:00,Hearing Loss,C09.218.458.341
22502488,2012-04-01T00:00:00,Hearing Loss,C10.597.751.418.341
22502488,2012-04-01T00:00:00,Hearing Loss,C23.888.592.763.393.341
22502488,2012-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22502488,2012-04-01T00:00:00,Middle Aged,M01.060.116.630
22502488,2012-04-01T00:00:00,Noise,G01.595.907.567
22502488,2012-04-01T00:00:00,Noise,G16.500.275.600
22502488,2012-04-01T00:00:00,Noise,N06.230.400
22502488,2012-04-01T00:00:00,Noise,N06.850.460.610
22502488,2012-04-01T00:00:00,Perceptual Masking,F02.463.593.071.594
22502488,2012-04-01T00:00:00,Perceptual Masking,F02.463.593.932.733
22534343,2012-04-01T00:00:00,Cognitive Therapy,F04.754.137.428
22534343,2012-04-01T00:00:00,Depression,F01.145.126.350
22534343,2012-04-01T00:00:00,Family Practice,H02.403.280
22534343,2012-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22553784,2012-04-01T00:00:00,"History, 20th Century",K01.400.504.968
22553784,2012-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22966490,2012-04-01T00:00:00,Animals,B01.050
22966490,2012-04-01T00:00:00,Biological Assay,E05.091
22966490,2012-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22966490,2012-04-01T00:00:00,"Models, Biological",E05.599.395
21939292,2012-04-02T00:00:00,Adult,M01.060.116
21939292,2012-04-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21939292,2012-04-02T00:00:00,"Infant, Newborn",M01.060.703.520
21939292,2012-04-02T00:00:00,Pregnancy,G08.686.785.760.769
21939292,2012-04-02T00:00:00,Premature Birth,C13.703.420.491.500
21939292,2012-04-02T00:00:00,Young Adult,M01.060.116.815
22468897,2012-04-02T00:00:00,Double-Blind Method,E05.318.780.300
22468897,2012-04-02T00:00:00,Double-Blind Method,E05.581.500.300
22468897,2012-04-02T00:00:00,Double-Blind Method,N05.715.360.780.320
22468897,2012-04-02T00:00:00,Double-Blind Method,N06.850.520.445.300
22468897,2012-04-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22468897,2012-04-02T00:00:00,Motivation,F01.658
22468897,2012-04-02T00:00:00,Motivation,F01.752.543.500.750
22468897,2012-04-02T00:00:00,Smoking,F01.145.466.753
22468897,2012-04-02T00:00:00,Smoking Cessation,F01.145.940.700
22468897,2012-04-02T00:00:00,Valproic Acid,D02.241.081.944.509.900
22468897,2012-04-02T00:00:00,Valproic Acid,D10.251.400.895.593.900
22475443,2012-04-03T00:00:00,Adolescent,M01.060.057
22475443,2012-04-03T00:00:00,Adult,M01.060.116
22475443,2012-04-03T00:00:00,Aged,M01.060.116.100
22475443,2012-04-03T00:00:00,Deglutition,G10.261.326.215
22475443,2012-04-03T00:00:00,"Esophageal Spasm, Diffuse",C06.405.117.119.500.450
22475443,2012-04-03T00:00:00,Esophagus,A03.556.875.500
22475443,2012-04-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22475443,2012-04-03T00:00:00,Manometry,E05.559
22475443,2012-04-03T00:00:00,Middle Aged,M01.060.116.630
22475443,2012-04-03T00:00:00,Muscle Contraction,G11.427.590.540
22475443,2012-04-03T00:00:00,Young Adult,M01.060.116.815
22471735,2012-04-04T00:00:00,Adolescent,M01.060.057
22471735,2012-04-04T00:00:00,Adult,M01.060.116
22471735,2012-04-04T00:00:00,Aged,M01.060.116.100
22471735,2012-04-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22471735,2012-04-04T00:00:00,Middle Aged,M01.060.116.630
22471735,2012-04-04T00:00:00,Smoking,F01.145.466.753
22471735,2012-04-04T00:00:00,Smoking Cessation,F01.145.940.700
22471735,2012-04-04T00:00:00,United States,Z01.107.567.875
22471735,2012-04-04T00:00:00,Young Adult,M01.060.116.815
22474203,2012-04-04T00:00:00,Adult,M01.060.116
22474203,2012-04-04T00:00:00,Aged,M01.060.116.100
22474203,2012-04-04T00:00:00,Breast Neoplasms,C04.588.180
22474203,2012-04-04T00:00:00,Breast Neoplasms,C17.800.090.500
22474203,2012-04-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22474203,2012-04-04T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
22474203,2012-04-04T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
22474203,2012-04-04T00:00:00,Mammography,E01.370.350.700.500
22474203,2012-04-04T00:00:00,Middle Aged,M01.060.116.630
22474203,2012-04-04T00:00:00,Risk Factors,E05.318.740.600.800.725
22474203,2012-04-04T00:00:00,Risk Factors,N05.715.350.200.700
22474203,2012-04-04T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22474203,2012-04-04T00:00:00,Risk Factors,N06.850.490.625.750
22474203,2012-04-04T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22474203,2012-04-04T00:00:00,Young Adult,M01.060.116.815
22475068,2012-04-04T00:00:00,Adolescent,M01.060.057
22475068,2012-04-04T00:00:00,Adult,M01.060.116
22475068,2012-04-04T00:00:00,Aged,M01.060.116.100
22475068,2012-04-04T00:00:00,Ambulatory Care,E02.760.106
22475068,2012-04-04T00:00:00,Ambulatory Care,N02.421.585.106
22475068,2012-04-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22475068,2012-04-04T00:00:00,Middle Aged,M01.060.116.630
22475068,2012-04-04T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
22475068,2012-04-04T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
22475068,2012-04-04T00:00:00,Patient Compliance,F01.145.488.500
22475068,2012-04-04T00:00:00,Patient Compliance,N05.300.150.600.600
22475068,2012-04-04T00:00:00,Questionnaires,E05.318.308.750
22475068,2012-04-04T00:00:00,Questionnaires,L01.280.800
22475068,2012-04-04T00:00:00,Questionnaires,N05.715.360.300.695
22475068,2012-04-04T00:00:00,Questionnaires,N06.850.520.308.750
22475068,2012-04-04T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
22475068,2012-04-04T00:00:00,Substance Abuse Treatment Centers,N02.278.035.128.800
22475068,2012-04-04T00:00:00,Substance Abuse Treatment Centers,N02.278.808.930
22475068,2012-04-04T00:00:00,Substance-Related Disorders,C21.739
22475068,2012-04-04T00:00:00,Substance-Related Disorders,F03.900
22475068,2012-04-04T00:00:00,United States,Z01.107.567.875
22475068,2012-04-04T00:00:00,Young Adult,M01.060.116.815
22475195,2012-04-04T00:00:00,Clinical Competence,I02.399.630.210
22475195,2012-04-04T00:00:00,Clinical Competence,N04.761.210
22475195,2012-04-04T00:00:00,Communication,F01.145.209
22475195,2012-04-04T00:00:00,Communication,L01.143
22475195,2012-04-04T00:00:00,"Education, Medical, Graduate",I02.358.337.350
22475195,2012-04-04T00:00:00,"Education, Medical, Graduate",I02.358.399.350
22475195,2012-04-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22475195,2012-04-04T00:00:00,Internal Medicine,H02.403.429
22475195,2012-04-04T00:00:00,Palliative Care,E02.760.666
22475195,2012-04-04T00:00:00,Palliative Care,N02.421.585.666
22475195,2012-04-04T00:00:00,Physician-Patient Relations,F01.829.401.650.675
22475195,2012-04-04T00:00:00,Physician-Patient Relations,N05.300.660.625
22475195,2012-04-04T00:00:00,Psychometrics,F04.711.780
22475195,2012-04-04T00:00:00,Questionnaires,E05.318.308.750
22475195,2012-04-04T00:00:00,Questionnaires,L01.280.800
22475195,2012-04-04T00:00:00,Questionnaires,N05.715.360.300.695
22475195,2012-04-04T00:00:00,Questionnaires,N06.850.520.308.750
22475195,2012-04-04T00:00:00,Truth Disclosure,F01.145.209.259.800
22475248,2012-04-04T00:00:00,Celiac Disease,C06.405.469.637.250
22475248,2012-04-04T00:00:00,Celiac Disease,C18.452.603.250
22475248,2012-04-04T00:00:00,Child,M01.060.406
22475248,2012-04-04T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
22475248,2012-04-04T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
22475248,2012-04-04T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
22475248,2012-04-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22481037,2012-04-04T00:00:00,"Adaptation, Psychological",F01.058
22481037,2012-04-04T00:00:00,Adolescent,M01.060.057
22481037,2012-04-04T00:00:00,Caregivers,M01.085
22481037,2012-04-04T00:00:00,Caregivers,M01.526.485.200
22481037,2012-04-04T00:00:00,Caregivers,N02.360.200
22481037,2012-04-04T00:00:00,Child,M01.060.406
22481037,2012-04-04T00:00:00,Depression,F01.145.126.350
22481037,2012-04-04T00:00:00,Epilepsy,C10.228.140.490
22481037,2012-04-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22481037,2012-04-04T00:00:00,"Interview, Psychological",F04.669.599
22492212,2012-04-04T00:00:00,Aged,M01.060.116.100
22492212,2012-04-04T00:00:00,Brain Ischemia,C10.228.140.300.150
22492212,2012-04-04T00:00:00,Brain Ischemia,C14.907.253.092
22492212,2012-04-04T00:00:00,Carotid Stenosis,C10.228.140.300.200.360
22492212,2012-04-04T00:00:00,Carotid Stenosis,C14.907.137.230
22492212,2012-04-04T00:00:00,Carotid Stenosis,C14.907.253.123.360
22492212,2012-04-04T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.500.150
22492212,2012-04-04T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.825.500.150
22492212,2012-04-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22492212,2012-04-04T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
22492212,2012-04-04T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
22492212,2012-04-04T00:00:00,Middle Aged,M01.060.116.630
22492212,2012-04-04T00:00:00,Temporal Lobe,A08.186.211.730.885.287.500.863
22492779,2012-04-04T00:00:00,Epilepsy,C10.228.140.490
22492779,2012-04-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22492779,2012-04-04T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
22492779,2012-04-04T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
22492779,2012-04-04T00:00:00,Middle Aged,M01.060.116.630
22492779,2012-04-04T00:00:00,Risk Factors,E05.318.740.600.800.725
22492779,2012-04-04T00:00:00,Risk Factors,N05.715.350.200.700
22492779,2012-04-04T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22492779,2012-04-04T00:00:00,Risk Factors,N06.850.490.625.750
22492779,2012-04-04T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22520637,2012-04-04T00:00:00,Antioxidants,D27.505.519.217
22520637,2012-04-04T00:00:00,Antioxidants,D27.505.696.706.125
22520637,2012-04-04T00:00:00,Antioxidants,D27.720.799.047
22520637,2012-04-04T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
22520637,2012-04-04T00:00:00,Light,G01.201.875.770.578
22520637,2012-04-04T00:00:00,Light,G01.590.540
22520637,2012-04-04T00:00:00,Mass Spectrometry,E05.196.566
22520637,2012-04-04T00:00:00,Plant Extracts,D20.215.784.500
22520637,2012-04-04T00:00:00,Plant Extracts,D26.667
22520637,2012-04-04T00:00:00,Regression Analysis,E05.318.740.750
22520637,2012-04-04T00:00:00,Regression Analysis,N05.715.360.750.695
22520637,2012-04-04T00:00:00,Regression Analysis,N06.850.520.830.750
22520637,2012-04-04T00:00:00,"Scattering, Radiation",E05.196.822
22520637,2012-04-04T00:00:00,"Scattering, Radiation",G01.595.861
22560558,2012-04-04T00:00:00,Animals,B01.050
22560558,2012-04-04T00:00:00,"Lipoproteins, LDL",D10.532.515
22560558,2012-04-04T00:00:00,"Lipoproteins, LDL",D12.776.521.550
22560558,2012-04-04T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
22560558,2012-04-04T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
22560558,2012-04-04T00:00:00,Nitric Oxide Synthase Type II,D08.811.682.664.500.772.500
22560558,2012-04-04T00:00:00,Nitric Oxide Synthase Type III,D08.811.682.664.500.772.750
22560558,2012-04-04T00:00:00,Sphingolipids,D10.570.877
22560558,2012-04-04T00:00:00,Sphingolipids,D10.808
22476155,2012-04-05T00:00:00,African Americans,M01.686.508.100.100
22476155,2012-04-05T00:00:00,African Americans,M01.686.754.100
22476155,2012-04-05T00:00:00,Alleles,G05.360.340.024.340.030
22476155,2012-04-05T00:00:00,European Continental Ancestry Group,M01.686.508.400
22476155,2012-04-05T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
22476155,2012-04-05T00:00:00,Genetic Predisposition to Disease,G05.380.355
22476155,2012-04-05T00:00:00,Hispanic Americans,M01.686.754.441
22476155,2012-04-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22476155,2012-04-05T00:00:00,Linkage Disequilibrium,G05.540.500
22476155,2012-04-05T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
22476155,2012-04-05T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
22476155,2012-04-05T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
22481410,2012-04-05T00:00:00,Animals,B01.050
22481410,2012-04-05T00:00:00,Brain,A08.186.211
22481410,2012-04-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22481410,2012-04-05T00:00:00,Long-Term Synaptic Depression,G11.561.600.635.355
22481410,2012-04-05T00:00:00,"Models, Biological",E05.599.395
22481410,2012-04-05T00:00:00,Substance-Related Disorders,C21.739
22481410,2012-04-05T00:00:00,Substance-Related Disorders,F03.900
22483528,2012-04-05T00:00:00,Adult,M01.060.116
22483528,2012-04-05T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
22483528,2012-04-05T00:00:00,Child,M01.060.406
22483528,2012-04-05T00:00:00,Decision Support Techniques,E05.245
22483528,2012-04-05T00:00:00,Decision Support Techniques,L01.700.508.190
22483528,2012-04-05T00:00:00,Drug Prescriptions,E02.319.307
22483528,2012-04-05T00:00:00,Drug Prescriptions,N02.421.668.778.500
22483528,2012-04-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22483528,2012-04-05T00:00:00,Primary Health Care,N04.590.233.727
22484516,2012-04-05T00:00:00,Adolescent,M01.060.057
22484516,2012-04-05T00:00:00,Adult,M01.060.116
22484516,2012-04-05T00:00:00,Brain,A08.186.211
22484516,2012-04-05T00:00:00,Forecasting,I01.320
22484516,2012-04-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22484516,2012-04-05T00:00:00,Photic Stimulation,E05.723.729
22484516,2012-04-05T00:00:00,Psychomotor Performance,F02.808
22484516,2012-04-05T00:00:00,Psychomotor Performance,G11.427.700
22484516,2012-04-05T00:00:00,Psychomotor Performance,G11.561.623
22484516,2012-04-05T00:00:00,Reaction Time,F02.830.650
22484516,2012-04-05T00:00:00,Reaction Time,F04.669.817
22484516,2012-04-05T00:00:00,Reaction Time,G11.561.677
22484516,2012-04-05T00:00:00,Young Adult,M01.060.116.815
22491892,2012-04-05T00:00:00,Adolescent,M01.060.057
22491892,2012-04-05T00:00:00,Adult,M01.060.116
22491892,2012-04-05T00:00:00,Attitude to Health,F01.100.150
22491892,2012-04-05T00:00:00,Attitude to Health,N05.300.150
22491892,2012-04-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22491892,2012-04-05T00:00:00,Middle Aged,M01.060.116.630
22491892,2012-04-05T00:00:00,"Models, Theoretical",E05.599
22491892,2012-04-05T00:00:00,Population Surveillance,E05.318.308.250.700
22491892,2012-04-05T00:00:00,Population Surveillance,N05.715.360.300.375.625
22491892,2012-04-05T00:00:00,Population Surveillance,N06.850.520.308.250.700
22491892,2012-04-05T00:00:00,Population Surveillance,N06.850.780.675
22491892,2012-04-05T00:00:00,Smoking,F01.145.466.753
22491892,2012-04-05T00:00:00,Smoking Cessation,F01.145.940.700
22491892,2012-04-05T00:00:00,Social Support,I01.880.656.600
22491892,2012-04-05T00:00:00,Tobacco Smoke Pollution,D20.633.937.680
22491892,2012-04-05T00:00:00,Tobacco Smoke Pollution,N06.850.460.100.555
22491892,2012-04-05T00:00:00,Young Adult,M01.060.116.815
22496821,2012-04-05T00:00:00,Adult,M01.060.116
22496821,2012-04-05T00:00:00,Aged,M01.060.116.100
22496821,2012-04-05T00:00:00,Aging,G07.700.320.124
22496821,2012-04-05T00:00:00,Animals,B01.050
22496821,2012-04-05T00:00:00,Cochlear Nerve,A08.800.800.120.910.120
22496821,2012-04-05T00:00:00,Hearing,F02.830.816.263
22496821,2012-04-05T00:00:00,Hearing,G11.561.600.810.263
22496821,2012-04-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22496821,2012-04-05T00:00:00,"Mice, Inbred CBA",B01.050.050.157.520.440
22496821,2012-04-05T00:00:00,"Mice, Inbred CBA",B01.050.050.199.520.520.440
22496821,2012-04-05T00:00:00,"Mice, Inbred CBA",B01.050.150.900.649.865.635.505.500.400.440
22496821,2012-04-05T00:00:00,"Microscopy, Electron, Transmission",E01.370.350.515.402.580
22496821,2012-04-05T00:00:00,"Microscopy, Electron, Transmission",E05.595.402.580
22496821,2012-04-05T00:00:00,Middle Aged,M01.060.116.630
22484462,2012-04-06T00:00:00,Biological Markers,D23.101
22484462,2012-04-06T00:00:00,Environmental Monitoring,N06.850.460.350.080
22484462,2012-04-06T00:00:00,Environmental Monitoring,N06.850.780.375
22484462,2012-04-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22484462,2012-04-06T00:00:00,Nicotine,D03.132.760.570
22484462,2012-04-06T00:00:00,Nicotine,D03.383.725.518
22484462,2012-04-06T00:00:00,Pyridines,D03.383.725
22484462,2012-04-06T00:00:00,Saliva,A12.200.666
22484462,2012-04-06T00:00:00,Smoking,F01.145.466.753
22484462,2012-04-06T00:00:00,Tobacco Smoke Pollution,D20.633.937.680
22484462,2012-04-06T00:00:00,Tobacco Smoke Pollution,N06.850.460.100.555
22490378,2012-04-06T00:00:00,Animals,B01.050
22490378,2012-04-06T00:00:00,"DNA, Mitochondrial",D13.444.308.283.225
22490378,2012-04-06T00:00:00,Fluoxetine,D02.092.831.280
22490378,2012-04-06T00:00:00,Heart,A07.541
22490378,2012-04-06T00:00:00,Kidney,A05.810.453
22490378,2012-04-06T00:00:00,Mitochondria,A11.284.430.214.190.875.564
22490378,2012-04-06T00:00:00,Mitochondria,A11.284.835.626
22490378,2012-04-06T00:00:00,Oxygen Consumption,G03.730
22490378,2012-04-06T00:00:00,Propanolamines,D02.033.100.624
22490378,2012-04-06T00:00:00,Propanolamines,D02.033.755.624
22490378,2012-04-06T00:00:00,Propanolamines,D02.092.063.624
22490378,2012-04-06T00:00:00,Rabbits,B01.050.150.900.649.521.700
22490378,2012-04-06T00:00:00,Signal Transduction,G02.111.087.800
22490378,2012-04-06T00:00:00,Signal Transduction,G02.149.115.800
22490378,2012-04-06T00:00:00,Signal Transduction,G04.299.880
22484324,2012-04-09T00:00:00,Aged,M01.060.116.100
22484324,2012-04-09T00:00:00,Algorithms,G17.035
22484324,2012-04-09T00:00:00,Algorithms,L01.224.050
22484324,2012-04-09T00:00:00,Granulocyte Colony-Stimulating Factor,D12.644.276.374.410.240.350
22484324,2012-04-09T00:00:00,Granulocyte Colony-Stimulating Factor,D12.776.395.240.200
22484324,2012-04-09T00:00:00,Granulocyte Colony-Stimulating Factor,D12.776.467.374.410.240.350
22484324,2012-04-09T00:00:00,Granulocyte Colony-Stimulating Factor,D23.529.374.410.240.350
22484324,2012-04-09T00:00:00,Hematopoietic Stem Cell Mobilization,E02.095.410
22484324,2012-04-09T00:00:00,Hematopoietic Stem Cells,A11.148.378
22484324,2012-04-09T00:00:00,Hematopoietic Stem Cells,A11.872.378
22484324,2012-04-09T00:00:00,Hematopoietic Stem Cells,A15.378.316.378
22484324,2012-04-09T00:00:00,Heterocyclic Compounds,D03
22484324,2012-04-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22484324,2012-04-09T00:00:00,Middle Aged,M01.060.116.630
22484324,2012-04-09T00:00:00,Multiple Myeloma,C04.557.595.500
22484324,2012-04-09T00:00:00,Multiple Myeloma,C14.907.454.460
22484324,2012-04-09T00:00:00,Multiple Myeloma,C15.378.147.780.650
22484324,2012-04-09T00:00:00,Multiple Myeloma,C15.378.463.835.460
22484324,2012-04-09T00:00:00,Multiple Myeloma,C20.683.515.845
22484324,2012-04-09T00:00:00,Multiple Myeloma,C20.683.780.650
22484324,2012-04-09T00:00:00,Recombinant Proteins,D12.776.828
22494793,2012-04-09T00:00:00,Adolescent,M01.060.057
22494793,2012-04-09T00:00:00,Case-Control Studies,E05.318.760.500.500
22494793,2012-04-09T00:00:00,Case-Control Studies,N05.715.360.775.175.200
22494793,2012-04-09T00:00:00,Case-Control Studies,N06.850.520.450.500.500
22494793,2012-04-09T00:00:00,Child,M01.060.406
22494793,2012-04-09T00:00:00,"Child, Preschool",M01.060.406.448
22494793,2012-04-09T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
22494793,2012-04-09T00:00:00,Genetic Predisposition to Disease,G05.380.355
22494793,2012-04-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22494793,2012-04-09T00:00:00,"Immunity, Innate",G12.450.575
22494793,2012-04-09T00:00:00,Infant,M01.060.703
22494793,2012-04-09T00:00:00,Otitis Media,C09.218.705.663
22494793,2012-04-09T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
22494793,2012-04-09T00:00:00,Toll-Like Receptors,D12.776.543.750.705.910.500
22491013,2012-04-10T00:00:00,"Adaptor Proteins, Vesicular Transport",D12.776.543.990.150
22491013,2012-04-10T00:00:00,Animals,B01.050
22491013,2012-04-10T00:00:00,Clathrin,D12.776.543.990.200
22491013,2012-04-10T00:00:00,Wnt Proteins,D12.644.276.984
22491013,2012-04-10T00:00:00,Wnt Proteins,D12.776.467.984
22491013,2012-04-10T00:00:00,Wnt Proteins,D23.529.984
22491013,2012-04-10T00:00:00,Zebrafish,B01.050.150.900.493.200.244.828
22491013,2012-04-10T00:00:00,beta Catenin,D12.776.091.249
22491013,2012-04-10T00:00:00,beta Catenin,D12.776.220.145.500
22491013,2012-04-10T00:00:00,beta Catenin,D12.776.930.130
22494948,2012-04-10T00:00:00,Adult,M01.060.116
22494948,2012-04-10T00:00:00,Health Services Accessibility,N04.590.374.350
22494948,2012-04-10T00:00:00,Health Services Accessibility,N05.300.430
22494948,2012-04-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22494948,2012-04-10T00:00:00,Incidence,E05.318.308.985.525.375
22494948,2012-04-10T00:00:00,Incidence,L01.280.975.525.375
22494948,2012-04-10T00:00:00,Incidence,N01.224.935.597.500
22494948,2012-04-10T00:00:00,Incidence,N06.850.505.400.975.525.375
22494948,2012-04-10T00:00:00,Incidence,N06.850.520.308.985.525.375
22494948,2012-04-10T00:00:00,Middle Aged,M01.060.116.630
22494948,2012-04-10T00:00:00,Pressure Ulcer,C17.800.893.665
22494948,2012-04-10T00:00:00,Quadriplegia,C10.597.622.760
22494948,2012-04-10T00:00:00,Quadriplegia,C23.888.592.636.786
22494948,2012-04-10T00:00:00,Questionnaires,E05.318.308.750
22494948,2012-04-10T00:00:00,Questionnaires,L01.280.800
22494948,2012-04-10T00:00:00,Questionnaires,N05.715.360.300.695
22494948,2012-04-10T00:00:00,Questionnaires,N06.850.520.308.750
22494948,2012-04-10T00:00:00,Risk Assessment,E05.318.740.600.800.715
22494948,2012-04-10T00:00:00,Risk Assessment,N04.452.871.715
22494948,2012-04-10T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
22494948,2012-04-10T00:00:00,Risk Assessment,N06.850.505.715
22494948,2012-04-10T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
22494948,2012-04-10T00:00:00,Spinal Cord Injuries,C10.228.854.770
22494948,2012-04-10T00:00:00,Spinal Cord Injuries,C10.900.850
22494948,2012-04-10T00:00:00,Spinal Cord Injuries,C21.866.819
22494948,2012-04-10T00:00:00,United States,Z01.107.567.875
22496537,2012-04-10T00:00:00,African Americans,M01.686.508.100.100
22496537,2012-04-10T00:00:00,African Americans,M01.686.754.100
22496537,2012-04-10T00:00:00,Aged,M01.060.116.100
22496537,2012-04-10T00:00:00,Aging,G07.700.320.124
22496537,2012-04-10T00:00:00,Antihypertensive Agents,D27.505.954.411.162
22496537,2012-04-10T00:00:00,Attitude to Health,F01.100.150
22496537,2012-04-10T00:00:00,Attitude to Health,N05.300.150
22496537,2012-04-10T00:00:00,Blood Pressure,E01.370.600.875.249
22496537,2012-04-10T00:00:00,Blood Pressure,G09.330.380.076
22496537,2012-04-10T00:00:00,"Databases, Factual",L01.470.750.750
22496537,2012-04-10T00:00:00,"Databases, Factual",L01.700.508.300.188.400
22496537,2012-04-10T00:00:00,European Continental Ancestry Group,M01.686.508.400
22496537,2012-04-10T00:00:00,Geriatric Assessment,E05.318.308.225
22496537,2012-04-10T00:00:00,Geriatric Assessment,I01.240.425.350
22496537,2012-04-10T00:00:00,Geriatric Assessment,L01.280.360
22496537,2012-04-10T00:00:00,Geriatric Assessment,N01.224.425.350
22496537,2012-04-10T00:00:00,Geriatric Assessment,N05.715.360.300.360
22496537,2012-04-10T00:00:00,Geriatric Assessment,N06.850.505.400.425.350
22496537,2012-04-10T00:00:00,Geriatric Assessment,N06.850.520.308.225
22496537,2012-04-10T00:00:00,Healthcare Disparities,N04.590.374.380
22496537,2012-04-10T00:00:00,Healthcare Disparities,N05.300.493
22496537,2012-04-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22496537,2012-04-10T00:00:00,Hypertension,C14.907.489
22496537,2012-04-10T00:00:00,Medicare,N03.219.521.346.506.564.663
22496537,2012-04-10T00:00:00,Medicare,N03.219.521.576.343.840
22496537,2012-04-10T00:00:00,Medicare,N03.706.615.696
22496537,2012-04-10T00:00:00,Risk Assessment,E05.318.740.600.800.715
22496537,2012-04-10T00:00:00,Risk Assessment,N04.452.871.715
22496537,2012-04-10T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
22496537,2012-04-10T00:00:00,Risk Assessment,N06.850.505.715
22496537,2012-04-10T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
22496537,2012-04-10T00:00:00,United States,Z01.107.567.875
22507272,2012-04-10T00:00:00,Antineoplastic Agents,D27.505.954.248
22507272,2012-04-10T00:00:00,Apoptosis,G04.299.139.160
22507272,2012-04-10T00:00:00,Caspases,D08.811.277.656.262.500.126
22507272,2012-04-10T00:00:00,Caspases,D08.811.277.656.300.200.126
22507272,2012-04-10T00:00:00,Caspases,D12.644.360.075.405
22507272,2012-04-10T00:00:00,Caspases,D12.776.476.075.405
22507272,2012-04-10T00:00:00,Cell Differentiation,G04.299.151
22507272,2012-04-10T00:00:00,Cell Movement,G04.299.283
22507272,2012-04-10T00:00:00,Cell Movement,G07.700.560.500.180
22507272,2012-04-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22507272,2012-04-10T00:00:00,"Neovascularization, Pathologic",C23.550.589.500
22507272,2012-04-10T00:00:00,Neuroblastoma,C04.557.465.625.600.590.650.550
22507272,2012-04-10T00:00:00,Neuroblastoma,C04.557.470.670.590.650.550
22507272,2012-04-10T00:00:00,Neuroblastoma,C04.557.580.625.600.590.650.550
22507272,2012-04-10T00:00:00,"RNA, Messenger",D13.444.735.544
22514211,2012-04-10T00:00:00,Dietary Supplements,J02.500.456
22514211,2012-04-10T00:00:00,Heart,A07.541
22514211,2012-04-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22514211,2012-04-10T00:00:00,Middle Aged,M01.060.116.630
22514211,2012-04-10T00:00:00,Particulate Matter,D20.633
22544953,2012-04-10T00:00:00,Curriculum,I02.158
22544953,2012-04-10T00:00:00,"Education, Pharmacy",I02.358.525
22544953,2012-04-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22544953,2012-04-10T00:00:00,"Schools, Pharmacy",I02.783.660.694
22544960,2012-04-10T00:00:00,Adult,M01.060.116
22544960,2012-04-10T00:00:00,Career Choice,F02.463.785.373.346.400
22544960,2012-04-10T00:00:00,Clinical Competence,I02.399.630.210
22544960,2012-04-10T00:00:00,Clinical Competence,N04.761.210
22544960,2012-04-10T00:00:00,Curriculum,I02.158
22544960,2012-04-10T00:00:00,"Education, Pharmacy",I02.358.525
22544960,2012-04-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22544960,2012-04-10T00:00:00,Internet,L01.224.230.110.500
22544960,2012-04-10T00:00:00,"Internship, Nonmedical",I02.358.750
22544960,2012-04-10T00:00:00,Program Evaluation,E05.337.820
22544960,2012-04-10T00:00:00,Program Evaluation,N04.761.685
22544960,2012-04-10T00:00:00,Program Evaluation,N05.715.360.650
22544960,2012-04-10T00:00:00,Questionnaires,E05.318.308.750
22544960,2012-04-10T00:00:00,Questionnaires,L01.280.800
22544960,2012-04-10T00:00:00,Questionnaires,N05.715.360.300.695
22544960,2012-04-10T00:00:00,Questionnaires,N06.850.520.308.750
22544960,2012-04-10T00:00:00,"Schools, Pharmacy",I02.783.660.694
22544960,2012-04-10T00:00:00,South Carolina,Z01.107.567.875.075.662
22544960,2012-04-10T00:00:00,South Carolina,Z01.107.567.875.750.700
22544960,2012-04-10T00:00:00,"Students, Pharmacy",I02.851.686.768
22544960,2012-04-10T00:00:00,"Students, Pharmacy",M01.848.769.768
22496125,2012-04-11T00:00:00,Aged,M01.060.116.100
22496125,2012-04-11T00:00:00,Amputation,E04.555.080
22496125,2012-04-11T00:00:00,Angioplasty,E02.148.050
22496125,2012-04-11T00:00:00,Angioplasty,E04.100.814.050
22496125,2012-04-11T00:00:00,"Constriction, Pathologic",C23.300.287
22496125,2012-04-11T00:00:00,Femoral Artery,A07.231.114.351
22496125,2012-04-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22496125,2012-04-11T00:00:00,Intermittent Claudication,C14.907.137.126.669
22496125,2012-04-11T00:00:00,Intermittent Claudication,C23.888.531
22496125,2012-04-11T00:00:00,Ischemia,C23.550.513
22496125,2012-04-11T00:00:00,Leg,A01.378.610.500
22496125,2012-04-11T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
22496125,2012-04-11T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
22496125,2012-04-11T00:00:00,Peripheral Vascular Diseases,C14.907.617
22496125,2012-04-11T00:00:00,Stents,E07.695.750
22498216,2012-04-11T00:00:00,Developing Countries,I01.615.500.300
22498216,2012-04-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22498216,2012-04-11T00:00:00,Incidence,E05.318.308.985.525.375
22498216,2012-04-11T00:00:00,Incidence,L01.280.975.525.375
22498216,2012-04-11T00:00:00,Incidence,N01.224.935.597.500
22498216,2012-04-11T00:00:00,Incidence,N06.850.505.400.975.525.375
22498216,2012-04-11T00:00:00,Incidence,N06.850.520.308.985.525.375
22498216,2012-04-11T00:00:00,Kidney Neoplasms,C04.588.945.947.535
22498216,2012-04-11T00:00:00,Kidney Neoplasms,C12.758.820.750
22498216,2012-04-11T00:00:00,Kidney Neoplasms,C12.777.419.473
22498216,2012-04-11T00:00:00,Kidney Neoplasms,C13.351.937.820.535
22498216,2012-04-11T00:00:00,Kidney Neoplasms,C13.351.968.419.473
22560674,2012-04-11T00:00:00,Animals,B01.050
22560674,2012-04-11T00:00:00,B-Lymphocytes,A11.063.438
22560674,2012-04-11T00:00:00,B-Lymphocytes,A11.118.637.555.567.562
22560674,2012-04-11T00:00:00,B-Lymphocytes,A15.145.229.637.555.567.562
22560674,2012-04-11T00:00:00,B-Lymphocytes,A15.382.032.438
22560674,2012-04-11T00:00:00,B-Lymphocytes,A15.382.490.555.567.562
22560674,2012-04-11T00:00:00,Bone Marrow,A15.382.216
22560674,2012-04-11T00:00:00,Cell Survival,G04.299.316
22560674,2012-04-11T00:00:00,Cyclophosphamide,D02.455.526.728.650.730.243
22560674,2012-04-11T00:00:00,Cyclophosphamide,D02.705.670.243
22560674,2012-04-11T00:00:00,Myeloid Cells,A11.627
22560674,2012-04-11T00:00:00,Spleen,A10.549.700
22560674,2012-04-11T00:00:00,Spleen,A15.382.520.604.700
22560674,2012-04-11T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
22560674,2012-04-11T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
22560674,2012-04-11T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
22697333,2012-04-11T00:00:00,Aged,M01.060.116.100
22697333,2012-04-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22697333,2012-04-11T00:00:00,Middle Aged,M01.060.116.630
22697333,2012-04-11T00:00:00,Pancreatic Neoplasms,C04.588.274.761
22697333,2012-04-11T00:00:00,Pancreatic Neoplasms,C04.588.322.421
22697333,2012-04-11T00:00:00,Pancreatic Neoplasms,C06.301.761
22697333,2012-04-11T00:00:00,Pancreatic Neoplasms,C06.689.667
22697333,2012-04-11T00:00:00,Pancreatic Neoplasms,C19.344.421
22697333,2012-04-11T00:00:00,Particle Accelerators,E07.710.680
22697333,2012-04-11T00:00:00,"Radiotherapy, Conformal",E02.815.635.700
22697333,2012-04-11T00:00:00,"Radiotherapy, Conformal",L01.700.508.100.710.600.550
22697333,2012-04-11T00:00:00,Treatment Outcome,E01.789.800
22697333,2012-04-11T00:00:00,Treatment Outcome,N04.761.559.590.800
22697333,2012-04-11T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22494121,2012-04-12T00:00:00,Adult,M01.060.116
22494121,2012-04-12T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.350.700.715.200.200
22494121,2012-04-12T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.200.200
22494121,2012-04-12T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.250.200
22494121,2012-04-12T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.388.250.250.160
22494121,2012-04-12T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.210.240.160
22494121,2012-04-12T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.800.250.250.160
22494121,2012-04-12T00:00:00,Double-Blind Method,E05.318.780.300
22494121,2012-04-12T00:00:00,Double-Blind Method,E05.581.500.300
22494121,2012-04-12T00:00:00,Double-Blind Method,N05.715.360.780.320
22494121,2012-04-12T00:00:00,Double-Blind Method,N06.850.520.445.300
22494121,2012-04-12T00:00:00,Hospitalization,E02.760.400
22494121,2012-04-12T00:00:00,Hospitalization,N02.421.585.400
22494121,2012-04-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22494121,2012-04-12T00:00:00,Indomethacin,D03.438.473.420
22494121,2012-04-12T00:00:00,Length of Stay,E02.760.400.480
22494121,2012-04-12T00:00:00,Length of Stay,N02.421.585.400.480
22494121,2012-04-12T00:00:00,Middle Aged,M01.060.116.630
22494121,2012-04-12T00:00:00,Pancreatitis,C06.689.750
22494121,2012-04-12T00:00:00,Risk Factors,E05.318.740.600.800.725
22494121,2012-04-12T00:00:00,Risk Factors,N05.715.350.200.700
22494121,2012-04-12T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22494121,2012-04-12T00:00:00,Risk Factors,N06.850.490.625.750
22494121,2012-04-12T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22499027,2012-04-12T00:00:00,Algorithms,G17.035
22499027,2012-04-12T00:00:00,Algorithms,L01.224.050
22499027,2012-04-12T00:00:00,Artifacts,E05.047
22499027,2012-04-12T00:00:00,Brain,A08.186.211
22499027,2012-04-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22499027,2012-04-12T00:00:00,Image Enhancement,E01.370.350.600.350
22499027,2012-04-12T00:00:00,Image Enhancement,L01.224.308.380
22499027,2012-04-12T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
22499027,2012-04-12T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
22499027,2012-04-12T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
22499501,2012-04-12T00:00:00,Aged,M01.060.116.100
22499501,2012-04-12T00:00:00,Case-Control Studies,E05.318.760.500.500
22499501,2012-04-12T00:00:00,Case-Control Studies,N05.715.360.775.175.200
22499501,2012-04-12T00:00:00,Case-Control Studies,N06.850.520.450.500.500
22499501,2012-04-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22499501,2012-04-12T00:00:00,Linkage Disequilibrium,G05.540.500
22499501,2012-04-12T00:00:00,Middle Aged,M01.060.116.630
22499501,2012-04-12T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
22499501,2012-04-12T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
22499501,2012-04-12T00:00:00,Prostatic Neoplasms,C12.294.260.750
22499501,2012-04-12T00:00:00,Prostatic Neoplasms,C12.294.565.625
22499501,2012-04-12T00:00:00,Prostatic Neoplasms,C12.758.409.750
22499501,2012-04-12T00:00:00,Risk Assessment,E05.318.740.600.800.715
22499501,2012-04-12T00:00:00,Risk Assessment,N04.452.871.715
22499501,2012-04-12T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
22499501,2012-04-12T00:00:00,Risk Assessment,N06.850.505.715
22499501,2012-04-12T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
22499501,2012-04-12T00:00:00,Risk Factors,E05.318.740.600.800.725
22499501,2012-04-12T00:00:00,Risk Factors,N05.715.350.200.700
22499501,2012-04-12T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22499501,2012-04-12T00:00:00,Risk Factors,N06.850.490.625.750
22499501,2012-04-12T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22499501,2012-04-12T00:00:00,Signal Transduction,G02.111.087.800
22499501,2012-04-12T00:00:00,Signal Transduction,G02.149.115.800
22499501,2012-04-12T00:00:00,Signal Transduction,G04.299.880
22499501,2012-04-12T00:00:00,Vitamin D,D04.808.812.768
22528617,2012-04-12T00:00:00,Aged,M01.060.116.100
22528617,2012-04-12T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
22528617,2012-04-12T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
22528617,2012-04-12T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
22528617,2012-04-12T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
22528617,2012-04-12T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
22528617,2012-04-12T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
22528617,2012-04-12T00:00:00,Delivery of Health Care,N04.590.374
22528617,2012-04-12T00:00:00,Delivery of Health Care,N05.300
22528617,2012-04-12T00:00:00,Health Services Accessibility,N04.590.374.350
22528617,2012-04-12T00:00:00,Health Services Accessibility,N05.300.430
22528617,2012-04-12T00:00:00,Healthcare Disparities,N04.590.374.380
22528617,2012-04-12T00:00:00,Healthcare Disparities,N05.300.493
22528617,2012-04-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22528617,2012-04-12T00:00:00,Middle Aged,M01.060.116.630
22528617,2012-04-12T00:00:00,Time Factors,G01.910.857
22503203,2012-04-13T00:00:00,Extracorporeal Membrane Oxygenation,E02.880.301
22503203,2012-04-13T00:00:00,Extracorporeal Membrane Oxygenation,E04.292.451
22503203,2012-04-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22503203,2012-04-13T00:00:00,Hypoplastic Left Heart Syndrome,C14.240.400.625
22503203,2012-04-13T00:00:00,Hypoplastic Left Heart Syndrome,C14.280.400.625
22503203,2012-04-13T00:00:00,Hypoplastic Left Heart Syndrome,C16.131.240.400.625
22503203,2012-04-13T00:00:00,"Infant, Newborn",M01.060.703.520
22503203,2012-04-13T00:00:00,Palliative Care,E02.760.666
22503203,2012-04-13T00:00:00,Palliative Care,N02.421.585.666
22503203,2012-04-13T00:00:00,Patient Discharge,E02.760.400.610
22503203,2012-04-13T00:00:00,Patient Discharge,N02.421.585.400.610
22503203,2012-04-13T00:00:00,Postoperative Complications,C23.550.767
22503203,2012-04-13T00:00:00,"Respiration, Artificial",E02.365.647.729
22503203,2012-04-13T00:00:00,"Respiration, Artificial",E02.880.820
22503203,2012-04-13T00:00:00,Risk Assessment,E05.318.740.600.800.715
22503203,2012-04-13T00:00:00,Risk Assessment,N04.452.871.715
22503203,2012-04-13T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
22503203,2012-04-13T00:00:00,Risk Assessment,N06.850.505.715
22503203,2012-04-13T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
22503203,2012-04-13T00:00:00,Risk Factors,E05.318.740.600.800.725
22503203,2012-04-13T00:00:00,Risk Factors,N05.715.350.200.700
22503203,2012-04-13T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22503203,2012-04-13T00:00:00,Risk Factors,N06.850.490.625.750
22503203,2012-04-13T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22503203,2012-04-13T00:00:00,Time Factors,G01.910.857
22503203,2012-04-13T00:00:00,Treatment Outcome,E01.789.800
22503203,2012-04-13T00:00:00,Treatment Outcome,N04.761.559.590.800
22503203,2012-04-13T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22503203,2012-04-13T00:00:00,United States,Z01.107.567.875
22514719,2012-04-13T00:00:00,Animals,B01.050
22514719,2012-04-13T00:00:00,Cell Line,A11.251.210
22514719,2012-04-13T00:00:00,Hepatectomy,E04.210.556
22514719,2012-04-13T00:00:00,Liposomes,D25.479.517
22514719,2012-04-13T00:00:00,Liposomes,D26.255.260.517
22514719,2012-04-13T00:00:00,Liposomes,D27.720.280.260.517
22514719,2012-04-13T00:00:00,Liposomes,J01.637.051.479.517
22514719,2012-04-13T00:00:00,Liposomes,J01.637.087.500.517
22514719,2012-04-13T00:00:00,Liver Regeneration,G10.261.326.520
22514719,2012-04-13T00:00:00,Liver Regeneration,G16.100.856.468
22514719,2012-04-13T00:00:00,Macrophages,A11.329.372
22514719,2012-04-13T00:00:00,Macrophages,A11.627.482
22514719,2012-04-13T00:00:00,Macrophages,A11.733.397
22514719,2012-04-13T00:00:00,Macrophages,A15.382.680.397
22514719,2012-04-13T00:00:00,Macrophages,A15.382.812.522
22514719,2012-04-13T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22514719,2012-04-13T00:00:00,Stem Cells,A11.872
22860215,2012-04-15T00:00:00,Amino Acid Sequence,G02.111.570.060
22860215,2012-04-15T00:00:00,Amino Acid Sequence,L01.453.245.667.060
22860215,2012-04-15T00:00:00,Animals,B01.050
22860215,2012-04-15T00:00:00,Brain,A08.186.211
22860215,2012-04-15T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
22860215,2012-04-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22860215,2012-04-15T00:00:00,Molecular Sequence Data,L01.453.245.667
22860215,2012-04-15T00:00:00,Nerve Tissue Proteins,D12.776.641
22860215,2012-04-15T00:00:00,"Receptors, G-Protein-Coupled",D12.776.543.750.100
22860215,2012-04-15T00:00:00,Signal Transduction,G02.111.087.800
22860215,2012-04-15T00:00:00,Signal Transduction,G02.149.115.800
22860215,2012-04-15T00:00:00,Signal Transduction,G04.299.880
22447412,2012-04-16T00:00:00,Animals,B01.050
22447412,2012-04-16T00:00:00,Anoxia,C23.888.852.079
22447412,2012-04-16T00:00:00,Cell Survival,G04.299.316
22447412,2012-04-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22447412,2012-04-16T00:00:00,Lung Neoplasms,C04.588.894.797.520
22447412,2012-04-16T00:00:00,Lung Neoplasms,C08.381.540
22447412,2012-04-16T00:00:00,Lung Neoplasms,C08.785.520
22447412,2012-04-16T00:00:00,Nicotine,D03.132.760.570
22447412,2012-04-16T00:00:00,Nicotine,D03.383.725.518
22508710,2012-04-16T00:00:00,Aged,M01.060.116.100
22508710,2012-04-16T00:00:00,"Biopsy, Fine-Needle",E01.370.388.100.100.500
22508710,2012-04-16T00:00:00,"Biopsy, Fine-Needle",E01.450.230.100.100.500
22508710,2012-04-16T00:00:00,"Biopsy, Fine-Needle",E01.450.865.100.100.500
22508710,2012-04-16T00:00:00,"Biopsy, Fine-Needle",E04.074.119.500
22508710,2012-04-16T00:00:00,Carcinoma,C04.557.470.200
22508710,2012-04-16T00:00:00,Cholecalciferol,D04.808.247.222.159
22508710,2012-04-16T00:00:00,Cholecalciferol,D04.808.247.808.146
22508710,2012-04-16T00:00:00,Cholecalciferol,D04.808.812.768.196
22508710,2012-04-16T00:00:00,Cholecalciferol,D10.570.938.146
22508710,2012-04-16T00:00:00,Dietary Supplements,J02.500.456
22508710,2012-04-16T00:00:00,Down-Regulation,G02.111.087.225
22508710,2012-04-16T00:00:00,Down-Regulation,G02.149.115.225
22508710,2012-04-16T00:00:00,Down-Regulation,G05.355.315.200
22508710,2012-04-16T00:00:00,Down-Regulation,G07.690.812.230
22508710,2012-04-16T00:00:00,Down-Regulation,G07.700.680.230
22508710,2012-04-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22508710,2012-04-16T00:00:00,Middle Aged,M01.060.116.630
22508710,2012-04-16T00:00:00,Population Surveillance,E05.318.308.250.700
22508710,2012-04-16T00:00:00,Population Surveillance,N05.715.360.300.375.625
22508710,2012-04-16T00:00:00,Population Surveillance,N06.850.520.308.250.700
22508710,2012-04-16T00:00:00,Population Surveillance,N06.850.780.675
22508710,2012-04-16T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
22508710,2012-04-16T00:00:00,Prostatic Neoplasms,C12.294.260.750
22508710,2012-04-16T00:00:00,Prostatic Neoplasms,C12.294.565.625
22508710,2012-04-16T00:00:00,Prostatic Neoplasms,C12.758.409.750
22508710,2012-04-16T00:00:00,Risk Factors,E05.318.740.600.800.725
22508710,2012-04-16T00:00:00,Risk Factors,N05.715.350.200.700
22508710,2012-04-16T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22508710,2012-04-16T00:00:00,Risk Factors,N06.850.490.625.750
22508710,2012-04-16T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22508710,2012-04-16T00:00:00,Time Factors,G01.910.857
22508710,2012-04-16T00:00:00,Treatment Outcome,E01.789.800
22508710,2012-04-16T00:00:00,Treatment Outcome,N04.761.559.590.800
22508710,2012-04-16T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22579665,2012-04-16T00:00:00,Environmental Pollutants,D27.888.284
22579665,2012-04-16T00:00:00,Hot Temperature,G01.906.595.543
22579665,2012-04-16T00:00:00,Hot Temperature,G16.500.275.063.725.710.380
22579665,2012-04-16T00:00:00,Hot Temperature,G16.500.750.775.710.380
22579665,2012-04-16T00:00:00,Hot Temperature,N06.230.300.100.725.232
22579665,2012-04-16T00:00:00,Hot Temperature,N06.230.300.100.725.710.380
22579665,2012-04-16T00:00:00,"Models, Chemical",E05.599.495
22579665,2012-04-16T00:00:00,Volatile Organic Compounds,D02.974
22896799,2012-04-16T00:00:00,"Adaptation, Physiological",G07.700.062
22896799,2012-04-16T00:00:00,"Adaptation, Physiological",G16.100.057.500
22896799,2012-04-16T00:00:00,Alcohol Drinking,F01.145.317.269
22896799,2012-04-16T00:00:00,Alcoholism,C21.739.100.250
22896799,2012-04-16T00:00:00,Alcoholism,F03.900.100.350
22896799,2012-04-16T00:00:00,Animals,B01.050
22896799,2012-04-16T00:00:00,Brain,A08.186.211
22896799,2012-04-16T00:00:00,Brain Chemistry,G02.111.100
22896799,2012-04-16T00:00:00,Brain Chemistry,G03.200
22896799,2012-04-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22896799,2012-04-16T00:00:00,Neuronal Plasticity,G11.561.600.635
22511208,2012-04-17T00:00:00,Behavior Therapy,F04.754.137
22511208,2012-04-17T00:00:00,Diet,E05.272
22511208,2012-04-17T00:00:00,Diet,G07.610.240
22511208,2012-04-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22511208,2012-04-17T00:00:00,Life Style,F01.829.458
22511208,2012-04-17T00:00:00,Muscarinic Antagonists,D27.505.519.625.120.200.500
22511208,2012-04-17T00:00:00,Muscarinic Antagonists,D27.505.696.577.120.200.500
22511208,2012-04-17T00:00:00,Referral and Consultation,N04.452.758.849
22511208,2012-04-17T00:00:00,"Urinary Bladder, Overactive",C12.777.829.866
22511208,2012-04-17T00:00:00,"Urinary Bladder, Overactive",C13.351.968.829.813
22511208,2012-04-17T00:00:00,"Urinary Bladder, Overactive",C23.888.942.775
22511260,2012-04-17T00:00:00,Adult,M01.060.116
22511260,2012-04-17T00:00:00,Albuminuria,C12.777.934.734.269
22511260,2012-04-17T00:00:00,Albuminuria,C13.351.968.934.734.269
22511260,2012-04-17T00:00:00,Albuminuria,C23.888.942.750.269
22511260,2012-04-17T00:00:00,Biological Markers,D23.101
22511260,2012-04-17T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
22511260,2012-04-17T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
22511260,2012-04-17T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
22511260,2012-04-17T00:00:00,Diabetic Retinopathy,C11.768.257
22511260,2012-04-17T00:00:00,Diabetic Retinopathy,C14.907.320.382
22511260,2012-04-17T00:00:00,Diabetic Retinopathy,C19.246.099.500.382
22511260,2012-04-17T00:00:00,Disease Progression,C23.550.291.656
22511260,2012-04-17T00:00:00,"Glycosylation End Products, Advanced",D02.415
22511260,2012-04-17T00:00:00,"Hemoglobin A, Glycosylated",D09.408.375
22511260,2012-04-17T00:00:00,"Hemoglobin A, Glycosylated",D12.776.124.400.405.440
22511260,2012-04-17T00:00:00,"Hemoglobin A, Glycosylated",D12.776.422.316.762.380.440
22511260,2012-04-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22511260,2012-04-17T00:00:00,"Lipoproteins, LDL",D10.532.515
22511260,2012-04-17T00:00:00,"Lipoproteins, LDL",D12.776.521.550
22511260,2012-04-17T00:00:00,Risk Factors,E05.318.740.600.800.725
22511260,2012-04-17T00:00:00,Risk Factors,N05.715.350.200.700
22511260,2012-04-17T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22511260,2012-04-17T00:00:00,Risk Factors,N06.850.490.625.750
22511260,2012-04-17T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22516361,2012-04-17T00:00:00,Age Factors,N05.715.350.075
22516361,2012-04-17T00:00:00,Age Factors,N06.850.490.250
22516361,2012-04-17T00:00:00,Bladder Exstrophy,C12.706.132
22516361,2012-04-17T00:00:00,Bladder Exstrophy,C12.777.829.132
22516361,2012-04-17T00:00:00,Bladder Exstrophy,C13.351.875.132
22516361,2012-04-17T00:00:00,Bladder Exstrophy,C13.351.968.829.132
22516361,2012-04-17T00:00:00,Bladder Exstrophy,C16.131.939.132
22516361,2012-04-17T00:00:00,"Child, Preschool",M01.060.406.448
22516361,2012-04-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22516361,2012-04-17T00:00:00,Treatment Outcome,E01.789.800
22516361,2012-04-17T00:00:00,Treatment Outcome,N04.761.559.590.800
22516361,2012-04-17T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22516835,2012-04-18T00:00:00,Adenocarcinoma,C04.557.470.200.025
22516835,2012-04-18T00:00:00,Adult,M01.060.116
22516835,2012-04-18T00:00:00,Aged,M01.060.116.100
22516835,2012-04-18T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
22516835,2012-04-18T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
22516835,2012-04-18T00:00:00,Combined Modality Therapy,E02.186
22516835,2012-04-18T00:00:00,Endosonography,E01.370.350.850.280
22516835,2012-04-18T00:00:00,Esophageal Neoplasms,C04.588.274.476.205
22516835,2012-04-18T00:00:00,Esophageal Neoplasms,C04.588.443.353
22516835,2012-04-18T00:00:00,Esophageal Neoplasms,C06.301.371.205
22516835,2012-04-18T00:00:00,Esophageal Neoplasms,C06.405.117.430
22516835,2012-04-18T00:00:00,Esophageal Neoplasms,C06.405.249.205
22516835,2012-04-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22516835,2012-04-18T00:00:00,Middle Aged,M01.060.116.630
22516835,2012-04-18T00:00:00,Neoplasm Invasiveness,C04.697.645
22516835,2012-04-18T00:00:00,Neoplasm Invasiveness,C23.550.727.645
22516835,2012-04-18T00:00:00,Neoplasm Staging,E01.370.550
22520967,2012-04-19T00:00:00,Adult,M01.060.116
22520967,2012-04-19T00:00:00,African Americans,M01.686.508.100.100
22520967,2012-04-19T00:00:00,African Americans,M01.686.754.100
22520967,2012-04-19T00:00:00,"Databases, Genetic",L01.470.750.750.325
22520967,2012-04-19T00:00:00,"Databases, Genetic",L01.700.508.300.188.400.325
22520967,2012-04-19T00:00:00,European Continental Ancestry Group,M01.686.508.400
22520967,2012-04-19T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
22520967,2012-04-19T00:00:00,Genetic Predisposition to Disease,G05.380.355
22520967,2012-04-19T00:00:00,Genome-Wide Association Study,E05.318.416.249
22520967,2012-04-19T00:00:00,Genome-Wide Association Study,E05.318.780.392
22520967,2012-04-19T00:00:00,Genome-Wide Association Study,E05.393.385.500
22520967,2012-04-19T00:00:00,Genome-Wide Association Study,E05.393.522.500
22520967,2012-04-19T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
22520967,2012-04-19T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
22520967,2012-04-19T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
22520967,2012-04-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22520967,2012-04-19T00:00:00,Marijuana Abuse,C21.739.635
22520967,2012-04-19T00:00:00,Marijuana Abuse,F03.900.635
22520967,2012-04-19T00:00:00,Middle Aged,M01.060.116.630
22520967,2012-04-19T00:00:00,Neuregulin-1,D12.644.276.860.550.750
22520967,2012-04-19T00:00:00,Neuregulin-1,D12.776.467.860.550.750
22520967,2012-04-19T00:00:00,Neuregulin-1,D12.776.641.600.550.750
22520967,2012-04-19T00:00:00,Neuregulin-1,D23.529.850.550.750
22520967,2012-04-19T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
22522673,2012-04-20T00:00:00,Adult,M01.060.116
22522673,2012-04-20T00:00:00,Aged,M01.060.116.100
22522673,2012-04-20T00:00:00,"Carcinoma, Merkel Cell",C04.557.465.625.650.240.325
22522673,2012-04-20T00:00:00,"Carcinoma, Merkel Cell",C04.557.470.200.025.370.325
22522673,2012-04-20T00:00:00,"Carcinoma, Merkel Cell",C04.557.580.625.650.240.325
22522673,2012-04-20T00:00:00,Combined Modality Therapy,E02.186
22522673,2012-04-20T00:00:00,"Databases, Factual",L01.470.750.750
22522673,2012-04-20T00:00:00,"Databases, Factual",L01.700.508.300.188.400
22522673,2012-04-20T00:00:00,Head and Neck Neoplasms,C04.588.443
22522673,2012-04-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22522673,2012-04-20T00:00:00,Middle Aged,M01.060.116.630
22522673,2012-04-20T00:00:00,Neoplasm Invasiveness,C04.697.645
22522673,2012-04-20T00:00:00,Neoplasm Invasiveness,C23.550.727.645
22522673,2012-04-20T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
22522673,2012-04-20T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
22522673,2012-04-20T00:00:00,Neoplasm Staging,E01.370.550
22522673,2012-04-20T00:00:00,Risk Assessment,E05.318.740.600.800.715
22522673,2012-04-20T00:00:00,Risk Assessment,N04.452.871.715
22522673,2012-04-20T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
22522673,2012-04-20T00:00:00,Risk Assessment,N06.850.505.715
22522673,2012-04-20T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
22522673,2012-04-20T00:00:00,SEER Program,E05.318.308.970.725
22522673,2012-04-20T00:00:00,SEER Program,L01.280.950.725
22522673,2012-04-20T00:00:00,SEER Program,N04.452.859.819.725
22522673,2012-04-20T00:00:00,SEER Program,N05.715.360.300.715.700.725
22522673,2012-04-20T00:00:00,SEER Program,N06.850.520.308.970.725
22522673,2012-04-20T00:00:00,Skin Neoplasms,C04.588.805
22522673,2012-04-20T00:00:00,Skin Neoplasms,C17.800.882
22522673,2012-04-20T00:00:00,Treatment Outcome,E01.789.800
22522673,2012-04-20T00:00:00,Treatment Outcome,N04.761.559.590.800
22522673,2012-04-20T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22522673,2012-04-20T00:00:00,"Tumor Markers, Biological",D23.101.840
22522673,2012-04-20T00:00:00,United States,Z01.107.567.875
22523388,2012-04-20T00:00:00,Animals,B01.050
22523388,2012-04-20T00:00:00,Chronic Disease,C23.550.291.500
22523388,2012-04-20T00:00:00,Spinal Cord Injuries,C10.228.854.770
22523388,2012-04-20T00:00:00,Spinal Cord Injuries,C10.900.850
22523388,2012-04-20T00:00:00,Spinal Cord Injuries,C21.866.819
22523388,2012-04-20T00:00:00,Spleen,A10.549.700
22523388,2012-04-20T00:00:00,Spleen,A15.382.520.604.700
22523388,2012-04-20T00:00:00,Thymus Gland,A10.549.750
22523388,2012-04-20T00:00:00,Thymus Gland,A15.382.520.604.750
22523428,2012-04-20T00:00:00,Cell Adhesion Molecules,D12.776.395.550.200
22523428,2012-04-20T00:00:00,Cell Adhesion Molecules,D12.776.543.550.200
22523428,2012-04-20T00:00:00,Cell Adhesion Molecules,D23.050.301.350
22523428,2012-04-20T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
22523428,2012-04-20T00:00:00,Genetic Predisposition to Disease,G05.380.355
22523428,2012-04-20T00:00:00,Genome-Wide Association Study,E05.318.416.249
22523428,2012-04-20T00:00:00,Genome-Wide Association Study,E05.318.780.392
22523428,2012-04-20T00:00:00,Genome-Wide Association Study,E05.393.385.500
22523428,2012-04-20T00:00:00,Genome-Wide Association Study,E05.393.522.500
22523428,2012-04-20T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
22523428,2012-04-20T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
22523428,2012-04-20T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
22523428,2012-04-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22523428,2012-04-20T00:00:00,Intercellular Adhesion Molecule-1,D12.776.395.550.200.450
22523428,2012-04-20T00:00:00,Intercellular Adhesion Molecule-1,D12.776.543.550.200.450
22523428,2012-04-20T00:00:00,Intercellular Adhesion Molecule-1,D23.050.301.264.035.400
22523428,2012-04-20T00:00:00,Intercellular Adhesion Molecule-1,D23.050.301.350.450
22523428,2012-04-20T00:00:00,Intercellular Adhesion Molecule-1,D23.101.100.110.400
22523428,2012-04-20T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
22523428,2012-04-20T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
22523428,2012-04-20T00:00:00,Nerve Tissue Proteins,D12.776.641
22523428,2012-04-20T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
22532866,2012-04-20T00:00:00,Animals,B01.050
22532866,2012-04-20T00:00:00,Antineoplastic Agents,D27.505.954.248
22532866,2012-04-20T00:00:00,Apoptosis,G04.299.139.160
22532866,2012-04-20T00:00:00,Endothelial Cells,A11.436.275
22532866,2012-04-20T00:00:00,Interleukin-2,D12.644.276.374.465.502
22532866,2012-04-20T00:00:00,Interleukin-2,D12.644.276.374.480.372
22532866,2012-04-20T00:00:00,Interleukin-2,D12.776.467.374.465.502
22532866,2012-04-20T00:00:00,Interleukin-2,D12.776.467.374.480.372
22532866,2012-04-20T00:00:00,Interleukin-2,D23.529.374.465.502
22532866,2012-04-20T00:00:00,Interleukin-2,D23.529.374.480.372
22532866,2012-04-20T00:00:00,Lung Neoplasms,C04.588.894.797.520
22532866,2012-04-20T00:00:00,Lung Neoplasms,C08.381.540
22532866,2012-04-20T00:00:00,Lung Neoplasms,C08.785.520
22532866,2012-04-20T00:00:00,Melanoma,C04.557.465.625.650.510
22532866,2012-04-20T00:00:00,Melanoma,C04.557.580.625.650.510
22532866,2012-04-20T00:00:00,Melanoma,C04.557.665.510
22532866,2012-04-20T00:00:00,Stilbenes,D02.455.426.559.389.150.700
22532866,2012-04-20T00:00:00,"T-Lymphocytes, Regulatory",A11.118.637.555.567.569.200.700
22532866,2012-04-20T00:00:00,"T-Lymphocytes, Regulatory",A15.145.229.637.555.567.569.200.700
22532866,2012-04-20T00:00:00,"T-Lymphocytes, Regulatory",A15.382.490.555.567.569.200.700
22659029,2012-04-20T00:00:00,Animals,B01.050
22659029,2012-04-20T00:00:00,B-Lymphocytes,A11.063.438
22659029,2012-04-20T00:00:00,B-Lymphocytes,A11.118.637.555.567.562
22659029,2012-04-20T00:00:00,B-Lymphocytes,A15.145.229.637.555.567.562
22659029,2012-04-20T00:00:00,B-Lymphocytes,A15.382.032.438
22659029,2012-04-20T00:00:00,B-Lymphocytes,A15.382.490.555.567.562
22659029,2012-04-20T00:00:00,Cytokines,D12.644.276.374
22659029,2012-04-20T00:00:00,Cytokines,D12.776.467.374
22659029,2012-04-20T00:00:00,Cytokines,D23.529.374
22659029,2012-04-20T00:00:00,Dendritic Cells,A11.066.270
22659029,2012-04-20T00:00:00,Dendritic Cells,A11.436.270
22659029,2012-04-20T00:00:00,Dendritic Cells,A15.382.066.270
22659029,2012-04-20T00:00:00,Dendritic Cells,A15.382.812.260
22659029,2012-04-20T00:00:00,"Disease Models, Animal",C22.232
22659029,2012-04-20T00:00:00,"Disease Models, Animal",E05.598.500
22659029,2012-04-20T00:00:00,"Disease Models, Animal",E05.599.395.080
22659029,2012-04-20T00:00:00,Estrogen Receptor alpha,D12.776.260.698.750.350.174
22659029,2012-04-20T00:00:00,Estrogen Receptor alpha,D12.776.826.750.350.174
22659029,2012-04-20T00:00:00,Estrogen Receptor alpha,D12.776.930.669.750.350.174
22659029,2012-04-20T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
22659029,2012-04-20T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
22659029,2012-04-20T00:00:00,Spleen,A10.549.700
22659029,2012-04-20T00:00:00,Spleen,A15.382.520.604.700
22659029,2012-04-20T00:00:00,Toll-Like Receptors,D12.776.543.750.705.910.500
22521854,2012-04-21T00:00:00,Adult,M01.060.116
22521854,2012-04-21T00:00:00,Amygdala,A08.186.211.464.090
22521854,2012-04-21T00:00:00,Amygdala,A08.186.211.730.885.287.249.152
22521854,2012-04-21T00:00:00,Bipolar Disorder,F03.600.150.150
22521854,2012-04-21T00:00:00,Depression,F01.145.126.350
22521854,2012-04-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22521854,2012-04-21T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
22521854,2012-04-21T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
22521854,2012-04-21T00:00:00,Middle Aged,M01.060.116.630
22579118,2012-04-21T00:00:00,Adult,M01.060.116
22579118,2012-04-21T00:00:00,African Continental Ancestry Group,M01.686.508.100
22579118,2012-04-21T00:00:00,Birth Weight,C23.888.144.186
22579118,2012-04-21T00:00:00,Birth Weight,E01.370.600.115.100.160.120.186
22579118,2012-04-21T00:00:00,Birth Weight,E05.041.124.160.750.149
22579118,2012-04-21T00:00:00,Birth Weight,G07.100.100.160.120.186
22579118,2012-04-21T00:00:00,Birth Weight,G07.700.320.249.314.120.186
22579118,2012-04-21T00:00:00,Environmental Monitoring,N06.850.460.350.080
22579118,2012-04-21T00:00:00,Environmental Monitoring,N06.850.780.375
22579118,2012-04-21T00:00:00,European Continental Ancestry Group,M01.686.508.400
22579118,2012-04-21T00:00:00,Geographic Information Systems,L01.470.750.750.462
22579118,2012-04-21T00:00:00,Geographic Information Systems,L01.700.508.300.314
22579118,2012-04-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22579118,2012-04-21T00:00:00,"Infant, Newborn",M01.060.703.520
22579118,2012-04-21T00:00:00,Pregnancy,G08.686.785.760.769
22579118,2012-04-21T00:00:00,Soil Pollutants,D27.888.284.756
22579118,2012-04-21T00:00:00,South Carolina,Z01.107.567.875.075.662
22579118,2012-04-21T00:00:00,South Carolina,Z01.107.567.875.750.700
22579118,2012-04-21T00:00:00,United States,Z01.107.567.875
22577471,2012-04-22T00:00:00,Algorithms,G17.035
22577471,2012-04-22T00:00:00,Algorithms,L01.224.050
22577471,2012-04-22T00:00:00,Artificial Intelligence,L01.224.065
22577471,2012-04-22T00:00:00,Binding Sites,G02.111.570.120
22577471,2012-04-22T00:00:00,Computer Simulation,L01.224.160
22577471,2012-04-22T00:00:00,"Databases, Genetic",L01.470.750.750.325
22577471,2012-04-22T00:00:00,"Databases, Genetic",L01.700.508.300.188.400.325
22577471,2012-04-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22577471,2012-04-22T00:00:00,"Models, Genetic",E05.599.395.397
22577471,2012-04-22T00:00:00,"Models, Molecular",E05.599.595
22577471,2012-04-22T00:00:00,Molecular Dynamics Simulation,E05.599.595.500
22577471,2012-04-22T00:00:00,Molecular Dynamics Simulation,G02.575.750
22577471,2012-04-22T00:00:00,Molecular Dynamics Simulation,L01.224.160.500
22577471,2012-04-22T00:00:00,"Mutation, Missense",G05.365.590.650
22577471,2012-04-22T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
22577471,2012-04-22T00:00:00,Protein Folding,G01.154.100.640
22577471,2012-04-22T00:00:00,Protein Folding,G01.595.100.640
22577471,2012-04-22T00:00:00,Protein Folding,G02.111.087.690
22577471,2012-04-22T00:00:00,Protein Folding,G02.149.115.690
22577471,2012-04-22T00:00:00,Protein Stability,G02.111.700
22682435,2012-04-22T00:00:00,Geographic Information Systems,L01.470.750.750.462
22682435,2012-04-22T00:00:00,Geographic Information Systems,L01.700.508.300.314
22524548,2012-04-23T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
22524548,2012-04-23T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
22524548,2012-04-23T00:00:00,Diet,E05.272
22524548,2012-04-23T00:00:00,Diet,G07.610.240
22524548,2012-04-23T00:00:00,Exercise,G11.427.590.237
22524548,2012-04-23T00:00:00,Exercise,I03.350
22524548,2012-04-23T00:00:00,Health Behavior,F01.145.488
22524548,2012-04-23T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
22524548,2012-04-23T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
22524548,2012-04-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22524548,2012-04-23T00:00:00,Hypoglycemic Agents,D27.505.696.422
22524548,2012-04-23T00:00:00,Medication Adherence,F01.145.488.500.500
22524548,2012-04-23T00:00:00,Medication Adherence,N05.300.150.600.600.500
22524548,2012-04-23T00:00:00,Self Care,E02.900
22524548,2012-04-23T00:00:00,Self Care,N02.421.784.680
22524548,2012-04-23T00:00:00,Smoking,F01.145.466.753
22531215,2012-04-23T00:00:00,Algorithms,G17.035
22531215,2012-04-23T00:00:00,Algorithms,L01.224.050
22531215,2012-04-23T00:00:00,Computational Biology,H01.158.273.180
22531215,2012-04-23T00:00:00,Internet,L01.224.230.110.500
22531215,2012-04-23T00:00:00,"Models, Molecular",E05.599.595
22531215,2012-04-23T00:00:00,Nanostructures,J01.637.512
22531215,2012-04-23T00:00:00,Software,L01.224.900
22531215,2012-04-23T00:00:00,Static Electricity,G01.201.249.820
22531215,2012-04-23T00:00:00,User-Computer Interface,L01.224.900.910
22419388,2012-04-24T00:00:00,Animals,B01.050
22419388,2012-04-24T00:00:00,Apoptosis,G04.299.139.160
22419388,2012-04-24T00:00:00,Breast Neoplasms,C04.588.180
22419388,2012-04-24T00:00:00,Breast Neoplasms,C17.800.090.500
22419388,2012-04-24T00:00:00,Cancer Vaccines,D20.215.894.200
22419388,2012-04-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22419388,2012-04-24T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
22419388,2012-04-24T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
22419388,2012-04-24T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
22419388,2012-04-24T00:00:00,Interferon-gamma,D12.644.276.374.440.893
22419388,2012-04-24T00:00:00,Interferon-gamma,D12.644.276.374.480.350
22419388,2012-04-24T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
22419388,2012-04-24T00:00:00,Interferon-gamma,D12.644.276.718.550
22419388,2012-04-24T00:00:00,Interferon-gamma,D12.776.467.374.440.893
22419388,2012-04-24T00:00:00,Interferon-gamma,D12.776.467.374.480.350
22419388,2012-04-24T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
22419388,2012-04-24T00:00:00,Interferon-gamma,D12.776.467.718.550
22419388,2012-04-24T00:00:00,Interferon-gamma,D23.529.374.440.893
22419388,2012-04-24T00:00:00,Interferon-gamma,D23.529.374.480.350
22419388,2012-04-24T00:00:00,Interferon-gamma,D23.529.374.480.615.350
22419388,2012-04-24T00:00:00,Interferon-gamma,D23.529.718.550
22419388,2012-04-24T00:00:00,"Receptors, TNF-Related Apoptosis-Inducing Ligand",D12.776.543.750.073.600
22419388,2012-04-24T00:00:00,"Receptors, TNF-Related Apoptosis-Inducing Ligand",D12.776.543.750.705.852.760.396
22419388,2012-04-24T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
22419388,2012-04-24T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
22419388,2012-04-24T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
22532510,2012-04-24T00:00:00,Enzymes,D08.811
22532510,2012-04-24T00:00:00,Nanoparticles,J01.637.512.600
22532510,2012-04-24T00:00:00,Nanotechnology,H01.603
22532510,2012-04-24T00:00:00,Nanotechnology,J01.897.520.600
22532561,2012-04-24T00:00:00,Animals,B01.050
22532561,2012-04-24T00:00:00,Gene Expression Regulation,G05.355.315
22532561,2012-04-24T00:00:00,HSP90 Heat-Shock Proteins,D12.776.580.216.380
22532561,2012-04-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22532561,2012-04-24T00:00:00,Lipopolysaccharides,D09.400.500
22532561,2012-04-24T00:00:00,Lipopolysaccharides,D09.698.718.450
22532561,2012-04-24T00:00:00,Lipopolysaccharides,D10.494
22532561,2012-04-24T00:00:00,Lipopolysaccharides,D23.050.161.616.525
22532561,2012-04-24T00:00:00,Lipopolysaccharides,D23.946.123.329.500
22532561,2012-04-24T00:00:00,Membrane Glycoproteins,D12.776.395.550
22532561,2012-04-24T00:00:00,Membrane Glycoproteins,D12.776.543.550
22532561,2012-04-24T00:00:00,Signal Transduction,G02.111.087.800
22532561,2012-04-24T00:00:00,Signal Transduction,G02.149.115.800
22532561,2012-04-24T00:00:00,Signal Transduction,G04.299.880
22534249,2012-04-24T00:00:00,Anticoagulants,D27.505.954.502.119
22534249,2012-04-24T00:00:00,"Arrhythmias, Cardiac",C14.280.067
22534249,2012-04-24T00:00:00,"Arrhythmias, Cardiac",C23.550.073
22534249,2012-04-24T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
22534249,2012-04-24T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
22534249,2012-04-24T00:00:00,"Defibrillators, Implantable",E07.695.175
22534249,2012-04-24T00:00:00,Hemorrhage,C23.550.414
22534249,2012-04-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22534249,2012-04-24T00:00:00,"Pacemaker, Artificial",E07.858.082.748
22534249,2012-04-24T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
22534249,2012-04-24T00:00:00,Practice Guidelines as Topic,N05.700.350.650
22534249,2012-04-24T00:00:00,Risk Factors,E05.318.740.600.800.725
22534249,2012-04-24T00:00:00,Risk Factors,N05.715.350.200.700
22534249,2012-04-24T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22534249,2012-04-24T00:00:00,Risk Factors,N06.850.490.625.750
22534249,2012-04-24T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22534249,2012-04-24T00:00:00,Thrombosis,C14.907.355.830
22537503,2012-04-24T00:00:00,Adult,M01.060.116
22537503,2012-04-24T00:00:00,Aged,M01.060.116.100
22537503,2012-04-24T00:00:00,Breast Neoplasms,C04.588.180
22537503,2012-04-24T00:00:00,Breast Neoplasms,C17.800.090.500
22537503,2012-04-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22537503,2012-04-24T00:00:00,Mammography,E01.370.350.700.500
22537503,2012-04-24T00:00:00,Mass Screening,E01.370.500
22537503,2012-04-24T00:00:00,Mass Screening,E05.318.308.250.580
22537503,2012-04-24T00:00:00,Mass Screening,N02.421.143.827.233.443
22537503,2012-04-24T00:00:00,Mass Screening,N02.421.726.233.443
22537503,2012-04-24T00:00:00,Mass Screening,N05.715.360.300.375.500
22537503,2012-04-24T00:00:00,Mass Screening,N06.850.520.308.250.580
22537503,2012-04-24T00:00:00,Mass Screening,N06.850.780.500
22537503,2012-04-24T00:00:00,Middle Aged,M01.060.116.630
22537503,2012-04-24T00:00:00,Photometry,E05.196.712
22537503,2012-04-24T00:00:00,Photons,G01.201.875.770.578.782
22537503,2012-04-24T00:00:00,Photons,G01.249.705
22537503,2012-04-24T00:00:00,Photons,G01.590.540.782
22537503,2012-04-24T00:00:00,Radiation Dosage,E05.799.513
22537503,2012-04-24T00:00:00,Radiation Dosage,G01.201.875.740
22537503,2012-04-24T00:00:00,Radiation Dosage,N06.850.810.250
22537503,2012-04-24T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
22537503,2012-04-24T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
22537503,2012-04-24T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
22546693,2012-04-24T00:00:00,Animals,B01.050
22546693,2012-04-24T00:00:00,Embryonic Development,G07.700.320.500.325.180
22546693,2012-04-24T00:00:00,Embryonic Development,G08.686.785.760.170.104
22546693,2012-04-24T00:00:00,Fibroblasts,A11.329.228
22546693,2012-04-24T00:00:00,Fibroblasts,A11.872.228
22546693,2012-04-24T00:00:00,Heart,A07.541
22546693,2012-04-24T00:00:00,Heart Valves,A07.541.510
22546693,2012-04-24T00:00:00,Heart Ventricles,A07.541.560
22546693,2012-04-24T00:00:00,Pericardium,A07.541.795
22546693,2012-04-24T00:00:00,Pericardium,A10.615.789.470
22534428,2012-04-25T00:00:00,Bayes Theorem,E05.318.740.600.200
22534428,2012-04-25T00:00:00,Bayes Theorem,N05.715.360.750.625.150
22534428,2012-04-25T00:00:00,Bayes Theorem,N06.850.520.830.600.200
22534428,2012-04-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22534428,2012-04-25T00:00:00,Incidence,E05.318.308.985.525.375
22534428,2012-04-25T00:00:00,Incidence,L01.280.975.525.375
22534428,2012-04-25T00:00:00,Incidence,N01.224.935.597.500
22534428,2012-04-25T00:00:00,Incidence,N06.850.505.400.975.525.375
22534428,2012-04-25T00:00:00,Incidence,N06.850.520.308.985.525.375
22534428,2012-04-25T00:00:00,"Infant, Low Birth Weight",M01.060.703.520.460
22534428,2012-04-25T00:00:00,"Infant, Newborn",M01.060.703.520
22534428,2012-04-25T00:00:00,"Models, Statistical",E05.318.740.500
22534428,2012-04-25T00:00:00,"Models, Statistical",E05.599.835
22534428,2012-04-25T00:00:00,"Models, Statistical",N05.715.360.750.530
22534428,2012-04-25T00:00:00,"Models, Statistical",N06.850.520.830.500
22535850,2012-04-25T00:00:00,Adult,M01.060.116
22535850,2012-04-25T00:00:00,Aged,M01.060.116.100
22535850,2012-04-25T00:00:00,Early Detection of Cancer,E01.390.500
22535850,2012-04-25T00:00:00,Health Surveys,E05.318.308.250
22535850,2012-04-25T00:00:00,Health Surveys,N05.715.360.300.375
22535850,2012-04-25T00:00:00,Health Surveys,N06.850.520.308.250
22535850,2012-04-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22535850,2012-04-25T00:00:00,Mass Screening,E01.370.500
22535850,2012-04-25T00:00:00,Mass Screening,E05.318.308.250.580
22535850,2012-04-25T00:00:00,Mass Screening,N02.421.143.827.233.443
22535850,2012-04-25T00:00:00,Mass Screening,N02.421.726.233.443
22535850,2012-04-25T00:00:00,Mass Screening,N05.715.360.300.375.500
22535850,2012-04-25T00:00:00,Mass Screening,N06.850.520.308.250.580
22535850,2012-04-25T00:00:00,Mass Screening,N06.850.780.500
22535850,2012-04-25T00:00:00,Middle Aged,M01.060.116.630
22535850,2012-04-25T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
22535850,2012-04-25T00:00:00,Practice Guidelines as Topic,N05.700.350.650
22535850,2012-04-25T00:00:00,Prostate-Specific Antigen,D08.811.277.656.300.760.442.750
22535850,2012-04-25T00:00:00,Prostate-Specific Antigen,D08.811.277.656.959.350.442.750
22535850,2012-04-25T00:00:00,Prostate-Specific Antigen,D12.776.866.249.500
22535850,2012-04-25T00:00:00,Prostate-Specific Antigen,D23.050.285.625
22535850,2012-04-25T00:00:00,Prostate-Specific Antigen,D23.101.840.625
22535850,2012-04-25T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
22535850,2012-04-25T00:00:00,Prostatic Neoplasms,C12.294.260.750
22535850,2012-04-25T00:00:00,Prostatic Neoplasms,C12.294.565.625
22535850,2012-04-25T00:00:00,Prostatic Neoplasms,C12.758.409.750
22535850,2012-04-25T00:00:00,United States,Z01.107.567.875
22535994,2012-04-25T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
22535994,2012-04-25T00:00:00,Genetic Predisposition to Disease,G05.380.355
22535994,2012-04-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22535994,2012-04-25T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
22607671,2012-04-25T00:00:00,Chlorambucil,D02.455.526.728.650.156
22607671,2012-04-25T00:00:00,Down-Regulation,G02.111.087.225
22607671,2012-04-25T00:00:00,Down-Regulation,G02.149.115.225
22607671,2012-04-25T00:00:00,Down-Regulation,G05.355.315.200
22607671,2012-04-25T00:00:00,Down-Regulation,G07.690.812.230
22607671,2012-04-25T00:00:00,Down-Regulation,G07.700.680.230
22607671,2012-04-25T00:00:00,Histones,D12.776.660.470
22607671,2012-04-25T00:00:00,Histones,D12.776.664.469
22607671,2012-04-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22607671,2012-04-25T00:00:00,Nylons,D05.750.716.392
22607671,2012-04-25T00:00:00,Nylons,D25.720.716.392
22607671,2012-04-25T00:00:00,Nylons,J01.576.885.800.600
22607671,2012-04-25T00:00:00,Nylons,J01.637.051.720.716.392
22607671,2012-04-25T00:00:00,Nylons,J01.637.548
22607671,2012-04-25T00:00:00,Pancreatic Neoplasms,C04.588.274.761
22607671,2012-04-25T00:00:00,Pancreatic Neoplasms,C04.588.322.421
22607671,2012-04-25T00:00:00,Pancreatic Neoplasms,C06.301.761
22607671,2012-04-25T00:00:00,Pancreatic Neoplasms,C06.689.667
22607671,2012-04-25T00:00:00,Pancreatic Neoplasms,C19.344.421
22607671,2012-04-25T00:00:00,Pyrroles,D03.383.129.578
22607671,2012-04-25T00:00:00,"RNA, Messenger",D13.444.735.544
22607671,2012-04-25T00:00:00,"Transcription, Genetic",G02.111.087.847
22607671,2012-04-25T00:00:00,"Transcription, Genetic",G02.149.115.847
22607671,2012-04-25T00:00:00,"Transcription, Genetic",G05.355.310.700
22542094,2012-04-26T00:00:00,Accidental Falls,N06.850.135.122
22542094,2012-04-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22542094,2012-04-26T00:00:00,Incidence,E05.318.308.985.525.375
22542094,2012-04-26T00:00:00,Incidence,L01.280.975.525.375
22542094,2012-04-26T00:00:00,Incidence,N01.224.935.597.500
22542094,2012-04-26T00:00:00,Incidence,N06.850.505.400.975.525.375
22542094,2012-04-26T00:00:00,Incidence,N06.850.520.308.985.525.375
22542094,2012-04-26T00:00:00,Parkinson Disease,C10.228.140.079.862.500
22542094,2012-04-26T00:00:00,Parkinson Disease,C10.228.662.600.400
22542094,2012-04-26T00:00:00,Parkinson Disease,C10.574.812
22542094,2012-04-26T00:00:00,Postural Balance,G11.427.690
22542094,2012-04-26T00:00:00,Postural Balance,G11.561.600.810.541.595
22542094,2012-04-26T00:00:00,Questionnaires,E05.318.308.750
22542094,2012-04-26T00:00:00,Questionnaires,L01.280.800
22542094,2012-04-26T00:00:00,Questionnaires,N05.715.360.300.695
22542094,2012-04-26T00:00:00,Questionnaires,N06.850.520.308.750
22542094,2012-04-26T00:00:00,Risk Assessment,E05.318.740.600.800.715
22542094,2012-04-26T00:00:00,Risk Assessment,N04.452.871.715
22542094,2012-04-26T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
22542094,2012-04-26T00:00:00,Risk Assessment,N06.850.505.715
22542094,2012-04-26T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
22542094,2012-04-26T00:00:00,Risk Factors,E05.318.740.600.800.725
22542094,2012-04-26T00:00:00,Risk Factors,N05.715.350.200.700
22542094,2012-04-26T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22542094,2012-04-26T00:00:00,Risk Factors,N06.850.490.625.750
22542094,2012-04-26T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22539065,2012-04-27T00:00:00,Adult,M01.060.116
22539065,2012-04-27T00:00:00,Attitude of Health Personnel,F01.100.050
22539065,2012-04-27T00:00:00,Attitude of Health Personnel,N05.300.100
22539065,2012-04-27T00:00:00,Colonoscopy,E01.370.372.250.250.200
22539065,2012-04-27T00:00:00,Colonoscopy,E01.370.388.250.250.250.160
22539065,2012-04-27T00:00:00,Colonoscopy,E04.210.240.250.160
22539065,2012-04-27T00:00:00,Colonoscopy,E04.800.250.250.250.160
22539065,2012-04-27T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
22539065,2012-04-27T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
22539065,2012-04-27T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
22539065,2012-04-27T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
22539065,2012-04-27T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
22539065,2012-04-27T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
22539065,2012-04-27T00:00:00,Early Detection of Cancer,E01.390.500
22539065,2012-04-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22539065,2012-04-27T00:00:00,Middle Aged,M01.060.116.630
22539065,2012-04-27T00:00:00,"Physicians, Family",M01.526.485.810.770
22539065,2012-04-27T00:00:00,"Physicians, Family",N02.360.810.770
22539065,2012-04-27T00:00:00,United States,Z01.107.567.875
22540399,2012-04-27T00:00:00,Blood Pressure,E01.370.600.875.249
22540399,2012-04-27T00:00:00,Blood Pressure,G09.330.380.076
22540399,2012-04-27T00:00:00,Electric Stimulation,E05.723.402
22540399,2012-04-27T00:00:00,Functional Laterality,F02.830.297.425
22540399,2012-04-27T00:00:00,Functional Laterality,G11.561.225.425
22540399,2012-04-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22540399,2012-04-27T00:00:00,Hypertension,C14.907.489
22540399,2012-04-27T00:00:00,Medulla Oblongata,A08.186.211.132.810.406
22540399,2012-04-27T00:00:00,Medulla Oblongata,A08.186.211.865.467.500
22540399,2012-04-27T00:00:00,"Muscle, Smooth, Vascular",A02.633.570.491
22540399,2012-04-27T00:00:00,"Muscle, Smooth, Vascular",A07.231.491
22540399,2012-04-27T00:00:00,"Muscle, Smooth, Vascular",A10.690.467.491
22540399,2012-04-27T00:00:00,Neurosurgical Procedures,E04.525
22541586,2012-04-27T00:00:00,Alcohol Drinking,F01.145.317.269
22541586,2012-04-27T00:00:00,Ethanol,D02.033.375
22541586,2012-04-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22541586,2012-04-27T00:00:00,"Stress, Psychological",F01.145.126.990
22541586,2012-04-27T00:00:00,"Stress, Psychological",F02.830.900
22541652,2012-04-27T00:00:00,Cataract Extraction,E04.540.825.249
22541652,2012-04-27T00:00:00,"Child, Preschool",M01.060.406.448
22541652,2012-04-27T00:00:00,Double-Blind Method,E05.318.780.300
22541652,2012-04-27T00:00:00,Double-Blind Method,E05.581.500.300
22541652,2012-04-27T00:00:00,Double-Blind Method,N05.715.360.780.320
22541652,2012-04-27T00:00:00,Double-Blind Method,N06.850.520.445.300
22541652,2012-04-27T00:00:00,Enoxaparin,D09.698.373.400.300.200
22541652,2012-04-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22541652,2012-04-27T00:00:00,Infant,M01.060.703
22541652,2012-04-27T00:00:00,"Lens Implantation, Intraocular",E04.540.825.600
22541652,2012-04-27T00:00:00,Postoperative Complications,C23.550.767
22541660,2012-04-27T00:00:00,Adolescent,M01.060.057
22541660,2012-04-27T00:00:00,Cataract Extraction,E04.540.825.249
22541660,2012-04-27T00:00:00,Child,M01.060.406
22541660,2012-04-27T00:00:00,"Child, Preschool",M01.060.406.448
22541660,2012-04-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22541660,2012-04-27T00:00:00,"Lens Implantation, Intraocular",E04.540.825.600
22541957,2012-04-27T00:00:00,Adult,M01.060.116
22541957,2012-04-27T00:00:00,Aged,M01.060.116.100
22541957,2012-04-27T00:00:00,Antineoplastic Agents,D27.505.954.248
22541957,2012-04-27T00:00:00,Head and Neck Neoplasms,C04.588.443
22541957,2012-04-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22541957,2012-04-27T00:00:00,Middle Aged,M01.060.116.630
22541957,2012-04-27T00:00:00,Quality of Life,I01.800
22541957,2012-04-27T00:00:00,Quality of Life,K01.752.400.750
22541957,2012-04-27T00:00:00,Radiation Injuries,C21.866.733
22541957,2012-04-27T00:00:00,Radiation Injuries,N06.850.810.300.360
22548826,2012-04-28T00:00:00,Animals,B01.050
22548826,2012-04-28T00:00:00,Culicidae,B01.050.500.131.617.289.275
22548826,2012-04-28T00:00:00,Feeding Behavior,F01.145.113.547
22548826,2012-04-28T00:00:00,Feeding Behavior,F01.145.407
22548826,2012-04-28T00:00:00,Gastrointestinal Tract,A03.556
22548826,2012-04-28T00:00:00,Phylogeny,G05.697
22548826,2012-04-28T00:00:00,Phylogeny,G16.100.275.605
22548826,2012-04-28T00:00:00,Phylogeny,L01.100.697
22548826,2012-04-28T00:00:00,South Carolina,Z01.107.567.875.075.662
22548826,2012-04-28T00:00:00,South Carolina,Z01.107.567.875.750.700
22435954,2012-04-30T00:00:00,Adenoviridae,B04.280.030
22435954,2012-04-30T00:00:00,Adenoviridae,B04.909.204.097
22435954,2012-04-30T00:00:00,Animals,B01.050
22435954,2012-04-30T00:00:00,Cell Differentiation,G04.299.151
22435954,2012-04-30T00:00:00,Cell Movement,G04.299.283
22435954,2012-04-30T00:00:00,Cell Movement,G07.700.560.500.180
22435954,2012-04-30T00:00:00,Endothelial Cells,A11.436.275
22435954,2012-04-30T00:00:00,Genetic Vectors,G05.360.337
22435954,2012-04-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22435954,2012-04-30T00:00:00,Myocardial Contraction,G09.330.190.541
22435954,2012-04-30T00:00:00,Myocardial Contraction,G11.427.590.540.570
22435954,2012-04-30T00:00:00,Myocardial Infarction,C14.280.647.500
22435954,2012-04-30T00:00:00,Myocardial Infarction,C14.907.585.500
22435954,2012-04-30T00:00:00,Myocardium,A02.633.580
22435954,2012-04-30T00:00:00,Myocardium,A07.541.704
22435954,2012-04-30T00:00:00,Myocardium,A10.690.552.750
22435954,2012-04-30T00:00:00,"Myocytes, Cardiac",A07.541.704.570
22435954,2012-04-30T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
22435954,2012-04-30T00:00:00,"Myocytes, Cardiac",A11.620.500
22435954,2012-04-30T00:00:00,"Neovascularization, Physiologic",G09.330.190.751
22435954,2012-04-30T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
22435954,2012-04-30T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
22435954,2012-04-30T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
22435954,2012-04-30T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22435954,2012-04-30T00:00:00,Signal Transduction,G02.111.087.800
22435954,2012-04-30T00:00:00,Signal Transduction,G02.149.115.800
22435954,2012-04-30T00:00:00,Signal Transduction,G04.299.880
22435954,2012-04-30T00:00:00,Stem Cells,A11.872
22435954,2012-04-30T00:00:00,Tissue Kallikreins,D08.811.277.656.300.760.442.875
22435954,2012-04-30T00:00:00,Tissue Kallikreins,D08.811.277.656.959.350.442.875
22435954,2012-04-30T00:00:00,Tissue Kallikreins,D23.101.840.870
22545725,2012-04-30T00:00:00,Adolescent,M01.060.057
22545725,2012-04-30T00:00:00,Adult,M01.060.116
22545725,2012-04-30T00:00:00,Gonadal Steroid Hormones,D06.472.334.851
22545725,2012-04-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22545725,2012-04-30T00:00:00,Middle Aged,M01.060.116.630
22545725,2012-04-30T00:00:00,Ovary,A05.360.319.114.630
22545725,2012-04-30T00:00:00,Ovary,A05.360.576.497
22545725,2012-04-30T00:00:00,Ovary,A06.407.312.497
22545725,2012-04-30T00:00:00,Smoking,F01.145.466.753
22545725,2012-04-30T00:00:00,Young Adult,M01.060.116.815
22547777,2012-04-30T00:00:00,Adult,M01.060.116
22547777,2012-04-30T00:00:00,Health Surveys,E05.318.308.250
22547777,2012-04-30T00:00:00,Health Surveys,N05.715.360.300.375
22547777,2012-04-30T00:00:00,Health Surveys,N06.850.520.308.250
22547777,2012-04-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22547777,2012-04-30T00:00:00,Smoking,F01.145.466.753
22547777,2012-04-30T00:00:00,Smoking Cessation,F01.145.940.700
22547777,2012-04-30T00:00:00,Tobacco Use Disorder,C21.739.912
22547777,2012-04-30T00:00:00,Tobacco Use Disorder,F03.900.912
22547777,2012-04-30T00:00:00,United States,Z01.107.567.875
22236141,2012-05-01T00:00:00,Animals,B01.050
22236141,2012-05-01T00:00:00,Cell Line,A11.251.210
22236141,2012-05-01T00:00:00,Cytokines,D12.644.276.374
22236141,2012-05-01T00:00:00,Cytokines,D12.776.467.374
22236141,2012-05-01T00:00:00,Cytokines,D23.529.374
22236141,2012-05-01T00:00:00,Exosomes,A11.284.430.214.190.875.190.880.495
22236141,2012-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22236141,2012-05-01T00:00:00,"Lipoproteins, LDL",D10.532.515
22236141,2012-05-01T00:00:00,"Lipoproteins, LDL",D12.776.521.550
22236141,2012-05-01T00:00:00,Lysosomes,A11.284.430.214.190.875.190.550
22236141,2012-05-01T00:00:00,Macrophages,A11.329.372
22236141,2012-05-01T00:00:00,Macrophages,A11.627.482
22236141,2012-05-01T00:00:00,Macrophages,A11.733.397
22236141,2012-05-01T00:00:00,Macrophages,A15.382.680.397
22236141,2012-05-01T00:00:00,Macrophages,A15.382.812.522
22236141,2012-05-01T00:00:00,Sphingomyelin Phosphodiesterase,D08.811.277.352.640.750
22343347,2012-05-01T00:00:00,Gastrointestinal Hemorrhage,C06.405.227
22343347,2012-05-01T00:00:00,Gastrointestinal Hemorrhage,C23.550.414.788
22343347,2012-05-01T00:00:00,Hepatic Encephalopathy,C06.552.308.500.356
22343347,2012-05-01T00:00:00,Hepatic Encephalopathy,C10.228.140.163.360
22343347,2012-05-01T00:00:00,Hepatic Encephalopathy,C18.452.132.360
22343347,2012-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22343347,2012-05-01T00:00:00,Liver Cirrhosis,C06.552.630
22374321,2012-05-01T00:00:00,Acoustic Stimulation,E02.037
22374321,2012-05-01T00:00:00,Acoustic Stimulation,E02.190.888.030
22374321,2012-05-01T00:00:00,Acoustic Stimulation,E05.723.136
22374321,2012-05-01T00:00:00,Adult,M01.060.116
22374321,2012-05-01T00:00:00,Age Factors,N05.715.350.075
22374321,2012-05-01T00:00:00,Age Factors,N06.850.490.250
22374321,2012-05-01T00:00:00,Aged,M01.060.116.100
22374321,2012-05-01T00:00:00,Attention,F02.830.104.214
22374321,2012-05-01T00:00:00,Auditory Cortex,A08.186.211.730.885.287.500.863.297
22374321,2012-05-01T00:00:00,Cognition,F02.463.188
22374321,2012-05-01T00:00:00,Electroencephalography,E01.370.376.300
22374321,2012-05-01T00:00:00,Electroencephalography,E01.370.405.245
22374321,2012-05-01T00:00:00,"Evoked Potentials, Auditory",G07.265.500.370
22374321,2012-05-01T00:00:00,"Evoked Potentials, Auditory",G11.561.270.370
22374321,2012-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22374321,2012-05-01T00:00:00,Middle Aged,M01.060.116.630
22374321,2012-05-01T00:00:00,Noise,G01.595.907.567
22374321,2012-05-01T00:00:00,Noise,G16.500.275.600
22374321,2012-05-01T00:00:00,Noise,N06.230.400
22374321,2012-05-01T00:00:00,Noise,N06.850.460.610
22374321,2012-05-01T00:00:00,Presbycusis,C09.218.458.341.887.772
22374321,2012-05-01T00:00:00,Presbycusis,C10.597.751.418.341.887.772
22374321,2012-05-01T00:00:00,Presbycusis,C23.888.592.763.393.341.887.772
22374321,2012-05-01T00:00:00,Reaction Time,F02.830.650
22374321,2012-05-01T00:00:00,Reaction Time,F04.669.817
22374321,2012-05-01T00:00:00,Reaction Time,G11.561.677
22374321,2012-05-01T00:00:00,Young Adult,M01.060.116.815
22450176,2012-05-01T00:00:00,Biomedical Research,H01.770.644.145
22450176,2012-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22450176,2012-05-01T00:00:00,Internship and Residency,I02.358.399.644
22450176,2012-05-01T00:00:00,Orthopedics,H02.403.810.494
22450181,2012-05-01T00:00:00,Aged,M01.060.116.100
22450181,2012-05-01T00:00:00,Aging,G07.700.320.124
22450181,2012-05-01T00:00:00,Clinical Competence,I02.399.630.210
22450181,2012-05-01T00:00:00,Clinical Competence,N04.761.210
22450181,2012-05-01T00:00:00,"Faculty, Medical",I02.463.373
22450181,2012-05-01T00:00:00,"Faculty, Medical",M01.526.339.373
22450181,2012-05-01T00:00:00,"Faculty, Medical",M01.526.485.375
22450181,2012-05-01T00:00:00,"Faculty, Medical",N02.360.375
22450181,2012-05-01T00:00:00,Geriatrics,H02.403.355
22450181,2012-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22450181,2012-05-01T00:00:00,Internal Medicine,H02.403.429
22450181,2012-05-01T00:00:00,Internship and Residency,I02.358.399.644
22450181,2012-05-01T00:00:00,Program Evaluation,E05.337.820
22450181,2012-05-01T00:00:00,Program Evaluation,N04.761.685
22450181,2012-05-01T00:00:00,Program Evaluation,N05.715.360.650
22450181,2012-05-01T00:00:00,United States,Z01.107.567.875
22450893,2012-05-01T00:00:00,Acetylcysteine,D02.886.030.230.259
22450893,2012-05-01T00:00:00,Acetylcysteine,D12.125.166.230.259
22450893,2012-05-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
22450893,2012-05-01T00:00:00,Drug-Induced Liver Injury,C06.552.195
22450893,2012-05-01T00:00:00,Drug-Induced Liver Injury,C21.613.260
22450893,2012-05-01T00:00:00,Genome-Wide Association Study,E05.318.416.249
22450893,2012-05-01T00:00:00,Genome-Wide Association Study,E05.318.780.392
22450893,2012-05-01T00:00:00,Genome-Wide Association Study,E05.393.385.500
22450893,2012-05-01T00:00:00,Genome-Wide Association Study,E05.393.522.500
22450893,2012-05-01T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
22450893,2012-05-01T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
22450893,2012-05-01T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
22450893,2012-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22450893,2012-05-01T00:00:00,Risk Factors,E05.318.740.600.800.725
22450893,2012-05-01T00:00:00,Risk Factors,N05.715.350.200.700
22450893,2012-05-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22450893,2012-05-01T00:00:00,Risk Factors,N06.850.490.625.750
22450893,2012-05-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22450893,2012-05-01T00:00:00,United States,Z01.107.567.875
22471576,2012-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22471576,2012-05-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.519.625.600.850
22471576,2012-05-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.519.625.850.900
22471576,2012-05-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.696.577.600.850
22471576,2012-05-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.696.577.850.900
22471576,2012-05-01T00:00:00,Substance-Related Disorders,C21.739
22471576,2012-05-01T00:00:00,Substance-Related Disorders,F03.900
22473221,2012-05-01T00:00:00,Adolescent,M01.060.057
22473221,2012-05-01T00:00:00,Adult,M01.060.116
22473221,2012-05-01T00:00:00,African Americans,M01.686.508.100.100
22473221,2012-05-01T00:00:00,African Americans,M01.686.754.100
22473221,2012-05-01T00:00:00,Aged,M01.060.116.100
22473221,2012-05-01T00:00:00,Attitude to Health,F01.100.150
22473221,2012-05-01T00:00:00,Attitude to Health,N05.300.150
22473221,2012-05-01T00:00:00,Delivery of Health Care,N04.590.374
22473221,2012-05-01T00:00:00,Delivery of Health Care,N05.300
22473221,2012-05-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
22473221,2012-05-01T00:00:00,Genetic Testing,E01.370.427
22473221,2012-05-01T00:00:00,Genetic Testing,E05.393.435
22473221,2012-05-01T00:00:00,Genetic Testing,N02.421.143.827.233.221
22473221,2012-05-01T00:00:00,Genetic Testing,N02.421.308.430
22473221,2012-05-01T00:00:00,Health Policy,I01.880.604.825.608.400
22473221,2012-05-01T00:00:00,Health Policy,N03.706.825.608.428
22473221,2012-05-01T00:00:00,Health Services Accessibility,N04.590.374.350
22473221,2012-05-01T00:00:00,Health Services Accessibility,N05.300.430
22473221,2012-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22473221,2012-05-01T00:00:00,Middle Aged,M01.060.116.630
22473221,2012-05-01T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
22473221,2012-05-01T00:00:00,United States,Z01.107.567.875
22473221,2012-05-01T00:00:00,Young Adult,M01.060.116.815
22476157,2012-05-01T00:00:00,Drug-Induced Liver Injury,C06.552.195
22476157,2012-05-01T00:00:00,Drug-Induced Liver Injury,C21.613.260
22476157,2012-05-01T00:00:00,Gastroenterology,H02.403.429.405
22476157,2012-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22476157,2012-05-01T00:00:00,Liver Transplantation,E04.210.650
22476157,2012-05-01T00:00:00,Liver Transplantation,E04.936.450.490
22476157,2012-05-01T00:00:00,Liver Transplantation,E04.936.580.490
22494223,2012-05-01T00:00:00,Adult,M01.060.116
22494223,2012-05-01T00:00:00,Cues,F02.463.425.234
22494223,2012-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22494223,2012-05-01T00:00:00,Sex Factors,N05.715.350.675
22494223,2012-05-01T00:00:00,Sex Factors,N06.850.490.875
22494223,2012-05-01T00:00:00,Smoking,F01.145.466.753
22494223,2012-05-01T00:00:00,Smoking Cessation,F01.145.940.700
22494223,2012-05-01T00:00:00,"Stress, Psychological",F01.145.126.990
22494223,2012-05-01T00:00:00,"Stress, Psychological",F02.830.900
22494223,2012-05-01T00:00:00,Substance Withdrawal Syndrome,C21.739.835
22494223,2012-05-01T00:00:00,Substance Withdrawal Syndrome,F03.900.825
22494223,2012-05-01T00:00:00,Tobacco Use Disorder,C21.739.912
22494223,2012-05-01T00:00:00,Tobacco Use Disorder,F03.900.912
22494425,2012-05-01T00:00:00,Dementia,C10.228.140.380
22494425,2012-05-01T00:00:00,Dementia,F03.087.400
22494425,2012-05-01T00:00:00,Eating,G07.610.593.260
22494425,2012-05-01T00:00:00,Eating,G07.700.620.260
22494425,2012-05-01T00:00:00,Eating,G10.261.326.240
22494425,2012-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22507025,2012-05-01T00:00:00,Activities of Daily Living,E02.831.067
22507025,2012-05-01T00:00:00,Activities of Daily Living,I03.050
22507025,2012-05-01T00:00:00,Activities of Daily Living,N02.421.784.110
22507025,2012-05-01T00:00:00,Adolescent,M01.060.057
22507025,2012-05-01T00:00:00,Adult,M01.060.116
22507025,2012-05-01T00:00:00,Aged,M01.060.116.100
22507025,2012-05-01T00:00:00,Disability Evaluation,E01.370.400
22507025,2012-05-01T00:00:00,Health Surveys,E05.318.308.250
22507025,2012-05-01T00:00:00,Health Surveys,N05.715.360.300.375
22507025,2012-05-01T00:00:00,Health Surveys,N06.850.520.308.250
22507025,2012-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22507025,2012-05-01T00:00:00,Middle Aged,M01.060.116.630
22507025,2012-05-01T00:00:00,Self-Help Devices,E07.796
22507025,2012-05-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
22507025,2012-05-01T00:00:00,Spinal Cord Injuries,C10.900.850
22507025,2012-05-01T00:00:00,Spinal Cord Injuries,C21.866.819
22507025,2012-05-01T00:00:00,Walking,G11.427.590.530.568.900
22507025,2012-05-01T00:00:00,Walking,G11.427.590.530.698.940
22507025,2012-05-01T00:00:00,Walking,I03.450.642.845.940
22510854,2012-05-01T00:00:00,"Aorta, Thoracic",A07.231.114.056.372
22510854,2012-05-01T00:00:00,Blood Vessel Prosthesis Implantation,E04.100.814.200
22510854,2012-05-01T00:00:00,Blood Vessel Prosthesis Implantation,E04.650.200
22510854,2012-05-01T00:00:00,Cardiac Surgical Procedures,E04.100.376
22510854,2012-05-01T00:00:00,Cardiac Surgical Procedures,E04.928.220
22510854,2012-05-01T00:00:00,Cardiopulmonary Bypass,E04.292.413
22510854,2012-05-01T00:00:00,Diagnostic Imaging,E01.370.350
22510854,2012-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22510854,2012-05-01T00:00:00,Postoperative Complications,C23.550.767
22520309,2012-05-01T00:00:00,"Child, Preschool",M01.060.406.448
22520309,2012-05-01T00:00:00,Cornea,A09.371.060.217
22520309,2012-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22520309,2012-05-01T00:00:00,Infant,M01.060.703
22520309,2012-05-01T00:00:00,"Lens Capsule, Crystalline",A09.371.060.500.155
22520309,2012-05-01T00:00:00,"Lens Implantation, Intraocular",E04.540.825.600
22520309,2012-05-01T00:00:00,Treatment Outcome,E01.789.800
22520309,2012-05-01T00:00:00,Treatment Outcome,N04.761.559.590.800
22520309,2012-05-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22520309,2012-05-01T00:00:00,Visual Acuity,E01.370.380.850.950
22520309,2012-05-01T00:00:00,Visual Acuity,F02.463.593.932.901
22520309,2012-05-01T00:00:00,Visual Acuity,G14.940
22529128,2012-05-01T00:00:00,Animals,B01.050
22529128,2012-05-01T00:00:00,Bacterial Proteins,D12.776.097
22529128,2012-05-01T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
22529128,2012-05-01T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
22529128,2012-05-01T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
22529128,2012-05-01T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
22539395,2012-05-01T00:00:00,Adolescent,M01.060.057
22539395,2012-05-01T00:00:00,Adult,M01.060.116
22539395,2012-05-01T00:00:00,African Americans,M01.686.508.100.100
22539395,2012-05-01T00:00:00,African Americans,M01.686.754.100
22539395,2012-05-01T00:00:00,African Continental Ancestry Group,M01.686.508.100
22539395,2012-05-01T00:00:00,Aged,M01.060.116.100
22539395,2012-05-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
22539395,2012-05-01T00:00:00,Genetic Variation,G05.365
22539395,2012-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22539395,2012-05-01T00:00:00,Lung Diseases,C08.381
22539395,2012-05-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
22539395,2012-05-01T00:00:00,Lung Neoplasms,C08.381.540
22539395,2012-05-01T00:00:00,Lung Neoplasms,C08.785.520
22539395,2012-05-01T00:00:00,Middle Aged,M01.060.116.630
22539395,2012-05-01T00:00:00,Phenotype,G05.695
22539395,2012-05-01T00:00:00,Smoking,F01.145.466.753
22546106,2012-05-01T00:00:00,Colonic Neoplasms,C04.588.274.476.411.307.180
22546106,2012-05-01T00:00:00,Colonic Neoplasms,C06.301.371.411.307.180
22546106,2012-05-01T00:00:00,Colonic Neoplasms,C06.405.249.411.307.180
22546106,2012-05-01T00:00:00,Colonic Neoplasms,C06.405.469.158.356.180
22546106,2012-05-01T00:00:00,Colonic Neoplasms,C06.405.469.491.307.180
22546106,2012-05-01T00:00:00,Colonoscopy,E01.370.372.250.250.200
22546106,2012-05-01T00:00:00,Colonoscopy,E01.370.388.250.250.250.160
22546106,2012-05-01T00:00:00,Colonoscopy,E04.210.240.250.160
22546106,2012-05-01T00:00:00,Colonoscopy,E04.800.250.250.250.160
22546106,2012-05-01T00:00:00,"Diagnosis, Differential",E01.171
22546106,2012-05-01T00:00:00,"Diverticulitis, Colonic",C06.405.469.158.587.500
22546106,2012-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22546106,2012-05-01T00:00:00,Intestinal Fistula,C06.267.550
22546106,2012-05-01T00:00:00,Intestinal Fistula,C06.405.469.471
22546106,2012-05-01T00:00:00,Intestinal Fistula,C23.300.575.185.550
22546106,2012-05-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
22546106,2012-05-01T00:00:00,Lung Neoplasms,C08.381.540
22546106,2012-05-01T00:00:00,Lung Neoplasms,C08.785.520
22546106,2012-05-01T00:00:00,Positron-Emission Tomography,E01.370.350.350.800.700
22546106,2012-05-01T00:00:00,Positron-Emission Tomography,E01.370.350.600.350.800.399
22546106,2012-05-01T00:00:00,Positron-Emission Tomography,E01.370.350.710.800.399
22546106,2012-05-01T00:00:00,Positron-Emission Tomography,E01.370.350.825.800.399
22546106,2012-05-01T00:00:00,Positron-Emission Tomography,E01.370.384.730.800.399
22546106,2012-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
22546106,2012-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
22546106,2012-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
22546106,2012-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
22546106,2012-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
22546106,2012-05-01T00:00:00,Urinary Bladder Fistula,C12.706.881.312
22546106,2012-05-01T00:00:00,Urinary Bladder Fistula,C12.777.829.733
22546106,2012-05-01T00:00:00,Urinary Bladder Fistula,C13.351.875.881.312
22546106,2012-05-01T00:00:00,Urinary Bladder Fistula,C13.351.968.829.548
22546106,2012-05-01T00:00:00,Urinary Bladder Fistula,C23.300.575.825.250
22547046,2012-05-01T00:00:00,Demography,I01.240
22547046,2012-05-01T00:00:00,Demography,N01.224
22547046,2012-05-01T00:00:00,Demography,N06.850.505.400
22547046,2012-05-01T00:00:00,Employment,N01.824.245
22547046,2012-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22547046,2012-05-01T00:00:00,Patient Discharge,E02.760.400.610
22547046,2012-05-01T00:00:00,Patient Discharge,N02.421.585.400.610
22547046,2012-05-01T00:00:00,Risk Factors,E05.318.740.600.800.725
22547046,2012-05-01T00:00:00,Risk Factors,N05.715.350.200.700
22547046,2012-05-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22547046,2012-05-01T00:00:00,Risk Factors,N06.850.490.625.750
22547046,2012-05-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22547046,2012-05-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
22547046,2012-05-01T00:00:00,Spinal Cord Injuries,C10.900.850
22547046,2012-05-01T00:00:00,Spinal Cord Injuries,C21.866.819
22550312,2012-05-01T00:00:00,Aged,M01.060.116.100
22550312,2012-05-01T00:00:00,Bayes Theorem,E05.318.740.600.200
22550312,2012-05-01T00:00:00,Bayes Theorem,N05.715.360.750.625.150
22550312,2012-05-01T00:00:00,Bayes Theorem,N06.850.520.830.600.200
22550312,2012-05-01T00:00:00,"Diagnosis, Differential",E01.171
22550312,2012-05-01T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.500.150
22550312,2012-05-01T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.825.500.150
22550312,2012-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22550312,2012-05-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
22550312,2012-05-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
22550312,2012-05-01T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
22550312,2012-05-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
22550312,2012-05-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
22550312,2012-05-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
22550312,2012-05-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
22551611,2012-05-01T00:00:00,Down Syndrome,C10.597.606.643.220
22551611,2012-05-01T00:00:00,Down Syndrome,C16.131.077.327
22551611,2012-05-01T00:00:00,Down Syndrome,C16.131.260.260
22551611,2012-05-01T00:00:00,Down Syndrome,C16.320.180.260
22551611,2012-05-01T00:00:00,Head,A01.456
22551611,2012-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22551611,2012-05-01T00:00:00,Posture,G11.427.695
22554179,2012-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22554179,2012-05-01T00:00:00,Lactation,G08.686.702.500
22554179,2012-05-01T00:00:00,Lactation,G08.686.785.420
22554179,2012-05-01T00:00:00,"Milk, Human",A12.200.467
22554179,2012-05-01T00:00:00,"Milk, Human",J02.200.700.500
22554179,2012-05-01T00:00:00,"Milk, Human",J02.500.350.525.500
22554179,2012-05-01T00:00:00,Pregnancy,G08.686.785.760.769
22554179,2012-05-01T00:00:00,Pregnancy Complications,C13.703
22554179,2012-05-01T00:00:00,Vitamin D,D04.808.812.768
22554179,2012-05-01T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
22554428,2012-05-01T00:00:00,"Adaptation, Psychological",F01.058
22554428,2012-05-01T00:00:00,Adolescent,M01.060.057
22554428,2012-05-01T00:00:00,Adult,M01.060.116
22554428,2012-05-01T00:00:00,Aged,M01.060.116.100
22554428,2012-05-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
22554428,2012-05-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
22554428,2012-05-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
22554428,2012-05-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
22554428,2012-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22554428,2012-05-01T00:00:00,Middle Aged,M01.060.116.630
22554428,2012-05-01T00:00:00,Patient Compliance,F01.145.488.500
22554428,2012-05-01T00:00:00,Patient Compliance,N05.300.150.600.600
22554428,2012-05-01T00:00:00,Self Care,E02.900
22554428,2012-05-01T00:00:00,Self Care,N02.421.784.680
22554428,2012-05-01T00:00:00,Young Adult,M01.060.116.815
22568896,2012-05-01T00:00:00,Animals,B01.050
22568896,2012-05-01T00:00:00,Calpain,D08.811.277.656.262.500.120
22568896,2012-05-01T00:00:00,Calpain,D08.811.277.656.300.200.120
22568896,2012-05-01T00:00:00,Chronic Disease,C23.550.291.500
22568896,2012-05-01T00:00:00,Down-Regulation,G02.111.087.225
22568896,2012-05-01T00:00:00,Down-Regulation,G02.149.115.225
22568896,2012-05-01T00:00:00,Down-Regulation,G05.355.315.200
22568896,2012-05-01T00:00:00,Down-Regulation,G07.690.812.230
22568896,2012-05-01T00:00:00,Down-Regulation,G07.700.680.230
22568896,2012-05-01T00:00:00,Hyperglycemia,C18.452.394.952
22568896,2012-05-01T00:00:00,Insulin,D06.472.699.587.740.625
22568896,2012-05-01T00:00:00,Insulin,D12.644.548.586.740.625
22568896,2012-05-01T00:00:00,Kidney,A05.810.453
22568896,2012-05-01T00:00:00,Mitochondria,A11.284.430.214.190.875.564
22568896,2012-05-01T00:00:00,Mitochondria,A11.284.835.626
22568896,2012-05-01T00:00:00,"RNA, Messenger",D13.444.735.544
22568896,2012-05-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22568896,2012-05-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
22568896,2012-05-01T00:00:00,Time Factors,G01.910.857
22592008,2012-05-01T00:00:00,Heart Ventricles,A07.541.560
22592008,2012-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22592008,2012-05-01T00:00:00,Inflammation,C23.550.470
22592008,2012-05-01T00:00:00,Insulin Resistance,C18.452.394.968.500
22592008,2012-05-01T00:00:00,Insulin Resistance,G07.690.320.617
22592008,2012-05-01T00:00:00,Obesity,C18.654.726.500
22592008,2012-05-01T00:00:00,Obesity,C23.888.144.699.500
22592008,2012-05-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
22592008,2012-05-01T00:00:00,Obesity,G07.100.100.160.120.699.500
22592008,2012-05-01T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
22623591,2012-05-01T00:00:00,Community Networks,I01.880.656.300
22623591,2012-05-01T00:00:00,Community Networks,L01.700.508.300.184
22623591,2012-05-01T00:00:00,Community Networks,N02.421.143.202
22623591,2012-05-01T00:00:00,Continuity of Patient Care,N04.590.233.727.210
22623591,2012-05-01T00:00:00,Early Detection of Cancer,E01.390.500
22623591,2012-05-01T00:00:00,Health Services Research,N03.349.380
22623591,2012-05-01T00:00:00,Health Services Research,N05.425
22623591,2012-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22623591,2012-05-01T00:00:00,Individualized Medicine,E02.574
22623591,2012-05-01T00:00:00,Individualized Medicine,H02.403.200.700
22623591,2012-05-01T00:00:00,Life Style,F01.829.458
22623591,2012-05-01T00:00:00,Medicare,N03.219.521.346.506.564.663
22623591,2012-05-01T00:00:00,Medicare,N03.219.521.576.343.840
22623591,2012-05-01T00:00:00,Medicare,N03.706.615.696
22623591,2012-05-01T00:00:00,Neoplasms,C04
22623591,2012-05-01T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
22623591,2012-05-01T00:00:00,Patient Care Team,N04.590.715
22623591,2012-05-01T00:00:00,Primary Prevention,N02.421.726.758
22623591,2012-05-01T00:00:00,Primary Prevention,N06.850.780.680
22623591,2012-05-01T00:00:00,Quality of Health Care,N04.761
22623591,2012-05-01T00:00:00,Quality of Health Care,N05.715
22623591,2012-05-01T00:00:00,Social Environment,I01.880.656
22623591,2012-05-01T00:00:00,Social Support,I01.880.656.600
22623591,2012-05-01T00:00:00,United States,Z01.107.567.875
22623591,2012-05-01T00:00:00,Unnecessary Procedures,N02.421.380.900
22623591,2012-05-01T00:00:00,Unnecessary Procedures,N05.300.150.395.900
22642634,2012-05-01T00:00:00,Cardiac Surgical Procedures,E04.100.376
22642634,2012-05-01T00:00:00,Cardiac Surgical Procedures,E04.928.220
22642634,2012-05-01T00:00:00,Conflict of Interest,K01.316.130
22642634,2012-05-01T00:00:00,Conflict of Interest,N05.350.225
22642634,2012-05-01T00:00:00,Decision Making,F02.463.785.373
22642634,2012-05-01T00:00:00,"Ethics, Medical",K01.316.333.132.750
22642634,2012-05-01T00:00:00,"Ethics, Medical",N05.350.340.162.500
22642634,2012-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22642634,2012-05-01T00:00:00,Informed Consent,I01.880.604.473.650.718
22642634,2012-05-01T00:00:00,Informed Consent,I01.880.604.583.427
22642634,2012-05-01T00:00:00,Informed Consent,N03.706.437.650.312
22642634,2012-05-01T00:00:00,Informed Consent,N03.706.535.489
22642634,2012-05-01T00:00:00,Physicians,M01.526.485.810
22642634,2012-05-01T00:00:00,Physicians,N02.360.810
22642634,2012-05-01T00:00:00,Thoracic Surgery,H02.403.810.803
22643555,2012-05-01T00:00:00,African Americans,M01.686.508.100.100
22643555,2012-05-01T00:00:00,African Americans,M01.686.754.100
22643555,2012-05-01T00:00:00,Breast Neoplasms,C04.588.180
22643555,2012-05-01T00:00:00,Breast Neoplasms,C17.800.090.500
22643555,2012-05-01T00:00:00,Community Networks,I01.880.656.300
22643555,2012-05-01T00:00:00,Community Networks,L01.700.508.300.184
22643555,2012-05-01T00:00:00,Community Networks,N02.421.143.202
22643555,2012-05-01T00:00:00,Cooperative Behavior,F01.145.813.115
22643555,2012-05-01T00:00:00,Evidence-Based Medicine,H02.249.750
22643555,2012-05-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
22643555,2012-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22643555,2012-05-01T00:00:00,Organizational Objectives,N04.452.615
22643555,2012-05-01T00:00:00,Program Evaluation,E05.337.820
22643555,2012-05-01T00:00:00,Program Evaluation,N04.761.685
22643555,2012-05-01T00:00:00,Program Evaluation,N05.715.360.650
22643555,2012-05-01T00:00:00,"Schools, Medical",I02.783.660.552
22643555,2012-05-01T00:00:00,"Schools, Medical",N02.278.020.578
22643555,2012-05-01T00:00:00,Uterine Cervical Neoplasms,C04.588.945.418.948.850
22643555,2012-05-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.593.131
22643555,2012-05-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.762.850
22643555,2012-05-01T00:00:00,Uterine Cervical Neoplasms,C13.351.937.418.875.850
22643946,2012-05-01T00:00:00,Bacterial Infections,C01.252
22643946,2012-05-01T00:00:00,Chronic Disease,C23.550.291.500
22643946,2012-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22643946,2012-05-01T00:00:00,Paranasal Sinuses,A04.531.621
22643946,2012-05-01T00:00:00,Patient Education as Topic,I02.233.332.500
22643946,2012-05-01T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
22643946,2012-05-01T00:00:00,Patient Education as Topic,N02.421.726.407.680
22643946,2012-05-01T00:00:00,Pseudomonas aeruginosa,B03.440.400.425.625.625.100
22643946,2012-05-01T00:00:00,Pseudomonas aeruginosa,B03.660.250.580.590.050
22643946,2012-05-01T00:00:00,Rhinitis,C08.460.799
22643946,2012-05-01T00:00:00,Rhinitis,C08.730.674
22643946,2012-05-01T00:00:00,Rhinitis,C09.603.799
22643946,2012-05-01T00:00:00,Sinusitis,C08.460.692.752
22643946,2012-05-01T00:00:00,Sinusitis,C08.730.749
22643946,2012-05-01T00:00:00,Sinusitis,C09.603.692.752
22643946,2012-05-01T00:00:00,Staphylococcus aureus,B03.300.390.400.800.750.100
22643946,2012-05-01T00:00:00,Staphylococcus aureus,B03.510.100.750.750.100
22643946,2012-05-01T00:00:00,Staphylococcus aureus,B03.510.400.790.750.100
22645873,2012-05-01T00:00:00,Hospitalists,M01.526.485.630.490.400
22645873,2012-05-01T00:00:00,Hospitalists,M01.526.485.740.422.400
22645873,2012-05-01T00:00:00,Hospitalists,M01.526.485.810.580
22645873,2012-05-01T00:00:00,Hospitalists,N02.360.630.490.400
22645873,2012-05-01T00:00:00,Hospitalists,N02.360.740.422.400
22645873,2012-05-01T00:00:00,Hospitalists,N02.360.810.580
22645873,2012-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22645873,2012-05-01T00:00:00,Military Medicine,H02.403.500
22645873,2012-05-01T00:00:00,War,I01.880.735.944
22673241,2012-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22673241,2012-05-01T00:00:00,Incidence,E05.318.308.985.525.375
22673241,2012-05-01T00:00:00,Incidence,L01.280.975.525.375
22673241,2012-05-01T00:00:00,Incidence,N01.224.935.597.500
22673241,2012-05-01T00:00:00,Incidence,N06.850.505.400.975.525.375
22673241,2012-05-01T00:00:00,Incidence,N06.850.520.308.985.525.375
22673241,2012-05-01T00:00:00,Intensive Care Units,N02.278.388.493
22673241,2012-05-01T00:00:00,Length of Stay,E02.760.400.480
22673241,2012-05-01T00:00:00,Length of Stay,N02.421.585.400.480
22673241,2012-05-01T00:00:00,Middle Aged,M01.060.116.630
22673241,2012-05-01T00:00:00,"Pneumonia, Ventilator-Associated",C01.539.248.500
22673241,2012-05-01T00:00:00,"Pneumonia, Ventilator-Associated",C08.381.520.750.750
22673241,2012-05-01T00:00:00,"Pneumonia, Ventilator-Associated",C08.381.677.800
22673241,2012-05-01T00:00:00,"Pneumonia, Ventilator-Associated",C08.730.610.750
22673241,2012-05-01T00:00:00,"Quality Assurance, Health Care",N04.761.700
22673241,2012-05-01T00:00:00,"Quality Assurance, Health Care",N05.700
22673241,2012-05-01T00:00:00,Risk Factors,E05.318.740.600.800.725
22673241,2012-05-01T00:00:00,Risk Factors,N05.715.350.200.700
22673241,2012-05-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22673241,2012-05-01T00:00:00,Risk Factors,N06.850.490.625.750
22673241,2012-05-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22673241,2012-05-01T00:00:00,Trauma Centers,N02.278.354.422.336.500
22673241,2012-05-01T00:00:00,Trauma Centers,N02.421.297.195.480
22673241,2012-05-01T00:00:00,Trauma Centers,N04.452.442.422.336.400
22673241,2012-05-01T00:00:00,United States,Z01.107.567.875
22673264,2012-05-01T00:00:00,Adult,M01.060.116
22673264,2012-05-01T00:00:00,Brain Injuries,C10.228.140.199
22673264,2012-05-01T00:00:00,Brain Injuries,C10.900.300.087
22673264,2012-05-01T00:00:00,Brain Injuries,C21.866.260.118
22673264,2012-05-01T00:00:00,Brain Injuries,C21.866.915.300.200
22673264,2012-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22673264,2012-05-01T00:00:00,"Monitoring, Physiologic",E01.370.520
22673264,2012-05-01T00:00:00,Oxygen,D01.268.185.550
22673264,2012-05-01T00:00:00,Oxygen,D01.362.670
22673264,2012-05-01T00:00:00,Oxygen Consumption,G03.730
22673264,2012-05-01T00:00:00,Time Factors,G01.910.857
22673264,2012-05-01T00:00:00,United States,Z01.107.567.875
22691329,2012-05-01T00:00:00,"Biopsy, Needle",E01.370.388.100.100
22691329,2012-05-01T00:00:00,"Biopsy, Needle",E01.450.230.100.100
22691329,2012-05-01T00:00:00,"Biopsy, Needle",E01.450.865.100.100
22691329,2012-05-01T00:00:00,"Biopsy, Needle",E01.450.865.632.100
22691329,2012-05-01T00:00:00,"Biopsy, Needle",E04.074.119
22691329,2012-05-01T00:00:00,Combined Modality Therapy,E02.186
22691329,2012-05-01T00:00:00,"Diverticulitis, Colonic",C06.405.469.158.587.500
22691329,2012-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22691329,2012-05-01T00:00:00,Intestinal Fistula,C06.267.550
22691329,2012-05-01T00:00:00,Intestinal Fistula,C06.405.469.471
22691329,2012-05-01T00:00:00,Intestinal Fistula,C23.300.575.185.550
22691329,2012-05-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
22691329,2012-05-01T00:00:00,Lung Neoplasms,C08.381.540
22691329,2012-05-01T00:00:00,Lung Neoplasms,C08.785.520
22691329,2012-05-01T00:00:00,Neoplasm Staging,E01.370.550
22691329,2012-05-01T00:00:00,Positron-Emission Tomography,E01.370.350.350.800.700
22691329,2012-05-01T00:00:00,Positron-Emission Tomography,E01.370.350.600.350.800.399
22691329,2012-05-01T00:00:00,Positron-Emission Tomography,E01.370.350.710.800.399
22691329,2012-05-01T00:00:00,Positron-Emission Tomography,E01.370.350.825.800.399
22691329,2012-05-01T00:00:00,Positron-Emission Tomography,E01.370.384.730.800.399
22691329,2012-05-01T00:00:00,Radiotherapy Dosage,E02.815.639
22691329,2012-05-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
22691329,2012-05-01T00:00:00,Risk Assessment,N04.452.871.715
22691329,2012-05-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
22691329,2012-05-01T00:00:00,Risk Assessment,N06.850.505.715
22691329,2012-05-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
22691329,2012-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
22691329,2012-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
22691329,2012-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
22691329,2012-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
22691329,2012-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
22691329,2012-05-01T00:00:00,Treatment Outcome,E01.789.800
22691329,2012-05-01T00:00:00,Treatment Outcome,N04.761.559.590.800
22691329,2012-05-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22691329,2012-05-01T00:00:00,Urinary Bladder Fistula,C12.706.881.312
22691329,2012-05-01T00:00:00,Urinary Bladder Fistula,C12.777.829.733
22691329,2012-05-01T00:00:00,Urinary Bladder Fistula,C13.351.875.881.312
22691329,2012-05-01T00:00:00,Urinary Bladder Fistula,C13.351.968.829.548
22691329,2012-05-01T00:00:00,Urinary Bladder Fistula,C23.300.575.825.250
22724273,2012-05-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
22724273,2012-05-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
22724273,2012-05-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
22724273,2012-05-01T00:00:00,Bronchoscopy,E01.370.386.105
22724273,2012-05-01T00:00:00,Bronchoscopy,E01.370.388.250.100
22724273,2012-05-01T00:00:00,Bronchoscopy,E04.800.250.100
22724273,2012-05-01T00:00:00,Bronchoscopy,E04.928.600.080
22724273,2012-05-01T00:00:00,Child,M01.060.406
22724273,2012-05-01T00:00:00,Cyclophosphamide,D02.455.526.728.650.730.243
22724273,2012-05-01T00:00:00,Cyclophosphamide,D02.705.670.243
22724273,2012-05-01T00:00:00,Glucocorticoids,D06.472.040.543
22724273,2012-05-01T00:00:00,Glucocorticoids,D27.505.696.399.472.488
22724273,2012-05-01T00:00:00,"Herpesvirus 4, Human",B04.280.382.400.500.450
22724273,2012-05-01T00:00:00,"Herpesvirus 4, Human",B04.909.204.210.400.500.400
22724273,2012-05-01T00:00:00,"Herpesvirus 4, Human",B04.909.204.382.400.500.400
22724273,2012-05-01T00:00:00,"Herpesvirus 4, Human",B04.909.574.204.500.500.400
22724273,2012-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22724273,2012-05-01T00:00:00,"Immunoglobulins, Intravenous",D12.776.124.486.485.114.619.393.536
22724273,2012-05-01T00:00:00,"Immunoglobulins, Intravenous",D12.776.124.486.485.114.632
22724273,2012-05-01T00:00:00,"Immunoglobulins, Intravenous",D12.776.124.790.651.114.632
22724273,2012-05-01T00:00:00,"Immunoglobulins, Intravenous",D12.776.377.715.548.114.632
22724273,2012-05-01T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
22724273,2012-05-01T00:00:00,Kidney Transplantation,E02.870.500
22724273,2012-05-01T00:00:00,Kidney Transplantation,E04.936.450.485
22724273,2012-05-01T00:00:00,Kidney Transplantation,E04.950.774.400
22724273,2012-05-01T00:00:00,Larynx,A04.329
22724273,2012-05-01T00:00:00,Nephrectomy,E04.950.774.435
22724273,2012-05-01T00:00:00,Trachea,A04.889
22724273,2012-05-01T00:00:00,Treatment Outcome,E01.789.800
22724273,2012-05-01T00:00:00,Treatment Outcome,N04.761.559.590.800
22724273,2012-05-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22751813,2012-05-01T00:00:00,Cooperative Behavior,F01.145.813.115
22751813,2012-05-01T00:00:00,"Education, Medical",I02.358.399
22751813,2012-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22751813,2012-05-01T00:00:00,Interdisciplinary Communication,F01.145.209.381
22751813,2012-05-01T00:00:00,Interdisciplinary Communication,F01.829.401.205.249
22751813,2012-05-01T00:00:00,Interdisciplinary Communication,L01.143.474
22751813,2012-05-01T00:00:00,Patient Care Team,N04.590.715
22751813,2012-05-01T00:00:00,Psychiatry,F04.096.544
22751813,2012-05-01T00:00:00,Psychiatry,H02.403.690
22519294,2012-05-02T00:00:00,Binding Sites,G02.111.570.120
22519294,2012-05-02T00:00:00,Biosensing Techniques,E05.601.123
22519294,2012-05-02T00:00:00,"Hemagglutinin Glycoproteins, Influenza Virus",D12.776.964.970.880.345.500
22519294,2012-05-02T00:00:00,Lactose,D09.698.629.305.340
22519294,2012-05-02T00:00:00,Polymers,D05.750
22519294,2012-05-02T00:00:00,Polymers,D25.720
22519294,2012-05-02T00:00:00,Polymers,J01.637.051.720
22519294,2012-05-02T00:00:00,Sialic Acids,D02.241.081.844.562.668
22519294,2012-05-02T00:00:00,Sialic Acids,D02.241.511.902.562.668
22519294,2012-05-02T00:00:00,Sialic Acids,D09.067.687.668
22519294,2012-05-02T00:00:00,Sialic Acids,D09.811.589.668
22519294,2012-05-02T00:00:00,Sialyltransferases,D08.811.913.400.800
22551004,2012-05-02T00:00:00,Animals,B01.050
22551004,2012-05-02T00:00:00,Biological Markers,D23.101
22551004,2012-05-02T00:00:00,Cell Death,G04.299.139
22551004,2012-05-02T00:00:00,Central Nervous System Depressants,D27.505.696.277
22551004,2012-05-02T00:00:00,Central Nervous System Depressants,D27.505.954.427.210
22551004,2012-05-02T00:00:00,"Disease Models, Animal",C22.232
22551004,2012-05-02T00:00:00,"Disease Models, Animal",E05.598.500
22551004,2012-05-02T00:00:00,"Disease Models, Animal",E05.599.395.080
22551004,2012-05-02T00:00:00,Ethanol,D02.033.375
22551004,2012-05-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22551004,2012-05-02T00:00:00,"Liver Diseases, Alcoholic",C06.552.645
22551004,2012-05-02T00:00:00,"Liver Diseases, Alcoholic",C21.739.100.087.645
22551004,2012-05-02T00:00:00,"Mitochondria, Liver",A11.284.430.214.190.875.564.461
22551004,2012-05-02T00:00:00,"Mitochondria, Liver",A11.284.835.626.461
22551004,2012-05-02T00:00:00,Proteins,D12.776
22551004,2012-05-02T00:00:00,Signal Transduction,G02.111.087.800
22551004,2012-05-02T00:00:00,Signal Transduction,G02.149.115.800
22551004,2012-05-02T00:00:00,Signal Transduction,G04.299.880
22551004,2012-05-02T00:00:00,Toll-Like Receptors,D12.776.543.750.705.910.500
22551036,2012-05-02T00:00:00,Adult,M01.060.116
22551036,2012-05-02T00:00:00,Aged,M01.060.116.100
22551036,2012-05-02T00:00:00,Alcohol Drinking,F01.145.317.269
22551036,2012-05-02T00:00:00,Alcoholism,C21.739.100.250
22551036,2012-05-02T00:00:00,Alcoholism,F03.900.100.350
22551036,2012-05-02T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.157.530.450.625.124
22551036,2012-05-02T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.157.530.562.374.500.500
22551036,2012-05-02T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.543.585.450.625.124
22551036,2012-05-02T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.543.585.562.374.500.500
22551036,2012-05-02T00:00:00,Double-Blind Method,E05.318.780.300
22551036,2012-05-02T00:00:00,Double-Blind Method,E05.581.500.300
22551036,2012-05-02T00:00:00,Double-Blind Method,N05.715.360.780.320
22551036,2012-05-02T00:00:00,Double-Blind Method,N06.850.520.445.300
22551036,2012-05-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22551036,2012-05-02T00:00:00,Middle Aged,M01.060.116.630
22551036,2012-05-02T00:00:00,Naltrexone,D03.132.577.249.706.550
22551036,2012-05-02T00:00:00,Naltrexone,D03.549.686.750.550
22551036,2012-05-02T00:00:00,Naltrexone,D03.605.497.750.550
22551036,2012-05-02T00:00:00,Naltrexone,D04.615.723.795.706.550
22551036,2012-05-02T00:00:00,Narcotic Antagonists,D27.505.696.543
22551036,2012-05-02T00:00:00,Narcotic Antagonists,D27.505.696.663.850.512
22551036,2012-05-02T00:00:00,Narcotic Antagonists,D27.505.954.427.550
22551036,2012-05-02T00:00:00,Social Environment,I01.880.656
22551036,2012-05-02T00:00:00,Treatment Outcome,E01.789.800
22551036,2012-05-02T00:00:00,Treatment Outcome,N04.761.559.590.800
22551036,2012-05-02T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22551036,2012-05-02T00:00:00,Young Adult,M01.060.116.815
22551231,2012-05-02T00:00:00,Alcohol Deterrents,D27.505.954.427.020
22551231,2012-05-02T00:00:00,Alcohol Drinking,F01.145.317.269
22551231,2012-05-02T00:00:00,Alcoholism,C21.739.100.250
22551231,2012-05-02T00:00:00,Alcoholism,F03.900.100.350
22551231,2012-05-02T00:00:00,Behavior Therapy,F04.754.137
22551231,2012-05-02T00:00:00,Combined Modality Therapy,E02.186
22551231,2012-05-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22551231,2012-05-02T00:00:00,Markov Chains,E05.318.740.600.500
22551231,2012-05-02T00:00:00,Markov Chains,E05.318.740.996.500
22551231,2012-05-02T00:00:00,Markov Chains,G17.830.500
22551231,2012-05-02T00:00:00,Markov Chains,N05.715.360.750.625.500
22551231,2012-05-02T00:00:00,Markov Chains,N05.715.360.750.770.500
22551231,2012-05-02T00:00:00,Markov Chains,N06.850.520.830.600.500
22551231,2012-05-02T00:00:00,Markov Chains,N06.850.520.830.996.500
22551231,2012-05-02T00:00:00,Naltrexone,D03.132.577.249.706.550
22551231,2012-05-02T00:00:00,Naltrexone,D03.549.686.750.550
22551231,2012-05-02T00:00:00,Naltrexone,D03.605.497.750.550
22551231,2012-05-02T00:00:00,Naltrexone,D04.615.723.795.706.550
22551231,2012-05-02T00:00:00,Quality of Life,I01.800
22551231,2012-05-02T00:00:00,Quality of Life,K01.752.400.750
22551231,2012-05-02T00:00:00,Taurine,D02.455.326.146.100.850
22551231,2012-05-02T00:00:00,Taurine,D02.886.645.600.055.850
22551231,2012-05-02T00:00:00,Treatment Outcome,E01.789.800
22551231,2012-05-02T00:00:00,Treatment Outcome,N04.761.559.590.800
22551231,2012-05-02T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22553242,2012-05-02T00:00:00,Bacteria,B03
22553242,2012-05-02T00:00:00,"Colony Count, Microbial",E05.200.875.220
22553242,2012-05-02T00:00:00,Copper,D01.268.556.195
22553242,2012-05-02T00:00:00,Copper,D01.268.956.170
22553242,2012-05-02T00:00:00,Copper,D01.552.544.195
22553242,2012-05-02T00:00:00,Disinfectants,D27.505.954.122.425
22553242,2012-05-02T00:00:00,Disinfectants,D27.720.274
22553242,2012-05-02T00:00:00,Disinfection,N06.850.780.200.450.850.375
22553242,2012-05-02T00:00:00,Environmental Microbiology,H01.158.273.540.274
22553242,2012-05-02T00:00:00,Environmental Microbiology,N06.850.425
22553242,2012-05-02T00:00:00,Hospitals,N02.278.421
22553242,2012-05-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22579583,2012-05-02T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
22579583,2012-05-02T00:00:00,Bacteriophages,B04.123
22579583,2012-05-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22579583,2012-05-02T00:00:00,Luminescent Measurements,E05.196.712.516
22579583,2012-05-02T00:00:00,Yersinia pestis,B03.440.450.425.900.600
22579583,2012-05-02T00:00:00,Yersinia pestis,B03.660.250.150.950.580
22580232,2012-05-02T00:00:00,Age Factors,N05.715.350.075
22580232,2012-05-02T00:00:00,Age Factors,N06.850.490.250
22580232,2012-05-02T00:00:00,Animals,B01.050
22580232,2012-05-02T00:00:00,"Animals, Newborn",B01.050.050.282
22580232,2012-05-02T00:00:00,Attention Deficit Disorder with Hyperactivity,F03.550.150.150
22580232,2012-05-02T00:00:00,Body Weight,C23.888.144
22580232,2012-05-02T00:00:00,Body Weight,E01.370.600.115.100.160.120
22580232,2012-05-02T00:00:00,Body Weight,E05.041.124.160.750
22580232,2012-05-02T00:00:00,Body Weight,G07.100.100.160.120
22580232,2012-05-02T00:00:00,Body Weight,G07.700.320.249.314.120
22580232,2012-05-02T00:00:00,Central Nervous System Stimulants,D27.505.696.282
22580232,2012-05-02T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
22580232,2012-05-02T00:00:00,"Disease Models, Animal",C22.232
22580232,2012-05-02T00:00:00,"Disease Models, Animal",E05.598.500
22580232,2012-05-02T00:00:00,"Disease Models, Animal",E05.599.395.080
22580232,2012-05-02T00:00:00,Dopamine,D02.092.211.215.311.342
22580232,2012-05-02T00:00:00,Dopamine,D02.092.311.342
22580232,2012-05-02T00:00:00,Methylphenidate,D02.241.223.601.600
22580232,2012-05-02T00:00:00,Methylphenidate,D03.383.621.460
22580232,2012-05-02T00:00:00,Motor Activity,F01.145.632
22580232,2012-05-02T00:00:00,Motor Activity,G11.427.590.530.698
22580232,2012-05-02T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
22580232,2012-05-02T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22580232,2012-05-02T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
22580232,2012-05-02T00:00:00,Social Isolation,F01.145.813.781
22580232,2012-05-02T00:00:00,Social Isolation,I01.880.683
22580232,2012-05-02T00:00:00,Synaptosomes,A11.284.835.859
22726859,2012-05-02T00:00:00,Adolescent,M01.060.057
22726859,2012-05-02T00:00:00,Autistic Disorder,F03.550.325.125
22726859,2012-05-02T00:00:00,Centers for Disease Control and Prevention (U.S.),I01.409.137.500.600.650.225
22726859,2012-05-02T00:00:00,Centers for Disease Control and Prevention (U.S.),N03.540.348.500.500.600.650.225
22726859,2012-05-02T00:00:00,Child,M01.060.406
22726859,2012-05-02T00:00:00,"Child Development Disorders, Pervasive",F03.550.325
22726859,2012-05-02T00:00:00,Developmental Disabilities,F03.550.362
22726859,2012-05-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22726859,2012-05-02T00:00:00,Population Surveillance,E05.318.308.250.700
22726859,2012-05-02T00:00:00,Population Surveillance,N05.715.360.300.375.625
22726859,2012-05-02T00:00:00,Population Surveillance,N06.850.520.308.250.700
22726859,2012-05-02T00:00:00,Population Surveillance,N06.850.780.675
22726859,2012-05-02T00:00:00,South Carolina,Z01.107.567.875.075.662
22726859,2012-05-02T00:00:00,South Carolina,Z01.107.567.875.750.700
22726859,2012-05-02T00:00:00,United States,Z01.107.567.875
22552763,2012-05-03T00:00:00,Aged,M01.060.116.100
22552763,2012-05-03T00:00:00,"Arthroplasty, Replacement, Hip",E04.555.110.110.110
22552763,2012-05-03T00:00:00,"Arthroplasty, Replacement, Hip",E04.650.110.110
22552763,2012-05-03T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
22552763,2012-05-03T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
22552763,2012-05-03T00:00:00,Drug Interactions,G07.690.812.240
22552763,2012-05-03T00:00:00,Drug Interactions,G07.700.680.240
22552763,2012-05-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22552763,2012-05-03T00:00:00,Middle Aged,M01.060.116.630
22552763,2012-05-03T00:00:00,Pyridines,D03.383.725
22931479,2012-05-03T00:00:00,Advanced Practice Nursing,H02.478.676.074
22931479,2012-05-03T00:00:00,"Education, Nursing",I02.358.462
22931479,2012-05-03T00:00:00,Educational Technology,J01.897.280
22931479,2012-05-03T00:00:00,Family Nursing,H02.478.676.218
22931479,2012-05-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22931479,2012-05-03T00:00:00,Manikins,J01.897.280.500.545.129.400
22931479,2012-05-03T00:00:00,Manikins,L01.178.820.090.545.129.400
22931479,2012-05-03T00:00:00,Professional Competence,I02.399.630
22931479,2012-05-03T00:00:00,"Students, Nursing",I02.851.686.685
22931479,2012-05-03T00:00:00,"Students, Nursing",M01.848.769.685
22931479,2012-05-03T00:00:00,Teaching,I02.903
22560810,2012-05-04T00:00:00,Aged,M01.060.116.100
22560810,2012-05-04T00:00:00,Antihypertensive Agents,D27.505.954.411.162
22560810,2012-05-04T00:00:00,Cerebral Hemorrhage,C10.228.140.300.535.200
22560810,2012-05-04T00:00:00,Cerebral Hemorrhage,C14.907.253.573.200
22560810,2012-05-04T00:00:00,Cerebral Hemorrhage,C23.550.414.913.100
22560810,2012-05-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22560810,2012-05-04T00:00:00,Middle Aged,M01.060.116.630
22561021,2012-05-04T00:00:00,Adult,M01.060.116
22561021,2012-05-04T00:00:00,Aged,M01.060.116.100
22561021,2012-05-04T00:00:00,Contrast Media,D27.720.259
22561021,2012-05-04T00:00:00,Coronary Angiography,E01.370.350.700.060.200
22561021,2012-05-04T00:00:00,Coronary Angiography,E01.370.370.050.200
22561021,2012-05-04T00:00:00,Coronary Angiography,E01.370.370.380.200
22561021,2012-05-04T00:00:00,Echocardiography,E01.370.350.850.220
22561021,2012-05-04T00:00:00,Echocardiography,E01.370.370.380.220
22561021,2012-05-04T00:00:00,Heart Transplantation,E04.100.376.475
22561021,2012-05-04T00:00:00,Heart Transplantation,E04.928.220.390
22561021,2012-05-04T00:00:00,Heart Transplantation,E04.936.450.475
22561021,2012-05-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22561021,2012-05-04T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
22561021,2012-05-04T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
22561021,2012-05-04T00:00:00,Middle Aged,M01.060.116.630
22561021,2012-05-04T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
22561021,2012-05-04T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
22561021,2012-05-04T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
22561021,2012-05-04T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
22561021,2012-05-04T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
22561021,2012-05-04T00:00:00,Treatment Outcome,E01.789.800
22561021,2012-05-04T00:00:00,Treatment Outcome,N04.761.559.590.800
22561021,2012-05-04T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22561021,2012-05-04T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
22566406,2012-05-04T00:00:00,Aged,M01.060.116.100
22566406,2012-05-04T00:00:00,Aortic Valve,A07.541.510.110
22566406,2012-05-04T00:00:00,Aortic Valve Stenosis,C14.280.484.150
22566406,2012-05-04T00:00:00,Aortic Valve Stenosis,C14.280.955.249
22566406,2012-05-04T00:00:00,"Arrhythmias, Cardiac",C14.280.067
22566406,2012-05-04T00:00:00,"Arrhythmias, Cardiac",C23.550.073
22566406,2012-05-04T00:00:00,Calcinosis,C18.452.174.130
22566406,2012-05-04T00:00:00,"Cardiac Pacing, Artificial",E02.145
22566406,2012-05-04T00:00:00,Heart Valve Prosthesis,E07.695.310
22566406,2012-05-04T00:00:00,Heart Valve Prosthesis Implantation,E04.100.376.485
22566406,2012-05-04T00:00:00,Heart Valve Prosthesis Implantation,E04.650.410
22566406,2012-05-04T00:00:00,Heart Valve Prosthesis Implantation,E04.928.220.410
22566406,2012-05-04T00:00:00,Hemodynamics,G09.330.190.400
22566406,2012-05-04T00:00:00,Hemodynamics,G09.330.380
22566406,2012-05-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22566406,2012-05-04T00:00:00,Myocardial Infarction,C14.280.647.500
22566406,2012-05-04T00:00:00,Myocardial Infarction,C14.907.585.500
22566406,2012-05-04T00:00:00,Prosthesis Design,E05.320.550
22566406,2012-05-04T00:00:00,Prosthesis Design,E07.695.680
22566406,2012-05-04T00:00:00,Stroke,C10.228.140.300.775
22566406,2012-05-04T00:00:00,Stroke,C14.907.253.855
22566406,2012-05-04T00:00:00,Time Factors,G01.910.857
22566406,2012-05-04T00:00:00,Treatment Outcome,E01.789.800
22566406,2012-05-04T00:00:00,Treatment Outcome,N04.761.559.590.800
22566406,2012-05-04T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22564539,2012-05-06T00:00:00,Adenocarcinoma,C04.557.470.200.025
22564539,2012-05-06T00:00:00,Aged,M01.060.116.100
22564539,2012-05-06T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
22564539,2012-05-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22564539,2012-05-06T00:00:00,Lung Neoplasms,C04.588.894.797.520
22564539,2012-05-06T00:00:00,Lung Neoplasms,C08.381.540
22564539,2012-05-06T00:00:00,Lung Neoplasms,C08.785.520
22564539,2012-05-06T00:00:00,Middle Aged,M01.060.116.630
22564539,2012-05-06T00:00:00,Risk Factors,E05.318.740.600.800.725
22564539,2012-05-06T00:00:00,Risk Factors,N05.715.350.200.700
22564539,2012-05-06T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22564539,2012-05-06T00:00:00,Risk Factors,N06.850.490.625.750
22564539,2012-05-06T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22564042,2012-05-07T00:00:00,Adenocarcinoma,C04.557.470.200.025
22564042,2012-05-07T00:00:00,Adult,M01.060.116
22564042,2012-05-07T00:00:00,African Americans,M01.686.508.100.100
22564042,2012-05-07T00:00:00,African Americans,M01.686.754.100
22564042,2012-05-07T00:00:00,Aged,M01.060.116.100
22564042,2012-05-07T00:00:00,Diet,E05.272
22564042,2012-05-07T00:00:00,Diet,G07.610.240
22564042,2012-05-07T00:00:00,European Continental Ancestry Group,M01.686.508.400
22564042,2012-05-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22564042,2012-05-07T00:00:00,Medical Records,E05.318.308.940.968
22564042,2012-05-07T00:00:00,Medical Records,L01.280.900.968
22564042,2012-05-07T00:00:00,Medical Records,N04.452.859.564
22564042,2012-05-07T00:00:00,Medical Records,N05.715.360.300.715.500
22564042,2012-05-07T00:00:00,Medical Records,N06.850.520.308.940.968
22564042,2012-05-07T00:00:00,Middle Aged,M01.060.116.630
22564042,2012-05-07T00:00:00,Neoplasm Staging,E01.370.550
22564042,2012-05-07T00:00:00,Prostate-Specific Antigen,D08.811.277.656.300.760.442.750
22564042,2012-05-07T00:00:00,Prostate-Specific Antigen,D08.811.277.656.959.350.442.750
22564042,2012-05-07T00:00:00,Prostate-Specific Antigen,D12.776.866.249.500
22564042,2012-05-07T00:00:00,Prostate-Specific Antigen,D23.050.285.625
22564042,2012-05-07T00:00:00,Prostate-Specific Antigen,D23.101.840.625
22564042,2012-05-07T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
22564042,2012-05-07T00:00:00,Prostatic Neoplasms,C12.294.260.750
22564042,2012-05-07T00:00:00,Prostatic Neoplasms,C12.294.565.625
22564042,2012-05-07T00:00:00,Prostatic Neoplasms,C12.758.409.750
22564042,2012-05-07T00:00:00,Questionnaires,E05.318.308.750
22564042,2012-05-07T00:00:00,Questionnaires,L01.280.800
22564042,2012-05-07T00:00:00,Questionnaires,N05.715.360.300.695
22564042,2012-05-07T00:00:00,Questionnaires,N06.850.520.308.750
22566568,2012-05-07T00:00:00,Animals,B01.050
22566568,2012-05-07T00:00:00,Complement Activation,G12.425.255
22566568,2012-05-07T00:00:00,Complement System Proteins,D12.776.124.486.274
22566568,2012-05-07T00:00:00,"Disease Models, Animal",C22.232
22566568,2012-05-07T00:00:00,"Disease Models, Animal",E05.598.500
22566568,2012-05-07T00:00:00,"Disease Models, Animal",E05.599.395.080
22586473,2012-05-07T00:00:00,Animals,B01.050
22586473,2012-05-07T00:00:00,Drosophila Proteins,D12.776.466.462
22586473,2012-05-07T00:00:00,Drosophila melanogaster,B01.050.500.131.617.289.310.250.500
22586473,2012-05-07T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
22586473,2012-05-07T00:00:00,Germ Cells,A05.360.490
22586473,2012-05-07T00:00:00,Germ Cells,A11.497
22586473,2012-05-07T00:00:00,Larva,B05.500.500
22586473,2012-05-07T00:00:00,Larva,G07.700.320.500.550.500.500
22586473,2012-05-07T00:00:00,Mitosis,G04.299.134.220.220.781
22586473,2012-05-07T00:00:00,Mitosis,G05.355.105.220.781
22586473,2012-05-07T00:00:00,"Receptor, Epidermal Growth Factor",D08.811.913.696.620.682.725.400.100
22586473,2012-05-07T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.060.249
22586473,2012-05-07T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.360.300
22586473,2012-05-07T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.400.340
22586473,2012-05-07T00:00:00,"Receptors, Invertebrate Peptide",D12.776.543.750.750.460
22586473,2012-05-07T00:00:00,Signal Transduction,G02.111.087.800
22586473,2012-05-07T00:00:00,Signal Transduction,G02.149.115.800
22586473,2012-05-07T00:00:00,Signal Transduction,G04.299.880
22586473,2012-05-07T00:00:00,Stem Cells,A11.872
22586473,2012-05-07T00:00:00,Testis,A05.360.444.849
22586473,2012-05-07T00:00:00,Testis,A05.360.576.782
22586473,2012-05-07T00:00:00,Testis,A06.407.312.782
22658305,2012-05-07T00:00:00,Adult,M01.060.116
22658305,2012-05-07T00:00:00,Aged,M01.060.116.100
22658305,2012-05-07T00:00:00,Alcoholism,C21.739.100.250
22658305,2012-05-07T00:00:00,Alcoholism,F03.900.100.350
22658305,2012-05-07T00:00:00,Anxiety Disorders,F03.080
22658305,2012-05-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22658305,2012-05-07T00:00:00,Middle Aged,M01.060.116.630
22658305,2012-05-07T00:00:00,Substance-Related Disorders,C21.739
22658305,2012-05-07T00:00:00,Substance-Related Disorders,F03.900
22658305,2012-05-07T00:00:00,Young Adult,M01.060.116.815
22565637,2012-05-08T00:00:00,Animals,B01.050
22565637,2012-05-08T00:00:00,"Disease Models, Animal",C22.232
22565637,2012-05-08T00:00:00,"Disease Models, Animal",E05.598.500
22565637,2012-05-08T00:00:00,"Disease Models, Animal",E05.599.395.080
22565637,2012-05-08T00:00:00,Evidence-Based Medicine,H02.249.750
22565637,2012-05-08T00:00:00,Evidence-Based Medicine,H02.403.200.400
22565637,2012-05-08T00:00:00,Gastric Acid,A12.200.307.603
22565637,2012-05-08T00:00:00,H(+)-K(+)-Exchanging ATPase,D08.811.277.040.025.325.625
22565637,2012-05-08T00:00:00,H(+)-K(+)-Exchanging ATPase,D12.776.157.530.450.250.875.500.625
22565637,2012-05-08T00:00:00,H(+)-K(+)-Exchanging ATPase,D12.776.543.585.450.250.875.500.625
22565637,2012-05-08T00:00:00,Helicobacter Infections,C01.252.400.466
22565637,2012-05-08T00:00:00,Helicobacter pylori,B03.440.500.550
22565637,2012-05-08T00:00:00,Helicobacter pylori,B03.660.150.280.550
22565637,2012-05-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22565637,2012-05-08T00:00:00,"Transcription, Genetic",G02.111.087.847
22565637,2012-05-08T00:00:00,"Transcription, Genetic",G02.149.115.847
22565637,2012-05-08T00:00:00,"Transcription, Genetic",G05.355.310.700
22570436,2012-05-08T00:00:00,Adult,M01.060.116
22570436,2012-05-08T00:00:00,Age Factors,N05.715.350.075
22570436,2012-05-08T00:00:00,Age Factors,N06.850.490.250
22570436,2012-05-08T00:00:00,Ethnic Groups,M01.686.754
22570436,2012-05-08T00:00:00,Ethnic Groups,N01.224.317
22570436,2012-05-08T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
22570436,2012-05-08T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
22570436,2012-05-08T00:00:00,Health Surveys,E05.318.308.250
22570436,2012-05-08T00:00:00,Health Surveys,N05.715.360.300.375
22570436,2012-05-08T00:00:00,Health Surveys,N06.850.520.308.250
22570436,2012-05-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22570436,2012-05-08T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
22570436,2012-05-08T00:00:00,Income,N01.824.417
22570436,2012-05-08T00:00:00,Middle Aged,M01.060.116.630
22570436,2012-05-08T00:00:00,South Carolina,Z01.107.567.875.075.662
22570436,2012-05-08T00:00:00,South Carolina,Z01.107.567.875.750.700
22570475,2012-05-08T00:00:00,ATP-Binding Cassette Transporters,D12.776.157.530.100
22570475,2012-05-08T00:00:00,ATP-Binding Cassette Transporters,D12.776.395.550.020
22570475,2012-05-08T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.550.192
22570475,2012-05-08T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.585.100
22570475,2012-05-08T00:00:00,Animals,B01.050
22570475,2012-05-08T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
22570475,2012-05-08T00:00:00,Color,G01.201.875.770.578.199
22570475,2012-05-08T00:00:00,Color,G01.590.540.199
22570475,2012-05-08T00:00:00,Light,G01.201.875.770.578
22570475,2012-05-08T00:00:00,Light,G01.590.540
22570475,2012-05-08T00:00:00,Macular Degeneration,C11.768.585.439
22570475,2012-05-08T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
22570475,2012-05-08T00:00:00,"Microscopy, Fluorescence",E05.595.458
22570475,2012-05-08T00:00:00,"Models, Biological",E05.599.395
22570475,2012-05-08T00:00:00,Retina,A09.371.729
22570475,2012-05-08T00:00:00,Retinal Pigment Epithelium,A09.371.670.500
22570475,2012-05-08T00:00:00,Retinal Pigment Epithelium,A09.371.729.887
22570475,2012-05-08T00:00:00,Retinaldehyde,D02.047.850
22570475,2012-05-08T00:00:00,Retinaldehyde,D02.455.326.271.665.202.495.690
22570475,2012-05-08T00:00:00,Retinaldehyde,D02.455.426.392.368.367.379.249.700.690
22570475,2012-05-08T00:00:00,Retinaldehyde,D02.455.849.131.495.690
22570475,2012-05-08T00:00:00,Retinaldehyde,D23.767.261.700.690
22570475,2012-05-08T00:00:00,Retinoids,D02.455.326.271.665.202.495
22570475,2012-05-08T00:00:00,Retinoids,D02.455.426.392.368.367.379.249.700
22570475,2012-05-08T00:00:00,Retinoids,D02.455.849.131.495
22570475,2012-05-08T00:00:00,Retinoids,D23.767.261.700
22569892,2012-05-09T00:00:00,Anti-Infective Agents,D27.505.954.122
22569892,2012-05-09T00:00:00,Bacteria,B03
22569892,2012-05-09T00:00:00,"Colony Count, Microbial",E05.200.875.220
22569892,2012-05-09T00:00:00,Copper,D01.268.556.195
22569892,2012-05-09T00:00:00,Copper,D01.268.956.170
22569892,2012-05-09T00:00:00,Copper,D01.552.544.195
22569892,2012-05-09T00:00:00,Environmental Microbiology,H01.158.273.540.274
22569892,2012-05-09T00:00:00,Environmental Microbiology,N06.850.425
22573730,2012-05-09T00:00:00,Adult,M01.060.116
22573730,2012-05-09T00:00:00,Benzazepines,D03.438.079
22573730,2012-05-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22573730,2012-05-09T00:00:00,Middle Aged,M01.060.116.630
22573730,2012-05-09T00:00:00,Patient Compliance,F01.145.488.500
22573730,2012-05-09T00:00:00,Patient Compliance,N05.300.150.600.600
22573730,2012-05-09T00:00:00,Smoking,F01.145.466.753
22573730,2012-05-09T00:00:00,Smoking Cessation,F01.145.940.700
22573730,2012-05-09T00:00:00,Treatment Outcome,E01.789.800
22573730,2012-05-09T00:00:00,Treatment Outcome,N04.761.559.590.800
22573730,2012-05-09T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22573012,2012-05-10T00:00:00,Aged,M01.060.116.100
22573012,2012-05-10T00:00:00,Antihypertensive Agents,D27.505.954.411.162
22573012,2012-05-10T00:00:00,Blood Pressure,E01.370.600.875.249
22573012,2012-05-10T00:00:00,Blood Pressure,G09.330.380.076
22573012,2012-05-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22573012,2012-05-10T00:00:00,Hypertension,C14.907.489
22573012,2012-05-10T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
22573012,2012-05-10T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
22573012,2012-05-10T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
22573012,2012-05-10T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
22573012,2012-05-10T00:00:00,Middle Aged,M01.060.116.630
22573012,2012-05-10T00:00:00,"Renal Insufficiency, Chronic",C12.777.419.780.750
22573012,2012-05-10T00:00:00,"Renal Insufficiency, Chronic",C13.351.968.419.780.750
22573012,2012-05-10T00:00:00,Risk Factors,E05.318.740.600.800.725
22573012,2012-05-10T00:00:00,Risk Factors,N05.715.350.200.700
22573012,2012-05-10T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22573012,2012-05-10T00:00:00,Risk Factors,N06.850.490.625.750
22573012,2012-05-10T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22574861,2012-05-10T00:00:00,Alcohol-Related Disorders,C21.739.100
22574861,2012-05-10T00:00:00,Alcohol-Related Disorders,F03.900.100
22574861,2012-05-10T00:00:00,Basal Ganglia,A08.186.211.730.885.287.249
22574861,2012-05-10T00:00:00,"Behavior, Addictive",F01.145.527.100.120
22574861,2012-05-10T00:00:00,Brain,A08.186.211
22574861,2012-05-10T00:00:00,Case-Control Studies,E05.318.760.500.500
22574861,2012-05-10T00:00:00,Case-Control Studies,N05.715.360.775.175.200
22574861,2012-05-10T00:00:00,Case-Control Studies,N06.850.520.450.500.500
22574861,2012-05-10T00:00:00,Cues,F02.463.425.234
22574861,2012-05-10T00:00:00,"Data Interpretation, Statistical",E05.245.380
22574861,2012-05-10T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
22574861,2012-05-10T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
22574861,2012-05-10T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
22574861,2012-05-10T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
22574861,2012-05-10T00:00:00,Ethanol,D02.033.375
22574861,2012-05-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22574861,2012-05-10T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
22574861,2012-05-10T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
22574861,2012-05-10T00:00:00,Positron-Emission Tomography,E01.370.350.350.800.700
22574861,2012-05-10T00:00:00,Positron-Emission Tomography,E01.370.350.600.350.800.399
22574861,2012-05-10T00:00:00,Positron-Emission Tomography,E01.370.350.710.800.399
22574861,2012-05-10T00:00:00,Positron-Emission Tomography,E01.370.350.825.800.399
22574861,2012-05-10T00:00:00,Positron-Emission Tomography,E01.370.384.730.800.399
22574861,2012-05-10T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
22574861,2012-05-10T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.350.800.800
22574861,2012-05-10T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.600.350.800.800
22574861,2012-05-10T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.710.800.800
22574861,2012-05-10T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.825.800.800
22574861,2012-05-10T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.384.730.800.800
22581819,2012-05-10T00:00:00,Adult,M01.060.116
22581819,2012-05-10T00:00:00,Aged,M01.060.116.100
22581819,2012-05-10T00:00:00,Brain Ischemia,C10.228.140.300.150
22581819,2012-05-10T00:00:00,Brain Ischemia,C14.907.253.092
22581819,2012-05-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22581819,2012-05-10T00:00:00,Middle Aged,M01.060.116.630
22581819,2012-05-10T00:00:00,Stroke,C10.228.140.300.775
22581819,2012-05-10T00:00:00,Stroke,C14.907.253.855
22578407,2012-05-11T00:00:00,Bayes Theorem,E05.318.740.600.200
22578407,2012-05-11T00:00:00,Bayes Theorem,N05.715.360.750.625.150
22578407,2012-05-11T00:00:00,Bayes Theorem,N06.850.520.830.600.200
22578407,2012-05-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22578407,2012-05-11T00:00:00,Lymph Nodes,A10.549.400
22578407,2012-05-11T00:00:00,Lymph Nodes,A15.382.520.604.412
22578407,2012-05-11T00:00:00,Markov Chains,E05.318.740.600.500
22578407,2012-05-11T00:00:00,Markov Chains,E05.318.740.996.500
22578407,2012-05-11T00:00:00,Markov Chains,G17.830.500
22578407,2012-05-11T00:00:00,Markov Chains,N05.715.360.750.625.500
22578407,2012-05-11T00:00:00,Markov Chains,N05.715.360.750.770.500
22578407,2012-05-11T00:00:00,Markov Chains,N06.850.520.830.600.500
22578407,2012-05-11T00:00:00,Markov Chains,N06.850.520.830.996.500
22578407,2012-05-11T00:00:00,Monte Carlo Method,E05.318.740.525
22578407,2012-05-11T00:00:00,Monte Carlo Method,L01.906.575.422
22578407,2012-05-11T00:00:00,Monte Carlo Method,N05.715.360.750.540
22578407,2012-05-11T00:00:00,Monte Carlo Method,N06.850.520.830.525
22578407,2012-05-11T00:00:00,Rhabdomyosarcoma,C04.557.450.590.550.660
22578407,2012-05-11T00:00:00,Rhabdomyosarcoma,C04.557.450.795.550.660
22578407,2012-05-11T00:00:00,Sarcoma,C04.557.450.795
22579502,2012-05-11T00:00:00,Animals,B01.050
22579502,2012-05-11T00:00:00,Cell Differentiation,G04.299.151
22579502,2012-05-11T00:00:00,Cell Lineage,G04.172
22579502,2012-05-11T00:00:00,Cell Lineage,G07.700.320.500.325.180.500
22579502,2012-05-11T00:00:00,Cell Lineage,G08.686.155
22579502,2012-05-11T00:00:00,Cell Lineage,G08.686.785.760.170.104.249
22579502,2012-05-11T00:00:00,Cell Movement,G04.299.283
22579502,2012-05-11T00:00:00,Cell Movement,G07.700.560.500.180
22579502,2012-05-11T00:00:00,Chick Embryo,A13.350.150
22579502,2012-05-11T00:00:00,Chick Embryo,A16.331.200
22579502,2012-05-11T00:00:00,Collagen Type I,D05.750.078.280.300.100
22579502,2012-05-11T00:00:00,Collagen Type I,D12.776.860.300.250.300.100
22579502,2012-05-11T00:00:00,Endocardium,A07.541.207
22579502,2012-05-11T00:00:00,Endothelial Cells,A11.436.275
22579502,2012-05-11T00:00:00,Extracellular Matrix,A11.284.295.310
22579502,2012-05-11T00:00:00,Fibroblasts,A11.329.228
22579502,2012-05-11T00:00:00,Fibroblasts,A11.872.228
22579502,2012-05-11T00:00:00,"Heart Defects, Congenital",C14.240.400
22579502,2012-05-11T00:00:00,"Heart Defects, Congenital",C14.280.400
22579502,2012-05-11T00:00:00,"Heart Defects, Congenital",C16.131.240.400
22579502,2012-05-11T00:00:00,Heart Valve Diseases,C14.280.484
22579502,2012-05-11T00:00:00,Heart Valves,A07.541.510
22579502,2012-05-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22579502,2012-05-11T00:00:00,Mesoderm,A16.504.660
22579502,2012-05-11T00:00:00,Mitral Valve,A07.541.510.507
22581838,2012-05-11T00:00:00,Adult,M01.060.116
22581838,2012-05-11T00:00:00,Aged,M01.060.116.100
22581838,2012-05-11T00:00:00,DNA Helicases,D08.811.277.040.025.159
22581838,2012-05-11T00:00:00,DNA Helicases,D08.811.399.340
22581838,2012-05-11T00:00:00,DNA Repair,G02.111.087.219
22581838,2012-05-11T00:00:00,DNA Repair,G02.149.115.219
22581838,2012-05-11T00:00:00,DNA Repair,G05.355.195
22581838,2012-05-11T00:00:00,DNA-Binding Proteins,D12.776.260
22581838,2012-05-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22581838,2012-05-11T00:00:00,Middle Aged,M01.060.116.630
22581838,2012-05-11T00:00:00,Phenotype,G05.695
22581838,2012-05-11T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
22581838,2012-05-11T00:00:00,Skin Neoplasms,C04.588.805
22581838,2012-05-11T00:00:00,Skin Neoplasms,C17.800.882
22581838,2012-05-11T00:00:00,Thymine DNA Glycosylase,D08.811.074.249.750
22581838,2012-05-11T00:00:00,Thymine DNA Glycosylase,D08.811.277.450.430.099.750
22581838,2012-05-11T00:00:00,"Tumor Markers, Biological",D23.101.840
22581845,2012-05-11T00:00:00,Animals,B01.050
22581845,2012-05-11T00:00:00,Apoptosis,G04.299.139.160
22581845,2012-05-11T00:00:00,Calcium,D01.268.552.100
22581845,2012-05-11T00:00:00,Calcium,D01.552.539.288
22581845,2012-05-11T00:00:00,Calcium,D23.119.100
22581845,2012-05-11T00:00:00,Calpain,D08.811.277.656.262.500.120
22581845,2012-05-11T00:00:00,Calpain,D08.811.277.656.300.200.120
22581845,2012-05-11T00:00:00,Endothelial Cells,A11.436.275
22581845,2012-05-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22581845,2012-05-11T00:00:00,Kidney,A05.810.453
22581845,2012-05-11T00:00:00,Mitochondria,A11.284.430.214.190.875.564
22581845,2012-05-11T00:00:00,Mitochondria,A11.284.835.626
22581845,2012-05-11T00:00:00,Myocardium,A02.633.580
22581845,2012-05-11T00:00:00,Myocardium,A07.541.704
22581845,2012-05-11T00:00:00,Myocardium,A10.690.552.750
22581845,2012-05-11T00:00:00,"Myocytes, Smooth Muscle",A11.620.520
22584685,2012-05-12T00:00:00,Animals,B01.050
22584685,2012-05-12T00:00:00,Calcium,D01.268.552.100
22584685,2012-05-12T00:00:00,Calcium,D01.552.539.288
22584685,2012-05-12T00:00:00,Calcium,D23.119.100
22584685,2012-05-12T00:00:00,Cell Death,G04.299.139
22584685,2012-05-12T00:00:00,Endoplasmic Reticulum,A11.284.430.214.190.875.248
22584685,2012-05-12T00:00:00,Rabbits,B01.050.150.900.649.521.700
22666277,2012-05-13T00:00:00,Adolescent,M01.060.057
22666277,2012-05-13T00:00:00,Adult,M01.060.116
22666277,2012-05-13T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
22666277,2012-05-13T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
22666277,2012-05-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22666277,2012-05-13T00:00:00,Middle Aged,M01.060.116.630
22666277,2012-05-13T00:00:00,Smoking,F01.145.466.753
22666277,2012-05-13T00:00:00,Tobacco,B01.650.388.100.905.900
22666277,2012-05-13T00:00:00,United States,Z01.107.567.875
22666277,2012-05-13T00:00:00,Young Adult,M01.060.116.815
22574850,2012-05-14T00:00:00,Amides,D02.065
22574850,2012-05-14T00:00:00,Amino Acid Sequence,G02.111.570.060
22574850,2012-05-14T00:00:00,Amino Acid Sequence,L01.453.245.667.060
22574850,2012-05-14T00:00:00,Cystine,D01.248.497.158.874.390.369
22574850,2012-05-14T00:00:00,Cystine,D01.875.350.850.150.369
22574850,2012-05-14T00:00:00,Cystine,D02.886.030.230.369
22574850,2012-05-14T00:00:00,Cystine,D02.886.520.150.087
22574850,2012-05-14T00:00:00,Cystine,D12.125.095.369
22574850,2012-05-14T00:00:00,Cystine,D12.125.119.369
22574850,2012-05-14T00:00:00,Cystine,D12.125.166.230.369
22574850,2012-05-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22574850,2012-05-14T00:00:00,Insulin,D06.472.699.587.740.625
22574850,2012-05-14T00:00:00,Insulin,D12.644.548.586.740.625
22574850,2012-05-14T00:00:00,Molecular Sequence Data,L01.453.245.667
22574850,2012-05-14T00:00:00,Proteins,D12.776
22574850,2012-05-14T00:00:00,Signal Transduction,G02.111.087.800
22574850,2012-05-14T00:00:00,Signal Transduction,G02.149.115.800
22574850,2012-05-14T00:00:00,Signal Transduction,G04.299.880
22585697,2012-05-14T00:00:00,Aged,M01.060.116.100
22585697,2012-05-14T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
22585697,2012-05-14T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
22585697,2012-05-14T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
22585697,2012-05-14T00:00:00,Double-Blind Method,E05.318.780.300
22585697,2012-05-14T00:00:00,Double-Blind Method,E05.581.500.300
22585697,2012-05-14T00:00:00,Double-Blind Method,N05.715.360.780.320
22585697,2012-05-14T00:00:00,Double-Blind Method,N06.850.520.445.300
22585697,2012-05-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22585697,2012-05-14T00:00:00,"Leukemia, Myeloid, Acute",C04.557.337.539.550
22585697,2012-05-14T00:00:00,Middle Aged,M01.060.116.630
22584822,2012-05-15T00:00:00,Animals,B01.050
22584822,2012-05-15T00:00:00,Extracellular Matrix,A11.284.295.310
22584822,2012-05-15T00:00:00,Materials Testing,E05.570
22584822,2012-05-15T00:00:00,Myocardium,A02.633.580
22584822,2012-05-15T00:00:00,Myocardium,A07.541.704
22584822,2012-05-15T00:00:00,Myocardium,A10.690.552.750
22584822,2012-05-15T00:00:00,Swine,B01.050.150.900.649.077.880
22584822,2012-05-15T00:00:00,Tissue Engineering,E05.200.249.750
22584822,2012-05-15T00:00:00,Tissue Scaffolds,E07.206.627
22584822,2012-05-15T00:00:00,Tissue Scaffolds,E07.695.825
22589022,2012-05-15T00:00:00,"Microscopy, Electron, Transmission",E01.370.350.515.402.580
22589022,2012-05-15T00:00:00,"Microscopy, Electron, Transmission",E05.595.402.580
22589022,2012-05-15T00:00:00,"Models, Molecular",E05.599.595
22589022,2012-05-15T00:00:00,Polymers,D05.750
22589022,2012-05-15T00:00:00,Polymers,D25.720
22589022,2012-05-15T00:00:00,Polymers,J01.637.051.720
22609250,2012-05-15T00:00:00,Adenosine,D03.438.759.590.138
22609250,2012-05-15T00:00:00,Adenosine,D13.570.583.138
22609250,2012-05-15T00:00:00,Adenosine,D13.570.800.096
22609250,2012-05-15T00:00:00,Animals,B01.050
22609250,2012-05-15T00:00:00,Ethanol,D02.033.375
22609250,2012-05-15T00:00:00,Fatty Liver,C06.552.241
22609250,2012-05-15T00:00:00,Gene Expression,G05.355.310
22609250,2012-05-15T00:00:00,Glutathione,D12.644.456.448
22609250,2012-05-15T00:00:00,Graft Survival,G12.425.901.545.340
22609250,2012-05-15T00:00:00,Insulin,D06.472.699.587.740.625
22609250,2012-05-15T00:00:00,Insulin,D12.644.548.586.740.625
22609250,2012-05-15T00:00:00,Liver Transplantation,E04.210.650
22609250,2012-05-15T00:00:00,Liver Transplantation,E04.936.450.490
22609250,2012-05-15T00:00:00,Liver Transplantation,E04.936.580.490
22609250,2012-05-15T00:00:00,Mitochondria,A11.284.430.214.190.875.564
22609250,2012-05-15T00:00:00,Mitochondria,A11.284.835.626
22609250,2012-05-15T00:00:00,Nitric Oxide Synthase Type II,D08.811.682.664.500.772.500
22609250,2012-05-15T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22609250,2012-05-15T00:00:00,Reactive Nitrogen Species,D01.625.700
22609250,2012-05-15T00:00:00,Reactive Nitrogen Species,D02.654.846
22609250,2012-05-15T00:00:00,Tyrosine,D12.125.072.050.875
22589042,2012-05-16T00:00:00,"Clinical Trials, Phase III as Topic",E05.318.760.535.220
22589042,2012-05-16T00:00:00,"Clinical Trials, Phase III as Topic",E05.337.250.220
22589042,2012-05-16T00:00:00,"Clinical Trials, Phase III as Topic",N05.715.360.775.235.220
22589042,2012-05-16T00:00:00,"Clinical Trials, Phase III as Topic",N06.850.520.450.535.220
22589042,2012-05-16T00:00:00,Computer Simulation,L01.224.160
22589042,2012-05-16T00:00:00,"Data Interpretation, Statistical",E05.245.380
22589042,2012-05-16T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
22589042,2012-05-16T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
22589042,2012-05-16T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
22589042,2012-05-16T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
22589042,2012-05-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22589042,2012-05-16T00:00:00,Monte Carlo Method,E05.318.740.525
22589042,2012-05-16T00:00:00,Monte Carlo Method,L01.906.575.422
22589042,2012-05-16T00:00:00,Monte Carlo Method,N05.715.360.750.540
22589042,2012-05-16T00:00:00,Monte Carlo Method,N06.850.520.830.525
22589042,2012-05-16T00:00:00,Probability,E05.318.740.600
22589042,2012-05-16T00:00:00,Probability,G17.680
22589042,2012-05-16T00:00:00,Probability,N05.715.360.750.625
22589042,2012-05-16T00:00:00,Probability,N06.850.520.830.600
22589042,2012-05-16T00:00:00,Research Design,E05.581.500
22589042,2012-05-16T00:00:00,Research Design,H01.770.644.728
22589042,2012-05-16T00:00:00,Treatment Outcome,E01.789.800
22589042,2012-05-16T00:00:00,Treatment Outcome,N04.761.559.590.800
22589042,2012-05-16T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22591552,2012-05-16T00:00:00,Adult,M01.060.116
22591552,2012-05-16T00:00:00,African Americans,M01.686.508.100.100
22591552,2012-05-16T00:00:00,African Americans,M01.686.754.100
22591552,2012-05-16T00:00:00,Alcoholism,C21.739.100.250
22591552,2012-05-16T00:00:00,Alcoholism,F03.900.100.350
22591552,2012-05-16T00:00:00,Cocaine-Related Disorders,C21.739.300
22591552,2012-05-16T00:00:00,Cocaine-Related Disorders,F03.900.300
22591552,2012-05-16T00:00:00,European Continental Ancestry Group,M01.686.508.400
22591552,2012-05-16T00:00:00,Genetic Variation,G05.365
22591552,2012-05-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22591552,2012-05-16T00:00:00,Linkage Disequilibrium,G05.540.500
22591552,2012-05-16T00:00:00,Marijuana Abuse,C21.739.635
22591552,2012-05-16T00:00:00,Marijuana Abuse,F03.900.635
22591552,2012-05-16T00:00:00,Middle Aged,M01.060.116.630
22591552,2012-05-16T00:00:00,Opioid-Related Disorders,C21.739.675
22591552,2012-05-16T00:00:00,Opioid-Related Disorders,F03.900.675
22591552,2012-05-16T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
22591552,2012-05-16T00:00:00,RGS Proteins,D12.644.360.325.150.750
22591552,2012-05-16T00:00:00,RGS Proteins,D12.776.402.150.750
22591552,2012-05-16T00:00:00,RGS Proteins,D12.776.476.325.150.750
22591552,2012-05-16T00:00:00,Risk Factors,E05.318.740.600.800.725
22591552,2012-05-16T00:00:00,Risk Factors,N05.715.350.200.700
22591552,2012-05-16T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22591552,2012-05-16T00:00:00,Risk Factors,N06.850.490.625.750
22591552,2012-05-16T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22591552,2012-05-16T00:00:00,Signal Transduction,G02.111.087.800
22591552,2012-05-16T00:00:00,Signal Transduction,G02.149.115.800
22591552,2012-05-16T00:00:00,Signal Transduction,G04.299.880
22591552,2012-05-16T00:00:00,Substance-Related Disorders,C21.739
22591552,2012-05-16T00:00:00,Substance-Related Disorders,F03.900
22591552,2012-05-16T00:00:00,United States,Z01.107.567.875
22592639,2012-05-16T00:00:00,Adult,M01.060.116
22592639,2012-05-16T00:00:00,Aged,M01.060.116.100
22592639,2012-05-16T00:00:00,Gene Expression Regulation,G05.355.315
22592639,2012-05-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22592639,2012-05-16T00:00:00,Middle Aged,M01.060.116.630
22592639,2012-05-16T00:00:00,Muscle Contraction,G11.427.590.540
22592639,2012-05-16T00:00:00,"Muscle, Smooth",A02.633.570
22592639,2012-05-16T00:00:00,"Muscle, Smooth",A10.690.467
22592639,2012-05-16T00:00:00,Polymerase Chain Reaction,E05.393.620.500
22592639,2012-05-16T00:00:00,"RNA, Messenger",D13.444.735.544
22592639,2012-05-16T00:00:00,Urinary Bladder,A05.810.890
22539012,2012-05-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22539012,2012-05-17T00:00:00,Middle Aged,M01.060.116.630
22539012,2012-05-17T00:00:00,Neoplasms,C04
22539012,2012-05-17T00:00:00,Questionnaires,E05.318.308.750
22539012,2012-05-17T00:00:00,Questionnaires,L01.280.800
22539012,2012-05-17T00:00:00,Questionnaires,N05.715.360.300.695
22539012,2012-05-17T00:00:00,Questionnaires,N06.850.520.308.750
22539012,2012-05-17T00:00:00,Risk Factors,E05.318.740.600.800.725
22539012,2012-05-17T00:00:00,Risk Factors,N05.715.350.200.700
22539012,2012-05-17T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22539012,2012-05-17T00:00:00,Risk Factors,N06.850.490.625.750
22539012,2012-05-17T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22539012,2012-05-17T00:00:00,Smoking,F01.145.466.753
22539012,2012-05-17T00:00:00,Smoking Cessation,F01.145.940.700
22592902,2012-05-17T00:00:00,Animals,B01.050
22592902,2012-05-17T00:00:00,Cognition Disorders,F03.087.250
22592902,2012-05-17T00:00:00,"Conditioning, Operant",F02.463.425.179.509
22592902,2012-05-17T00:00:00,Methamphetamine,D02.092.471.683.152.619
22592902,2012-05-17T00:00:00,Motivation,F01.658
22592902,2012-05-17T00:00:00,Motivation,F01.752.543.500.750
22592902,2012-05-17T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22592902,2012-05-17T00:00:00,Self Administration,E02.319.890
22592902,2012-05-17T00:00:00,Self Administration,E02.900.890
22592902,2012-05-17T00:00:00,Sex Factors,N05.715.350.675
22592902,2012-05-17T00:00:00,Sex Factors,N06.850.490.875
22592902,2012-05-17T00:00:00,Time Factors,G01.910.857
22595296,2012-05-17T00:00:00,Animals,B01.050
22595296,2012-05-17T00:00:00,Biomedical Research,H01.770.644.145
22595296,2012-05-17T00:00:00,Cardiology,H02.403.429.163
22595296,2012-05-17T00:00:00,"Cardiomyopathy, Dilated",C14.280.195.160
22595296,2012-05-17T00:00:00,"Cardiomyopathy, Dilated",C14.280.238.070
22595296,2012-05-17T00:00:00,"Disease Models, Animal",C22.232
22595296,2012-05-17T00:00:00,"Disease Models, Animal",E05.598.500
22595296,2012-05-17T00:00:00,"Disease Models, Animal",E05.599.395.080
22595296,2012-05-17T00:00:00,Disease Progression,C23.550.291.656
22595296,2012-05-17T00:00:00,Heart Failure,C14.280.434
22595296,2012-05-17T00:00:00,Heart Valve Diseases,C14.280.484
22595296,2012-05-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22595296,2012-05-17T00:00:00,Hypertension,C14.907.489
22595296,2012-05-17T00:00:00,Phenotype,G05.695
22595296,2012-05-17T00:00:00,Risk Factors,E05.318.740.600.800.725
22595296,2012-05-17T00:00:00,Risk Factors,N05.715.350.200.700
22595296,2012-05-17T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22595296,2012-05-17T00:00:00,Risk Factors,N06.850.490.625.750
22595296,2012-05-17T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22596222,2012-05-17T00:00:00,Endothelial Cells,A11.436.275
22596222,2012-05-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22596222,2012-05-17T00:00:00,Inflammation,C23.550.470
22596222,2012-05-17T00:00:00,Interleukin-6,D12.644.276.374.465.506
22596222,2012-05-17T00:00:00,Interleukin-6,D12.776.467.374.465.506
22596222,2012-05-17T00:00:00,Interleukin-6,D23.529.374.465.506
22596222,2012-05-17T00:00:00,Lipopolysaccharides,D09.400.500
22596222,2012-05-17T00:00:00,Lipopolysaccharides,D09.698.718.450
22596222,2012-05-17T00:00:00,Lipopolysaccharides,D10.494
22596222,2012-05-17T00:00:00,Lipopolysaccharides,D23.050.161.616.525
22596222,2012-05-17T00:00:00,Lipopolysaccharides,D23.946.123.329.500
22596222,2012-05-17T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.300.480.205.351
22596222,2012-05-17T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.300.480.525.700.100
22596222,2012-05-17T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.675.374.205.351
22596222,2012-05-17T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.675.374.525.700.100
22596222,2012-05-17T00:00:00,NF-kappa B,D12.776.260.600
22596222,2012-05-17T00:00:00,NF-kappa B,D12.776.660.600
22596222,2012-05-17T00:00:00,NF-kappa B,D12.776.930.600
22596222,2012-05-17T00:00:00,Toll-Like Receptor 4,D12.776.543.750.705.910.500.400
22605652,2012-05-17T00:00:00,Adolescent,M01.060.057
22605652,2012-05-17T00:00:00,Adult,M01.060.116
22605652,2012-05-17T00:00:00,Aged,M01.060.116.100
22605652,2012-05-17T00:00:00,Case-Control Studies,E05.318.760.500.500
22605652,2012-05-17T00:00:00,Case-Control Studies,N05.715.360.775.175.200
22605652,2012-05-17T00:00:00,Case-Control Studies,N06.850.520.450.500.500
22605652,2012-05-17T00:00:00,Child,M01.060.406
22605652,2012-05-17T00:00:00,"Child, Preschool",M01.060.406.448
22605652,2012-05-17T00:00:00,Head and Neck Neoplasms,C04.588.443
22605652,2012-05-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22605652,2012-05-17T00:00:00,Infant,M01.060.703
22605652,2012-05-17T00:00:00,Middle Aged,M01.060.116.630
22605652,2012-05-17T00:00:00,SEER Program,E05.318.308.970.725
22605652,2012-05-17T00:00:00,SEER Program,L01.280.950.725
22605652,2012-05-17T00:00:00,SEER Program,N04.452.859.819.725
22605652,2012-05-17T00:00:00,SEER Program,N05.715.360.300.715.700.725
22605652,2012-05-17T00:00:00,SEER Program,N06.850.520.308.970.725
22605652,2012-05-17T00:00:00,Sarcoma,C04.557.450.795
22605652,2012-05-17T00:00:00,United States,Z01.107.567.875
22605652,2012-05-17T00:00:00,Young Adult,M01.060.116.815
22608794,2012-05-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22608794,2012-05-18T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
22608794,2012-05-18T00:00:00,Prostatic Neoplasms,C12.294.260.750
22608794,2012-05-18T00:00:00,Prostatic Neoplasms,C12.294.565.625
22608794,2012-05-18T00:00:00,Prostatic Neoplasms,C12.758.409.750
22608794,2012-05-18T00:00:00,Testosterone,D04.808.054.079.429.824
22608794,2012-05-18T00:00:00,Testosterone,D06.472.334.851.968.984
22610170,2012-05-18T00:00:00,Animals,B01.050
22610170,2012-05-18T00:00:00,Cardiomegaly,C14.280.195
22610170,2012-05-18T00:00:00,Cardiomegaly,C23.300.775.250
22610170,2012-05-18T00:00:00,Chronic Disease,C23.550.291.500
22610170,2012-05-18T00:00:00,Collagen,D05.750.078.280
22610170,2012-05-18T00:00:00,Collagen,D12.776.860.300.250
22610170,2012-05-18T00:00:00,Fibroblasts,A11.329.228
22610170,2012-05-18T00:00:00,Fibroblasts,A11.872.228
22610170,2012-05-18T00:00:00,Glycoproteins,D09.400.430
22610170,2012-05-18T00:00:00,Glycoproteins,D12.776.395
22610170,2012-05-18T00:00:00,Heart,A07.541
22610170,2012-05-18T00:00:00,Myocardium,A02.633.580
22610170,2012-05-18T00:00:00,Myocardium,A07.541.704
22610170,2012-05-18T00:00:00,Myocardium,A10.690.552.750
22613211,2012-05-18T00:00:00,Bacteria,B03
22613211,2012-05-18T00:00:00,"Biodegradation, Environmental",N06.850.460.375.500
22613211,2012-05-18T00:00:00,"Biodegradation, Environmental",N06.850.860.510.900.299
22613211,2012-05-18T00:00:00,Ethylene Dibromide,D02.455.526.368.225
22613211,2012-05-18T00:00:00,Ethylene Dichlorides,D02.455.326.146.379.350
22613211,2012-05-18T00:00:00,Ethylene Dichlorides,D02.455.526.439.458
22613211,2012-05-18T00:00:00,Toluene,D02.455.426.559.389.832
22610791,2012-05-19T00:00:00,Animals,B01.050
22610791,2012-05-19T00:00:00,Heart Ventricles,A07.541.560
22610791,2012-05-19T00:00:00,"Hypertrophy, Left Ventricular",C14.280.195.400
22610791,2012-05-19T00:00:00,"Hypertrophy, Left Ventricular",C23.300.775.250.400
22610791,2012-05-19T00:00:00,Myocardium,A02.633.580
22610791,2012-05-19T00:00:00,Myocardium,A07.541.704
22610791,2012-05-19T00:00:00,Myocardium,A10.690.552.750
22610791,2012-05-19T00:00:00,Protein Biosynthesis,G02.111.087.675.871
22610791,2012-05-19T00:00:00,Protein Biosynthesis,G02.149.115.675.871
22610791,2012-05-19T00:00:00,Protein Biosynthesis,G03.495.770.871
22610791,2012-05-19T00:00:00,Protein Biosynthesis,G05.355.310.670
22610791,2012-05-19T00:00:00,"Stress, Physiological",G07.700.830
22610791,2012-05-19T00:00:00,Ventricular Pressure,G09.330.190.962.950
22610791,2012-05-19T00:00:00,Ventricular Pressure,G09.330.380.937
22613054,2012-05-19T00:00:00,Cocaine-Related Disorders,C21.739.300
22613054,2012-05-19T00:00:00,Cocaine-Related Disorders,F03.900.300
22613054,2012-05-19T00:00:00,Double-Blind Method,E05.318.780.300
22613054,2012-05-19T00:00:00,Double-Blind Method,E05.581.500.300
22613054,2012-05-19T00:00:00,Double-Blind Method,N05.715.360.780.320
22613054,2012-05-19T00:00:00,Double-Blind Method,N06.850.520.445.300
22613054,2012-05-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22613054,2012-05-19T00:00:00,Medication Adherence,F01.145.488.500.500
22613054,2012-05-19T00:00:00,Medication Adherence,N05.300.150.600.600.500
22613054,2012-05-19T00:00:00,Multicenter Studies as Topic,E05.318.760.535.500
22613054,2012-05-19T00:00:00,Multicenter Studies as Topic,E05.337.250.500
22613054,2012-05-19T00:00:00,Multicenter Studies as Topic,N05.715.360.775.235.545
22613054,2012-05-19T00:00:00,Multicenter Studies as Topic,N06.850.520.450.535.500
22613054,2012-05-19T00:00:00,Outpatients,M01.643.630
22613054,2012-05-19T00:00:00,Quality of Life,I01.800
22613054,2012-05-19T00:00:00,Quality of Life,K01.752.400.750
22613054,2012-05-19T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
22613054,2012-05-19T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
22613054,2012-05-19T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
22613054,2012-05-19T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
22613054,2012-05-19T00:00:00,Risk-Taking,F01.145.722
22613054,2012-05-19T00:00:00,Secondary Prevention,N02.421.726.825
22613054,2012-05-19T00:00:00,Secondary Prevention,N06.850.780.750
22613054,2012-05-19T00:00:00,Treatment Outcome,E01.789.800
22613054,2012-05-19T00:00:00,Treatment Outcome,N04.761.559.590.800
22613054,2012-05-19T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22617435,2012-05-19T00:00:00,Adult,M01.060.116
22617435,2012-05-19T00:00:00,DNA Damage,C21.111
22617435,2012-05-19T00:00:00,DNA Damage,G05.355.180
22617435,2012-05-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22617435,2012-05-19T00:00:00,Military Personnel,M01.526.625
22617435,2012-05-19T00:00:00,Occupational Exposure,N06.850.460.350.600
22617435,2012-05-19T00:00:00,Young Adult,M01.060.116.815
22609886,2012-05-21T00:00:00,Adolescent,M01.060.057
22609886,2012-05-21T00:00:00,Child,M01.060.406
22609886,2012-05-21T00:00:00,"Child, Preschool",M01.060.406.448
22609886,2012-05-21T00:00:00,Cyclosporine,D04.345.566.235.300
22609886,2012-05-21T00:00:00,Cyclosporine,D12.644.641.235.300
22609886,2012-05-21T00:00:00,Drug Monitoring,E01.370.520.200
22609886,2012-05-21T00:00:00,Drug-Induced Liver Injury,C06.552.195
22609886,2012-05-21T00:00:00,Drug-Induced Liver Injury,C21.613.260
22609886,2012-05-21T00:00:00,Folic Acid Antagonists,D27.505.519.389.350
22609886,2012-05-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22609886,2012-05-21T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
22609886,2012-05-21T00:00:00,Infant,M01.060.703
22609886,2012-05-21T00:00:00,Leucovorin,D03.438.733.631.400.800.350.450
22609886,2012-05-21T00:00:00,Leucovorin,D08.211.840.300.500
22609886,2012-05-21T00:00:00,Methotrexate,D03.438.733.631.192.500
22609886,2012-05-21T00:00:00,Mucositis,C06.405.205.798
22609886,2012-05-21T00:00:00,Mucositis,C07.465.584
22609886,2012-05-21T00:00:00,Vitamin B Complex,D27.505.696.377.605.600.708
22615491,2012-05-21T00:00:00,Alternative Splicing,G02.111.087.750.700.100
22615491,2012-05-21T00:00:00,Alternative Splicing,G02.149.115.750.700.100
22615491,2012-05-21T00:00:00,Alternative Splicing,G03.495.839.700.100
22615491,2012-05-21T00:00:00,Alternative Splicing,G05.355.315.700.700.100
22615491,2012-05-21T00:00:00,Amino Acid Sequence,G02.111.570.060
22615491,2012-05-21T00:00:00,Amino Acid Sequence,L01.453.245.667.060
22615491,2012-05-21T00:00:00,Animals,B01.050
22615491,2012-05-21T00:00:00,Cell Adhesion,G04.299.117
22615491,2012-05-21T00:00:00,Cell Line,A11.251.210
22615491,2012-05-21T00:00:00,Cell Proliferation,G04.299.233.750
22615491,2012-05-21T00:00:00,Cell Proliferation,G07.700.320.249.410.750
22615491,2012-05-21T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.567.342
22615491,2012-05-21T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.646.750.249
22615491,2012-05-21T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.644.360.450.169
22615491,2012-05-21T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.776.476.450.169
22615491,2012-05-21T00:00:00,Fibronectins,D12.776.377.715.390
22615491,2012-05-21T00:00:00,Fibronectins,D12.776.395.550.350
22615491,2012-05-21T00:00:00,Fibronectins,D12.776.543.550.350
22615491,2012-05-21T00:00:00,Fibronectins,D12.776.860.300.450
22615491,2012-05-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22615491,2012-05-21T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.567.342.500
22615491,2012-05-21T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.646.750.249.500
22615491,2012-05-21T00:00:00,Mitogen-Activated Protein Kinase 1,D12.644.360.450.169.500
22615491,2012-05-21T00:00:00,Mitogen-Activated Protein Kinase 1,D12.776.476.450.169.500
22615491,2012-05-21T00:00:00,Phosphorylation,G02.111.087.677
22615491,2012-05-21T00:00:00,Phosphorylation,G02.149.115.677
22615491,2012-05-21T00:00:00,Phosphorylation,G02.149.465.700
22615491,2012-05-21T00:00:00,Phosphorylation,G02.607.750.700
22615491,2012-05-21T00:00:00,Phosphorylation,G03.495.790
22615491,2012-05-21T00:00:00,RNA-Binding Proteins,D12.776.157.725
22615491,2012-05-21T00:00:00,RNA-Binding Proteins,D12.776.664.962
22615491,2012-05-21T00:00:00,"Receptor, erbB-2",D08.811.913.696.620.682.725.400.150
22615491,2012-05-21T00:00:00,"Receptor, erbB-2",D12.776.543.750.060.374
22615491,2012-05-21T00:00:00,"Receptor, erbB-2",D12.776.543.750.750.400.350
22615491,2012-05-21T00:00:00,"Receptor, erbB-2",D12.776.624.664.700.642
22615491,2012-05-21T00:00:00,"Receptor, erbB-2",D23.101.840.642
22615491,2012-05-21T00:00:00,Recombinant Proteins,D12.776.828
22624720,2012-05-22T00:00:00,Conscious Sedation,E03.250
22624720,2012-05-22T00:00:00,Curriculum,I02.158
22624720,2012-05-22T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
22624720,2012-05-22T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
22624720,2012-05-22T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
22624720,2012-05-22T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
22624720,2012-05-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22624793,2012-05-22T00:00:00,"Anesthesia, General",E03.155.197
22624793,2012-05-22T00:00:00,Conscious Sedation,E03.250
22624793,2012-05-22T00:00:00,Curriculum,I02.158
22624793,2012-05-22T00:00:00,"Education, Medical, Continuing",I02.358.212.350
22624793,2012-05-22T00:00:00,"Education, Medical, Continuing",I02.358.399.250
22624793,2012-05-22T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
22624793,2012-05-22T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
22624793,2012-05-22T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
22624793,2012-05-22T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
22624793,2012-05-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22624793,2012-05-22T00:00:00,"Monitoring, Intraoperative",E01.370.520.510
22624793,2012-05-22T00:00:00,"Monitoring, Intraoperative",E04.510
22618352,2012-05-23T00:00:00,Aged,M01.060.116.100
22618352,2012-05-23T00:00:00,Aging,G07.700.320.124
22618352,2012-05-23T00:00:00,Auditory Cortex,A08.186.211.730.885.287.500.863.297
22618352,2012-05-23T00:00:00,Auditory Threshold,F02.463.593.071.173
22618352,2012-05-23T00:00:00,Auditory Threshold,F02.463.593.710.190
22618352,2012-05-23T00:00:00,Hearing Loss,C09.218.458.341
22618352,2012-05-23T00:00:00,Hearing Loss,C10.597.751.418.341
22618352,2012-05-23T00:00:00,Hearing Loss,C23.888.592.763.393.341
22618352,2012-05-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22618352,2012-05-23T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
22618352,2012-05-23T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
22618352,2012-05-23T00:00:00,Middle Aged,M01.060.116.630
22622459,2012-05-23T00:00:00,Amino Acid Sequence,G02.111.570.060
22622459,2012-05-23T00:00:00,Amino Acid Sequence,L01.453.245.667.060
22622459,2012-05-23T00:00:00,Animals,B01.050
22622459,2012-05-23T00:00:00,Gene Expression Regulation,G05.355.315
22622459,2012-05-23T00:00:00,Molecular Sequence Data,L01.453.245.667
22622459,2012-05-23T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22622459,2012-05-23T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
22622459,2012-05-23T00:00:00,Sodium,D01.268.549.750
22622459,2012-05-23T00:00:00,Sodium,D01.552.528.850
22622459,2012-05-23T00:00:00,Tissue Kallikreins,D08.811.277.656.300.760.442.875
22622459,2012-05-23T00:00:00,Tissue Kallikreins,D08.811.277.656.959.350.442.875
22622459,2012-05-23T00:00:00,Tissue Kallikreins,D23.101.840.870
22622459,2012-05-23T00:00:00,Xenopus laevis,B01.050.150.900.090.180.610.500.562
22626914,2012-05-23T00:00:00,Government Regulation,I01.880.604.394
22626914,2012-05-23T00:00:00,Government Regulation,N03.706.358
22626914,2012-05-23T00:00:00,Healthcare Disparities,N04.590.374.380
22626914,2012-05-23T00:00:00,Healthcare Disparities,N05.300.493
22626914,2012-05-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22626914,2012-05-23T00:00:00,United States,Z01.107.567.875
22623177,2012-05-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22623177,2012-05-24T00:00:00,Pregnancy,G08.686.785.760.769
22623177,2012-05-24T00:00:00,Pregnancy Complications,C13.703
22623177,2012-05-24T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
22623177,2012-05-24T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
22623177,2012-05-24T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
22623177,2012-05-24T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
22623177,2012-05-24T00:00:00,Vitamin D,D04.808.812.768
22623177,2012-05-24T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
22627120,2012-05-24T00:00:00,Adolescent,M01.060.057
22627120,2012-05-24T00:00:00,Child,M01.060.406
22627120,2012-05-24T00:00:00,"Child, Preschool",M01.060.406.448
22627120,2012-05-24T00:00:00,Cholecalciferol,D04.808.247.222.159
22627120,2012-05-24T00:00:00,Cholecalciferol,D04.808.247.808.146
22627120,2012-05-24T00:00:00,Cholecalciferol,D04.808.812.768.196
22627120,2012-05-24T00:00:00,Cholecalciferol,D10.570.938.146
22627120,2012-05-24T00:00:00,Chronic Disease,C23.550.291.500
22627120,2012-05-24T00:00:00,Dendritic Cells,A11.066.270
22627120,2012-05-24T00:00:00,Dendritic Cells,A11.436.270
22627120,2012-05-24T00:00:00,Dendritic Cells,A15.382.066.270
22627120,2012-05-24T00:00:00,Dendritic Cells,A15.382.812.260
22627120,2012-05-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22627120,2012-05-24T00:00:00,Nasal Polyps,C08.460.572
22627120,2012-05-24T00:00:00,Nasal Polyps,C09.603.557
22627120,2012-05-24T00:00:00,Nasal Polyps,C23.300.825.557
22627120,2012-05-24T00:00:00,Sinusitis,C08.460.692.752
22627120,2012-05-24T00:00:00,Sinusitis,C08.730.749
22627120,2012-05-24T00:00:00,Sinusitis,C09.603.692.752
22627120,2012-05-24T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
22627990,2012-05-24T00:00:00,Cardiovascular Diseases,C14
22627990,2012-05-24T00:00:00,Health Personnel,M01.526.485
22627990,2012-05-24T00:00:00,Health Personnel,N02.360
22627990,2012-05-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22627990,2012-05-24T00:00:00,Risk Factors,E05.318.740.600.800.725
22627990,2012-05-24T00:00:00,Risk Factors,N05.715.350.200.700
22627990,2012-05-24T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22627990,2012-05-24T00:00:00,Risk Factors,N06.850.490.625.750
22627990,2012-05-24T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22627990,2012-05-24T00:00:00,Stroke,C10.228.140.300.775
22627990,2012-05-24T00:00:00,Stroke,C14.907.253.855
22627990,2012-05-24T00:00:00,United States,Z01.107.567.875
22628406,2012-05-24T00:00:00,Delivery of Health Care,N04.590.374
22628406,2012-05-24T00:00:00,Delivery of Health Care,N05.300
22628406,2012-05-24T00:00:00,Famous Persons,K01.517.211.506
22628406,2012-05-24T00:00:00,Famous Persons,M01.228
22628406,2012-05-24T00:00:00,"History, 20th Century",K01.400.504.968
22628406,2012-05-24T00:00:00,Hospitals,N02.278.421
22628406,2012-05-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22628406,2012-05-24T00:00:00,"Literature, Modern",K01.517.533
22628406,2012-05-24T00:00:00,Medicine in Literature,K01.517.584
22628406,2012-05-24T00:00:00,Physicians,M01.526.485.810
22628406,2012-05-24T00:00:00,Physicians,N02.360.810
22628406,2012-05-24T00:00:00,Publishing,L01.737
22628406,2012-05-24T00:00:00,Writing,L01.143.506.423.906
22628546,2012-05-24T00:00:00,Brain Neoplasms,C04.588.614.250.195
22628546,2012-05-24T00:00:00,Brain Neoplasms,C10.228.140.211
22628546,2012-05-24T00:00:00,Brain Neoplasms,C10.551.240.250
22628546,2012-05-24T00:00:00,Endoplasmic Reticulum,A11.284.430.214.190.875.248
22628546,2012-05-24T00:00:00,Glioma,C04.557.465.625.600.380
22628546,2012-05-24T00:00:00,Glioma,C04.557.470.670.380
22628546,2012-05-24T00:00:00,Glioma,C04.557.580.625.600.380
22628546,2012-05-24T00:00:00,Heat-Shock Proteins,D12.776.580.216
22628546,2012-05-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22628546,2012-05-24T00:00:00,Lysine,D12.125.068.555
22628546,2012-05-24T00:00:00,Lysine,D12.125.095.647
22628546,2012-05-24T00:00:00,Lysine,D12.125.142.497
22628546,2012-05-24T00:00:00,Membrane Proteins,D12.776.543
22628546,2012-05-24T00:00:00,Plasmids,G05.360.600
22628546,2012-05-24T00:00:00,Protein Folding,G01.154.100.640
22628546,2012-05-24T00:00:00,Protein Folding,G01.595.100.640
22628546,2012-05-24T00:00:00,Protein Folding,G02.111.087.690
22628546,2012-05-24T00:00:00,Protein Folding,G02.149.115.690
22628546,2012-05-24T00:00:00,"Protein Processing, Post-Translational",G02.111.087.675.871.790.600
22628546,2012-05-24T00:00:00,"Protein Processing, Post-Translational",G02.111.087.693.600
22628546,2012-05-24T00:00:00,"Protein Processing, Post-Translational",G02.149.115.675.871.790.600
22628546,2012-05-24T00:00:00,"Protein Processing, Post-Translational",G02.149.115.693.600
22628546,2012-05-24T00:00:00,"Protein Processing, Post-Translational",G03.495.770.871.790.600
22628546,2012-05-24T00:00:00,"Protein Processing, Post-Translational",G05.355.315.670.600
22628546,2012-05-24T00:00:00,Proteomics,H01.158.201.843
22628546,2012-05-24T00:00:00,Proteomics,H01.158.273.180.350.700
22628546,2012-05-24T00:00:00,Proteomics,H01.158.273.343.350.700
22628546,2012-05-24T00:00:00,Proteomics,H01.181.122.738
22748250,2012-05-24T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.350.700.715.200.200
22748250,2012-05-24T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.200.200
22748250,2012-05-24T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.250.200
22748250,2012-05-24T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.388.250.250.160
22748250,2012-05-24T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.210.240.160
22748250,2012-05-24T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.800.250.250.160
22748250,2012-05-24T00:00:00,Clinical Competence,I02.399.630.210
22748250,2012-05-24T00:00:00,Clinical Competence,N04.761.210
22748250,2012-05-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22748250,2012-05-24T00:00:00,Patient Selection,E05.581.500.653
22748250,2012-05-24T00:00:00,Patient Selection,N04.590.731
22748250,2012-05-24T00:00:00,Risk Assessment,E05.318.740.600.800.715
22748250,2012-05-24T00:00:00,Risk Assessment,N04.452.871.715
22748250,2012-05-24T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
22748250,2012-05-24T00:00:00,Risk Assessment,N06.850.505.715
22748250,2012-05-24T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
22748250,2012-05-24T00:00:00,Risk Factors,E05.318.740.600.800.725
22748250,2012-05-24T00:00:00,Risk Factors,N05.715.350.200.700
22748250,2012-05-24T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22748250,2012-05-24T00:00:00,Risk Factors,N06.850.490.625.750
22748250,2012-05-24T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22633979,2012-05-26T00:00:00,Animals,B01.050
22633979,2012-05-26T00:00:00,Electric Stimulation Therapy,E02.342
22633979,2012-05-26T00:00:00,Electric Stimulation Therapy,E02.779.468
22633979,2012-05-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22633979,2012-05-26T00:00:00,Motor Cortex,A08.186.211.730.885.287.500.270.548
22633979,2012-05-26T00:00:00,Pain,C10.597.617
22633979,2012-05-26T00:00:00,Pain,C23.888.592.612
22633979,2012-05-26T00:00:00,Pain,C23.888.646
22633979,2012-05-26T00:00:00,Pain,F02.830.816.444
22633979,2012-05-26T00:00:00,Pain,G11.561.600.810.444
22633979,2012-05-26T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
22633979,2012-05-26T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
22633979,2012-05-26T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
22631436,2012-05-28T00:00:00,Fibromyalgia,C05.651.324
22631436,2012-05-28T00:00:00,Fibromyalgia,C05.799.321
22631436,2012-05-28T00:00:00,Fibromyalgia,C10.668.491.425
22631436,2012-05-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22631436,2012-05-28T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
22631436,2012-05-28T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
22640366,2012-05-28T00:00:00,Animals,B01.050
22640366,2012-05-28T00:00:00,Biological Markers,D23.101
22640366,2012-05-28T00:00:00,Drug Interactions,G07.690.812.240
22640366,2012-05-28T00:00:00,Drug Interactions,G07.700.680.240
22640366,2012-05-28T00:00:00,Environmental Exposure,N06.850.460.350
22640366,2012-05-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22640366,2012-05-28T00:00:00,"Hydrocarbons, Halogenated",D02.455.526
22640366,2012-05-28T00:00:00,"Models, Biological",E05.599.395
22640366,2012-05-28T00:00:00,Nonlinear Dynamics,E05.599.850
22640366,2012-05-28T00:00:00,Nonlinear Dynamics,H01.548.675
22640366,2012-05-28T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22640366,2012-05-28T00:00:00,Risk Assessment,E05.318.740.600.800.715
22640366,2012-05-28T00:00:00,Risk Assessment,N04.452.871.715
22640366,2012-05-28T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
22640366,2012-05-28T00:00:00,Risk Assessment,N06.850.505.715
22640366,2012-05-28T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
22641388,2012-05-28T00:00:00,Bacteria,B03
22641388,2012-05-28T00:00:00,Electrolytes,D01.248
22641388,2012-05-28T00:00:00,Phenotype,G05.695
22641388,2012-05-28T00:00:00,Polylysine,D12.125.068.555.750
22641388,2012-05-28T00:00:00,Polylysine,D12.125.095.647.750
22641388,2012-05-28T00:00:00,Polylysine,D12.644.760
22641388,2012-05-28T00:00:00,Water,D01.455.900
22641388,2012-05-28T00:00:00,Water,D01.650.550.925
22642270,2012-05-29T00:00:00,Algorithms,G17.035
22642270,2012-05-29T00:00:00,Algorithms,L01.224.050
22642270,2012-05-29T00:00:00,Clinical Competence,I02.399.630.210
22642270,2012-05-29T00:00:00,Clinical Competence,N04.761.210
22642270,2012-05-29T00:00:00,"Decision Support Systems, Clinical",L01.700.508.300.190
22642270,2012-05-29T00:00:00,"Education, Medical, Graduate",I02.358.337.350
22642270,2012-05-29T00:00:00,"Education, Medical, Graduate",I02.358.399.350
22642270,2012-05-29T00:00:00,Educational Measurement,I02.399
22642270,2012-05-29T00:00:00,Geriatrics,H02.403.355
22642270,2012-05-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22642270,2012-05-29T00:00:00,Internal Medicine,H02.403.429
22642270,2012-05-29T00:00:00,Internship and Residency,I02.358.399.644
22642270,2012-05-29T00:00:00,Program Evaluation,E05.337.820
22642270,2012-05-29T00:00:00,Program Evaluation,N04.761.685
22642270,2012-05-29T00:00:00,Program Evaluation,N05.715.360.650
22642270,2012-05-29T00:00:00,"Quality Assurance, Health Care",N04.761.700
22642270,2012-05-29T00:00:00,"Quality Assurance, Health Care",N05.700
22642270,2012-05-29T00:00:00,Quality of Life,I01.800
22642270,2012-05-29T00:00:00,Quality of Life,K01.752.400.750
22642270,2012-05-29T00:00:00,South Carolina,Z01.107.567.875.075.662
22642270,2012-05-29T00:00:00,South Carolina,Z01.107.567.875.750.700
22643798,2012-05-29T00:00:00,Aged,M01.060.116.100
22643798,2012-05-29T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
22643798,2012-05-29T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
22643798,2012-05-29T00:00:00,Bone Malalignment,C05.116.214
22643798,2012-05-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22643798,2012-05-29T00:00:00,Knee Joint,A02.835.583.475
22643798,2012-05-29T00:00:00,Knee Prosthesis,E07.695.400.410
22643798,2012-05-29T00:00:00,Patient Satisfaction,N04.452.822.360.600
22643798,2012-05-29T00:00:00,Patient Satisfaction,N05.300.150.600.630
22643798,2012-05-29T00:00:00,Patient Satisfaction,N05.715.360.600
22643798,2012-05-29T00:00:00,Postoperative Complications,C23.550.767
22643798,2012-05-29T00:00:00,Prosthesis Design,E05.320.550
22643798,2012-05-29T00:00:00,Prosthesis Design,E07.695.680
22643798,2012-05-29T00:00:00,Recovery of Function,G16.757
22643798,2012-05-29T00:00:00,Treatment Outcome,E01.789.800
22643798,2012-05-29T00:00:00,Treatment Outcome,N04.761.559.590.800
22643798,2012-05-29T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22659736,2012-05-29T00:00:00,Animals,B01.050
22659736,2012-05-29T00:00:00,Apoptosis,G04.299.139.160
22659736,2012-05-29T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
22659736,2012-05-29T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
22659736,2012-05-29T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
22659736,2012-05-29T00:00:00,Cell Division,G04.299.134.220
22659736,2012-05-29T00:00:00,Cell Division,G04.299.233.750.500
22659736,2012-05-29T00:00:00,Cell Division,G05.355.105
22659736,2012-05-29T00:00:00,Cell Division,G07.700.320.249.410.750.500
22659736,2012-05-29T00:00:00,Cell Movement,G04.299.283
22659736,2012-05-29T00:00:00,Cell Movement,G07.700.560.500.180
22659736,2012-05-29T00:00:00,Cell Proliferation,G04.299.233.750
22659736,2012-05-29T00:00:00,Cell Proliferation,G07.700.320.249.410.750
22659736,2012-05-29T00:00:00,Cell Survival,G04.299.316
22659736,2012-05-29T00:00:00,Fruit,A18.024.500
22659736,2012-05-29T00:00:00,Fruit,J02.500.562
22659736,2012-05-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22659736,2012-05-29T00:00:00,Lung Neoplasms,C04.588.894.797.520
22659736,2012-05-29T00:00:00,Lung Neoplasms,C08.381.540
22659736,2012-05-29T00:00:00,Lung Neoplasms,C08.785.520
22659736,2012-05-29T00:00:00,NF-kappa B,D12.776.260.600
22659736,2012-05-29T00:00:00,NF-kappa B,D12.776.660.600
22659736,2012-05-29T00:00:00,NF-kappa B,D12.776.930.600
22659736,2012-05-29T00:00:00,Neoplasm Invasiveness,C04.697.645
22659736,2012-05-29T00:00:00,Neoplasm Invasiveness,C23.550.727.645
22659736,2012-05-29T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
22659736,2012-05-29T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
22659736,2012-05-29T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
22659736,2012-05-29T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
22659736,2012-05-29T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
22659736,2012-05-29T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
22659736,2012-05-29T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
22659736,2012-05-29T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
22659736,2012-05-29T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
22659736,2012-05-29T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
22659736,2012-05-29T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
22659736,2012-05-29T00:00:00,bcl-Associated Death Protein,D12.644.360.075.718.100
22659736,2012-05-29T00:00:00,bcl-Associated Death Protein,D12.776.476.075.718.100
22659736,2012-05-29T00:00:00,bcl-Associated Death Protein,D12.776.744.049
22643849,2012-05-30T00:00:00,Animals,B01.050
22643849,2012-05-30T00:00:00,"Antigens, CD",D23.050.301.264.035
22643849,2012-05-30T00:00:00,"Antigens, CD",D23.101.100.110
22643849,2012-05-30T00:00:00,Cell Differentiation,G04.299.151
22643849,2012-05-30T00:00:00,Cell Lineage,G04.172
22643849,2012-05-30T00:00:00,Cell Lineage,G07.700.320.500.325.180.500
22643849,2012-05-30T00:00:00,Cell Lineage,G08.686.155
22643849,2012-05-30T00:00:00,Cell Lineage,G08.686.785.760.170.104.249
22643849,2012-05-30T00:00:00,Colon,A03.556.124.526.356
22643849,2012-05-30T00:00:00,Colon,A03.556.249.249.356
22643849,2012-05-30T00:00:00,Dendritic Cells,A11.066.270
22643849,2012-05-30T00:00:00,Dendritic Cells,A11.436.270
22643849,2012-05-30T00:00:00,Dendritic Cells,A15.382.066.270
22643849,2012-05-30T00:00:00,Dendritic Cells,A15.382.812.260
22643849,2012-05-30T00:00:00,Gene Expression Regulation,G05.355.315
22643849,2012-05-30T00:00:00,Macaca mulatta,B01.050.150.900.649.801.400.112.199.120.510.550
22643849,2012-05-30T00:00:00,Simian Acquired Immunodeficiency Syndrome,C02.782.815.616.850
22643849,2012-05-30T00:00:00,Simian Acquired Immunodeficiency Syndrome,C02.839.850
22643849,2012-05-30T00:00:00,Simian Acquired Immunodeficiency Syndrome,C22.735.500.850
22659213,2012-05-30T00:00:00,"Arrhythmias, Cardiac",C14.280.067
22659213,2012-05-30T00:00:00,"Arrhythmias, Cardiac",C23.550.073
22659213,2012-05-30T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
22659213,2012-05-30T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
22659213,2012-05-30T00:00:00,"Defibrillators, Implantable",E07.695.175
22659213,2012-05-30T00:00:00,Hemoglobins,D12.776.124.400
22659213,2012-05-30T00:00:00,Hemoglobins,D12.776.422.316.762
22659213,2012-05-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22659213,2012-05-30T00:00:00,"Muscle, Skeletal",A02.633.567
22659213,2012-05-30T00:00:00,"Muscle, Skeletal",A10.690.552.500
22659213,2012-05-30T00:00:00,"Spectroscopy, Near-Infrared",E01.370.350.750
22659213,2012-05-30T00:00:00,"Spectroscopy, Near-Infrared",E05.196.867.851
22666364,2012-05-30T00:00:00,Animals,B01.050
22666364,2012-05-30T00:00:00,Attention,F02.830.104.214
22666364,2012-05-30T00:00:00,Cognition,F02.463.188
22666364,2012-05-30T00:00:00,Ethanol,D02.033.375
22666364,2012-05-30T00:00:00,Neuronal Plasticity,G11.561.600.635
22666364,2012-05-30T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
22666364,2012-05-30T00:00:00,"Receptors, AMPA",D12.776.543.750.720.200.450.200
22666364,2012-05-30T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
22666364,2012-05-30T00:00:00,Synapses,A08.850
22666364,2012-05-30T00:00:00,Synapses,A11.284.149.165.420.780
22666364,2012-05-30T00:00:00,Time Factors,G01.910.857
22540279,2012-05-31T00:00:00,Adult,M01.060.116
22540279,2012-05-31T00:00:00,Aged,M01.060.116.100
22540279,2012-05-31T00:00:00,Hematopoietic Stem Cells,A11.148.378
22540279,2012-05-31T00:00:00,Hematopoietic Stem Cells,A11.872.378
22540279,2012-05-31T00:00:00,Hematopoietic Stem Cells,A15.378.316.378
22540279,2012-05-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22540279,2012-05-31T00:00:00,Middle Aged,M01.060.116.630
22540279,2012-05-31T00:00:00,Multiple Myeloma,C04.557.595.500
22540279,2012-05-31T00:00:00,Multiple Myeloma,C14.907.454.460
22540279,2012-05-31T00:00:00,Multiple Myeloma,C15.378.147.780.650
22540279,2012-05-31T00:00:00,Multiple Myeloma,C15.378.463.835.460
22540279,2012-05-31T00:00:00,Multiple Myeloma,C20.683.515.845
22540279,2012-05-31T00:00:00,Multiple Myeloma,C20.683.780.650
22540279,2012-05-31T00:00:00,Time Factors,G01.910.857
22574971,2012-05-31T00:00:00,Adult,M01.060.116
22574971,2012-05-31T00:00:00,Age Factors,N05.715.350.075
22574971,2012-05-31T00:00:00,Age Factors,N06.850.490.250
22574971,2012-05-31T00:00:00,Aged,M01.060.116.100
22574971,2012-05-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22574971,2012-05-31T00:00:00,"In Situ Hybridization, Fluorescence",E05.200.500.620.670.325.350
22574971,2012-05-31T00:00:00,"In Situ Hybridization, Fluorescence",E05.200.750.600.670.325.350
22574971,2012-05-31T00:00:00,"In Situ Hybridization, Fluorescence",E05.393.285.350
22574971,2012-05-31T00:00:00,"In Situ Hybridization, Fluorescence",E05.393.661.475.350
22574971,2012-05-31T00:00:00,Middle Aged,M01.060.116.630
22574971,2012-05-31T00:00:00,Multiple Myeloma,C04.557.595.500
22574971,2012-05-31T00:00:00,Multiple Myeloma,C14.907.454.460
22574971,2012-05-31T00:00:00,Multiple Myeloma,C15.378.147.780.650
22574971,2012-05-31T00:00:00,Multiple Myeloma,C15.378.463.835.460
22574971,2012-05-31T00:00:00,Multiple Myeloma,C20.683.515.845
22574971,2012-05-31T00:00:00,Multiple Myeloma,C20.683.780.650
22574971,2012-05-31T00:00:00,Risk Assessment,E05.318.740.600.800.715
22574971,2012-05-31T00:00:00,Risk Assessment,N04.452.871.715
22574971,2012-05-31T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
22574971,2012-05-31T00:00:00,Risk Assessment,N06.850.505.715
22574971,2012-05-31T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
22574971,2012-05-31T00:00:00,Risk Factors,E05.318.740.600.800.725
22574971,2012-05-31T00:00:00,Risk Factors,N05.715.350.200.700
22574971,2012-05-31T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22574971,2012-05-31T00:00:00,Risk Factors,N06.850.490.625.750
22574971,2012-05-31T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22574971,2012-05-31T00:00:00,"Translocation, Genetic",C23.550.210.870
22574971,2012-05-31T00:00:00,"Translocation, Genetic",G05.355.600.860
22574971,2012-05-31T00:00:00,"Translocation, Genetic",G05.365.590.175.870
22574971,2012-05-31T00:00:00,Young Adult,M01.060.116.815
22612451,2012-05-31T00:00:00,Animals,B01.050
22612451,2012-05-31T00:00:00,Calcium,D01.268.552.100
22612451,2012-05-31T00:00:00,Calcium,D01.552.539.288
22612451,2012-05-31T00:00:00,Calcium,D23.119.100
22612451,2012-05-31T00:00:00,Calpain,D08.811.277.656.262.500.120
22612451,2012-05-31T00:00:00,Calpain,D08.811.277.656.300.200.120
22612451,2012-05-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22612451,2012-05-31T00:00:00,Kidney,A05.810.453
22612451,2012-05-31T00:00:00,Mitochondria,A11.284.430.214.190.875.564
22612451,2012-05-31T00:00:00,Mitochondria,A11.284.835.626
22612451,2012-05-31T00:00:00,"Models, Molecular",E05.599.595
22612451,2012-05-31T00:00:00,Peptides,D12.644
22612451,2012-05-31T00:00:00,Protein Conformation,G02.111.570.790.709
22612451,2012-05-31T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22653078,2012-05-31T00:00:00,Clinical Competence,I02.399.630.210
22653078,2012-05-31T00:00:00,Clinical Competence,N04.761.210
22653078,2012-05-31T00:00:00,Communication,F01.145.209
22653078,2012-05-31T00:00:00,Communication,L01.143
22653078,2012-05-31T00:00:00,Feedback,L01.143.283.425
22653078,2012-05-31T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
22653078,2012-05-31T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
22653078,2012-05-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22653078,2012-05-31T00:00:00,Perception,F02.463.593
22653078,2012-05-31T00:00:00,Physician-Patient Relations,F01.829.401.650.675
22653078,2012-05-31T00:00:00,Physician-Patient Relations,N05.300.660.625
22653078,2012-05-31T00:00:00,Quality of Health Care,N04.761
22653078,2012-05-31T00:00:00,Quality of Health Care,N05.715
22657748,2012-05-31T00:00:00,Adult,M01.060.116
22657748,2012-05-31T00:00:00,Central Nervous System Stimulants,D27.505.696.282
22657748,2012-05-31T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
22657748,2012-05-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22657748,2012-05-31T00:00:00,Middle Aged,M01.060.116.630
22657748,2012-05-31T00:00:00,Patient Compliance,F01.145.488.500
22657748,2012-05-31T00:00:00,Patient Compliance,N05.300.150.600.600
22657748,2012-05-31T00:00:00,Referral and Consultation,N04.452.758.849
22657748,2012-05-31T00:00:00,Self-Help Groups,N03.540.782
22657748,2012-05-31T00:00:00,Substance Abuse Detection,E05.885
22657748,2012-05-31T00:00:00,Substance Abuse Detection,N06.850.780.500.765
22657748,2012-05-31T00:00:00,Substance-Related Disorders,C21.739
22657748,2012-05-31T00:00:00,Substance-Related Disorders,F03.900
22657748,2012-05-31T00:00:00,Time Factors,G01.910.857
22657748,2012-05-31T00:00:00,Treatment Outcome,E01.789.800
22657748,2012-05-31T00:00:00,Treatment Outcome,N04.761.559.590.800
22657748,2012-05-31T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22657748,2012-05-31T00:00:00,United States,Z01.107.567.875
21249467,2012-06-01T00:00:00,Adult,M01.060.116
21249467,2012-06-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
21249467,2012-06-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
21249467,2012-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21249467,2012-06-01T00:00:00,Interleukin-10,D12.644.276.374.465.510
21249467,2012-06-01T00:00:00,Interleukin-10,D12.776.467.374.465.510
21249467,2012-06-01T00:00:00,Interleukin-10,D23.529.374.465.510
21249467,2012-06-01T00:00:00,Interleukin-4,D12.644.276.374.465.504
21249467,2012-06-01T00:00:00,Interleukin-4,D12.776.467.374.465.504
21249467,2012-06-01T00:00:00,Interleukin-4,D23.529.374.465.504
21249467,2012-06-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
21249467,2012-06-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
21249467,2012-06-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
21249467,2012-06-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
21249467,2012-06-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
21249467,2012-06-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
21249467,2012-06-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
21249467,2012-06-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
21249467,2012-06-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
21249467,2012-06-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
21249467,2012-06-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
21249467,2012-06-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
21953328,2012-06-01T00:00:00,Attitude to Health,F01.100.150
21953328,2012-06-01T00:00:00,Attitude to Health,N05.300.150
21953328,2012-06-01T00:00:00,Health Services Accessibility,N04.590.374.350
21953328,2012-06-01T00:00:00,Health Services Accessibility,N05.300.430
21953328,2012-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21953328,2012-06-01T00:00:00,South Carolina,Z01.107.567.875.075.662
21953328,2012-06-01T00:00:00,South Carolina,Z01.107.567.875.750.700
22300406,2012-06-01T00:00:00,Age Factors,N05.715.350.075
22300406,2012-06-01T00:00:00,Age Factors,N06.850.490.250
22300406,2012-06-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
22300406,2012-06-01T00:00:00,Alzheimer Disease,C10.574.945.249
22300406,2012-06-01T00:00:00,Alzheimer Disease,F03.087.400.100
22300406,2012-06-01T00:00:00,Gene Expression Regulation,G05.355.315
22300406,2012-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22300406,2012-06-01T00:00:00,"Models, Biological",E05.599.395
22300406,2012-06-01T00:00:00,Risk Factors,E05.318.740.600.800.725
22300406,2012-06-01T00:00:00,Risk Factors,N05.715.350.200.700
22300406,2012-06-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22300406,2012-06-01T00:00:00,Risk Factors,N06.850.490.625.750
22300406,2012-06-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22351876,2012-06-01T00:00:00,Adult,M01.060.116
22351876,2012-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22351876,2012-06-01T00:00:00,Kidney Transplantation,E02.870.500
22351876,2012-06-01T00:00:00,Kidney Transplantation,E04.936.450.485
22351876,2012-06-01T00:00:00,Kidney Transplantation,E04.950.774.400
22351876,2012-06-01T00:00:00,Middle Aged,M01.060.116.630
22351876,2012-06-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
22351876,2012-06-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
22351876,2012-06-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
22351876,2012-06-01T00:00:00,Risk Assessment,N04.452.871.715
22351876,2012-06-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
22351876,2012-06-01T00:00:00,Risk Assessment,N06.850.505.715
22351876,2012-06-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
22351876,2012-06-01T00:00:00,United States,Z01.107.567.875
22481166,2012-06-01T00:00:00,Adult,M01.060.116
22481166,2012-06-01T00:00:00,African Americans,M01.686.508.100.100
22481166,2012-06-01T00:00:00,African Americans,M01.686.754.100
22481166,2012-06-01T00:00:00,Coronary Artery Disease,C14.280.647.250.260
22481166,2012-06-01T00:00:00,Coronary Artery Disease,C14.907.137.126.339
22481166,2012-06-01T00:00:00,Coronary Artery Disease,C14.907.585.250.260
22481166,2012-06-01T00:00:00,HIV Infections,C02.782.815.616.400
22481166,2012-06-01T00:00:00,HIV Infections,C02.800.801.400
22481166,2012-06-01T00:00:00,HIV Infections,C20.673.480
22481166,2012-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22481166,2012-06-01T00:00:00,Middle Aged,M01.060.116.630
22481166,2012-06-01T00:00:00,Risk Factors,E05.318.740.600.800.725
22481166,2012-06-01T00:00:00,Risk Factors,N05.715.350.200.700
22481166,2012-06-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22481166,2012-06-01T00:00:00,Risk Factors,N06.850.490.625.750
22481166,2012-06-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22481166,2012-06-01T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
22510634,2012-06-01T00:00:00,Antiviral Agents,D27.505.954.122.388
22510634,2012-06-01T00:00:00,Breast Feeding,G07.610.220.500.500
22510634,2012-06-01T00:00:00,Breast Feeding,G07.610.593.185
22510634,2012-06-01T00:00:00,Breast Feeding,G07.700.620.185
22510634,2012-06-01T00:00:00,"Fetal Membranes, Premature Rupture",C13.703.420.339
22510634,2012-06-01T00:00:00,Herpes Simplex,C02.256.466.382
22510634,2012-06-01T00:00:00,Herpes Simplex,C02.825.320
22510634,2012-06-01T00:00:00,Herpes Simplex,C17.800.838.790.320
22510634,2012-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22510634,2012-06-01T00:00:00,"Infant, Newborn",M01.060.703.520
22510634,2012-06-01T00:00:00,"Infectious Disease Transmission, Vertical",N06.850.310.425
22510634,2012-06-01T00:00:00,Pregnancy,G08.686.785.760.769
22510634,2012-06-01T00:00:00,"Pregnancy Complications, Infectious",C01.539.674
22510634,2012-06-01T00:00:00,"Pregnancy Complications, Infectious",C13.703.700
22510634,2012-06-01T00:00:00,Premature Birth,C13.703.420.491.500
22515557,2012-06-01T00:00:00,Cardiovascular Diseases,C14
22515557,2012-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22515557,2012-06-01T00:00:00,Perioperative Care,E02.760.722
22515557,2012-06-01T00:00:00,Perioperative Care,E04.604
22515557,2012-06-01T00:00:00,Perioperative Care,N02.421.585.722
22515557,2012-06-01T00:00:00,Propanolamines,D02.033.100.624
22515557,2012-06-01T00:00:00,Propanolamines,D02.033.755.624
22515557,2012-06-01T00:00:00,Propanolamines,D02.092.063.624
22528636,2012-06-01T00:00:00,Adult,M01.060.116
22528636,2012-06-01T00:00:00,Community Networks,I01.880.656.300
22528636,2012-06-01T00:00:00,Community Networks,L01.700.508.300.184
22528636,2012-06-01T00:00:00,Community Networks,N02.421.143.202
22528636,2012-06-01T00:00:00,Community-Based Participatory Research,N05.425.104
22528636,2012-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22528636,2012-06-01T00:00:00,Middle Aged,M01.060.116.630
22528636,2012-06-01T00:00:00,Minority Groups,I01.880.371
22528636,2012-06-01T00:00:00,Neoplasms,C04
22549320,2012-06-01T00:00:00,"Data Interpretation, Statistical",E05.245.380
22549320,2012-06-01T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
22549320,2012-06-01T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
22549320,2012-06-01T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
22549320,2012-06-01T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
22549320,2012-06-01T00:00:00,Radiation Monitoring,E05.799.638
22549320,2012-06-01T00:00:00,Radiation Monitoring,N06.850.780.375.700
22549320,2012-06-01T00:00:00,Radiation Monitoring,N06.850.810.370
22549320,2012-06-01T00:00:00,Time Factors,G01.910.857
22608815,2012-06-01T00:00:00,Dislocations,C21.866.289
22608815,2012-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22608815,2012-06-01T00:00:00,Temporomandibular Joint Disorders,C05.500.607.221.897
22608815,2012-06-01T00:00:00,Temporomandibular Joint Disorders,C05.550.905
22608815,2012-06-01T00:00:00,Temporomandibular Joint Disorders,C05.651.243.897
22608815,2012-06-01T00:00:00,Temporomandibular Joint Disorders,C07.320.610.291.897
22608815,2012-06-01T00:00:00,Temporomandibular Joint Disorders,C07.678
22623692,2012-06-01T00:00:00,Adult,M01.060.116
22623692,2012-06-01T00:00:00,Aged,M01.060.116.100
22623692,2012-06-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
22623692,2012-06-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
22623692,2012-06-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
22623692,2012-06-01T00:00:00,Breast Neoplasms,C04.588.180
22623692,2012-06-01T00:00:00,Breast Neoplasms,C17.800.090.500
22623692,2012-06-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
22623692,2012-06-01T00:00:00,Clinical Trials as Topic,E05.337.250
22623692,2012-06-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
22623692,2012-06-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
22623692,2012-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22623692,2012-06-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
22623692,2012-06-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
22623692,2012-06-01T00:00:00,Middle Aged,M01.060.116.630
22623692,2012-06-01T00:00:00,Neoplasm Invasiveness,C04.697.645
22623692,2012-06-01T00:00:00,Neoplasm Invasiveness,C23.550.727.645
22623692,2012-06-01T00:00:00,Neoplasm Staging,E01.370.550
22623692,2012-06-01T00:00:00,Treatment Outcome,E01.789.800
22623692,2012-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
22623692,2012-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22632483,2012-06-01T00:00:00,"Ethics, Medical",K01.316.333.132.750
22632483,2012-06-01T00:00:00,"Ethics, Medical",N05.350.340.162.500
22632483,2012-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22632483,2012-06-01T00:00:00,Informed Consent,I01.880.604.473.650.718
22632483,2012-06-01T00:00:00,Informed Consent,I01.880.604.583.427
22632483,2012-06-01T00:00:00,Informed Consent,N03.706.437.650.312
22632483,2012-06-01T00:00:00,Informed Consent,N03.706.535.489
22632483,2012-06-01T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
22632483,2012-06-01T00:00:00,Tissue Donors,M01.898
22632483,2012-06-01T00:00:00,Tissue and Organ Procurement,N02.421.911
22632483,2012-06-01T00:00:00,United States,Z01.107.567.875
22633307,2012-06-01T00:00:00,Case-Control Studies,E05.318.760.500.500
22633307,2012-06-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
22633307,2012-06-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
22633307,2012-06-01T00:00:00,Echocardiography,E01.370.350.850.220
22633307,2012-06-01T00:00:00,Echocardiography,E01.370.370.380.220
22633307,2012-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22633307,2012-06-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
22633307,2012-06-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
22633307,2012-06-01T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
22633307,2012-06-01T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
22633307,2012-06-01T00:00:00,Middle Aged,M01.060.116.630
22633307,2012-06-01T00:00:00,Takotsubo Cardiomyopathy,C14.280.945.900.500
22633307,2012-06-01T00:00:00,Tissue Inhibitor of Metalloproteinases,D12.776.926
22641642,2012-06-01T00:00:00,Animals,B01.050
22641642,2012-06-01T00:00:00,Cell Membrane,A11.284.149
22641642,2012-06-01T00:00:00,Light,G01.201.875.770.578
22641642,2012-06-01T00:00:00,Light,G01.590.540
22641642,2012-06-01T00:00:00,Retinal Rod Photoreceptor Cells,A08.663.650.850.625.670.650
22641642,2012-06-01T00:00:00,Retinal Rod Photoreceptor Cells,A08.663.650.915.937.670.650
22641642,2012-06-01T00:00:00,Retinal Rod Photoreceptor Cells,A08.800.950.937.670.650
22641642,2012-06-01T00:00:00,Retinal Rod Photoreceptor Cells,A09.371.729.831.625.670.650
22641642,2012-06-01T00:00:00,Retinal Rod Photoreceptor Cells,A11.671.650.850.625.670.650
22641642,2012-06-01T00:00:00,Retinal Rod Photoreceptor Cells,A11.671.650.915.937.670.650
22641642,2012-06-01T00:00:00,Retinaldehyde,D02.047.850
22641642,2012-06-01T00:00:00,Retinaldehyde,D02.455.326.271.665.202.495.690
22641642,2012-06-01T00:00:00,Retinaldehyde,D02.455.426.392.368.367.379.249.700.690
22641642,2012-06-01T00:00:00,Retinaldehyde,D02.455.849.131.495.690
22641642,2012-06-01T00:00:00,Retinaldehyde,D23.767.261.700.690
22641642,2012-06-01T00:00:00,Retinoids,D02.455.326.271.665.202.495
22641642,2012-06-01T00:00:00,Retinoids,D02.455.426.392.368.367.379.249.700
22641642,2012-06-01T00:00:00,Retinoids,D02.455.849.131.495
22641642,2012-06-01T00:00:00,Retinoids,D23.767.261.700
22641642,2012-06-01T00:00:00,Solubility,G02.842.800
22643245,2012-06-01T00:00:00,Adult,M01.060.116
22643245,2012-06-01T00:00:00,"Diagnosis, Differential",E01.171
22643245,2012-06-01T00:00:00,Gastric Bypass,E02.065.062.249
22643245,2012-06-01T00:00:00,Gastric Bypass,E04.035.398.385
22643245,2012-06-01T00:00:00,Gastric Bypass,E04.062.249
22643245,2012-06-01T00:00:00,Gastric Bypass,E04.210.457.430
22643245,2012-06-01T00:00:00,Hernia,C23.300.707
22643245,2012-06-01T00:00:00,Hernia,C23.300.842.500.374
22643245,2012-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22643245,2012-06-01T00:00:00,Laparoscopy,E01.370.388.250.520
22643245,2012-06-01T00:00:00,Laparoscopy,E04.800.250.520
22643245,2012-06-01T00:00:00,Mesocolon,A01.047.025.600.451.535
22643245,2012-06-01T00:00:00,"Obesity, Morbid",C18.654.726.500.700
22643245,2012-06-01T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
22643245,2012-06-01T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
22643245,2012-06-01T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
22643245,2012-06-01T00:00:00,Peritoneal Diseases,C06.844
22643245,2012-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
22643245,2012-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
22643245,2012-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
22643245,2012-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
22643245,2012-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
22643247,2012-06-01T00:00:00,Child,M01.060.406
22643247,2012-06-01T00:00:00,"Diagnosis, Differential",E01.171
22643247,2012-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22643247,2012-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
22643247,2012-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
22643247,2012-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
22643247,2012-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
22643247,2012-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
22653465,2012-06-01T00:00:00,Animals,B01.050
22653465,2012-06-01T00:00:00,Cattle,B01.050.150.900.649.077.380.271
22653465,2012-06-01T00:00:00,Polypropylenes,D02.455.326.271.665.590
22653465,2012-06-01T00:00:00,Polypropylenes,D05.750.716.550
22653465,2012-06-01T00:00:00,Polypropylenes,D25.720.716.550
22653465,2012-06-01T00:00:00,Polypropylenes,J01.637.051.720.716.550
22653465,2012-06-01T00:00:00,Proteins,D12.776
22653465,2012-06-01T00:00:00,"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",E05.196.566.755
22656404,2012-06-01T00:00:00,Adolescent,M01.060.057
22656404,2012-06-01T00:00:00,Child,M01.060.406
22656404,2012-06-01T00:00:00,Communication,F01.145.209
22656404,2012-06-01T00:00:00,Communication,L01.143
22656404,2012-06-01T00:00:00,"Hospitals, Pediatric",N02.278.421.556.437
22656404,2012-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22656404,2012-06-01T00:00:00,Parent-Child Relations,F01.829.263.370.290
22656404,2012-06-01T00:00:00,Parents,F01.829.263.500.320
22656404,2012-06-01T00:00:00,Parents,I01.880.225.500.340
22656404,2012-06-01T00:00:00,Parents,M01.620
22656404,2012-06-01T00:00:00,Pediatrics,H02.403.670
22656404,2012-06-01T00:00:00,Physician-Patient Relations,F01.829.401.650.675
22656404,2012-06-01T00:00:00,Physician-Patient Relations,N05.300.660.625
22656404,2012-06-01T00:00:00,Telemedicine,H02.403.840
22656404,2012-06-01T00:00:00,Telemedicine,L01.178.847.652
22656404,2012-06-01T00:00:00,Telemedicine,N04.590.374.800
22656404,2012-06-01T00:00:00,United States,Z01.107.567.875
22664009,2012-06-01T00:00:00,Adrenal Cortex Hormones,D06.472.040
22664009,2012-06-01T00:00:00,Adult,M01.060.116
22664009,2012-06-01T00:00:00,Graft Rejection,G12.425.901.545.328
22664009,2012-06-01T00:00:00,Graft Survival,G12.425.901.545.340
22664009,2012-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22664009,2012-06-01T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
22664009,2012-06-01T00:00:00,Liver Transplantation,E04.210.650
22664009,2012-06-01T00:00:00,Liver Transplantation,E04.936.450.490
22664009,2012-06-01T00:00:00,Liver Transplantation,E04.936.580.490
22664009,2012-06-01T00:00:00,Middle Aged,M01.060.116.630
22664009,2012-06-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
22664009,2012-06-01T00:00:00,Risk Assessment,N04.452.871.715
22664009,2012-06-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
22664009,2012-06-01T00:00:00,Risk Assessment,N06.850.505.715
22664009,2012-06-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
22664009,2012-06-01T00:00:00,Risk Factors,E05.318.740.600.800.725
22664009,2012-06-01T00:00:00,Risk Factors,N05.715.350.200.700
22664009,2012-06-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22664009,2012-06-01T00:00:00,Risk Factors,N06.850.490.625.750
22664009,2012-06-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22664009,2012-06-01T00:00:00,South Carolina,Z01.107.567.875.075.662
22664009,2012-06-01T00:00:00,South Carolina,Z01.107.567.875.750.700
22664009,2012-06-01T00:00:00,Time Factors,G01.910.857
22664009,2012-06-01T00:00:00,Treatment Outcome,E01.789.800
22664009,2012-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
22664009,2012-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22670023,2012-06-01T00:00:00,Animals,B01.050
22670023,2012-06-01T00:00:00,Cognition Disorders,F03.087.250
22670023,2012-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22670023,2012-06-01T00:00:00,Neuropsychological Tests,F04.711.513
22670023,2012-06-01T00:00:00,Risk Factors,E05.318.740.600.800.725
22670023,2012-06-01T00:00:00,Risk Factors,N05.715.350.200.700
22670023,2012-06-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22670023,2012-06-01T00:00:00,Risk Factors,N06.850.490.625.750
22670023,2012-06-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22670023,2012-06-01T00:00:00,"Sleep Apnea, Obstructive",C08.618.085.852.850
22670023,2012-06-01T00:00:00,"Sleep Apnea, Obstructive",C10.886.425.800.750.850
22672120,2012-06-01T00:00:00,Gonadotropin-Releasing Hormone,D06.472.699.327.740.320
22672120,2012-06-01T00:00:00,Gonadotropin-Releasing Hormone,D12.644.400.400.740.320
22672120,2012-06-01T00:00:00,Gonadotropin-Releasing Hormone,D12.644.456.460
22672120,2012-06-01T00:00:00,Gonadotropin-Releasing Hormone,D12.644.548.365.740.320
22672120,2012-06-01T00:00:00,Gonadotropin-Releasing Hormone,D12.776.641.650.405.740.320
22672120,2012-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22672120,2012-06-01T00:00:00,Oligopeptides,D12.644.456
22672120,2012-06-01T00:00:00,Prostate-Specific Antigen,D08.811.277.656.300.760.442.750
22672120,2012-06-01T00:00:00,Prostate-Specific Antigen,D08.811.277.656.959.350.442.750
22672120,2012-06-01T00:00:00,Prostate-Specific Antigen,D12.776.866.249.500
22672120,2012-06-01T00:00:00,Prostate-Specific Antigen,D23.050.285.625
22672120,2012-06-01T00:00:00,Prostate-Specific Antigen,D23.101.840.625
22672120,2012-06-01T00:00:00,Prostatectomy,E04.950.774.860.625
22672120,2012-06-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
22672120,2012-06-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
22672120,2012-06-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
22672120,2012-06-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
22672120,2012-06-01T00:00:00,Testosterone,D04.808.054.079.429.824
22672120,2012-06-01T00:00:00,Testosterone,D06.472.334.851.968.984
22672120,2012-06-01T00:00:00,Treatment Outcome,E01.789.800
22672120,2012-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
22672120,2012-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22709747,2012-06-01T00:00:00,Heart,A07.541
22709747,2012-06-01T00:00:00,Heart Failure,C14.280.434
22709747,2012-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22709747,2012-06-01T00:00:00,Patient Selection,E05.581.500.653
22709747,2012-06-01T00:00:00,Patient Selection,N04.590.731
22709747,2012-06-01T00:00:00,Research Design,E05.581.500
22709747,2012-06-01T00:00:00,Research Design,H01.770.644.728
22709747,2012-06-01T00:00:00,Treatment Outcome,E01.789.800
22709747,2012-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
22709747,2012-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22709747,2012-06-01T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
22709788,2012-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22709788,2012-06-01T00:00:00,"Infant, Newborn",M01.060.703.520
22709788,2012-06-01T00:00:00,Pregnancy,G08.686.785.760.769
22709788,2012-06-01T00:00:00,Young Adult,M01.060.116.815
22712642,2012-06-01T00:00:00,Aged,M01.060.116.100
22712642,2012-06-01T00:00:00,Attention,F02.830.104.214
22712642,2012-06-01T00:00:00,Cardiovascular Diseases,C14
22712642,2012-06-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
22712642,2012-06-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
22712642,2012-06-01T00:00:00,Executive Function,F02.463.217
22712642,2012-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22712642,2012-06-01T00:00:00,Middle Aged,M01.060.116.630
22712642,2012-06-01T00:00:00,Neuropsychological Tests,F04.711.513
22712642,2012-06-01T00:00:00,"Polymorphism, Genetic",G05.365.795
22712642,2012-06-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
22712642,2012-06-01T00:00:00,Psychometrics,F04.711.780
22712642,2012-06-01T00:00:00,Psychomotor Performance,F02.808
22712642,2012-06-01T00:00:00,Psychomotor Performance,G11.427.700
22712642,2012-06-01T00:00:00,Psychomotor Performance,G11.561.623
22712642,2012-06-01T00:00:00,Reaction Time,F02.830.650
22712642,2012-06-01T00:00:00,Reaction Time,F04.669.817
22712642,2012-06-01T00:00:00,Reaction Time,G11.561.677
22715237,2012-06-01T00:00:00,"Arrhythmias, Cardiac",C14.280.067
22715237,2012-06-01T00:00:00,"Arrhythmias, Cardiac",C23.550.073
22715237,2012-06-01T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
22715237,2012-06-01T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
22715237,2012-06-01T00:00:00,"Defibrillators, Implantable",E07.695.175
22715237,2012-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22755665,2012-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22755665,2012-06-01T00:00:00,Nanotechnology,H01.603
22755665,2012-06-01T00:00:00,Nanotechnology,J01.897.520.600
22755665,2012-06-01T00:00:00,Nanotubes,J01.637.512.850
22755665,2012-06-01T00:00:00,Nickel,D01.268.556.607
22755665,2012-06-01T00:00:00,Nickel,D01.268.956.625
22755665,2012-06-01T00:00:00,Nickel,D01.552.544.607
22755665,2012-06-01T00:00:00,Rheology,E05.830
22755665,2012-06-01T00:00:00,Rheology,H01.671.808
22755680,2012-06-01T00:00:00,Cell Survival,G04.299.316
22755680,2012-06-01T00:00:00,Radiosurgery,E02.815.530
22755680,2012-06-01T00:00:00,Radiosurgery,E04.525.800.650
22755680,2012-06-01T00:00:00,Radiosurgery,E05.873.500
22755680,2012-06-01T00:00:00,"Radiotherapy Planning, Computer-Assisted",E02.950.825
22755680,2012-06-01T00:00:00,"Radiotherapy Planning, Computer-Assisted",L01.700.508.100.710.600.608
22755680,2012-06-01T00:00:00,Time Factors,G01.910.857
22893990,2012-06-01T00:00:00,Animals,B01.050
22893990,2012-06-01T00:00:00,Cardiac Surgical Procedures,E04.100.376
22893990,2012-06-01T00:00:00,Cardiac Surgical Procedures,E04.928.220
22893990,2012-06-01T00:00:00,Dogs,B01.050.150.900.649.147.153.200
22893990,2012-06-01T00:00:00,Extracorporeal Circulation,E04.292
22893990,2012-06-01T00:00:00,"History, 20th Century",K01.400.504.968
22893990,2012-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22893990,2012-06-01T00:00:00,Suction,E04.237.890
23272384,2012-06-01T00:00:00,Consumer Participation,N02.421.143.262
23272384,2012-06-01T00:00:00,Consumer Participation,N03.540.245.360
23272384,2012-06-01T00:00:00,Disaster Planning,N06.230.100.035
23272384,2012-06-01T00:00:00,Federal Government,I01.409.137
23272384,2012-06-01T00:00:00,Federal Government,N03.540.348.500
23272384,2012-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23272384,2012-06-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23272384,2012-06-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23272384,2012-06-01T00:00:00,United States,Z01.107.567.875
23272386,2012-06-01T00:00:00,Civil Defense,I01.451.227
23272386,2012-06-01T00:00:00,Disasters,N06.230.100
23272386,2012-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23272386,2012-06-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23272386,2012-06-01T00:00:00,South Carolina,Z01.107.567.875.750.700
22710029,2012-06-02T00:00:00,Adult,M01.060.116
22710029,2012-06-02T00:00:00,Age of Onset,N05.715.350.075.100
22710029,2012-06-02T00:00:00,Age of Onset,N06.850.490.250.100
22710029,2012-06-02T00:00:00,Cocaine-Related Disorders,C21.739.300
22710029,2012-06-02T00:00:00,Cocaine-Related Disorders,F03.900.300
22710029,2012-06-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22710029,2012-06-02T00:00:00,Impulsive Behavior,F01.145.527
22710029,2012-06-02T00:00:00,Middle Aged,M01.060.116.630
22710029,2012-06-02T00:00:00,Personality Inventory,F04.711.647.513
22710029,2012-06-02T00:00:00,Questionnaires,E05.318.308.750
22710029,2012-06-02T00:00:00,Questionnaires,L01.280.800
22710029,2012-06-02T00:00:00,Questionnaires,N05.715.360.300.695
22710029,2012-06-02T00:00:00,Questionnaires,N06.850.520.308.750
22710029,2012-06-02T00:00:00,Risk Factors,E05.318.740.600.800.725
22710029,2012-06-02T00:00:00,Risk Factors,N05.715.350.200.700
22710029,2012-06-02T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22710029,2012-06-02T00:00:00,Risk Factors,N06.850.490.625.750
22710029,2012-06-02T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22710029,2012-06-02T00:00:00,Substance-Related Disorders,C21.739
22710029,2012-06-02T00:00:00,Substance-Related Disorders,F03.900
22710029,2012-06-02T00:00:00,Young Adult,M01.060.116.815
22632177,2012-06-04T00:00:00,Adsorption,G02.149.047
22632177,2012-06-04T00:00:00,Adsorption,G02.149.767.029
22632177,2012-06-04T00:00:00,Adsorption,G02.842.750.029
22632177,2012-06-04T00:00:00,Amines,D02.092
22632177,2012-06-04T00:00:00,Gold,D01.268.556.322
22632177,2012-06-04T00:00:00,Gold,D01.268.956.186
22632177,2012-06-04T00:00:00,Gold,D01.552.544.322
22632177,2012-06-04T00:00:00,Liposomes,D25.479.517
22632177,2012-06-04T00:00:00,Liposomes,D26.255.260.517
22632177,2012-06-04T00:00:00,Liposomes,D27.720.280.260.517
22632177,2012-06-04T00:00:00,Liposomes,J01.637.051.479.517
22632177,2012-06-04T00:00:00,Liposomes,J01.637.087.500.517
22632177,2012-06-04T00:00:00,Materials Testing,E05.570
22632177,2012-06-04T00:00:00,Nanoparticles,J01.637.512.600
22632177,2012-06-04T00:00:00,Surface Properties,G02.842.850
22632177,2012-06-04T00:00:00,Temperature,G01.906.595
22632177,2012-06-04T00:00:00,Temperature,G16.500.275.063.725.710
22632177,2012-06-04T00:00:00,Temperature,G16.500.750.775.710
22632177,2012-06-04T00:00:00,Temperature,N06.230.150.450
22632177,2012-06-04T00:00:00,Temperature,N06.230.300.100.725.710
22674480,2012-06-04T00:00:00,Algorithms,G17.035
22674480,2012-06-04T00:00:00,Algorithms,L01.224.050
22674480,2012-06-04T00:00:00,Computational Biology,H01.158.273.180
22674480,2012-06-04T00:00:00,Software,L01.224.900
22674480,2012-06-04T00:00:00,Static Electricity,G01.201.249.820
22670051,2012-06-05T00:00:00,Action Potentials,G04.580.100
22670051,2012-06-05T00:00:00,Action Potentials,G07.265.750.100
22670051,2012-06-05T00:00:00,Action Potentials,G11.561.570.100
22670051,2012-06-05T00:00:00,Aged,M01.060.116.100
22670051,2012-06-05T00:00:00,Atrial Fibrillation,C14.280.067.198
22670051,2012-06-05T00:00:00,Atrial Fibrillation,C23.550.073.198
22670051,2012-06-05T00:00:00,"Cardiac Pacing, Artificial",E02.145
22670051,2012-06-05T00:00:00,Heart Conduction System,A07.541.409
22670051,2012-06-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22670051,2012-06-05T00:00:00,"Pacemaker, Artificial",E07.858.082.748
22670051,2012-06-05T00:00:00,Risk Assessment,E05.318.740.600.800.715
22670051,2012-06-05T00:00:00,Risk Assessment,N04.452.871.715
22670051,2012-06-05T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
22670051,2012-06-05T00:00:00,Risk Assessment,N06.850.505.715
22670051,2012-06-05T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
22670051,2012-06-05T00:00:00,Risk Factors,E05.318.740.600.800.725
22670051,2012-06-05T00:00:00,Risk Factors,N05.715.350.200.700
22670051,2012-06-05T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22670051,2012-06-05T00:00:00,Risk Factors,N06.850.490.625.750
22670051,2012-06-05T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22670051,2012-06-05T00:00:00,Stroke,C10.228.140.300.775
22670051,2012-06-05T00:00:00,Stroke,C14.907.253.855
22670051,2012-06-05T00:00:00,Time Factors,G01.910.857
22670051,2012-06-05T00:00:00,Treatment Outcome,E01.789.800
22670051,2012-06-05T00:00:00,Treatment Outcome,N04.761.559.590.800
22670051,2012-06-05T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22677152,2012-06-05T00:00:00,Adult,M01.060.116
22677152,2012-06-05T00:00:00,Case-Control Studies,E05.318.760.500.500
22677152,2012-06-05T00:00:00,Case-Control Studies,N05.715.360.775.175.200
22677152,2012-06-05T00:00:00,Case-Control Studies,N06.850.520.450.500.500
22677152,2012-06-05T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
22677152,2012-06-05T00:00:00,Genetic Predisposition to Disease,G05.380.355
22677152,2012-06-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22677152,2012-06-05T00:00:00,Medical Record Linkage,E05.318.308.940.968.500
22677152,2012-06-05T00:00:00,Medical Record Linkage,L01.280.900.968.500
22677152,2012-06-05T00:00:00,Medical Record Linkage,N04.452.859.564.550
22677152,2012-06-05T00:00:00,Medical Record Linkage,N05.715.360.300.715.500.500
22677152,2012-06-05T00:00:00,Medical Record Linkage,N06.850.520.308.940.968.500
22677152,2012-06-05T00:00:00,Middle Aged,M01.060.116.630
22677152,2012-06-05T00:00:00,Mutation,G05.365.590
22677152,2012-06-05T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
22677152,2012-06-05T00:00:00,Risk Factors,E05.318.740.600.800.725
22677152,2012-06-05T00:00:00,Risk Factors,N05.715.350.200.700
22677152,2012-06-05T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22677152,2012-06-05T00:00:00,Risk Factors,N06.850.490.625.750
22677152,2012-06-05T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22677152,2012-06-05T00:00:00,Skin Neoplasms,C04.588.805
22677152,2012-06-05T00:00:00,Skin Neoplasms,C17.800.882
22677152,2012-06-05T00:00:00,Smoking,F01.145.466.753
22637218,2012-06-06T00:00:00,Adult,M01.060.116
22637218,2012-06-06T00:00:00,Age Factors,N05.715.350.075
22637218,2012-06-06T00:00:00,Age Factors,N06.850.490.250
22637218,2012-06-06T00:00:00,Career Choice,F02.463.785.373.346.400
22637218,2012-06-06T00:00:00,Decision Making,F02.463.785.373
22637218,2012-06-06T00:00:00,"Education, Medical, Graduate",I02.358.337.350
22637218,2012-06-06T00:00:00,"Education, Medical, Graduate",I02.358.399.350
22637218,2012-06-06T00:00:00,"Education, Medical, Undergraduate",I02.358.399.450
22637218,2012-06-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22637218,2012-06-06T00:00:00,Income,N01.824.417
22637218,2012-06-06T00:00:00,Internship and Residency,I02.358.399.644
22637218,2012-06-06T00:00:00,Life Style,F01.829.458
22637218,2012-06-06T00:00:00,Orthopedics,H02.403.810.494
22637218,2012-06-06T00:00:00,Questionnaires,E05.318.308.750
22637218,2012-06-06T00:00:00,Questionnaires,L01.280.800
22637218,2012-06-06T00:00:00,Questionnaires,N05.715.360.300.695
22637218,2012-06-06T00:00:00,Questionnaires,N06.850.520.308.750
22637218,2012-06-06T00:00:00,Research,H01.770.644
22637218,2012-06-06T00:00:00,Sex Factors,N05.715.350.675
22637218,2012-06-06T00:00:00,Sex Factors,N06.850.490.875
22637218,2012-06-06T00:00:00,"Students, Medical",I02.851.686.602
22637218,2012-06-06T00:00:00,"Students, Medical",M01.848.769.602
22637218,2012-06-06T00:00:00,United States,Z01.107.567.875
22669129,2012-06-06T00:00:00,"Analgesics, Opioid",D27.505.696.663.850.014.520
22669129,2012-06-06T00:00:00,"Analgesics, Opioid",D27.505.954.427.040.325
22669129,2012-06-06T00:00:00,"Analgesics, Opioid",D27.505.954.427.210.049
22669129,2012-06-06T00:00:00,Animals,B01.050
22669129,2012-06-06T00:00:00,Dopamine,D02.092.211.215.311.342
22669129,2012-06-06T00:00:00,Dopamine,D02.092.311.342
22669129,2012-06-06T00:00:00,Oligopeptides,D12.644.456
22669129,2012-06-06T00:00:00,Pain,C10.597.617
22669129,2012-06-06T00:00:00,Pain,C23.888.592.612
22669129,2012-06-06T00:00:00,Pain,C23.888.646
22669129,2012-06-06T00:00:00,Pain,F02.830.816.444
22669129,2012-06-06T00:00:00,Pain,G11.561.600.810.444
22669129,2012-06-06T00:00:00,Protein Precursors,D12.776.811
22669129,2012-06-06T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22669129,2012-06-06T00:00:00,"Receptors, Opioid",D12.776.543.750.100.620
22669129,2012-06-06T00:00:00,"Receptors, Opioid",D12.776.543.750.720.600.610
22669129,2012-06-06T00:00:00,"Receptors, Opioid",D12.776.543.750.750.555.610
22669129,2012-06-06T00:00:00,Self Administration,E02.319.890
22669129,2012-06-06T00:00:00,Self Administration,E02.900.890
22669173,2012-06-06T00:00:00,Adolescent,M01.060.057
22669173,2012-06-06T00:00:00,Adult,M01.060.116
22669173,2012-06-06T00:00:00,Amygdala,A08.186.211.464.090
22669173,2012-06-06T00:00:00,Amygdala,A08.186.211.730.885.287.249.152
22669173,2012-06-06T00:00:00,Case-Control Studies,E05.318.760.500.500
22669173,2012-06-06T00:00:00,Case-Control Studies,N05.715.360.775.175.200
22669173,2012-06-06T00:00:00,Case-Control Studies,N06.850.520.450.500.500
22669173,2012-06-06T00:00:00,Functional Laterality,F02.830.297.425
22669173,2012-06-06T00:00:00,Functional Laterality,G11.561.225.425
22669173,2012-06-06T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
22669173,2012-06-06T00:00:00,Genetic Predisposition to Disease,G05.380.355
22669173,2012-06-06T00:00:00,Hippocampus,A08.186.211.464.405
22669173,2012-06-06T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
22669173,2012-06-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22669173,2012-06-06T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
22669173,2012-06-06T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
22669173,2012-06-06T00:00:00,Marijuana Abuse,C21.739.635
22669173,2012-06-06T00:00:00,Marijuana Abuse,F03.900.635
22669173,2012-06-06T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
22669173,2012-06-06T00:00:00,"Receptor, Cannabinoid, CB1",D12.776.543.750.100.125.100
22669173,2012-06-06T00:00:00,Young Adult,M01.060.116.815
22563716,2012-06-07T00:00:00,Anti-HIV Agents,D27.505.954.122.388.077.088
22563716,2012-06-07T00:00:00,HIV Protease Inhibitors,D27.505.519.389.745.420
22563716,2012-06-07T00:00:00,HIV Protease Inhibitors,D27.505.954.122.388.077.088.420
22563716,2012-06-07T00:00:00,Health Status,I01.240.425
22563716,2012-06-07T00:00:00,Health Status,N01.224.425
22563716,2012-06-07T00:00:00,Health Status,N06.850.505.400.425
22563716,2012-06-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22563716,2012-06-07T00:00:00,Markov Chains,E05.318.740.600.500
22563716,2012-06-07T00:00:00,Markov Chains,E05.318.740.996.500
22563716,2012-06-07T00:00:00,Markov Chains,G17.830.500
22563716,2012-06-07T00:00:00,Markov Chains,N05.715.360.750.625.500
22563716,2012-06-07T00:00:00,Markov Chains,N05.715.360.750.770.500
22563716,2012-06-07T00:00:00,Markov Chains,N06.850.520.830.600.500
22563716,2012-06-07T00:00:00,Markov Chains,N06.850.520.830.996.500
22563716,2012-06-07T00:00:00,Oligopeptides,D12.644.456
22563716,2012-06-07T00:00:00,Pyridines,D03.383.725
22563716,2012-06-07T00:00:00,Quality of Life,I01.800
22563716,2012-06-07T00:00:00,Quality of Life,K01.752.400.750
22563716,2012-06-07T00:00:00,Ritonavir,D02.886.675.653
22563716,2012-06-07T00:00:00,Ritonavir,D03.383.129.708.653
22673963,2012-06-07T00:00:00,Asthma,C08.127.108
22673963,2012-06-07T00:00:00,Asthma,C08.381.495.108
22673963,2012-06-07T00:00:00,Asthma,C08.674.095
22673963,2012-06-07T00:00:00,Asthma,C20.543.480.680.095
22673963,2012-06-07T00:00:00,Child,M01.060.406
22673963,2012-06-07T00:00:00,Genome-Wide Association Study,E05.318.416.249
22673963,2012-06-07T00:00:00,Genome-Wide Association Study,E05.318.780.392
22673963,2012-06-07T00:00:00,Genome-Wide Association Study,E05.393.385.500
22673963,2012-06-07T00:00:00,Genome-Wide Association Study,E05.393.522.500
22673963,2012-06-07T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
22673963,2012-06-07T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
22673963,2012-06-07T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
22673963,2012-06-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22673963,2012-06-07T00:00:00,Phenotype,G05.695
22673963,2012-06-07T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
22673963,2012-06-07T00:00:00,Vitamin D,D04.808.812.768
22677795,2012-06-07T00:00:00,Blood Glucose,D09.546.359.448.500
22677795,2012-06-07T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
22677795,2012-06-07T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
22677795,2012-06-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22677795,2012-06-07T00:00:00,Risk Factors,E05.318.740.600.800.725
22677795,2012-06-07T00:00:00,Risk Factors,N05.715.350.200.700
22677795,2012-06-07T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22677795,2012-06-07T00:00:00,Risk Factors,N06.850.490.625.750
22677795,2012-06-07T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22677795,2012-06-07T00:00:00,Stroke,C10.228.140.300.775
22677795,2012-06-07T00:00:00,Stroke,C14.907.253.855
22679129,2012-06-07T00:00:00,Drug Therapy,E02.319
22679129,2012-06-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22679129,2012-06-07T00:00:00,Medication Errors,E02.319.529
22679129,2012-06-07T00:00:00,Medication Errors,N02.421.450.500
22679129,2012-06-07T00:00:00,Primary Health Care,N04.590.233.727
22679240,2012-06-07T00:00:00,Adult,M01.060.116
22679240,2012-06-07T00:00:00,Behavior Therapy,F04.754.137
22679240,2012-06-07T00:00:00,Depression,F01.145.126.350
22679240,2012-06-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22679240,2012-06-07T00:00:00,Implosive Therapy,F04.754.137.506.325
22679240,2012-06-07T00:00:00,Psychiatric Status Rating Scales,F04.586
22679240,2012-06-07T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
22679240,2012-06-07T00:00:00,Telemedicine,H02.403.840
22679240,2012-06-07T00:00:00,Telemedicine,L01.178.847.652
22679240,2012-06-07T00:00:00,Telemedicine,N04.590.374.800
22679240,2012-06-07T00:00:00,Veterans,M01.930
22867781,2012-06-07T00:00:00,Aged,M01.060.116.100
22867781,2012-06-07T00:00:00,Cost of Illness,I01.137
22867781,2012-06-07T00:00:00,Cost of Illness,N03.219.151.165
22867781,2012-06-07T00:00:00,Data Collection,E05.318.308
22867781,2012-06-07T00:00:00,Data Collection,L01.280
22867781,2012-06-07T00:00:00,Data Collection,N05.715.360.300
22867781,2012-06-07T00:00:00,Data Collection,N06.850.520.308
22867781,2012-06-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22867781,2012-06-07T00:00:00,Middle Aged,M01.060.116.630
22867781,2012-06-07T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
22867781,2012-06-07T00:00:00,Prostatic Neoplasms,C12.294.260.750
22867781,2012-06-07T00:00:00,Prostatic Neoplasms,C12.294.565.625
22867781,2012-06-07T00:00:00,Prostatic Neoplasms,C12.758.409.750
22867781,2012-06-07T00:00:00,Regression Analysis,E05.318.740.750
22867781,2012-06-07T00:00:00,Regression Analysis,N05.715.360.750.695
22867781,2012-06-07T00:00:00,Regression Analysis,N06.850.520.830.750
22867781,2012-06-07T00:00:00,Time Factors,G01.910.857
22681620,2012-06-08T00:00:00,Breast Neoplasms,C04.588.180
22681620,2012-06-08T00:00:00,Breast Neoplasms,C17.800.090.500
22681620,2012-06-08T00:00:00,Cell Survival,G04.299.316
22681620,2012-06-08T00:00:00,DNA-Binding Proteins,D12.776.260
22681620,2012-06-08T00:00:00,Gene Expression,G05.355.310
22681620,2012-06-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22681620,2012-06-08T00:00:00,Membrane Proteins,D12.776.543
22681620,2012-06-08T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
22681620,2012-06-08T00:00:00,RNA Interference,G05.355.315.203.374.790
22681620,2012-06-08T00:00:00,Signal Transduction,G02.111.087.800
22681620,2012-06-08T00:00:00,Signal Transduction,G02.149.115.800
22681620,2012-06-08T00:00:00,Signal Transduction,G04.299.880
22681620,2012-06-08T00:00:00,Transcription Factors,D12.776.930
22682058,2012-06-08T00:00:00,Bacterial Adhesion,G06.099.112.100
22682058,2012-06-08T00:00:00,Bacterial Adhesion,G06.590.110.100
22682058,2012-06-08T00:00:00,Bacterial Proteins,D12.776.097
22682058,2012-06-08T00:00:00,Biofilms,G06.120
22682058,2012-06-08T00:00:00,"Catheters, Indwelling",E07.150
22682058,2012-06-08T00:00:00,Down-Regulation,G02.111.087.225
22682058,2012-06-08T00:00:00,Down-Regulation,G02.149.115.225
22682058,2012-06-08T00:00:00,Down-Regulation,G05.355.315.200
22682058,2012-06-08T00:00:00,Down-Regulation,G07.690.812.230
22682058,2012-06-08T00:00:00,Down-Regulation,G07.700.680.230
22682058,2012-06-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22682058,2012-06-08T00:00:00,Trans-Activators,D12.776.260.755
22682058,2012-06-08T00:00:00,Trans-Activators,D12.776.930.900
22682058,2012-06-08T00:00:00,Trans-Activators,D12.776.964.925.984
22683918,2012-06-08T00:00:00,Competency-Based Education,I02.158.210
22683918,2012-06-08T00:00:00,"Education, Graduate",I02.358.337
22683918,2012-06-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22683918,2012-06-08T00:00:00,Medical Informatics,L01.313.500
22683918,2012-06-08T00:00:00,Medical Informatics,L01.700
22683918,2012-06-08T00:00:00,Terminology as Topic,L01.143.506.598.400
22683918,2012-06-08T00:00:00,United States,Z01.107.567.875
22794213,2012-06-08T00:00:00,Alveolar Bone Loss,C05.116.264.150
22794213,2012-06-08T00:00:00,Alveolar Bone Loss,C07.465.714.354.500
22794213,2012-06-08T00:00:00,Animals,B01.050
22794213,2012-06-08T00:00:00,Dual Specificity Phosphatase 1,D08.811.277.352.650.587.200
22794213,2012-06-08T00:00:00,Dual Specificity Phosphatase 1,D08.811.277.352.650.625.225.200
22794213,2012-06-08T00:00:00,Dual Specificity Phosphatase 1,D08.811.277.352.650.775.250.200
22794213,2012-06-08T00:00:00,Dual Specificity Phosphatase 1,D12.644.360.268.200
22794213,2012-06-08T00:00:00,Dual Specificity Phosphatase 1,D12.644.360.445.100
22794213,2012-06-08T00:00:00,Dual Specificity Phosphatase 1,D12.776.476.268.200
22794213,2012-06-08T00:00:00,Dual Specificity Phosphatase 1,D12.776.476.445.200
22794213,2012-06-08T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
22794213,2012-06-08T00:00:00,"Immunity, Innate",G12.450.575
22794213,2012-06-08T00:00:00,Inflammation,C23.550.470
22794213,2012-06-08T00:00:00,MAP Kinase Signaling System,G02.111.087.800.560
22794213,2012-06-08T00:00:00,MAP Kinase Signaling System,G02.149.115.800.560
22794213,2012-06-08T00:00:00,MAP Kinase Signaling System,G03.495.553.560
22794213,2012-06-08T00:00:00,MAP Kinase Signaling System,G04.299.880.560
22794213,2012-06-08T00:00:00,Neutrophils,A11.118.637.415.583
22794213,2012-06-08T00:00:00,Neutrophils,A11.627.340.583
22794213,2012-06-08T00:00:00,Neutrophils,A11.733.689
22794213,2012-06-08T00:00:00,Neutrophils,A15.145.229.637.415.583
22794213,2012-06-08T00:00:00,Neutrophils,A15.382.490.315.583
22794213,2012-06-08T00:00:00,Neutrophils,A15.382.680.689
22794213,2012-06-08T00:00:00,Sex Characteristics,G08.686.815
22794213,2012-06-08T00:00:00,Time Factors,G01.910.857
22794213,2012-06-08T00:00:00,X-Ray Microtomography,E01.370.350.700.810.810.900
22794213,2012-06-08T00:00:00,X-Ray Microtomography,E01.370.350.825.810.810.900
22683195,2012-06-09T00:00:00,Contrast Media,D27.720.259
22683195,2012-06-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22683195,2012-06-09T00:00:00,Iodine,D01.268.380.400
22683195,2012-06-09T00:00:00,Liver Neoplasms,C04.588.274.623
22683195,2012-06-09T00:00:00,Liver Neoplasms,C06.301.623
22683195,2012-06-09T00:00:00,Liver Neoplasms,C06.552.697
22683195,2012-06-09T00:00:00,Middle Aged,M01.060.116.630
22683195,2012-06-09T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
22683195,2012-06-09T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
22683195,2012-06-09T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
22683195,2012-06-09T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
22683195,2012-06-09T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
22686269,2012-06-11T00:00:00,Adolescent,M01.060.057
22686269,2012-06-11T00:00:00,Family Therapy,F04.754.864.581.273
22686269,2012-06-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22686269,2012-06-11T00:00:00,Mental Disorders,F03
22686269,2012-06-11T00:00:00,Pilot Projects,E05.318.760.750
22686269,2012-06-11T00:00:00,Pilot Projects,E05.337.737
22686269,2012-06-11T00:00:00,Pilot Projects,N05.715.360.775.625
22686269,2012-06-11T00:00:00,Pilot Projects,N06.850.520.450.720
22686269,2012-06-11T00:00:00,Psychiatric Status Rating Scales,F04.586
22686269,2012-06-11T00:00:00,Rape,I01.198.240.748.640
22686269,2012-06-11T00:00:00,Risk Factors,E05.318.740.600.800.725
22686269,2012-06-11T00:00:00,Risk Factors,N05.715.350.200.700
22686269,2012-06-11T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22686269,2012-06-11T00:00:00,Risk Factors,N06.850.490.625.750
22686269,2012-06-11T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22686269,2012-06-11T00:00:00,Sexual Behavior,F01.145.802
22686269,2012-06-11T00:00:00,Substance-Related Disorders,C21.739
22686269,2012-06-11T00:00:00,Substance-Related Disorders,F03.900
22689290,2012-06-11T00:00:00,Double-Blind Method,E05.318.780.300
22689290,2012-06-11T00:00:00,Double-Blind Method,E05.581.500.300
22689290,2012-06-11T00:00:00,Double-Blind Method,N05.715.360.780.320
22689290,2012-06-11T00:00:00,Double-Blind Method,N06.850.520.445.300
22689290,2012-06-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22689290,2012-06-11T00:00:00,Middle Aged,M01.060.116.630
22689290,2012-06-11T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
22689290,2012-06-11T00:00:00,Psychiatric Status Rating Scales,F04.586
22689290,2012-06-11T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
22689290,2012-06-11T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
22689290,2012-06-11T00:00:00,Treatment Outcome,E01.789.800
22689290,2012-06-11T00:00:00,Treatment Outcome,N04.761.559.590.800
22689290,2012-06-11T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22689574,2012-06-11T00:00:00,Animals,B01.050
22689574,2012-06-11T00:00:00,Complement Activation,G12.425.255
22689574,2012-06-11T00:00:00,Complement C3,D12.776.124.050.140
22689574,2012-06-11T00:00:00,Complement C3,D12.776.124.486.274.250
22689794,2012-06-11T00:00:00,Clinical Trials as Topic,E05.318.760.535
22689794,2012-06-11T00:00:00,Clinical Trials as Topic,E05.337.250
22689794,2012-06-11T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
22689794,2012-06-11T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
22689794,2012-06-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22689794,2012-06-11T00:00:00,Neoplasms,C04
22689794,2012-06-11T00:00:00,Risk Assessment,E05.318.740.600.800.715
22689794,2012-06-11T00:00:00,Risk Assessment,N04.452.871.715
22689794,2012-06-11T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
22689794,2012-06-11T00:00:00,Risk Assessment,N06.850.505.715
22689794,2012-06-11T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
22689794,2012-06-11T00:00:00,Smoking,F01.145.466.753
22689143,2012-06-12T00:00:00,Animals,B01.050
22689143,2012-06-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22689143,2012-06-12T00:00:00,"Mitochondria, Heart",A11.284.430.214.190.875.564.627.603
22689143,2012-06-12T00:00:00,"Mitochondria, Heart",A11.284.835.626.627.603
22689143,2012-06-12T00:00:00,"Myocytes, Cardiac",A07.541.704.570
22689143,2012-06-12T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
22689143,2012-06-12T00:00:00,"Myocytes, Cardiac",A11.620.500
22689143,2012-06-12T00:00:00,Oxygen Consumption,G03.730
22693267,2012-06-12T00:00:00,Adult,M01.060.116
22693267,2012-06-12T00:00:00,Auditory Threshold,F02.463.593.071.173
22693267,2012-06-12T00:00:00,Auditory Threshold,F02.463.593.710.190
22693267,2012-06-12T00:00:00,Hearing,F02.830.816.263
22693267,2012-06-12T00:00:00,Hearing,G11.561.600.810.263
22693267,2012-06-12T00:00:00,"Hearing Loss, Noise-Induced",C09.218.458.341.887.460
22693267,2012-06-12T00:00:00,"Hearing Loss, Noise-Induced",C10.597.751.418.341.887.460
22693267,2012-06-12T00:00:00,"Hearing Loss, Noise-Induced",C23.888.592.763.393.341.887.460
22693267,2012-06-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22693267,2012-06-12T00:00:00,Noise,G01.595.907.567
22693267,2012-06-12T00:00:00,Noise,G16.500.275.600
22693267,2012-06-12T00:00:00,Noise,N06.230.400
22693267,2012-06-12T00:00:00,Noise,N06.850.460.610
22693267,2012-06-12T00:00:00,Occupational Exposure,N06.850.460.350.600
22693267,2012-06-12T00:00:00,"Otoacoustic Emissions, Spontaneous",G11.561.600.810.263.570
22693267,2012-06-12T00:00:00,Young Adult,M01.060.116.815
22698562,2012-06-12T00:00:00,Cause of Death,E05.318.308.985.550.250
22698562,2012-06-12T00:00:00,Cause of Death,L01.280.975.550.250
22698562,2012-06-12T00:00:00,Cause of Death,N01.224.935.698.100
22698562,2012-06-12T00:00:00,Cause of Death,N06.850.505.400.975.550.250
22698562,2012-06-12T00:00:00,Cause of Death,N06.850.520.308.985.550.250
22698562,2012-06-12T00:00:00,"Heart Defects, Congenital",C14.240.400
22698562,2012-06-12T00:00:00,"Heart Defects, Congenital",C14.280.400
22698562,2012-06-12T00:00:00,"Heart Defects, Congenital",C16.131.240.400
22698562,2012-06-12T00:00:00,Heart Ventricles,A07.541.560
22698562,2012-06-12T00:00:00,Hemodynamics,G09.330.190.400
22698562,2012-06-12T00:00:00,Hemodynamics,G09.330.380
22698562,2012-06-12T00:00:00,Hospital Mortality,E05.318.308.985.550.400
22698562,2012-06-12T00:00:00,Hospital Mortality,L01.280.975.550.400
22698562,2012-06-12T00:00:00,Hospital Mortality,N01.224.935.698.400
22698562,2012-06-12T00:00:00,Hospital Mortality,N06.850.505.400.975.550.400
22698562,2012-06-12T00:00:00,Hospital Mortality,N06.850.520.308.985.550.400
22698562,2012-06-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22698562,2012-06-12T00:00:00,Hypoplastic Left Heart Syndrome,C14.240.400.625
22698562,2012-06-12T00:00:00,Hypoplastic Left Heart Syndrome,C14.280.400.625
22698562,2012-06-12T00:00:00,Hypoplastic Left Heart Syndrome,C16.131.240.400.625
22698562,2012-06-12T00:00:00,Infant Mortality,E05.318.308.985.550.475
22698562,2012-06-12T00:00:00,Infant Mortality,L01.280.975.550.475
22698562,2012-06-12T00:00:00,Infant Mortality,N01.224.935.698.489
22698562,2012-06-12T00:00:00,Infant Mortality,N06.850.505.400.975.550.475
22698562,2012-06-12T00:00:00,Infant Mortality,N06.850.520.308.985.550.475
22698562,2012-06-12T00:00:00,"Infant, Newborn",M01.060.703.520
22698562,2012-06-12T00:00:00,North America,Z01.107.567
22698562,2012-06-12T00:00:00,Perioperative Care,E02.760.722
22698562,2012-06-12T00:00:00,Perioperative Care,E04.604
22698562,2012-06-12T00:00:00,Perioperative Care,N02.421.585.722
22698562,2012-06-12T00:00:00,Postoperative Complications,C23.550.767
22698562,2012-06-12T00:00:00,Quality of Health Care,N04.761
22698562,2012-06-12T00:00:00,Quality of Health Care,N05.715
22698562,2012-06-12T00:00:00,Risk Assessment,E05.318.740.600.800.715
22698562,2012-06-12T00:00:00,Risk Assessment,N04.452.871.715
22698562,2012-06-12T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
22698562,2012-06-12T00:00:00,Risk Assessment,N06.850.505.715
22698562,2012-06-12T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
22698562,2012-06-12T00:00:00,Risk Factors,E05.318.740.600.800.725
22698562,2012-06-12T00:00:00,Risk Factors,N05.715.350.200.700
22698562,2012-06-12T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22698562,2012-06-12T00:00:00,Risk Factors,N06.850.490.625.750
22698562,2012-06-12T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22698562,2012-06-12T00:00:00,Time Factors,G01.910.857
22698562,2012-06-12T00:00:00,Treatment Outcome,E01.789.800
22698562,2012-06-12T00:00:00,Treatment Outcome,N04.761.559.590.800
22698562,2012-06-12T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22698689,2012-06-12T00:00:00,Adult,M01.060.116
22698689,2012-06-12T00:00:00,Astrocytes,A08.637.200
22698689,2012-06-12T00:00:00,Astrocytes,A11.650.200
22698689,2012-06-12T00:00:00,"Epilepsy, Temporal Lobe",C10.228.140.490.360.290
22698689,2012-06-12T00:00:00,Hippocampus,A08.186.211.464.405
22698689,2012-06-12T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
22698689,2012-06-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22698689,2012-06-12T00:00:00,Inflammation,C23.550.470
22698765,2012-06-12T00:00:00,Aged,M01.060.116.100
22698765,2012-06-12T00:00:00,Algorithms,G17.035
22698765,2012-06-12T00:00:00,Algorithms,L01.224.050
22698765,2012-06-12T00:00:00,Atrial Fibrillation,C14.280.067.198
22698765,2012-06-12T00:00:00,Atrial Fibrillation,C23.550.073.198
22698765,2012-06-12T00:00:00,"Cardiac Pacing, Artificial",E02.145
22698765,2012-06-12T00:00:00,Cardiovascular Diseases,C14
22698765,2012-06-12T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
22698765,2012-06-12T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
22698765,2012-06-12T00:00:00,"Defibrillators, Implantable",E07.695.175
22698765,2012-06-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22698765,2012-06-12T00:00:00,Treatment Outcome,E01.789.800
22698765,2012-06-12T00:00:00,Treatment Outcome,N04.761.559.590.800
22698765,2012-06-12T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22748276,2012-06-12T00:00:00,ATP-Binding Cassette Transporters,D12.776.157.530.100
22748276,2012-06-12T00:00:00,ATP-Binding Cassette Transporters,D12.776.395.550.020
22748276,2012-06-12T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.550.192
22748276,2012-06-12T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.585.100
22748276,2012-06-12T00:00:00,Animals,B01.050
22748276,2012-06-12T00:00:00,Aortic Diseases,C14.907.109
22748276,2012-06-12T00:00:00,Apoptosis,G04.299.139.160
22748276,2012-06-12T00:00:00,Bone Marrow Transplantation,E04.936.580.040
22748276,2012-06-12T00:00:00,Cholesterol,D04.808.247.222.284
22748276,2012-06-12T00:00:00,Cholesterol,D04.808.247.808.197
22748276,2012-06-12T00:00:00,Cholesterol,D10.570.938.208
22748276,2012-06-12T00:00:00,Cholesterol,D10.851.208
22748276,2012-06-12T00:00:00,"Disease Models, Animal",C22.232
22748276,2012-06-12T00:00:00,"Disease Models, Animal",E05.598.500
22748276,2012-06-12T00:00:00,"Disease Models, Animal",E05.599.395.080
22748276,2012-06-12T00:00:00,Homeostasis,G07.700.360
22748276,2012-06-12T00:00:00,"Lipoproteins, LDL",D10.532.515
22748276,2012-06-12T00:00:00,"Lipoproteins, LDL",D12.776.521.550
22748276,2012-06-12T00:00:00,Lysosomes,A11.284.430.214.190.875.190.550
22748276,2012-06-12T00:00:00,Macrophages,A11.329.372
22748276,2012-06-12T00:00:00,Macrophages,A11.627.482
22748276,2012-06-12T00:00:00,Macrophages,A11.733.397
22748276,2012-06-12T00:00:00,Macrophages,A15.382.680.397
22748276,2012-06-12T00:00:00,Macrophages,A15.382.812.522
22748276,2012-06-12T00:00:00,Time Factors,G01.910.857
22540427,2012-06-13T00:00:00,Animals,B01.050
22540427,2012-06-13T00:00:00,Cell Death,G04.299.139
22540427,2012-06-13T00:00:00,Cell Survival,G04.299.316
22540427,2012-06-13T00:00:00,Glutathione Transferase,D08.811.913.225.500
22540427,2012-06-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22540427,2012-06-13T00:00:00,"Models, Biological",E05.599.395
22692431,2012-06-13T00:00:00,Adolescent,M01.060.057
22692431,2012-06-13T00:00:00,Adult,M01.060.116
22692431,2012-06-13T00:00:00,Aged,M01.060.116.100
22692431,2012-06-13T00:00:00,Clinical Competence,I02.399.630.210
22692431,2012-06-13T00:00:00,Clinical Competence,N04.761.210
22692431,2012-06-13T00:00:00,Contrast Media,D27.720.259
22692431,2012-06-13T00:00:00,Deglutition Disorders,C06.405.117.119
22692431,2012-06-13T00:00:00,Deglutition Disorders,C09.775.174
22692431,2012-06-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22692431,2012-06-13T00:00:00,Middle Aged,M01.060.116.630
22692431,2012-06-13T00:00:00,Radiation Dosage,E05.799.513
22692431,2012-06-13T00:00:00,Radiation Dosage,G01.201.875.740
22692431,2012-06-13T00:00:00,Radiation Dosage,N06.850.810.250
22692431,2012-06-13T00:00:00,Time Factors,G01.910.857
22692431,2012-06-13T00:00:00,Young Adult,M01.060.116.815
22694592,2012-06-13T00:00:00,Animals,B01.050
22694592,2012-06-13T00:00:00,Glycoproteins,D09.400.430
22694592,2012-06-13T00:00:00,Glycoproteins,D12.776.395
22694592,2012-06-13T00:00:00,Intercellular Signaling Peptides and Proteins,D12.644.276
22694592,2012-06-13T00:00:00,Intercellular Signaling Peptides and Proteins,D12.776.467
22694592,2012-06-13T00:00:00,Intercellular Signaling Peptides and Proteins,D23.529
22694592,2012-06-13T00:00:00,Liver Regeneration,G10.261.326.520
22694592,2012-06-13T00:00:00,Liver Regeneration,G16.100.856.468
22698998,2012-06-13T00:00:00,Adult,M01.060.116
22698998,2012-06-13T00:00:00,Bone Cements,D05.750.716.822.300
22698998,2012-06-13T00:00:00,Bone Cements,D25.720.716.822.300
22698998,2012-06-13T00:00:00,Bone Cements,D27.720.102.158
22698998,2012-06-13T00:00:00,Bone Cements,J01.637.051.720.716.822.300
22698998,2012-06-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22698998,2012-06-13T00:00:00,Orthopedic Procedures,E02.718
22698998,2012-06-13T00:00:00,Orthopedic Procedures,E04.555
22698998,2012-06-13T00:00:00,"Surgery, Computer-Assisted",E02.950.875
22698998,2012-06-13T00:00:00,"Surgery, Computer-Assisted",E04.749
22698998,2012-06-13T00:00:00,"Surgery, Computer-Assisted",L01.700.508.100.710.800
22698998,2012-06-13T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
22698998,2012-06-13T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
22698998,2012-06-13T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
22698998,2012-06-13T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
22698998,2012-06-13T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
22699015,2012-06-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22699015,2012-06-13T00:00:00,Patient Selection,E05.581.500.653
22699015,2012-06-13T00:00:00,Patient Selection,N04.590.731
22699015,2012-06-13T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
22699015,2012-06-13T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
22699015,2012-06-13T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
22699015,2012-06-13T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
22700429,2012-06-13T00:00:00,Animals,B01.050
22700429,2012-06-13T00:00:00,Energy Metabolism,G03.495.335
22700429,2012-06-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22700429,2012-06-13T00:00:00,Mitochondria,A11.284.430.214.190.875.564
22700429,2012-06-13T00:00:00,Mitochondria,A11.284.835.626
22700429,2012-06-13T00:00:00,Neoplasms,C04
22700429,2012-06-13T00:00:00,Voltage-Dependent Anion Channels,D12.776.157.530.400.500.520
22700429,2012-06-13T00:00:00,Voltage-Dependent Anion Channels,D12.776.543.550.425.730.520
22700429,2012-06-13T00:00:00,Voltage-Dependent Anion Channels,D12.776.543.585.400.730.520
22749212,2012-06-13T00:00:00,Bayes Theorem,E05.318.740.600.200
22749212,2012-06-13T00:00:00,Bayes Theorem,N05.715.360.750.625.150
22749212,2012-06-13T00:00:00,Bayes Theorem,N06.850.520.830.600.200
22749212,2012-06-13T00:00:00,Child,M01.060.406
22749212,2012-06-13T00:00:00,"Child, Preschool",M01.060.406.448
22749212,2012-06-13T00:00:00,Environmental Exposure,N06.850.460.350
22749212,2012-06-13T00:00:00,Fetus,A16.378
22749212,2012-06-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22749212,2012-06-13T00:00:00,Mercury,D01.268.556.504
22749212,2012-06-13T00:00:00,Mercury,D01.268.956.437
22749212,2012-06-13T00:00:00,Mercury,D01.552.544.504
22749212,2012-06-13T00:00:00,Pregnancy,G08.686.785.760.769
22749212,2012-06-13T00:00:00,Soil Pollutants,D27.888.284.756
22703994,2012-06-14T00:00:00,Animals,B01.050
22703994,2012-06-14T00:00:00,Ethanol,D02.033.375
22703994,2012-06-14T00:00:00,Hippocampus,A08.186.211.464.405
22703994,2012-06-14T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
22703994,2012-06-14T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
22703994,2012-06-14T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
22703994,2012-06-14T00:00:00,Membrane Proteins,D12.776.543
22703994,2012-06-14T00:00:00,Neurons,A08.663
22703994,2012-06-14T00:00:00,Neurons,A11.671
22703994,2012-06-14T00:00:00,Nuclear Proteins,D12.776.660
22703994,2012-06-14T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22703994,2012-06-14T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
22703028,2012-06-15T00:00:00,Adult,M01.060.116
22703028,2012-06-15T00:00:00,Alcohol Drinking,F01.145.317.269
22703028,2012-06-15T00:00:00,Alcoholism,C21.739.100.250
22703028,2012-06-15T00:00:00,Alcoholism,F03.900.100.350
22703028,2012-06-15T00:00:00,Demography,I01.240
22703028,2012-06-15T00:00:00,Demography,N01.224
22703028,2012-06-15T00:00:00,Demography,N06.850.505.400
22703028,2012-06-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22703028,2012-06-15T00:00:00,Middle Aged,M01.060.116.630
22703028,2012-06-15T00:00:00,New York,Z01.107.567.875.075.437
22703028,2012-06-15T00:00:00,New York,Z01.107.567.875.350.530
22703028,2012-06-15T00:00:00,New York,Z01.107.567.875.500.530
22703028,2012-06-15T00:00:00,Risk-Taking,F01.145.722
22703028,2012-06-15T00:00:00,Smoking Cessation,F01.145.940.700
22703028,2012-06-15T00:00:00,United States,Z01.107.567.875
22704284,2012-06-15T00:00:00,"Heart Defects, Congenital",C14.240.400
22704284,2012-06-15T00:00:00,"Heart Defects, Congenital",C14.280.400
22704284,2012-06-15T00:00:00,"Heart Defects, Congenital",C16.131.240.400
22704284,2012-06-15T00:00:00,Heart Ventricles,A07.541.560
22704284,2012-06-15T00:00:00,Hemodynamics,G09.330.190.400
22704284,2012-06-15T00:00:00,Hemodynamics,G09.330.380
22704284,2012-06-15T00:00:00,Hospital Mortality,E05.318.308.985.550.400
22704284,2012-06-15T00:00:00,Hospital Mortality,L01.280.975.550.400
22704284,2012-06-15T00:00:00,Hospital Mortality,N01.224.935.698.400
22704284,2012-06-15T00:00:00,Hospital Mortality,N06.850.505.400.975.550.400
22704284,2012-06-15T00:00:00,Hospital Mortality,N06.850.520.308.985.550.400
22704284,2012-06-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22704284,2012-06-15T00:00:00,Hypoplastic Left Heart Syndrome,C14.240.400.625
22704284,2012-06-15T00:00:00,Hypoplastic Left Heart Syndrome,C14.280.400.625
22704284,2012-06-15T00:00:00,Hypoplastic Left Heart Syndrome,C16.131.240.400.625
22704284,2012-06-15T00:00:00,Infant Mortality,E05.318.308.985.550.475
22704284,2012-06-15T00:00:00,Infant Mortality,L01.280.975.550.475
22704284,2012-06-15T00:00:00,Infant Mortality,N01.224.935.698.489
22704284,2012-06-15T00:00:00,Infant Mortality,N06.850.505.400.975.550.475
22704284,2012-06-15T00:00:00,Infant Mortality,N06.850.520.308.985.550.475
22704284,2012-06-15T00:00:00,"Infant, Newborn",M01.060.703.520
22704284,2012-06-15T00:00:00,Length of Stay,E02.760.400.480
22704284,2012-06-15T00:00:00,Length of Stay,N02.421.585.400.480
22704284,2012-06-15T00:00:00,North America,Z01.107.567
22704284,2012-06-15T00:00:00,Postoperative Complications,C23.550.767
22704284,2012-06-15T00:00:00,Risk Assessment,E05.318.740.600.800.715
22704284,2012-06-15T00:00:00,Risk Assessment,N04.452.871.715
22704284,2012-06-15T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
22704284,2012-06-15T00:00:00,Risk Assessment,N06.850.505.715
22704284,2012-06-15T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
22704284,2012-06-15T00:00:00,Risk Factors,E05.318.740.600.800.725
22704284,2012-06-15T00:00:00,Risk Factors,N05.715.350.200.700
22704284,2012-06-15T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22704284,2012-06-15T00:00:00,Risk Factors,N06.850.490.625.750
22704284,2012-06-15T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22704284,2012-06-15T00:00:00,Time Factors,G01.910.857
22704284,2012-06-15T00:00:00,Treatment Outcome,E01.789.800
22704284,2012-06-15T00:00:00,Treatment Outcome,N04.761.559.590.800
22704284,2012-06-15T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22704426,2012-06-15T00:00:00,Adult,M01.060.116
22704426,2012-06-15T00:00:00,Aged,M01.060.116.100
22704426,2012-06-15T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
22704426,2012-06-15T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
22704426,2012-06-15T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
22704426,2012-06-15T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
22704426,2012-06-15T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
22704426,2012-06-15T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
22704426,2012-06-15T00:00:00,Cisplatin,D01.210.375
22704426,2012-06-15T00:00:00,Cisplatin,D01.625.125
22704426,2012-06-15T00:00:00,Cisplatin,D01.710.100
22704426,2012-06-15T00:00:00,Deoxycytidine,D03.383.742.680.245.500
22704426,2012-06-15T00:00:00,Deoxycytidine,D13.570.230.329
22704426,2012-06-15T00:00:00,Deoxycytidine,D13.570.685.245.500
22704426,2012-06-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22704426,2012-06-15T00:00:00,Lung Neoplasms,C04.588.894.797.520
22704426,2012-06-15T00:00:00,Lung Neoplasms,C08.381.540
22704426,2012-06-15T00:00:00,Lung Neoplasms,C08.785.520
22704426,2012-06-15T00:00:00,Middle Aged,M01.060.116.630
22704426,2012-06-15T00:00:00,Treatment Outcome,E01.789.800
22704426,2012-06-15T00:00:00,Treatment Outcome,N04.761.559.590.800
22704426,2012-06-15T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22704442,2012-06-15T00:00:00,Animals,B01.050
22704442,2012-06-15T00:00:00,"Antigens, CD",D23.050.301.264.035
22704442,2012-06-15T00:00:00,"Antigens, CD",D23.101.100.110
22704442,2012-06-15T00:00:00,Cell Movement,G04.299.283
22704442,2012-06-15T00:00:00,Cell Movement,G07.700.560.500.180
22704442,2012-06-15T00:00:00,"Cell Transformation, Neoplastic",C04.697.152
22704442,2012-06-15T00:00:00,"Cell Transformation, Neoplastic",C23.550.727.152
22704442,2012-06-15T00:00:00,Disease Progression,C23.550.291.656
22704442,2012-06-15T00:00:00,Down-Regulation,G02.111.087.225
22704442,2012-06-15T00:00:00,Down-Regulation,G02.149.115.225
22704442,2012-06-15T00:00:00,Down-Regulation,G05.355.315.200
22704442,2012-06-15T00:00:00,Down-Regulation,G07.690.812.230
22704442,2012-06-15T00:00:00,Down-Regulation,G07.700.680.230
22704442,2012-06-15T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
22704442,2012-06-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22704442,2012-06-15T00:00:00,Neoplasm Invasiveness,C04.697.645
22704442,2012-06-15T00:00:00,Neoplasm Invasiveness,C23.550.727.645
22704442,2012-06-15T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
22704442,2012-06-15T00:00:00,Prostatic Neoplasms,C12.294.260.750
22704442,2012-06-15T00:00:00,Prostatic Neoplasms,C12.294.565.625
22704442,2012-06-15T00:00:00,Prostatic Neoplasms,C12.758.409.750
22704695,2012-06-15T00:00:00,"Anemia, Sickle Cell",C15.378.071.141.150.150
22704695,2012-06-15T00:00:00,"Anemia, Sickle Cell",C15.378.420.155
22704695,2012-06-15T00:00:00,"Anemia, Sickle Cell",C16.320.070.150
22704695,2012-06-15T00:00:00,"Anemia, Sickle Cell",C16.320.365.155
22704695,2012-06-15T00:00:00,Biological Markers,D23.101
22704695,2012-06-15T00:00:00,Child,M01.060.406
22704695,2012-06-15T00:00:00,"Child, Preschool",M01.060.406.448
22704695,2012-06-15T00:00:00,Cytokines,D12.644.276.374
22704695,2012-06-15T00:00:00,Cytokines,D12.776.467.374
22704695,2012-06-15T00:00:00,Cytokines,D23.529.374
22704695,2012-06-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22704695,2012-06-15T00:00:00,Stroke,C10.228.140.300.775
22704695,2012-06-15T00:00:00,Stroke,C14.907.253.855
22704695,2012-06-15T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.700.560.260.850
22704695,2012-06-15T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.850.260.850
22704695,2012-06-15T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.850.850.870
22704695,2012-06-15T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.376.560.260.850
22706995,2012-06-15T00:00:00,Cerebrospinal Fluid Rhinorrhea,C10.597.267
22706995,2012-06-15T00:00:00,Cerebrospinal Fluid Rhinorrhea,C10.900.300.153
22706995,2012-06-15T00:00:00,Cerebrospinal Fluid Rhinorrhea,C21.866.260.207
22706995,2012-06-15T00:00:00,Cerebrospinal Fluid Rhinorrhea,C21.866.915.300.300
22706995,2012-06-15T00:00:00,Cerebrospinal Fluid Rhinorrhea,C23.888.592.264
22706995,2012-06-15T00:00:00,Endoscopy,E01.370.388.250
22706995,2012-06-15T00:00:00,Endoscopy,E04.800.250
22706995,2012-06-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22715960,2012-06-15T00:00:00,Aged,M01.060.116.100
22715960,2012-06-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22715960,2012-06-15T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
22715960,2012-06-15T00:00:00,Practice Guidelines as Topic,N05.700.350.650
22715960,2012-06-15T00:00:00,Vaccination,E02.095.465.425.400.530.890
22715960,2012-06-15T00:00:00,Vaccination,E05.478.550.600.890
22715960,2012-06-15T00:00:00,Vaccination,N02.421.726.758.310.890
22715960,2012-06-15T00:00:00,Vaccination,N06.850.780.200.425.900
22715960,2012-06-15T00:00:00,Vaccination,N06.850.780.680.310.890
22707406,2012-06-18T00:00:00,Animals,B01.050
22707406,2012-06-18T00:00:00,"Disease Models, Animal",C22.232
22707406,2012-06-18T00:00:00,"Disease Models, Animal",E05.598.500
22707406,2012-06-18T00:00:00,"Disease Models, Animal",E05.599.395.080
22707406,2012-06-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22707406,2012-06-18T00:00:00,Lung Neoplasms,C04.588.894.797.520
22707406,2012-06-18T00:00:00,Lung Neoplasms,C08.381.540
22707406,2012-06-18T00:00:00,Lung Neoplasms,C08.785.520
22707406,2012-06-18T00:00:00,Lysophospholipids,D10.570.755.375.760.550
22707406,2012-06-18T00:00:00,Phosphotransferases (Alcohol Group Acceptor),D08.811.913.696.620
22707406,2012-06-18T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
22707406,2012-06-18T00:00:00,Prostatic Neoplasms,C12.294.260.750
22707406,2012-06-18T00:00:00,Prostatic Neoplasms,C12.294.565.625
22707406,2012-06-18T00:00:00,Prostatic Neoplasms,C12.758.409.750
22707406,2012-06-18T00:00:00,"Receptors, Lysosphingolipid",D12.776.543.750.100.420.500
22707406,2012-06-18T00:00:00,Repressor Proteins,D12.776.260.703
22707406,2012-06-18T00:00:00,Repressor Proteins,D12.776.930.700
22707406,2012-06-18T00:00:00,Signal Transduction,G02.111.087.800
22707406,2012-06-18T00:00:00,Signal Transduction,G02.149.115.800
22707406,2012-06-18T00:00:00,Signal Transduction,G04.299.880
22707406,2012-06-18T00:00:00,Sphingosine,D02.033.100.700
22707406,2012-06-18T00:00:00,Sphingosine,D02.033.455.843
22707406,2012-06-18T00:00:00,Sphingosine,D02.092.063.700
22707406,2012-06-18T00:00:00,Urinary Bladder Neoplasms,C04.588.945.947.960
22707406,2012-06-18T00:00:00,Urinary Bladder Neoplasms,C12.758.820.968
22707406,2012-06-18T00:00:00,Urinary Bladder Neoplasms,C12.777.829.813
22707406,2012-06-18T00:00:00,Urinary Bladder Neoplasms,C13.351.937.820.945
22707406,2012-06-18T00:00:00,Urinary Bladder Neoplasms,C13.351.968.829.707
22717219,2012-06-18T00:00:00,Adrenal Cortex Hormones,D06.472.040
22717219,2012-06-18T00:00:00,Asthma,C08.127.108
22717219,2012-06-18T00:00:00,Asthma,C08.381.495.108
22717219,2012-06-18T00:00:00,Asthma,C08.674.095
22717219,2012-06-18T00:00:00,Asthma,C20.543.480.680.095
22717219,2012-06-18T00:00:00,Child,M01.060.406
22717219,2012-06-18T00:00:00,Cost-Benefit Analysis,N03.219.151.125
22717219,2012-06-18T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
22717219,2012-06-18T00:00:00,"Emergency Service, Hospital",N02.421.297.195
22717219,2012-06-18T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
22717219,2012-06-18T00:00:00,Health Care Costs,N03.219.151.400
22717219,2012-06-18T00:00:00,Health Care Costs,N05.300.375
22717219,2012-06-18T00:00:00,Hospitalization,E02.760.400
22717219,2012-06-18T00:00:00,Hospitalization,N02.421.585.400
22717219,2012-06-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22717219,2012-06-18T00:00:00,Pediatrics,H02.403.670
22717219,2012-06-18T00:00:00,Treatment Outcome,E01.789.800
22717219,2012-06-18T00:00:00,Treatment Outcome,N04.761.559.590.800
22717219,2012-06-18T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22724016,2012-06-18T00:00:00,Alternative Splicing,G02.111.087.750.700.100
22724016,2012-06-18T00:00:00,Alternative Splicing,G02.149.115.750.700.100
22724016,2012-06-18T00:00:00,Alternative Splicing,G03.495.839.700.100
22724016,2012-06-18T00:00:00,Alternative Splicing,G05.355.315.700.700.100
22724016,2012-06-18T00:00:00,Animals,B01.050
22724016,2012-06-18T00:00:00,Basophils,A11.118.637.415.120
22724016,2012-06-18T00:00:00,Basophils,A11.627.340.120
22724016,2012-06-18T00:00:00,Basophils,A15.145.229.637.415.120
22724016,2012-06-18T00:00:00,Basophils,A15.382.490.315.120
22724016,2012-06-18T00:00:00,Endoplasmic Reticulum,A11.284.430.214.190.875.248
22724016,2012-06-18T00:00:00,Gene Deletion,G05.355.600.800.320
22724016,2012-06-18T00:00:00,Gene Deletion,G05.365.590.762.320
22724016,2012-06-18T00:00:00,Gene Expression Regulation,G05.355.315
22724016,2012-06-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22724016,2012-06-18T00:00:00,Membrane Glycoproteins,D12.776.395.550
22724016,2012-06-18T00:00:00,Membrane Glycoproteins,D12.776.543.550
22724016,2012-06-18T00:00:00,Molecular Chaperones,D12.776.580
22710579,2012-06-19T00:00:00,Adolescent,M01.060.057
22710579,2012-06-19T00:00:00,Adult,M01.060.116
22710579,2012-06-19T00:00:00,Aged,M01.060.116.100
22710579,2012-06-19T00:00:00,Hepatic Encephalopathy,C06.552.308.500.356
22710579,2012-06-19T00:00:00,Hepatic Encephalopathy,C10.228.140.163.360
22710579,2012-06-19T00:00:00,Hepatic Encephalopathy,C18.452.132.360
22710579,2012-06-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22710579,2012-06-19T00:00:00,Liver Cirrhosis,C06.552.630
22710579,2012-06-19T00:00:00,Middle Aged,M01.060.116.630
22710579,2012-06-19T00:00:00,Neuropsychological Tests,F04.711.513
22710579,2012-06-19T00:00:00,Psychometrics,F04.711.780
22710579,2012-06-19T00:00:00,Secondary Prevention,N02.421.726.825
22710579,2012-06-19T00:00:00,Secondary Prevention,N06.850.780.750
22710579,2012-06-19T00:00:00,Treatment Outcome,E01.789.800
22710579,2012-06-19T00:00:00,Treatment Outcome,N04.761.559.590.800
22710579,2012-06-19T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22717491,2012-06-19T00:00:00,Adult,M01.060.116
22717491,2012-06-19T00:00:00,Case-Control Studies,E05.318.760.500.500
22717491,2012-06-19T00:00:00,Case-Control Studies,N05.715.360.775.175.200
22717491,2012-06-19T00:00:00,Case-Control Studies,N06.850.520.450.500.500
22717491,2012-06-19T00:00:00,Cough,C08.618.248
22717491,2012-06-19T00:00:00,Cough,C23.888.852.293
22717491,2012-06-19T00:00:00,Deglutition,G10.261.326.215
22717491,2012-06-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22717491,2012-06-19T00:00:00,Larynx,A04.329
22717491,2012-06-19T00:00:00,Middle Aged,M01.060.116.630
22717491,2012-06-19T00:00:00,Voice Disorders,C08.360.940
22717491,2012-06-19T00:00:00,Voice Disorders,C09.400.940
22717491,2012-06-19T00:00:00,Voice Disorders,C10.597.975
22717491,2012-06-19T00:00:00,Voice Disorders,C23.888.592.979
22728312,2012-06-19T00:00:00,Adult,M01.060.116
22728312,2012-06-19T00:00:00,Case-Control Studies,E05.318.760.500.500
22728312,2012-06-19T00:00:00,Case-Control Studies,N05.715.360.775.175.200
22728312,2012-06-19T00:00:00,Case-Control Studies,N06.850.520.450.500.500
22728312,2012-06-19T00:00:00,Ceramides,D02.065.313
22728312,2012-06-19T00:00:00,Ceramides,D09.400.410.420.525.200
22728312,2012-06-19T00:00:00,Ceramides,D10.390.470.675.200
22728312,2012-06-19T00:00:00,Ceramides,D10.570.877.360.612.200
22728312,2012-06-19T00:00:00,Crohn Disease,C06.405.205.731.500
22728312,2012-06-19T00:00:00,Crohn Disease,C06.405.469.432.500
22728312,2012-06-19T00:00:00,Demography,I01.240
22728312,2012-06-19T00:00:00,Demography,N01.224
22728312,2012-06-19T00:00:00,Demography,N06.850.505.400
22728312,2012-06-19T00:00:00,Escherichia coli,B03.440.450.425.325.300
22728312,2012-06-19T00:00:00,Escherichia coli,B03.660.250.150.180.100
22728312,2012-06-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22728312,2012-06-19T00:00:00,Macrophages,A11.329.372
22728312,2012-06-19T00:00:00,Macrophages,A11.627.482
22728312,2012-06-19T00:00:00,Macrophages,A11.733.397
22728312,2012-06-19T00:00:00,Macrophages,A15.382.680.397
22728312,2012-06-19T00:00:00,Macrophages,A15.382.812.522
22728312,2012-06-19T00:00:00,Middle Aged,M01.060.116.630
22728312,2012-06-19T00:00:00,Sphingolipids,D10.570.877
22728312,2012-06-19T00:00:00,Sphingolipids,D10.808
22735539,2012-06-19T00:00:00,Algorithms,G17.035
22735539,2012-06-19T00:00:00,Algorithms,L01.224.050
22735539,2012-06-19T00:00:00,Binding Sites,G02.111.570.120
22735539,2012-06-19T00:00:00,Computational Biology,H01.158.273.180
22735539,2012-06-19T00:00:00,Molecular Dynamics Simulation,E05.599.595.500
22735539,2012-06-19T00:00:00,Molecular Dynamics Simulation,G02.575.750
22735539,2012-06-19T00:00:00,Molecular Dynamics Simulation,L01.224.160.500
22735539,2012-06-19T00:00:00,Poisson Distribution,E05.318.740.994.750
22735539,2012-06-19T00:00:00,Poisson Distribution,G17.820.750
22735539,2012-06-19T00:00:00,Poisson Distribution,N05.715.360.750.750.620
22735539,2012-06-19T00:00:00,Poisson Distribution,N06.850.520.830.994.750
22735539,2012-06-19T00:00:00,Proteins,D12.776
22735539,2012-06-19T00:00:00,Static Electricity,G01.201.249.820
22668085,2012-06-20T00:00:00,Nanotubes,J01.637.512.850
22668085,2012-06-20T00:00:00,Rheology,E05.830
22668085,2012-06-20T00:00:00,Rheology,H01.671.808
22668085,2012-06-20T00:00:00,Time Factors,G01.910.857
22714136,2012-06-20T00:00:00,Adolescent,M01.060.057
22714136,2012-06-20T00:00:00,Adult,M01.060.116
22714136,2012-06-20T00:00:00,Government Regulation,I01.880.604.394
22714136,2012-06-20T00:00:00,Government Regulation,N03.706.358
22714136,2012-06-20T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
22714136,2012-06-20T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
22714136,2012-06-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22714136,2012-06-20T00:00:00,Middle Aged,M01.060.116.630
22714136,2012-06-20T00:00:00,Questionnaires,E05.318.308.750
22714136,2012-06-20T00:00:00,Questionnaires,L01.280.800
22714136,2012-06-20T00:00:00,Questionnaires,N05.715.360.300.695
22714136,2012-06-20T00:00:00,Questionnaires,N06.850.520.308.750
22714136,2012-06-20T00:00:00,Smoking,F01.145.466.753
22714136,2012-06-20T00:00:00,Smoking Cessation,F01.145.940.700
22714136,2012-06-20T00:00:00,Tobacco Industry,J01.576.919
22714136,2012-06-20T00:00:00,United States,Z01.107.567.875
22714136,2012-06-20T00:00:00,Young Adult,M01.060.116.815
22715087,2012-06-20T00:00:00,Animals,B01.050
22715087,2012-06-20T00:00:00,Apoptosis,G04.299.139.160
22715087,2012-06-20T00:00:00,Calpain,D08.811.277.656.262.500.120
22715087,2012-06-20T00:00:00,Calpain,D08.811.277.656.300.200.120
22715087,2012-06-20T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.114.703.300
22715087,2012-06-20T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.314.350.250
22715087,2012-06-20T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C20.111.258.625.300
22715087,2012-06-20T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",E05.598.500.500.500
22715087,2012-06-20T00:00:00,"Muscle, Skeletal",A02.633.567
22715087,2012-06-20T00:00:00,"Muscle, Skeletal",A10.690.552.500
22715087,2012-06-20T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22766277,2012-06-20T00:00:00,Breast Neoplasms,C04.588.180
22766277,2012-06-20T00:00:00,Breast Neoplasms,C17.800.090.500
22766277,2012-06-20T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
22766277,2012-06-20T00:00:00,Histones,D12.776.660.470
22766277,2012-06-20T00:00:00,Histones,D12.776.664.469
22766277,2012-06-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22766277,2012-06-20T00:00:00,Mutation,G05.365.590
22727647,2012-06-21T00:00:00,Case-Control Studies,E05.318.760.500.500
22727647,2012-06-21T00:00:00,Case-Control Studies,N05.715.360.775.175.200
22727647,2012-06-21T00:00:00,Case-Control Studies,N06.850.520.450.500.500
22727647,2012-06-21T00:00:00,Child,M01.060.406
22727647,2012-06-21T00:00:00,"Child, Preschool",M01.060.406.448
22727647,2012-06-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22727647,2012-06-21T00:00:00,Radiation Monitoring,E05.799.638
22727647,2012-06-21T00:00:00,Radiation Monitoring,N06.850.780.375.700
22727647,2012-06-21T00:00:00,Radiation Monitoring,N06.850.810.370
22725265,2012-06-22T00:00:00,Adult,M01.060.116
22725265,2012-06-22T00:00:00,Alcohol Drinking,F01.145.317.269
22725265,2012-06-22T00:00:00,Biological Markers,D23.101
22725265,2012-06-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22725265,2012-06-22T00:00:00,Liver Diseases,C06.552
22725265,2012-06-22T00:00:00,Middle Aged,M01.060.116.630
22726759,2012-06-22T00:00:00,Adult,M01.060.116
22726759,2012-06-22T00:00:00,Aged,M01.060.116.100
22726759,2012-06-22T00:00:00,Attitude of Health Personnel,F01.100.050
22726759,2012-06-22T00:00:00,Attitude of Health Personnel,N05.300.100
22726759,2012-06-22T00:00:00,Child,M01.060.406
22726759,2012-06-22T00:00:00,Community Mental Health Services,F04.408.307
22726759,2012-06-22T00:00:00,Community Mental Health Services,N02.421.143.183
22726759,2012-06-22T00:00:00,Community Mental Health Services,N02.421.461.232
22726759,2012-06-22T00:00:00,Diffusion of Innovation,L01.143.320
22726759,2012-06-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22726759,2012-06-22T00:00:00,Middle Aged,M01.060.116.630
22726759,2012-06-22T00:00:00,United States,Z01.107.567.875
22728001,2012-06-22T00:00:00,Blood Coagulation Disorders,C15.378.100
22728001,2012-06-22T00:00:00,Hemorrhage,C23.550.414
22728001,2012-06-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22728001,2012-06-22T00:00:00,Incidence,E05.318.308.985.525.375
22728001,2012-06-22T00:00:00,Incidence,L01.280.975.525.375
22728001,2012-06-22T00:00:00,Incidence,N01.224.935.597.500
22728001,2012-06-22T00:00:00,Incidence,N06.850.505.400.975.525.375
22728001,2012-06-22T00:00:00,Incidence,N06.850.520.308.985.525.375
22728001,2012-06-22T00:00:00,Liver Transplantation,E04.210.650
22728001,2012-06-22T00:00:00,Liver Transplantation,E04.936.450.490
22728001,2012-06-22T00:00:00,Liver Transplantation,E04.936.580.490
22728001,2012-06-22T00:00:00,Middle Aged,M01.060.116.630
22728001,2012-06-22T00:00:00,Preoperative Care,E02.760.795
22728001,2012-06-22T00:00:00,Preoperative Care,E04.641
22728001,2012-06-22T00:00:00,Preoperative Care,N02.421.585.795
22728001,2012-06-22T00:00:00,Risk Factors,E05.318.740.600.800.725
22728001,2012-06-22T00:00:00,Risk Factors,N05.715.350.200.700
22728001,2012-06-22T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22728001,2012-06-22T00:00:00,Risk Factors,N06.850.490.625.750
22728001,2012-06-22T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22728001,2012-06-22T00:00:00,South Carolina,Z01.107.567.875.075.662
22728001,2012-06-22T00:00:00,South Carolina,Z01.107.567.875.750.700
22724917,2012-06-23T00:00:00,Animals,B01.050
22724917,2012-06-23T00:00:00,Antineoplastic Agents,D27.505.954.248
22724917,2012-06-23T00:00:00,Clinical Trials as Topic,E05.318.760.535
22724917,2012-06-23T00:00:00,Clinical Trials as Topic,E05.337.250
22724917,2012-06-23T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
22724917,2012-06-23T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
22724917,2012-06-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22724917,2012-06-23T00:00:00,"Leukemia, Myeloid, Acute",C04.557.337.539.550
22724917,2012-06-23T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
22724917,2012-06-23T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
22724917,2012-06-23T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
22724917,2012-06-23T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
22724917,2012-06-23T00:00:00,Thiazoles,D02.886.675
22724917,2012-06-23T00:00:00,Thiazoles,D03.383.129.708
22676250,2012-06-25T00:00:00,Acetylcysteine,D02.886.030.230.259
22676250,2012-06-25T00:00:00,Acetylcysteine,D12.125.166.230.259
22676250,2012-06-25T00:00:00,Animals,B01.050
22676250,2012-06-25T00:00:00,Connexin 43,D12.776.543.585.250.200
22676250,2012-06-25T00:00:00,Contractile Proteins,D12.776.210
22676250,2012-06-25T00:00:00,Cyclooxygenase 2,D08.811.600.720.750
22676250,2012-06-25T00:00:00,Down-Regulation,G02.111.087.225
22676250,2012-06-25T00:00:00,Down-Regulation,G02.149.115.225
22676250,2012-06-25T00:00:00,Down-Regulation,G05.355.315.200
22676250,2012-06-25T00:00:00,Down-Regulation,G07.690.812.230
22676250,2012-06-25T00:00:00,Down-Regulation,G07.700.680.230
22676250,2012-06-25T00:00:00,Gene Expression Regulation,G05.355.315
22676250,2012-06-25T00:00:00,Lipopolysaccharides,D09.400.500
22676250,2012-06-25T00:00:00,Lipopolysaccharides,D09.698.718.450
22676250,2012-06-25T00:00:00,Lipopolysaccharides,D10.494
22676250,2012-06-25T00:00:00,Lipopolysaccharides,D23.050.161.616.525
22676250,2012-06-25T00:00:00,Lipopolysaccharides,D23.946.123.329.500
22676250,2012-06-25T00:00:00,"Models, Animal",E05.598
22676250,2012-06-25T00:00:00,"Models, Biological",E05.599.395
22676250,2012-06-25T00:00:00,NF-kappa B,D12.776.260.600
22676250,2012-06-25T00:00:00,NF-kappa B,D12.776.660.600
22676250,2012-06-25T00:00:00,NF-kappa B,D12.776.930.600
22676250,2012-06-25T00:00:00,Pregnancy,G08.686.785.760.769
22676250,2012-06-25T00:00:00,Premature Birth,C13.703.420.491.500
22676250,2012-06-25T00:00:00,Uterine Contraction,G08.686.785.760.769.326.700
22676250,2012-06-25T00:00:00,Uterine Contraction,G11.427.590.540.890
22676250,2012-06-25T00:00:00,Uterus,A05.360.319.679
22716475,2012-06-25T00:00:00,"Models, Molecular",E05.599.595
22716475,2012-06-25T00:00:00,Polymers,D05.750
22716475,2012-06-25T00:00:00,Polymers,D25.720
22716475,2012-06-25T00:00:00,Polymers,J01.637.051.720
22716475,2012-06-25T00:00:00,Solvents,D27.720.844
22716475,2012-06-25T00:00:00,Surface Properties,G02.842.850
22733971,2012-06-25T00:00:00,Animals,B01.050
22733971,2012-06-25T00:00:00,Cyclic AMP-Dependent Protein Kinases,D08.811.913.696.620.682.700.150.125
22733971,2012-06-25T00:00:00,Cyclic AMP-Dependent Protein Kinases,D12.644.360.200.125
22733971,2012-06-25T00:00:00,Cyclic AMP-Dependent Protein Kinases,D12.776.476.200.125
22733971,2012-06-25T00:00:00,Phosphorylation,G02.111.087.677
22733971,2012-06-25T00:00:00,Phosphorylation,G02.149.115.677
22733971,2012-06-25T00:00:00,Phosphorylation,G02.149.465.700
22733971,2012-06-25T00:00:00,Phosphorylation,G02.607.750.700
22733971,2012-06-25T00:00:00,Phosphorylation,G03.495.790
22733971,2012-06-25T00:00:00,Polymerase Chain Reaction,E05.393.620.500
22739348,2012-06-25T00:00:00,Autoimmune Diseases,C20.111
22739348,2012-06-25T00:00:00,Case-Control Studies,E05.318.760.500.500
22739348,2012-06-25T00:00:00,Case-Control Studies,N05.715.360.775.175.200
22739348,2012-06-25T00:00:00,Case-Control Studies,N06.850.520.450.500.500
22739348,2012-06-25T00:00:00,Environmental Exposure,N06.850.460.350
22739348,2012-06-25T00:00:00,Environmental Pollutants,D27.888.284
22739348,2012-06-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22739348,2012-06-25T00:00:00,Risk Factors,E05.318.740.600.800.725
22739348,2012-06-25T00:00:00,Risk Factors,N05.715.350.200.700
22739348,2012-06-25T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22739348,2012-06-25T00:00:00,Risk Factors,N06.850.490.625.750
22739348,2012-06-25T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22739348,2012-06-25T00:00:00,Smoking,F01.145.466.753
22739348,2012-06-25T00:00:00,Solvents,D27.720.844
22739348,2012-06-25T00:00:00,United States,Z01.107.567.875
22736403,2012-06-26T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
22736403,2012-06-26T00:00:00,Antifungal Agents,D27.505.954.122.136
22736403,2012-06-26T00:00:00,Chronic Disease,C23.550.291.500
22736403,2012-06-26T00:00:00,Evidence-Based Medicine,H02.249.750
22736403,2012-06-26T00:00:00,Evidence-Based Medicine,H02.403.200.400
22736403,2012-06-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22736403,2012-06-26T00:00:00,Nasal Polyps,C08.460.572
22736403,2012-06-26T00:00:00,Nasal Polyps,C09.603.557
22736403,2012-06-26T00:00:00,Nasal Polyps,C23.300.825.557
22736403,2012-06-26T00:00:00,Rhinitis,C08.460.799
22736403,2012-06-26T00:00:00,Rhinitis,C08.730.674
22736403,2012-06-26T00:00:00,Rhinitis,C09.603.799
22736403,2012-06-26T00:00:00,Sinusitis,C08.460.692.752
22736403,2012-06-26T00:00:00,Sinusitis,C08.730.749
22736403,2012-06-26T00:00:00,Sinusitis,C09.603.692.752
22736403,2012-06-26T00:00:00,Treatment Outcome,E01.789.800
22736403,2012-06-26T00:00:00,Treatment Outcome,N04.761.559.590.800
22736403,2012-06-26T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22736422,2012-06-26T00:00:00,Chronic Disease,C23.550.291.500
22736422,2012-06-26T00:00:00,Endoscopy,E01.370.388.250
22736422,2012-06-26T00:00:00,Endoscopy,E04.800.250
22736422,2012-06-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22736422,2012-06-26T00:00:00,Middle Aged,M01.060.116.630
22736422,2012-06-26T00:00:00,Paranasal Sinuses,A04.531.621
22736422,2012-06-26T00:00:00,Quality of Life,I01.800
22736422,2012-06-26T00:00:00,Quality of Life,K01.752.400.750
22736422,2012-06-26T00:00:00,Rhinitis,C08.460.799
22736422,2012-06-26T00:00:00,Rhinitis,C08.730.674
22736422,2012-06-26T00:00:00,Rhinitis,C09.603.799
22736422,2012-06-26T00:00:00,Sinusitis,C08.460.692.752
22736422,2012-06-26T00:00:00,Sinusitis,C08.730.749
22736422,2012-06-26T00:00:00,Sinusitis,C09.603.692.752
22736422,2012-06-26T00:00:00,Treatment Outcome,E01.789.800
22736422,2012-06-26T00:00:00,Treatment Outcome,N04.761.559.590.800
22736422,2012-06-26T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22736507,2012-06-26T00:00:00,Animals,B01.050
22736507,2012-06-26T00:00:00,Biological Markers,D23.101
22736507,2012-06-26T00:00:00,"Diabetes Mellitus, Experimental",C18.452.394.750.074
22736507,2012-06-26T00:00:00,"Diabetes Mellitus, Experimental",C19.246.240
22736507,2012-06-26T00:00:00,"Diabetes Mellitus, Experimental",E05.598.500.374
22736507,2012-06-26T00:00:00,Diabetic Nephropathies,C12.777.419.192
22736507,2012-06-26T00:00:00,Diabetic Nephropathies,C13.351.968.419.192
22736507,2012-06-26T00:00:00,Diabetic Nephropathies,C19.246.099.875
22736507,2012-06-26T00:00:00,Intercellular Adhesion Molecule-1,D12.776.395.550.200.450
22736507,2012-06-26T00:00:00,Intercellular Adhesion Molecule-1,D12.776.543.550.200.450
22736507,2012-06-26T00:00:00,Intercellular Adhesion Molecule-1,D23.050.301.264.035.400
22736507,2012-06-26T00:00:00,Intercellular Adhesion Molecule-1,D23.050.301.350.450
22736507,2012-06-26T00:00:00,Intercellular Adhesion Molecule-1,D23.101.100.110.400
22736507,2012-06-26T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
22736507,2012-06-26T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
22736507,2012-06-26T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
22736507,2012-06-26T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
22736507,2012-06-26T00:00:00,NF-kappa B,D12.776.260.600
22736507,2012-06-26T00:00:00,NF-kappa B,D12.776.660.600
22736507,2012-06-26T00:00:00,NF-kappa B,D12.776.930.600
22736507,2012-06-26T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22736507,2012-06-26T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
22736507,2012-06-26T00:00:00,Transforming Growth Factor beta1,D12.644.276.374.687.100
22736507,2012-06-26T00:00:00,Transforming Growth Factor beta1,D12.644.276.954.800.720.100
22736507,2012-06-26T00:00:00,Transforming Growth Factor beta1,D12.644.276.963.720.100
22736507,2012-06-26T00:00:00,Transforming Growth Factor beta1,D12.776.467.374.687.100
22736507,2012-06-26T00:00:00,Transforming Growth Factor beta1,D12.776.467.942.800.720.100
22736507,2012-06-26T00:00:00,Transforming Growth Factor beta1,D12.776.467.960.720.100
22736507,2012-06-26T00:00:00,Transforming Growth Factor beta1,D23.529.374.687.100
22736507,2012-06-26T00:00:00,Transforming Growth Factor beta1,D23.529.942.800.720.100
22736507,2012-06-26T00:00:00,Transforming Growth Factor beta1,D23.529.960.720.100
22736507,2012-06-26T00:00:00,Treatment Outcome,E01.789.800
22736507,2012-06-26T00:00:00,Treatment Outcome,N04.761.559.590.800
22736507,2012-06-26T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22739648,2012-06-26T00:00:00,Adult,M01.060.116
22739648,2012-06-26T00:00:00,Aged,M01.060.116.100
22739648,2012-06-26T00:00:00,Brachiocephalic Veins,A07.231.908.130
22739648,2012-06-26T00:00:00,Catheter Ablation,E01.370.370.380.410.200
22739648,2012-06-26T00:00:00,Catheter Ablation,E02.148.110
22739648,2012-06-26T00:00:00,Catheter Ablation,E02.148.442.110
22739648,2012-06-26T00:00:00,Catheter Ablation,E02.154.402.110
22739648,2012-06-26T00:00:00,Catheter Ablation,E04.014.170.402.110
22739648,2012-06-26T00:00:00,"Catheterization, Central Venous",E02.148.167
22739648,2012-06-26T00:00:00,"Constriction, Pathologic",C23.300.287
22739648,2012-06-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22739648,2012-06-26T00:00:00,Middle Aged,M01.060.116.630
22739648,2012-06-26T00:00:00,"Radiography, Interventional",E01.370.350.700.725
22739648,2012-06-26T00:00:00,"Radiography, Interventional",E02.148.694
22739648,2012-06-26T00:00:00,"Radiography, Interventional",E04.800.780
22739648,2012-06-26T00:00:00,South Carolina,Z01.107.567.875.075.662
22739648,2012-06-26T00:00:00,South Carolina,Z01.107.567.875.750.700
22739648,2012-06-26T00:00:00,Stents,E07.695.750
22739648,2012-06-26T00:00:00,Subclavian Vein,A07.231.908.877
22739648,2012-06-26T00:00:00,Superior Vena Cava Syndrome,C14.907.800
22739648,2012-06-26T00:00:00,Time Factors,G01.910.857
22739648,2012-06-26T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
22739648,2012-06-26T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
22739648,2012-06-26T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
22739648,2012-06-26T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
22739648,2012-06-26T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
22739648,2012-06-26T00:00:00,"Vena Cava, Superior",A07.231.908.949.815
22761716,2012-06-26T00:00:00,Adolescent,M01.060.057
22761716,2012-06-26T00:00:00,Adult,M01.060.116
22761716,2012-06-26T00:00:00,Aged,M01.060.116.100
22761716,2012-06-26T00:00:00,Anxiety Disorders,F03.080
22761716,2012-06-26T00:00:00,Cyclonic Storms,G16.500.240.135.500
22761716,2012-06-26T00:00:00,Depressive Disorder,F03.600.300
22761716,2012-06-26T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
22761716,2012-06-26T00:00:00,Disasters,N06.230.100
22761716,2012-06-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22761716,2012-06-26T00:00:00,"Interview, Psychological",F04.669.599
22761716,2012-06-26T00:00:00,Middle Aged,M01.060.116.630
22761716,2012-06-26T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
22761716,2012-06-26T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
22761716,2012-06-26T00:00:00,"Resilience, Psychological",F02.940
22761716,2012-06-26T00:00:00,Risk Factors,E05.318.740.600.800.725
22761716,2012-06-26T00:00:00,Risk Factors,N05.715.350.200.700
22761716,2012-06-26T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22761716,2012-06-26T00:00:00,Risk Factors,N06.850.490.625.750
22761716,2012-06-26T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22761716,2012-06-26T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
22761716,2012-06-26T00:00:00,Suicide,F01.145.126.980.875
22761716,2012-06-26T00:00:00,Suicide,I01.880.735.856
22761716,2012-06-26T00:00:00,Young Adult,M01.060.116.815
22619183,2012-06-27T00:00:00,Animals,B01.050
22619183,2012-06-27T00:00:00,Cattle,B01.050.150.900.649.077.380.271
22619183,2012-06-27T00:00:00,Cell Line,A11.251.210
22619183,2012-06-27T00:00:00,Cell Proliferation,G04.299.233.750
22619183,2012-06-27T00:00:00,Cell Proliferation,G07.700.320.249.410.750
22619183,2012-06-27T00:00:00,Cell Size,G04.190
22619183,2012-06-27T00:00:00,Endothelial Cells,A11.436.275
22619183,2012-06-27T00:00:00,Fibroblasts,A11.329.228
22619183,2012-06-27T00:00:00,Fibroblasts,A11.872.228
22619183,2012-06-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22619183,2012-06-27T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
22619183,2012-06-27T00:00:00,"Microscopy, Fluorescence",E05.595.458
22619183,2012-06-27T00:00:00,Phenotype,G05.695
22736228,2012-06-27T00:00:00,Adsorption,G02.149.047
22736228,2012-06-27T00:00:00,Adsorption,G02.149.767.029
22736228,2012-06-27T00:00:00,Adsorption,G02.842.750.029
22736228,2012-06-27T00:00:00,Animals,B01.050
22736228,2012-06-27T00:00:00,Cattle,B01.050.150.900.649.077.380.271
22736228,2012-06-27T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
22736228,2012-06-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22736228,2012-06-27T00:00:00,Materials Testing,E05.570
22736228,2012-06-27T00:00:00,Polypropylenes,D02.455.326.271.665.590
22736228,2012-06-27T00:00:00,Polypropylenes,D05.750.716.550
22736228,2012-06-27T00:00:00,Polypropylenes,D25.720.716.550
22736228,2012-06-27T00:00:00,Polypropylenes,J01.637.051.720.716.550
22736228,2012-06-27T00:00:00,Transferrin,D12.776.124.050.800
22736228,2012-06-27T00:00:00,Transferrin,D12.776.124.790.223.839
22736228,2012-06-27T00:00:00,Transferrin,D12.776.157.427.500
22736228,2012-06-27T00:00:00,Transferrin,D12.776.377.715.182.839
22736228,2012-06-27T00:00:00,Transferrin,D12.776.556.579.500
22910420,2012-06-27T00:00:00,Cardiovascular Agents,D27.505.954.411
22910420,2012-06-27T00:00:00,Coronary Artery Disease,C14.280.647.250.260
22910420,2012-06-27T00:00:00,Coronary Artery Disease,C14.907.137.126.339
22910420,2012-06-27T00:00:00,Coronary Artery Disease,C14.907.585.250.260
22910420,2012-06-27T00:00:00,Coronary Restenosis,C14.280.647.250.285.200
22910420,2012-06-27T00:00:00,Coronary Restenosis,C14.907.585.250.285.200
22910420,2012-06-27T00:00:00,Drug-Eluting Stents,E07.695.750.500
22910420,2012-06-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22910420,2012-06-27T00:00:00,Patient Selection,E05.581.500.653
22910420,2012-06-27T00:00:00,Patient Selection,N04.590.731
22910420,2012-06-27T00:00:00,Prosthesis Design,E05.320.550
22910420,2012-06-27T00:00:00,Prosthesis Design,E07.695.680
22910420,2012-06-27T00:00:00,Risk Assessment,E05.318.740.600.800.715
22910420,2012-06-27T00:00:00,Risk Assessment,N04.452.871.715
22910420,2012-06-27T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
22910420,2012-06-27T00:00:00,Risk Assessment,N06.850.505.715
22910420,2012-06-27T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
22910420,2012-06-27T00:00:00,Risk Factors,E05.318.740.600.800.725
22910420,2012-06-27T00:00:00,Risk Factors,N05.715.350.200.700
22910420,2012-06-27T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22910420,2012-06-27T00:00:00,Risk Factors,N06.850.490.625.750
22910420,2012-06-27T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22910420,2012-06-27T00:00:00,Treatment Outcome,E01.789.800
22910420,2012-06-27T00:00:00,Treatment Outcome,N04.761.559.590.800
22910420,2012-06-27T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22661469,2012-06-28T00:00:00,"Analgesics, Opioid",D27.505.696.663.850.014.520
22661469,2012-06-28T00:00:00,"Analgesics, Opioid",D27.505.954.427.040.325
22661469,2012-06-28T00:00:00,"Analgesics, Opioid",D27.505.954.427.210.049
22661469,2012-06-28T00:00:00,Animals,B01.050
22661469,2012-06-28T00:00:00,Caspases,D08.811.277.656.262.500.126
22661469,2012-06-28T00:00:00,Caspases,D08.811.277.656.300.200.126
22661469,2012-06-28T00:00:00,Caspases,D12.644.360.075.405
22661469,2012-06-28T00:00:00,Caspases,D12.776.476.075.405
22661469,2012-06-28T00:00:00,Cell Survival,G04.299.316
22661469,2012-06-28T00:00:00,Chronic Disease,C23.550.291.500
22661469,2012-06-28T00:00:00,"Disease Models, Animal",C22.232
22661469,2012-06-28T00:00:00,"Disease Models, Animal",E05.598.500
22661469,2012-06-28T00:00:00,"Disease Models, Animal",E05.599.395.080
22661469,2012-06-28T00:00:00,Disease Progression,C23.550.291.656
22661469,2012-06-28T00:00:00,Intraocular Pressure,G14.440
22661469,2012-06-28T00:00:00,Morphine,D03.132.577.249.547
22661469,2012-06-28T00:00:00,Morphine,D03.549.686.575
22661469,2012-06-28T00:00:00,Morphine,D03.605.497.575
22661469,2012-06-28T00:00:00,Morphine,D04.615.723.795.547
22661469,2012-06-28T00:00:00,Ocular Hypertension,C11.525
22661469,2012-06-28T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22661469,2012-06-28T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
22661469,2012-06-28T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
22661469,2012-06-28T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
22661469,2012-06-28T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
22661469,2012-06-28T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
22661469,2012-06-28T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
22661469,2012-06-28T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
22661469,2012-06-28T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
22661469,2012-06-28T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
22661469,2012-06-28T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
22661469,2012-06-28T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
23121787,2012-06-28T00:00:00,Adult,M01.060.116
23121787,2012-06-28T00:00:00,Body Mass Index,E01.370.600.115.100.125
23121787,2012-06-28T00:00:00,Body Mass Index,E05.041.124.125
23121787,2012-06-28T00:00:00,Body Mass Index,G07.100.100.125
23121787,2012-06-28T00:00:00,Body Mass Index,N06.850.505.200.100.175
23121787,2012-06-28T00:00:00,"Diet, Reducing",E02.642.249.285
23121787,2012-06-28T00:00:00,"Diet, Reducing",G07.610.240.285
23121787,2012-06-28T00:00:00,Eating,G07.610.593.260
23121787,2012-06-28T00:00:00,Eating,G07.700.620.260
23121787,2012-06-28T00:00:00,Eating,G10.261.326.240
23121787,2012-06-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23121787,2012-06-28T00:00:00,Middle Aged,M01.060.116.630
23121787,2012-06-28T00:00:00,Overweight,C23.888.144.699
23121787,2012-06-28T00:00:00,Overweight,E01.370.600.115.100.160.120.699
23121787,2012-06-28T00:00:00,Overweight,G07.100.100.160.120.699
23121787,2012-06-28T00:00:00,Treatment Outcome,E01.789.800
23121787,2012-06-28T00:00:00,Treatment Outcome,N04.761.559.590.800
23121787,2012-06-28T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23121787,2012-06-28T00:00:00,Weight Loss,C23.888.144.243.963
23121787,2012-06-28T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
22752474,2012-06-29T00:00:00,"Child, Preschool",M01.060.406.448
22752474,2012-06-29T00:00:00,Developmental Disabilities,F03.550.362
22752474,2012-06-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22752474,2012-06-29T00:00:00,"Translocation, Genetic",C23.550.210.870
22752474,2012-06-29T00:00:00,"Translocation, Genetic",G05.355.600.860
22752474,2012-06-29T00:00:00,"Translocation, Genetic",G05.365.590.175.870
22752474,2012-06-29T00:00:00,Trisomy,C23.550.210.050.750
22752474,2012-06-29T00:00:00,Trisomy,G05.365.590.175.050.750
22752474,2012-06-29T00:00:00,Trisomy,G05.700.131.750
22768167,2012-06-29T00:00:00,Angiogenesis Inhibitors,D27.505.696.377.077.099
22768167,2012-06-29T00:00:00,Angiogenesis Inhibitors,D27.505.696.377.450.100
22768167,2012-06-29T00:00:00,Angiogenesis Inhibitors,D27.505.954.248.025
22768167,2012-06-29T00:00:00,Animals,B01.050
22768167,2012-06-29T00:00:00,"Antigens, Bacterial",D23.050.161
22768167,2012-06-29T00:00:00,Bacterial Toxins,D23.946.123
22768167,2012-06-29T00:00:00,Cisplatin,D01.210.375
22768167,2012-06-29T00:00:00,Cisplatin,D01.625.125
22768167,2012-06-29T00:00:00,Cisplatin,D01.710.100
22768167,2012-06-29T00:00:00,Fluorescence Resonance Energy Transfer,E05.196.712.516.600.676.500
22768167,2012-06-29T00:00:00,Fluorescence Resonance Energy Transfer,G01.154.100.240.280
22768167,2012-06-29T00:00:00,Fluorescence Resonance Energy Transfer,G01.595.100.240.280
22768167,2012-06-29T00:00:00,Fluorescence Resonance Energy Transfer,G02.111.087.242.280
22768167,2012-06-29T00:00:00,Fluorescence Resonance Energy Transfer,G02.149.115.242.280
22768167,2012-06-29T00:00:00,Membrane Proteins,D12.776.543
22768167,2012-06-29T00:00:00,Pilot Projects,E05.318.760.750
22768167,2012-06-29T00:00:00,Pilot Projects,E05.337.737
22768167,2012-06-29T00:00:00,Pilot Projects,N05.715.360.775.625
22768167,2012-06-29T00:00:00,Pilot Projects,N06.850.520.450.720
22768167,2012-06-29T00:00:00,"Receptors, Peptide",D12.776.543.750.750
22768167,2012-06-29T00:00:00,Surface Plasmon Resonance,E05.196.890
22768167,2012-06-29T00:00:00,Surface Plasmon Resonance,E05.601.123.700
22768167,2012-06-29T00:00:00,Time Factors,G01.910.857
22752328,2012-06-30T00:00:00,Animals,B01.050
22752328,2012-06-30T00:00:00,"Behavior, Animal",F01.145.113
22752328,2012-06-30T00:00:00,"Conditioning, Operant",F02.463.425.179.509
22752328,2012-06-30T00:00:00,Excitatory Amino Acid Antagonists,D27.505.519.625.190.300
22752328,2012-06-30T00:00:00,Excitatory Amino Acid Antagonists,D27.505.696.577.190.300
22752328,2012-06-30T00:00:00,Light,G01.201.875.770.578
22752328,2012-06-30T00:00:00,Light,G01.590.540
22752328,2012-06-30T00:00:00,Motivation,F01.658
22752328,2012-06-30T00:00:00,Motivation,F01.752.543.500.750
22752328,2012-06-30T00:00:00,Motor Activity,F01.145.632
22752328,2012-06-30T00:00:00,Motor Activity,G11.427.590.530.698
22752328,2012-06-30T00:00:00,Photic Stimulation,E05.723.729
22752328,2012-06-30T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22752328,2012-06-30T00:00:00,"Receptors, AMPA",D12.776.543.750.720.200.450.200
22752328,2012-06-30T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
22752328,2012-06-30T00:00:00,Self Administration,E02.319.890
22752328,2012-06-30T00:00:00,Self Administration,E02.900.890
22752328,2012-06-30T00:00:00,Time Factors,G01.910.857
22752328,2012-06-30T00:00:00,"Vision, Ocular",F02.830.816.964
22752328,2012-06-30T00:00:00,"Vision, Ocular",G02.111.087.800.480.900
22752328,2012-06-30T00:00:00,"Vision, Ocular",G02.149.115.800.480.900
22752328,2012-06-30T00:00:00,"Vision, Ocular",G04.299.880.480.900
22752328,2012-06-30T00:00:00,"Vision, Ocular",G11.561.600.810.964
22752328,2012-06-30T00:00:00,"Vision, Ocular",G14.640.816
22131127,2012-07-01T00:00:00,Adult,M01.060.116
22131127,2012-07-01T00:00:00,Aged,M01.060.116.100
22131127,2012-07-01T00:00:00,"Arthritis, Rheumatoid",C05.550.114.154
22131127,2012-07-01T00:00:00,"Arthritis, Rheumatoid",C05.799.114
22131127,2012-07-01T00:00:00,"Arthritis, Rheumatoid",C17.300.775.099
22131127,2012-07-01T00:00:00,"Arthritis, Rheumatoid",C20.111.199
22131127,2012-07-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
22131127,2012-07-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
22131127,2012-07-01T00:00:00,Biological Markers,D23.101
22131127,2012-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22131127,2012-07-01T00:00:00,Middle Aged,M01.060.116.630
22131127,2012-07-01T00:00:00,New York,Z01.107.567.875.075.437
22131127,2012-07-01T00:00:00,New York,Z01.107.567.875.350.530
22131127,2012-07-01T00:00:00,New York,Z01.107.567.875.500.530
22131127,2012-07-01T00:00:00,"Osteoarthritis, Knee",C05.550.114.606.500
22131127,2012-07-01T00:00:00,"Osteoarthritis, Knee",C05.799.613.500
22131127,2012-07-01T00:00:00,Pilot Projects,E05.318.760.750
22131127,2012-07-01T00:00:00,Pilot Projects,E05.337.737
22131127,2012-07-01T00:00:00,Pilot Projects,N05.715.360.775.625
22131127,2012-07-01T00:00:00,Pilot Projects,N06.850.520.450.720
22131127,2012-07-01T00:00:00,Prosthesis Failure,C23.550.767.865
22131127,2012-07-01T00:00:00,Prosthesis Failure,E05.325.771
22131127,2012-07-01T00:00:00,Reoperation,E04.690
22227844,2012-07-01T00:00:00,Adult,M01.060.116
22227844,2012-07-01T00:00:00,Anti-Retroviral Agents,D27.505.954.122.388.077
22227844,2012-07-01T00:00:00,Anus Neoplasms,C04.588.274.476.411.307.790.040
22227844,2012-07-01T00:00:00,Anus Neoplasms,C06.301.371.411.307.790.040
22227844,2012-07-01T00:00:00,Anus Neoplasms,C06.405.249.411.307.790.040
22227844,2012-07-01T00:00:00,Anus Neoplasms,C06.405.469.491.307.790.040
22227844,2012-07-01T00:00:00,Anus Neoplasms,C06.405.469.860.101.163
22227844,2012-07-01T00:00:00,Anus Neoplasms,C06.405.469.860.180.500.040
22227844,2012-07-01T00:00:00,Combined Modality Therapy,E02.186
22227844,2012-07-01T00:00:00,Cost-Benefit Analysis,N03.219.151.125
22227844,2012-07-01T00:00:00,Early Detection of Cancer,E01.390.500
22227844,2012-07-01T00:00:00,HIV Infections,C02.782.815.616.400
22227844,2012-07-01T00:00:00,HIV Infections,C02.800.801.400
22227844,2012-07-01T00:00:00,HIV Infections,C20.673.480
22227844,2012-07-01T00:00:00,HIV Seropositivity,C02.782.815.616.400.500
22227844,2012-07-01T00:00:00,HIV Seropositivity,C02.800.801.400.500
22227844,2012-07-01T00:00:00,HIV Seropositivity,C20.673.480.500
22227844,2012-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22227844,2012-07-01T00:00:00,Incidence,E05.318.308.985.525.375
22227844,2012-07-01T00:00:00,Incidence,L01.280.975.525.375
22227844,2012-07-01T00:00:00,Incidence,N01.224.935.597.500
22227844,2012-07-01T00:00:00,Incidence,N06.850.505.400.975.525.375
22227844,2012-07-01T00:00:00,Incidence,N06.850.520.308.985.525.375
22227844,2012-07-01T00:00:00,Markov Chains,E05.318.740.600.500
22227844,2012-07-01T00:00:00,Markov Chains,E05.318.740.996.500
22227844,2012-07-01T00:00:00,Markov Chains,G17.830.500
22227844,2012-07-01T00:00:00,Markov Chains,N05.715.360.750.625.500
22227844,2012-07-01T00:00:00,Markov Chains,N05.715.360.750.770.500
22227844,2012-07-01T00:00:00,Markov Chains,N06.850.520.830.600.500
22227844,2012-07-01T00:00:00,Markov Chains,N06.850.520.830.996.500
22227844,2012-07-01T00:00:00,Mass Screening,E01.370.500
22227844,2012-07-01T00:00:00,Mass Screening,E05.318.308.250.580
22227844,2012-07-01T00:00:00,Mass Screening,N02.421.143.827.233.443
22227844,2012-07-01T00:00:00,Mass Screening,N02.421.726.233.443
22227844,2012-07-01T00:00:00,Mass Screening,N05.715.360.300.375.500
22227844,2012-07-01T00:00:00,Mass Screening,N06.850.520.308.250.580
22227844,2012-07-01T00:00:00,Mass Screening,N06.850.780.500
22227844,2012-07-01T00:00:00,Middle Aged,M01.060.116.630
22227844,2012-07-01T00:00:00,Neoplasm Invasiveness,C04.697.645
22227844,2012-07-01T00:00:00,Neoplasm Invasiveness,C23.550.727.645
22227844,2012-07-01T00:00:00,Neoplasm Staging,E01.370.550
22227844,2012-07-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
22227844,2012-07-01T00:00:00,Risk Assessment,N04.452.871.715
22227844,2012-07-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
22227844,2012-07-01T00:00:00,Risk Assessment,N06.850.505.715
22227844,2012-07-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
22227844,2012-07-01T00:00:00,United States,Z01.107.567.875
22227844,2012-07-01T00:00:00,Young Adult,M01.060.116.815
22494048,2012-07-01T00:00:00,Animals,B01.050
22494048,2012-07-01T00:00:00,Apoptosis,G04.299.139.160
22494048,2012-07-01T00:00:00,Biphenyl Compounds,D02.455.426.559.389.185
22494048,2012-07-01T00:00:00,Caspases,D08.811.277.656.262.500.126
22494048,2012-07-01T00:00:00,Caspases,D08.811.277.656.300.200.126
22494048,2012-07-01T00:00:00,Caspases,D12.644.360.075.405
22494048,2012-07-01T00:00:00,Caspases,D12.776.476.075.405
22494048,2012-07-01T00:00:00,Ceramides,D02.065.313
22494048,2012-07-01T00:00:00,Ceramides,D09.400.410.420.525.200
22494048,2012-07-01T00:00:00,Ceramides,D10.390.470.675.200
22494048,2012-07-01T00:00:00,Ceramides,D10.570.877.360.612.200
22494048,2012-07-01T00:00:00,Computer Simulation,L01.224.160
22494048,2012-07-01T00:00:00,"Mitochondria, Liver",A11.284.430.214.190.875.564.461
22494048,2012-07-01T00:00:00,"Mitochondria, Liver",A11.284.835.626.461
22494048,2012-07-01T00:00:00,"Models, Molecular",E05.599.595
22494048,2012-07-01T00:00:00,Piperazines,D03.383.606
22494048,2012-07-01T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.644.360.075.718
22494048,2012-07-01T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.476.075.718
22494048,2012-07-01T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.624.664.700.169
22494048,2012-07-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22494048,2012-07-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
22494048,2012-07-01T00:00:00,bcl-2-Associated X Protein,D12.644.360.075.718.400
22494048,2012-07-01T00:00:00,bcl-2-Associated X Protein,D12.776.476.075.718.400
22583991,2012-07-01T00:00:00,African Americans,M01.686.508.100.100
22583991,2012-07-01T00:00:00,African Americans,M01.686.754.100
22583991,2012-07-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
22583991,2012-07-01T00:00:00,Healthcare Disparities,N04.590.374.380
22583991,2012-07-01T00:00:00,Healthcare Disparities,N05.300.493
22583991,2012-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22583991,2012-07-01T00:00:00,Incidence,E05.318.308.985.525.375
22583991,2012-07-01T00:00:00,Incidence,L01.280.975.525.375
22583991,2012-07-01T00:00:00,Incidence,N01.224.935.597.500
22583991,2012-07-01T00:00:00,Incidence,N06.850.505.400.975.525.375
22583991,2012-07-01T00:00:00,Incidence,N06.850.520.308.985.525.375
22583991,2012-07-01T00:00:00,Neoplasms,C04
22583991,2012-07-01T00:00:00,Quality of Health Care,N04.761
22583991,2012-07-01T00:00:00,Quality of Health Care,N05.715
22583991,2012-07-01T00:00:00,Risk Factors,E05.318.740.600.800.725
22583991,2012-07-01T00:00:00,Risk Factors,N05.715.350.200.700
22583991,2012-07-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22583991,2012-07-01T00:00:00,Risk Factors,N06.850.490.625.750
22583991,2012-07-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22583991,2012-07-01T00:00:00,United States,Z01.107.567.875
22623228,2012-07-01T00:00:00,Animals,B01.050
22623228,2012-07-01T00:00:00,Apoptosis,G04.299.139.160
22623228,2012-07-01T00:00:00,Ceramides,D02.065.313
22623228,2012-07-01T00:00:00,Ceramides,D09.400.410.420.525.200
22623228,2012-07-01T00:00:00,Ceramides,D10.390.470.675.200
22623228,2012-07-01T00:00:00,Ceramides,D10.570.877.360.612.200
22623228,2012-07-01T00:00:00,Neurilemmoma,C04.557.465.625.650.595
22623228,2012-07-01T00:00:00,Neurilemmoma,C04.557.580.600.290
22623228,2012-07-01T00:00:00,Neurilemmoma,C04.557.580.600.610.595
22623228,2012-07-01T00:00:00,Neurilemmoma,C04.557.580.625.650.595
22623228,2012-07-01T00:00:00,Neurilemmoma,C10.551.775.500.500
22623228,2012-07-01T00:00:00,Neurilemmoma,C10.668.829.725.500.500
22623228,2012-07-01T00:00:00,Proteins,D12.776
22623228,2012-07-01T00:00:00,Signal Transduction,G02.111.087.800
22623228,2012-07-01T00:00:00,Signal Transduction,G02.149.115.800
22623228,2012-07-01T00:00:00,Signal Transduction,G04.299.880
22623228,2012-07-01T00:00:00,Tandem Mass Spectrometry,E05.196.566.880
22660340,2012-07-01T00:00:00,Attitude of Health Personnel,F01.100.050
22660340,2012-07-01T00:00:00,Attitude of Health Personnel,N05.300.100
22660340,2012-07-01T00:00:00,Case Management,N04.590.233.624.250
22660340,2012-07-01T00:00:00,Continuity of Patient Care,N04.590.233.727.210
22660340,2012-07-01T00:00:00,Cooperative Behavior,F01.145.813.115
22660340,2012-07-01T00:00:00,Home Nursing,E02.760.611.470
22660340,2012-07-01T00:00:00,Home Nursing,N02.421.143.524.470
22660340,2012-07-01T00:00:00,Home Nursing,N02.421.533.320
22660340,2012-07-01T00:00:00,Home Nursing,N02.421.585.611.470
22660340,2012-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22660340,2012-07-01T00:00:00,Nursing,H02.478
22660340,2012-07-01T00:00:00,Nursing,N04.452.758.377
22660340,2012-07-01T00:00:00,Patient Discharge,E02.760.400.610
22660340,2012-07-01T00:00:00,Patient Discharge,N02.421.585.400.610
22660340,2012-07-01T00:00:00,Perception,F02.463.593
22677593,2012-07-01T00:00:00,Career Choice,F02.463.785.373.346.400
22677593,2012-07-01T00:00:00,Clinical Competence,I02.399.630.210
22677593,2012-07-01T00:00:00,Clinical Competence,N04.761.210
22677593,2012-07-01T00:00:00,Curriculum,I02.158
22677593,2012-07-01T00:00:00,"Education, Medical, Undergraduate",I02.358.399.450
22677593,2012-07-01T00:00:00,General Surgery,H02.403.810.300
22677593,2012-07-01T00:00:00,"Hospitals, University",N02.278.020.300.310
22677593,2012-07-01T00:00:00,"Hospitals, University",N02.278.421.639.725
22677593,2012-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22677593,2012-07-01T00:00:00,"Students, Medical",I02.851.686.602
22677593,2012-07-01T00:00:00,"Students, Medical",M01.848.769.602
22677593,2012-07-01T00:00:00,Time Factors,G01.910.857
22677593,2012-07-01T00:00:00,Young Adult,M01.060.116.815
22700496,2012-07-01T00:00:00,Animals,B01.050
22700496,2012-07-01T00:00:00,Chickens,B01.050.150.900.248.350.150
22700496,2012-07-01T00:00:00,Chickens,B01.050.150.900.248.617.192
22700496,2012-07-01T00:00:00,Temperature,G01.906.595
22700496,2012-07-01T00:00:00,Temperature,G16.500.275.063.725.710
22700496,2012-07-01T00:00:00,Temperature,G16.500.750.775.710
22700496,2012-07-01T00:00:00,Temperature,N06.230.150.450
22700496,2012-07-01T00:00:00,Temperature,N06.230.300.100.725.710
22700498,2012-07-01T00:00:00,Animals,B01.050
22700498,2012-07-01T00:00:00,Chick Embryo,A13.350.150
22700498,2012-07-01T00:00:00,Chick Embryo,A16.331.200
22700498,2012-07-01T00:00:00,Chickens,B01.050.150.900.248.350.150
22700498,2012-07-01T00:00:00,Chickens,B01.050.150.900.248.617.192
22700498,2012-07-01T00:00:00,Temperature,G01.906.595
22700498,2012-07-01T00:00:00,Temperature,G16.500.275.063.725.710
22700498,2012-07-01T00:00:00,Temperature,G16.500.750.775.710
22700498,2012-07-01T00:00:00,Temperature,N06.230.150.450
22700498,2012-07-01T00:00:00,Temperature,N06.230.300.100.725.710
22704647,2012-07-01T00:00:00,Continuity of Patient Care,N04.590.233.727.210
22704647,2012-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22704647,2012-07-01T00:00:00,Medication Adherence,F01.145.488.500.500
22704647,2012-07-01T00:00:00,Medication Adherence,N05.300.150.600.600.500
22704647,2012-07-01T00:00:00,Schizophrenia,F03.700.750
22704754,2012-07-01T00:00:00,Adolescent,M01.060.057
22704754,2012-07-01T00:00:00,Adult,M01.060.116
22704754,2012-07-01T00:00:00,Breast Neoplasms,C04.588.180
22704754,2012-07-01T00:00:00,Breast Neoplasms,C17.800.090.500
22704754,2012-07-01T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
22704754,2012-07-01T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
22704754,2012-07-01T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
22704754,2012-07-01T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
22704754,2012-07-01T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
22704754,2012-07-01T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
22704754,2012-07-01T00:00:00,Health Promotion,N02.370
22704754,2012-07-01T00:00:00,Health Promotion,N02.421.726.507
22704754,2012-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22704754,2012-07-01T00:00:00,Mass Screening,E01.370.500
22704754,2012-07-01T00:00:00,Mass Screening,E05.318.308.250.580
22704754,2012-07-01T00:00:00,Mass Screening,N02.421.143.827.233.443
22704754,2012-07-01T00:00:00,Mass Screening,N02.421.726.233.443
22704754,2012-07-01T00:00:00,Mass Screening,N05.715.360.300.375.500
22704754,2012-07-01T00:00:00,Mass Screening,N06.850.520.308.250.580
22704754,2012-07-01T00:00:00,Mass Screening,N06.850.780.500
22704754,2012-07-01T00:00:00,Uterine Cervical Neoplasms,C04.588.945.418.948.850
22704754,2012-07-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.593.131
22704754,2012-07-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.762.850
22704754,2012-07-01T00:00:00,Uterine Cervical Neoplasms,C13.351.937.418.875.850
22704754,2012-07-01T00:00:00,Young Adult,M01.060.116.815
22732042,2012-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22732042,2012-07-01T00:00:00,Kidney Transplantation,E02.870.500
22732042,2012-07-01T00:00:00,Kidney Transplantation,E04.936.450.485
22732042,2012-07-01T00:00:00,Kidney Transplantation,E04.950.774.400
22732042,2012-07-01T00:00:00,Living Donors,M01.898.656
22732042,2012-07-01T00:00:00,Nephrectomy,E04.950.774.435
22732042,2012-07-01T00:00:00,"Renal Insufficiency, Chronic",C12.777.419.780.750
22732042,2012-07-01T00:00:00,"Renal Insufficiency, Chronic",C13.351.968.419.780.750
22735242,2012-07-01T00:00:00,Curriculum,I02.158
22735242,2012-07-01T00:00:00,"Education, Medical, Undergraduate",I02.358.399.450
22735242,2012-07-01T00:00:00,Educational Measurement,I02.399
22735242,2012-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22735242,2012-07-01T00:00:00,"Schools, Medical",I02.783.660.552
22735242,2012-07-01T00:00:00,"Schools, Medical",N02.278.020.578
22735242,2012-07-01T00:00:00,South Carolina,Z01.107.567.875.075.662
22735242,2012-07-01T00:00:00,South Carolina,Z01.107.567.875.750.700
22735242,2012-07-01T00:00:00,"Students, Medical",I02.851.686.602
22735242,2012-07-01T00:00:00,"Students, Medical",M01.848.769.602
22735242,2012-07-01T00:00:00,Time Factors,G01.910.857
22737973,2012-07-01T00:00:00,Aged,M01.060.116.100
22737973,2012-07-01T00:00:00,Anxiety,F01.470.132
22737973,2012-07-01T00:00:00,Depression,F01.145.126.350
22737973,2012-07-01T00:00:00,Elder Abuse,I01.198.240.856.350.390
22737973,2012-07-01T00:00:00,Elder Abuse,I01.880.735.900.350.390
22737973,2012-07-01T00:00:00,Health Status,I01.240.425
22737973,2012-07-01T00:00:00,Health Status,N01.224.425
22737973,2012-07-01T00:00:00,Health Status,N06.850.505.400.425
22737973,2012-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22737973,2012-07-01T00:00:00,Interviews as Topic,E05.318.308.420
22737973,2012-07-01T00:00:00,Interviews as Topic,L01.280.520
22737973,2012-07-01T00:00:00,Interviews as Topic,N05.715.360.300.400
22737973,2012-07-01T00:00:00,Interviews as Topic,N06.850.520.308.420
22737973,2012-07-01T00:00:00,Middle Aged,M01.060.116.630
22737973,2012-07-01T00:00:00,Sex Offenses,I01.198.240.748
22744375,2012-07-01T00:00:00,Academic Medical Centers,N02.278.020
22744375,2012-07-01T00:00:00,Adult,M01.060.116
22744375,2012-07-01T00:00:00,Career Choice,F02.463.785.373.346.400
22744375,2012-07-01T00:00:00,"Faculty, Medical",I02.463.373
22744375,2012-07-01T00:00:00,"Faculty, Medical",M01.526.339.373
22744375,2012-07-01T00:00:00,"Faculty, Medical",M01.526.485.375
22744375,2012-07-01T00:00:00,"Faculty, Medical",N02.360.375
22744375,2012-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22744375,2012-07-01T00:00:00,United States,Z01.107.567.875
22753704,2012-07-01T00:00:00,Apoptosis,G04.299.139.160
22753704,2012-07-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
22753704,2012-07-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
22753704,2012-07-01T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
22753704,2012-07-01T00:00:00,Down-Regulation,G02.111.087.225
22753704,2012-07-01T00:00:00,Down-Regulation,G02.149.115.225
22753704,2012-07-01T00:00:00,Down-Regulation,G05.355.315.200
22753704,2012-07-01T00:00:00,Down-Regulation,G07.690.812.230
22753704,2012-07-01T00:00:00,Down-Regulation,G07.700.680.230
22753704,2012-07-01T00:00:00,Head and Neck Neoplasms,C04.588.443
22753704,2012-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22753704,2012-07-01T00:00:00,Membrane Proteins,D12.776.543
22753704,2012-07-01T00:00:00,Photochemotherapy,E02.186.500
22753704,2012-07-01T00:00:00,Photochemotherapy,E02.319.685
22753704,2012-07-01T00:00:00,Photochemotherapy,E02.774.722
22753704,2012-07-01T00:00:00,Sphingolipids,D10.570.877
22753704,2012-07-01T00:00:00,Sphingolipids,D10.808
22753704,2012-07-01T00:00:00,Sphingosine N-Acyltransferase,D08.811.913.050.712
22757701,2012-07-01T00:00:00,Animals,B01.050
22757701,2012-07-01T00:00:00,Color,G01.201.875.770.578.199
22757701,2012-07-01T00:00:00,Color,G01.590.540.199
22757701,2012-07-01T00:00:00,Hydrogen Peroxide,D01.248.497.158.685.750.424
22757701,2012-07-01T00:00:00,Hydrogen Peroxide,D01.339.431.374.424
22757701,2012-07-01T00:00:00,Hydrogen Peroxide,D01.650.550.750.400
22757701,2012-07-01T00:00:00,Temperature,G01.906.595
22757701,2012-07-01T00:00:00,Temperature,G16.500.275.063.725.710
22757701,2012-07-01T00:00:00,Temperature,G16.500.750.775.710
22757701,2012-07-01T00:00:00,Temperature,N06.230.150.450
22757701,2012-07-01T00:00:00,Temperature,N06.230.300.100.725.710
22757701,2012-07-01T00:00:00,Volatile Organic Compounds,D02.974
22760188,2012-07-01T00:00:00,Adult,M01.060.116
22760188,2012-07-01T00:00:00,Alcoholism,C21.739.100.250
22760188,2012-07-01T00:00:00,Alcoholism,F03.900.100.350
22760188,2012-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22760188,2012-07-01T00:00:00,Psychiatric Status Rating Scales,F04.586
22760188,2012-07-01T00:00:00,Psychotherapy,F04.754
22760188,2012-07-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
22760188,2012-07-01T00:00:00,Veterans,M01.930
22765512,2012-07-01T00:00:00,Dementia,C10.228.140.380
22765512,2012-07-01T00:00:00,Dementia,F03.087.400
22765512,2012-07-01T00:00:00,Geriatric Nursing,H02.478.676.236
22765512,2012-07-01T00:00:00,Geriatric Nursing,N02.421.533.245
22765512,2012-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22765512,2012-07-01T00:00:00,Nursing Homes,N02.278.825.610
22765512,2012-07-01T00:00:00,Patient-Centered Care,N04.590.233.675
22765512,2012-07-01T00:00:00,Patient-Centered Care,N04.590.233.727.407
22765512,2012-07-01T00:00:00,Patient-Centered Care,N04.590.720
22765512,2012-07-01T00:00:00,United States,Z01.107.567.875
22766665,2012-07-01T00:00:00,Animals,B01.050
22766665,2012-07-01T00:00:00,Beverages,J02.200
22766665,2012-07-01T00:00:00,Child Health Services,N02.421.143.130
22766665,2012-07-01T00:00:00,"Child, Preschool",M01.060.406.448
22766665,2012-07-01T00:00:00,Diet,E05.272
22766665,2012-07-01T00:00:00,Diet,G07.610.240
22766665,2012-07-01T00:00:00,Fruit,A18.024.500
22766665,2012-07-01T00:00:00,Fruit,J02.500.562
22766665,2012-07-01T00:00:00,Health Behavior,F01.145.488
22766665,2012-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22766665,2012-07-01T00:00:00,Infant,M01.060.703
22766665,2012-07-01T00:00:00,South Carolina,Z01.107.567.875.075.662
22766665,2012-07-01T00:00:00,South Carolina,Z01.107.567.875.750.700
22773711,2012-07-01T00:00:00,Adolescent,M01.060.057
22773711,2012-07-01T00:00:00,Adult,M01.060.116
22773711,2012-07-01T00:00:00,Genetic Testing,E01.370.427
22773711,2012-07-01T00:00:00,Genetic Testing,E05.393.435
22773711,2012-07-01T00:00:00,Genetic Testing,N02.421.143.827.233.221
22773711,2012-07-01T00:00:00,Genetic Testing,N02.421.308.430
22773711,2012-07-01T00:00:00,Health Surveys,E05.318.308.250
22773711,2012-07-01T00:00:00,Health Surveys,N05.715.360.300.375
22773711,2012-07-01T00:00:00,Health Surveys,N06.850.520.308.250
22773711,2012-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22773711,2012-07-01T00:00:00,Middle Aged,M01.060.116.630
22773711,2012-07-01T00:00:00,Patient Education as Topic,I02.233.332.500
22773711,2012-07-01T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
22773711,2012-07-01T00:00:00,Patient Education as Topic,N02.421.726.407.680
22773711,2012-07-01T00:00:00,United States,Z01.107.567.875
22773711,2012-07-01T00:00:00,Young Adult,M01.060.116.815
22778129,2012-07-01T00:00:00,Biomedical Research,H01.770.644.145
22778129,2012-07-01T00:00:00,Consumer Participation,N02.421.143.262
22778129,2012-07-01T00:00:00,Consumer Participation,N03.540.245.360
22778129,2012-07-01T00:00:00,Cultural Diversity,I01.076.201.450.350
22778129,2012-07-01T00:00:00,Cultural Diversity,I01.880.143.450
22778129,2012-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22778129,2012-07-01T00:00:00,Minority Groups,I01.880.371
22778129,2012-07-01T00:00:00,Patient Selection,E05.581.500.653
22778129,2012-07-01T00:00:00,Patient Selection,N04.590.731
22779310,2012-07-01T00:00:00,Adult,M01.060.116
22779310,2012-07-01T00:00:00,Aircraft,J01.937.285.100
22779310,2012-07-01T00:00:00,Altitude,G16.500.275.058
22779310,2012-07-01T00:00:00,Altitude,N06.230.058
22779310,2012-07-01T00:00:00,Anoxia,C23.888.852.079
22779310,2012-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22779310,2012-07-01T00:00:00,"Hypertension, Pulmonary",C08.381.423
22779310,2012-07-01T00:00:00,Pulmonary Artery,A07.231.114.715
22805378,2012-07-01T00:00:00,Adolescent,M01.060.057
22805378,2012-07-01T00:00:00,African Americans,M01.686.508.100.100
22805378,2012-07-01T00:00:00,African Americans,M01.686.754.100
22805378,2012-07-01T00:00:00,Child,M01.060.406
22805378,2012-07-01T00:00:00,Graft Survival,G12.425.901.545.340
22805378,2012-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22805378,2012-07-01T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
22805378,2012-07-01T00:00:00,Kidney Transplantation,E02.870.500
22805378,2012-07-01T00:00:00,Kidney Transplantation,E04.936.450.485
22805378,2012-07-01T00:00:00,Kidney Transplantation,E04.950.774.400
22805378,2012-07-01T00:00:00,Risk Factors,E05.318.740.600.800.725
22805378,2012-07-01T00:00:00,Risk Factors,N05.715.350.200.700
22805378,2012-07-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22805378,2012-07-01T00:00:00,Risk Factors,N06.850.490.625.750
22805378,2012-07-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22805378,2012-07-01T00:00:00,Treatment Outcome,E01.789.800
22805378,2012-07-01T00:00:00,Treatment Outcome,N04.761.559.590.800
22805378,2012-07-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22829037,2012-07-01T00:00:00,Aged,M01.060.116.100
22829037,2012-07-01T00:00:00,Ear Canal,A09.246.272.396
22829037,2012-07-01T00:00:00,"Hearing Loss, Conductive",C09.218.458.341.562
22829037,2012-07-01T00:00:00,"Hearing Loss, Conductive",C10.597.751.418.341.562
22829037,2012-07-01T00:00:00,"Hearing Loss, Conductive",C23.888.592.763.393.341.562
22829037,2012-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22829037,2012-07-01T00:00:00,Plasmacytoma,C04.557.595.600
22829037,2012-07-01T00:00:00,Plasmacytoma,C20.683.515.880
22829037,2012-07-01T00:00:00,Skull,A02.835.232.781
22834355,2012-07-01T00:00:00,General Surgery,H02.403.810.300
22834355,2012-07-01T00:00:00,Internationality,I01.615
22834355,2012-07-01T00:00:00,United States,Z01.107.567.875
22847586,2012-07-01T00:00:00,Early Detection of Cancer,E01.390.500
22847586,2012-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22847586,2012-07-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
22847586,2012-07-01T00:00:00,Lung Neoplasms,C08.381.540
22847586,2012-07-01T00:00:00,Lung Neoplasms,C08.785.520
22847586,2012-07-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
22847586,2012-07-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
22847586,2012-07-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
22847586,2012-07-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
22847588,2012-07-01T00:00:00,Health Policy,I01.880.604.825.608.400
22847588,2012-07-01T00:00:00,Health Policy,N03.706.825.608.428
22847588,2012-07-01T00:00:00,"History, 19th Century",K01.400.504.937
22847588,2012-07-01T00:00:00,"History, 20th Century",K01.400.504.968
22847588,2012-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22847588,2012-07-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
22847588,2012-07-01T00:00:00,Lung Neoplasms,C08.381.540
22847588,2012-07-01T00:00:00,Lung Neoplasms,C08.785.520
22847588,2012-07-01T00:00:00,Smoking,F01.145.466.753
22847588,2012-07-01T00:00:00,Tobacco Smoke Pollution,D20.633.937.680
22847588,2012-07-01T00:00:00,Tobacco Smoke Pollution,N06.850.460.100.555
22847588,2012-07-01T00:00:00,United States,Z01.107.567.875
22872954,2012-07-01T00:00:00,Brain,A08.186.211
22872954,2012-07-01T00:00:00,Brain Ischemia,C10.228.140.300.150
22872954,2012-07-01T00:00:00,Brain Ischemia,C14.907.253.092
22872954,2012-07-01T00:00:00,Emergency Medical Services,N02.421.297
22872954,2012-07-01T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
22872954,2012-07-01T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
22872954,2012-07-01T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
22872954,2012-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22872954,2012-07-01T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
22872954,2012-07-01T00:00:00,Stroke,C10.228.140.300.775
22872954,2012-07-01T00:00:00,Stroke,C14.907.253.855
22872954,2012-07-01T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
22872954,2012-07-01T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
22872954,2012-07-01T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
22872954,2012-07-01T00:00:00,Tissue Plasminogen Activator,D23.119.970
22872954,2012-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
22872954,2012-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
22872954,2012-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
22872954,2012-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
22872954,2012-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23092046,2012-07-01T00:00:00,Adult,M01.060.116
23092046,2012-07-01T00:00:00,African Americans,M01.686.508.100.100
23092046,2012-07-01T00:00:00,African Americans,M01.686.754.100
23092046,2012-07-01T00:00:00,Decision Making,F02.463.785.373
23092046,2012-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23092046,2012-07-01T00:00:00,Middle Aged,M01.060.116.630
23092046,2012-07-01T00:00:00,Neoplasms,C04
23092046,2012-07-01T00:00:00,Qualitative Research,H01.770.644.241.850
22751926,2012-07-02T00:00:00,Amino Acid Sequence,G02.111.570.060
22751926,2012-07-02T00:00:00,Amino Acid Sequence,L01.453.245.667.060
22751926,2012-07-02T00:00:00,Animals,B01.050
22751926,2012-07-02T00:00:00,Apoptosis,G04.299.139.160
22751926,2012-07-02T00:00:00,Caspases,D08.811.277.656.262.500.126
22751926,2012-07-02T00:00:00,Caspases,D08.811.277.656.300.200.126
22751926,2012-07-02T00:00:00,Caspases,D12.644.360.075.405
22751926,2012-07-02T00:00:00,Caspases,D12.776.476.075.405
22751926,2012-07-02T00:00:00,Cell Line,A11.251.210
22751926,2012-07-02T00:00:00,Endoplasmic Reticulum,A11.284.430.214.190.875.248
22751926,2012-07-02T00:00:00,Fas Ligand Protein,D12.644.276.374.750.249
22751926,2012-07-02T00:00:00,Fas Ligand Protein,D12.644.276.972.249
22751926,2012-07-02T00:00:00,Fas Ligand Protein,D12.776.395.550.312
22751926,2012-07-02T00:00:00,Fas Ligand Protein,D12.776.467.374.750.249
22751926,2012-07-02T00:00:00,Fas Ligand Protein,D12.776.467.972.249
22751926,2012-07-02T00:00:00,Fas Ligand Protein,D12.776.543.550.312
22751926,2012-07-02T00:00:00,Fas Ligand Protein,D23.050.301.264.035.283
22751926,2012-07-02T00:00:00,Fas Ligand Protein,D23.101.100.110.282
22751926,2012-07-02T00:00:00,Fas Ligand Protein,D23.529.374.750.249
22751926,2012-07-02T00:00:00,Fas Ligand Protein,D23.529.972.249
22751926,2012-07-02T00:00:00,Glutathione,D12.644.456.448
22751926,2012-07-02T00:00:00,Molecular Sequence Data,L01.453.245.667
22751926,2012-07-02T00:00:00,Pulmonary Fibrosis,C08.381.765
22753318,2012-07-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22753318,2012-07-02T00:00:00,Neoplasm Invasiveness,C04.697.645
22753318,2012-07-02T00:00:00,Neoplasm Invasiveness,C23.550.727.645
22753318,2012-07-02T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
22753318,2012-07-02T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
22753318,2012-07-02T00:00:00,Neoplasm Staging,E01.370.550
22753318,2012-07-02T00:00:00,Parotid Gland,A03.556.500.760.464
22753318,2012-07-02T00:00:00,Parotid Gland,A10.336.779.464
22753318,2012-07-02T00:00:00,Parotid Gland,A14.549.760.464
22753318,2012-07-02T00:00:00,Parotid Neoplasms,C04.588.443.591.824.695
22753318,2012-07-02T00:00:00,Parotid Neoplasms,C07.465.565.824.695
22753318,2012-07-02T00:00:00,Parotid Neoplasms,C07.465.815.470.770
22753318,2012-07-02T00:00:00,Parotid Neoplasms,C07.465.815.718.589
22753318,2012-07-02T00:00:00,Risk Assessment,E05.318.740.600.800.715
22753318,2012-07-02T00:00:00,Risk Assessment,N04.452.871.715
22753318,2012-07-02T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
22753318,2012-07-02T00:00:00,Risk Assessment,N06.850.505.715
22753318,2012-07-02T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
22753318,2012-07-02T00:00:00,"Surgical Procedures, Operative",E04
22753318,2012-07-02T00:00:00,Treatment Outcome,E01.789.800
22753318,2012-07-02T00:00:00,Treatment Outcome,N04.761.559.590.800
22753318,2012-07-02T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22753548,2012-07-02T00:00:00,Amino Acid Sequence,G02.111.570.060
22753548,2012-07-02T00:00:00,Amino Acid Sequence,L01.453.245.667.060
22753548,2012-07-02T00:00:00,Animals,B01.050
22753548,2012-07-02T00:00:00,Anoxia,C23.888.852.079
22753548,2012-07-02T00:00:00,Binding Sites,G02.111.570.120
22753548,2012-07-02T00:00:00,"Calcium Channels, L-Type",D12.776.157.530.400.150.400
22753548,2012-07-02T00:00:00,"Calcium Channels, L-Type",D12.776.543.550.425.150.400
22753548,2012-07-02T00:00:00,"Calcium Channels, L-Type",D12.776.543.585.400.150.400
22753548,2012-07-02T00:00:00,Calcium Signaling,G02.111.087.800.800.100
22753548,2012-07-02T00:00:00,Calcium Signaling,G02.149.115.800.800.100
22753548,2012-07-02T00:00:00,Calcium Signaling,G03.495.166.500.100
22753548,2012-07-02T00:00:00,Calcium Signaling,G04.299.880.800.100
22753548,2012-07-02T00:00:00,Calmodulin,D12.644.360.381.249
22753548,2012-07-02T00:00:00,Calmodulin,D12.776.157.125.412.249
22753548,2012-07-02T00:00:00,Calmodulin,D12.776.476.387.249
22753548,2012-07-02T00:00:00,Cyclic AMP-Dependent Protein Kinases,D08.811.913.696.620.682.700.150.125
22753548,2012-07-02T00:00:00,Cyclic AMP-Dependent Protein Kinases,D12.644.360.200.125
22753548,2012-07-02T00:00:00,Cyclic AMP-Dependent Protein Kinases,D12.776.476.200.125
22753548,2012-07-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22753548,2012-07-02T00:00:00,Molecular Sequence Data,L01.453.245.667
22753548,2012-07-02T00:00:00,Myocardium,A02.633.580
22753548,2012-07-02T00:00:00,Myocardium,A07.541.704
22753548,2012-07-02T00:00:00,Myocardium,A10.690.552.750
22753548,2012-07-02T00:00:00,"Myocytes, Cardiac",A07.541.704.570
22753548,2012-07-02T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
22753548,2012-07-02T00:00:00,"Myocytes, Cardiac",A11.620.500
22753548,2012-07-02T00:00:00,Phosphorylation,G02.111.087.677
22753548,2012-07-02T00:00:00,Phosphorylation,G02.149.115.677
22753548,2012-07-02T00:00:00,Phosphorylation,G02.149.465.700
22753548,2012-07-02T00:00:00,Phosphorylation,G02.607.750.700
22753548,2012-07-02T00:00:00,Phosphorylation,G03.495.790
22753548,2012-07-02T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22898081,2012-07-02T00:00:00,ATP-Binding Cassette Transporters,D12.776.157.530.100
22898081,2012-07-02T00:00:00,ATP-Binding Cassette Transporters,D12.776.395.550.020
22898081,2012-07-02T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.550.192
22898081,2012-07-02T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.585.100
22898081,2012-07-02T00:00:00,Animals,B01.050
22898081,2012-07-02T00:00:00,Estradiol,D04.808.365.415.248
22898081,2012-07-02T00:00:00,Estradiol,D06.472.334.851.437.500
22898081,2012-07-02T00:00:00,Estrogens,D27.505.696.399.472.277
22898081,2012-07-02T00:00:00,Estrone,D04.808.365.415.414
22898081,2012-07-02T00:00:00,Estrone,D04.808.578.502.497
22898081,2012-07-02T00:00:00,Estrone,D06.472.040.502.497
22898081,2012-07-02T00:00:00,Estrone,D06.472.334.851.437.996
22898081,2012-07-02T00:00:00,Gastric Mucosa,A03.556.875.875.440
22898081,2012-07-02T00:00:00,Gastric Mucosa,A10.615.550.291
22898081,2012-07-02T00:00:00,Mucositis,C06.405.205.798
22898081,2012-07-02T00:00:00,Mucositis,C07.465.584
22898081,2012-07-02T00:00:00,Nitric Oxide Synthase Type III,D08.811.682.664.500.772.750
22898081,2012-07-02T00:00:00,Seizures,C10.228.140.490.631
22898081,2012-07-02T00:00:00,Seizures,C10.597.742
22898081,2012-07-02T00:00:00,Seizures,C23.888.592.742
22751755,2012-07-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22751755,2012-07-03T00:00:00,Medication Adherence,F01.145.488.500.500
22751755,2012-07-03T00:00:00,Medication Adherence,N05.300.150.600.600.500
22751755,2012-07-03T00:00:00,Medication Errors,E02.319.529
22751755,2012-07-03T00:00:00,Medication Errors,N02.421.450.500
22751755,2012-07-03T00:00:00,Middle Aged,M01.060.116.630
22751755,2012-07-03T00:00:00,Patient Discharge,E02.760.400.610
22751755,2012-07-03T00:00:00,Patient Discharge,N02.421.585.400.610
22751755,2012-07-03T00:00:00,Patient Education as Topic,I02.233.332.500
22751755,2012-07-03T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
22751755,2012-07-03T00:00:00,Patient Education as Topic,N02.421.726.407.680
22751755,2012-07-03T00:00:00,Pharmacists,M01.526.485.780
22751755,2012-07-03T00:00:00,Pharmacists,N02.360.780
22752852,2012-07-03T00:00:00,Adult,M01.060.116
22752852,2012-07-03T00:00:00,Age Factors,N05.715.350.075
22752852,2012-07-03T00:00:00,Age Factors,N06.850.490.250
22752852,2012-07-03T00:00:00,Child,M01.060.406
22752852,2012-07-03T00:00:00,"Child, Preschool",M01.060.406.448
22752852,2012-07-03T00:00:00,Environmental Exposure,N06.850.460.350
22752852,2012-07-03T00:00:00,Environmental Monitoring,N06.850.460.350.080
22752852,2012-07-03T00:00:00,Environmental Monitoring,N06.850.780.375
22752852,2012-07-03T00:00:00,Ethnic Groups,M01.686.754
22752852,2012-07-03T00:00:00,Ethnic Groups,N01.224.317
22752852,2012-07-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22752852,2012-07-03T00:00:00,Rural Population,N01.600.725
22752852,2012-07-03T00:00:00,Soil Pollutants,D27.888.284.756
22752852,2012-07-03T00:00:00,South Carolina,Z01.107.567.875.075.662
22752852,2012-07-03T00:00:00,South Carolina,Z01.107.567.875.750.700
22752852,2012-07-03T00:00:00,Urban Population,N01.600.900
22759620,2012-07-03T00:00:00,Adult,M01.060.116
22759620,2012-07-03T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
22759620,2012-07-03T00:00:00,Child,M01.060.406
22759620,2012-07-03T00:00:00,"Decision Support Systems, Clinical",L01.700.508.300.190
22759620,2012-07-03T00:00:00,Electronic Health Records,E05.318.308.940.968.625.500
22759620,2012-07-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22759620,2012-07-03T00:00:00,Physician's Practice Patterns,N04.590.748
22759620,2012-07-03T00:00:00,Physician's Practice Patterns,N05.300.625
22759620,2012-07-03T00:00:00,Primary Health Care,N04.590.233.727
22759620,2012-07-03T00:00:00,Systems Integration,H01.770.787
22759620,2012-07-03T00:00:00,Systems Integration,L01.906.787
22759620,2012-07-03T00:00:00,United States,Z01.107.567.875
22759620,2012-07-03T00:00:00,User-Computer Interface,L01.224.900.910
22760568,2012-07-03T00:00:00,African Americans,M01.686.508.100.100
22760568,2012-07-03T00:00:00,African Americans,M01.686.754.100
22760568,2012-07-03T00:00:00,Aged,M01.060.116.100
22760568,2012-07-03T00:00:00,Body Mass Index,E01.370.600.115.100.125
22760568,2012-07-03T00:00:00,Body Mass Index,E05.041.124.125
22760568,2012-07-03T00:00:00,Body Mass Index,G07.100.100.125
22760568,2012-07-03T00:00:00,Body Mass Index,N06.850.505.200.100.175
22760568,2012-07-03T00:00:00,Cholecalciferol,D04.808.247.222.159
22760568,2012-07-03T00:00:00,Cholecalciferol,D04.808.247.808.146
22760568,2012-07-03T00:00:00,Cholecalciferol,D04.808.812.768.196
22760568,2012-07-03T00:00:00,Cholecalciferol,D10.570.938.146
22760568,2012-07-03T00:00:00,Dietary Supplements,J02.500.456
22760568,2012-07-03T00:00:00,European Continental Ancestry Group,M01.686.508.400
22760568,2012-07-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22760568,2012-07-03T00:00:00,Middle Aged,M01.060.116.630
22760568,2012-07-03T00:00:00,Vitamin D,D04.808.812.768
22760568,2012-07-03T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
22762711,2012-07-03T00:00:00,Aged,M01.060.116.100
22762711,2012-07-03T00:00:00,Coronary Angiography,E01.370.350.700.060.200
22762711,2012-07-03T00:00:00,Coronary Angiography,E01.370.370.050.200
22762711,2012-07-03T00:00:00,Coronary Angiography,E01.370.370.380.200
22762711,2012-07-03T00:00:00,Coronary Artery Disease,C14.280.647.250.260
22762711,2012-07-03T00:00:00,Coronary Artery Disease,C14.907.137.126.339
22762711,2012-07-03T00:00:00,Coronary Artery Disease,C14.907.585.250.260
22762711,2012-07-03T00:00:00,Drug-Eluting Stents,E07.695.750.500
22762711,2012-07-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22762711,2012-07-03T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
22762711,2012-07-03T00:00:00,Middle Aged,M01.060.116.630
22762711,2012-07-03T00:00:00,Treatment Outcome,E01.789.800
22762711,2012-07-03T00:00:00,Treatment Outcome,N04.761.559.590.800
22762711,2012-07-03T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22762711,2012-07-03T00:00:00,United States,Z01.107.567.875
22762716,2012-07-03T00:00:00,Adolescent,M01.060.057
22762716,2012-07-03T00:00:00,Adult,M01.060.116
22762716,2012-07-03T00:00:00,Aged,M01.060.116.100
22762716,2012-07-03T00:00:00,HIV Seropositivity,C02.782.815.616.400.500
22762716,2012-07-03T00:00:00,HIV Seropositivity,C02.800.801.400.500
22762716,2012-07-03T00:00:00,HIV Seropositivity,C20.673.480.500
22762716,2012-07-03T00:00:00,Hospital Mortality,E05.318.308.985.550.400
22762716,2012-07-03T00:00:00,Hospital Mortality,L01.280.975.550.400
22762716,2012-07-03T00:00:00,Hospital Mortality,N01.224.935.698.400
22762716,2012-07-03T00:00:00,Hospital Mortality,N06.850.505.400.975.550.400
22762716,2012-07-03T00:00:00,Hospital Mortality,N06.850.520.308.985.550.400
22762716,2012-07-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22762716,2012-07-03T00:00:00,Length of Stay,E02.760.400.480
22762716,2012-07-03T00:00:00,Length of Stay,N02.421.585.400.480
22762716,2012-07-03T00:00:00,Middle Aged,M01.060.116.630
22762716,2012-07-03T00:00:00,Myocardial Infarction,C14.280.647.500
22762716,2012-07-03T00:00:00,Myocardial Infarction,C14.907.585.500
22762716,2012-07-03T00:00:00,Risk Factors,E05.318.740.600.800.725
22762716,2012-07-03T00:00:00,Risk Factors,N05.715.350.200.700
22762716,2012-07-03T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22762716,2012-07-03T00:00:00,Risk Factors,N06.850.490.625.750
22762716,2012-07-03T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22762716,2012-07-03T00:00:00,United States,Z01.107.567.875
22762718,2012-07-03T00:00:00,Age Factors,N05.715.350.075
22762718,2012-07-03T00:00:00,Age Factors,N06.850.490.250
22762718,2012-07-03T00:00:00,Aged,M01.060.116.100
22762718,2012-07-03T00:00:00,Cause of Death,E05.318.308.985.550.250
22762718,2012-07-03T00:00:00,Cause of Death,L01.280.975.550.250
22762718,2012-07-03T00:00:00,Cause of Death,N01.224.935.698.100
22762718,2012-07-03T00:00:00,Cause of Death,N06.850.505.400.975.550.250
22762718,2012-07-03T00:00:00,Cause of Death,N06.850.520.308.985.550.250
22762718,2012-07-03T00:00:00,Cost-Benefit Analysis,N03.219.151.125
22762718,2012-07-03T00:00:00,"Death, Sudden, Cardiac",C14.280.383.220
22762718,2012-07-03T00:00:00,"Death, Sudden, Cardiac",C23.550.260.322.250
22762718,2012-07-03T00:00:00,Exercise Therapy,E02.779.483
22762718,2012-07-03T00:00:00,Exercise Therapy,E02.831.387
22762718,2012-07-03T00:00:00,Heart Failure,C14.280.434
22762718,2012-07-03T00:00:00,Hospital Costs,N03.219.151.400.687
22762718,2012-07-03T00:00:00,Hospital Costs,N03.219.262.500
22762718,2012-07-03T00:00:00,Hospital Costs,N05.300.375.500
22762718,2012-07-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22762718,2012-07-03T00:00:00,Length of Stay,E02.760.400.480
22762718,2012-07-03T00:00:00,Length of Stay,N02.421.585.400.480
22762718,2012-07-03T00:00:00,Middle Aged,M01.060.116.630
22762718,2012-07-03T00:00:00,Risk Factors,E05.318.740.600.800.725
22762718,2012-07-03T00:00:00,Risk Factors,N05.715.350.200.700
22762718,2012-07-03T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22762718,2012-07-03T00:00:00,Risk Factors,N06.850.490.625.750
22762718,2012-07-03T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22762718,2012-07-03T00:00:00,Terminal Care,E02.760.905
22762718,2012-07-03T00:00:00,Terminal Care,N02.421.585.905
22764328,2012-07-03T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
22764328,2012-07-03T00:00:00,Anticoagulants,D27.505.954.502.119
22764328,2012-07-03T00:00:00,Cephalosporins,D02.065.589.099.249
22764328,2012-07-03T00:00:00,Cephalosporins,D02.886.665.074
22764328,2012-07-03T00:00:00,Cephalosporins,D04.075.080.875.099.221.249
22764328,2012-07-03T00:00:00,Drug Interactions,G07.690.812.240
22764328,2012-07-03T00:00:00,Drug Interactions,G07.700.680.240
22764328,2012-07-03T00:00:00,Hemarthrosis,C05.550.459
22764328,2012-07-03T00:00:00,Hemarthrosis,C23.550.414.794
22764328,2012-07-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22764328,2012-07-03T00:00:00,Warfarin,D03.438.150.446.520.914
22764328,2012-07-03T00:00:00,Warfarin,D03.830.219.446.520.914
22764263,2012-07-04T00:00:00,Adult,M01.060.116
22764263,2012-07-04T00:00:00,Brain Mapping,E01.370.350.086
22764263,2012-07-04T00:00:00,Brain Mapping,E01.370.376.149
22764263,2012-07-04T00:00:00,Brain Mapping,E05.132
22764263,2012-07-04T00:00:00,Case-Control Studies,E05.318.760.500.500
22764263,2012-07-04T00:00:00,Case-Control Studies,N05.715.360.775.175.200
22764263,2012-07-04T00:00:00,Case-Control Studies,N06.850.520.450.500.500
22764263,2012-07-04T00:00:00,Diffusion Tensor Imaging,E01.370.350.500.150.500
22764263,2012-07-04T00:00:00,Diffusion Tensor Imaging,E01.370.376.224
22764263,2012-07-04T00:00:00,Diffusion Tensor Imaging,E05.278
22764263,2012-07-04T00:00:00,"Epilepsy, Temporal Lobe",C10.228.140.490.360.290
22764263,2012-07-04T00:00:00,Hippocampus,A08.186.211.464.405
22764263,2012-07-04T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
22764263,2012-07-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22764263,2012-07-04T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
22764263,2012-07-04T00:00:00,Limbic System,A08.186.211.464
22764263,2012-07-04T00:00:00,Neural Pathways,A08.612
22764263,2012-07-04T00:00:00,Neurons,A08.663
22764263,2012-07-04T00:00:00,Neurons,A11.671
22763971,2012-07-05T00:00:00,Animals,B01.050
22763971,2012-07-05T00:00:00,Gene Expression Profiling,E05.393.332
22763971,2012-07-05T00:00:00,Gene Expression Regulation,G05.355.315
22763971,2012-07-05T00:00:00,"Muscle, Skeletal",A02.633.567
22763971,2012-07-05T00:00:00,"Muscle, Skeletal",A10.690.552.500
22763971,2012-07-05T00:00:00,Nerve Growth Factor,D12.644.276.860.437
22763971,2012-07-05T00:00:00,Nerve Growth Factor,D12.776.467.860.437
22763971,2012-07-05T00:00:00,Nerve Growth Factor,D12.776.641.600.437
22763971,2012-07-05T00:00:00,Nerve Growth Factor,D23.529.850.437
22763971,2012-07-05T00:00:00,Neurons,A08.663
22763971,2012-07-05T00:00:00,Neurons,A11.671
22763971,2012-07-05T00:00:00,Protein Precursors,D12.776.811
22763971,2012-07-05T00:00:00,"RNA, Messenger",D13.444.735.544
22763971,2012-07-05T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22765277,2012-07-05T00:00:00,Adult,M01.060.116
22765277,2012-07-05T00:00:00,Attitude to Health,F01.100.150
22765277,2012-07-05T00:00:00,Attitude to Health,N05.300.150
22765277,2012-07-05T00:00:00,Counseling,F02.784.176
22765277,2012-07-05T00:00:00,Counseling,F04.408.413
22765277,2012-07-05T00:00:00,Counseling,N02.421.143.303
22765277,2012-07-05T00:00:00,Counseling,N02.421.461.363
22765277,2012-07-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22765277,2012-07-05T00:00:00,Middle Aged,M01.060.116.630
22765277,2012-07-05T00:00:00,New York,Z01.107.567.875.075.437
22765277,2012-07-05T00:00:00,New York,Z01.107.567.875.350.530
22765277,2012-07-05T00:00:00,New York,Z01.107.567.875.500.530
22765277,2012-07-05T00:00:00,Program Evaluation,E05.337.820
22765277,2012-07-05T00:00:00,Program Evaluation,N04.761.685
22765277,2012-07-05T00:00:00,Program Evaluation,N05.715.360.650
22765277,2012-07-05T00:00:00,Smoking,F01.145.466.753
22765277,2012-07-05T00:00:00,Smoking Cessation,F01.145.940.700
22767572,2012-07-05T00:00:00,Animals,B01.050
22767572,2012-07-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22767572,2012-07-05T00:00:00,Interleukin-15,D12.644.276.374.465.515
22767572,2012-07-05T00:00:00,Interleukin-15,D12.776.467.374.465.515
22767572,2012-07-05T00:00:00,Interleukin-15,D23.529.374.465.515
22767572,2012-07-05T00:00:00,Interleukin-15 Receptor alpha Subunit,D12.776.543.750.705.852.420.800.550
22771886,2012-07-06T00:00:00,Calcinosis,C18.452.174.130
22771886,2012-07-06T00:00:00,Coronary Artery Disease,C14.280.647.250.260
22771886,2012-07-06T00:00:00,Coronary Artery Disease,C14.907.137.126.339
22771886,2012-07-06T00:00:00,Coronary Artery Disease,C14.907.585.250.260
22771886,2012-07-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22771886,2012-07-06T00:00:00,Middle Aged,M01.060.116.630
22771886,2012-07-06T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.158.600.680
22771886,2012-07-06T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.350.700
22771886,2012-07-06T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.700.705
22771886,2012-07-06T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",L01.700.508.100.158.600.680
22771886,2012-07-06T00:00:00,Regression Analysis,E05.318.740.750
22771886,2012-07-06T00:00:00,Regression Analysis,N05.715.360.750.695
22771886,2012-07-06T00:00:00,Regression Analysis,N06.850.520.830.750
22771886,2012-07-06T00:00:00,Risk Assessment,E05.318.740.600.800.715
22771886,2012-07-06T00:00:00,Risk Assessment,N04.452.871.715
22771886,2012-07-06T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
22771886,2012-07-06T00:00:00,Risk Assessment,N06.850.505.715
22771886,2012-07-06T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
22771886,2012-07-06T00:00:00,Software,L01.224.900
22771886,2012-07-06T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
22771886,2012-07-06T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
22771886,2012-07-06T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
22771886,2012-07-06T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
22771886,2012-07-06T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
22777948,2012-07-06T00:00:00,Animals,B01.050
22777948,2012-07-06T00:00:00,"Nanotubes, Carbon",D01.268.150.250.500
22777948,2012-07-06T00:00:00,"Nanotubes, Carbon",J01.637.512.850.500
22784442,2012-07-06T00:00:00,Deep Brain Stimulation,E02.342.250
22784442,2012-07-06T00:00:00,Deep Brain Stimulation,E04.190
22784442,2012-07-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22784442,2012-07-06T00:00:00,Periodicals as Topic,L01.178.682.829.678
22784442,2012-07-06T00:00:00,Publishing,L01.737
22772138,2012-07-08T00:00:00,Magnetic Resonance Spectroscopy,E05.196.867.519
22688528,2012-07-09T00:00:00,Adult,M01.060.116
22688528,2012-07-09T00:00:00,Aged,M01.060.116.100
22688528,2012-07-09T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
22688528,2012-07-09T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
22688528,2012-07-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22688528,2012-07-09T00:00:00,Hypoglycemic Agents,D27.505.696.422
22688528,2012-07-09T00:00:00,Incidence,E05.318.308.985.525.375
22688528,2012-07-09T00:00:00,Incidence,L01.280.975.525.375
22688528,2012-07-09T00:00:00,Incidence,N01.224.935.597.500
22688528,2012-07-09T00:00:00,Incidence,N06.850.505.400.975.525.375
22688528,2012-07-09T00:00:00,Incidence,N06.850.520.308.985.525.375
22688528,2012-07-09T00:00:00,Middle Aged,M01.060.116.630
22688528,2012-07-09T00:00:00,Risk Assessment,E05.318.740.600.800.715
22688528,2012-07-09T00:00:00,Risk Assessment,N04.452.871.715
22688528,2012-07-09T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
22688528,2012-07-09T00:00:00,Risk Assessment,N06.850.505.715
22688528,2012-07-09T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
22777764,2012-07-09T00:00:00,Checklist,N05.715.360.300.179
22777764,2012-07-09T00:00:00,Endoscopy,E01.370.388.250
22777764,2012-07-09T00:00:00,Endoscopy,E04.800.250
22777764,2012-07-09T00:00:00,Evidence-Based Medicine,H02.249.750
22777764,2012-07-09T00:00:00,Evidence-Based Medicine,H02.403.200.400
22777764,2012-07-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22777764,2012-07-09T00:00:00,Otorhinolaryngologic Surgical Procedures,E04.580
22777764,2012-07-09T00:00:00,Sinusitis,C08.460.692.752
22777764,2012-07-09T00:00:00,Sinusitis,C08.730.749
22777764,2012-07-09T00:00:00,Sinusitis,C09.603.692.752
22777764,2012-07-09T00:00:00,Task Performance and Analysis,F02.784.412.846
22777764,2012-07-09T00:00:00,Task Performance and Analysis,F02.784.692.746
22777764,2012-07-09T00:00:00,Task Performance and Analysis,F02.808.600
22782639,2012-07-09T00:00:00,Adolescent,M01.060.057
22782639,2012-07-09T00:00:00,Adult,M01.060.116
22782639,2012-07-09T00:00:00,Aged,M01.060.116.100
22782639,2012-07-09T00:00:00,Aging,G07.700.320.124
22782639,2012-07-09T00:00:00,DNA Replication,G02.111.087.222
22782639,2012-07-09T00:00:00,DNA Replication,G02.149.115.222
22782639,2012-07-09T00:00:00,DNA Replication,G05.355.200
22782639,2012-07-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22782639,2012-07-09T00:00:00,Inheritance Patterns,G05.420
22782639,2012-07-09T00:00:00,Middle Aged,M01.060.116.630
22782639,2012-07-09T00:00:00,Spermatozoa,A05.360.490.890
22782639,2012-07-09T00:00:00,Spermatozoa,A11.497.760
22781424,2012-07-10T00:00:00,Aged,M01.060.116.100
22781424,2012-07-10T00:00:00,Heart,A07.541
22781424,2012-07-10T00:00:00,Heart Failure,C14.280.434
22781424,2012-07-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22781424,2012-07-10T00:00:00,Middle Aged,M01.060.116.630
22781424,2012-07-10T00:00:00,Myocardial Ischemia,C14.280.647
22781424,2012-07-10T00:00:00,Myocardial Ischemia,C14.907.585
22781424,2012-07-10T00:00:00,Treatment Outcome,E01.789.800
22781424,2012-07-10T00:00:00,Treatment Outcome,N04.761.559.590.800
22781424,2012-07-10T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22781424,2012-07-10T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
22781424,2012-07-10T00:00:00,Ventricular Remodeling,C23.300.985
22781424,2012-07-10T00:00:00,Ventricular Remodeling,G09.330.190.962.975
22787145,2012-07-11T00:00:00,Animals,B01.050
22787145,2012-07-11T00:00:00,CHO Cells,A11.251.210.200
22787145,2012-07-11T00:00:00,CHO Cells,A11.436.155
22787145,2012-07-11T00:00:00,Cricetinae,B01.050.150.900.649.865.635.150
22787145,2012-07-11T00:00:00,DNA-Binding Proteins,D12.776.260
22787145,2012-07-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22787145,2012-07-11T00:00:00,Membrane Proteins,D12.776.543
22787145,2012-07-11T00:00:00,Membrane Transport Proteins,D12.776.157.530
22787145,2012-07-11T00:00:00,Membrane Transport Proteins,D12.776.543.585
22787145,2012-07-11T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
22787145,2012-07-11T00:00:00,Transcription Factors,D12.776.930
22789296,2012-07-11T00:00:00,African Continental Ancestry Group,M01.686.508.100
22789296,2012-07-11T00:00:00,European Continental Ancestry Group,M01.686.508.400
22789296,2012-07-11T00:00:00,Health Services Accessibility,N04.590.374.350
22789296,2012-07-11T00:00:00,Health Services Accessibility,N05.300.430
22789296,2012-07-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22789296,2012-07-11T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
22789296,2012-07-11T00:00:00,Prostate-Specific Antigen,D08.811.277.656.300.760.442.750
22789296,2012-07-11T00:00:00,Prostate-Specific Antigen,D08.811.277.656.959.350.442.750
22789296,2012-07-11T00:00:00,Prostate-Specific Antigen,D12.776.866.249.500
22789296,2012-07-11T00:00:00,Prostate-Specific Antigen,D23.050.285.625
22789296,2012-07-11T00:00:00,Prostate-Specific Antigen,D23.101.840.625
22789296,2012-07-11T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
22789296,2012-07-11T00:00:00,Prostatic Neoplasms,C12.294.260.750
22789296,2012-07-11T00:00:00,Prostatic Neoplasms,C12.294.565.625
22789296,2012-07-11T00:00:00,Prostatic Neoplasms,C12.758.409.750
22795436,2012-07-11T00:00:00,"Heart Defects, Congenital",C14.240.400
22795436,2012-07-11T00:00:00,"Heart Defects, Congenital",C14.280.400
22795436,2012-07-11T00:00:00,"Heart Defects, Congenital",C16.131.240.400
22795436,2012-07-11T00:00:00,Heart Ventricles,A07.541.560
22795436,2012-07-11T00:00:00,Hemodynamics,G09.330.190.400
22795436,2012-07-11T00:00:00,Hemodynamics,G09.330.380
22795436,2012-07-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22795436,2012-07-11T00:00:00,Hypoplastic Left Heart Syndrome,C14.240.400.625
22795436,2012-07-11T00:00:00,Hypoplastic Left Heart Syndrome,C14.280.400.625
22795436,2012-07-11T00:00:00,Hypoplastic Left Heart Syndrome,C16.131.240.400.625
22795436,2012-07-11T00:00:00,Infant Mortality,E05.318.308.985.550.475
22795436,2012-07-11T00:00:00,Infant Mortality,L01.280.975.550.475
22795436,2012-07-11T00:00:00,Infant Mortality,N01.224.935.698.489
22795436,2012-07-11T00:00:00,Infant Mortality,N06.850.505.400.975.550.475
22795436,2012-07-11T00:00:00,Infant Mortality,N06.850.520.308.985.550.475
22795436,2012-07-11T00:00:00,"Infant, Newborn",M01.060.703.520
22795436,2012-07-11T00:00:00,North America,Z01.107.567
22795436,2012-07-11T00:00:00,Postoperative Complications,C23.550.767
22795436,2012-07-11T00:00:00,Risk Assessment,E05.318.740.600.800.715
22795436,2012-07-11T00:00:00,Risk Assessment,N04.452.871.715
22795436,2012-07-11T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
22795436,2012-07-11T00:00:00,Risk Assessment,N06.850.505.715
22795436,2012-07-11T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
22795436,2012-07-11T00:00:00,Risk Factors,E05.318.740.600.800.725
22795436,2012-07-11T00:00:00,Risk Factors,N05.715.350.200.700
22795436,2012-07-11T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22795436,2012-07-11T00:00:00,Risk Factors,N06.850.490.625.750
22795436,2012-07-11T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22795436,2012-07-11T00:00:00,Time Factors,G01.910.857
22795436,2012-07-11T00:00:00,Treatment Outcome,E01.789.800
22795436,2012-07-11T00:00:00,Treatment Outcome,N04.761.559.590.800
22795436,2012-07-11T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22958388,2012-07-11T00:00:00,Animals,B01.050
22958388,2012-07-11T00:00:00,Bone Resorption,C05.116.264
22958388,2012-07-11T00:00:00,Bone Resorption,G11.427.590.195.150
22958388,2012-07-11T00:00:00,Cell Line,A11.251.210
22958388,2012-07-11T00:00:00,Fibroblasts,A11.329.228
22958388,2012-07-11T00:00:00,Fibroblasts,A11.872.228
22958388,2012-07-11T00:00:00,Interleukin-10,D12.644.276.374.465.510
22958388,2012-07-11T00:00:00,Interleukin-10,D12.776.467.374.465.510
22958388,2012-07-11T00:00:00,Interleukin-10,D23.529.374.465.510
22958388,2012-07-11T00:00:00,Interleukin-6,D12.644.276.374.465.506
22958388,2012-07-11T00:00:00,Interleukin-6,D12.776.467.374.465.506
22958388,2012-07-11T00:00:00,Interleukin-6,D23.529.374.465.506
22958388,2012-07-11T00:00:00,Lipopolysaccharides,D09.400.500
22958388,2012-07-11T00:00:00,Lipopolysaccharides,D09.698.718.450
22958388,2012-07-11T00:00:00,Lipopolysaccharides,D10.494
22958388,2012-07-11T00:00:00,Lipopolysaccharides,D23.050.161.616.525
22958388,2012-07-11T00:00:00,Lipopolysaccharides,D23.946.123.329.500
22958388,2012-07-11T00:00:00,MAP Kinase Signaling System,G02.111.087.800.560
22958388,2012-07-11T00:00:00,MAP Kinase Signaling System,G02.149.115.800.560
22958388,2012-07-11T00:00:00,MAP Kinase Signaling System,G03.495.553.560
22958388,2012-07-11T00:00:00,MAP Kinase Signaling System,G04.299.880.560
22958388,2012-07-11T00:00:00,Macrophages,A11.329.372
22958388,2012-07-11T00:00:00,Macrophages,A11.627.482
22958388,2012-07-11T00:00:00,Macrophages,A11.733.397
22958388,2012-07-11T00:00:00,Macrophages,A15.382.680.397
22958388,2012-07-11T00:00:00,Macrophages,A15.382.812.522
22958388,2012-07-11T00:00:00,Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567
22958388,2012-07-11T00:00:00,Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750
22958388,2012-07-11T00:00:00,Mitogen-Activated Protein Kinases,D12.644.360.450
22958388,2012-07-11T00:00:00,Mitogen-Activated Protein Kinases,D12.776.476.450
22958388,2012-07-11T00:00:00,NF-kappa B,D12.776.260.600
22958388,2012-07-11T00:00:00,NF-kappa B,D12.776.660.600
22958388,2012-07-11T00:00:00,NF-kappa B,D12.776.930.600
22958388,2012-07-11T00:00:00,Osteoclasts,A11.329.372.700
22958388,2012-07-11T00:00:00,Osteoclasts,A11.627.482.700
22958388,2012-07-11T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22958388,2012-07-11T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
22958388,2012-07-11T00:00:00,Skull,A02.835.232.781
22958388,2012-07-11T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
22958388,2012-07-11T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
22958388,2012-07-11T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
22958388,2012-07-11T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
22958388,2012-07-11T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
22958388,2012-07-11T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
22958388,2012-07-11T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
22958388,2012-07-11T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
22958388,2012-07-11T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
22958388,2012-07-11T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
22958388,2012-07-11T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
22958388,2012-07-11T00:00:00,X-Ray Microtomography,E01.370.350.700.810.810.900
22958388,2012-07-11T00:00:00,X-Ray Microtomography,E01.370.350.825.810.810.900
23289649,2012-07-11T00:00:00,Adolescent,M01.060.057
23289649,2012-07-11T00:00:00,Adult,M01.060.116
23289649,2012-07-11T00:00:00,Body Mass Index,E01.370.600.115.100.125
23289649,2012-07-11T00:00:00,Body Mass Index,E05.041.124.125
23289649,2012-07-11T00:00:00,Body Mass Index,G07.100.100.125
23289649,2012-07-11T00:00:00,Body Mass Index,N06.850.505.200.100.175
23289649,2012-07-11T00:00:00,Healthcare Disparities,N04.590.374.380
23289649,2012-07-11T00:00:00,Healthcare Disparities,N05.300.493
23289649,2012-07-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23289649,2012-07-11T00:00:00,Obesity,C18.654.726.500
23289649,2012-07-11T00:00:00,Obesity,C23.888.144.699.500
23289649,2012-07-11T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
23289649,2012-07-11T00:00:00,Obesity,G07.100.100.160.120.699.500
23289649,2012-07-11T00:00:00,Pregnancy,G08.686.785.760.769
23289649,2012-07-11T00:00:00,Rural Population,N01.600.725
23289649,2012-07-11T00:00:00,South Carolina,Z01.107.567.875.075.662
23289649,2012-07-11T00:00:00,South Carolina,Z01.107.567.875.750.700
23289649,2012-07-11T00:00:00,Urban Population,N01.600.900
23289649,2012-07-11T00:00:00,Weight Gain,C23.888.144.243.926
23289649,2012-07-11T00:00:00,Weight Gain,G07.700.320.249.314.120.200.926
23289649,2012-07-11T00:00:00,Young Adult,M01.060.116.815
22786563,2012-07-12T00:00:00,Adolescent,M01.060.057
22786563,2012-07-12T00:00:00,Adult,M01.060.116
22786563,2012-07-12T00:00:00,African Americans,M01.686.508.100.100
22786563,2012-07-12T00:00:00,African Americans,M01.686.754.100
22786563,2012-07-12T00:00:00,Blood Pressure,E01.370.600.875.249
22786563,2012-07-12T00:00:00,Blood Pressure,G09.330.380.076
22786563,2012-07-12T00:00:00,"Blood Pressure Monitoring, Ambulatory",E01.370.370.140.100
22786563,2012-07-12T00:00:00,"Blood Pressure Monitoring, Ambulatory",E01.370.520.500.100
22786563,2012-07-12T00:00:00,Child,M01.060.406
22786563,2012-07-12T00:00:00,European Continental Ancestry Group,M01.686.508.400
22786563,2012-07-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22786563,2012-07-12T00:00:00,Norepinephrine,D02.033.100.291.502
22786563,2012-07-12T00:00:00,Norepinephrine,D02.092.063.480
22786563,2012-07-12T00:00:00,Norepinephrine,D02.092.211.215.311.560
22786563,2012-07-12T00:00:00,Norepinephrine,D02.092.311.461.484
22790832,2012-07-12T00:00:00,African Continental Ancestry Group,M01.686.508.100
22790832,2012-07-12T00:00:00,Breast Neoplasms,C04.588.180
22790832,2012-07-12T00:00:00,Breast Neoplasms,C17.800.090.500
22790832,2012-07-12T00:00:00,"Genes, BRCA1",G05.360.340.024.340.375.249.100
22790832,2012-07-12T00:00:00,"Genes, BRCA1",G05.360.340.024.340.415.400.100
22790832,2012-07-12T00:00:00,"Genes, BRCA2",G05.360.340.024.340.375.249.105
22790832,2012-07-12T00:00:00,"Genes, BRCA2",G05.360.340.024.340.415.400.105
22790832,2012-07-12T00:00:00,Genetic Counseling,H01.158.273.343.315.384
22790832,2012-07-12T00:00:00,Genetic Counseling,N02.421.308.400
22790832,2012-07-12T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
22790832,2012-07-12T00:00:00,Genetic Predisposition to Disease,G05.380.355
22790832,2012-07-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22790832,2012-07-12T00:00:00,Mutation,G05.365.590
22790832,2012-07-12T00:00:00,Ovarian Neoplasms,C04.588.322.455
22790832,2012-07-12T00:00:00,Ovarian Neoplasms,C13.351.500.056.630.705
22790832,2012-07-12T00:00:00,Ovarian Neoplasms,C13.351.937.418.685
22790832,2012-07-12T00:00:00,Ovarian Neoplasms,C19.344.410
22790832,2012-07-12T00:00:00,Ovarian Neoplasms,C19.391.630.705
22790832,2012-07-12T00:00:00,Patient Satisfaction,N04.452.822.360.600
22790832,2012-07-12T00:00:00,Patient Satisfaction,N05.300.150.600.630
22790832,2012-07-12T00:00:00,Patient Satisfaction,N05.715.360.600
22796435,2012-07-13T00:00:00,Animals,B01.050
22796435,2012-07-13T00:00:00,Biological Availability,G03.787.151
22796435,2012-07-13T00:00:00,Biological Availability,G07.690.725.129
22796435,2012-07-13T00:00:00,CD4-Positive T-Lymphocytes,A11.118.637.555.567.569.200
22796435,2012-07-13T00:00:00,CD4-Positive T-Lymphocytes,A15.145.229.637.555.567.569.200
22796435,2012-07-13T00:00:00,CD4-Positive T-Lymphocytes,A15.382.490.555.567.569.200
22796435,2012-07-13T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.114.703.300
22796435,2012-07-13T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.314.350.250
22796435,2012-07-13T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C20.111.258.625.300
22796435,2012-07-13T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",E05.598.500.500.500
22796435,2012-07-13T00:00:00,Immunosuppression,E02.095.465.425.450
22796435,2012-07-13T00:00:00,Immunosuppression,E05.478.610
22796435,2012-07-13T00:00:00,Inflammation,C23.550.470
22796435,2012-07-13T00:00:00,Lovastatin,D02.455.426.559.847.638.400
22796435,2012-07-13T00:00:00,Lovastatin,D04.615.638.400
22796435,2012-07-13T00:00:00,Mevalonic Acid,D02.241.511.579
22796435,2012-07-13T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
22796435,2012-07-13T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22796435,2012-07-13T00:00:00,Signal Transduction,G02.111.087.800
22796435,2012-07-13T00:00:00,Signal Transduction,G02.149.115.800
22796435,2012-07-13T00:00:00,Signal Transduction,G04.299.880
22796435,2012-07-13T00:00:00,Spinal Cord,A08.186.854
22796435,2012-07-13T00:00:00,Vitamin D,D04.808.812.768
22798675,2012-07-13T00:00:00,Animals,B01.050
22798675,2012-07-13T00:00:00,Autoimmunity,G12.450.192
22798675,2012-07-13T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
22798675,2012-07-13T00:00:00,Flow Cytometry,E05.200.500.386.350
22798675,2012-07-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22798675,2012-07-13T00:00:00,"Immunotherapy, Adoptive",E02.095.465.425.400.330.050.400
22798675,2012-07-13T00:00:00,"Immunotherapy, Adoptive",E05.478.550.520.050.400
22798675,2012-07-13T00:00:00,"Lymphocytes, Tumor-Infiltrating",A11.118.637.555.567.650
22798675,2012-07-13T00:00:00,"Lymphocytes, Tumor-Infiltrating",A15.145.229.637.555.567.650
22798675,2012-07-13T00:00:00,"Lymphocytes, Tumor-Infiltrating",A15.382.490.555.567.650
22798675,2012-07-13T00:00:00,Melanoma,C04.557.465.625.650.510
22798675,2012-07-13T00:00:00,Melanoma,C04.557.580.625.650.510
22798675,2012-07-13T00:00:00,Melanoma,C04.557.665.510
22798675,2012-07-13T00:00:00,T-Lymphocyte Subsets,A11.118.637.555.567.550.500
22798675,2012-07-13T00:00:00,T-Lymphocyte Subsets,A11.118.637.555.567.569.500
22798675,2012-07-13T00:00:00,T-Lymphocyte Subsets,A15.145.229.637.555.567.550.500
22798675,2012-07-13T00:00:00,T-Lymphocyte Subsets,A15.145.229.637.555.567.569.500
22798675,2012-07-13T00:00:00,T-Lymphocyte Subsets,A15.382.490.555.567.550.500
22798675,2012-07-13T00:00:00,T-Lymphocyte Subsets,A15.382.490.555.567.569.500
22751431,2012-07-15T00:00:00,Animals,B01.050
22751431,2012-07-15T00:00:00,Cell Aging,G04.299.119
22751431,2012-07-15T00:00:00,Connective Tissue Growth Factor,D12.644.276.200.100
22751431,2012-07-15T00:00:00,Connective Tissue Growth Factor,D12.776.467.200.100
22751431,2012-07-15T00:00:00,Connective Tissue Growth Factor,D12.776.860.300.200.100
22751431,2012-07-15T00:00:00,Connective Tissue Growth Factor,D23.529.237.100
22751431,2012-07-15T00:00:00,Fibroblasts,A11.329.228
22751431,2012-07-15T00:00:00,Fibroblasts,A11.872.228
22751431,2012-07-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23121789,2012-07-16T00:00:00,Adult,M01.060.116
23121789,2012-07-16T00:00:00,Bariatric Surgery,E02.065.062
23121789,2012-07-16T00:00:00,Bariatric Surgery,E04.062
23121789,2012-07-16T00:00:00,Eating Disorders,F03.375
23121789,2012-07-16T00:00:00,Feeding Behavior,F01.145.113.547
23121789,2012-07-16T00:00:00,Feeding Behavior,F01.145.407
23121789,2012-07-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23121789,2012-07-16T00:00:00,Middle Aged,M01.060.116.630
23121789,2012-07-16T00:00:00,Obesity,C18.654.726.500
23121789,2012-07-16T00:00:00,Obesity,C23.888.144.699.500
23121789,2012-07-16T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
23121789,2012-07-16T00:00:00,Obesity,G07.100.100.160.120.699.500
23121789,2012-07-16T00:00:00,Questionnaires,E05.318.308.750
23121789,2012-07-16T00:00:00,Questionnaires,L01.280.800
23121789,2012-07-16T00:00:00,Questionnaires,N05.715.360.300.695
23121789,2012-07-16T00:00:00,Questionnaires,N06.850.520.308.750
23121789,2012-07-16T00:00:00,Treatment Outcome,E01.789.800
23121789,2012-07-16T00:00:00,Treatment Outcome,N04.761.559.590.800
23121789,2012-07-16T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23121789,2012-07-16T00:00:00,Weight Loss,C23.888.144.243.963
23121789,2012-07-16T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
22747103,2012-07-17T00:00:00,Hydrogen Bonding,G02.149.767.620
22747103,2012-07-17T00:00:00,Hydrogen Bonding,G02.842.750.620
22747103,2012-07-17T00:00:00,Molecular Dynamics Simulation,E05.599.595.500
22747103,2012-07-17T00:00:00,Molecular Dynamics Simulation,G02.575.750
22747103,2012-07-17T00:00:00,Molecular Dynamics Simulation,L01.224.160.500
22747103,2012-07-17T00:00:00,Solvents,D27.720.844
22747103,2012-07-17T00:00:00,Static Electricity,G01.201.249.820
22747103,2012-07-17T00:00:00,Water,D01.455.900
22747103,2012-07-17T00:00:00,Water,D01.650.550.925
22803743,2012-07-17T00:00:00,Adult,M01.060.116
22803743,2012-07-17T00:00:00,Aged,M01.060.116.100
22803743,2012-07-17T00:00:00,Cytomegalovirus,B04.280.382.150.150
22803743,2012-07-17T00:00:00,Cytomegalovirus,B04.909.204.382.150.150
22803743,2012-07-17T00:00:00,Hematopoietic Stem Cell Transplantation,E04.936.225.687.500
22803743,2012-07-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22803743,2012-07-17T00:00:00,"Immunity, Humoral",G12.450.050.420
22803743,2012-07-17T00:00:00,Middle Aged,M01.060.116.630
22803743,2012-07-17T00:00:00,Young Adult,M01.060.116.815
22811346,2012-07-17T00:00:00,Antipsychotic Agents,D27.505.696.277.950.040
22811346,2012-07-17T00:00:00,Antipsychotic Agents,D27.505.954.427.210.950.040
22811346,2012-07-17T00:00:00,Antipsychotic Agents,D27.505.954.427.700.872.331
22811346,2012-07-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22811346,2012-07-17T00:00:00,Piperazines,D03.383.606
22811346,2012-07-17T00:00:00,Quinolones,D03.438.810.835
22811346,2012-07-17T00:00:00,Schizophrenia,F03.700.750
22805873,2012-07-18T00:00:00,Brain,A08.186.211
22805873,2012-07-18T00:00:00,Cytokines,D12.644.276.374
22805873,2012-07-18T00:00:00,Cytokines,D12.776.467.374
22805873,2012-07-18T00:00:00,Cytokines,D23.529.374
22805873,2012-07-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22805873,2012-07-18T00:00:00,"Hypothermia, Induced",E02.258.750
22805873,2012-07-18T00:00:00,"Hypoxia-Ischemia, Brain",C10.228.140.300.150.716
22805873,2012-07-18T00:00:00,"Hypoxia-Ischemia, Brain",C10.228.140.624.500
22805873,2012-07-18T00:00:00,"Hypoxia-Ischemia, Brain",C14.907.253.092.716
22805873,2012-07-18T00:00:00,Infant,M01.060.703
22805873,2012-07-18T00:00:00,"Infant, Newborn",M01.060.703.520
22805873,2012-07-18T00:00:00,Interleukin-12,D12.644.276.374.465.512
22805873,2012-07-18T00:00:00,Interleukin-12,D12.776.467.374.465.512
22805873,2012-07-18T00:00:00,Interleukin-12,D23.529.374.465.512
22805873,2012-07-18T00:00:00,Interleukin-6,D12.644.276.374.465.506
22805873,2012-07-18T00:00:00,Interleukin-6,D12.776.467.374.465.506
22805873,2012-07-18T00:00:00,Interleukin-6,D23.529.374.465.506
22805873,2012-07-18T00:00:00,Sex Factors,N05.715.350.675
22805873,2012-07-18T00:00:00,Sex Factors,N06.850.490.875
22805873,2012-07-18T00:00:00,Time Factors,G01.910.857
22805873,2012-07-18T00:00:00,Treatment Outcome,E01.789.800
22805873,2012-07-18T00:00:00,Treatment Outcome,N04.761.559.590.800
22805873,2012-07-18T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22805990,2012-07-18T00:00:00,Biological Markers,D23.101
22805990,2012-07-18T00:00:00,Environmental Exposure,N06.850.460.350
22805990,2012-07-18T00:00:00,Epithelial Cells,A11.436
22805990,2012-07-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22805990,2012-07-18T00:00:00,Lung,A04.411
22805990,2012-07-18T00:00:00,Tobacco Smoke Pollution,D20.633.937.680
22805990,2012-07-18T00:00:00,Tobacco Smoke Pollution,N06.850.460.100.555
22809256,2012-07-18T00:00:00,Adult,M01.060.116
22809256,2012-07-18T00:00:00,Beverages,J02.200
22809256,2012-07-18T00:00:00,Fructose,D09.546.359.250
22809256,2012-07-18T00:00:00,Fructose,D09.546.465.354
22809256,2012-07-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22809256,2012-07-18T00:00:00,Lysine,D12.125.068.555
22809256,2012-07-18T00:00:00,Lysine,D12.125.095.647
22809256,2012-07-18T00:00:00,Lysine,D12.125.142.497
22809256,2012-07-18T00:00:00,Middle Aged,M01.060.116.630
22809256,2012-07-18T00:00:00,Sweetening Agents,D27.720.364.609
22809256,2012-07-18T00:00:00,Sweetening Agents,D27.720.888
22809256,2012-07-18T00:00:00,Sweetening Agents,J02.500.512.400.700
22809256,2012-07-18T00:00:00,Young Adult,M01.060.116.815
22811485,2012-07-18T00:00:00,Animals,B01.050
22811485,2012-07-18T00:00:00,Hypertension,C14.907.489
22811485,2012-07-18T00:00:00,Inflammation,C23.550.470
22811485,2012-07-18T00:00:00,Kidney,A05.810.453
22811485,2012-07-18T00:00:00,Kidney Diseases,C12.777.419
22811485,2012-07-18T00:00:00,Kidney Diseases,C13.351.968.419
22811485,2012-07-18T00:00:00,Oxidative Stress,G03.495.710
22811485,2012-07-18T00:00:00,Oxidative Stress,G07.700.830.750
22811485,2012-07-18T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22811485,2012-07-18T00:00:00,Serpins,D12.644.822.750
22811485,2012-07-18T00:00:00,Serpins,D12.644.861
22811485,2012-07-18T00:00:00,Serpins,D12.776.645.750
22811485,2012-07-18T00:00:00,Serpins,D12.776.872
22811485,2012-07-18T00:00:00,Superoxides,D01.248.497.158.685.750.850
22811485,2012-07-18T00:00:00,Superoxides,D01.339.431.374.850
22811485,2012-07-18T00:00:00,Superoxides,D01.339.431.750
22811485,2012-07-18T00:00:00,Superoxides,D01.650.550.750.800
22767299,2012-07-19T00:00:00,3T3 Cells,A11.251.210.700
22767299,2012-07-19T00:00:00,3T3 Cells,A11.329.228.900
22767299,2012-07-19T00:00:00,Animals,B01.050
22767299,2012-07-19T00:00:00,Cell Survival,G04.299.316
22767299,2012-07-19T00:00:00,Tissue Engineering,E05.200.249.750
22767299,2012-07-19T00:00:00,Tissue Scaffolds,E07.206.627
22767299,2012-07-19T00:00:00,Tissue Scaffolds,E07.695.825
22811280,2012-07-19T00:00:00,Animals,B01.050
22811280,2012-07-19T00:00:00,Connexin 43,D12.776.543.585.250.200
22811280,2012-07-19T00:00:00,"Myocytes, Cardiac",A07.541.704.570
22811280,2012-07-19T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
22811280,2012-07-19T00:00:00,"Myocytes, Cardiac",A11.620.500
22811280,2012-07-19T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22811280,2012-07-19T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
22814392,2012-07-19T00:00:00,Amino Acid Sequence,G02.111.570.060
22814392,2012-07-19T00:00:00,Amino Acid Sequence,L01.453.245.667.060
22814392,2012-07-19T00:00:00,Calcium,D01.268.552.100
22814392,2012-07-19T00:00:00,Calcium,D01.552.539.288
22814392,2012-07-19T00:00:00,Calcium,D23.119.100
22814392,2012-07-19T00:00:00,Cardiomegaly,C14.280.195
22814392,2012-07-19T00:00:00,Cardiomegaly,C23.300.775.250
22814392,2012-07-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22814392,2012-07-19T00:00:00,Molecular Sequence Data,L01.453.245.667
22814392,2012-07-19T00:00:00,Mutation,G05.365.590
22814392,2012-07-19T00:00:00,"Myocytes, Cardiac",A07.541.704.570
22814392,2012-07-19T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
22814392,2012-07-19T00:00:00,"Myocytes, Cardiac",A11.620.500
22814392,2012-07-19T00:00:00,Ryanodine Receptor Calcium Release Channel,D12.776.157.530.400.150.800
22814392,2012-07-19T00:00:00,Ryanodine Receptor Calcium Release Channel,D12.776.210.500.800
22814392,2012-07-19T00:00:00,Ryanodine Receptor Calcium Release Channel,D12.776.543.550.425.150.800
22814392,2012-07-19T00:00:00,Ryanodine Receptor Calcium Release Channel,D12.776.543.585.400.150.800
22818134,2012-07-19T00:00:00,Aged,M01.060.116.100
22818134,2012-07-19T00:00:00,Hospitals,N02.278.421
22818134,2012-07-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22818134,2012-07-19T00:00:00,Physician's Practice Patterns,N04.590.748
22818134,2012-07-19T00:00:00,Physician's Practice Patterns,N05.300.625
22818134,2012-07-19T00:00:00,Prostatectomy,E04.950.774.860.625
22818134,2012-07-19T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
22818134,2012-07-19T00:00:00,Prostatic Neoplasms,C12.294.260.750
22818134,2012-07-19T00:00:00,Prostatic Neoplasms,C12.294.565.625
22818134,2012-07-19T00:00:00,Prostatic Neoplasms,C12.758.409.750
22818134,2012-07-19T00:00:00,"Surgical Procedures, Minimally Invasive",E04.800
22818134,2012-07-19T00:00:00,United States,Z01.107.567.875
22818144,2012-07-19T00:00:00,Adult,M01.060.116
22818144,2012-07-19T00:00:00,Aged,M01.060.116.100
22818144,2012-07-19T00:00:00,Calcium Channels,D12.776.157.530.400.150
22818144,2012-07-19T00:00:00,Calcium Channels,D12.776.543.550.425.150
22818144,2012-07-19T00:00:00,Calcium Channels,D12.776.543.585.400.150
22818144,2012-07-19T00:00:00,Double-Blind Method,E05.318.780.300
22818144,2012-07-19T00:00:00,Double-Blind Method,E05.581.500.300
22818144,2012-07-19T00:00:00,Double-Blind Method,N05.715.360.780.320
22818144,2012-07-19T00:00:00,Double-Blind Method,N06.850.520.445.300
22818144,2012-07-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22818144,2012-07-19T00:00:00,Middle Aged,M01.060.116.630
22818144,2012-07-19T00:00:00,Young Adult,M01.060.116.815
22821614,2012-07-19T00:00:00,Aged,M01.060.116.100
22821614,2012-07-19T00:00:00,Carotid Arteries,A07.231.114.186
22821614,2012-07-19T00:00:00,Carotid Stenosis,C10.228.140.300.200.360
22821614,2012-07-19T00:00:00,Carotid Stenosis,C14.907.137.230
22821614,2012-07-19T00:00:00,Carotid Stenosis,C14.907.253.123.360
22821614,2012-07-19T00:00:00,Cost-Benefit Analysis,N03.219.151.125
22821614,2012-07-19T00:00:00,Health Care Costs,N03.219.151.400
22821614,2012-07-19T00:00:00,Health Care Costs,N05.300.375
22821614,2012-07-19T00:00:00,Hospitalization,E02.760.400
22821614,2012-07-19T00:00:00,Hospitalization,N02.421.585.400
22821614,2012-07-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22821614,2012-07-19T00:00:00,Markov Chains,E05.318.740.600.500
22821614,2012-07-19T00:00:00,Markov Chains,E05.318.740.996.500
22821614,2012-07-19T00:00:00,Markov Chains,G17.830.500
22821614,2012-07-19T00:00:00,Markov Chains,N05.715.360.750.625.500
22821614,2012-07-19T00:00:00,Markov Chains,N05.715.360.750.770.500
22821614,2012-07-19T00:00:00,Markov Chains,N06.850.520.830.600.500
22821614,2012-07-19T00:00:00,Markov Chains,N06.850.520.830.996.500
22821614,2012-07-19T00:00:00,Middle Aged,M01.060.116.630
22821614,2012-07-19T00:00:00,"Models, Statistical",E05.318.740.500
22821614,2012-07-19T00:00:00,"Models, Statistical",E05.599.835
22821614,2012-07-19T00:00:00,"Models, Statistical",N05.715.360.750.530
22821614,2012-07-19T00:00:00,"Models, Statistical",N06.850.520.830.500
22821614,2012-07-19T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
22821614,2012-07-19T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
22821614,2012-07-19T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
22821614,2012-07-19T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
22821614,2012-07-19T00:00:00,Stents,E07.695.750
22821614,2012-07-19T00:00:00,Stroke,C10.228.140.300.775
22821614,2012-07-19T00:00:00,Stroke,C14.907.253.855
22821614,2012-07-19T00:00:00,Treatment Outcome,E01.789.800
22821614,2012-07-19T00:00:00,Treatment Outcome,N04.761.559.590.800
22821614,2012-07-19T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22829910,2012-07-19T00:00:00,Adult,M01.060.116
22829910,2012-07-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22829910,2012-07-19T00:00:00,Melanoma,C04.557.465.625.650.510
22829910,2012-07-19T00:00:00,Melanoma,C04.557.580.625.650.510
22829910,2012-07-19T00:00:00,Melanoma,C04.557.665.510
22829910,2012-07-19T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
22829910,2012-07-19T00:00:00,"Microscopy, Fluorescence",E05.595.458
22829910,2012-07-19T00:00:00,Middle Aged,M01.060.116.630
22829910,2012-07-19T00:00:00,Neoplasm Staging,E01.370.550
22829910,2012-07-19T00:00:00,"Tumor Markers, Biological",D23.101.840
22815042,2012-07-20T00:00:00,African Americans,M01.686.508.100.100
22815042,2012-07-20T00:00:00,African Americans,M01.686.754.100
22815042,2012-07-20T00:00:00,Blood Glucose,D09.546.359.448.500
22815042,2012-07-20T00:00:00,Blood Pressure,E01.370.600.875.249
22815042,2012-07-20T00:00:00,Blood Pressure,G09.330.380.076
22815042,2012-07-20T00:00:00,Diabetes Mellitus,C18.452.394.750
22815042,2012-07-20T00:00:00,Diabetes Mellitus,C19.246
22815042,2012-07-20T00:00:00,Ethnic Groups,M01.686.754
22815042,2012-07-20T00:00:00,Ethnic Groups,N01.224.317
22815042,2012-07-20T00:00:00,European Continental Ancestry Group,M01.686.508.400
22815042,2012-07-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22815042,2012-07-20T00:00:00,Lipids,D10
22815042,2012-07-20T00:00:00,Quality of Life,I01.800
22815042,2012-07-20T00:00:00,Quality of Life,K01.752.400.750
22815042,2012-07-20T00:00:00,United States,Z01.107.567.875
22816373,2012-07-20T00:00:00,Aged,M01.060.116.100
22816373,2012-07-20T00:00:00,Chronic Disease,C23.550.291.500
22816373,2012-07-20T00:00:00,Diabetes Mellitus,C18.452.394.750
22816373,2012-07-20T00:00:00,Diabetes Mellitus,C19.246
22816373,2012-07-20T00:00:00,Health Services Accessibility,N04.590.374.350
22816373,2012-07-20T00:00:00,Health Services Accessibility,N05.300.430
22816373,2012-07-20T00:00:00,Healthcare Disparities,N04.590.374.380
22816373,2012-07-20T00:00:00,Healthcare Disparities,N05.300.493
22816373,2012-07-20T00:00:00,Hospitalization,E02.760.400
22816373,2012-07-20T00:00:00,Hospitalization,N02.421.585.400
22816373,2012-07-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22816373,2012-07-20T00:00:00,Insurance Claim Reporting,N03.219.521.576.210
22816373,2012-07-20T00:00:00,Medicare,N03.219.521.346.506.564.663
22816373,2012-07-20T00:00:00,Medicare,N03.219.521.576.343.840
22816373,2012-07-20T00:00:00,Medicare,N03.706.615.696
22816373,2012-07-20T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
22816373,2012-07-20T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
22816373,2012-07-20T00:00:00,Primary Health Care,N04.590.233.727
22816373,2012-07-20T00:00:00,Rural Population,N01.600.725
22816373,2012-07-20T00:00:00,United States,Z01.107.567.875
22816373,2012-07-20T00:00:00,Urban Population,N01.600.900
22819005,2012-07-20T00:00:00,Agriculture,J01.040
22819005,2012-07-20T00:00:00,Amyotrophic Lateral Sclerosis,C10.228.854.139
22819005,2012-07-20T00:00:00,Amyotrophic Lateral Sclerosis,C10.574.562.250
22819005,2012-07-20T00:00:00,Amyotrophic Lateral Sclerosis,C10.574.950.050
22819005,2012-07-20T00:00:00,Amyotrophic Lateral Sclerosis,C10.668.460.250
22819005,2012-07-20T00:00:00,Amyotrophic Lateral Sclerosis,C18.452.845.800.050
22819005,2012-07-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22819005,2012-07-20T00:00:00,"Models, Statistical",E05.318.740.500
22819005,2012-07-20T00:00:00,"Models, Statistical",E05.599.835
22819005,2012-07-20T00:00:00,"Models, Statistical",N05.715.360.750.530
22819005,2012-07-20T00:00:00,"Models, Statistical",N06.850.520.830.500
22819005,2012-07-20T00:00:00,Occupational Exposure,N06.850.460.350.600
22819005,2012-07-20T00:00:00,Pesticides,D27.720.031.700
22819005,2012-07-20T00:00:00,Pesticides,D27.720.723
22819005,2012-07-20T00:00:00,Pesticides,D27.888.723
22819005,2012-07-20T00:00:00,Risk Factors,E05.318.740.600.800.725
22819005,2012-07-20T00:00:00,Risk Factors,N05.715.350.200.700
22819005,2012-07-20T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22819005,2012-07-20T00:00:00,Risk Factors,N06.850.490.625.750
22819005,2012-07-20T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22819201,2012-07-21T00:00:00,Adolescent,M01.060.057
22819201,2012-07-21T00:00:00,Child,M01.060.406
22819201,2012-07-21T00:00:00,"Child, Preschool",M01.060.406.448
22819201,2012-07-21T00:00:00,Cost Savings,N03.219.151.160.200
22819201,2012-07-21T00:00:00,Electronic Health Records,E05.318.308.940.968.625.500
22819201,2012-07-21T00:00:00,Health Care Costs,N03.219.151.400
22819201,2012-07-21T00:00:00,Health Care Costs,N05.300.375
22819201,2012-07-21T00:00:00,Hospitalization,E02.760.400
22819201,2012-07-21T00:00:00,Hospitalization,N02.421.585.400
22819201,2012-07-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22819201,2012-07-21T00:00:00,Infant,M01.060.703
22819201,2012-07-21T00:00:00,"Infant, Newborn",M01.060.703.520
22819201,2012-07-21T00:00:00,Medical Informatics,L01.313.500
22819201,2012-07-21T00:00:00,Medical Informatics,L01.700
22819201,2012-07-21T00:00:00,Patient Care,E02.760
22819201,2012-07-21T00:00:00,Patient Care,N02.421.585
22819201,2012-07-21T00:00:00,Pediatrics,H02.403.670
22819201,2012-07-21T00:00:00,United States,Z01.107.567.875
22819201,2012-07-21T00:00:00,Young Adult,M01.060.116.815
22820100,2012-07-23T00:00:00,Animals,B01.050
22820100,2012-07-23T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
22820100,2012-07-23T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
22820100,2012-07-23T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
22820100,2012-07-23T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
22820100,2012-07-23T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
22820100,2012-07-23T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
22820100,2012-07-23T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
22820100,2012-07-23T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
22820100,2012-07-23T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
22820100,2012-07-23T00:00:00,Drug Resistance,G07.690.320
22820100,2012-07-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22820100,2012-07-23T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.606.586
22820100,2012-07-23T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.619.393.522.400
22820100,2012-07-23T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.705.500.380.500
22820100,2012-07-23T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.606.586
22820100,2012-07-23T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.619.393.522.400
22820100,2012-07-23T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.705.500.380.500
22820100,2012-07-23T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.606.586
22820100,2012-07-23T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.619.393.522.400
22820100,2012-07-23T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.705.500.380.500
22820100,2012-07-23T00:00:00,Immunoglobulin Gm Allotypes,G12.500.400.586
22823160,2012-07-24T00:00:00,Animals,B01.050
22823160,2012-07-24T00:00:00,Cocaine,D02.145.074.722.388
22823160,2012-07-24T00:00:00,Cocaine,D03.132.889.354
22823160,2012-07-24T00:00:00,Cocaine,D03.605.869.388
22823160,2012-07-24T00:00:00,Cocaine,D04.075.080.875.099.722.388
22823160,2012-07-24T00:00:00,Neural Inhibition,G07.265.337.615
22823160,2012-07-24T00:00:00,Neural Inhibition,G07.700.240.615
22823160,2012-07-24T00:00:00,Neural Inhibition,G11.561.600.625
22823160,2012-07-24T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
22823160,2012-07-24T00:00:00,Photic Stimulation,E05.723.729
22823160,2012-07-24T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
22823160,2012-07-24T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22823160,2012-07-24T00:00:00,Self Administration,E02.319.890
22823160,2012-07-24T00:00:00,Self Administration,E02.900.890
22832134,2012-07-24T00:00:00,Anxiety Disorders,F03.080
22832134,2012-07-24T00:00:00,"Depressive Disorder, Major",F03.600.300.375
22832134,2012-07-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22832134,2012-07-24T00:00:00,International Classification of Diseases,L01.453.245.945.400
22832134,2012-07-24T00:00:00,"Interview, Psychological",F04.669.599
22832134,2012-07-24T00:00:00,Primary Health Care,N04.590.233.727
22832134,2012-07-24T00:00:00,Psychometrics,F04.711.780
22833671,2012-07-24T00:00:00,Animals,B01.050
22833671,2012-07-24T00:00:00,Cell Membrane,A11.284.149
22833671,2012-07-24T00:00:00,"Cell Transformation, Neoplastic",C04.697.152
22833671,2012-07-24T00:00:00,"Cell Transformation, Neoplastic",C23.550.727.152
22833671,2012-07-24T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.567.342
22833671,2012-07-24T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.646.750.249
22833671,2012-07-24T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.644.360.450.169
22833671,2012-07-24T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.776.476.450.169
22833671,2012-07-24T00:00:00,Fibroblasts,A11.329.228
22833671,2012-07-24T00:00:00,Fibroblasts,A11.872.228
22833671,2012-07-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22833671,2012-07-24T00:00:00,"Models, Biological",E05.599.395
22833671,2012-07-24T00:00:00,Phosphorylation,G02.111.087.677
22833671,2012-07-24T00:00:00,Phosphorylation,G02.149.115.677
22833671,2012-07-24T00:00:00,Phosphorylation,G02.149.465.700
22833671,2012-07-24T00:00:00,Phosphorylation,G02.607.750.700
22833671,2012-07-24T00:00:00,Phosphorylation,G03.495.790
22833671,2012-07-24T00:00:00,Phosphotransferases (Alcohol Group Acceptor),D08.811.913.696.620
22833671,2012-07-24T00:00:00,Proto-Oncogene Proteins,D12.776.624.664.700
22833671,2012-07-24T00:00:00,Sphingolipids,D10.570.877
22833671,2012-07-24T00:00:00,Sphingolipids,D10.808
22835574,2012-07-24T00:00:00,Adenocarcinoma,C04.557.470.200.025
22835574,2012-07-24T00:00:00,Adult,M01.060.116
22835574,2012-07-24T00:00:00,Aged,M01.060.116.100
22835574,2012-07-24T00:00:00,Colonoscopy,E01.370.372.250.250.200
22835574,2012-07-24T00:00:00,Colonoscopy,E01.370.388.250.250.250.160
22835574,2012-07-24T00:00:00,Colonoscopy,E04.210.240.250.160
22835574,2012-07-24T00:00:00,Colonoscopy,E04.800.250.250.250.160
22835574,2012-07-24T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
22835574,2012-07-24T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
22835574,2012-07-24T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
22835574,2012-07-24T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
22835574,2012-07-24T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
22835574,2012-07-24T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
22835574,2012-07-24T00:00:00,Early Detection of Cancer,E01.390.500
22835574,2012-07-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22835574,2012-07-24T00:00:00,Incidence,E05.318.308.985.525.375
22835574,2012-07-24T00:00:00,Incidence,L01.280.975.525.375
22835574,2012-07-24T00:00:00,Incidence,N01.224.935.597.500
22835574,2012-07-24T00:00:00,Incidence,N06.850.505.400.975.525.375
22835574,2012-07-24T00:00:00,Incidence,N06.850.520.308.985.525.375
22835574,2012-07-24T00:00:00,Middle Aged,M01.060.116.630
22835574,2012-07-24T00:00:00,Polyps,C23.300.825
22889665,2012-07-24T00:00:00,Hydrogen Peroxide,D01.248.497.158.685.750.424
22889665,2012-07-24T00:00:00,Hydrogen Peroxide,D01.339.431.374.424
22889665,2012-07-24T00:00:00,Hydrogen Peroxide,D01.650.550.750.400
22889665,2012-07-24T00:00:00,Water Purification,N06.850.780.200.800.800.900.900
22889665,2012-07-24T00:00:00,Water Purification,N06.850.860.510.900.900
22889665,2012-07-24T00:00:00,Water Purification,N06.850.860.510.915.900
22980684,2012-07-24T00:00:00,Adult,M01.060.116
22980684,2012-07-24T00:00:00,Child,M01.060.406
22980684,2012-07-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22980684,2012-07-24T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
22980684,2012-07-24T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
22980684,2012-07-24T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
22980684,2012-07-24T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
22980684,2012-07-24T00:00:00,Risk Factors,E05.318.740.600.800.725
22980684,2012-07-24T00:00:00,Risk Factors,N05.715.350.200.700
22980684,2012-07-24T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22980684,2012-07-24T00:00:00,Risk Factors,N06.850.490.625.750
22980684,2012-07-24T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22980684,2012-07-24T00:00:00,Treatment Outcome,E01.789.800
22980684,2012-07-24T00:00:00,Treatment Outcome,N04.761.559.590.800
22980684,2012-07-24T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22830441,2012-07-25T00:00:00,Aged,M01.060.116.100
22830441,2012-07-25T00:00:00,"Cardiac Pacing, Artificial",E02.145
22830441,2012-07-25T00:00:00,Heart Atria,A07.541.358
22830441,2012-07-25T00:00:00,Heart Failure,C14.280.434
22830441,2012-07-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22830441,2012-07-25T00:00:00,Incidence,E05.318.308.985.525.375
22830441,2012-07-25T00:00:00,Incidence,L01.280.975.525.375
22830441,2012-07-25T00:00:00,Incidence,N01.224.935.597.500
22830441,2012-07-25T00:00:00,Incidence,N06.850.505.400.975.525.375
22830441,2012-07-25T00:00:00,Incidence,N06.850.520.308.985.525.375
22830441,2012-07-25T00:00:00,Risk Factors,E05.318.740.600.800.725
22830441,2012-07-25T00:00:00,Risk Factors,N05.715.350.200.700
22830441,2012-07-25T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22830441,2012-07-25T00:00:00,Risk Factors,N06.850.490.625.750
22830441,2012-07-25T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22830441,2012-07-25T00:00:00,Treatment Outcome,E01.789.800
22830441,2012-07-25T00:00:00,Treatment Outcome,N04.761.559.590.800
22830441,2012-07-25T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22830441,2012-07-25T00:00:00,United States,Z01.107.567.875
22830441,2012-07-25T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
22832516,2012-07-25T00:00:00,Academic Medical Centers,N02.278.020
22832516,2012-07-25T00:00:00,Adult,M01.060.116
22832516,2012-07-25T00:00:00,Aged,M01.060.116.100
22832516,2012-07-25T00:00:00,Attitude to Health,F01.100.150
22832516,2012-07-25T00:00:00,Attitude to Health,N05.300.150
22832516,2012-07-25T00:00:00,Data Collection,E05.318.308
22832516,2012-07-25T00:00:00,Data Collection,L01.280
22832516,2012-07-25T00:00:00,Data Collection,N05.715.360.300
22832516,2012-07-25T00:00:00,Data Collection,N06.850.520.308
22832516,2012-07-25T00:00:00,Fear,F01.470.361
22832516,2012-07-25T00:00:00,Health Services Accessibility,N04.590.374.350
22832516,2012-07-25T00:00:00,Health Services Accessibility,N05.300.430
22832516,2012-07-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22832516,2012-07-25T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
22832516,2012-07-25T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
22832516,2012-07-25T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
22832516,2012-07-25T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
22832516,2012-07-25T00:00:00,Kidney Transplantation,E02.870.500
22832516,2012-07-25T00:00:00,Kidney Transplantation,E04.936.450.485
22832516,2012-07-25T00:00:00,Kidney Transplantation,E04.950.774.400
22832516,2012-07-25T00:00:00,Middle Aged,M01.060.116.630
22832516,2012-07-25T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
22832516,2012-07-25T00:00:00,Patient Dropouts,M01.643.673
22832516,2012-07-25T00:00:00,South Carolina,Z01.107.567.875.075.662
22832516,2012-07-25T00:00:00,South Carolina,Z01.107.567.875.750.700
22832516,2012-07-25T00:00:00,Waiting Lists,N04.452.095.738
22832516,2012-07-25T00:00:00,Young Adult,M01.060.116.815
22843703,2012-07-25T00:00:00,Animals,B01.050
22843703,2012-07-25T00:00:00,Contractile Proteins,D12.776.210
22843703,2012-07-25T00:00:00,GTP-Binding Proteins,D08.811.277.040.330.300
22843703,2012-07-25T00:00:00,GTP-Binding Proteins,D12.776.157.325
22843703,2012-07-25T00:00:00,"Heart Defects, Congenital",C14.240.400
22843703,2012-07-25T00:00:00,"Heart Defects, Congenital",C14.280.400
22843703,2012-07-25T00:00:00,"Heart Defects, Congenital",C16.131.240.400
22843703,2012-07-25T00:00:00,Mitral Valve,A07.541.510.507
22843703,2012-07-25T00:00:00,Serotonin Plasma Membrane Transport Proteins,D12.776.157.530.450.625.311
22843703,2012-07-25T00:00:00,Serotonin Plasma Membrane Transport Proteins,D12.776.157.530.562.374.875
22843703,2012-07-25T00:00:00,Serotonin Plasma Membrane Transport Proteins,D12.776.543.585.450.625.374
22843703,2012-07-25T00:00:00,Serotonin Plasma Membrane Transport Proteins,D12.776.543.585.562.374.875
22843703,2012-07-25T00:00:00,Transglutaminases,D08.811.913.050.200.800
22848628,2012-07-25T00:00:00,Animals,B01.050
22848628,2012-07-25T00:00:00,Cell Adhesion Molecules,D12.776.395.550.200
22848628,2012-07-25T00:00:00,Cell Adhesion Molecules,D12.776.543.550.200
22848628,2012-07-25T00:00:00,Cell Adhesion Molecules,D23.050.301.350
22848628,2012-07-25T00:00:00,Enzyme Inhibitors,D27.505.519.389
22848628,2012-07-25T00:00:00,Inflammation,C23.550.470
22848628,2012-07-25T00:00:00,Liver,A03.620
22848628,2012-07-25T00:00:00,Liver Transplantation,E04.210.650
22848628,2012-07-25T00:00:00,Liver Transplantation,E04.936.450.490
22848628,2012-07-25T00:00:00,Liver Transplantation,E04.936.580.490
22848628,2012-07-25T00:00:00,Lysophospholipids,D10.570.755.375.760.550
22848628,2012-07-25T00:00:00,NF-kappa B,D12.776.260.600
22848628,2012-07-25T00:00:00,NF-kappa B,D12.776.660.600
22848628,2012-07-25T00:00:00,NF-kappa B,D12.776.930.600
22848628,2012-07-25T00:00:00,Phosphotransferases (Alcohol Group Acceptor),D08.811.913.696.620
22848628,2012-07-25T00:00:00,Pyridines,D03.383.725
22848628,2012-07-25T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22848628,2012-07-25T00:00:00,Reactive Oxygen Species,D01.339.431
22848628,2012-07-25T00:00:00,Reactive Oxygen Species,D01.650.775
22848628,2012-07-25T00:00:00,Reperfusion Injury,C14.907.725
22848628,2012-07-25T00:00:00,Reperfusion Injury,C23.550.767.877
22848628,2012-07-25T00:00:00,Sphingosine,D02.033.100.700
22848628,2012-07-25T00:00:00,Sphingosine,D02.033.455.843
22848628,2012-07-25T00:00:00,Sphingosine,D02.092.063.700
22848628,2012-07-25T00:00:00,Toll-Like Receptor 4,D12.776.543.750.705.910.500.400
22840686,2012-07-26T00:00:00,Aged,M01.060.116.100
22840686,2012-07-26T00:00:00,"Arthroplasty, Replacement, Hip",E04.555.110.110.110
22840686,2012-07-26T00:00:00,"Arthroplasty, Replacement, Hip",E04.650.110.110
22840686,2012-07-26T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
22840686,2012-07-26T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
22840686,2012-07-26T00:00:00,Body Mass Index,E01.370.600.115.100.125
22840686,2012-07-26T00:00:00,Body Mass Index,E05.041.124.125
22840686,2012-07-26T00:00:00,Body Mass Index,G07.100.100.125
22840686,2012-07-26T00:00:00,Body Mass Index,N06.850.505.200.100.175
22840686,2012-07-26T00:00:00,"Clinical Trials, Phase III as Topic",E05.318.760.535.220
22840686,2012-07-26T00:00:00,"Clinical Trials, Phase III as Topic",E05.337.250.220
22840686,2012-07-26T00:00:00,"Clinical Trials, Phase III as Topic",N05.715.360.775.235.220
22840686,2012-07-26T00:00:00,"Clinical Trials, Phase III as Topic",N06.850.520.450.535.220
22840686,2012-07-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22840686,2012-07-26T00:00:00,Middle Aged,M01.060.116.630
22840686,2012-07-26T00:00:00,Obesity,C18.654.726.500
22840686,2012-07-26T00:00:00,Obesity,C23.888.144.699.500
22840686,2012-07-26T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
22840686,2012-07-26T00:00:00,Obesity,G07.100.100.160.120.699.500
22840686,2012-07-26T00:00:00,Postoperative Complications,C23.550.767
22840686,2012-07-26T00:00:00,Risk Factors,E05.318.740.600.800.725
22840686,2012-07-26T00:00:00,Risk Factors,N05.715.350.200.700
22840686,2012-07-26T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22840686,2012-07-26T00:00:00,Risk Factors,N06.850.490.625.750
22840686,2012-07-26T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22840686,2012-07-26T00:00:00,Treatment Outcome,E01.789.800
22840686,2012-07-26T00:00:00,Treatment Outcome,N04.761.559.590.800
22840686,2012-07-26T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22840686,2012-07-26T00:00:00,Venous Thromboembolism,C14.907.355.590.700
22840686,2012-07-26T00:00:00,Venous Thromboembolism,C14.907.355.830.850.700
22847652,2012-07-31T00:00:00,Adolescent,M01.060.057
22847652,2012-07-31T00:00:00,Adult,M01.060.116
22847652,2012-07-31T00:00:00,Age Factors,N05.715.350.075
22847652,2012-07-31T00:00:00,Age Factors,N06.850.490.250
22847652,2012-07-31T00:00:00,Aged,M01.060.116.100
22847652,2012-07-31T00:00:00,"Data Interpretation, Statistical",E05.245.380
22847652,2012-07-31T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
22847652,2012-07-31T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
22847652,2012-07-31T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
22847652,2012-07-31T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
22847652,2012-07-31T00:00:00,Ethnic Groups,M01.686.754
22847652,2012-07-31T00:00:00,Ethnic Groups,N01.224.317
22847652,2012-07-31T00:00:00,Hospital Mortality,E05.318.308.985.550.400
22847652,2012-07-31T00:00:00,Hospital Mortality,L01.280.975.550.400
22847652,2012-07-31T00:00:00,Hospital Mortality,N01.224.935.698.400
22847652,2012-07-31T00:00:00,Hospital Mortality,N06.850.505.400.975.550.400
22847652,2012-07-31T00:00:00,Hospital Mortality,N06.850.520.308.985.550.400
22847652,2012-07-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22847652,2012-07-31T00:00:00,Middle Aged,M01.060.116.630
22847652,2012-07-31T00:00:00,Multiple Trauma,C21.866.640
22847652,2012-07-31T00:00:00,Regression Analysis,E05.318.740.750
22847652,2012-07-31T00:00:00,Regression Analysis,N05.715.360.750.695
22847652,2012-07-31T00:00:00,Regression Analysis,N06.850.520.830.750
22847652,2012-07-31T00:00:00,Risk Factors,E05.318.740.600.800.725
22847652,2012-07-31T00:00:00,Risk Factors,N05.715.350.200.700
22847652,2012-07-31T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22847652,2012-07-31T00:00:00,Risk Factors,N06.850.490.625.750
22847652,2012-07-31T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22847652,2012-07-31T00:00:00,Sex Factors,N05.715.350.675
22847652,2012-07-31T00:00:00,Sex Factors,N06.850.490.875
22847652,2012-07-31T00:00:00,South Carolina,Z01.107.567.875.075.662
22847652,2012-07-31T00:00:00,South Carolina,Z01.107.567.875.750.700
22847652,2012-07-31T00:00:00,Spinal Cord Injuries,C10.228.854.770
22847652,2012-07-31T00:00:00,Spinal Cord Injuries,C10.900.850
22847652,2012-07-31T00:00:00,Spinal Cord Injuries,C21.866.819
22847652,2012-07-31T00:00:00,Trauma Centers,N02.278.354.422.336.500
22847652,2012-07-31T00:00:00,Trauma Centers,N02.421.297.195.480
22847652,2012-07-31T00:00:00,Trauma Centers,N04.452.442.422.336.400
22847652,2012-07-31T00:00:00,Young Adult,M01.060.116.815
22849379,2012-07-31T00:00:00,Adolescent,M01.060.057
22849379,2012-07-31T00:00:00,Asthma,C08.127.108
22849379,2012-07-31T00:00:00,Asthma,C08.381.495.108
22849379,2012-07-31T00:00:00,Asthma,C08.674.095
22849379,2012-07-31T00:00:00,Asthma,C20.543.480.680.095
22849379,2012-07-31T00:00:00,Child,M01.060.406
22849379,2012-07-31T00:00:00,"Child, Preschool",M01.060.406.448
22849379,2012-07-31T00:00:00,Cost of Illness,I01.137
22849379,2012-07-31T00:00:00,Cost of Illness,N03.219.151.165
22849379,2012-07-31T00:00:00,Cost-Benefit Analysis,N03.219.151.125
22849379,2012-07-31T00:00:00,Decision Support Techniques,E05.245
22849379,2012-07-31T00:00:00,Decision Support Techniques,L01.700.508.190
22849379,2012-07-31T00:00:00,Dexamethasone,D04.808.745.432.769.344
22849379,2012-07-31T00:00:00,Dexamethasone,D04.808.908.238
22849379,2012-07-31T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
22849379,2012-07-31T00:00:00,"Emergency Service, Hospital",N02.421.297.195
22849379,2012-07-31T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
22849379,2012-07-31T00:00:00,Glucocorticoids,D06.472.040.543
22849379,2012-07-31T00:00:00,Glucocorticoids,D27.505.696.399.472.488
22849379,2012-07-31T00:00:00,Hospitalization,E02.760.400
22849379,2012-07-31T00:00:00,Hospitalization,N02.421.585.400
22849379,2012-07-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22849379,2012-07-31T00:00:00,Prednisone,D04.808.745.432.719.702
22849402,2012-07-31T00:00:00,Adolescent,M01.060.057
22849402,2012-07-31T00:00:00,Adult,M01.060.116
22849402,2012-07-31T00:00:00,Behavior,F01.145
22849402,2012-07-31T00:00:00,Brain,A08.186.211
22849402,2012-07-31T00:00:00,Brain Mapping,E01.370.350.086
22849402,2012-07-31T00:00:00,Brain Mapping,E01.370.376.149
22849402,2012-07-31T00:00:00,Brain Mapping,E05.132
22849402,2012-07-31T00:00:00,"Data Interpretation, Statistical",E05.245.380
22849402,2012-07-31T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
22849402,2012-07-31T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
22849402,2012-07-31T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
22849402,2012-07-31T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
22849402,2012-07-31T00:00:00,Face,A01.456.505
22849402,2012-07-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22849402,2012-07-31T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
22849402,2012-07-31T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
22849402,2012-07-31T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
22849402,2012-07-31T00:00:00,Photic Stimulation,E05.723.729
22849402,2012-07-31T00:00:00,Psychomotor Performance,F02.808
22849402,2012-07-31T00:00:00,Psychomotor Performance,G11.427.700
22849402,2012-07-31T00:00:00,Psychomotor Performance,G11.561.623
22849402,2012-07-31T00:00:00,Reaction Time,F02.830.650
22849402,2012-07-31T00:00:00,Reaction Time,F04.669.817
22849402,2012-07-31T00:00:00,Reaction Time,G11.561.677
22849402,2012-07-31T00:00:00,Visual Perception,F02.463.593.932
22849402,2012-07-31T00:00:00,Young Adult,M01.060.116.815
21980059,2012-08-01T00:00:00,"Biopsy, Needle",E01.370.388.100.100
21980059,2012-08-01T00:00:00,"Biopsy, Needle",E01.450.230.100.100
21980059,2012-08-01T00:00:00,"Biopsy, Needle",E01.450.865.100.100
21980059,2012-08-01T00:00:00,"Biopsy, Needle",E01.450.865.632.100
21980059,2012-08-01T00:00:00,"Biopsy, Needle",E04.074.119
21980059,2012-08-01T00:00:00,Bronchoscopy,E01.370.386.105
21980059,2012-08-01T00:00:00,Bronchoscopy,E01.370.388.250.100
21980059,2012-08-01T00:00:00,Bronchoscopy,E04.800.250.100
21980059,2012-08-01T00:00:00,Bronchoscopy,E04.928.600.080
21980059,2012-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21980059,2012-08-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
21980059,2012-08-01T00:00:00,Lung Neoplasms,C08.381.540
21980059,2012-08-01T00:00:00,Lung Neoplasms,C08.785.520
21980059,2012-08-01T00:00:00,"Surgery, Computer-Assisted",E02.950.875
21980059,2012-08-01T00:00:00,"Surgery, Computer-Assisted",E04.749
21980059,2012-08-01T00:00:00,"Surgery, Computer-Assisted",L01.700.508.100.710.800
22350278,2012-08-01T00:00:00,Adolescent,M01.060.057
22350278,2012-08-01T00:00:00,Circadian Rhythm,G07.180.562.190
22350278,2012-08-01T00:00:00,Family Therapy,F04.754.864.581.273
22350278,2012-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22350278,2012-08-01T00:00:00,Hydrocortisone,D04.808.745.745.654.600
22350278,2012-08-01T00:00:00,Hydrocortisone,D06.472.040.585.353.476
22350278,2012-08-01T00:00:00,Hydrocortisone,D06.472.040.585.478.392
22350278,2012-08-01T00:00:00,Hypothalamo-Hypophyseal System,A06.688.357
22350278,2012-08-01T00:00:00,Hypothalamo-Hypophyseal System,A08.186.211.730.317.357.352.435
22350278,2012-08-01T00:00:00,Hypothalamo-Hypophyseal System,A08.713.357
22350278,2012-08-01T00:00:00,Internal-External Control,F01.829.379
22350278,2012-08-01T00:00:00,Pituitary-Adrenal System,A06.407.691
22350278,2012-08-01T00:00:00,Psychotherapy,F04.754
22350278,2012-08-01T00:00:00,Saliva,A12.200.666
22350278,2012-08-01T00:00:00,"Stress, Psychological",F01.145.126.990
22350278,2012-08-01T00:00:00,"Stress, Psychological",F02.830.900
22473887,2012-08-01T00:00:00,Adolescent,M01.060.057
22473887,2012-08-01T00:00:00,Cause of Death,E05.318.308.985.550.250
22473887,2012-08-01T00:00:00,Cause of Death,L01.280.975.550.250
22473887,2012-08-01T00:00:00,Cause of Death,N01.224.935.698.100
22473887,2012-08-01T00:00:00,Cause of Death,N06.850.505.400.975.550.250
22473887,2012-08-01T00:00:00,Cause of Death,N06.850.520.308.985.550.250
22473887,2012-08-01T00:00:00,Child,M01.060.406
22473887,2012-08-01T00:00:00,"Child, Preschool",M01.060.406.448
22473887,2012-08-01T00:00:00,Heart Diseases,C14.280
22473887,2012-08-01T00:00:00,Hospital Mortality,E05.318.308.985.550.400
22473887,2012-08-01T00:00:00,Hospital Mortality,L01.280.975.550.400
22473887,2012-08-01T00:00:00,Hospital Mortality,N01.224.935.698.400
22473887,2012-08-01T00:00:00,Hospital Mortality,N06.850.505.400.975.550.400
22473887,2012-08-01T00:00:00,Hospital Mortality,N06.850.520.308.985.550.400
22473887,2012-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22473887,2012-08-01T00:00:00,Infant,M01.060.703
22473887,2012-08-01T00:00:00,"Infant, Newborn",M01.060.703.520
22473887,2012-08-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
22473887,2012-08-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
22473887,2012-08-01T00:00:00,Terminal Care,E02.760.905
22473887,2012-08-01T00:00:00,Terminal Care,N02.421.585.905
22473887,2012-08-01T00:00:00,Young Adult,M01.060.116.815
22476039,2012-08-01T00:00:00,Adult,M01.060.116
22476039,2012-08-01T00:00:00,Aged,M01.060.116.100
22476039,2012-08-01T00:00:00,Esophageal Motility Disorders,C06.405.117.119.500
22476039,2012-08-01T00:00:00,Esophagus,A03.556.875.500
22476039,2012-08-01T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
22476039,2012-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22476039,2012-08-01T00:00:00,Manometry,E05.559
22476039,2012-08-01T00:00:00,Middle Aged,M01.060.116.630
22476039,2012-08-01T00:00:00,Young Adult,M01.060.116.815
22553077,2012-08-01T00:00:00,"Antibodies, Antinuclear",D12.776.124.486.485.114.323.204
22553077,2012-08-01T00:00:00,"Antibodies, Antinuclear",D12.776.124.790.651.114.323.204
22553077,2012-08-01T00:00:00,"Antibodies, Antinuclear",D12.776.377.715.548.114.323.204
22553077,2012-08-01T00:00:00,DNA,D13.444.308
22553077,2012-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22553077,2012-08-01T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
22553077,2012-08-01T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
22553077,2012-08-01T00:00:00,Lupus Nephritis,C12.777.419.570.363.680
22553077,2012-08-01T00:00:00,Lupus Nephritis,C13.351.968.419.570.363.680
22553077,2012-08-01T00:00:00,Lupus Nephritis,C17.300.480.680
22553077,2012-08-01T00:00:00,Lupus Nephritis,C20.111.590.560
22606978,2012-08-01T00:00:00,Adult,M01.060.116
22606978,2012-08-01T00:00:00,Hepatic Encephalopathy,C06.552.308.500.356
22606978,2012-08-01T00:00:00,Hepatic Encephalopathy,C10.228.140.163.360
22606978,2012-08-01T00:00:00,Hepatic Encephalopathy,C18.452.132.360
22606978,2012-08-01T00:00:00,Hospitalization,E02.760.400
22606978,2012-08-01T00:00:00,Hospitalization,N02.421.585.400
22606978,2012-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22606978,2012-08-01T00:00:00,Liver Cirrhosis,C06.552.630
22606978,2012-08-01T00:00:00,Middle Aged,M01.060.116.630
22606978,2012-08-01T00:00:00,Neuropsychological Tests,F04.711.513
22606978,2012-08-01T00:00:00,Primary Prevention,N02.421.726.758
22606978,2012-08-01T00:00:00,Primary Prevention,N06.850.780.680
22606978,2012-08-01T00:00:00,Psychometrics,F04.711.780
22606978,2012-08-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
22606978,2012-08-01T00:00:00,Risk Assessment,N04.452.871.715
22606978,2012-08-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
22606978,2012-08-01T00:00:00,Risk Assessment,N06.850.505.715
22606978,2012-08-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
22606978,2012-08-01T00:00:00,Risk Factors,E05.318.740.600.800.725
22606978,2012-08-01T00:00:00,Risk Factors,N05.715.350.200.700
22606978,2012-08-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22606978,2012-08-01T00:00:00,Risk Factors,N06.850.490.625.750
22606978,2012-08-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22606978,2012-08-01T00:00:00,Time Factors,G01.910.857
22606978,2012-08-01T00:00:00,Treatment Outcome,E01.789.800
22606978,2012-08-01T00:00:00,Treatment Outcome,N04.761.559.590.800
22606978,2012-08-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22681251,2012-08-01T00:00:00,"Feedback, Physiological",G07.700.360.732
22681251,2012-08-01T00:00:00,"Feedback, Physiological",L01.143.283.425.311
22681251,2012-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22681251,2012-08-01T00:00:00,Protein Conformation,G02.111.570.790.709
22681251,2012-08-01T00:00:00,"Receptors, G-Protein-Coupled",D12.776.543.750.100
22681251,2012-08-01T00:00:00,Signal Transduction,G02.111.087.800
22681251,2012-08-01T00:00:00,Signal Transduction,G02.149.115.800
22681251,2012-08-01T00:00:00,Signal Transduction,G04.299.880
22706327,2012-08-01T00:00:00,Acetylcysteine,D02.886.030.230.259
22706327,2012-08-01T00:00:00,Acetylcysteine,D12.125.166.230.259
22706327,2012-08-01T00:00:00,Adolescent,M01.060.057
22706327,2012-08-01T00:00:00,Cannabinoids,D02.455.849.090
22706327,2012-08-01T00:00:00,Counseling,F02.784.176
22706327,2012-08-01T00:00:00,Counseling,F04.408.413
22706327,2012-08-01T00:00:00,Counseling,N02.421.143.303
22706327,2012-08-01T00:00:00,Counseling,N02.421.461.363
22706327,2012-08-01T00:00:00,Double-Blind Method,E05.318.780.300
22706327,2012-08-01T00:00:00,Double-Blind Method,E05.581.500.300
22706327,2012-08-01T00:00:00,Double-Blind Method,N05.715.360.780.320
22706327,2012-08-01T00:00:00,Double-Blind Method,N06.850.520.445.300
22706327,2012-08-01T00:00:00,Excitatory Amino Acid Antagonists,D27.505.519.625.190.300
22706327,2012-08-01T00:00:00,Excitatory Amino Acid Antagonists,D27.505.696.577.190.300
22706327,2012-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22706327,2012-08-01T00:00:00,Marijuana Abuse,C21.739.635
22706327,2012-08-01T00:00:00,Marijuana Abuse,F03.900.635
22706327,2012-08-01T00:00:00,Treatment Outcome,E01.789.800
22706327,2012-08-01T00:00:00,Treatment Outcome,N04.761.559.590.800
22706327,2012-08-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22706327,2012-08-01T00:00:00,Young Adult,M01.060.116.815
22813683,2012-08-01T00:00:00,Adolescent,M01.060.057
22813683,2012-08-01T00:00:00,Adult,M01.060.116
22813683,2012-08-01T00:00:00,Aged,M01.060.116.100
22813683,2012-08-01T00:00:00,Crime Victims,M01.135
22813683,2012-08-01T00:00:00,Data Collection,E05.318.308
22813683,2012-08-01T00:00:00,Data Collection,L01.280
22813683,2012-08-01T00:00:00,Data Collection,N05.715.360.300
22813683,2012-08-01T00:00:00,Data Collection,N06.850.520.308
22813683,2012-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22813683,2012-08-01T00:00:00,Mandatory Reporting,F01.145.209.259.300
22813683,2012-08-01T00:00:00,Mandatory Reporting,I01.880.604.583.527
22813683,2012-08-01T00:00:00,Mandatory Reporting,I01.880.604.622.249
22813683,2012-08-01T00:00:00,Mandatory Reporting,N03.706.535.615
22813683,2012-08-01T00:00:00,Mandatory Reporting,N03.706.657.249
22813683,2012-08-01T00:00:00,Middle Aged,M01.060.116.630
22813683,2012-08-01T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
22813683,2012-08-01T00:00:00,Patient Care,E02.760
22813683,2012-08-01T00:00:00,Patient Care,N02.421.585
22813683,2012-08-01T00:00:00,Rape,I01.198.240.748.640
22813683,2012-08-01T00:00:00,United States,Z01.107.567.875
22813683,2012-08-01T00:00:00,Young Adult,M01.060.116.815
22815080,2012-08-01T00:00:00,Age of Onset,N05.715.350.075.100
22815080,2012-08-01T00:00:00,Age of Onset,N06.850.490.250.100
22815080,2012-08-01T00:00:00,Aged,M01.060.116.100
22815080,2012-08-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
22815080,2012-08-01T00:00:00,Alzheimer Disease,C10.574.945.249
22815080,2012-08-01T00:00:00,Alzheimer Disease,F03.087.400.100
22815080,2012-08-01T00:00:00,Apolipoproteins E,D10.532.091.500
22815080,2012-08-01T00:00:00,Apolipoproteins E,D12.776.070.400.500
22815080,2012-08-01T00:00:00,Apolipoproteins E,D12.776.521.120.500
22815080,2012-08-01T00:00:00,Cognition Disorders,F03.087.250
22815080,2012-08-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
22815080,2012-08-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
22815080,2012-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22815080,2012-08-01T00:00:00,Middle Aged,M01.060.116.630
22840881,2012-08-01T00:00:00,Data Collection,E05.318.308
22840881,2012-08-01T00:00:00,Data Collection,L01.280
22840881,2012-08-01T00:00:00,Data Collection,N05.715.360.300
22840881,2012-08-01T00:00:00,Data Collection,N06.850.520.308
22840881,2012-08-01T00:00:00,"Data Interpretation, Statistical",E05.245.380
22840881,2012-08-01T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
22840881,2012-08-01T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
22840881,2012-08-01T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
22840881,2012-08-01T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
22840881,2012-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22840881,2012-08-01T00:00:00,"Models, Statistical",E05.318.740.500
22840881,2012-08-01T00:00:00,"Models, Statistical",E05.599.835
22840881,2012-08-01T00:00:00,"Models, Statistical",N05.715.360.750.530
22840881,2012-08-01T00:00:00,"Models, Statistical",N06.850.520.830.500
22840881,2012-08-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
22840881,2012-08-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
22840881,2012-08-01T00:00:00,Research Design,E05.581.500
22840881,2012-08-01T00:00:00,Research Design,H01.770.644.728
22846942,2012-08-01T00:00:00,Adolescent,M01.060.057
22846942,2012-08-01T00:00:00,Child,M01.060.406
22846942,2012-08-01T00:00:00,"Child, Preschool",M01.060.406.448
22846942,2012-08-01T00:00:00,Cost Savings,N03.219.151.160.200
22846942,2012-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22846942,2012-08-01T00:00:00,Length of Stay,E02.760.400.480
22846942,2012-08-01T00:00:00,Length of Stay,N02.421.585.400.480
22846942,2012-08-01T00:00:00,Multiple Trauma,C21.866.640
22846942,2012-08-01T00:00:00,Radiation Injuries,C21.866.733
22846942,2012-08-01T00:00:00,Radiation Injuries,N06.850.810.300.360
22846942,2012-08-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
22846942,2012-08-01T00:00:00,Risk Assessment,N04.452.871.715
22846942,2012-08-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
22846942,2012-08-01T00:00:00,Risk Assessment,N06.850.505.715
22846942,2012-08-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
22846942,2012-08-01T00:00:00,Thoracic Injuries,C21.866.891
22846942,2012-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
22846942,2012-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
22846942,2012-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
22846942,2012-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
22846942,2012-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
22846942,2012-08-01T00:00:00,Trauma Centers,N02.278.354.422.336.500
22846942,2012-08-01T00:00:00,Trauma Centers,N02.421.297.195.480
22846942,2012-08-01T00:00:00,Trauma Centers,N04.452.442.422.336.400
22846942,2012-08-01T00:00:00,Unnecessary Procedures,N02.421.380.900
22846942,2012-08-01T00:00:00,Unnecessary Procedures,N05.300.150.395.900
22846942,2012-08-01T00:00:00,"Wounds, Nonpenetrating",C21.866.974
22846948,2012-08-01T00:00:00,Adult,M01.060.116
22846948,2012-08-01T00:00:00,Aged,M01.060.116.100
22846948,2012-08-01T00:00:00,Biological Markers,D23.101
22846948,2012-08-01T00:00:00,Calcitonin,D06.472.699.150
22846948,2012-08-01T00:00:00,Calcitonin,D12.644.400.095
22846948,2012-08-01T00:00:00,Calcitonin,D12.644.548.150
22846948,2012-08-01T00:00:00,Calcitonin,D12.776.641.650.095
22846948,2012-08-01T00:00:00,Critical Care,E02.760.190
22846948,2012-08-01T00:00:00,Critical Care,N02.421.585.190
22846948,2012-08-01T00:00:00,Critical Illness,C23.550.291.625
22846948,2012-08-01T00:00:00,"Diagnosis, Differential",E01.171
22846948,2012-08-01T00:00:00,Disease Progression,C23.550.291.656
22846948,2012-08-01T00:00:00,Hospital Mortality,E05.318.308.985.550.400
22846948,2012-08-01T00:00:00,Hospital Mortality,L01.280.975.550.400
22846948,2012-08-01T00:00:00,Hospital Mortality,N01.224.935.698.400
22846948,2012-08-01T00:00:00,Hospital Mortality,N06.850.505.400.975.550.400
22846948,2012-08-01T00:00:00,Hospital Mortality,N06.850.520.308.985.550.400
22846948,2012-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22846948,2012-08-01T00:00:00,Middle Aged,M01.060.116.630
22846948,2012-08-01T00:00:00,Protein Precursors,D12.776.811
22846948,2012-08-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
22846948,2012-08-01T00:00:00,Risk Assessment,N04.452.871.715
22846948,2012-08-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
22846948,2012-08-01T00:00:00,Risk Assessment,N06.850.505.715
22846948,2012-08-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
22846948,2012-08-01T00:00:00,Sepsis,C01.539.757
22846948,2012-08-01T00:00:00,Sepsis,C23.550.470.790.500
22846948,2012-08-01T00:00:00,Trauma Centers,N02.278.354.422.336.500
22846948,2012-08-01T00:00:00,Trauma Centers,N02.421.297.195.480
22846948,2012-08-01T00:00:00,Trauma Centers,N04.452.442.422.336.400
22846948,2012-08-01T00:00:00,"Wounds, Nonpenetrating",C21.866.974
22856498,2012-08-01T00:00:00,Adult,M01.060.116
22856498,2012-08-01T00:00:00,"Analgesics, Opioid",D27.505.696.663.850.014.520
22856498,2012-08-01T00:00:00,"Analgesics, Opioid",D27.505.954.427.040.325
22856498,2012-08-01T00:00:00,"Analgesics, Opioid",D27.505.954.427.210.049
22856498,2012-08-01T00:00:00,Drainage,E02.309
22856498,2012-08-01T00:00:00,Drainage,E04.237
22856498,2012-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22856498,2012-08-01T00:00:00,Insulin,D06.472.699.587.740.625
22856498,2012-08-01T00:00:00,Insulin,D12.644.548.586.740.625
22856498,2012-08-01T00:00:00,Islets of Langerhans Transplantation,E04.270.550
22856498,2012-08-01T00:00:00,Islets of Langerhans Transplantation,E04.936.225.375
22856498,2012-08-01T00:00:00,Pancreatectomy,E04.210.752
22856498,2012-08-01T00:00:00,"Pancreatitis, Chronic",C06.689.750.830
22856498,2012-08-01T00:00:00,Quality of Life,I01.800
22856498,2012-08-01T00:00:00,Quality of Life,K01.752.400.750
22856498,2012-08-01T00:00:00,Questionnaires,E05.318.308.750
22856498,2012-08-01T00:00:00,Questionnaires,L01.280.800
22856498,2012-08-01T00:00:00,Questionnaires,N05.715.360.300.695
22856498,2012-08-01T00:00:00,Questionnaires,N06.850.520.308.750
22856498,2012-08-01T00:00:00,Reoperation,E04.690
22856498,2012-08-01T00:00:00,Treatment Outcome,E01.789.800
22856498,2012-08-01T00:00:00,Treatment Outcome,N04.761.559.590.800
22856498,2012-08-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22863996,2012-08-01T00:00:00,Advanced Cardiac Life Support,E02.365.647.110.500
22863996,2012-08-01T00:00:00,Certification,N03.706.110.120
22863996,2012-08-01T00:00:00,Certification,N05.700.200.190
22863996,2012-08-01T00:00:00,Checklist,N05.715.360.300.179
22863996,2012-08-01T00:00:00,Clinical Competence,I02.399.630.210
22863996,2012-08-01T00:00:00,Clinical Competence,N04.761.210
22863996,2012-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22863996,2012-08-01T00:00:00,Patient Simulation,I02.903.525
22863996,2012-08-01T00:00:00,Software,L01.224.900
22863996,2012-08-01T00:00:00,Task Performance and Analysis,F02.784.412.846
22863996,2012-08-01T00:00:00,Task Performance and Analysis,F02.784.692.746
22863996,2012-08-01T00:00:00,Task Performance and Analysis,F02.808.600
22863996,2012-08-01T00:00:00,Video Recording,L01.240.960
22864006,2012-08-01T00:00:00,Hospital Costs,N03.219.151.400.687
22864006,2012-08-01T00:00:00,Hospital Costs,N03.219.262.500
22864006,2012-08-01T00:00:00,Hospital Costs,N05.300.375.500
22864006,2012-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22864006,2012-08-01T00:00:00,Infant Formula,J02.200.700.249
22864006,2012-08-01T00:00:00,Infant Formula,J02.200.712.249
22864006,2012-08-01T00:00:00,Infant Formula,J02.500.350.525.332
22864006,2012-08-01T00:00:00,Infant Formula,J02.500.525.350.500
22864006,2012-08-01T00:00:00,Infant Formula,J02.500.525.500.500
22864006,2012-08-01T00:00:00,"Infant, Newborn",M01.060.703.520
22864006,2012-08-01T00:00:00,"Infant, Premature",M01.060.703.520.520
22864006,2012-08-01T00:00:00,"Infant, Very Low Birth Weight",M01.060.703.520.460.600
22864006,2012-08-01T00:00:00,"Intensive Care Units, Neonatal",N02.278.388.493.390.380
22864006,2012-08-01T00:00:00,Length of Stay,E02.760.400.480
22864006,2012-08-01T00:00:00,Length of Stay,N02.421.585.400.480
22864006,2012-08-01T00:00:00,"Milk, Human",A12.200.467
22864006,2012-08-01T00:00:00,"Milk, Human",J02.200.700.500
22864006,2012-08-01T00:00:00,"Milk, Human",J02.500.350.525.500
22871747,2012-08-01T00:00:00,Bronchoscopy,E01.370.386.105
22871747,2012-08-01T00:00:00,Bronchoscopy,E01.370.388.250.100
22871747,2012-08-01T00:00:00,Bronchoscopy,E04.800.250.100
22871747,2012-08-01T00:00:00,Bronchoscopy,E04.928.600.080
22871747,2012-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22871747,2012-08-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
22871747,2012-08-01T00:00:00,Lung Neoplasms,C08.381.540
22871747,2012-08-01T00:00:00,Lung Neoplasms,C08.785.520
22871747,2012-08-01T00:00:00,"Surgery, Computer-Assisted",E02.950.875
22871747,2012-08-01T00:00:00,"Surgery, Computer-Assisted",E04.749
22871747,2012-08-01T00:00:00,"Surgery, Computer-Assisted",L01.700.508.100.710.800
22871747,2012-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
22871747,2012-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
22871747,2012-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
22871747,2012-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
22871747,2012-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
22911067,2012-08-01T00:00:00,General Surgery,H02.403.810.300
22911067,2012-08-01T00:00:00,Hepatic Veins,A07.231.908.380
22911067,2012-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22911067,2012-08-01T00:00:00,Liver,A03.620
22911067,2012-08-01T00:00:00,Portal Vein,A07.231.908.670.567
22973746,2012-08-01T00:00:00,General Surgery,H02.403.810.300
22973746,2012-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22973746,2012-08-01T00:00:00,Leadership,F01.752.609
22973746,2012-08-01T00:00:00,United States,Z01.107.567.875
23270103,2012-08-01T00:00:00,Adolescent,M01.060.057
23270103,2012-08-01T00:00:00,Adult,M01.060.116
23270103,2012-08-01T00:00:00,"Education, Medical, Continuing",I02.358.212.350
23270103,2012-08-01T00:00:00,"Education, Medical, Continuing",I02.358.399.250
23270103,2012-08-01T00:00:00,Evidence-Based Medicine,H02.249.750
23270103,2012-08-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
23270103,2012-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23270103,2012-08-01T00:00:00,Middle Aged,M01.060.116.630
23270103,2012-08-01T00:00:00,Nurse Practitioners,M01.526.485.650.640
23270103,2012-08-01T00:00:00,Nurse Practitioners,N02.360.650.640
23270103,2012-08-01T00:00:00,Psychiatry,F04.096.544
23270103,2012-08-01T00:00:00,Psychiatry,H02.403.690
23270103,2012-08-01T00:00:00,Schizophrenia,F03.700.750
23270103,2012-08-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23270103,2012-08-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23270103,2012-08-01T00:00:00,United States,Z01.107.567.875
23270103,2012-08-01T00:00:00,Young Adult,M01.060.116.815
22857850,2012-08-02T00:00:00,Aged,M01.060.116.100
22857850,2012-08-02T00:00:00,Carotid Arteries,A07.231.114.186
22857850,2012-08-02T00:00:00,Carotid Stenosis,C10.228.140.300.200.360
22857850,2012-08-02T00:00:00,Carotid Stenosis,C14.907.137.230
22857850,2012-08-02T00:00:00,Carotid Stenosis,C14.907.253.123.360
22857850,2012-08-02T00:00:00,"Endarterectomy, Carotid",E04.100.814.456.250
22857850,2012-08-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22857850,2012-08-02T00:00:00,Magnetic Resonance Angiography,E01.370.350.500.500
22857850,2012-08-02T00:00:00,Magnetic Resonance Angiography,E01.370.350.825.500.500
22857850,2012-08-02T00:00:00,Magnetic Resonance Angiography,E01.370.370.050.500
22857850,2012-08-02T00:00:00,Middle Aged,M01.060.116.630
22857850,2012-08-02T00:00:00,Stents,E07.695.750
22857850,2012-08-02T00:00:00,Stroke,C10.228.140.300.775
22857850,2012-08-02T00:00:00,Stroke,C14.907.253.855
22857850,2012-08-02T00:00:00,Time Factors,G01.910.857
22857850,2012-08-02T00:00:00,"Tomography Scanners, X-Ray Computed",E07.913
22858728,2012-08-02T00:00:00,Atrial Fibrillation,C14.280.067.198
22858728,2012-08-02T00:00:00,Atrial Fibrillation,C23.550.073.198
22858728,2012-08-02T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
22858728,2012-08-02T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
22858728,2012-08-02T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
22858728,2012-08-02T00:00:00,Heart Valves,A07.541.510
22858728,2012-08-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22858728,2012-08-02T00:00:00,Stroke,C10.228.140.300.775
22858728,2012-08-02T00:00:00,Stroke,C14.907.253.855
22858728,2012-08-02T00:00:00,United States,Z01.107.567.875
22667998,2012-08-03T00:00:00,Animals,B01.050
22667998,2012-08-03T00:00:00,Cystine,D01.248.497.158.874.390.369
22667998,2012-08-03T00:00:00,Cystine,D01.875.350.850.150.369
22667998,2012-08-03T00:00:00,Cystine,D02.886.030.230.369
22667998,2012-08-03T00:00:00,Cystine,D02.886.520.150.087
22667998,2012-08-03T00:00:00,Cystine,D12.125.095.369
22667998,2012-08-03T00:00:00,Cystine,D12.125.119.369
22667998,2012-08-03T00:00:00,Cystine,D12.125.166.230.369
22667998,2012-08-03T00:00:00,Glutamic Acid,D12.125.067.750
22667998,2012-08-03T00:00:00,Glutamic Acid,D12.125.119.450
22667998,2012-08-03T00:00:00,Glutamic Acid,D12.125.427.300
22667998,2012-08-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22667998,2012-08-03T00:00:00,Phylogeny,G05.697
22667998,2012-08-03T00:00:00,Phylogeny,G16.100.275.605
22667998,2012-08-03T00:00:00,Phylogeny,L01.100.697
22863149,2012-08-03T00:00:00,Adolescent,M01.060.057
22863149,2012-08-03T00:00:00,Bladder Exstrophy,C12.706.132
22863149,2012-08-03T00:00:00,Bladder Exstrophy,C12.777.829.132
22863149,2012-08-03T00:00:00,Bladder Exstrophy,C13.351.875.132
22863149,2012-08-03T00:00:00,Bladder Exstrophy,C13.351.968.829.132
22863149,2012-08-03T00:00:00,Bladder Exstrophy,C16.131.939.132
22863149,2012-08-03T00:00:00,Child,M01.060.406
22863149,2012-08-03T00:00:00,"Child, Preschool",M01.060.406.448
22863149,2012-08-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22863149,2012-08-03T00:00:00,Reconstructive Surgical Procedures,E04.680
22863149,2012-08-03T00:00:00,Urinary Bladder,A05.810.890
22864647,2012-08-03T00:00:00,Child Development,F01.525.200
22864647,2012-08-03T00:00:00,Child Development,G07.700.320.374.750
22864647,2012-08-03T00:00:00,Developmental Disabilities,F03.550.362
22864647,2012-08-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22864647,2012-08-03T00:00:00,Hypoplastic Left Heart Syndrome,C14.240.400.625
22864647,2012-08-03T00:00:00,Hypoplastic Left Heart Syndrome,C14.280.400.625
22864647,2012-08-03T00:00:00,Hypoplastic Left Heart Syndrome,C16.131.240.400.625
22864647,2012-08-03T00:00:00,Incidence,E05.318.308.985.525.375
22864647,2012-08-03T00:00:00,Incidence,L01.280.975.525.375
22864647,2012-08-03T00:00:00,Incidence,N01.224.935.597.500
22864647,2012-08-03T00:00:00,Incidence,N06.850.505.400.975.525.375
22864647,2012-08-03T00:00:00,Incidence,N06.850.520.308.985.525.375
22864647,2012-08-03T00:00:00,Infant,M01.060.703
22864647,2012-08-03T00:00:00,"Models, Neurological",E05.599.395.642
22864647,2012-08-03T00:00:00,Neuropsychological Tests,F04.711.513
22864647,2012-08-03T00:00:00,Postoperative Complications,C23.550.767
22864647,2012-08-03T00:00:00,Risk Assessment,E05.318.740.600.800.715
22864647,2012-08-03T00:00:00,Risk Assessment,N04.452.871.715
22864647,2012-08-03T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
22864647,2012-08-03T00:00:00,Risk Assessment,N06.850.505.715
22864647,2012-08-03T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
22864647,2012-08-03T00:00:00,Risk Factors,E05.318.740.600.800.725
22864647,2012-08-03T00:00:00,Risk Factors,N05.715.350.200.700
22864647,2012-08-03T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22864647,2012-08-03T00:00:00,Risk Factors,N06.850.490.625.750
22864647,2012-08-03T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22864647,2012-08-03T00:00:00,United States,Z01.107.567.875
23031147,2012-08-03T00:00:00,Age Factors,N05.715.350.075
23031147,2012-08-03T00:00:00,Age Factors,N06.850.490.250
23031147,2012-08-03T00:00:00,Aged,M01.060.116.100
23031147,2012-08-03T00:00:00,Antihypertensive Agents,D27.505.954.411.162
23031147,2012-08-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23031147,2012-08-03T00:00:00,Hypertension,C14.907.489
23031147,2012-08-03T00:00:00,Medication Adherence,F01.145.488.500.500
23031147,2012-08-03T00:00:00,Medication Adherence,N05.300.150.600.600.500
23031147,2012-08-03T00:00:00,Risk Factors,E05.318.740.600.800.725
23031147,2012-08-03T00:00:00,Risk Factors,N05.715.350.200.700
23031147,2012-08-03T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23031147,2012-08-03T00:00:00,Risk Factors,N06.850.490.625.750
23031147,2012-08-03T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23031147,2012-08-03T00:00:00,United States,Z01.107.567.875
22869836,2012-08-06T00:00:00,Adolescent,M01.060.057
22869836,2012-08-06T00:00:00,Child,M01.060.406
22869836,2012-08-06T00:00:00,"Child, Preschool",M01.060.406.448
22869836,2012-08-06T00:00:00,Critical Illness,C23.550.291.625
22869836,2012-08-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22869836,2012-08-06T00:00:00,Infant,M01.060.703
22869836,2012-08-06T00:00:00,"Intensive Care Units, Pediatric",N02.278.388.493.390
22869836,2012-08-06T00:00:00,Vitamin D,D04.808.812.768
22869836,2012-08-06T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
22869836,2012-08-06T00:00:00,Young Adult,M01.060.116.815
22869892,2012-08-06T00:00:00,Animals,B01.050
22869892,2012-08-06T00:00:00,Apoptosis,G04.299.139.160
22869892,2012-08-06T00:00:00,Apoptosis Inducing Factor,D08.811.682.608.047
22869892,2012-08-06T00:00:00,Apoptosis Inducing Factor,D12.644.360.075.311
22869892,2012-08-06T00:00:00,Apoptosis Inducing Factor,D12.776.331.161
22869892,2012-08-06T00:00:00,Apoptosis Inducing Factor,D12.776.476.075.311
22869892,2012-08-06T00:00:00,Cell Death,G04.299.139
22869892,2012-08-06T00:00:00,Cell Lineage,G04.172
22869892,2012-08-06T00:00:00,Cell Lineage,G07.700.320.500.325.180.500
22869892,2012-08-06T00:00:00,Cell Lineage,G08.686.155
22869892,2012-08-06T00:00:00,Cell Lineage,G08.686.785.760.170.104.249
22869892,2012-08-06T00:00:00,DNA,D13.444.308
22869892,2012-08-06T00:00:00,Reactive Oxygen Species,D01.339.431
22869892,2012-08-06T00:00:00,Reactive Oxygen Species,D01.650.775
22869892,2012-08-06T00:00:00,"Recombination, Genetic",G05.355.760
22869892,2012-08-06T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
22869892,2012-08-06T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
22869892,2012-08-06T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
22869892,2012-08-06T00:00:00,Thymus Gland,A10.549.750
22869892,2012-08-06T00:00:00,Thymus Gland,A15.382.520.604.750
22882750,2012-08-06T00:00:00,Adolescent,M01.060.057
22882750,2012-08-06T00:00:00,Adult,M01.060.116
22882750,2012-08-06T00:00:00,Aged,M01.060.116.100
22882750,2012-08-06T00:00:00,Graft Rejection,G12.425.901.545.328
22882750,2012-08-06T00:00:00,Graft Survival,G12.425.901.545.340
22882750,2012-08-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22882750,2012-08-06T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
22882750,2012-08-06T00:00:00,Kidney,A05.810.453
22882750,2012-08-06T00:00:00,Liver Transplantation,E04.210.650
22882750,2012-08-06T00:00:00,Liver Transplantation,E04.936.450.490
22882750,2012-08-06T00:00:00,Liver Transplantation,E04.936.580.490
22882750,2012-08-06T00:00:00,Middle Aged,M01.060.116.630
22882750,2012-08-06T00:00:00,Risk Assessment,E05.318.740.600.800.715
22882750,2012-08-06T00:00:00,Risk Assessment,N04.452.871.715
22882750,2012-08-06T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
22882750,2012-08-06T00:00:00,Risk Assessment,N06.850.505.715
22882750,2012-08-06T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
22882750,2012-08-06T00:00:00,Time Factors,G01.910.857
22882750,2012-08-06T00:00:00,Treatment Outcome,E01.789.800
22882750,2012-08-06T00:00:00,Treatment Outcome,N04.761.559.590.800
22882750,2012-08-06T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22882750,2012-08-06T00:00:00,Young Adult,M01.060.116.815
22821409,2012-08-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22821409,2012-08-07T00:00:00,Neoplasms,C04
22821409,2012-08-07T00:00:00,Smoking,F01.145.466.753
22872663,2012-08-07T00:00:00,Breast Neoplasms,C04.588.180
22872663,2012-08-07T00:00:00,Breast Neoplasms,C17.800.090.500
22872663,2012-08-07T00:00:00,"Carcinoma, Ductal, Breast",C04.557.470.200.025.232.500
22872663,2012-08-07T00:00:00,"Carcinoma, Ductal, Breast",C04.557.470.615.132.500
22872663,2012-08-07T00:00:00,"Carcinoma, Ductal, Breast",C04.588.180.390
22872663,2012-08-07T00:00:00,"Carcinoma, Ductal, Breast",C17.800.090.500.390
22872663,2012-08-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22872663,2012-08-07T00:00:00,Middle Aged,M01.060.116.630
22872663,2012-08-07T00:00:00,Pleural Neoplasms,C04.588.894.797.640
22872663,2012-08-07T00:00:00,Pleural Neoplasms,C08.528.694
22872663,2012-08-07T00:00:00,Pleural Neoplasms,C08.785.640
22872663,2012-08-07T00:00:00,Positron-Emission Tomography,E01.370.350.350.800.700
22872663,2012-08-07T00:00:00,Positron-Emission Tomography,E01.370.350.600.350.800.399
22872663,2012-08-07T00:00:00,Positron-Emission Tomography,E01.370.350.710.800.399
22872663,2012-08-07T00:00:00,Positron-Emission Tomography,E01.370.350.825.800.399
22872663,2012-08-07T00:00:00,Positron-Emission Tomography,E01.370.384.730.800.399
22872663,2012-08-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
22872663,2012-08-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
22872663,2012-08-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
22872663,2012-08-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
22872663,2012-08-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
22872750,2012-08-07T00:00:00,Accidental Falls,N06.850.135.122
22872750,2012-08-07T00:00:00,Aged,M01.060.116.100
22872750,2012-08-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22872750,2012-08-07T00:00:00,Outpatients,M01.643.630
22872750,2012-08-07T00:00:00,Polypharmacy,E02.319.698
22967858,2012-08-07T00:00:00,Animals,B01.050
22967858,2012-08-07T00:00:00,"Disease Models, Animal",C22.232
22967858,2012-08-07T00:00:00,"Disease Models, Animal",E05.598.500
22967858,2012-08-07T00:00:00,"Disease Models, Animal",E05.599.395.080
22967858,2012-08-07T00:00:00,"Gait Disorders, Neurologic",C10.597.404
22967858,2012-08-07T00:00:00,"Gait Disorders, Neurologic",C23.888.592.413
22967858,2012-08-07T00:00:00,Parkinsonian Disorders,C10.228.140.079.862
22967858,2012-08-07T00:00:00,Parkinsonian Disorders,C10.228.662.600
22971541,2012-08-07T00:00:00,Animals,B01.050
22971541,2012-08-07T00:00:00,Cocaine,D02.145.074.722.388
22971541,2012-08-07T00:00:00,Cocaine,D03.132.889.354
22971541,2012-08-07T00:00:00,Cocaine,D03.605.869.388
22971541,2012-08-07T00:00:00,Cocaine,D04.075.080.875.099.722.388
22971541,2012-08-07T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22971541,2012-08-07T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
22971541,2012-08-07T00:00:00,"Receptors, G-Protein-Coupled",D12.776.543.750.100
22971541,2012-08-07T00:00:00,"Receptors, Neuropeptide",D12.776.543.750.720.600
22971541,2012-08-07T00:00:00,"Receptors, Neuropeptide",D12.776.543.750.750.555
22971541,2012-08-07T00:00:00,Self Administration,E02.319.890
22971541,2012-08-07T00:00:00,Self Administration,E02.900.890
22872414,2012-08-08T00:00:00,Adult,M01.060.116
22872414,2012-08-08T00:00:00,Cues,F02.463.425.234
22872414,2012-08-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22872414,2012-08-08T00:00:00,Noise,G01.595.907.567
22872414,2012-08-08T00:00:00,Noise,G16.500.275.600
22872414,2012-08-08T00:00:00,Noise,N06.230.400
22872414,2012-08-08T00:00:00,Noise,N06.850.460.610
22872414,2012-08-08T00:00:00,Speech Perception,F02.463.593.071.875
22872414,2012-08-08T00:00:00,Young Adult,M01.060.116.815
22875657,2012-08-08T00:00:00,Adult,M01.060.116
22875657,2012-08-08T00:00:00,Biological Markers,D23.101
22875657,2012-08-08T00:00:00,Case-Control Studies,E05.318.760.500.500
22875657,2012-08-08T00:00:00,Case-Control Studies,N05.715.360.775.175.200
22875657,2012-08-08T00:00:00,Case-Control Studies,N06.850.520.450.500.500
22875657,2012-08-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22875657,2012-08-08T00:00:00,Pre-Eclampsia,C13.703.395.249
22875657,2012-08-08T00:00:00,Pregnancy,G08.686.785.760.769
22875657,2012-08-08T00:00:00,Vitamin D,D04.808.812.768
22875657,2012-08-08T00:00:00,Young Adult,M01.060.116.815
22875799,2012-08-08T00:00:00,Coronary Angiography,E01.370.350.700.060.200
22875799,2012-08-08T00:00:00,Coronary Angiography,E01.370.370.050.200
22875799,2012-08-08T00:00:00,Coronary Angiography,E01.370.370.380.200
22875799,2012-08-08T00:00:00,Coronary Artery Disease,C14.280.647.250.260
22875799,2012-08-08T00:00:00,Coronary Artery Disease,C14.907.137.126.339
22875799,2012-08-08T00:00:00,Coronary Artery Disease,C14.907.585.250.260
22875799,2012-08-08T00:00:00,Decision Making,F02.463.785.373
22875799,2012-08-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22875799,2012-08-08T00:00:00,Middle Aged,M01.060.116.630
22875799,2012-08-08T00:00:00,Patient Selection,E05.581.500.653
22875799,2012-08-08T00:00:00,Patient Selection,N04.590.731
22875799,2012-08-08T00:00:00,Preoperative Care,E02.760.795
22875799,2012-08-08T00:00:00,Preoperative Care,E04.641
22875799,2012-08-08T00:00:00,Preoperative Care,N02.421.585.795
22875799,2012-08-08T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
22875799,2012-08-08T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
22875799,2012-08-08T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
22875799,2012-08-08T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
22875799,2012-08-08T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
22878591,2012-08-08T00:00:00,Age Factors,N05.715.350.075
22878591,2012-08-08T00:00:00,Age Factors,N06.850.490.250
22878591,2012-08-08T00:00:00,Alcohol Drinking,F01.145.317.269
22878591,2012-08-08T00:00:00,Biological Markers,D23.101
22878591,2012-08-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22878591,2012-08-08T00:00:00,Pregnancy,G08.686.785.760.769
22878591,2012-08-08T00:00:00,Questionnaires,E05.318.308.750
22878591,2012-08-08T00:00:00,Questionnaires,L01.280.800
22878591,2012-08-08T00:00:00,Questionnaires,N05.715.360.300.695
22878591,2012-08-08T00:00:00,Questionnaires,N06.850.520.308.750
22878591,2012-08-08T00:00:00,Transferrin,D12.776.124.050.800
22878591,2012-08-08T00:00:00,Transferrin,D12.776.124.790.223.839
22878591,2012-08-08T00:00:00,Transferrin,D12.776.157.427.500
22878591,2012-08-08T00:00:00,Transferrin,D12.776.377.715.182.839
22878591,2012-08-08T00:00:00,Transferrin,D12.776.556.579.500
22878591,2012-08-08T00:00:00,Young Adult,M01.060.116.815
22884177,2012-08-08T00:00:00,"Abdomen, Acute",C23.888.646.100.200
22884177,2012-08-08T00:00:00,"Abdomen, Acute",C23.888.821.030.249
22884177,2012-08-08T00:00:00,Hereditary Angioedema Type III,C14.907.079.500.500
22884177,2012-08-08T00:00:00,Hereditary Angioedema Type III,C17.800.862.945.066.500.500
22884177,2012-08-08T00:00:00,Hereditary Angioedema Type III,C20.543.480.904.066.500.500
22884177,2012-08-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22884177,2012-08-08T00:00:00,Middle Aged,M01.060.116.630
22884177,2012-08-08T00:00:00,"Remission, Spontaneous",C23.550.291.656.700
22884177,2012-08-08T00:00:00,"Remission, Spontaneous",G16.100.870
22884177,2012-08-08T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
22884177,2012-08-08T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
22884177,2012-08-08T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
22884177,2012-08-08T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
22884177,2012-08-08T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
22902769,2012-08-08T00:00:00,Adolescent,M01.060.057
22902769,2012-08-08T00:00:00,Adult,M01.060.116
22902769,2012-08-08T00:00:00,Brain Mapping,E01.370.350.086
22902769,2012-08-08T00:00:00,Brain Mapping,E01.370.376.149
22902769,2012-08-08T00:00:00,Brain Mapping,E05.132
22902769,2012-08-08T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
22902769,2012-08-08T00:00:00,Hemodynamics,G09.330.190.400
22902769,2012-08-08T00:00:00,Hemodynamics,G09.330.380
22902769,2012-08-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22902769,2012-08-08T00:00:00,Impulsive Behavior,F01.145.527
22902769,2012-08-08T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
22902769,2012-08-08T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
22902769,2012-08-08T00:00:00,Motor Cortex,A08.186.211.730.885.287.500.270.548
22902769,2012-08-08T00:00:00,Neural Inhibition,G07.265.337.615
22902769,2012-08-08T00:00:00,Neural Inhibition,G07.700.240.615
22902769,2012-08-08T00:00:00,Neural Inhibition,G11.561.600.625
22902769,2012-08-08T00:00:00,Parietal Lobe,A08.186.211.730.885.287.500.670
22902769,2012-08-08T00:00:00,Personality,F01.752
22902769,2012-08-08T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
22902769,2012-08-08T00:00:00,Risk-Taking,F01.145.722
22902769,2012-08-08T00:00:00,Young Adult,M01.060.116.815
22876936,2012-08-09T00:00:00,Adolescent,M01.060.057
22876936,2012-08-09T00:00:00,Adult,M01.060.116
22876936,2012-08-09T00:00:00,Aged,M01.060.116.100
22876936,2012-08-09T00:00:00,Brain Injuries,C10.228.140.199
22876936,2012-08-09T00:00:00,Brain Injuries,C10.900.300.087
22876936,2012-08-09T00:00:00,Brain Injuries,C21.866.260.118
22876936,2012-08-09T00:00:00,Brain Injuries,C21.866.915.300.200
22876936,2012-08-09T00:00:00,Disability Evaluation,E01.370.400
22876936,2012-08-09T00:00:00,Executive Function,F02.463.217
22876936,2012-08-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22876936,2012-08-09T00:00:00,Middle Aged,M01.060.116.630
22876936,2012-08-09T00:00:00,Neuropsychological Tests,F04.711.513
22876936,2012-08-09T00:00:00,Personality Inventory,F04.711.647.513
22876936,2012-08-09T00:00:00,Psychometrics,F04.711.780
22876936,2012-08-09T00:00:00,Questionnaires,E05.318.308.750
22876936,2012-08-09T00:00:00,Questionnaires,L01.280.800
22876936,2012-08-09T00:00:00,Questionnaires,N05.715.360.300.695
22876936,2012-08-09T00:00:00,Questionnaires,N06.850.520.308.750
22876936,2012-08-09T00:00:00,United States,Z01.107.567.875
22876936,2012-08-09T00:00:00,Young Adult,M01.060.116.815
22883217,2012-08-09T00:00:00,Adolescent,M01.060.057
22883217,2012-08-09T00:00:00,Adult,M01.060.116
22883217,2012-08-09T00:00:00,Aged,M01.060.116.100
22883217,2012-08-09T00:00:00,Biological Markers,D23.101
22883217,2012-08-09T00:00:00,Case-Control Studies,E05.318.760.500.500
22883217,2012-08-09T00:00:00,Case-Control Studies,N05.715.360.775.175.200
22883217,2012-08-09T00:00:00,Case-Control Studies,N06.850.520.450.500.500
22883217,2012-08-09T00:00:00,Endotoxins,D23.946.123.329
22883217,2012-08-09T00:00:00,Hepatic Encephalopathy,C06.552.308.500.356
22883217,2012-08-09T00:00:00,Hepatic Encephalopathy,C10.228.140.163.360
22883217,2012-08-09T00:00:00,Hepatic Encephalopathy,C18.452.132.360
22883217,2012-08-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22883217,2012-08-09T00:00:00,Interleukin-6,D12.644.276.374.465.506
22883217,2012-08-09T00:00:00,Interleukin-6,D12.776.467.374.465.506
22883217,2012-08-09T00:00:00,Interleukin-6,D23.529.374.465.506
22883217,2012-08-09T00:00:00,Liver Cirrhosis,C06.552.630
22883217,2012-08-09T00:00:00,Middle Aged,M01.060.116.630
22883217,2012-08-09T00:00:00,Psychological Tests,F04.711
22883217,2012-08-09T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
22883217,2012-08-09T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
22883217,2012-08-09T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
22883217,2012-08-09T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
22883217,2012-08-09T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
22883217,2012-08-09T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
22883217,2012-08-09T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
22883217,2012-08-09T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
22883217,2012-08-09T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
22883217,2012-08-09T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
22883217,2012-08-09T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
22883217,2012-08-09T00:00:00,Young Adult,M01.060.116.815
22884217,2012-08-09T00:00:00,Adult,M01.060.116
22884217,2012-08-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22884217,2012-08-09T00:00:00,Life Change Events,F01.829.458.410
22884217,2012-08-09T00:00:00,Middle Aged,M01.060.116.630
22884217,2012-08-09T00:00:00,Perception,F02.463.593
22884217,2012-08-09T00:00:00,Psychiatric Status Rating Scales,F04.586
22884217,2012-08-09T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
22884217,2012-08-09T00:00:00,Veterans,M01.930
22884983,2012-08-09T00:00:00,Breast Neoplasms,C04.588.180
22884983,2012-08-09T00:00:00,Breast Neoplasms,C17.800.090.500
22884983,2012-08-09T00:00:00,Case-Control Studies,E05.318.760.500.500
22884983,2012-08-09T00:00:00,Case-Control Studies,N05.715.360.775.175.200
22884983,2012-08-09T00:00:00,Case-Control Studies,N06.850.520.450.500.500
22884983,2012-08-09T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
22884983,2012-08-09T00:00:00,Genetic Predisposition to Disease,G05.380.355
22884983,2012-08-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22884983,2012-08-09T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
22884983,2012-08-09T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
22884983,2012-08-09T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
22884983,2012-08-09T00:00:00,"Receptors, IgG",D12.776.543.750.705.871.300
22884983,2012-08-09T00:00:00,"Receptors, IgG",D23.050.301.264.035.695
22884983,2012-08-09T00:00:00,"Receptors, IgG",D23.101.100.110.695
22883684,2012-08-10T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
22883684,2012-08-10T00:00:00,Cystic Fibrosis,C06.689.202
22883684,2012-08-10T00:00:00,Cystic Fibrosis,C08.381.187
22883684,2012-08-10T00:00:00,Cystic Fibrosis,C16.320.190
22883684,2012-08-10T00:00:00,Cystic Fibrosis,C16.614.213
22883684,2012-08-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22887722,2012-08-10T00:00:00,Age Factors,N05.715.350.075
22887722,2012-08-10T00:00:00,Age Factors,N06.850.490.250
22887722,2012-08-10T00:00:00,Aged,M01.060.116.100
22887722,2012-08-10T00:00:00,Biphenyl Compounds,D02.455.426.559.389.185
22887722,2012-08-10T00:00:00,Heart Failure,C14.280.434
22887722,2012-08-10T00:00:00,Hospitalization,E02.760.400
22887722,2012-08-10T00:00:00,Hospitalization,N02.421.585.400
22887722,2012-08-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22887722,2012-08-10T00:00:00,Middle Aged,M01.060.116.630
22887722,2012-08-10T00:00:00,Risk Assessment,E05.318.740.600.800.715
22887722,2012-08-10T00:00:00,Risk Assessment,N04.452.871.715
22887722,2012-08-10T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
22887722,2012-08-10T00:00:00,Risk Assessment,N06.850.505.715
22887722,2012-08-10T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
22887722,2012-08-10T00:00:00,Risk Factors,E05.318.740.600.800.725
22887722,2012-08-10T00:00:00,Risk Factors,N05.715.350.200.700
22887722,2012-08-10T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22887722,2012-08-10T00:00:00,Risk Factors,N06.850.490.625.750
22887722,2012-08-10T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22887722,2012-08-10T00:00:00,Sex Factors,N05.715.350.675
22887722,2012-08-10T00:00:00,Sex Factors,N06.850.490.875
22887722,2012-08-10T00:00:00,Stroke Volume,E01.370.370.380.150.700
22887722,2012-08-10T00:00:00,Stroke Volume,G09.330.380.124.882
22887722,2012-08-10T00:00:00,Time Factors,G01.910.857
22887722,2012-08-10T00:00:00,Treatment Outcome,E01.789.800
22887722,2012-08-10T00:00:00,Treatment Outcome,N04.761.559.590.800
22887722,2012-08-10T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22887722,2012-08-10T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
22888145,2012-08-10T00:00:00,Animals,B01.050
22888145,2012-08-10T00:00:00,Apoptosis,G04.299.139.160
22888145,2012-08-10T00:00:00,Cell Differentiation,G04.299.151
22888145,2012-08-10T00:00:00,Cell Line,A11.251.210
22888145,2012-08-10T00:00:00,Fas Ligand Protein,D12.644.276.374.750.249
22888145,2012-08-10T00:00:00,Fas Ligand Protein,D12.644.276.972.249
22888145,2012-08-10T00:00:00,Fas Ligand Protein,D12.776.395.550.312
22888145,2012-08-10T00:00:00,Fas Ligand Protein,D12.776.467.374.750.249
22888145,2012-08-10T00:00:00,Fas Ligand Protein,D12.776.467.972.249
22888145,2012-08-10T00:00:00,Fas Ligand Protein,D12.776.543.550.312
22888145,2012-08-10T00:00:00,Fas Ligand Protein,D23.050.301.264.035.283
22888145,2012-08-10T00:00:00,Fas Ligand Protein,D23.101.100.110.282
22888145,2012-08-10T00:00:00,Fas Ligand Protein,D23.529.374.750.249
22888145,2012-08-10T00:00:00,Fas Ligand Protein,D23.529.972.249
22888145,2012-08-10T00:00:00,Gene Expression,G05.355.310
22888145,2012-08-10T00:00:00,Lymphocyte Activation,E01.450.495.482
22888145,2012-08-10T00:00:00,Lymphocyte Activation,E05.478.594.530
22888145,2012-08-10T00:00:00,Lymphocyte Activation,G12.425.747
22888145,2012-08-10T00:00:00,Lymphocyte Activation,G12.450.050.400.545
22888145,2012-08-10T00:00:00,Molecular Sequence Data,L01.453.245.667
22888145,2012-08-10T00:00:00,NF-kappa B,D12.776.260.600
22888145,2012-08-10T00:00:00,NF-kappa B,D12.776.660.600
22888145,2012-08-10T00:00:00,NF-kappa B,D12.776.930.600
22888145,2012-08-10T00:00:00,Pregnancy,G08.686.785.760.769
22888145,2012-08-10T00:00:00,Prenatal Exposure Delayed Effects,C13.703.824.500
22888145,2012-08-10T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
22888145,2012-08-10T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
22888145,2012-08-10T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
22888145,2012-08-10T00:00:00,"Receptors, Estrogen",D12.776.260.698.750.350
22888145,2012-08-10T00:00:00,"Receptors, Estrogen",D12.776.826.750.350
22888145,2012-08-10T00:00:00,"Receptors, Estrogen",D12.776.930.669.750.350
22888145,2012-08-10T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
22888145,2012-08-10T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
22888145,2012-08-10T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
22888145,2012-08-10T00:00:00,Thymus Gland,A10.549.750
22888145,2012-08-10T00:00:00,Thymus Gland,A15.382.520.604.750
22919099,2012-08-10T00:00:00,Data Collection,E05.318.308
22919099,2012-08-10T00:00:00,Data Collection,L01.280
22919099,2012-08-10T00:00:00,Data Collection,N05.715.360.300
22919099,2012-08-10T00:00:00,Data Collection,N06.850.520.308
22919099,2012-08-10T00:00:00,"Education, Pharmacy",I02.358.525
22919099,2012-08-10T00:00:00,Faculty,I02.463
22919099,2012-08-10T00:00:00,Faculty,M01.526.339
22919099,2012-08-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22919099,2012-08-10T00:00:00,Leadership,F01.752.609
22919099,2012-08-10T00:00:00,Professional Competence,I02.399.630
22919099,2012-08-10T00:00:00,Staff Development,I02.574.700
22919099,2012-08-10T00:00:00,Staff Development,N04.452.677.822
22919099,2012-08-10T00:00:00,United States,Z01.107.567.875
22884409,2012-08-11T00:00:00,Adult,M01.060.116
22884409,2012-08-11T00:00:00,Aged,M01.060.116.100
22884409,2012-08-11T00:00:00,Cardiovascular Diseases,C14
22884409,2012-08-11T00:00:00,Coronary Disease,C14.280.647.250
22884409,2012-08-11T00:00:00,Coronary Disease,C14.907.585.250
22884409,2012-08-11T00:00:00,Folic Acid,D03.438.733.631.400
22884409,2012-08-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22884409,2012-08-11T00:00:00,Middle Aged,M01.060.116.630
22884409,2012-08-11T00:00:00,Myocardial Infarction,C14.280.647.500
22884409,2012-08-11T00:00:00,Myocardial Infarction,C14.907.585.500
22884409,2012-08-11T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
22884409,2012-08-11T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
22884409,2012-08-11T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
22884409,2012-08-11T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
22884409,2012-08-11T00:00:00,Risk Assessment,E05.318.740.600.800.715
22884409,2012-08-11T00:00:00,Risk Assessment,N04.452.871.715
22884409,2012-08-11T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
22884409,2012-08-11T00:00:00,Risk Assessment,N06.850.505.715
22884409,2012-08-11T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
22884409,2012-08-11T00:00:00,Risk Factors,E05.318.740.600.800.725
22884409,2012-08-11T00:00:00,Risk Factors,N05.715.350.200.700
22884409,2012-08-11T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22884409,2012-08-11T00:00:00,Risk Factors,N06.850.490.625.750
22884409,2012-08-11T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22884409,2012-08-11T00:00:00,Stroke,C10.228.140.300.775
22884409,2012-08-11T00:00:00,Stroke,C14.907.253.855
22884409,2012-08-11T00:00:00,Vitamin B Complex,D27.505.696.377.605.600.708
22906436,2012-08-11T00:00:00,Apoptosis,G04.299.139.160
22906436,2012-08-11T00:00:00,Caspases,D08.811.277.656.262.500.126
22906436,2012-08-11T00:00:00,Caspases,D08.811.277.656.300.200.126
22906436,2012-08-11T00:00:00,Caspases,D12.644.360.075.405
22906436,2012-08-11T00:00:00,Caspases,D12.776.476.075.405
22906436,2012-08-11T00:00:00,Ceramides,D02.065.313
22906436,2012-08-11T00:00:00,Ceramides,D09.400.410.420.525.200
22906436,2012-08-11T00:00:00,Ceramides,D10.390.470.675.200
22906436,2012-08-11T00:00:00,Ceramides,D10.570.877.360.612.200
22906436,2012-08-11T00:00:00,Gene Expression,G05.355.310
22906436,2012-08-11T00:00:00,Hepatocytes,A11.436.348
22906436,2012-08-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22906436,2012-08-11T00:00:00,RNA Interference,G05.355.315.203.374.790
22906436,2012-08-11T00:00:00,Sphingomyelin Phosphodiesterase,D08.811.277.352.640.750
22906788,2012-08-11T00:00:00,Adolescent,M01.060.057
22906788,2012-08-11T00:00:00,Adult,M01.060.116
22906788,2012-08-11T00:00:00,Brain,A08.186.211
22906788,2012-08-11T00:00:00,Brain Mapping,E01.370.350.086
22906788,2012-08-11T00:00:00,Brain Mapping,E01.370.376.149
22906788,2012-08-11T00:00:00,Brain Mapping,E05.132
22906788,2012-08-11T00:00:00,Child,M01.060.406
22906788,2012-08-11T00:00:00,"Child, Preschool",M01.060.406.448
22906788,2012-08-11T00:00:00,Face,A01.456.505
22906788,2012-08-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22906788,2012-08-11T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
22906788,2012-08-11T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
22906788,2012-08-11T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
22906788,2012-08-11T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
22906788,2012-08-11T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
22906788,2012-08-11T00:00:00,Neural Pathways,A08.612
22906788,2012-08-11T00:00:00,"Pattern Recognition, Visual",F02.463.593.524.500
22906788,2012-08-11T00:00:00,"Pattern Recognition, Visual",F02.463.593.932.622
22906788,2012-08-11T00:00:00,"Pattern Recognition, Visual",F02.463.593.932.869.435.673
22906788,2012-08-11T00:00:00,Young Adult,M01.060.116.815
22882295,2012-08-12T00:00:00,Actins,D05.750.078.730.250
22882295,2012-08-12T00:00:00,Actins,D12.776.210.500.100
22882295,2012-08-12T00:00:00,Actins,D12.776.220.525.255
22882295,2012-08-12T00:00:00,Animals,B01.050
22882295,2012-08-12T00:00:00,"Bicyclo Compounds, Heterocyclic",D02.455.426.100.080.085
22882295,2012-08-12T00:00:00,"Bicyclo Compounds, Heterocyclic",D03.438.260
22882295,2012-08-12T00:00:00,"Bicyclo Compounds, Heterocyclic",D03.605.084
22882295,2012-08-12T00:00:00,"Bicyclo Compounds, Heterocyclic",D04.075.080.875
22882295,2012-08-12T00:00:00,Cocaine,D02.145.074.722.388
22882295,2012-08-12T00:00:00,Cocaine,D03.132.889.354
22882295,2012-08-12T00:00:00,Cocaine,D03.605.869.388
22882295,2012-08-12T00:00:00,Cocaine,D04.075.080.875.099.722.388
22882295,2012-08-12T00:00:00,Gene Expression,G05.355.310
22882295,2012-08-12T00:00:00,Motor Activity,F01.145.632
22882295,2012-08-12T00:00:00,Motor Activity,G11.427.590.530.698
22882295,2012-08-12T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
22882295,2012-08-12T00:00:00,Phosphorylation,G02.111.087.677
22882295,2012-08-12T00:00:00,Phosphorylation,G02.149.115.677
22882295,2012-08-12T00:00:00,Phosphorylation,G02.149.465.700
22882295,2012-08-12T00:00:00,Phosphorylation,G02.607.750.700
22882295,2012-08-12T00:00:00,Phosphorylation,G03.495.790
22882295,2012-08-12T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
22882295,2012-08-12T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22882295,2012-08-12T00:00:00,"Receptors, AMPA",D12.776.543.750.720.200.450.200
22882295,2012-08-12T00:00:00,"Restraint, Physical",E02.085.700
22882295,2012-08-12T00:00:00,"Restraint, Physical",E05.472.760
22882295,2012-08-12T00:00:00,"Stress, Psychological",F01.145.126.990
22882295,2012-08-12T00:00:00,"Stress, Psychological",F02.830.900
22807098,2012-08-13T00:00:00,Aged,M01.060.116.100
22807098,2012-08-13T00:00:00,Antihypertensive Agents,D27.505.954.411.162
22807098,2012-08-13T00:00:00,Blood Pressure,E01.370.600.875.249
22807098,2012-08-13T00:00:00,Blood Pressure,G09.330.380.076
22807098,2012-08-13T00:00:00,"Blood Pressure Monitoring, Ambulatory",E01.370.370.140.100
22807098,2012-08-13T00:00:00,"Blood Pressure Monitoring, Ambulatory",E01.370.520.500.100
22807098,2012-08-13T00:00:00,Catheter Ablation,E01.370.370.380.410.200
22807098,2012-08-13T00:00:00,Catheter Ablation,E02.148.110
22807098,2012-08-13T00:00:00,Catheter Ablation,E02.148.442.110
22807098,2012-08-13T00:00:00,Catheter Ablation,E02.154.402.110
22807098,2012-08-13T00:00:00,Catheter Ablation,E04.014.170.402.110
22807098,2012-08-13T00:00:00,Drug Resistance,G07.690.320
22807098,2012-08-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22807098,2012-08-13T00:00:00,Hypertension,C14.907.489
22807098,2012-08-13T00:00:00,Kidney,A05.810.453
22807098,2012-08-13T00:00:00,Middle Aged,M01.060.116.630
22807098,2012-08-13T00:00:00,Office Visits,N04.452.758.635
22807098,2012-08-13T00:00:00,Pilot Projects,E05.318.760.750
22807098,2012-08-13T00:00:00,Pilot Projects,E05.337.737
22807098,2012-08-13T00:00:00,Pilot Projects,N05.715.360.775.625
22807098,2012-08-13T00:00:00,Pilot Projects,N06.850.520.450.720
22807098,2012-08-13T00:00:00,Time Factors,G01.910.857
22807098,2012-08-13T00:00:00,Treatment Outcome,E01.789.800
22807098,2012-08-13T00:00:00,Treatment Outcome,N04.761.559.590.800
22807098,2012-08-13T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22898443,2012-08-13T00:00:00,Adult,M01.060.116
22898443,2012-08-13T00:00:00,Aged,M01.060.116.100
22898443,2012-08-13T00:00:00,Central Nervous System Depressants,D27.505.696.277
22898443,2012-08-13T00:00:00,Central Nervous System Depressants,D27.505.954.427.210
22898443,2012-08-13T00:00:00,Ethanol,D02.033.375
22898443,2012-08-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22898443,2012-08-13T00:00:00,Middle Aged,M01.060.116.630
22898443,2012-08-13T00:00:00,Substance Withdrawal Syndrome,C21.739.835
22898443,2012-08-13T00:00:00,Substance Withdrawal Syndrome,F03.900.825
22898443,2012-08-13T00:00:00,Time Factors,G01.910.857
22898443,2012-08-13T00:00:00,Treatment Outcome,E01.789.800
22898443,2012-08-13T00:00:00,Treatment Outcome,N04.761.559.590.800
22898443,2012-08-13T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22898447,2012-08-13T00:00:00,Adult,M01.060.116
22898447,2012-08-13T00:00:00,Aged,M01.060.116.100
22898447,2012-08-13T00:00:00,Attitude to Health,F01.100.150
22898447,2012-08-13T00:00:00,Attitude to Health,N05.300.150
22898447,2012-08-13T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
22898447,2012-08-13T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
22898447,2012-08-13T00:00:00,Exercise,G11.427.590.237
22898447,2012-08-13T00:00:00,Exercise,I03.350
22898447,2012-08-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22898447,2012-08-13T00:00:00,Medication Adherence,F01.145.488.500.500
22898447,2012-08-13T00:00:00,Medication Adherence,N05.300.150.600.600.500
22898447,2012-08-13T00:00:00,Middle Aged,M01.060.116.630
22898447,2012-08-13T00:00:00,Patient Compliance,F01.145.488.500
22898447,2012-08-13T00:00:00,Patient Compliance,N05.300.150.600.600
22898447,2012-08-13T00:00:00,Self Care,E02.900
22898447,2012-08-13T00:00:00,Self Care,N02.421.784.680
22910273,2012-08-13T00:00:00,Antineoplastic Agents,D27.505.954.248
22910273,2012-08-13T00:00:00,Apoptosis,G04.299.139.160
22910273,2012-08-13T00:00:00,Cell Line,A11.251.210
22910273,2012-08-13T00:00:00,Glioblastoma,C04.557.465.625.600.380.080.335
22910273,2012-08-13T00:00:00,Glioblastoma,C04.557.470.670.380.080.335
22910273,2012-08-13T00:00:00,Glioblastoma,C04.557.580.625.600.380.080.335
22910273,2012-08-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22910273,2012-08-13T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
22910273,2012-08-13T00:00:00,"Microscopy, Fluorescence",E05.595.458
22910273,2012-08-13T00:00:00,Neoplastic Stem Cells,A11.872.650
22891869,2012-08-14T00:00:00,Adolescent,M01.060.057
22891869,2012-08-14T00:00:00,Adult,M01.060.116
22891869,2012-08-14T00:00:00,Aged,M01.060.116.100
22891869,2012-08-14T00:00:00,Benzazepines,D03.438.079
22891869,2012-08-14T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.150.800
22891869,2012-08-14T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.600.220
22891869,2012-08-14T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.150.800
22891869,2012-08-14T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.600.220
22891869,2012-08-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22891869,2012-08-14T00:00:00,Middle Aged,M01.060.116.630
22891869,2012-08-14T00:00:00,Nicotinic Agonists,D27.505.519.625.120.140.700
22891869,2012-08-14T00:00:00,Nicotinic Agonists,D27.505.696.577.120.140.700
22891869,2012-08-14T00:00:00,Smoking,F01.145.466.753
22891869,2012-08-14T00:00:00,Smoking Cessation,F01.145.940.700
22891869,2012-08-14T00:00:00,Treatment Outcome,E01.789.800
22891869,2012-08-14T00:00:00,Treatment Outcome,N04.761.559.590.800
22891869,2012-08-14T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22891869,2012-08-14T00:00:00,United States,Z01.107.567.875
22891869,2012-08-14T00:00:00,Young Adult,M01.060.116.815
22855106,2012-08-15T00:00:00,Academic Medical Centers,N02.278.020
22855106,2012-08-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22855106,2012-08-15T00:00:00,Intensive Care Units,N02.278.388.493
22855106,2012-08-15T00:00:00,"Intensive Care Units, Neonatal",N02.278.388.493.390.380
22855106,2012-08-15T00:00:00,Medical Order Entry Systems,L01.700.508.300.408.600
22855106,2012-08-15T00:00:00,Medical Order Entry Systems,L01.700.508.300.680.360.450
22855106,2012-08-15T00:00:00,Medical Order Entry Systems,L01.700.508.300.695.600
22855106,2012-08-15T00:00:00,Medical Order Entry Systems,N04.452.442.452.500
22855106,2012-08-15T00:00:00,Medical Order Entry Systems,N04.452.515.360.500
22855106,2012-08-15T00:00:00,Medical Order Entry Systems,N04.452.859.564.650.500
22855106,2012-08-15T00:00:00,Needs Assessment,I02.594
22855106,2012-08-15T00:00:00,Needs Assessment,N03.349.380.565
22855106,2012-08-15T00:00:00,Needs Assessment,N05.300.537
22855106,2012-08-15T00:00:00,Personnel Staffing and Scheduling,N04.452.677.650
22855106,2012-08-15T00:00:00,Pharmacists,M01.526.485.780
22855106,2012-08-15T00:00:00,Pharmacists,N02.360.780
22893166,2012-08-15T00:00:00,Adult,M01.060.116
22893166,2012-08-15T00:00:00,Combined Modality Therapy,E02.186
22893166,2012-08-15T00:00:00,Counseling,F02.784.176
22893166,2012-08-15T00:00:00,Counseling,F04.408.413
22893166,2012-08-15T00:00:00,Counseling,N02.421.143.303
22893166,2012-08-15T00:00:00,Counseling,N02.421.461.363
22893166,2012-08-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22893166,2012-08-15T00:00:00,Implosive Therapy,F04.754.137.506.325
22893166,2012-08-15T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
22893166,2012-08-15T00:00:00,Substance-Related Disorders,C21.739
22893166,2012-08-15T00:00:00,Substance-Related Disorders,F03.900
22893166,2012-08-15T00:00:00,Treatment Outcome,E01.789.800
22893166,2012-08-15T00:00:00,Treatment Outcome,N04.761.559.590.800
22893166,2012-08-15T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22893166,2012-08-15T00:00:00,Young Adult,M01.060.116.815
22896041,2012-08-15T00:00:00,Aged,M01.060.116.100
22896041,2012-08-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22896041,2012-08-15T00:00:00,Middle Aged,M01.060.116.630
22896041,2012-08-15T00:00:00,Muscle Contraction,G11.427.590.540
22896041,2012-08-15T00:00:00,"Muscle, Smooth",A02.633.570
22896041,2012-08-15T00:00:00,"Muscle, Smooth",A10.690.467
22896041,2012-08-15T00:00:00,Urinary Bladder,A05.810.890
22901498,2012-08-15T00:00:00,Cause of Death,E05.318.308.985.550.250
22901498,2012-08-15T00:00:00,Cause of Death,L01.280.975.550.250
22901498,2012-08-15T00:00:00,Cause of Death,N01.224.935.698.100
22901498,2012-08-15T00:00:00,Cause of Death,N06.850.505.400.975.550.250
22901498,2012-08-15T00:00:00,Cause of Death,N06.850.520.308.985.550.250
22901498,2012-08-15T00:00:00,"Heart Defects, Congenital",C14.240.400
22901498,2012-08-15T00:00:00,"Heart Defects, Congenital",C14.280.400
22901498,2012-08-15T00:00:00,"Heart Defects, Congenital",C16.131.240.400
22901498,2012-08-15T00:00:00,Heart Ventricles,A07.541.560
22901498,2012-08-15T00:00:00,Hemodynamics,G09.330.190.400
22901498,2012-08-15T00:00:00,Hemodynamics,G09.330.380
22901498,2012-08-15T00:00:00,Hospital Mortality,E05.318.308.985.550.400
22901498,2012-08-15T00:00:00,Hospital Mortality,L01.280.975.550.400
22901498,2012-08-15T00:00:00,Hospital Mortality,N01.224.935.698.400
22901498,2012-08-15T00:00:00,Hospital Mortality,N06.850.505.400.975.550.400
22901498,2012-08-15T00:00:00,Hospital Mortality,N06.850.520.308.985.550.400
22901498,2012-08-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22901498,2012-08-15T00:00:00,Hypoplastic Left Heart Syndrome,C14.240.400.625
22901498,2012-08-15T00:00:00,Hypoplastic Left Heart Syndrome,C14.280.400.625
22901498,2012-08-15T00:00:00,Hypoplastic Left Heart Syndrome,C16.131.240.400.625
22901498,2012-08-15T00:00:00,Infant Mortality,E05.318.308.985.550.475
22901498,2012-08-15T00:00:00,Infant Mortality,L01.280.975.550.475
22901498,2012-08-15T00:00:00,Infant Mortality,N01.224.935.698.489
22901498,2012-08-15T00:00:00,Infant Mortality,N06.850.505.400.975.550.475
22901498,2012-08-15T00:00:00,Infant Mortality,N06.850.520.308.985.550.475
22901498,2012-08-15T00:00:00,"Infant, Newborn",M01.060.703.520
22901498,2012-08-15T00:00:00,North America,Z01.107.567
22901498,2012-08-15T00:00:00,Postoperative Complications,C23.550.767
22901498,2012-08-15T00:00:00,Risk Assessment,E05.318.740.600.800.715
22901498,2012-08-15T00:00:00,Risk Assessment,N04.452.871.715
22901498,2012-08-15T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
22901498,2012-08-15T00:00:00,Risk Assessment,N06.850.505.715
22901498,2012-08-15T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
22901498,2012-08-15T00:00:00,Risk Factors,E05.318.740.600.800.725
22901498,2012-08-15T00:00:00,Risk Factors,N05.715.350.200.700
22901498,2012-08-15T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22901498,2012-08-15T00:00:00,Risk Factors,N06.850.490.625.750
22901498,2012-08-15T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22901498,2012-08-15T00:00:00,Time Factors,G01.910.857
22901498,2012-08-15T00:00:00,Treatment Outcome,E01.789.800
22901498,2012-08-15T00:00:00,Treatment Outcome,N04.761.559.590.800
22901498,2012-08-15T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22901585,2012-08-15T00:00:00,"Carcinoma, Renal Cell",C04.557.470.200.025.390
22901585,2012-08-15T00:00:00,"Carcinoma, Renal Cell",C04.588.945.947.535.160
22901585,2012-08-15T00:00:00,"Carcinoma, Renal Cell",C12.758.820.750.160
22901585,2012-08-15T00:00:00,"Carcinoma, Renal Cell",C12.777.419.473.160
22901585,2012-08-15T00:00:00,"Carcinoma, Renal Cell",C13.351.937.820.535.160
22901585,2012-08-15T00:00:00,"Carcinoma, Renal Cell",C13.351.968.419.473.160
22901585,2012-08-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22901585,2012-08-15T00:00:00,Kidney Neoplasms,C04.588.945.947.535
22901585,2012-08-15T00:00:00,Kidney Neoplasms,C12.758.820.750
22901585,2012-08-15T00:00:00,Kidney Neoplasms,C12.777.419.473
22901585,2012-08-15T00:00:00,Kidney Neoplasms,C13.351.937.820.535
22901585,2012-08-15T00:00:00,Kidney Neoplasms,C13.351.968.419.473
22901817,2012-08-15T00:00:00,"Education, Medical, Graduate",I02.358.337.350
22901817,2012-08-15T00:00:00,"Education, Medical, Graduate",I02.358.399.350
22901817,2012-08-15T00:00:00,Endoscopy,E01.370.388.250
22901817,2012-08-15T00:00:00,Endoscopy,E04.800.250
22901817,2012-08-15T00:00:00,Fellowships and Scholarships,N03.219.483.838.276
22901817,2012-08-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22901817,2012-08-15T00:00:00,Physician's Practice Patterns,N04.590.748
22901817,2012-08-15T00:00:00,Physician's Practice Patterns,N05.300.625
22901817,2012-08-15T00:00:00,Urologic Surgical Procedures,E04.950.774
22895361,2012-08-16T00:00:00,Animals,B01.050
22895361,2012-08-16T00:00:00,Collagen,D05.750.078.280
22895361,2012-08-16T00:00:00,Collagen,D12.776.860.300.250
22895361,2012-08-16T00:00:00,Estrogen Receptor alpha,D12.776.260.698.750.350.174
22895361,2012-08-16T00:00:00,Estrogen Receptor alpha,D12.776.826.750.350.174
22895361,2012-08-16T00:00:00,Estrogen Receptor alpha,D12.776.930.669.750.350.174
22895361,2012-08-16T00:00:00,Extracellular Matrix,A11.284.295.310
22895361,2012-08-16T00:00:00,Fibroblasts,A11.329.228
22895361,2012-08-16T00:00:00,Fibroblasts,A11.872.228
22895361,2012-08-16T00:00:00,Skin,A17.815
22899855,2012-08-16T00:00:00,Animals,B01.050
22899855,2012-08-16T00:00:00,Cell Differentiation,G04.299.151
22899855,2012-08-16T00:00:00,Dual Specificity Phosphatase 1,D08.811.277.352.650.587.200
22899855,2012-08-16T00:00:00,Dual Specificity Phosphatase 1,D08.811.277.352.650.625.225.200
22899855,2012-08-16T00:00:00,Dual Specificity Phosphatase 1,D08.811.277.352.650.775.250.200
22899855,2012-08-16T00:00:00,Dual Specificity Phosphatase 1,D12.644.360.268.200
22899855,2012-08-16T00:00:00,Dual Specificity Phosphatase 1,D12.644.360.445.100
22899855,2012-08-16T00:00:00,Dual Specificity Phosphatase 1,D12.776.476.268.200
22899855,2012-08-16T00:00:00,Dual Specificity Phosphatase 1,D12.776.476.445.200
22899855,2012-08-16T00:00:00,Osteoclasts,A11.329.372.700
22899855,2012-08-16T00:00:00,Osteoclasts,A11.627.482.700
22899855,2012-08-16T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
22899855,2012-08-16T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
22899855,2012-08-16T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
22899855,2012-08-16T00:00:00,RANK Ligand,D12.644.276.374.750.562
22899855,2012-08-16T00:00:00,RANK Ligand,D12.644.276.972.562
22899855,2012-08-16T00:00:00,RANK Ligand,D12.776.467.374.750.562
22899855,2012-08-16T00:00:00,RANK Ligand,D12.776.467.972.562
22899855,2012-08-16T00:00:00,RANK Ligand,D23.529.374.750.562
22899855,2012-08-16T00:00:00,RANK Ligand,D23.529.972.562
22899855,2012-08-16T00:00:00,Retinoid X Receptor alpha,D12.776.260.698.701.500.500
22899855,2012-08-16T00:00:00,Retinoid X Receptor alpha,D12.776.826.701.500.500
22899855,2012-08-16T00:00:00,Retinoid X Receptor alpha,D12.776.930.669.701.500.500
22899855,2012-08-16T00:00:00,Signal Transduction,G02.111.087.800
22899855,2012-08-16T00:00:00,Signal Transduction,G02.149.115.800
22899855,2012-08-16T00:00:00,Signal Transduction,G04.299.880
22899855,2012-08-16T00:00:00,"Transcription, Genetic",G02.111.087.847
22899855,2012-08-16T00:00:00,"Transcription, Genetic",G02.149.115.847
22899855,2012-08-16T00:00:00,"Transcription, Genetic",G05.355.310.700
22899855,2012-08-16T00:00:00,Vitamin D,D04.808.812.768
22899005,2012-08-17T00:00:00,Adolescent,M01.060.057
22899005,2012-08-17T00:00:00,Adult,M01.060.116
22899005,2012-08-17T00:00:00,European Continental Ancestry Group,M01.686.508.400
22899005,2012-08-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22899005,2012-08-17T00:00:00,Macular Degeneration,C11.768.585.439
22899005,2012-08-17T00:00:00,Middle Aged,M01.060.116.630
22899005,2012-08-17T00:00:00,Photography,E01.370.350.600
22899005,2012-08-17T00:00:00,Photography,E05.712
22899005,2012-08-17T00:00:00,Retinal Pigment Epithelium,A09.371.670.500
22899005,2012-08-17T00:00:00,Retinal Pigment Epithelium,A09.371.729.887
22899005,2012-08-17T00:00:00,Young Adult,M01.060.116.815
22904263,2012-08-17T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
22904263,2012-08-17T00:00:00,Genetic Predisposition to Disease,G05.380.355
22904263,2012-08-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22904263,2012-08-17T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
22904263,2012-08-17T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
22904263,2012-08-17T00:00:00,Molecular Sequence Data,L01.453.245.667
22904263,2012-08-17T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
22904263,2012-08-17T00:00:00,Risk Factors,E05.318.740.600.800.725
22904263,2012-08-17T00:00:00,Risk Factors,N05.715.350.200.700
22904263,2012-08-17T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22904263,2012-08-17T00:00:00,Risk Factors,N06.850.490.625.750
22904263,2012-08-17T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22906647,2012-08-17T00:00:00,"Child, Preschool",M01.060.406.448
22906647,2012-08-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22906647,2012-08-17T00:00:00,Infant,M01.060.703
22906647,2012-08-17T00:00:00,Risk Factors,E05.318.740.600.800.725
22906647,2012-08-17T00:00:00,Risk Factors,N05.715.350.200.700
22906647,2012-08-17T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22906647,2012-08-17T00:00:00,Risk Factors,N06.850.490.625.750
22906647,2012-08-17T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22906647,2012-08-17T00:00:00,Time Factors,G01.910.857
22906647,2012-08-17T00:00:00,Treatment Outcome,E01.789.800
22906647,2012-08-17T00:00:00,Treatment Outcome,N04.761.559.590.800
22906647,2012-08-17T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22906647,2012-08-17T00:00:00,Urologic Surgical Procedures,E04.950.774
22906647,2012-08-17T00:00:00,Vesico-Ureteral Reflux,C12.777.829.920
22906647,2012-08-17T00:00:00,Vesico-Ureteral Reflux,C13.351.968.829.920
23026271,2012-08-17T00:00:00,Adenocarcinoma,C04.557.470.200.025
23026271,2012-08-17T00:00:00,Alcohol Drinking,F01.145.317.269
23026271,2012-08-17T00:00:00,Biological Markers,D23.101
23026271,2012-08-17T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
23026271,2012-08-17T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
23026271,2012-08-17T00:00:00,"Cell Transformation, Neoplastic",C04.697.152
23026271,2012-08-17T00:00:00,"Cell Transformation, Neoplastic",C23.550.727.152
23026271,2012-08-17T00:00:00,Esophageal Neoplasms,C04.588.274.476.205
23026271,2012-08-17T00:00:00,Esophageal Neoplasms,C04.588.443.353
23026271,2012-08-17T00:00:00,Esophageal Neoplasms,C06.301.371.205
23026271,2012-08-17T00:00:00,Esophageal Neoplasms,C06.405.117.430
23026271,2012-08-17T00:00:00,Esophageal Neoplasms,C06.405.249.205
23026271,2012-08-17T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
23026271,2012-08-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23026271,2012-08-17T00:00:00,Mutation,G05.365.590
23026271,2012-08-17T00:00:00,Smoking,F01.145.466.753
23026287,2012-08-17T00:00:00,Adenocarcinoma,C04.557.470.200.025
23026287,2012-08-17T00:00:00,Esophageal Neoplasms,C04.588.274.476.205
23026287,2012-08-17T00:00:00,Esophageal Neoplasms,C04.588.443.353
23026287,2012-08-17T00:00:00,Esophageal Neoplasms,C06.301.371.205
23026287,2012-08-17T00:00:00,Esophageal Neoplasms,C06.405.117.430
23026287,2012-08-17T00:00:00,Esophageal Neoplasms,C06.405.249.205
23026287,2012-08-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23026287,2012-08-17T00:00:00,Palliative Care,E02.760.666
23026287,2012-08-17T00:00:00,Palliative Care,N02.421.585.666
22910242,2012-08-19T00:00:00,Aged,M01.060.116.100
22910242,2012-08-19T00:00:00,Bladder Exstrophy,C12.706.132
22910242,2012-08-19T00:00:00,Bladder Exstrophy,C12.777.829.132
22910242,2012-08-19T00:00:00,Bladder Exstrophy,C13.351.875.132
22910242,2012-08-19T00:00:00,Bladder Exstrophy,C13.351.968.829.132
22910242,2012-08-19T00:00:00,Bladder Exstrophy,C16.131.939.132
22910242,2012-08-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22910242,2012-08-19T00:00:00,Middle Aged,M01.060.116.630
22910242,2012-08-19T00:00:00,"Myocytes, Smooth Muscle",A11.620.520
22910257,2012-08-19T00:00:00,Adult,M01.060.116
22910257,2012-08-19T00:00:00,Child,M01.060.406
22910257,2012-08-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22910257,2012-08-19T00:00:00,Middle Aged,M01.060.116.630
22910257,2012-08-19T00:00:00,Pediatrics,H02.403.670
22910257,2012-08-19T00:00:00,Publishing,L01.737
22910257,2012-08-19T00:00:00,Treatment Outcome,E01.789.800
22910257,2012-08-19T00:00:00,Treatment Outcome,N04.761.559.590.800
22910257,2012-08-19T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22910257,2012-08-19T00:00:00,Urologic Surgical Procedures,E04.950.774
22910257,2012-08-19T00:00:00,Urology,H02.403.810.860
22910259,2012-08-19T00:00:00,Bladder Exstrophy,C12.706.132
22910259,2012-08-19T00:00:00,Bladder Exstrophy,C12.777.829.132
22910259,2012-08-19T00:00:00,Bladder Exstrophy,C13.351.875.132
22910259,2012-08-19T00:00:00,Bladder Exstrophy,C13.351.968.829.132
22910259,2012-08-19T00:00:00,Bladder Exstrophy,C16.131.939.132
22910259,2012-08-19T00:00:00,Cell Movement,G04.299.283
22910259,2012-08-19T00:00:00,Cell Movement,G07.700.560.500.180
22910259,2012-08-19T00:00:00,"Child, Preschool",M01.060.406.448
22910259,2012-08-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22910259,2012-08-19T00:00:00,"Myocytes, Smooth Muscle",A11.620.520
22910259,2012-08-19T00:00:00,Transforming Growth Factor beta1,D12.644.276.374.687.100
22910259,2012-08-19T00:00:00,Transforming Growth Factor beta1,D12.644.276.954.800.720.100
22910259,2012-08-19T00:00:00,Transforming Growth Factor beta1,D12.644.276.963.720.100
22910259,2012-08-19T00:00:00,Transforming Growth Factor beta1,D12.776.467.374.687.100
22910259,2012-08-19T00:00:00,Transforming Growth Factor beta1,D12.776.467.942.800.720.100
22910259,2012-08-19T00:00:00,Transforming Growth Factor beta1,D12.776.467.960.720.100
22910259,2012-08-19T00:00:00,Transforming Growth Factor beta1,D23.529.374.687.100
22910259,2012-08-19T00:00:00,Transforming Growth Factor beta1,D23.529.942.800.720.100
22910259,2012-08-19T00:00:00,Transforming Growth Factor beta1,D23.529.960.720.100
22910265,2012-08-19T00:00:00,Bladder Exstrophy,C12.706.132
22910265,2012-08-19T00:00:00,Bladder Exstrophy,C12.777.829.132
22910265,2012-08-19T00:00:00,Bladder Exstrophy,C13.351.875.132
22910265,2012-08-19T00:00:00,Bladder Exstrophy,C13.351.968.829.132
22910265,2012-08-19T00:00:00,Bladder Exstrophy,C16.131.939.132
22910265,2012-08-19T00:00:00,"Child, Preschool",M01.060.406.448
22910265,2012-08-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22910265,2012-08-19T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
22910265,2012-08-19T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
22910265,2012-08-19T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
22910265,2012-08-19T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
22910265,2012-08-19T00:00:00,Pelvic Floor,A01.673.600
22910265,2012-08-19T00:00:00,Pelvic Floor,A02.633.567.050.750
23010478,2012-08-19T00:00:00,Adenosine Triphosphate,D03.438.759.646.138.236
23010478,2012-08-19T00:00:00,Adenosine Triphosphate,D13.695.667.138.236
23010478,2012-08-19T00:00:00,Adenosine Triphosphate,D13.695.827.068.236
23010478,2012-08-19T00:00:00,Adult Stem Cells,A11.872.040
23010478,2012-08-19T00:00:00,Animals,B01.050
23010478,2012-08-19T00:00:00,Calcium Signaling,G02.111.087.800.800.100
23010478,2012-08-19T00:00:00,Calcium Signaling,G02.149.115.800.800.100
23010478,2012-08-19T00:00:00,Calcium Signaling,G03.495.166.500.100
23010478,2012-08-19T00:00:00,Calcium Signaling,G04.299.880.800.100
23010478,2012-08-19T00:00:00,Cell Differentiation,G04.299.151
23010478,2012-08-19T00:00:00,Connexin 43,D12.776.543.585.250.200
23010478,2012-08-19T00:00:00,Gap Junctions,A11.284.149.165.420.471
23010478,2012-08-19T00:00:00,Green Fluorescent Proteins,D12.776.532.265
23010478,2012-08-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23010478,2012-08-19T00:00:00,"Myocytes, Cardiac",A07.541.704.570
23010478,2012-08-19T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
23010478,2012-08-19T00:00:00,"Myocytes, Cardiac",A11.620.500
23010478,2012-08-19T00:00:00,Phenotype,G05.695
23010478,2012-08-19T00:00:00,Proto-Oncogene Proteins c-pim-1,D08.811.913.696.620.682.700.776
23010478,2012-08-19T00:00:00,Proto-Oncogene Proteins c-pim-1,D12.776.624.664.700.191
23010478,2012-08-19T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23010478,2012-08-19T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
23010478,2012-08-19T00:00:00,Sodium-Calcium Exchanger,D12.776.157.530.450.162.442
23010478,2012-08-19T00:00:00,Sodium-Calcium Exchanger,D12.776.543.585.450.162.442
22900949,2012-08-20T00:00:00,Adult,M01.060.116
22900949,2012-08-20T00:00:00,Biological Markers,D23.101
22900949,2012-08-20T00:00:00,Case-Control Studies,E05.318.760.500.500
22900949,2012-08-20T00:00:00,Case-Control Studies,N05.715.360.775.175.200
22900949,2012-08-20T00:00:00,Case-Control Studies,N06.850.520.450.500.500
22900949,2012-08-20T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
22900949,2012-08-20T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
22900949,2012-08-20T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
22900949,2012-08-20T00:00:00,"Glycosylation End Products, Advanced",D02.415
22900949,2012-08-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22900949,2012-08-20T00:00:00,Lysine,D12.125.068.555
22900949,2012-08-20T00:00:00,Lysine,D12.125.095.647
22900949,2012-08-20T00:00:00,Lysine,D12.125.142.497
22900949,2012-08-20T00:00:00,Pre-Eclampsia,C13.703.395.249
22900949,2012-08-20T00:00:00,Pregnancy,G08.686.785.760.769
22917626,2012-08-20T00:00:00,Aged,M01.060.116.100
22917626,2012-08-20T00:00:00,Body Weight,C23.888.144
22917626,2012-08-20T00:00:00,Body Weight,E01.370.600.115.100.160.120
22917626,2012-08-20T00:00:00,Body Weight,E05.041.124.160.750
22917626,2012-08-20T00:00:00,Body Weight,G07.100.100.160.120
22917626,2012-08-20T00:00:00,Body Weight,G07.700.320.249.314.120
22917626,2012-08-20T00:00:00,Exercise Therapy,E02.779.483
22917626,2012-08-20T00:00:00,Exercise Therapy,E02.831.387
22917626,2012-08-20T00:00:00,"Gait Disorders, Neurologic",C10.597.404
22917626,2012-08-20T00:00:00,"Gait Disorders, Neurologic",C23.888.592.413
22917626,2012-08-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22917626,2012-08-20T00:00:00,Middle Aged,M01.060.116.630
22917626,2012-08-20T00:00:00,Paresis,C10.597.636
22917626,2012-08-20T00:00:00,Paresis,C23.888.592.643
22917626,2012-08-20T00:00:00,Recovery of Function,G16.757
22917626,2012-08-20T00:00:00,Stroke,C10.228.140.300.775
22917626,2012-08-20T00:00:00,Stroke,C14.907.253.855
22917626,2012-08-20T00:00:00,Walking,G11.427.590.530.568.900
22917626,2012-08-20T00:00:00,Walking,G11.427.590.530.698.940
22917626,2012-08-20T00:00:00,Walking,I03.450.642.845.940
22912429,2012-08-21T00:00:00,Cost Savings,N03.219.151.160.200
22912429,2012-08-21T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
22912429,2012-08-21T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
22912429,2012-08-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22912429,2012-08-21T00:00:00,Hypoglycemic Agents,D27.505.696.422
22912429,2012-08-21T00:00:00,Medication Adherence,F01.145.488.500.500
22912429,2012-08-21T00:00:00,Medication Adherence,N05.300.150.600.600.500
22912429,2012-08-21T00:00:00,"Models, Statistical",E05.318.740.500
22912429,2012-08-21T00:00:00,"Models, Statistical",E05.599.835
22912429,2012-08-21T00:00:00,"Models, Statistical",N05.715.360.750.530
22912429,2012-08-21T00:00:00,"Models, Statistical",N06.850.520.830.500
22963984,2012-08-21T00:00:00,Antigen-Antibody Complex,D12.776.124.486.485.114.257
22963984,2012-08-21T00:00:00,Antigen-Antibody Complex,D12.776.124.790.651.114.257
22963984,2012-08-21T00:00:00,Antigen-Antibody Complex,D12.776.377.715.548.114.257
22963984,2012-08-21T00:00:00,Antigen-Antibody Complex,D23.050.101
22963984,2012-08-21T00:00:00,Autoantibodies,D12.776.124.486.485.114.323
22963984,2012-08-21T00:00:00,Autoantibodies,D12.776.124.790.651.114.323
22963984,2012-08-21T00:00:00,Autoantibodies,D12.776.377.715.548.114.323
22963984,2012-08-21T00:00:00,Biological Markers,D23.101
22963984,2012-08-21T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
22963984,2012-08-21T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
22963984,2012-08-21T00:00:00,"Glycosylation End Products, Advanced",D02.415
22963984,2012-08-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22963984,2012-08-21T00:00:00,Incidence,E05.318.308.985.525.375
22963984,2012-08-21T00:00:00,Incidence,L01.280.975.525.375
22963984,2012-08-21T00:00:00,Incidence,N01.224.935.597.500
22963984,2012-08-21T00:00:00,Incidence,N06.850.505.400.975.525.375
22963984,2012-08-21T00:00:00,Incidence,N06.850.520.308.985.525.375
22963984,2012-08-21T00:00:00,"Lipoproteins, LDL",D10.532.515
22963984,2012-08-21T00:00:00,"Lipoproteins, LDL",D12.776.521.550
22963984,2012-08-21T00:00:00,Middle Aged,M01.060.116.630
22963984,2012-08-21T00:00:00,Myocardial Infarction,C14.280.647.500
22963984,2012-08-21T00:00:00,Myocardial Infarction,C14.907.585.500
22963984,2012-08-21T00:00:00,Risk Assessment,E05.318.740.600.800.715
22963984,2012-08-21T00:00:00,Risk Assessment,N04.452.871.715
22963984,2012-08-21T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
22963984,2012-08-21T00:00:00,Risk Assessment,N06.850.505.715
22963984,2012-08-21T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
22963984,2012-08-21T00:00:00,Risk Factors,E05.318.740.600.800.725
22963984,2012-08-21T00:00:00,Risk Factors,N05.715.350.200.700
22963984,2012-08-21T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22963984,2012-08-21T00:00:00,Risk Factors,N06.850.490.625.750
22963984,2012-08-21T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22963984,2012-08-21T00:00:00,Time Factors,G01.910.857
22963984,2012-08-21T00:00:00,United States,Z01.107.567.875
22909294,2012-08-22T00:00:00,Adolescent,M01.060.057
22909294,2012-08-22T00:00:00,Adolescent Behavior,F01.145.022
22909294,2012-08-22T00:00:00,Anti-HIV Agents,D27.505.954.122.388.077.088
22909294,2012-08-22T00:00:00,CD4 Lymphocyte Count,E01.450.375.107.595.500.150
22909294,2012-08-22T00:00:00,CD4 Lymphocyte Count,E05.200.500.195.107.595.500.150
22909294,2012-08-22T00:00:00,CD4 Lymphocyte Count,G04.170.107.595.500.150
22909294,2012-08-22T00:00:00,CD4 Lymphocyte Count,G09.188.105.595.500.150
22909294,2012-08-22T00:00:00,Child,M01.060.406
22909294,2012-08-22T00:00:00,Community Health Services,N02.421.143
22909294,2012-08-22T00:00:00,HIV Seropositivity,C02.782.815.616.400.500
22909294,2012-08-22T00:00:00,HIV Seropositivity,C02.800.801.400.500
22909294,2012-08-22T00:00:00,HIV Seropositivity,C20.673.480.500
22909294,2012-08-22T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
22909294,2012-08-22T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
22909294,2012-08-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22909294,2012-08-22T00:00:00,Medication Adherence,F01.145.488.500.500
22909294,2012-08-22T00:00:00,Medication Adherence,N05.300.150.600.600.500
22909294,2012-08-22T00:00:00,Pilot Projects,E05.318.760.750
22909294,2012-08-22T00:00:00,Pilot Projects,E05.337.737
22909294,2012-08-22T00:00:00,Pilot Projects,N05.715.360.775.625
22909294,2012-08-22T00:00:00,Pilot Projects,N06.850.520.450.720
22909294,2012-08-22T00:00:00,Risk Factors,E05.318.740.600.800.725
22909294,2012-08-22T00:00:00,Risk Factors,N05.715.350.200.700
22909294,2012-08-22T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22909294,2012-08-22T00:00:00,Risk Factors,N06.850.490.625.750
22909294,2012-08-22T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22909294,2012-08-22T00:00:00,Self Care,E02.900
22909294,2012-08-22T00:00:00,Self Care,N02.421.784.680
22909294,2012-08-22T00:00:00,United States,Z01.107.567.875
22913336,2012-08-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22913336,2012-08-22T00:00:00,Hyperoxia,C23.888.852.567
22913336,2012-08-22T00:00:00,Oxygen,D01.268.185.550
22913336,2012-08-22T00:00:00,Oxygen,D01.362.670
22913336,2012-08-22T00:00:00,Perioperative Care,E02.760.722
22913336,2012-08-22T00:00:00,Perioperative Care,E04.604
22913336,2012-08-22T00:00:00,Perioperative Care,N02.421.585.722
22913336,2012-08-22T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
22913336,2012-08-22T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
22913336,2012-08-22T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
22913336,2012-08-22T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
22913336,2012-08-22T00:00:00,Surgical Wound Infection,C01.539.947.692
22913336,2012-08-22T00:00:00,Surgical Wound Infection,C23.550.767.925
23084616,2012-08-22T00:00:00,Communication,F01.145.209
23084616,2012-08-22T00:00:00,Communication,L01.143
23084616,2012-08-22T00:00:00,Confidentiality,F04.096.544.335.240
23084616,2012-08-22T00:00:00,Confidentiality,I01.880.604.473.650.500
23084616,2012-08-22T00:00:00,Confidentiality,I01.880.604.583.080
23084616,2012-08-22T00:00:00,Confidentiality,N03.706.437.650.124
23084616,2012-08-22T00:00:00,Confidentiality,N03.706.535.230
23084616,2012-08-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23084616,2012-08-22T00:00:00,Informed Consent,I01.880.604.473.650.718
23084616,2012-08-22T00:00:00,Informed Consent,I01.880.604.583.427
23084616,2012-08-22T00:00:00,Informed Consent,N03.706.437.650.312
23084616,2012-08-22T00:00:00,Informed Consent,N03.706.535.489
23084616,2012-08-22T00:00:00,Internet,L01.224.230.110.500
23084616,2012-08-22T00:00:00,Licensure,N03.706.110.510
23084616,2012-08-22T00:00:00,Licensure,N05.700.200.450
23084616,2012-08-22T00:00:00,Physician-Patient Relations,F01.829.401.650.675
23084616,2012-08-22T00:00:00,Physician-Patient Relations,N05.300.660.625
23084616,2012-08-22T00:00:00,Social Support,I01.880.656.600
23084616,2012-08-22T00:00:00,Telemedicine,H02.403.840
23084616,2012-08-22T00:00:00,Telemedicine,L01.178.847.652
23084616,2012-08-22T00:00:00,Telemedicine,N04.590.374.800
22914673,2012-08-23T00:00:00,Adult,M01.060.116
22914673,2012-08-23T00:00:00,Alcoholism,C21.739.100.250
22914673,2012-08-23T00:00:00,Alcoholism,F03.900.100.350
22914673,2012-08-23T00:00:00,Case-Control Studies,E05.318.760.500.500
22914673,2012-08-23T00:00:00,Case-Control Studies,N05.715.360.775.175.200
22914673,2012-08-23T00:00:00,Case-Control Studies,N06.850.520.450.500.500
22914673,2012-08-23T00:00:00,Cocaine-Related Disorders,C21.739.300
22914673,2012-08-23T00:00:00,Cocaine-Related Disorders,F03.900.300
22914673,2012-08-23T00:00:00,DNA Methylation,G02.111.087.029.538.161
22914673,2012-08-23T00:00:00,DNA Methylation,G02.111.087.218
22914673,2012-08-23T00:00:00,DNA Methylation,G02.149.115.029.538.161
22914673,2012-08-23T00:00:00,DNA Methylation,G02.149.115.218
22914673,2012-08-23T00:00:00,DNA Methylation,G03.495.130.538.161
22914673,2012-08-23T00:00:00,DNA Methylation,G05.355.190
22914673,2012-08-23T00:00:00,European Continental Ancestry Group,M01.686.508.400
22914673,2012-08-23T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
22914673,2012-08-23T00:00:00,Genetic Predisposition to Disease,G05.380.355
22914673,2012-08-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22914673,2012-08-23T00:00:00,Marijuana Abuse,C21.739.635
22914673,2012-08-23T00:00:00,Marijuana Abuse,F03.900.635
22914673,2012-08-23T00:00:00,Middle Aged,M01.060.116.630
22914673,2012-08-23T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
22914673,2012-08-23T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
22914673,2012-08-23T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
22914673,2012-08-23T00:00:00,Risk Factors,E05.318.740.600.800.725
22914673,2012-08-23T00:00:00,Risk Factors,N05.715.350.200.700
22914673,2012-08-23T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22914673,2012-08-23T00:00:00,Risk Factors,N06.850.490.625.750
22914673,2012-08-23T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22914673,2012-08-23T00:00:00,"Sequence Analysis, DNA",E05.393.760.700
22922329,2012-08-23T00:00:00,Age Factors,N05.715.350.075
22922329,2012-08-23T00:00:00,Age Factors,N06.850.490.250
22922329,2012-08-23T00:00:00,Hospitalization,E02.760.400
22922329,2012-08-23T00:00:00,Hospitalization,N02.421.585.400
22922329,2012-08-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22922329,2012-08-23T00:00:00,Length of Stay,E02.760.400.480
22922329,2012-08-23T00:00:00,Length of Stay,N02.421.585.400.480
22922329,2012-08-23T00:00:00,Middle Aged,M01.060.116.630
22922329,2012-08-23T00:00:00,Office Visits,N04.452.758.635
22922329,2012-08-23T00:00:00,Questionnaires,E05.318.308.750
22922329,2012-08-23T00:00:00,Questionnaires,L01.280.800
22922329,2012-08-23T00:00:00,Questionnaires,N05.715.360.300.695
22922329,2012-08-23T00:00:00,Questionnaires,N06.850.520.308.750
22922329,2012-08-23T00:00:00,Recovery of Function,G16.757
22922329,2012-08-23T00:00:00,South Carolina,Z01.107.567.875.075.662
22922329,2012-08-23T00:00:00,South Carolina,Z01.107.567.875.750.700
22922329,2012-08-23T00:00:00,Spinal Cord Injuries,C10.228.854.770
22922329,2012-08-23T00:00:00,Spinal Cord Injuries,C10.900.850
22922329,2012-08-23T00:00:00,Spinal Cord Injuries,C21.866.819
22922329,2012-08-23T00:00:00,Time Factors,G01.910.857
22924764,2012-08-24T00:00:00,African Americans,M01.686.508.100.100
22924764,2012-08-24T00:00:00,African Americans,M01.686.754.100
22924764,2012-08-24T00:00:00,Alcoholism,C21.739.100.250
22924764,2012-08-24T00:00:00,Alcoholism,F03.900.100.350
22924764,2012-08-24T00:00:00,DNA Methylation,G02.111.087.029.538.161
22924764,2012-08-24T00:00:00,DNA Methylation,G02.111.087.218
22924764,2012-08-24T00:00:00,DNA Methylation,G02.149.115.029.538.161
22924764,2012-08-24T00:00:00,DNA Methylation,G02.149.115.218
22924764,2012-08-24T00:00:00,DNA Methylation,G03.495.130.538.161
22924764,2012-08-24T00:00:00,DNA Methylation,G05.355.190
22924764,2012-08-24T00:00:00,European Continental Ancestry Group,M01.686.508.400
22924764,2012-08-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22924764,2012-08-24T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
22924764,2012-08-24T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
22924764,2012-08-24T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
22924764,2012-08-24T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
22924764,2012-08-24T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
22924764,2012-08-24T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
22940018,2012-08-24T00:00:00,Adrenergic alpha-Antagonists,D27.505.519.625.050.200.100
22940018,2012-08-24T00:00:00,Adrenergic alpha-Antagonists,D27.505.696.577.050.200.100
22940018,2012-08-24T00:00:00,Amphetamine-Related Disorders,C21.739.225
22940018,2012-08-24T00:00:00,Amphetamine-Related Disorders,F03.900.225
22940018,2012-08-24T00:00:00,Animals,B01.050
22940018,2012-08-24T00:00:00,"Behavior, Addictive",F01.145.527.100.120
22940018,2012-08-24T00:00:00,Central Nervous System Stimulants,D27.505.696.282
22940018,2012-08-24T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
22940018,2012-08-24T00:00:00,"Conditioning, Operant",F02.463.425.179.509
22940018,2012-08-24T00:00:00,Cues,F02.463.425.234
22940018,2012-08-24T00:00:00,Methamphetamine,D02.092.471.683.152.619
22940018,2012-08-24T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22940018,2012-08-24T00:00:00,Self Administration,E02.319.890
22940018,2012-08-24T00:00:00,Self Administration,E02.900.890
22940018,2012-08-24T00:00:00,Yohimbine,D03.132.436.681.933
22940018,2012-08-24T00:00:00,Yohimbine,D03.438.473.402.681.933
22932717,2012-08-26T00:00:00,Aged,M01.060.116.100
22932717,2012-08-26T00:00:00,Double-Blind Method,E05.318.780.300
22932717,2012-08-26T00:00:00,Double-Blind Method,E05.581.500.300
22932717,2012-08-26T00:00:00,Double-Blind Method,N05.715.360.780.320
22932717,2012-08-26T00:00:00,Double-Blind Method,N06.850.520.445.300
22932717,2012-08-26T00:00:00,Heart Failure,C14.280.434
22932717,2012-08-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22932717,2012-08-26T00:00:00,Middle Aged,M01.060.116.630
22932717,2012-08-26T00:00:00,Peptide Fragments,D12.644.541
22932717,2012-08-26T00:00:00,Stroke Volume,E01.370.370.380.150.700
22932717,2012-08-26T00:00:00,Stroke Volume,G09.330.380.124.882
22924759,2012-08-27T00:00:00,Antioxidants,D27.505.519.217
22924759,2012-08-27T00:00:00,Antioxidants,D27.505.696.706.125
22924759,2012-08-27T00:00:00,Antioxidants,D27.720.799.047
22924759,2012-08-27T00:00:00,Biological Assay,E05.091
22924759,2012-08-27T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
22924759,2012-08-27T00:00:00,Mass Spectrometry,E05.196.566
22924759,2012-08-27T00:00:00,Reactive Oxygen Species,D01.339.431
22924759,2012-08-27T00:00:00,Reactive Oxygen Species,D01.650.775
22966240,2012-08-27T00:00:00,Adult,M01.060.116
22966240,2012-08-27T00:00:00,Aged,M01.060.116.100
22966240,2012-08-27T00:00:00,Gene Expression Profiling,E05.393.332
22966240,2012-08-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22966240,2012-08-27T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
22966240,2012-08-27T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
22966240,2012-08-27T00:00:00,MAP Kinase Signaling System,G02.111.087.800.560
22966240,2012-08-27T00:00:00,MAP Kinase Signaling System,G02.149.115.800.560
22966240,2012-08-27T00:00:00,MAP Kinase Signaling System,G03.495.553.560
22966240,2012-08-27T00:00:00,MAP Kinase Signaling System,G04.299.880.560
22966240,2012-08-27T00:00:00,Middle Aged,M01.060.116.630
22966240,2012-08-27T00:00:00,Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567
22966240,2012-08-27T00:00:00,Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750
22966240,2012-08-27T00:00:00,Mitogen-Activated Protein Kinases,D12.644.360.450
22966240,2012-08-27T00:00:00,Mitogen-Activated Protein Kinases,D12.776.476.450
22966240,2012-08-27T00:00:00,Phosphorylation,G02.111.087.677
22966240,2012-08-27T00:00:00,Phosphorylation,G02.149.115.677
22966240,2012-08-27T00:00:00,Phosphorylation,G02.149.465.700
22966240,2012-08-27T00:00:00,Phosphorylation,G02.607.750.700
22966240,2012-08-27T00:00:00,Phosphorylation,G03.495.790
22966240,2012-08-27T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
22966240,2012-08-27T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
22966240,2012-08-27T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
22966240,2012-08-27T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
22966240,2012-08-27T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
22966240,2012-08-27T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
22966240,2012-08-27T00:00:00,Transforming Growth Factor beta,D23.529.374.687
22966240,2012-08-27T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
22966240,2012-08-27T00:00:00,Transforming Growth Factor beta,D23.529.960.720
22966240,2012-08-27T00:00:00,Young Adult,M01.060.116.815
22930484,2012-08-28T00:00:00,"Hearing Loss, Sensorineural",C09.218.458.341.887
22930484,2012-08-28T00:00:00,"Hearing Loss, Sensorineural",C10.597.751.418.341.887
22930484,2012-08-28T00:00:00,"Hearing Loss, Sensorineural",C23.888.592.763.393.341.887
22930484,2012-08-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22930484,2012-08-28T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
22930484,2012-08-28T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
22930484,2012-08-28T00:00:00,Temporal Bone,A02.835.232.781.885
22930484,2012-08-28T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
22930484,2012-08-28T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
22930484,2012-08-28T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
22930484,2012-08-28T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
22930484,2012-08-28T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
22930484,2012-08-28T00:00:00,Vestibulocochlear Nerve Diseases,C09.218.807.800
22930484,2012-08-28T00:00:00,Vestibulocochlear Nerve Diseases,C10.292.910
22930778,2012-08-28T00:00:00,Adolescent,M01.060.057
22930778,2012-08-28T00:00:00,Albuterol,D02.033.100.291.057
22930778,2012-08-28T00:00:00,Albuterol,D02.092.063.291.057
22930778,2012-08-28T00:00:00,Albuterol,D02.092.471.683.061
22930778,2012-08-28T00:00:00,Asthma,C08.127.108
22930778,2012-08-28T00:00:00,Asthma,C08.381.495.108
22930778,2012-08-28T00:00:00,Asthma,C08.674.095
22930778,2012-08-28T00:00:00,Asthma,C20.543.480.680.095
22930778,2012-08-28T00:00:00,Bronchodilator Agents,D27.505.696.663.050.110
22930778,2012-08-28T00:00:00,Bronchodilator Agents,D27.505.954.796.050.100
22930778,2012-08-28T00:00:00,Child,M01.060.406
22930778,2012-08-28T00:00:00,"Child, Preschool",M01.060.406.448
22930778,2012-08-28T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
22930778,2012-08-28T00:00:00,"Emergency Service, Hospital",N02.421.297.195
22930778,2012-08-28T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
22930778,2012-08-28T00:00:00,Hospitalization,E02.760.400
22930778,2012-08-28T00:00:00,Hospitalization,N02.421.585.400
22930778,2012-08-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22930778,2012-08-28T00:00:00,Infant,M01.060.703
22930778,2012-08-28T00:00:00,Length of Stay,E02.760.400.480
22930778,2012-08-28T00:00:00,Length of Stay,N02.421.585.400.480
22930778,2012-08-28T00:00:00,Nebulizers and Vaporizers,E07.605
22930778,2012-08-28T00:00:00,Nebulizers and Vaporizers,E07.858.400
22930778,2012-08-28T00:00:00,Regression Analysis,E05.318.740.750
22930778,2012-08-28T00:00:00,Regression Analysis,N05.715.360.750.695
22930778,2012-08-28T00:00:00,Regression Analysis,N06.850.520.830.750
22930778,2012-08-28T00:00:00,Treatment Outcome,E01.789.800
22930778,2012-08-28T00:00:00,Treatment Outcome,N04.761.559.590.800
22930778,2012-08-28T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22933581,2012-08-28T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.500.150
22933581,2012-08-28T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.825.500.150
22933581,2012-08-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22933581,2012-08-28T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
22933581,2012-08-28T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
22933581,2012-08-28T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
22933581,2012-08-28T00:00:00,Pilot Projects,E05.318.760.750
22933581,2012-08-28T00:00:00,Pilot Projects,E05.337.737
22933581,2012-08-28T00:00:00,Pilot Projects,N05.715.360.775.625
22933581,2012-08-28T00:00:00,Pilot Projects,N06.850.520.450.720
22933581,2012-08-28T00:00:00,Stroke,C10.228.140.300.775
22933581,2012-08-28T00:00:00,Stroke,C14.907.253.855
22935384,2012-08-28T00:00:00,Animals,B01.050
22935384,2012-08-28T00:00:00,Clinical Trials as Topic,E05.318.760.535
22935384,2012-08-28T00:00:00,Clinical Trials as Topic,E05.337.250
22935384,2012-08-28T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
22935384,2012-08-28T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
22935384,2012-08-28T00:00:00,Gene Transfer Techniques,E05.393.350
22935384,2012-08-28T00:00:00,Genetic Vectors,G05.360.337
22935384,2012-08-28T00:00:00,Heart Failure,C14.280.434
22935384,2012-08-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22935384,2012-08-28T00:00:00,Myocardial Ischemia,C14.280.647
22935384,2012-08-28T00:00:00,Myocardial Ischemia,C14.907.585
22935384,2012-08-28T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
22935384,2012-08-28T00:00:00,Ventricular Remodeling,C23.300.985
22935384,2012-08-28T00:00:00,Ventricular Remodeling,G09.330.190.962.975
22939855,2012-08-28T00:00:00,Age Factors,N05.715.350.075
22939855,2012-08-28T00:00:00,Age Factors,N06.850.490.250
22939855,2012-08-28T00:00:00,Double-Blind Method,E05.318.780.300
22939855,2012-08-28T00:00:00,Double-Blind Method,E05.581.500.300
22939855,2012-08-28T00:00:00,Double-Blind Method,N05.715.360.780.320
22939855,2012-08-28T00:00:00,Double-Blind Method,N06.850.520.445.300
22939855,2012-08-28T00:00:00,"Heart Defects, Congenital",C14.240.400
22939855,2012-08-28T00:00:00,"Heart Defects, Congenital",C14.280.400
22939855,2012-08-28T00:00:00,"Heart Defects, Congenital",C16.131.240.400
22939855,2012-08-28T00:00:00,Heart Transplantation,E04.100.376.475
22939855,2012-08-28T00:00:00,Heart Transplantation,E04.928.220.390
22939855,2012-08-28T00:00:00,Heart Transplantation,E04.936.450.475
22939855,2012-08-28T00:00:00,Heart Ventricles,A07.541.560
22939855,2012-08-28T00:00:00,Hospital Mortality,E05.318.308.985.550.400
22939855,2012-08-28T00:00:00,Hospital Mortality,L01.280.975.550.400
22939855,2012-08-28T00:00:00,Hospital Mortality,N01.224.935.698.400
22939855,2012-08-28T00:00:00,Hospital Mortality,N06.850.505.400.975.550.400
22939855,2012-08-28T00:00:00,Hospital Mortality,N06.850.520.308.985.550.400
22939855,2012-08-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22939855,2012-08-28T00:00:00,Infant,M01.060.703
22939855,2012-08-28T00:00:00,"Infant, Newborn",M01.060.703.520
22939855,2012-08-28T00:00:00,Length of Stay,E02.760.400.480
22939855,2012-08-28T00:00:00,Length of Stay,N02.421.585.400.480
22939855,2012-08-28T00:00:00,North America,Z01.107.567
22939855,2012-08-28T00:00:00,Patient Selection,E05.581.500.653
22939855,2012-08-28T00:00:00,Patient Selection,N04.590.731
22939855,2012-08-28T00:00:00,Reoperation,E04.690
22939855,2012-08-28T00:00:00,"Respiration, Artificial",E02.365.647.729
22939855,2012-08-28T00:00:00,"Respiration, Artificial",E02.880.820
22939855,2012-08-28T00:00:00,Risk Assessment,E05.318.740.600.800.715
22939855,2012-08-28T00:00:00,Risk Assessment,N04.452.871.715
22939855,2012-08-28T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
22939855,2012-08-28T00:00:00,Risk Assessment,N06.850.505.715
22939855,2012-08-28T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
22939855,2012-08-28T00:00:00,Risk Factors,E05.318.740.600.800.725
22939855,2012-08-28T00:00:00,Risk Factors,N05.715.350.200.700
22939855,2012-08-28T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22939855,2012-08-28T00:00:00,Risk Factors,N06.850.490.625.750
22939855,2012-08-28T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22939855,2012-08-28T00:00:00,Time Factors,G01.910.857
22939855,2012-08-28T00:00:00,Treatment Outcome,E01.789.800
22939855,2012-08-28T00:00:00,Treatment Outcome,N04.761.559.590.800
22939855,2012-08-28T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22954524,2012-08-28T00:00:00,General Surgery,H02.403.810.300
22954524,2012-08-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22954524,2012-08-28T00:00:00,Periodicals as Topic,L01.178.682.829.678
22954524,2012-08-28T00:00:00,United States,Z01.107.567.875
22939900,2012-08-30T00:00:00,Animals,B01.050
22939900,2012-08-30T00:00:00,"Carcinoma, Renal Cell",C04.557.470.200.025.390
22939900,2012-08-30T00:00:00,"Carcinoma, Renal Cell",C04.588.945.947.535.160
22939900,2012-08-30T00:00:00,"Carcinoma, Renal Cell",C12.758.820.750.160
22939900,2012-08-30T00:00:00,"Carcinoma, Renal Cell",C12.777.419.473.160
22939900,2012-08-30T00:00:00,"Carcinoma, Renal Cell",C13.351.937.820.535.160
22939900,2012-08-30T00:00:00,"Carcinoma, Renal Cell",C13.351.968.419.473.160
22939900,2012-08-30T00:00:00,Cholesterol,D04.808.247.222.284
22939900,2012-08-30T00:00:00,Cholesterol,D04.808.247.808.197
22939900,2012-08-30T00:00:00,Cholesterol,D10.570.938.208
22939900,2012-08-30T00:00:00,Cholesterol,D10.851.208
22939900,2012-08-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22939900,2012-08-30T00:00:00,Kidney Neoplasms,C04.588.945.947.535
22939900,2012-08-30T00:00:00,Kidney Neoplasms,C12.758.820.750
22939900,2012-08-30T00:00:00,Kidney Neoplasms,C12.777.419.473
22939900,2012-08-30T00:00:00,Kidney Neoplasms,C13.351.937.820.535
22939900,2012-08-30T00:00:00,Kidney Neoplasms,C13.351.968.419.473
22939900,2012-08-30T00:00:00,Lipids,D10
22939900,2012-08-30T00:00:00,Mevalonic Acid,D02.241.511.579
22939900,2012-08-30T00:00:00,Obesity,C18.654.726.500
22939900,2012-08-30T00:00:00,Obesity,C23.888.144.699.500
22939900,2012-08-30T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
22939900,2012-08-30T00:00:00,Obesity,G07.100.100.160.120.699.500
22881392,2012-08-31T00:00:00,Animals,B01.050
22881392,2012-08-31T00:00:00,Cattle,B01.050.150.900.649.077.380.271
22881392,2012-08-31T00:00:00,Cell Line,A11.251.210
22881392,2012-08-31T00:00:00,Gold,D01.268.556.322
22881392,2012-08-31T00:00:00,Gold,D01.268.956.186
22881392,2012-08-31T00:00:00,Gold,D01.552.544.322
22881392,2012-08-31T00:00:00,Metal Nanoparticles,J01.637.512.600.500
22881392,2012-08-31T00:00:00,"Serum Albumin, Bovine",D12.776.034.841.540
22881392,2012-08-31T00:00:00,"Serum Albumin, Bovine",D12.776.124.727.540
22881392,2012-08-31T00:00:00,Silver,D01.268.556.812
22881392,2012-08-31T00:00:00,Silver,D01.268.956.843
22881392,2012-08-31T00:00:00,Silver,D01.552.544.812
22881392,2012-08-31T00:00:00,"Spectrum Analysis, Raman",E05.196.822.860
22881392,2012-08-31T00:00:00,"Spectrum Analysis, Raman",E05.196.867.890
22881392,2012-08-31T00:00:00,Surface Properties,G02.842.850
22935961,2012-08-31T00:00:00,Acetylcysteine,D02.886.030.230.259
22935961,2012-08-31T00:00:00,Acetylcysteine,D12.125.166.230.259
22935961,2012-08-31T00:00:00,Apoptosis,G04.299.139.160
22935961,2012-08-31T00:00:00,Cell Survival,G04.299.316
22935961,2012-08-31T00:00:00,Cyclosporine,D04.345.566.235.300
22935961,2012-08-31T00:00:00,Cyclosporine,D12.644.641.235.300
22935961,2012-08-31T00:00:00,Diabetic Retinopathy,C11.768.257
22935961,2012-08-31T00:00:00,Diabetic Retinopathy,C14.907.320.382
22935961,2012-08-31T00:00:00,Diabetic Retinopathy,C19.246.099.500.382
22935961,2012-08-31T00:00:00,Enzyme Inhibitors,D27.505.519.389
22935961,2012-08-31T00:00:00,Heat-Shock Proteins,D12.776.580.216
22935961,2012-08-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22935961,2012-08-31T00:00:00,"Lipoproteins, LDL",D10.532.515
22935961,2012-08-31T00:00:00,"Lipoproteins, LDL",D12.776.521.550
22935961,2012-08-31T00:00:00,Mitochondria,A11.284.430.214.190.875.564
22935961,2012-08-31T00:00:00,Mitochondria,A11.284.835.626
22935961,2012-08-31T00:00:00,Oxidative Stress,G03.495.710
22935961,2012-08-31T00:00:00,Oxidative Stress,G07.700.830.750
22935961,2012-08-31T00:00:00,Retina,A09.371.729
22935961,2012-08-31T00:00:00,Retinal Vessels,A07.231.611
22942178,2012-08-31T00:00:00,Animals,B01.050
22942178,2012-08-31T00:00:00,Blood Pressure,E01.370.600.875.249
22942178,2012-08-31T00:00:00,Blood Pressure,G09.330.380.076
22942178,2012-08-31T00:00:00,Collagen,D05.750.078.280
22942178,2012-08-31T00:00:00,Collagen,D12.776.860.300.250
22942178,2012-08-31T00:00:00,"Disease Models, Animal",C22.232
22942178,2012-08-31T00:00:00,"Disease Models, Animal",E05.598.500
22942178,2012-08-31T00:00:00,"Disease Models, Animal",E05.599.395.080
22942178,2012-08-31T00:00:00,Fibroblasts,A11.329.228
22942178,2012-08-31T00:00:00,Fibroblasts,A11.872.228
22942178,2012-08-31T00:00:00,Fibrosis,C23.550.355
22942178,2012-08-31T00:00:00,Myocardium,A02.633.580
22942178,2012-08-31T00:00:00,Myocardium,A07.541.704
22942178,2012-08-31T00:00:00,Myocardium,A10.690.552.750
22942178,2012-08-31T00:00:00,Osteonectin,D12.776.157.125.715
22942178,2012-08-31T00:00:00,Osteonectin,D12.776.395.600
22942178,2012-08-31T00:00:00,Procollagen,D12.776.811.690
22942178,2012-08-31T00:00:00,Procollagen,D12.776.860.300.250.600
22942178,2012-08-31T00:00:00,Time Factors,G01.910.857
22942178,2012-08-31T00:00:00,"Ventricular Dysfunction, Right",C14.280.945.910
22124619,2012-09-01T00:00:00,African Americans,M01.686.508.100.100
22124619,2012-09-01T00:00:00,African Americans,M01.686.754.100
22124619,2012-09-01T00:00:00,Community-Based Participatory Research,N05.425.104
22124619,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22124619,2012-09-01T00:00:00,Patient Education as Topic,I02.233.332.500
22124619,2012-09-01T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
22124619,2012-09-01T00:00:00,Patient Education as Topic,N02.421.726.407.680
22124619,2012-09-01T00:00:00,Peer Group,F01.829.316.483
22124619,2012-09-01T00:00:00,Pilot Projects,E05.318.760.750
22124619,2012-09-01T00:00:00,Pilot Projects,E05.337.737
22124619,2012-09-01T00:00:00,Pilot Projects,N05.715.360.775.625
22124619,2012-09-01T00:00:00,Pilot Projects,N06.850.520.450.720
22124619,2012-09-01T00:00:00,Smoking Cessation,F01.145.940.700
22124619,2012-09-01T00:00:00,Tobacco,B01.650.388.100.905.900
22124619,2012-09-01T00:00:00,Urban Population,N01.600.900
22187108,2012-09-01T00:00:00,Adolescent,M01.060.057
22187108,2012-09-01T00:00:00,Child,M01.060.406
22187108,2012-09-01T00:00:00,"Child Development Disorders, Pervasive",F03.550.325
22187108,2012-09-01T00:00:00,Developmental Disabilities,F03.550.362
22187108,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22187108,2012-09-01T00:00:00,South Carolina,Z01.107.567.875.075.662
22187108,2012-09-01T00:00:00,South Carolina,Z01.107.567.875.750.700
22277251,2012-09-01T00:00:00,Caveolin 1,D12.644.360.024.264
22277251,2012-09-01T00:00:00,Caveolin 1,D12.776.157.057.010
22277251,2012-09-01T00:00:00,Caveolin 1,D12.776.476.024.280
22277251,2012-09-01T00:00:00,Caveolin 1,D12.776.543.990.100.500
22277251,2012-09-01T00:00:00,Caveolin 1,D12.776.744.287
22277251,2012-09-01T00:00:00,Connective Tissue Growth Factor,D12.644.276.200.100
22277251,2012-09-01T00:00:00,Connective Tissue Growth Factor,D12.776.467.200.100
22277251,2012-09-01T00:00:00,Connective Tissue Growth Factor,D12.776.860.300.200.100
22277251,2012-09-01T00:00:00,Connective Tissue Growth Factor,D23.529.237.100
22277251,2012-09-01T00:00:00,Down-Regulation,G02.111.087.225
22277251,2012-09-01T00:00:00,Down-Regulation,G02.149.115.225
22277251,2012-09-01T00:00:00,Down-Regulation,G05.355.315.200
22277251,2012-09-01T00:00:00,Down-Regulation,G07.690.812.230
22277251,2012-09-01T00:00:00,Down-Regulation,G07.700.680.230
22277251,2012-09-01T00:00:00,Fibroblasts,A11.329.228
22277251,2012-09-01T00:00:00,Fibroblasts,A11.872.228
22277251,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22277251,2012-09-01T00:00:00,Phosphorylation,G02.111.087.677
22277251,2012-09-01T00:00:00,Phosphorylation,G02.149.115.677
22277251,2012-09-01T00:00:00,Phosphorylation,G02.149.465.700
22277251,2012-09-01T00:00:00,Phosphorylation,G02.607.750.700
22277251,2012-09-01T00:00:00,Phosphorylation,G03.495.790
22277251,2012-09-01T00:00:00,"Scleroderma, Systemic",C17.300.799
22277251,2012-09-01T00:00:00,"Scleroderma, Systemic",C17.800.784
22277251,2012-09-01T00:00:00,Signal Transduction,G02.111.087.800
22277251,2012-09-01T00:00:00,Signal Transduction,G02.149.115.800
22277251,2012-09-01T00:00:00,Signal Transduction,G04.299.880
22277251,2012-09-01T00:00:00,Skin,A17.815
22277251,2012-09-01T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
22277251,2012-09-01T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
22277251,2012-09-01T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
22277251,2012-09-01T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
22277251,2012-09-01T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
22277251,2012-09-01T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
22277251,2012-09-01T00:00:00,Transforming Growth Factor beta,D23.529.374.687
22277251,2012-09-01T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
22277251,2012-09-01T00:00:00,Transforming Growth Factor beta,D23.529.960.720
22383668,2012-09-01T00:00:00,Adolescent,M01.060.057
22383668,2012-09-01T00:00:00,Adult,M01.060.116
22383668,2012-09-01T00:00:00,Alleles,G05.360.340.024.340.030
22383668,2012-09-01T00:00:00,Biological Markers,D23.101
22383668,2012-09-01T00:00:00,Child,M01.060.406
22383668,2012-09-01T00:00:00,Cystic Fibrosis,C06.689.202
22383668,2012-09-01T00:00:00,Cystic Fibrosis,C08.381.187
22383668,2012-09-01T00:00:00,Cystic Fibrosis,C16.320.190
22383668,2012-09-01T00:00:00,Cystic Fibrosis,C16.614.213
22383668,2012-09-01T00:00:00,Cystic Fibrosis Transmembrane Conductance Regulator,D12.776.157.530.400.175.125
22383668,2012-09-01T00:00:00,Cystic Fibrosis Transmembrane Conductance Regulator,D12.776.543.550.425.175.125
22383668,2012-09-01T00:00:00,Cystic Fibrosis Transmembrane Conductance Regulator,D12.776.543.585.400.175.125
22383668,2012-09-01T00:00:00,Double-Blind Method,E05.318.780.300
22383668,2012-09-01T00:00:00,Double-Blind Method,E05.581.500.300
22383668,2012-09-01T00:00:00,Double-Blind Method,N05.715.360.780.320
22383668,2012-09-01T00:00:00,Double-Blind Method,N06.850.520.445.300
22383668,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22383668,2012-09-01T00:00:00,Middle Aged,M01.060.116.630
22383668,2012-09-01T00:00:00,Mutation,G05.365.590
22383668,2012-09-01T00:00:00,Pharmacogenetics,H01.158.273.343.750
22383668,2012-09-01T00:00:00,Pharmacogenetics,H01.158.703.052
22383668,2012-09-01T00:00:00,Pharmacogenetics,H02.628.479
22383668,2012-09-01T00:00:00,Quinolones,D03.438.810.835
22383668,2012-09-01T00:00:00,Treatment Outcome,E01.789.800
22383668,2012-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
22383668,2012-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22383668,2012-09-01T00:00:00,Young Adult,M01.060.116.815
22565603,2012-09-01T00:00:00,Aged,M01.060.116.100
22565603,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22565603,2012-09-01T00:00:00,Middle Aged,M01.060.116.630
22565603,2012-09-01T00:00:00,Pancreatitis,C06.689.750
22566561,2012-09-01T00:00:00,Adolescent,M01.060.057
22566561,2012-09-01T00:00:00,Adult,M01.060.116
22566561,2012-09-01T00:00:00,Age Factors,N05.715.350.075
22566561,2012-09-01T00:00:00,Age Factors,N06.850.490.250
22566561,2012-09-01T00:00:00,Child,M01.060.406
22566561,2012-09-01T00:00:00,"Child Abuse, Sexual",I01.198.240.748.300
22566561,2012-09-01T00:00:00,"Child Abuse, Sexual",I01.198.240.856.350.250.255
22566561,2012-09-01T00:00:00,"Child Abuse, Sexual",I01.880.735.900.350.250.255
22566561,2012-09-01T00:00:00,"Child Abuse, Sexual",I01.880.787.293.292.325
22566561,2012-09-01T00:00:00,Crime Victims,M01.135
22566561,2012-09-01T00:00:00,Health Surveys,E05.318.308.250
22566561,2012-09-01T00:00:00,Health Surveys,N05.715.360.300.375
22566561,2012-09-01T00:00:00,Health Surveys,N06.850.520.308.250
22566561,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22566561,2012-09-01T00:00:00,Mass Screening,E01.370.500
22566561,2012-09-01T00:00:00,Mass Screening,E05.318.308.250.580
22566561,2012-09-01T00:00:00,Mass Screening,N02.421.143.827.233.443
22566561,2012-09-01T00:00:00,Mass Screening,N02.421.726.233.443
22566561,2012-09-01T00:00:00,Mass Screening,N05.715.360.300.375.500
22566561,2012-09-01T00:00:00,Mass Screening,N06.850.520.308.250.580
22566561,2012-09-01T00:00:00,Mass Screening,N06.850.780.500
22566561,2012-09-01T00:00:00,Rape,I01.198.240.748.640
22566561,2012-09-01T00:00:00,Risk Factors,E05.318.740.600.800.725
22566561,2012-09-01T00:00:00,Risk Factors,N05.715.350.200.700
22566561,2012-09-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22566561,2012-09-01T00:00:00,Risk Factors,N06.850.490.625.750
22566561,2012-09-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22566561,2012-09-01T00:00:00,Sex Offenses,I01.198.240.748
22566561,2012-09-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
22566561,2012-09-01T00:00:00,United States,Z01.107.567.875
22566561,2012-09-01T00:00:00,Young Adult,M01.060.116.815
22739562,2012-09-01T00:00:00,Adult,M01.060.116
22739562,2012-09-01T00:00:00,"Antimetabolites, Antineoplastic",D27.505.519.186.144
22739562,2012-09-01T00:00:00,"Antimetabolites, Antineoplastic",D27.505.954.248.144
22739562,2012-09-01T00:00:00,"Antimetabolites, Antineoplastic",D27.888.569.042.030
22739562,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22739562,2012-09-01T00:00:00,"Translocation, Genetic",C23.550.210.870
22739562,2012-09-01T00:00:00,"Translocation, Genetic",G05.355.600.860
22739562,2012-09-01T00:00:00,"Translocation, Genetic",G05.365.590.175.870
22739562,2012-09-01T00:00:00,Treatment Outcome,E01.789.800
22739562,2012-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
22739562,2012-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22850423,2012-09-01T00:00:00,Adolescent,M01.060.057
22850423,2012-09-01T00:00:00,Bone Plates,E07.695.125
22850423,2012-09-01T00:00:00,Bone Plates,E07.858.442.660.110
22850423,2012-09-01T00:00:00,Bone Plates,E07.858.690.650.110
22850423,2012-09-01T00:00:00,Child,M01.060.406
22850423,2012-09-01T00:00:00,Critical Care,E02.760.190
22850423,2012-09-01T00:00:00,Critical Care,N02.421.585.190
22850423,2012-09-01T00:00:00,External Fixators,E07.858.442.660.430
22850423,2012-09-01T00:00:00,External Fixators,E07.858.690.650.430
22850423,2012-09-01T00:00:00,Femoral Fractures,C21.866.404.061
22850423,2012-09-01T00:00:00,Femoral Fractures,C21.866.558.276
22850423,2012-09-01T00:00:00,"Fracture Fixation, Internal",E04.555.300.300
22850423,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22850423,2012-09-01T00:00:00,Multiple Trauma,C21.866.640
22850423,2012-09-01T00:00:00,Treatment Outcome,E01.789.800
22850423,2012-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
22850423,2012-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22858715,2012-09-01T00:00:00,Adult,M01.060.116
22858715,2012-09-01T00:00:00,Aged,M01.060.116.100
22858715,2012-09-01T00:00:00,Dexamethasone,D04.808.745.432.769.344
22858715,2012-09-01T00:00:00,Dexamethasone,D04.808.908.238
22858715,2012-09-01T00:00:00,Double-Blind Method,E05.318.780.300
22858715,2012-09-01T00:00:00,Double-Blind Method,E05.581.500.300
22858715,2012-09-01T00:00:00,Double-Blind Method,N05.715.360.780.320
22858715,2012-09-01T00:00:00,Double-Blind Method,N06.850.520.445.300
22858715,2012-09-01T00:00:00,Glucocorticoids,D06.472.040.543
22858715,2012-09-01T00:00:00,Glucocorticoids,D27.505.696.399.472.488
22858715,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22858715,2012-09-01T00:00:00,Middle Aged,M01.060.116.630
22858715,2012-09-01T00:00:00,Treatment Outcome,E01.789.800
22858715,2012-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
22858715,2012-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22858715,2012-09-01T00:00:00,Vertigo,C09.218.568.900.883
22858715,2012-09-01T00:00:00,Vertigo,C10.597.951
22858715,2012-09-01T00:00:00,Vertigo,C23.888.592.958
22882394,2012-09-01T00:00:00,African Americans,M01.686.508.100.100
22882394,2012-09-01T00:00:00,African Americans,M01.686.754.100
22882394,2012-09-01T00:00:00,Alcoholism,C21.739.100.250
22882394,2012-09-01T00:00:00,Alcoholism,F03.900.100.350
22882394,2012-09-01T00:00:00,"Depressive Disorder, Major",F03.600.300.375
22882394,2012-09-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
22882394,2012-09-01T00:00:00,Health Surveys,E05.318.308.250
22882394,2012-09-01T00:00:00,Health Surveys,N05.715.360.300.375
22882394,2012-09-01T00:00:00,Health Surveys,N06.850.520.308.250
22882394,2012-09-01T00:00:00,Hispanic Americans,M01.686.754.441
22882394,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22882394,2012-09-01T00:00:00,Marijuana Abuse,C21.739.635
22882394,2012-09-01T00:00:00,Marijuana Abuse,F03.900.635
22882394,2012-09-01T00:00:00,Regression Analysis,E05.318.740.750
22882394,2012-09-01T00:00:00,Regression Analysis,N05.715.360.750.695
22882394,2012-09-01T00:00:00,Regression Analysis,N06.850.520.830.750
22882394,2012-09-01T00:00:00,United States,Z01.107.567.875
22906448,2012-09-01T00:00:00,Adolescent,M01.060.057
22906448,2012-09-01T00:00:00,Antihypertensive Agents,D27.505.954.411.162
22906448,2012-09-01T00:00:00,Child,M01.060.406
22906448,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22906448,2012-09-01T00:00:00,Intraocular Pressure,G14.440
22906448,2012-09-01T00:00:00,"Lens Implantation, Intraocular",E04.540.825.600
22906448,2012-09-01T00:00:00,Ocular Hypertension,C11.525
22906448,2012-09-01T00:00:00,Postoperative Complications,C23.550.767
22906448,2012-09-01T00:00:00,Risk Factors,E05.318.740.600.800.725
22906448,2012-09-01T00:00:00,Risk Factors,N05.715.350.200.700
22906448,2012-09-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22906448,2012-09-01T00:00:00,Risk Factors,N06.850.490.625.750
22906448,2012-09-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22906448,2012-09-01T00:00:00,Young Adult,M01.060.116.815
22906451,2012-09-01T00:00:00,Cataract,C11.510.245
22906451,2012-09-01T00:00:00,Cataract Extraction,E04.540.825.249
22906451,2012-09-01T00:00:00,Child,M01.060.406
22906451,2012-09-01T00:00:00,"Child, Preschool",M01.060.406.448
22906451,2012-09-01T00:00:00,Glucocorticoids,D06.472.040.543
22906451,2012-09-01T00:00:00,Glucocorticoids,D27.505.696.399.472.488
22906451,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22914125,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22914125,2012-09-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
22914125,2012-09-01T00:00:00,Lung Neoplasms,C08.381.540
22914125,2012-09-01T00:00:00,Lung Neoplasms,C08.785.520
22914125,2012-09-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
22914125,2012-09-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
22914125,2012-09-01T00:00:00,Neoplasm Staging,E01.370.550
22914125,2012-09-01T00:00:00,Positron-Emission Tomography,E01.370.350.350.800.700
22914125,2012-09-01T00:00:00,Positron-Emission Tomography,E01.370.350.600.350.800.399
22914125,2012-09-01T00:00:00,Positron-Emission Tomography,E01.370.350.710.800.399
22914125,2012-09-01T00:00:00,Positron-Emission Tomography,E01.370.350.825.800.399
22914125,2012-09-01T00:00:00,Positron-Emission Tomography,E01.370.384.730.800.399
22914125,2012-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
22914125,2012-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
22914125,2012-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
22914125,2012-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
22914125,2012-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
22915432,2012-09-01T00:00:00,Breast Neoplasms,C04.588.180
22915432,2012-09-01T00:00:00,Breast Neoplasms,C17.800.090.500
22915432,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22915432,2012-09-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
22915432,2012-09-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
22915432,2012-09-01T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
22915432,2012-09-01T00:00:00,Mammography,E01.370.350.700.500
22915432,2012-09-01T00:00:00,Middle Aged,M01.060.116.630
22915432,2012-09-01T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
22915432,2012-09-01T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
22915432,2012-09-01T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
22929426,2012-09-01T00:00:00,Delivery of Health Care,N04.590.374
22929426,2012-09-01T00:00:00,Delivery of Health Care,N05.300
22929426,2012-09-01T00:00:00,"Education, Medical",I02.358.399
22929426,2012-09-01T00:00:00,Electronic Health Records,E05.318.308.940.968.625.500
22929426,2012-09-01T00:00:00,Forecasting,I01.320
22929426,2012-09-01T00:00:00,Health Education,I02.233.332
22929426,2012-09-01T00:00:00,Health Education,N02.421.143.827.407
22929426,2012-09-01T00:00:00,Health Education,N02.421.726.407
22929426,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22929426,2012-09-01T00:00:00,Needs Assessment,I02.594
22929426,2012-09-01T00:00:00,Needs Assessment,N03.349.380.565
22929426,2012-09-01T00:00:00,Needs Assessment,N05.300.537
22929426,2012-09-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
22929426,2012-09-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
22929426,2012-09-01T00:00:00,Patient-Centered Care,N04.590.233.675
22929426,2012-09-01T00:00:00,Patient-Centered Care,N04.590.233.727.407
22929426,2012-09-01T00:00:00,Patient-Centered Care,N04.590.720
22929426,2012-09-01T00:00:00,United States,Z01.107.567.875
22929612,2012-09-01T00:00:00,"Glomerulonephritis, Membranoproliferative",C12.777.419.570.363.615
22929612,2012-09-01T00:00:00,"Glomerulonephritis, Membranoproliferative",C13.351.968.419.570.363.615
22929612,2012-09-01T00:00:00,"Glomerulonephritis, Membranoproliferative",C20.425
22929612,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22929612,2012-09-01T00:00:00,"Influenza, Human",C02.782.620.365
22929612,2012-09-01T00:00:00,"Influenza, Human",C08.730.310
22929612,2012-09-01T00:00:00,Treatment Outcome,E01.789.800
22929612,2012-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
22929612,2012-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22929612,2012-09-01T00:00:00,Young Adult,M01.060.116.815
22930117,2012-09-01T00:00:00,Adult,M01.060.116
22930117,2012-09-01T00:00:00,Attitude of Health Personnel,F01.100.050
22930117,2012-09-01T00:00:00,Attitude of Health Personnel,N05.300.100
22930117,2012-09-01T00:00:00,Clinical Competence,I02.399.630.210
22930117,2012-09-01T00:00:00,Clinical Competence,N04.761.210
22930117,2012-09-01T00:00:00,Family Practice,H02.403.280
22930117,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22930117,2012-09-01T00:00:00,Internship and Residency,I02.358.399.644
22930117,2012-09-01T00:00:00,Perception,F02.463.593
22930117,2012-09-01T00:00:00,Personnel Staffing and Scheduling,N04.452.677.650
22930117,2012-09-01T00:00:00,South Carolina,Z01.107.567.875.075.662
22930117,2012-09-01T00:00:00,South Carolina,Z01.107.567.875.750.700
22930117,2012-09-01T00:00:00,Workload,N04.452.677.950
22930122,2012-09-01T00:00:00,Family Practice,H02.403.280
22930122,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22930122,2012-09-01T00:00:00,Internship and Residency,I02.358.399.644
22930122,2012-09-01T00:00:00,Program Evaluation,E05.337.820
22930122,2012-09-01T00:00:00,Program Evaluation,N04.761.685
22930122,2012-09-01T00:00:00,Program Evaluation,N05.715.360.650
22930122,2012-09-01T00:00:00,"Quality Indicators, Health Care",N04.761.789
22930699,2012-09-01T00:00:00,Aged,M01.060.116.100
22930699,2012-09-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
22930699,2012-09-01T00:00:00,Alzheimer Disease,C10.574.945.249
22930699,2012-09-01T00:00:00,Alzheimer Disease,F03.087.400.100
22930699,2012-09-01T00:00:00,Apolipoproteins E,D10.532.091.500
22930699,2012-09-01T00:00:00,Apolipoproteins E,D12.776.070.400.500
22930699,2012-09-01T00:00:00,Apolipoproteins E,D12.776.521.120.500
22930699,2012-09-01T00:00:00,Dopamine Agents,D27.505.519.625.150
22930699,2012-09-01T00:00:00,Dopamine Agents,D27.505.696.577.150
22930699,2012-09-01T00:00:00,Double-Blind Method,E05.318.780.300
22930699,2012-09-01T00:00:00,Double-Blind Method,E05.581.500.300
22930699,2012-09-01T00:00:00,Double-Blind Method,N05.715.360.780.320
22930699,2012-09-01T00:00:00,Double-Blind Method,N06.850.520.445.300
22930699,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22930699,2012-09-01T00:00:00,Neuropsychological Tests,F04.711.513
22930699,2012-09-01T00:00:00,Piperidines,D03.383.621
22930699,2012-09-01T00:00:00,United States,Z01.107.567.875
22930717,2012-09-01T00:00:00,Heart Failure,C14.280.434
22930717,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22930717,2012-09-01T00:00:00,"Monitoring, Physiologic",E01.370.520
22930717,2012-09-01T00:00:00,Treatment Outcome,E01.789.800
22930717,2012-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
22930717,2012-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22933732,2012-09-01T00:00:00,"Education, Medical, Continuing",I02.358.212.350
22933732,2012-09-01T00:00:00,"Education, Medical, Continuing",I02.358.399.250
22933732,2012-09-01T00:00:00,Fellowships and Scholarships,N03.219.483.838.276
22933732,2012-09-01T00:00:00,Health Manpower,N02.350
22933732,2012-09-01T00:00:00,Health Manpower,N05.300.420.400
22933732,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22933732,2012-09-01T00:00:00,Physicians,M01.526.485.810
22933732,2012-09-01T00:00:00,Physicians,N02.360.810
22939223,2012-09-01T00:00:00,Heart Failure,C14.280.434
22939223,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22939223,2012-09-01T00:00:00,"Monitoring, Physiologic",E01.370.520
22939223,2012-09-01T00:00:00,Treatment Outcome,E01.789.800
22939223,2012-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
22939223,2012-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22940896,2012-09-01T00:00:00,Adolescent,M01.060.057
22940896,2012-09-01T00:00:00,Athletic Injuries,C21.866.115
22940896,2012-09-01T00:00:00,Brain Concussion,C10.228.140.199.250
22940896,2012-09-01T00:00:00,Brain Concussion,C10.900.300.087.125
22940896,2012-09-01T00:00:00,Brain Concussion,C10.900.300.350.300
22940896,2012-09-01T00:00:00,Brain Concussion,C21.866.260.118.150
22940896,2012-09-01T00:00:00,Brain Concussion,C21.866.915.300.200.150
22940896,2012-09-01T00:00:00,Brain Concussion,C21.866.974.150
22940896,2012-09-01T00:00:00,Brain Concussion,C21.866.974.382.200
22940896,2012-09-01T00:00:00,Child,M01.060.406
22940896,2012-09-01T00:00:00,Demography,I01.240
22940896,2012-09-01T00:00:00,Demography,N01.224
22940896,2012-09-01T00:00:00,Demography,N06.850.505.400
22940896,2012-09-01T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
22940896,2012-09-01T00:00:00,"Emergency Service, Hospital",N02.421.297.195
22940896,2012-09-01T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
22940896,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22941539,2012-09-01T00:00:00,Adsorption,G02.149.047
22941539,2012-09-01T00:00:00,Adsorption,G02.149.767.029
22941539,2012-09-01T00:00:00,Adsorption,G02.842.750.029
22941539,2012-09-01T00:00:00,Computer Simulation,L01.224.160
22941539,2012-09-01T00:00:00,Glass,J01.637.241.400
22941539,2012-09-01T00:00:00,Glass,J01.637.437
22941539,2012-09-01T00:00:00,Proteins,D12.776
22948324,2012-09-01T00:00:00,Adolescent,M01.060.057
22948324,2012-09-01T00:00:00,Adult,M01.060.116
22948324,2012-09-01T00:00:00,Attitude of Health Personnel,F01.100.050
22948324,2012-09-01T00:00:00,Attitude of Health Personnel,N05.300.100
22948324,2012-09-01T00:00:00,Child,M01.060.406
22948324,2012-09-01T00:00:00,Curriculum,I02.158
22948324,2012-09-01T00:00:00,"Education, Medical, Graduate",I02.358.337.350
22948324,2012-09-01T00:00:00,"Education, Medical, Graduate",I02.358.399.350
22948324,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22948324,2012-09-01T00:00:00,Internal Medicine,H02.403.429
22948324,2012-09-01T00:00:00,Internship and Residency,I02.358.399.644
22948324,2012-09-01T00:00:00,Pediatrics,H02.403.670
22948324,2012-09-01T00:00:00,Primary Health Care,N04.590.233.727
22948324,2012-09-01T00:00:00,Questionnaires,E05.318.308.750
22948324,2012-09-01T00:00:00,Questionnaires,L01.280.800
22948324,2012-09-01T00:00:00,Questionnaires,N05.715.360.300.695
22948324,2012-09-01T00:00:00,Questionnaires,N06.850.520.308.750
22948324,2012-09-01T00:00:00,Time Factors,G01.910.857
22948324,2012-09-01T00:00:00,Young Adult,M01.060.116.815
22948575,2012-09-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
22948575,2012-09-01T00:00:00,Clinical Trials as Topic,E05.337.250
22948575,2012-09-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
22948575,2012-09-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
22948575,2012-09-01T00:00:00,Critical Care,E02.760.190
22948575,2012-09-01T00:00:00,Critical Care,N02.421.585.190
22948575,2012-09-01T00:00:00,Evidence-Based Medicine,H02.249.750
22948575,2012-09-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
22948575,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22948575,2012-09-01T00:00:00,Intensive Care Units,N02.278.388.493
22948575,2012-09-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
22948575,2012-09-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
22948575,2012-09-01T00:00:00,United States,Z01.107.567.875
22956695,2012-09-01T00:00:00,Electronic Health Records,E05.318.308.940.968.625.500
22956695,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22956695,2012-09-01T00:00:00,Primary Health Care,N04.590.233.727
22956695,2012-09-01T00:00:00,Program Development,N04.452.760
22956695,2012-09-01T00:00:00,Qualitative Research,H01.770.644.241.850
22956695,2012-09-01T00:00:00,United States,Z01.107.567.875
22957915,2012-09-01T00:00:00,Adolescent,M01.060.057
22957915,2012-09-01T00:00:00,Adult,M01.060.116
22957915,2012-09-01T00:00:00,Aged,M01.060.116.100
22957915,2012-09-01T00:00:00,Consumer Satisfaction,N04.452.822.360
22957915,2012-09-01T00:00:00,Diet,E05.272
22957915,2012-09-01T00:00:00,Diet,G07.610.240
22957915,2012-09-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
22957915,2012-09-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
22957915,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22957915,2012-09-01T00:00:00,Middle Aged,M01.060.116.630
22957915,2012-09-01T00:00:00,Risk Factors,E05.318.740.600.800.725
22957915,2012-09-01T00:00:00,Risk Factors,N05.715.350.200.700
22957915,2012-09-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22957915,2012-09-01T00:00:00,Risk Factors,N06.850.490.625.750
22957915,2012-09-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22957915,2012-09-01T00:00:00,Young Adult,M01.060.116.815
22964196,2012-09-01T00:00:00,General Surgery,H02.403.810.300
22964196,2012-09-01T00:00:00,"History, 19th Century",K01.400.504.937
22964196,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22965322,2012-09-01T00:00:00,Algorithms,G17.035
22965322,2012-09-01T00:00:00,Algorithms,L01.224.050
22965322,2012-09-01T00:00:00,Anticoagulants,D27.505.954.502.119
22965322,2012-09-01T00:00:00,Antihypertensive Agents,D27.505.954.411.162
22965322,2012-09-01T00:00:00,Blood Coagulation Disorders,C15.378.100
22965322,2012-09-01T00:00:00,Cerebral Hemorrhage,C10.228.140.300.535.200
22965322,2012-09-01T00:00:00,Cerebral Hemorrhage,C14.907.253.573.200
22965322,2012-09-01T00:00:00,Cerebral Hemorrhage,C23.550.414.913.100
22965322,2012-09-01T00:00:00,Emergency Medical Services,N02.421.297
22965322,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22965322,2012-09-01T00:00:00,Hypertension,C14.907.489
22965322,2012-09-01T00:00:00,"Intracranial Hemorrhage, Hypertensive",C10.228.140.300.535.325
22965322,2012-09-01T00:00:00,"Intracranial Hemorrhage, Hypertensive",C14.907.253.573.350
22965322,2012-09-01T00:00:00,Neurosurgical Procedures,E04.525
22965322,2012-09-01T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
22965322,2012-09-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
22965322,2012-09-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
22965322,2012-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
22965322,2012-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
22965322,2012-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
22965322,2012-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
22965322,2012-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
22967738,2012-09-01T00:00:00,Aged,M01.060.116.100
22967738,2012-09-01T00:00:00,Aging,G07.700.320.124
22967738,2012-09-01T00:00:00,Evidence-Based Medicine,H02.249.750
22967738,2012-09-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
22967738,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22967738,2012-09-01T00:00:00,Presbycusis,C09.218.458.341.887.772
22967738,2012-09-01T00:00:00,Presbycusis,C10.597.751.418.341.887.772
22967738,2012-09-01T00:00:00,Presbycusis,C23.888.592.763.393.341.887.772
22967738,2012-09-01T00:00:00,Vestibulocochlear Nerve Diseases,C09.218.807.800
22967738,2012-09-01T00:00:00,Vestibulocochlear Nerve Diseases,C10.292.910
22990726,2012-09-01T00:00:00,Adult,M01.060.116
22990726,2012-09-01T00:00:00,Aged,M01.060.116.100
22990726,2012-09-01T00:00:00,Electroencephalography,E01.370.376.300
22990726,2012-09-01T00:00:00,Electroencephalography,E01.370.405.245
22990726,2012-09-01T00:00:00,"Epilepsy, Temporal Lobe",C10.228.140.490.360.290
22990726,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22990726,2012-09-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
22990726,2012-09-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
22990726,2012-09-01T00:00:00,Middle Aged,M01.060.116.630
22990726,2012-09-01T00:00:00,Seizures,C10.228.140.490.631
22990726,2012-09-01T00:00:00,Seizures,C10.597.742
22990726,2012-09-01T00:00:00,Seizures,C23.888.592.742
22990726,2012-09-01T00:00:00,Treatment Outcome,E01.789.800
22990726,2012-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
22990726,2012-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22990726,2012-09-01T00:00:00,Video Recording,L01.240.960
22990726,2012-09-01T00:00:00,Young Adult,M01.060.116.815
22991019,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22991019,2012-09-01T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
22991019,2012-09-01T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
22991019,2012-09-01T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
22991019,2012-09-01T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
22991019,2012-09-01T00:00:00,Middle Aged,M01.060.116.630
22991019,2012-09-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
22991019,2012-09-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
22991019,2012-09-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
22991019,2012-09-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
22991350,2012-09-01T00:00:00,Cardiovascular Agents,D27.505.954.411
22991350,2012-09-01T00:00:00,Combined Modality Therapy,E02.186
22991350,2012-09-01T00:00:00,"Constriction, Pathologic",C23.300.287
22991350,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22991350,2012-09-01T00:00:00,Intracranial Arteriosclerosis,C10.228.140.300.510.800
22991350,2012-09-01T00:00:00,Intracranial Arteriosclerosis,C14.907.137.126.372
22991350,2012-09-01T00:00:00,Intracranial Arteriosclerosis,C14.907.253.560.350
22991350,2012-09-01T00:00:00,Research Design,E05.581.500
22991350,2012-09-01T00:00:00,Research Design,H01.770.644.728
22991350,2012-09-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
22991350,2012-09-01T00:00:00,Risk Assessment,N04.452.871.715
22991350,2012-09-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
22991350,2012-09-01T00:00:00,Risk Assessment,N06.850.505.715
22991350,2012-09-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
22991350,2012-09-01T00:00:00,Risk Factors,E05.318.740.600.800.725
22991350,2012-09-01T00:00:00,Risk Factors,N05.715.350.200.700
22991350,2012-09-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22991350,2012-09-01T00:00:00,Risk Factors,N06.850.490.625.750
22991350,2012-09-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22991350,2012-09-01T00:00:00,Risk Reduction Behavior,F01.145.699
22991350,2012-09-01T00:00:00,Stents,E07.695.750
22991350,2012-09-01T00:00:00,Stroke,C10.228.140.300.775
22991350,2012-09-01T00:00:00,Stroke,C14.907.253.855
22991350,2012-09-01T00:00:00,Treatment Outcome,E01.789.800
22991350,2012-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
22991350,2012-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22993337,2012-09-01T00:00:00,African Americans,M01.686.508.100.100
22993337,2012-09-01T00:00:00,African Americans,M01.686.754.100
22993337,2012-09-01T00:00:00,Aged,M01.060.116.100
22993337,2012-09-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
22993337,2012-09-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
22993337,2012-09-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
22993337,2012-09-01T00:00:00,Case-Control Studies,E05.318.760.500.500
22993337,2012-09-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
22993337,2012-09-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
22993337,2012-09-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
22993337,2012-09-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
22993337,2012-09-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
22993337,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22993337,2012-09-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
22993337,2012-09-01T00:00:00,Lung Neoplasms,C08.381.540
22993337,2012-09-01T00:00:00,Lung Neoplasms,C08.785.520
22993337,2012-09-01T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.300.480.205.351
22993337,2012-09-01T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.300.480.525.700.100
22993337,2012-09-01T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.675.374.205.351
22993337,2012-09-01T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.675.374.525.700.100
22993337,2012-09-01T00:00:00,Middle Aged,M01.060.116.630
22993337,2012-09-01T00:00:00,"Polymorphism, Genetic",G05.365.795
22993337,2012-09-01T00:00:00,"Pulmonary Disease, Chronic Obstructive",C08.381.495.389
22993338,2012-09-01T00:00:00,African Americans,M01.686.508.100.100
22993338,2012-09-01T00:00:00,African Americans,M01.686.754.100
22993338,2012-09-01T00:00:00,Aged,M01.060.116.100
22993338,2012-09-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
22993338,2012-09-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
22993338,2012-09-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
22993338,2012-09-01T00:00:00,Case-Control Studies,E05.318.760.500.500
22993338,2012-09-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
22993338,2012-09-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
22993338,2012-09-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
22993338,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22993338,2012-09-01T00:00:00,Leukocyte Elastase,D08.811.277.656.300.760.560.500
22993338,2012-09-01T00:00:00,Leukocyte Elastase,D08.811.277.656.959.350.560.500
22993338,2012-09-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
22993338,2012-09-01T00:00:00,Lung Neoplasms,C08.381.540
22993338,2012-09-01T00:00:00,Lung Neoplasms,C08.785.520
22993338,2012-09-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
22993338,2012-09-01T00:00:00,"Pulmonary Disease, Chronic Obstructive",C08.381.495.389
22994222,2012-09-01T00:00:00,Brain Ischemia,C10.228.140.300.150
22994222,2012-09-01T00:00:00,Brain Ischemia,C14.907.253.092
22994222,2012-09-01T00:00:00,Efficiency,F02.784.692.351
22994222,2012-09-01T00:00:00,Emergency Medical Service Communication Systems,N02.421.297.058
22994222,2012-09-01T00:00:00,Emergency Medical Services,N02.421.297
22994222,2012-09-01T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
22994222,2012-09-01T00:00:00,"Emergency Service, Hospital",N02.421.297.195
22994222,2012-09-01T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
22994222,2012-09-01T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
22994222,2012-09-01T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
22994222,2012-09-01T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
22994222,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22994222,2012-09-01T00:00:00,Patient Care Team,N04.590.715
22994222,2012-09-01T00:00:00,Recombinant Proteins,D12.776.828
22994222,2012-09-01T00:00:00,Task Performance and Analysis,F02.784.412.846
22994222,2012-09-01T00:00:00,Task Performance and Analysis,F02.784.692.746
22994222,2012-09-01T00:00:00,Task Performance and Analysis,F02.808.600
22994222,2012-09-01T00:00:00,Telemedicine,H02.403.840
22994222,2012-09-01T00:00:00,Telemedicine,L01.178.847.652
22994222,2012-09-01T00:00:00,Telemedicine,N04.590.374.800
22994222,2012-09-01T00:00:00,Thrombolytic Therapy,E02.319.913
22994222,2012-09-01T00:00:00,Time Factors,G01.910.857
22994222,2012-09-01T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
22994222,2012-09-01T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
22994222,2012-09-01T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
22994222,2012-09-01T00:00:00,Tissue Plasminogen Activator,D23.119.970
22994222,2012-09-01T00:00:00,Transportation of Patients,E02.365.839
22994222,2012-09-01T00:00:00,Transportation of Patients,N02.421.297.879
22995085,2012-09-01T00:00:00,Aged,M01.060.116.100
22995085,2012-09-01T00:00:00,"Echocardiography, Transesophageal",E01.370.350.850.220.235
22995085,2012-09-01T00:00:00,"Echocardiography, Transesophageal",E01.370.370.380.220.235
22995085,2012-09-01T00:00:00,Heart Valve Prosthesis Implantation,E04.100.376.485
22995085,2012-09-01T00:00:00,Heart Valve Prosthesis Implantation,E04.650.410
22995085,2012-09-01T00:00:00,Heart Valve Prosthesis Implantation,E04.928.220.410
22995085,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22995085,2012-09-01T00:00:00,Mitral Valve,A07.541.510.507
22995887,2012-09-01T00:00:00,Aged,M01.060.116.100
22995887,2012-09-01T00:00:00,Aortic Valve,A07.541.510.110
22995887,2012-09-01T00:00:00,Aortic Valve Stenosis,C14.280.484.150
22995887,2012-09-01T00:00:00,Aortic Valve Stenosis,C14.280.955.249
22995887,2012-09-01T00:00:00,Heart Valve Prosthesis,E07.695.310
22995887,2012-09-01T00:00:00,Heart Valve Prosthesis Implantation,E04.100.376.485
22995887,2012-09-01T00:00:00,Heart Valve Prosthesis Implantation,E04.650.410
22995887,2012-09-01T00:00:00,Heart Valve Prosthesis Implantation,E04.928.220.410
22995887,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22995887,2012-09-01T00:00:00,Patient Selection,E05.581.500.653
22995887,2012-09-01T00:00:00,Patient Selection,N04.590.731
22995887,2012-09-01T00:00:00,Prosthesis Design,E05.320.550
22995887,2012-09-01T00:00:00,Prosthesis Design,E07.695.680
22995887,2012-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
22995887,2012-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
22995887,2012-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
22995887,2012-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
22995887,2012-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
22996707,2012-09-01T00:00:00,Child,M01.060.406
22996707,2012-09-01T00:00:00,"Ear, Inner",A09.246.631
22996707,2012-09-01T00:00:00,Hallermann's Syndrome,C05.116.099.370.231.427
22996707,2012-09-01T00:00:00,Hallermann's Syndrome,C05.660.207.231.427
22996707,2012-09-01T00:00:00,Hallermann's Syndrome,C16.131.621.207.231.427
22996707,2012-09-01T00:00:00,"Hearing Loss, Sensorineural",C09.218.458.341.887
22996707,2012-09-01T00:00:00,"Hearing Loss, Sensorineural",C10.597.751.418.341.887
22996707,2012-09-01T00:00:00,"Hearing Loss, Sensorineural",C23.888.592.763.393.341.887
22996707,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22996707,2012-09-01T00:00:00,Semicircular Canals,A09.246.631.663
22996707,2012-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
22996707,2012-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
22996707,2012-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
22996707,2012-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
22996707,2012-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23018167,2012-09-01T00:00:00,Capsule Endoscopy,E01.370.388.250.250.250.140
23018167,2012-09-01T00:00:00,Clinical Competence,I02.399.630.210
23018167,2012-09-01T00:00:00,Clinical Competence,N04.761.210
23018167,2012-09-01T00:00:00,"Education, Nursing",I02.358.462
23018167,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23018167,2012-09-01T00:00:00,Inservice Training,I02.574
23018167,2012-09-01T00:00:00,United States,Z01.107.567.875
23018172,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23018172,2012-09-01T00:00:00,Interprofessional Relations,F01.829.401.205
23018172,2012-09-01T00:00:00,Nurse's Role,F01.829.316.616.625.450
23018172,2012-09-01T00:00:00,Nurse's Role,N05.300.100.337
23018172,2012-09-01T00:00:00,Terminology as Topic,L01.143.506.598.400
23018172,2012-09-01T00:00:00,United States,Z01.107.567.875
23043472,2012-09-01T00:00:00,Animals,B01.050
23043472,2012-09-01T00:00:00,"Disease Models, Animal",C22.232
23043472,2012-09-01T00:00:00,"Disease Models, Animal",E05.598.500
23043472,2012-09-01T00:00:00,"Disease Models, Animal",E05.599.395.080
23043472,2012-09-01T00:00:00,Drug Discovery,E05.295
23043472,2012-09-01T00:00:00,Drug Discovery,H01.158.703.007.675
23043472,2012-09-01T00:00:00,Drug Discovery,H01.181.466.675
23043472,2012-09-01T00:00:00,Swine,B01.050.150.900.649.077.880
23168148,2012-09-01T00:00:00,Animals,B01.050
23168148,2012-09-01T00:00:00,"Diagnosis, Differential",E01.171
23168148,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23168148,2012-09-01T00:00:00,Paranasal Sinuses,A04.531.621
23168148,2012-09-01T00:00:00,Quinolines,D03.438.810
23168148,2012-09-01T00:00:00,Rhinitis,C08.460.799
23168148,2012-09-01T00:00:00,Rhinitis,C08.730.674
23168148,2012-09-01T00:00:00,Rhinitis,C09.603.799
23168148,2012-09-01T00:00:00,Sinusitis,C08.460.692.752
23168148,2012-09-01T00:00:00,Sinusitis,C08.730.749
23168148,2012-09-01T00:00:00,Sinusitis,C09.603.692.752
23168148,2012-09-01T00:00:00,Steroids,D04.808
23168148,2012-09-01T00:00:00,Treatment Outcome,E01.789.800
23168148,2012-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23168148,2012-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23198391,2012-09-01T00:00:00,Adolescent,M01.060.057
23198391,2012-09-01T00:00:00,Adult,M01.060.116
23198391,2012-09-01T00:00:00,Cardiopulmonary Bypass,E04.292.413
23198391,2012-09-01T00:00:00,Clinical Competence,I02.399.630.210
23198391,2012-09-01T00:00:00,Clinical Competence,N04.761.210
23198391,2012-09-01T00:00:00,Fatigue,C23.888.369
23198391,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23198391,2012-09-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23198391,2012-09-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23198391,2012-09-01T00:00:00,"Students, Health Occupations",I02.851.686
23198391,2012-09-01T00:00:00,"Students, Health Occupations",M01.848.769
23198391,2012-09-01T00:00:00,Task Performance and Analysis,F02.784.412.846
23198391,2012-09-01T00:00:00,Task Performance and Analysis,F02.784.692.746
23198391,2012-09-01T00:00:00,Task Performance and Analysis,F02.808.600
23198391,2012-09-01T00:00:00,Young Adult,M01.060.116.815
23211894,2012-09-01T00:00:00,African Americans,M01.686.508.100.100
23211894,2012-09-01T00:00:00,African Americans,M01.686.754.100
23211894,2012-09-01T00:00:00,"Child, Preschool",M01.060.406.448
23211894,2012-09-01T00:00:00,Dental Care for Children,E06.170.152
23211894,2012-09-01T00:00:00,Dental Care for Children,N02.421.240.190.215
23211894,2012-09-01T00:00:00,Dental Health Services,N02.421.240
23211894,2012-09-01T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
23211894,2012-09-01T00:00:00,"Emergency Service, Hospital",N02.421.297.195
23211894,2012-09-01T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
23211894,2012-09-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
23211894,2012-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23211894,2012-09-01T00:00:00,Primary Health Care,N04.590.233.727
23211894,2012-09-01T00:00:00,Rural Population,N01.600.725
23211894,2012-09-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23211894,2012-09-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23211894,2012-09-01T00:00:00,United States,Z01.107.567.875
23285736,2012-09-01T00:00:00,Animals,B01.050
23285736,2012-09-01T00:00:00,Collagen,D05.750.078.280
23285736,2012-09-01T00:00:00,Collagen,D12.776.860.300.250
23285736,2012-09-01T00:00:00,Extracellular Matrix,A11.284.295.310
23285736,2012-09-01T00:00:00,Fibronectins,D12.776.377.715.390
23285736,2012-09-01T00:00:00,Fibronectins,D12.776.395.550.350
23285736,2012-09-01T00:00:00,Fibronectins,D12.776.543.550.350
23285736,2012-09-01T00:00:00,Fibronectins,D12.776.860.300.450
23285736,2012-09-01T00:00:00,"Models, Biological",E05.599.395
23285736,2012-09-01T00:00:00,"Myocytes, Cardiac",A07.541.704.570
23285736,2012-09-01T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
23285736,2012-09-01T00:00:00,"Myocytes, Cardiac",A11.620.500
23285736,2012-09-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23285736,2012-09-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
22945501,2012-09-03T00:00:00,Adult,M01.060.116
22945501,2012-09-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22945501,2012-09-03T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
22945501,2012-09-03T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
22945501,2012-09-03T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
22945501,2012-09-03T00:00:00,Metabolic Syndrome X,C18.452.625
22945501,2012-09-03T00:00:00,North America,Z01.107.567
22876979,2012-09-04T00:00:00,Enzyme Inhibitors,D27.505.519.389
22876979,2012-09-04T00:00:00,Histone Demethylases,D08.811.682.662.582.475
22876979,2012-09-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22876979,2012-09-04T00:00:00,"Models, Molecular",E05.599.595
22876979,2012-09-04T00:00:00,Molecular Weight,G02.842.580
22949086,2012-09-04T00:00:00,Coronary Angiography,E01.370.350.700.060.200
22949086,2012-09-04T00:00:00,Coronary Angiography,E01.370.370.050.200
22949086,2012-09-04T00:00:00,Coronary Angiography,E01.370.370.380.200
22949086,2012-09-04T00:00:00,Coronary Artery Disease,C14.280.647.250.260
22949086,2012-09-04T00:00:00,Coronary Artery Disease,C14.907.137.126.339
22949086,2012-09-04T00:00:00,Coronary Artery Disease,C14.907.585.250.260
22949086,2012-09-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22949086,2012-09-04T00:00:00,Middle Aged,M01.060.116.630
22949086,2012-09-04T00:00:00,Polysomnography,E01.370.520.625
22949086,2012-09-04T00:00:00,Risk Assessment,E05.318.740.600.800.715
22949086,2012-09-04T00:00:00,Risk Assessment,N04.452.871.715
22949086,2012-09-04T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
22949086,2012-09-04T00:00:00,Risk Assessment,N06.850.505.715
22949086,2012-09-04T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
22949086,2012-09-04T00:00:00,"Sleep Apnea, Obstructive",C08.618.085.852.850
22949086,2012-09-04T00:00:00,"Sleep Apnea, Obstructive",C10.886.425.800.750.850
22949086,2012-09-04T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
22949086,2012-09-04T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
22949086,2012-09-04T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
22949086,2012-09-04T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
22949086,2012-09-04T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
22949086,2012-09-04T00:00:00,United States,Z01.107.567.875
22949478,2012-09-04T00:00:00,Adult,M01.060.116
22949478,2012-09-04T00:00:00,Coronary Disease,C14.280.647.250
22949478,2012-09-04T00:00:00,Coronary Disease,C14.907.585.250
22949478,2012-09-04T00:00:00,Double-Blind Method,E05.318.780.300
22949478,2012-09-04T00:00:00,Double-Blind Method,E05.581.500.300
22949478,2012-09-04T00:00:00,Double-Blind Method,N05.715.360.780.320
22949478,2012-09-04T00:00:00,Double-Blind Method,N06.850.520.445.300
22949478,2012-09-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22949478,2012-09-04T00:00:00,Middle Aged,M01.060.116.630
22949478,2012-09-04T00:00:00,Myocardial Infarction,C14.280.647.500
22949478,2012-09-04T00:00:00,Myocardial Infarction,C14.907.585.500
22949478,2012-09-04T00:00:00,Risk Factors,E05.318.740.600.800.725
22949478,2012-09-04T00:00:00,Risk Factors,N05.715.350.200.700
22949478,2012-09-04T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22949478,2012-09-04T00:00:00,Risk Factors,N06.850.490.625.750
22949478,2012-09-04T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22949478,2012-09-04T00:00:00,Stroke,C10.228.140.300.775
22949478,2012-09-04T00:00:00,Stroke,C14.907.253.855
22949496,2012-09-04T00:00:00,Biological Markers,D23.101
22949496,2012-09-04T00:00:00,Environmental Exposure,N06.850.460.350
22949496,2012-09-04T00:00:00,Environmental Monitoring,N06.850.460.350.080
22949496,2012-09-04T00:00:00,Environmental Monitoring,N06.850.780.375
22949496,2012-09-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22949496,2012-09-04T00:00:00,Tobacco Smoke Pollution,D20.633.937.680
22949496,2012-09-04T00:00:00,Tobacco Smoke Pollution,N06.850.460.100.555
22954422,2012-09-04T00:00:00,Animals,B01.050
22954422,2012-09-04T00:00:00,"Aorta, Thoracic",A07.231.114.056.372
22954422,2012-09-04T00:00:00,Cardiomegaly,C14.280.195
22954422,2012-09-04T00:00:00,Cardiomegaly,C23.300.775.250
22954422,2012-09-04T00:00:00,Cell Proliferation,G04.299.233.750
22954422,2012-09-04T00:00:00,Cell Proliferation,G07.700.320.249.410.750
22954422,2012-09-04T00:00:00,Collagen,D05.750.078.280
22954422,2012-09-04T00:00:00,Collagen,D12.776.860.300.250
22954422,2012-09-04T00:00:00,"Constriction, Pathologic",C23.300.287
22954422,2012-09-04T00:00:00,"Disease Models, Animal",C22.232
22954422,2012-09-04T00:00:00,"Disease Models, Animal",E05.598.500
22954422,2012-09-04T00:00:00,"Disease Models, Animal",E05.599.395.080
22954422,2012-09-04T00:00:00,Extracellular Matrix,A11.284.295.310
22954422,2012-09-04T00:00:00,Gene Expression Regulation,G05.355.315
22954422,2012-09-04T00:00:00,Myocardium,A02.633.580
22954422,2012-09-04T00:00:00,Myocardium,A07.541.704
22954422,2012-09-04T00:00:00,Myocardium,A10.690.552.750
22954422,2012-09-04T00:00:00,"Myocytes, Cardiac",A07.541.704.570
22954422,2012-09-04T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
22954422,2012-09-04T00:00:00,"Myocytes, Cardiac",A11.620.500
22954422,2012-09-04T00:00:00,"RNA, Messenger",D13.444.735.544
22954422,2012-09-04T00:00:00,Ventricular Remodeling,C23.300.985
22954422,2012-09-04T00:00:00,Ventricular Remodeling,G09.330.190.962.975
22948932,2012-09-05T00:00:00,African Americans,M01.686.508.100.100
22948932,2012-09-05T00:00:00,African Americans,M01.686.754.100
22948932,2012-09-05T00:00:00,Aged,M01.060.116.100
22948932,2012-09-05T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
22948932,2012-09-05T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
22948932,2012-09-05T00:00:00,European Continental Ancestry Group,M01.686.508.400
22948932,2012-09-05T00:00:00,Hispanic Americans,M01.686.754.441
22948932,2012-09-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22948932,2012-09-05T00:00:00,Hypoglycemic Agents,D27.505.696.422
22948932,2012-09-05T00:00:00,Insulin,D06.472.699.587.740.625
22948932,2012-09-05T00:00:00,Insulin,D12.644.548.586.740.625
22948932,2012-09-05T00:00:00,Medical Record Linkage,E05.318.308.940.968.500
22948932,2012-09-05T00:00:00,Medical Record Linkage,L01.280.900.968.500
22948932,2012-09-05T00:00:00,Medical Record Linkage,N04.452.859.564.550
22948932,2012-09-05T00:00:00,Medical Record Linkage,N05.715.360.300.715.500.500
22948932,2012-09-05T00:00:00,Medical Record Linkage,N06.850.520.308.940.968.500
22948932,2012-09-05T00:00:00,Medication Adherence,F01.145.488.500.500
22948932,2012-09-05T00:00:00,Medication Adherence,N05.300.150.600.600.500
22948932,2012-09-05T00:00:00,Middle Aged,M01.060.116.630
22948932,2012-09-05T00:00:00,Risk Factors,E05.318.740.600.800.725
22948932,2012-09-05T00:00:00,Risk Factors,N05.715.350.200.700
22948932,2012-09-05T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22948932,2012-09-05T00:00:00,Risk Factors,N06.850.490.625.750
22948932,2012-09-05T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22948932,2012-09-05T00:00:00,United States,Z01.107.567.875
22948932,2012-09-05T00:00:00,Veterans,M01.930
22952110,2012-09-05T00:00:00,Adult,M01.060.116
22952110,2012-09-05T00:00:00,Aged,M01.060.116.100
22952110,2012-09-05T00:00:00,Endoscopy,E01.370.388.250
22952110,2012-09-05T00:00:00,Endoscopy,E04.800.250
22952110,2012-09-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22952110,2012-09-05T00:00:00,Middle Aged,M01.060.116.630
22952110,2012-09-05T00:00:00,"Sleep Apnea, Obstructive",C08.618.085.852.850
22952110,2012-09-05T00:00:00,"Sleep Apnea, Obstructive",C10.886.425.800.750.850
22952110,2012-09-05T00:00:00,Young Adult,M01.060.116.815
22956831,2012-09-05T00:00:00,Animals,B01.050
22956831,2012-09-05T00:00:00,Cocaine,D02.145.074.722.388
22956831,2012-09-05T00:00:00,Cocaine,D03.132.889.354
22956831,2012-09-05T00:00:00,Cocaine,D03.605.869.388
22956831,2012-09-05T00:00:00,Cocaine,D04.075.080.875.099.722.388
22956831,2012-09-05T00:00:00,Glutamic Acid,D12.125.067.750
22956831,2012-09-05T00:00:00,Glutamic Acid,D12.125.119.450
22956831,2012-09-05T00:00:00,Glutamic Acid,D12.125.427.300
22956831,2012-09-05T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
22956831,2012-09-05T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22956831,2012-09-05T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
22956831,2012-09-05T00:00:00,Self Administration,E02.319.890
22956831,2012-09-05T00:00:00,Self Administration,E02.900.890
22956831,2012-09-05T00:00:00,Synaptic Transmission,G02.111.087.800.850
22956831,2012-09-05T00:00:00,Synaptic Transmission,G02.149.115.800.850
22956831,2012-09-05T00:00:00,Synaptic Transmission,G04.299.880.850
22956831,2012-09-05T00:00:00,Synaptic Transmission,G07.265.337.900
22956831,2012-09-05T00:00:00,Synaptic Transmission,G07.700.240.900
22956831,2012-09-05T00:00:00,Synaptic Transmission,G11.561.600.835
22992860,2012-09-05T00:00:00,Adult,M01.060.116
22992860,2012-09-05T00:00:00,Clinical Competence,I02.399.630.210
22992860,2012-09-05T00:00:00,Clinical Competence,N04.761.210
22992860,2012-09-05T00:00:00,"Education, Medical, Graduate",I02.358.337.350
22992860,2012-09-05T00:00:00,"Education, Medical, Graduate",I02.358.399.350
22992860,2012-09-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22992860,2012-09-05T00:00:00,Internship and Residency,I02.358.399.644
22992860,2012-09-05T00:00:00,Personnel Staffing and Scheduling,N04.452.677.650
22992860,2012-09-05T00:00:00,United States,Z01.107.567.875
22992860,2012-09-05T00:00:00,Work Schedule Tolerance,I03.946.900
22992860,2012-09-05T00:00:00,Workload,N04.452.677.950
23006247,2012-09-05T00:00:00,Adolescent,M01.060.057
23006247,2012-09-05T00:00:00,Adolescent Behavior,F01.145.022
23006247,2012-09-05T00:00:00,Attention,F02.830.104.214
23006247,2012-09-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23006247,2012-09-05T00:00:00,Impulsive Behavior,F01.145.527
23006247,2012-09-05T00:00:00,Personality,F01.752
23006247,2012-09-05T00:00:00,Regression Analysis,E05.318.740.750
23006247,2012-09-05T00:00:00,Regression Analysis,N05.715.360.750.695
23006247,2012-09-05T00:00:00,Regression Analysis,N06.850.520.830.750
23006247,2012-09-05T00:00:00,Risk-Taking,F01.145.722
23006247,2012-09-05T00:00:00,Smoking,F01.145.466.753
23006247,2012-09-05T00:00:00,Tobacco Use Disorder,C21.739.912
23006247,2012-09-05T00:00:00,Tobacco Use Disorder,F03.900.912
23006247,2012-09-05T00:00:00,Young Adult,M01.060.116.815
22956574,2012-09-06T00:00:00,Aged,M01.060.116.100
22956574,2012-09-06T00:00:00,Biological Markers,D23.101
22956574,2012-09-06T00:00:00,Double-Blind Method,E05.318.780.300
22956574,2012-09-06T00:00:00,Double-Blind Method,E05.581.500.300
22956574,2012-09-06T00:00:00,Double-Blind Method,N05.715.360.780.320
22956574,2012-09-06T00:00:00,Double-Blind Method,N06.850.520.445.300
22956574,2012-09-06T00:00:00,Echocardiography,E01.370.350.850.220
22956574,2012-09-06T00:00:00,Echocardiography,E01.370.370.380.220
22956574,2012-09-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22956574,2012-09-06T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
22956574,2012-09-06T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
22956574,2012-09-06T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
22956574,2012-09-06T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
22956574,2012-09-06T00:00:00,Middle Aged,M01.060.116.630
22956574,2012-09-06T00:00:00,Risk Factors,E05.318.740.600.800.725
22956574,2012-09-06T00:00:00,Risk Factors,N05.715.350.200.700
22956574,2012-09-06T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22956574,2012-09-06T00:00:00,Risk Factors,N06.850.490.625.750
22956574,2012-09-06T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22956574,2012-09-06T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
22956574,2012-09-06T00:00:00,Ventricular Remodeling,C23.300.985
22956574,2012-09-06T00:00:00,Ventricular Remodeling,G09.330.190.962.975
22960782,2012-09-06T00:00:00,Animals,B01.050
22960782,2012-09-06T00:00:00,CHO Cells,A11.251.210.200
22960782,2012-09-06T00:00:00,CHO Cells,A11.436.155
22960782,2012-09-06T00:00:00,Cricetinae,B01.050.150.900.649.865.635.150
22960782,2012-09-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22960782,2012-09-06T00:00:00,Nicotinic Agonists,D27.505.519.625.120.140.700
22960782,2012-09-06T00:00:00,Nicotinic Agonists,D27.505.696.577.120.140.700
22960782,2012-09-06T00:00:00,"Receptors, Nicotinic",D12.776.543.750.720.360.550
22955568,2012-09-07T00:00:00,Animals,B01.050
22955568,2012-09-07T00:00:00,"Behavior, Animal",F01.145.113
22955568,2012-09-07T00:00:00,Conditioning (Psychology),F02.463.425.179
22955568,2012-09-07T00:00:00,Discrimination (Psychology),F02.463.593.257
22955568,2012-09-07T00:00:00,Drug Interactions,G07.690.812.240
22955568,2012-09-07T00:00:00,Drug Interactions,G07.700.680.240
22955568,2012-09-07T00:00:00,Ethanol,D02.033.375
22955568,2012-09-07T00:00:00,Methylphenidate,D02.241.223.601.600
22955568,2012-09-07T00:00:00,Methylphenidate,D03.383.621.460
22955568,2012-09-07T00:00:00,Motor Activity,F01.145.632
22955568,2012-09-07T00:00:00,Motor Activity,G11.427.590.530.698
22962267,2012-09-07T00:00:00,Animals,B01.050
22962267,2012-09-07T00:00:00,Dogs,B01.050.150.900.649.147.153.200
22962267,2012-09-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22962267,2012-09-07T00:00:00,Lung,A04.411
22962267,2012-09-07T00:00:00,Nuclear Power Plants,E07.305.437.600
22962267,2012-09-07T00:00:00,Nuclear Power Plants,E07.710.600.500
22962267,2012-09-07T00:00:00,Nuclear Power Plants,J01.780.600
22962267,2012-09-07T00:00:00,Occupational Exposure,N06.850.460.350.600
22962267,2012-09-07T00:00:00,Plutonium,D01.268.033.700
22962267,2012-09-07T00:00:00,Plutonium,D01.268.271.100.700
22962267,2012-09-07T00:00:00,Plutonium,D01.268.556.700
22962267,2012-09-07T00:00:00,Plutonium,D01.552.020.734
22962267,2012-09-07T00:00:00,Plutonium,D01.552.544.700
22963207,2012-09-10T00:00:00,Adolescent,M01.060.057
22963207,2012-09-10T00:00:00,Adolescent Behavior,F01.145.022
22963207,2012-09-10T00:00:00,Alcohol Drinking,F01.145.317.269
22963207,2012-09-10T00:00:00,Crime Victims,M01.135
22963207,2012-09-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22963207,2012-09-10T00:00:00,Interpersonal Relations,F01.829.401
22963207,2012-09-10T00:00:00,Questionnaires,E05.318.308.750
22963207,2012-09-10T00:00:00,Questionnaires,L01.280.800
22963207,2012-09-10T00:00:00,Questionnaires,N05.715.360.300.695
22963207,2012-09-10T00:00:00,Questionnaires,N06.850.520.308.750
22963207,2012-09-10T00:00:00,Risk Assessment,E05.318.740.600.800.715
22963207,2012-09-10T00:00:00,Risk Assessment,N04.452.871.715
22963207,2012-09-10T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
22963207,2012-09-10T00:00:00,Risk Assessment,N06.850.505.715
22963207,2012-09-10T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
22963207,2012-09-10T00:00:00,Risk Factors,E05.318.740.600.800.725
22963207,2012-09-10T00:00:00,Risk Factors,N05.715.350.200.700
22963207,2012-09-10T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22963207,2012-09-10T00:00:00,Risk Factors,N06.850.490.625.750
22963207,2012-09-10T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22963207,2012-09-10T00:00:00,Risk-Taking,F01.145.722
22963207,2012-09-10T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
22963207,2012-09-10T00:00:00,United States,Z01.107.567.875
22963833,2012-09-10T00:00:00,Age Factors,N05.715.350.075
22963833,2012-09-10T00:00:00,Age Factors,N06.850.490.250
22963833,2012-09-10T00:00:00,Aged,M01.060.116.100
22963833,2012-09-10T00:00:00,Antihypertensive Agents,D27.505.954.411.162
22963833,2012-09-10T00:00:00,Arteries,A07.231.114
22963833,2012-09-10T00:00:00,Blood Pressure,E01.370.600.875.249
22963833,2012-09-10T00:00:00,Blood Pressure,G09.330.380.076
22963833,2012-09-10T00:00:00,Clinical Trials as Topic,E05.318.760.535
22963833,2012-09-10T00:00:00,Clinical Trials as Topic,E05.337.250
22963833,2012-09-10T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
22963833,2012-09-10T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
22963833,2012-09-10T00:00:00,Heart Failure,C14.280.434
22963833,2012-09-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22963833,2012-09-10T00:00:00,Hypertension,C14.907.489
22963833,2012-09-10T00:00:00,Middle Aged,M01.060.116.630
22963833,2012-09-10T00:00:00,Sex Factors,N05.715.350.675
22963833,2012-09-10T00:00:00,Sex Factors,N06.850.490.875
22963833,2012-09-10T00:00:00,Stroke Volume,E01.370.370.380.150.700
22963833,2012-09-10T00:00:00,Stroke Volume,G09.330.380.124.882
22963833,2012-09-10T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
22963833,2012-09-10T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
22963833,2012-09-10T00:00:00,Ventricular Remodeling,C23.300.985
22963833,2012-09-10T00:00:00,Ventricular Remodeling,G09.330.190.962.975
22964485,2012-09-10T00:00:00,Animals,B01.050
22964485,2012-09-10T00:00:00,Antineoplastic Agents,D27.505.954.248
22964485,2012-09-10T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
22964485,2012-09-10T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
22964485,2012-09-10T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
22964485,2012-09-10T00:00:00,Cell Death,G04.299.139
22964485,2012-09-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22964485,2012-09-10T00:00:00,Multiple Myeloma,C04.557.595.500
22964485,2012-09-10T00:00:00,Multiple Myeloma,C14.907.454.460
22964485,2012-09-10T00:00:00,Multiple Myeloma,C15.378.147.780.650
22964485,2012-09-10T00:00:00,Multiple Myeloma,C15.378.463.835.460
22964485,2012-09-10T00:00:00,Multiple Myeloma,C20.683.515.845
22964485,2012-09-10T00:00:00,Multiple Myeloma,C20.683.780.650
22964485,2012-09-10T00:00:00,Piperidines,D03.383.621
22964485,2012-09-10T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
22964485,2012-09-10T00:00:00,"Translocation, Genetic",C23.550.210.870
22964485,2012-09-10T00:00:00,"Translocation, Genetic",G05.355.600.860
22964485,2012-09-10T00:00:00,"Translocation, Genetic",G05.365.590.175.870
22964485,2012-09-10T00:00:00,Treatment Outcome,E01.789.800
22964485,2012-09-10T00:00:00,Treatment Outcome,N04.761.559.590.800
22964485,2012-09-10T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22964593,2012-09-10T00:00:00,Clinical Trials as Topic,E05.318.760.535
22964593,2012-09-10T00:00:00,Clinical Trials as Topic,E05.337.250
22964593,2012-09-10T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
22964593,2012-09-10T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
22964593,2012-09-10T00:00:00,Hematopoietic Stem Cell Transplantation,E04.936.225.687.500
22964593,2012-09-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22964593,2012-09-10T00:00:00,Multiple Myeloma,C04.557.595.500
22964593,2012-09-10T00:00:00,Multiple Myeloma,C14.907.454.460
22964593,2012-09-10T00:00:00,Multiple Myeloma,C15.378.147.780.650
22964593,2012-09-10T00:00:00,Multiple Myeloma,C15.378.463.835.460
22964593,2012-09-10T00:00:00,Multiple Myeloma,C20.683.515.845
22964593,2012-09-10T00:00:00,Multiple Myeloma,C20.683.780.650
22964593,2012-09-10T00:00:00,Risk Factors,E05.318.740.600.800.725
22964593,2012-09-10T00:00:00,Risk Factors,N05.715.350.200.700
22964593,2012-09-10T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22964593,2012-09-10T00:00:00,Risk Factors,N06.850.490.625.750
22964593,2012-09-10T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22964593,2012-09-10T00:00:00,Transplantation Conditioning,E02.095.465.425.450.800
22964593,2012-09-10T00:00:00,Transplantation Conditioning,E05.478.610.800
22965703,2012-09-10T00:00:00,Adult,M01.060.116
22965703,2012-09-10T00:00:00,Aged,M01.060.116.100
22965703,2012-09-10T00:00:00,Chronic Disease,C23.550.291.500
22965703,2012-09-10T00:00:00,Hematopoietic Stem Cell Transplantation,E04.936.225.687.500
22965703,2012-09-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22965703,2012-09-10T00:00:00,Incidence,E05.318.308.985.525.375
22965703,2012-09-10T00:00:00,Incidence,L01.280.975.525.375
22965703,2012-09-10T00:00:00,Incidence,N01.224.935.597.500
22965703,2012-09-10T00:00:00,Incidence,N06.850.505.400.975.525.375
22965703,2012-09-10T00:00:00,Incidence,N06.850.520.308.985.525.375
22965703,2012-09-10T00:00:00,Middle Aged,M01.060.116.630
22965703,2012-09-10T00:00:00,Postoperative Complications,C23.550.767
22965703,2012-09-10T00:00:00,Rhinitis,C08.460.799
22965703,2012-09-10T00:00:00,Rhinitis,C08.730.674
22965703,2012-09-10T00:00:00,Rhinitis,C09.603.799
22965703,2012-09-10T00:00:00,Risk Factors,E05.318.740.600.800.725
22965703,2012-09-10T00:00:00,Risk Factors,N05.715.350.200.700
22965703,2012-09-10T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22965703,2012-09-10T00:00:00,Risk Factors,N06.850.490.625.750
22965703,2012-09-10T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22965703,2012-09-10T00:00:00,Sinusitis,C08.460.692.752
22965703,2012-09-10T00:00:00,Sinusitis,C08.730.749
22965703,2012-09-10T00:00:00,Sinusitis,C09.603.692.752
22965703,2012-09-10T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
22965703,2012-09-10T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
22965703,2012-09-10T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
22965703,2012-09-10T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
22965703,2012-09-10T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
22965703,2012-09-10T00:00:00,United States,Z01.107.567.875
22965703,2012-09-10T00:00:00,Young Adult,M01.060.116.815
22975336,2012-09-10T00:00:00,Adult,M01.060.116
22975336,2012-09-10T00:00:00,Embolism,C14.907.355.350
22975336,2012-09-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22975336,2012-09-10T00:00:00,Thrombectomy,E04.100.814.842
22996660,2012-09-10T00:00:00,Adipocytes,A11.329.114
22996660,2012-09-10T00:00:00,Adult,M01.060.116
22996660,2012-09-10T00:00:00,Animals,B01.050
22996660,2012-09-10T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
22996660,2012-09-10T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
22996660,2012-09-10T00:00:00,Ferritins,D12.776.157.427.249
22996660,2012-09-10T00:00:00,Ferritins,D12.776.556.579.249
22996660,2012-09-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22996660,2012-09-10T00:00:00,Insulin Resistance,C18.452.394.968.500
22996660,2012-09-10T00:00:00,Insulin Resistance,G07.690.320.617
22996660,2012-09-10T00:00:00,Iron,D01.268.556.412
22996660,2012-09-10T00:00:00,Iron,D01.268.956.287
22996660,2012-09-10T00:00:00,Iron,D01.552.544.412
22996660,2012-09-10T00:00:00,Membrane Proteins,D12.776.543
22996660,2012-09-10T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
22996660,2012-09-10T00:00:00,Metabolic Syndrome X,C18.452.625
22996660,2012-09-10T00:00:00,Middle Aged,M01.060.116.630
22996660,2012-09-10T00:00:00,Obesity,C18.654.726.500
22996660,2012-09-10T00:00:00,Obesity,C23.888.144.699.500
22996660,2012-09-10T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
22996660,2012-09-10T00:00:00,Obesity,G07.100.100.160.120.699.500
22996660,2012-09-10T00:00:00,Phlebotomy,E01.450.865.632.150.625
22996660,2012-09-10T00:00:00,Phlebotomy,E02.800.558
22996660,2012-09-10T00:00:00,"RNA, Messenger",D13.444.735.544
22965260,2012-09-11T00:00:00,"Arthroplasty, Replacement, Hip",E04.555.110.110.110
22965260,2012-09-11T00:00:00,"Arthroplasty, Replacement, Hip",E04.650.110.110
22965260,2012-09-11T00:00:00,Cadaver,C23.550.260.224
22965260,2012-09-11T00:00:00,Hip Joint,A02.835.583.411
22965260,2012-09-11T00:00:00,Hip Prosthesis,E07.695.400.400
22965260,2012-09-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22965260,2012-09-11T00:00:00,Prosthesis Design,E05.320.550
22965260,2012-09-11T00:00:00,Prosthesis Design,E07.695.680
22967280,2012-09-11T00:00:00,Adult,M01.060.116
22967280,2012-09-11T00:00:00,Awareness,F02.463.188.150
22967280,2012-09-11T00:00:00,Blood Pressure,E01.370.600.875.249
22967280,2012-09-11T00:00:00,Blood Pressure,G09.330.380.076
22967280,2012-09-11T00:00:00,"Blood Pressure Monitoring, Ambulatory",E01.370.370.140.100
22967280,2012-09-11T00:00:00,"Blood Pressure Monitoring, Ambulatory",E01.370.520.500.100
22967280,2012-09-11T00:00:00,Cellular Phone,L01.178.847.698.300
22967280,2012-09-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22967280,2012-09-11T00:00:00,Internet,L01.224.230.110.500
22967280,2012-09-11T00:00:00,Meditation,E02.190.525.374
22967280,2012-09-11T00:00:00,Meditation,E02.190.901.455
22967280,2012-09-11T00:00:00,Meditation,F04.754.137.750.500
22967280,2012-09-11T00:00:00,Middle Aged,M01.060.116.630
22967280,2012-09-11T00:00:00,Patient Compliance,F01.145.488.500
22967280,2012-09-11T00:00:00,Patient Compliance,N05.300.150.600.600
22967280,2012-09-11T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
22967280,2012-09-11T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
22967280,2012-09-11T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
22967280,2012-09-11T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
22967280,2012-09-11T00:00:00,South Carolina,Z01.107.567.875.075.662
22967280,2012-09-11T00:00:00,South Carolina,Z01.107.567.875.750.700
22967280,2012-09-11T00:00:00,"Stress, Psychological",F01.145.126.990
22967280,2012-09-11T00:00:00,"Stress, Psychological",F02.830.900
22984613,2012-09-12T00:00:00,Animals,B01.050
22984613,2012-09-12T00:00:00,Cardiomegaly,C14.280.195
22984613,2012-09-12T00:00:00,Cardiomegaly,C23.300.775.250
22984613,2012-09-12T00:00:00,Cell Adhesion,G04.299.117
22984613,2012-09-12T00:00:00,Cell Movement,G04.299.283
22984613,2012-09-12T00:00:00,Cell Movement,G07.700.560.500.180
22984613,2012-09-12T00:00:00,Cell Proliferation,G04.299.233.750
22984613,2012-09-12T00:00:00,Cell Proliferation,G07.700.320.249.410.750
22984613,2012-09-12T00:00:00,Collagen,D05.750.078.280
22984613,2012-09-12T00:00:00,Collagen,D12.776.860.300.250
22984613,2012-09-12T00:00:00,"Constriction, Pathologic",C23.300.287
22984613,2012-09-12T00:00:00,Extracellular Matrix,A11.284.295.310
22984613,2012-09-12T00:00:00,Fibroblasts,A11.329.228
22984613,2012-09-12T00:00:00,Fibroblasts,A11.872.228
22984613,2012-09-12T00:00:00,Fibronectins,D12.776.377.715.390
22984613,2012-09-12T00:00:00,Fibronectins,D12.776.395.550.350
22984613,2012-09-12T00:00:00,Fibronectins,D12.776.543.550.350
22984613,2012-09-12T00:00:00,Fibronectins,D12.776.860.300.450
22984613,2012-09-12T00:00:00,Integrin beta3,D12.776.543.750.705.408.200.750
22984613,2012-09-12T00:00:00,Integrin beta3,D23.050.301.264.035.302
22984613,2012-09-12T00:00:00,Integrin beta3,D23.101.100.110.299
22984613,2012-09-12T00:00:00,Myocardium,A02.633.580
22984613,2012-09-12T00:00:00,Myocardium,A07.541.704
22984613,2012-09-12T00:00:00,Myocardium,A10.690.552.750
22984613,2012-09-12T00:00:00,Pressure,G01.374.715
22984613,2012-09-12T00:00:00,S100 Proteins,D12.776.157.125.750
22984613,2012-09-12T00:00:00,S100 Proteins,D12.776.641.655
22971164,2012-09-13T00:00:00,Aged,M01.060.116.100
22971164,2012-09-13T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
22971164,2012-09-13T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
22971164,2012-09-13T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
22971164,2012-09-13T00:00:00,Creatinine,D03.383.129.308.207
22971164,2012-09-13T00:00:00,Cyclophosphamide,D02.455.526.728.650.730.243
22971164,2012-09-13T00:00:00,Cyclophosphamide,D02.705.670.243
22971164,2012-09-13T00:00:00,Dexamethasone,D04.808.745.432.769.344
22971164,2012-09-13T00:00:00,Dexamethasone,D04.808.908.238
22971164,2012-09-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22971164,2012-09-13T00:00:00,Middle Aged,M01.060.116.630
22971164,2012-09-13T00:00:00,Multiple Myeloma,C04.557.595.500
22971164,2012-09-13T00:00:00,Multiple Myeloma,C14.907.454.460
22971164,2012-09-13T00:00:00,Multiple Myeloma,C15.378.147.780.650
22971164,2012-09-13T00:00:00,Multiple Myeloma,C15.378.463.835.460
22971164,2012-09-13T00:00:00,Multiple Myeloma,C20.683.515.845
22971164,2012-09-13T00:00:00,Multiple Myeloma,C20.683.780.650
22971164,2012-09-13T00:00:00,Renal Insufficiency,C12.777.419.780
22971164,2012-09-13T00:00:00,Renal Insufficiency,C13.351.968.419.780
22971164,2012-09-13T00:00:00,Treatment Outcome,E01.789.800
22971164,2012-09-13T00:00:00,Treatment Outcome,N04.761.559.590.800
22971164,2012-09-13T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22976904,2012-09-13T00:00:00,Adult,M01.060.116
22976904,2012-09-13T00:00:00,Alcoholic Intoxication,C21.739.100.175
22976904,2012-09-13T00:00:00,Alcoholic Intoxication,F03.900.100.300
22976904,2012-09-13T00:00:00,Battered Women,M01.975.155
22976904,2012-09-13T00:00:00,Crime Victims,M01.135
22976904,2012-09-13T00:00:00,Depression,F01.145.126.350
22976904,2012-09-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22976904,2012-09-13T00:00:00,Middle Aged,M01.060.116.630
22976904,2012-09-13T00:00:00,Rape,I01.198.240.748.640
22976904,2012-09-13T00:00:00,Social Perception,F02.463.593.752
22976904,2012-09-13T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
22976904,2012-09-13T00:00:00,Substance-Related Disorders,C21.739
22976904,2012-09-13T00:00:00,Substance-Related Disorders,F03.900
22976904,2012-09-13T00:00:00,Truth Disclosure,F01.145.209.259.800
22976904,2012-09-13T00:00:00,United States,Z01.107.567.875
22976904,2012-09-13T00:00:00,Young Adult,M01.060.116.815
22981679,2012-09-13T00:00:00,Aged,M01.060.116.100
22981679,2012-09-13T00:00:00,Case-Control Studies,E05.318.760.500.500
22981679,2012-09-13T00:00:00,Case-Control Studies,N05.715.360.775.175.200
22981679,2012-09-13T00:00:00,Case-Control Studies,N06.850.520.450.500.500
22981679,2012-09-13T00:00:00,Electromyography,E01.370.405.255
22981679,2012-09-13T00:00:00,Electromyography,E01.370.530.255
22981679,2012-09-13T00:00:00,"Gait Disorders, Neurologic",C10.597.404
22981679,2012-09-13T00:00:00,"Gait Disorders, Neurologic",C23.888.592.413
22981679,2012-09-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22981679,2012-09-13T00:00:00,Leg,A01.378.610.500
22981679,2012-09-13T00:00:00,Middle Aged,M01.060.116.630
22981679,2012-09-13T00:00:00,"Muscle, Skeletal",A02.633.567
22981679,2012-09-13T00:00:00,"Muscle, Skeletal",A10.690.552.500
22981679,2012-09-13T00:00:00,Paresis,C10.597.636
22981679,2012-09-13T00:00:00,Paresis,C23.888.592.643
22981679,2012-09-13T00:00:00,Stroke,C10.228.140.300.775
22981679,2012-09-13T00:00:00,Stroke,C14.907.253.855
22981679,2012-09-13T00:00:00,Walking,G11.427.590.530.568.900
22981679,2012-09-13T00:00:00,Walking,G11.427.590.530.698.940
22981679,2012-09-13T00:00:00,Walking,I03.450.642.845.940
22984008,2012-09-13T00:00:00,Aged,M01.060.116.100
22984008,2012-09-13T00:00:00,Angioplasty,E02.148.050
22984008,2012-09-13T00:00:00,Angioplasty,E04.100.814.050
22984008,2012-09-13T00:00:00,"Constriction, Pathologic",C23.300.287
22984008,2012-09-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22984008,2012-09-13T00:00:00,Incidence,E05.318.308.985.525.375
22984008,2012-09-13T00:00:00,Incidence,L01.280.975.525.375
22984008,2012-09-13T00:00:00,Incidence,N01.224.935.597.500
22984008,2012-09-13T00:00:00,Incidence,N06.850.505.400.975.525.375
22984008,2012-09-13T00:00:00,Incidence,N06.850.520.308.985.525.375
22984008,2012-09-13T00:00:00,Middle Aged,M01.060.116.630
22984008,2012-09-13T00:00:00,Risk Factors,E05.318.740.600.800.725
22984008,2012-09-13T00:00:00,Risk Factors,N05.715.350.200.700
22984008,2012-09-13T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22984008,2012-09-13T00:00:00,Risk Factors,N06.850.490.625.750
22984008,2012-09-13T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22984008,2012-09-13T00:00:00,Stents,E07.695.750
22984008,2012-09-13T00:00:00,Stroke,C10.228.140.300.775
22984008,2012-09-13T00:00:00,Stroke,C14.907.253.855
22984008,2012-09-13T00:00:00,Time Factors,G01.910.857
22984008,2012-09-13T00:00:00,Treatment Outcome,E01.789.800
22984008,2012-09-13T00:00:00,Treatment Outcome,N04.761.559.590.800
22984008,2012-09-13T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22947127,2012-09-14T00:00:00,Fluorocarbons,D02.455.526.510.435
22947127,2012-09-14T00:00:00,Temperature,G01.906.595
22947127,2012-09-14T00:00:00,Temperature,G16.500.275.063.725.710
22947127,2012-09-14T00:00:00,Temperature,G16.500.750.775.710
22947127,2012-09-14T00:00:00,Temperature,N06.230.150.450
22947127,2012-09-14T00:00:00,Temperature,N06.230.300.100.725.710
22982155,2012-09-14T00:00:00,Animals,B01.050
22982155,2012-09-14T00:00:00,Cardiopulmonary Bypass,E04.292.413
22982155,2012-09-14T00:00:00,Heart Arrest,C14.280.383
22982155,2012-09-14T00:00:00,Hemodynamics,G09.330.190.400
22982155,2012-09-14T00:00:00,Hemodynamics,G09.330.380
22982155,2012-09-14T00:00:00,Hyperoxia,C23.888.852.567
22982155,2012-09-14T00:00:00,"Mitochondria, Heart",A11.284.430.214.190.875.564.627.603
22982155,2012-09-14T00:00:00,"Mitochondria, Heart",A11.284.835.626.627.603
22982155,2012-09-14T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22982155,2012-09-14T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
22982155,2012-09-14T00:00:00,Time Factors,G01.910.857
22982155,2012-09-14T00:00:00,Tyrosine,D12.125.072.050.875
23024789,2012-09-14T00:00:00,Arabidopsis,B01.650.388.100.157.100
23024789,2012-09-14T00:00:00,Computational Biology,H01.158.273.180
23024789,2012-09-14T00:00:00,Gene Expression Profiling,E05.393.332
23024789,2012-09-14T00:00:00,Gene Regulatory Networks,G05.360.080.689.360
23024789,2012-09-14T00:00:00,"Models, Biological",E05.599.395
23024791,2012-09-14T00:00:00,Animals,B01.050
23024791,2012-09-14T00:00:00,Apoptosis,G04.299.139.160
23024791,2012-09-14T00:00:00,Cytochrome P-450 CYP1A1,D08.244.453.040.555
23024791,2012-09-14T00:00:00,Cytochrome P-450 CYP1A1,D08.811.682.690.708.170.040.332
23024791,2012-09-14T00:00:00,Cytochrome P-450 CYP1A1,D12.776.422.220.453.040.332
23024791,2012-09-14T00:00:00,Fas Ligand Protein,D12.644.276.374.750.249
23024791,2012-09-14T00:00:00,Fas Ligand Protein,D12.644.276.972.249
23024791,2012-09-14T00:00:00,Fas Ligand Protein,D12.776.395.550.312
23024791,2012-09-14T00:00:00,Fas Ligand Protein,D12.776.467.374.750.249
23024791,2012-09-14T00:00:00,Fas Ligand Protein,D12.776.467.972.249
23024791,2012-09-14T00:00:00,Fas Ligand Protein,D12.776.543.550.312
23024791,2012-09-14T00:00:00,Fas Ligand Protein,D23.050.301.264.035.283
23024791,2012-09-14T00:00:00,Fas Ligand Protein,D23.101.100.110.282
23024791,2012-09-14T00:00:00,Fas Ligand Protein,D23.529.374.750.249
23024791,2012-09-14T00:00:00,Fas Ligand Protein,D23.529.972.249
23024791,2012-09-14T00:00:00,Gene Expression Profiling,E05.393.332
23024791,2012-09-14T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
23024791,2012-09-14T00:00:00,Gene Regulatory Networks,G05.360.080.689.360
23024791,2012-09-14T00:00:00,MicroRNAs,D13.150.650.319
23024791,2012-09-14T00:00:00,MicroRNAs,D13.444.735.150.319
23024791,2012-09-14T00:00:00,MicroRNAs,D13.444.735.790.099
23024791,2012-09-14T00:00:00,Neoplasms,C04
23024791,2012-09-14T00:00:00,Pregnancy,G08.686.785.760.769
23024791,2012-09-14T00:00:00,"Receptors, Aryl Hydrocarbon",D12.776.260.698.209.715
23024791,2012-09-14T00:00:00,"Receptors, Aryl Hydrocarbon",D12.776.826.209.715
23024791,2012-09-14T00:00:00,"Receptors, Aryl Hydrocarbon",D12.776.930.662
23024791,2012-09-14T00:00:00,"Receptors, Aryl Hydrocarbon",D12.776.930.669.209.715
23024791,2012-09-14T00:00:00,Signal Transduction,G02.111.087.800
23024791,2012-09-14T00:00:00,Signal Transduction,G02.149.115.800
23024791,2012-09-14T00:00:00,Signal Transduction,G04.299.880
23024791,2012-09-14T00:00:00,Tetrachlorodibenzodioxin,D03.383.231.900
23024791,2012-09-14T00:00:00,Thymus Gland,A10.549.750
23024791,2012-09-14T00:00:00,Thymus Gland,A15.382.520.604.750
22980446,2012-09-15T00:00:00,Developing Countries,I01.615.500.300
22980446,2012-09-15T00:00:00,Emergency Medical Services,N02.421.297
22980446,2012-09-15T00:00:00,Healthcare Disparities,N04.590.374.380
22980446,2012-09-15T00:00:00,Healthcare Disparities,N05.300.493
22980446,2012-09-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22980446,2012-09-15T00:00:00,"Surgical Procedures, Operative",E04
22980446,2012-09-15T00:00:00,Wounds and Injuries,C21.866
22989723,2012-09-16T00:00:00,Animals,B01.050
22989723,2012-09-16T00:00:00,Bone Resorption,C05.116.264
22989723,2012-09-16T00:00:00,Bone Resorption,G11.427.590.195.150
22989723,2012-09-16T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
22989723,2012-09-16T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
22989723,2012-09-16T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
22989723,2012-09-16T00:00:00,Flow Cytometry,E05.200.500.386.350
22989723,2012-09-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22989723,2012-09-16T00:00:00,Mouth Neoplasms,C04.588.443.591
22989723,2012-09-16T00:00:00,Mouth Neoplasms,C07.465.565
22989723,2012-09-16T00:00:00,Osteoclasts,A11.329.372.700
22989723,2012-09-16T00:00:00,Osteoclasts,A11.627.482.700
22989723,2012-09-16T00:00:00,Polymerase Chain Reaction,E05.393.620.500
22989723,2012-09-16T00:00:00,RANK Ligand,D12.644.276.374.750.562
22989723,2012-09-16T00:00:00,RANK Ligand,D12.644.276.972.562
22989723,2012-09-16T00:00:00,RANK Ligand,D12.776.467.374.750.562
22989723,2012-09-16T00:00:00,RANK Ligand,D12.776.467.972.562
22989723,2012-09-16T00:00:00,RANK Ligand,D23.529.374.750.562
22989723,2012-09-16T00:00:00,RANK Ligand,D23.529.972.562
22989723,2012-09-16T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
22989723,2012-09-16T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
22989723,2012-09-16T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
22989723,2012-09-16T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
22989723,2012-09-16T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
22909099,2012-09-17T00:00:00,DNA Replication,G02.111.087.222
22909099,2012-09-17T00:00:00,DNA Replication,G02.149.115.222
22909099,2012-09-17T00:00:00,DNA Replication,G05.355.200
22909099,2012-09-17T00:00:00,"DNA, Fungal",D13.444.308.300
22909099,2012-09-17T00:00:00,DNA-Binding Proteins,D12.776.260
22909099,2012-09-17T00:00:00,Gene Silencing,G05.355.315.203.374
22909099,2012-09-17T00:00:00,Plasmids,G05.360.600
22909099,2012-09-17T00:00:00,"Recombination, Genetic",G05.355.760
22909099,2012-09-17T00:00:00,Saccharomyces cerevisiae,B01.300.107.795.785.800
22909099,2012-09-17T00:00:00,Saccharomyces cerevisiae,B01.300.930.705.655
22909099,2012-09-17T00:00:00,Saccharomyces cerevisiae Proteins,D12.776.354.750
22986220,2012-09-17T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
22986220,2012-09-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22986220,2012-09-17T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
22986220,2012-09-17T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
22986220,2012-09-17T00:00:00,Prostate-Specific Antigen,D08.811.277.656.300.760.442.750
22986220,2012-09-17T00:00:00,Prostate-Specific Antigen,D08.811.277.656.959.350.442.750
22986220,2012-09-17T00:00:00,Prostate-Specific Antigen,D12.776.866.249.500
22986220,2012-09-17T00:00:00,Prostate-Specific Antigen,D23.050.285.625
22986220,2012-09-17T00:00:00,Prostate-Specific Antigen,D23.101.840.625
22986220,2012-09-17T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
22986220,2012-09-17T00:00:00,Prostatic Neoplasms,C12.294.260.750
22986220,2012-09-17T00:00:00,Prostatic Neoplasms,C12.294.565.625
22986220,2012-09-17T00:00:00,Prostatic Neoplasms,C12.758.409.750
22986220,2012-09-17T00:00:00,Tissue Inhibitor of Metalloproteinase-1,D12.776.926.450
22986220,2012-09-17T00:00:00,Transglutaminases,D08.811.913.050.200.800
22986220,2012-09-17T00:00:00,"Tumor Markers, Biological",D23.101.840
22998096,2012-09-17T00:00:00,Aged,M01.060.116.100
22998096,2012-09-17T00:00:00,Cardiovascular Diseases,C14
22998096,2012-09-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22998096,2012-09-17T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370
22998096,2012-09-17T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370
22998096,2012-09-17T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.230.202.370
23041504,2012-09-17T00:00:00,Age Factors,N05.715.350.075
23041504,2012-09-17T00:00:00,Age Factors,N06.850.490.250
23041504,2012-09-17T00:00:00,Animals,B01.050
23041504,2012-09-17T00:00:00,"Antigens, CD",D23.050.301.264.035
23041504,2012-09-17T00:00:00,"Antigens, CD",D23.101.100.110
23041504,2012-09-17T00:00:00,B-Lymphocytes,A11.063.438
23041504,2012-09-17T00:00:00,B-Lymphocytes,A11.118.637.555.567.562
23041504,2012-09-17T00:00:00,B-Lymphocytes,A15.145.229.637.555.567.562
23041504,2012-09-17T00:00:00,B-Lymphocytes,A15.382.032.438
23041504,2012-09-17T00:00:00,B-Lymphocytes,A15.382.490.555.567.562
23041504,2012-09-17T00:00:00,Kidney Glomerulus,A05.810.453.324.359
23041504,2012-09-17T00:00:00,Kidney Glomerulus,A05.810.453.736.520
23041504,2012-09-17T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
23041504,2012-09-17T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
23041504,2012-09-17T00:00:00,Mesenchymal Stem Cell Transplantation,E04.936.225.687.625
23041504,2012-09-17T00:00:00,Spleen,A10.549.700
23041504,2012-09-17T00:00:00,Spleen,A15.382.520.604.700
23041504,2012-09-17T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
23041504,2012-09-17T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
23041504,2012-09-17T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
22989880,2012-09-18T00:00:00,Cell Movement,G04.299.283
22989880,2012-09-18T00:00:00,Cell Movement,G07.700.560.500.180
22989880,2012-09-18T00:00:00,Disease Progression,C23.550.291.656
22989880,2012-09-18T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
22989880,2012-09-18T00:00:00,HSP90 Heat-Shock Proteins,D12.776.580.216.380
22989880,2012-09-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22989880,2012-09-18T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.205.352
22989880,2012-09-18T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.252.420
22989880,2012-09-18T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.525.700.150
22989880,2012-09-18T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.205.352
22989880,2012-09-18T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.252.420
22989880,2012-09-18T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.525.700.150
22989880,2012-09-18T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.205.360
22989880,2012-09-18T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.252.445
22989880,2012-09-18T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.525.700.350
22989880,2012-09-18T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.205.360
22989880,2012-09-18T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.252.445
22989880,2012-09-18T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.525.700.350
22989880,2012-09-18T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
22989880,2012-09-18T00:00:00,Prostatic Neoplasms,C12.294.260.750
22989880,2012-09-18T00:00:00,Prostatic Neoplasms,C12.294.565.625
22989880,2012-09-18T00:00:00,Prostatic Neoplasms,C12.758.409.750
22989880,2012-09-18T00:00:00,RNA Interference,G05.355.315.203.374.790
22989880,2012-09-18T00:00:00,Signal Transduction,G02.111.087.800
22989880,2012-09-18T00:00:00,Signal Transduction,G02.149.115.800
22989880,2012-09-18T00:00:00,Signal Transduction,G04.299.880
22990589,2012-09-18T00:00:00,Bacteriophages,B04.123
22990589,2012-09-18T00:00:00,Luminescent Measurements,E05.196.712.516
22990589,2012-09-18T00:00:00,Pseudomonas,B03.440.400.425.625.625
22990589,2012-09-18T00:00:00,Pseudomonas,B03.660.250.580.590
23028588,2012-09-18T00:00:00,Animals,B01.050
23028588,2012-09-18T00:00:00,Blood Glucose,D09.546.359.448.500
23028588,2012-09-18T00:00:00,"Diabetes Mellitus, Experimental",C18.452.394.750.074
23028588,2012-09-18T00:00:00,"Diabetes Mellitus, Experimental",C19.246.240
23028588,2012-09-18T00:00:00,"Diabetes Mellitus, Experimental",E05.598.500.374
23028588,2012-09-18T00:00:00,Diabetic Nephropathies,C12.777.419.192
23028588,2012-09-18T00:00:00,Diabetic Nephropathies,C13.351.968.419.192
23028588,2012-09-18T00:00:00,Diabetic Nephropathies,C19.246.099.875
23028588,2012-09-18T00:00:00,Gene Expression Profiling,E05.393.332
23028588,2012-09-18T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.100.080.500
23028588,2012-09-18T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.720.600.220.500
23028588,2012-09-18T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.750.555.220.500
23028588,2012-09-18T00:00:00,Signal Transduction,G02.111.087.800
23028588,2012-09-18T00:00:00,Signal Transduction,G02.149.115.800
23028588,2012-09-18T00:00:00,Signal Transduction,G04.299.880
23028842,2012-09-18T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
23028842,2012-09-18T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
23028842,2012-09-18T00:00:00,Cell Movement,G04.299.283
23028842,2012-09-18T00:00:00,Cell Movement,G07.700.560.500.180
23028842,2012-09-18T00:00:00,Cell Proliferation,G04.299.233.750
23028842,2012-09-18T00:00:00,Cell Proliferation,G07.700.320.249.410.750
23028842,2012-09-18T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
23028842,2012-09-18T00:00:00,Gene Silencing,G05.355.315.203.374
23028842,2012-09-18T00:00:00,Head and Neck Neoplasms,C04.588.443
23028842,2012-09-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23028842,2012-09-18T00:00:00,Neoplasm Invasiveness,C04.697.645
23028842,2012-09-18T00:00:00,Neoplasm Invasiveness,C23.550.727.645
23028842,2012-09-18T00:00:00,Signal Transduction,G02.111.087.800
23028842,2012-09-18T00:00:00,Signal Transduction,G02.149.115.800
23028842,2012-09-18T00:00:00,Signal Transduction,G04.299.880
23028842,2012-09-18T00:00:00,Suppressor of Cytokine Signaling Proteins,D12.644.360.024.374
23028842,2012-09-18T00:00:00,Suppressor of Cytokine Signaling Proteins,D12.776.157.057.249
23028842,2012-09-18T00:00:00,Suppressor of Cytokine Signaling Proteins,D12.776.476.024.437
22934964,2012-09-19T00:00:00,Actins,D05.750.078.730.250
22934964,2012-09-19T00:00:00,Actins,D12.776.210.500.100
22934964,2012-09-19T00:00:00,Actins,D12.776.220.525.255
22934964,2012-09-19T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
22934964,2012-09-19T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
22934964,2012-09-19T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
22934964,2012-09-19T00:00:00,Cell Adhesion,G04.299.117
22934964,2012-09-19T00:00:00,Cell Movement,G04.299.283
22934964,2012-09-19T00:00:00,Cell Movement,G07.700.560.500.180
22934964,2012-09-19T00:00:00,Glutathione,D12.644.456.448
22934964,2012-09-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22934964,2012-09-19T00:00:00,Lung Neoplasms,C04.588.894.797.520
22934964,2012-09-19T00:00:00,Lung Neoplasms,C08.381.540
22934964,2012-09-19T00:00:00,Lung Neoplasms,C08.785.520
22934964,2012-09-19T00:00:00,"Models, Molecular",E05.599.595
22934964,2012-09-19T00:00:00,Protein Interaction Mapping,E05.601.690
22934964,2012-09-19T00:00:00,S100 Proteins,D12.776.157.125.750
22934964,2012-09-19T00:00:00,S100 Proteins,D12.776.641.655
22990271,2012-09-19T00:00:00,Adolescent,M01.060.057
22990271,2012-09-19T00:00:00,Adult,M01.060.116
22990271,2012-09-19T00:00:00,Aged,M01.060.116.100
22990271,2012-09-19T00:00:00,Cardiovascular Diseases,C14
22990271,2012-09-19T00:00:00,Case-Control Studies,E05.318.760.500.500
22990271,2012-09-19T00:00:00,Case-Control Studies,N05.715.360.775.175.200
22990271,2012-09-19T00:00:00,Case-Control Studies,N06.850.520.450.500.500
22990271,2012-09-19T00:00:00,Diabetes Mellitus,C18.452.394.750
22990271,2012-09-19T00:00:00,Diabetes Mellitus,C19.246
22990271,2012-09-19T00:00:00,Gastric Bypass,E02.065.062.249
22990271,2012-09-19T00:00:00,Gastric Bypass,E04.035.398.385
22990271,2012-09-19T00:00:00,Gastric Bypass,E04.062.249
22990271,2012-09-19T00:00:00,Gastric Bypass,E04.210.457.430
22990271,2012-09-19T00:00:00,Health Status,I01.240.425
22990271,2012-09-19T00:00:00,Health Status,N01.224.425
22990271,2012-09-19T00:00:00,Health Status,N06.850.505.400.425
22990271,2012-09-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22990271,2012-09-19T00:00:00,Middle Aged,M01.060.116.630
22990271,2012-09-19T00:00:00,Obesity,C18.654.726.500
22990271,2012-09-19T00:00:00,Obesity,C23.888.144.699.500
22990271,2012-09-19T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
22990271,2012-09-19T00:00:00,Obesity,G07.100.100.160.120.699.500
22990271,2012-09-19T00:00:00,Quality of Life,I01.800
22990271,2012-09-19T00:00:00,Quality of Life,K01.752.400.750
22990271,2012-09-19T00:00:00,Risk Factors,E05.318.740.600.800.725
22990271,2012-09-19T00:00:00,Risk Factors,N05.715.350.200.700
22990271,2012-09-19T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22990271,2012-09-19T00:00:00,Risk Factors,N06.850.490.625.750
22990271,2012-09-19T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22990271,2012-09-19T00:00:00,Weight Loss,C23.888.144.243.963
22990271,2012-09-19T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
22990271,2012-09-19T00:00:00,Young Adult,M01.060.116.815
22990273,2012-09-19T00:00:00,Adult,M01.060.116
22990273,2012-09-19T00:00:00,Continuous Positive Airway Pressure,E02.880.820.790.259
22990273,2012-09-19T00:00:00,"Diet, Reducing",E02.642.249.285
22990273,2012-09-19T00:00:00,"Diet, Reducing",G07.610.240.285
22990273,2012-09-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22990273,2012-09-19T00:00:00,Middle Aged,M01.060.116.630
22990273,2012-09-19T00:00:00,Obesity,C18.654.726.500
22990273,2012-09-19T00:00:00,Obesity,C23.888.144.699.500
22990273,2012-09-19T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
22990273,2012-09-19T00:00:00,Obesity,G07.100.100.160.120.699.500
22990273,2012-09-19T00:00:00,"Sleep Apnea, Obstructive",C08.618.085.852.850
22990273,2012-09-19T00:00:00,"Sleep Apnea, Obstructive",C10.886.425.800.750.850
22990273,2012-09-19T00:00:00,Treatment Outcome,E01.789.800
22990273,2012-09-19T00:00:00,Treatment Outcome,N04.761.559.590.800
22990273,2012-09-19T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22990273,2012-09-19T00:00:00,Weight Loss,C23.888.144.243.963
22990273,2012-09-19T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
22990679,2012-09-19T00:00:00,Adult,M01.060.116
22990679,2012-09-19T00:00:00,"Biopsy, Fine-Needle",E01.370.388.100.100.500
22990679,2012-09-19T00:00:00,"Biopsy, Fine-Needle",E01.450.230.100.100.500
22990679,2012-09-19T00:00:00,"Biopsy, Fine-Needle",E01.450.865.100.100.500
22990679,2012-09-19T00:00:00,"Biopsy, Fine-Needle",E04.074.119.500
22990679,2012-09-19T00:00:00,Combined Modality Therapy,E02.186
22990679,2012-09-19T00:00:00,Desmin,D05.750.078.593.200
22990679,2012-09-19T00:00:00,Desmin,D12.776.220.475.200
22990679,2012-09-19T00:00:00,"Diagnosis, Differential",E01.171
22990679,2012-09-19T00:00:00,Head and Neck Neoplasms,C04.588.443
22990679,2012-09-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22990679,2012-09-19T00:00:00,Lung Neoplasms,C04.588.894.797.520
22990679,2012-09-19T00:00:00,Lung Neoplasms,C08.381.540
22990679,2012-09-19T00:00:00,Lung Neoplasms,C08.785.520
22990679,2012-09-19T00:00:00,Maxillary Neoplasms,C04.588.149.721.450.601
22990679,2012-09-19T00:00:00,Maxillary Neoplasms,C05.116.231.754.450.601
22990679,2012-09-19T00:00:00,Maxillary Neoplasms,C05.500.499.601
22990679,2012-09-19T00:00:00,Maxillary Neoplasms,C05.500.693.528
22990679,2012-09-19T00:00:00,Maxillary Neoplasms,C07.320.515.601
22990679,2012-09-19T00:00:00,Maxillary Neoplasms,C07.320.660.601
22990679,2012-09-19T00:00:00,Myogenin,D12.776.210.500.570.600
22990679,2012-09-19T00:00:00,Myogenin,D12.776.260.103.750.600
22990679,2012-09-19T00:00:00,Myogenin,D12.776.930.125.750.600
22990679,2012-09-19T00:00:00,Rhabdomyosarcoma,C04.557.450.590.550.660
22990679,2012-09-19T00:00:00,Rhabdomyosarcoma,C04.557.450.795.550.660
22990679,2012-09-19T00:00:00,Sarcoma,C04.557.450.795
22990679,2012-09-19T00:00:00,"Tumor Markers, Biological",D23.101.840
22992675,2012-09-19T00:00:00,Animals,B01.050
22992675,2012-09-19T00:00:00,Cyclic AMP,D03.438.759.646.138.395
22992675,2012-09-19T00:00:00,Cyclic AMP,D13.695.462.200
22992675,2012-09-19T00:00:00,Cyclic AMP,D13.695.667.138.395
22992675,2012-09-19T00:00:00,Cyclic AMP,D13.695.827.068.395
22992675,2012-09-19T00:00:00,Electric Stimulation,E05.723.402
22992675,2012-09-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22992675,2012-09-19T00:00:00,"Muscle, Smooth",A02.633.570
22992675,2012-09-19T00:00:00,"Muscle, Smooth",A10.690.467
22992675,2012-09-19T00:00:00,Ryanodine Receptor Calcium Release Channel,D12.776.157.530.400.150.800
22992675,2012-09-19T00:00:00,Ryanodine Receptor Calcium Release Channel,D12.776.210.500.800
22992675,2012-09-19T00:00:00,Ryanodine Receptor Calcium Release Channel,D12.776.543.550.425.150.800
22992675,2012-09-19T00:00:00,Ryanodine Receptor Calcium Release Channel,D12.776.543.585.400.150.800
22992675,2012-09-19T00:00:00,Signal Transduction,G02.111.087.800
22992675,2012-09-19T00:00:00,Signal Transduction,G02.149.115.800
22992675,2012-09-19T00:00:00,Signal Transduction,G04.299.880
22992675,2012-09-19T00:00:00,Urinary Bladder,A05.810.890
22993446,2012-09-19T00:00:00,Animals,B01.050
22993446,2012-09-19T00:00:00,Cocaine,D02.145.074.722.388
22993446,2012-09-19T00:00:00,Cocaine,D03.132.889.354
22993446,2012-09-19T00:00:00,Cocaine,D03.605.869.388
22993446,2012-09-19T00:00:00,Cocaine,D04.075.080.875.099.722.388
22993446,2012-09-19T00:00:00,"Conditioning, Operant",F02.463.425.179.509
22993446,2012-09-19T00:00:00,Cues,F02.463.425.234
22993446,2012-09-19T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.150.800
22993446,2012-09-19T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.600.220
22993446,2012-09-19T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.150.800
22993446,2012-09-19T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.600.220
22993446,2012-09-19T00:00:00,Gene Expression Regulation,G05.355.315
22993446,2012-09-19T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22993446,2012-09-19T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
22993446,2012-09-19T00:00:00,Self Administration,E02.319.890
22993446,2012-09-19T00:00:00,Self Administration,E02.900.890
22993446,2012-09-19T00:00:00,Ventral Tegmental Area,A08.186.211.132.659.822.820
22993446,2012-09-19T00:00:00,Ventral Tegmental Area,A08.186.211.653.822.820
22999697,2012-09-19T00:00:00,Aged,M01.060.116.100
22999697,2012-09-19T00:00:00,Electrolytes,D01.248
22999697,2012-09-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22999697,2012-09-19T00:00:00,Polyethylene Glycols,D02.033.455.250.700
22999697,2012-09-19T00:00:00,Polyethylene Glycols,D05.750.741
22999697,2012-09-19T00:00:00,Polyethylene Glycols,D25.720.741
22999697,2012-09-19T00:00:00,Polyethylene Glycols,J01.637.051.720.741
22999697,2012-09-19T00:00:00,Postoperative Complications,C23.550.767
22999697,2012-09-19T00:00:00,Preoperative Care,E02.760.795
22999697,2012-09-19T00:00:00,Preoperative Care,E04.641
22999697,2012-09-19T00:00:00,Preoperative Care,N02.421.585.795
23267805,2012-09-19T00:00:00,Adult,M01.060.116
23267805,2012-09-19T00:00:00,Graft Survival,G12.425.901.545.340
23267805,2012-09-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23267805,2012-09-19T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
23267805,2012-09-19T00:00:00,Liver Transplantation,E04.210.650
23267805,2012-09-19T00:00:00,Liver Transplantation,E04.936.450.490
23267805,2012-09-19T00:00:00,Liver Transplantation,E04.936.580.490
23267805,2012-09-19T00:00:00,Middle Aged,M01.060.116.630
23267805,2012-09-19T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
23267805,2012-09-19T00:00:00,Thrombosis,C14.907.355.830
23267805,2012-09-19T00:00:00,Treatment Outcome,E01.789.800
23267805,2012-09-19T00:00:00,Treatment Outcome,N04.761.559.590.800
23267805,2012-09-19T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23267805,2012-09-19T00:00:00,Young Adult,M01.060.116.815
22994185,2012-09-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22994185,2012-09-20T00:00:00,Minority Groups,I01.880.371
22994185,2012-09-20T00:00:00,Sexual Behavior,F01.145.802
22994185,2012-09-20T00:00:00,Smoking,F01.145.466.753
22994185,2012-09-20T00:00:00,United States,Z01.107.567.875
22996916,2012-09-20T00:00:00,Adult,M01.060.116
22996916,2012-09-20T00:00:00,Aged,M01.060.116.100
22996916,2012-09-20T00:00:00,Breast Neoplasms,C04.588.180
22996916,2012-09-20T00:00:00,Breast Neoplasms,C17.800.090.500
22996916,2012-09-20T00:00:00,"Carcinoma, Ductal, Breast",C04.557.470.200.025.232.500
22996916,2012-09-20T00:00:00,"Carcinoma, Ductal, Breast",C04.557.470.615.132.500
22996916,2012-09-20T00:00:00,"Carcinoma, Ductal, Breast",C04.588.180.390
22996916,2012-09-20T00:00:00,"Carcinoma, Ductal, Breast",C17.800.090.500.390
22996916,2012-09-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22996916,2012-09-20T00:00:00,Middle Aged,M01.060.116.630
22996916,2012-09-20T00:00:00,Neoplasm Invasiveness,C04.697.645
22996916,2012-09-20T00:00:00,Neoplasm Invasiveness,C23.550.727.645
22996916,2012-09-20T00:00:00,Neoplasm Staging,E01.370.550
22996916,2012-09-20T00:00:00,"Receptor, erbB-2",D08.811.913.696.620.682.725.400.150
22996916,2012-09-20T00:00:00,"Receptor, erbB-2",D12.776.543.750.060.374
22996916,2012-09-20T00:00:00,"Receptor, erbB-2",D12.776.543.750.750.400.350
22996916,2012-09-20T00:00:00,"Receptor, erbB-2",D12.776.624.664.700.642
22996916,2012-09-20T00:00:00,"Receptor, erbB-2",D23.101.840.642
22996916,2012-09-20T00:00:00,"Receptors, Estrogen",D12.776.260.698.750.350
22996916,2012-09-20T00:00:00,"Receptors, Estrogen",D12.776.826.750.350
22996916,2012-09-20T00:00:00,"Receptors, Estrogen",D12.776.930.669.750.350
22996916,2012-09-20T00:00:00,"Receptors, Progesterone",D12.776.260.698.750.765
22996916,2012-09-20T00:00:00,"Receptors, Progesterone",D12.776.826.750.765
22996916,2012-09-20T00:00:00,"Receptors, Progesterone",D12.776.930.669.750.765
22996916,2012-09-20T00:00:00,"Tumor Markers, Biological",D23.101.840
22996916,2012-09-20T00:00:00,"Ultrasonography, Mammary",E01.370.350.850.860
22996916,2012-09-20T00:00:00,"Ultrasonography, Mammary",E01.370.378.850
23001564,2012-09-21T00:00:00,Genome-Wide Association Study,E05.318.416.249
23001564,2012-09-21T00:00:00,Genome-Wide Association Study,E05.318.780.392
23001564,2012-09-21T00:00:00,Genome-Wide Association Study,E05.393.385.500
23001564,2012-09-21T00:00:00,Genome-Wide Association Study,E05.393.522.500
23001564,2012-09-21T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
23001564,2012-09-21T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
23001564,2012-09-21T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
23001564,2012-09-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23001672,2012-09-21T00:00:00,Bacteria,B03
23001672,2012-09-21T00:00:00,Electrodes,E07.305.250
23001672,2012-09-21T00:00:00,Methane,D02.455.326.146.571
23001672,2012-09-21T00:00:00,"Sequence Analysis, DNA",E05.393.760.700
23009800,2012-09-23T00:00:00,Alcohol Drinking,F01.145.317.269
23009800,2012-09-23T00:00:00,Alcoholism,C21.739.100.250
23009800,2012-09-23T00:00:00,Alcoholism,F03.900.100.350
23009800,2012-09-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23009800,2012-09-23T00:00:00,Middle Aged,M01.060.116.630
23009800,2012-09-23T00:00:00,Psychiatric Status Rating Scales,F04.586
23009800,2012-09-23T00:00:00,Questionnaires,E05.318.308.750
23009800,2012-09-23T00:00:00,Questionnaires,L01.280.800
23009800,2012-09-23T00:00:00,Questionnaires,N05.715.360.300.695
23009800,2012-09-23T00:00:00,Questionnaires,N06.850.520.308.750
23009800,2012-09-23T00:00:00,Self Efficacy,F01.752.747.792.700
23009800,2012-09-23T00:00:00,Substance Abuse Treatment Centers,N02.278.035.128.800
23009800,2012-09-23T00:00:00,Substance Abuse Treatment Centers,N02.278.808.930
23009800,2012-09-23T00:00:00,Treatment Outcome,E01.789.800
23009800,2012-09-23T00:00:00,Treatment Outcome,N04.761.559.590.800
23009800,2012-09-23T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23009800,2012-09-23T00:00:00,United States,Z01.107.567.875
23009800,2012-09-23T00:00:00,Veterans,M01.930
23009800,2012-09-23T00:00:00,Video Games,I03.450.642.693.930
23009800,2012-09-23T00:00:00,Video Games,L01.224.900.930
22949170,2012-09-24T00:00:00,Adsorption,G02.149.047
22949170,2012-09-24T00:00:00,Adsorption,G02.149.767.029
22949170,2012-09-24T00:00:00,Adsorption,G02.842.750.029
22949170,2012-09-24T00:00:00,Anion Exchange Resins,D27.720.470.420.050
22949170,2012-09-24T00:00:00,"Chromatography, Ion Exchange",E05.196.181.400.383
22949170,2012-09-24T00:00:00,Electric Conductivity,G01.201.249.277
22949170,2012-09-24T00:00:00,"Membranes, Artificial",D25.479
22949170,2012-09-24T00:00:00,"Membranes, Artificial",J01.637.051.479
22949170,2012-09-24T00:00:00,"Membranes, Artificial",J01.637.087.500
23029214,2012-09-24T00:00:00,"Genes, Plant",G05.360.340.024.340.393
23029214,2012-09-24T00:00:00,"Genes, Plant",G05.360.340.365.500
23029214,2012-09-24T00:00:00,Gossypium,B01.650.388.100.700.244
23029214,2012-09-24T00:00:00,Quantitative Trait Loci,G05.360.340.024.380.937
23052231,2012-09-24T00:00:00,Animals,B01.050
23052231,2012-09-24T00:00:00,Cell Line,A11.251.210
23052231,2012-09-24T00:00:00,Cell Survival,G04.299.316
23052231,2012-09-24T00:00:00,Ceramides,D02.065.313
23052231,2012-09-24T00:00:00,Ceramides,D09.400.410.420.525.200
23052231,2012-09-24T00:00:00,Ceramides,D10.390.470.675.200
23052231,2012-09-24T00:00:00,Ceramides,D10.570.877.360.612.200
23052231,2012-09-24T00:00:00,Membrane Glycoproteins,D12.776.395.550
23052231,2012-09-24T00:00:00,Membrane Glycoproteins,D12.776.543.550
23052231,2012-09-24T00:00:00,Mitochondria,A11.284.430.214.190.875.564
23052231,2012-09-24T00:00:00,Mitochondria,A11.284.835.626
23052231,2012-09-24T00:00:00,Oxidative Stress,G03.495.710
23052231,2012-09-24T00:00:00,Oxidative Stress,G07.700.830.750
23052231,2012-09-24T00:00:00,Pyridinium Compounds,D03.383.725.762
23052231,2012-09-24T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23052231,2012-09-24T00:00:00,Reactive Oxygen Species,D01.339.431
23052231,2012-09-24T00:00:00,Reactive Oxygen Species,D01.650.775
22900545,2012-09-25T00:00:00,Adult,M01.060.116
22900545,2012-09-25T00:00:00,Animals,B01.050
22900545,2012-09-25T00:00:00,Cathepsin B,D08.811.277.656.224.125
22900545,2012-09-25T00:00:00,Cathepsin B,D08.811.277.656.262.500.133
22900545,2012-09-25T00:00:00,Cathepsin B,D08.811.277.656.300.200.133
22900545,2012-09-25T00:00:00,Drug-Induced Liver Injury,C06.552.195
22900545,2012-09-25T00:00:00,Drug-Induced Liver Injury,C21.613.260
22900545,2012-09-25T00:00:00,Hepatocytes,A11.436.348
22900545,2012-09-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22900545,2012-09-25T00:00:00,Ketones,D02.522
22900545,2012-09-25T00:00:00,Liver,A03.620
22900545,2012-09-25T00:00:00,Lysosomes,A11.284.430.214.190.875.190.550
22900545,2012-09-25T00:00:00,Middle Aged,M01.060.116.630
23004679,2012-09-25T00:00:00,Animals,B01.050
23004679,2012-09-25T00:00:00,Asthma,C08.127.108
23004679,2012-09-25T00:00:00,Asthma,C08.381.495.108
23004679,2012-09-25T00:00:00,Asthma,C08.674.095
23004679,2012-09-25T00:00:00,Asthma,C20.543.480.680.095
23004679,2012-09-25T00:00:00,Caveolin 1,D12.644.360.024.264
23004679,2012-09-25T00:00:00,Caveolin 1,D12.776.157.057.010
23004679,2012-09-25T00:00:00,Caveolin 1,D12.776.476.024.280
23004679,2012-09-25T00:00:00,Caveolin 1,D12.776.543.990.100.500
23004679,2012-09-25T00:00:00,Caveolin 1,D12.776.744.287
23004679,2012-09-25T00:00:00,"Disease Models, Animal",C22.232
23004679,2012-09-25T00:00:00,"Disease Models, Animal",E05.598.500
23004679,2012-09-25T00:00:00,"Disease Models, Animal",E05.599.395.080
23004679,2012-09-25T00:00:00,Epithelial Cells,A11.436
23004679,2012-09-25T00:00:00,Extracellular Matrix Proteins,D12.776.860.300
23004679,2012-09-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23004679,2012-09-25T00:00:00,Lung,A04.411
23004679,2012-09-25T00:00:00,Monocytes,A11.118.637.555.652
23004679,2012-09-25T00:00:00,Monocytes,A11.148.580
23004679,2012-09-25T00:00:00,Monocytes,A11.627.624
23004679,2012-09-25T00:00:00,Monocytes,A11.733.547
23004679,2012-09-25T00:00:00,Monocytes,A15.145.229.637.555.652
23004679,2012-09-25T00:00:00,Monocytes,A15.378.316.580
23004679,2012-09-25T00:00:00,Monocytes,A15.382.490.555.652
23004679,2012-09-25T00:00:00,Monocytes,A15.382.680.547
23004679,2012-09-25T00:00:00,Monocytes,A15.382.812.547
23004679,2012-09-25T00:00:00,Signal Transduction,G02.111.087.800
23004679,2012-09-25T00:00:00,Signal Transduction,G02.149.115.800
23004679,2012-09-25T00:00:00,Signal Transduction,G04.299.880
23010362,2012-09-25T00:00:00,Adrenergic Uptake Inhibitors,D27.505.519.625.050.601
23010362,2012-09-25T00:00:00,Adrenergic Uptake Inhibitors,D27.505.519.625.600.050
23010362,2012-09-25T00:00:00,Adrenergic Uptake Inhibitors,D27.505.696.577.050.601
23010362,2012-09-25T00:00:00,Adrenergic Uptake Inhibitors,D27.505.696.577.600.050
23010362,2012-09-25T00:00:00,Alkaloids,D03.132
23010362,2012-09-25T00:00:00,Animals,B01.050
23010362,2012-09-25T00:00:00,"Bicyclo Compounds, Heterocyclic",D02.455.426.100.080.085
23010362,2012-09-25T00:00:00,"Bicyclo Compounds, Heterocyclic",D03.438.260
23010362,2012-09-25T00:00:00,"Bicyclo Compounds, Heterocyclic",D03.605.084
23010362,2012-09-25T00:00:00,"Bicyclo Compounds, Heterocyclic",D04.075.080.875
23010362,2012-09-25T00:00:00,Calcium,D01.268.552.100
23010362,2012-09-25T00:00:00,Calcium,D01.552.539.288
23010362,2012-09-25T00:00:00,Calcium,D23.119.100
23010362,2012-09-25T00:00:00,Epithelial Cells,A11.436
23010362,2012-09-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23010362,2012-09-25T00:00:00,"Models, Molecular",E05.599.595
23010362,2012-09-25T00:00:00,Nicotinic Agonists,D27.505.519.625.120.140.700
23010362,2012-09-25T00:00:00,Nicotinic Agonists,D27.505.696.577.120.140.700
23010362,2012-09-25T00:00:00,Pyridines,D03.383.725
23010362,2012-09-25T00:00:00,"Receptors, Nicotinic",D12.776.543.750.720.360.550
23015609,2012-09-25T00:00:00,Adult,M01.060.116
23015609,2012-09-25T00:00:00,Alcohol Drinking,F01.145.317.269
23015609,2012-09-25T00:00:00,Hair,A17.360
23015609,2012-09-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23015609,2012-09-25T00:00:00,"Liver Diseases, Alcoholic",C06.552.645
23015609,2012-09-25T00:00:00,"Liver Diseases, Alcoholic",C21.739.100.087.645
23015609,2012-09-25T00:00:00,Middle Aged,M01.060.116.630
23015609,2012-09-25T00:00:00,Substance Abuse Detection,E05.885
23015609,2012-09-25T00:00:00,Substance Abuse Detection,N06.850.780.500.765
23022214,2012-09-25T00:00:00,Animals,B01.050
23022214,2012-09-25T00:00:00,Cell Death,G04.299.139
23022214,2012-09-25T00:00:00,DNA-Binding Proteins,D12.776.260
23022214,2012-09-25T00:00:00,Gene Expression Regulation,G05.355.315
23022214,2012-09-25T00:00:00,Glutamic Acid,D12.125.067.750
23022214,2012-09-25T00:00:00,Glutamic Acid,D12.125.119.450
23022214,2012-09-25T00:00:00,Glutamic Acid,D12.125.427.300
23022214,2012-09-25T00:00:00,Neoplasm Proteins,D12.776.624
23022214,2012-09-25T00:00:00,Neurons,A08.663
23022214,2012-09-25T00:00:00,Neurons,A11.671
23022214,2012-09-25T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23022214,2012-09-25T00:00:00,Repressor Proteins,D12.776.260.703
23022214,2012-09-25T00:00:00,Repressor Proteins,D12.776.930.700
23022214,2012-09-25T00:00:00,Spinal Cord,A08.186.854
23049763,2012-09-25T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
23049763,2012-09-25T00:00:00,Bacterial Proteins,D12.776.097
23049763,2012-09-25T00:00:00,Catalytic Domain,G02.111.570.120.704
23049763,2012-09-25T00:00:00,Catalytic Domain,G02.111.570.790.709.610.189
23049763,2012-09-25T00:00:00,Cephalosporins,D02.065.589.099.249
23049763,2012-09-25T00:00:00,Cephalosporins,D02.886.665.074
23049763,2012-09-25T00:00:00,Cephalosporins,D04.075.080.875.099.221.249
23049763,2012-09-25T00:00:00,Microbial Sensitivity Tests,E05.200.875.595
23049763,2012-09-25T00:00:00,Microbial Sensitivity Tests,E05.337.550.400
23049763,2012-09-25T00:00:00,Neisseria gonorrhoeae,B03.440.400.425.550.550.474
23049763,2012-09-25T00:00:00,Neisseria gonorrhoeae,B03.660.075.525.520.400
23049763,2012-09-25T00:00:00,Penicillin-Binding Proteins,D08.811.710
23049763,2012-09-25T00:00:00,Penicillin-Binding Proteins,D12.776.097.545
23049763,2012-09-25T00:00:00,Penicillins,D02.065.589.099.750
23049763,2012-09-25T00:00:00,Penicillins,D02.886.108.750
23049763,2012-09-25T00:00:00,Penicillins,D03.438.260.825
23049763,2012-09-25T00:00:00,Penicillins,D03.605.084.737
23049763,2012-09-25T00:00:00,Penicillins,D04.075.080.875.099.221.750
23049763,2012-09-25T00:00:00,Recombinant Proteins,D12.776.828
23049763,2012-09-25T00:00:00,Small Molecule Libraries,D27.720.470.765
23202752,2012-09-25T00:00:00,Adolescent,M01.060.057
23202752,2012-09-25T00:00:00,Adult,M01.060.116
23202752,2012-09-25T00:00:00,Ambulatory Care,E02.760.106
23202752,2012-09-25T00:00:00,Ambulatory Care,N02.421.585.106
23202752,2012-09-25T00:00:00,Chlorine,D01.268.380.150
23202752,2012-09-25T00:00:00,Chlorine,D01.362.225
23202752,2012-09-25T00:00:00,Disasters,N06.230.100
23202752,2012-09-25T00:00:00,Health Services Accessibility,N04.590.374.350
23202752,2012-09-25T00:00:00,Health Services Accessibility,N05.300.430
23202752,2012-09-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23202752,2012-09-25T00:00:00,Middle Aged,M01.060.116.630
23202752,2012-09-25T00:00:00,"Models, Theoretical",E05.599
23202752,2012-09-25T00:00:00,Primary Health Care,N04.590.233.727
23202752,2012-09-25T00:00:00,South Carolina,Z01.107.567.875.075.662
23202752,2012-09-25T00:00:00,South Carolina,Z01.107.567.875.750.700
23202752,2012-09-25T00:00:00,United States,Z01.107.567.875
23202752,2012-09-25T00:00:00,Young Adult,M01.060.116.815
23014131,2012-09-26T00:00:00,Aged,M01.060.116.100
23014131,2012-09-26T00:00:00,Calcium,D01.268.552.100
23014131,2012-09-26T00:00:00,Calcium,D01.552.539.288
23014131,2012-09-26T00:00:00,Calcium,D23.119.100
23014131,2012-09-26T00:00:00,Case-Control Studies,E05.318.760.500.500
23014131,2012-09-26T00:00:00,Case-Control Studies,N05.715.360.775.175.200
23014131,2012-09-26T00:00:00,Case-Control Studies,N06.850.520.450.500.500
23014131,2012-09-26T00:00:00,Coronary Artery Disease,C14.280.647.250.260
23014131,2012-09-26T00:00:00,Coronary Artery Disease,C14.907.137.126.339
23014131,2012-09-26T00:00:00,Coronary Artery Disease,C14.907.585.250.260
23014131,2012-09-26T00:00:00,Heart,A07.541
23014131,2012-09-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23014131,2012-09-26T00:00:00,Hypertension,C14.907.489
23014131,2012-09-26T00:00:00,Middle Aged,M01.060.116.630
23014131,2012-09-26T00:00:00,Phosphorylation,G02.111.087.677
23014131,2012-09-26T00:00:00,Phosphorylation,G02.149.115.677
23014131,2012-09-26T00:00:00,Phosphorylation,G02.149.465.700
23014131,2012-09-26T00:00:00,Phosphorylation,G02.607.750.700
23014131,2012-09-26T00:00:00,Phosphorylation,G03.495.790
23014131,2012-09-26T00:00:00,Ventricular Remodeling,C23.300.985
23014131,2012-09-26T00:00:00,Ventricular Remodeling,G09.330.190.962.975
23024244,2012-09-27T00:00:00,Bias (Epidemiology),N05.715.350.150
23024244,2012-09-27T00:00:00,Bias (Epidemiology),N06.850.490.500
23024244,2012-09-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23024244,2012-09-27T00:00:00,Nicotinic Agonists,D27.505.519.625.120.140.700
23024244,2012-09-27T00:00:00,Nicotinic Agonists,D27.505.696.577.120.140.700
23024244,2012-09-27T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
23024244,2012-09-27T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
23024244,2012-09-27T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
23024244,2012-09-27T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
23024244,2012-09-27T00:00:00,Smoking,F01.145.466.753
23024244,2012-09-27T00:00:00,Smoking Cessation,F01.145.940.700
22811568,2012-09-28T00:00:00,Alligators and Crocodiles,B01.050.150.900.833.100
22811568,2012-09-28T00:00:00,Animals,B01.050
22811568,2012-09-28T00:00:00,Chick Embryo,A13.350.150
22811568,2012-09-28T00:00:00,Chick Embryo,A16.331.200
22811568,2012-09-28T00:00:00,Chickens,B01.050.150.900.248.350.150
22811568,2012-09-28T00:00:00,Chickens,B01.050.150.900.248.617.192
22811568,2012-09-28T00:00:00,Chorioallantoic Membrane,A10.615.284.375
22811568,2012-09-28T00:00:00,Chorioallantoic Membrane,A13.350.575
22811568,2012-09-28T00:00:00,Chorioallantoic Membrane,A16.331.400
22811568,2012-09-28T00:00:00,"Embryo, Nonmammalian",A13.350
22811568,2012-09-28T00:00:00,"Embryo, Nonmammalian",A16.331
22811568,2012-09-28T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
22811568,2012-09-28T00:00:00,Gonadal Steroid Hormones,D06.472.334.851
22811568,2012-09-28T00:00:00,"Models, Biological",E05.599.395
22811568,2012-09-28T00:00:00,Oviparity,G08.686.650
22811568,2012-09-28T00:00:00,Reptiles,B01.050.150.900.833
22811568,2012-09-28T00:00:00,Signal Transduction,G02.111.087.800
22811568,2012-09-28T00:00:00,Signal Transduction,G02.149.115.800
22811568,2012-09-28T00:00:00,Signal Transduction,G04.299.880
22811568,2012-09-28T00:00:00,Steroids,D04.808
23019638,2012-09-28T00:00:00,Diet,E05.272
23019638,2012-09-28T00:00:00,Diet,G07.610.240
23019638,2012-09-28T00:00:00,Embryonic Development,G07.700.320.500.325.180
23019638,2012-09-28T00:00:00,Embryonic Development,G08.686.785.760.170.104
23019638,2012-09-28T00:00:00,Environmental Exposure,N06.850.460.350
23019638,2012-09-28T00:00:00,Health Status,I01.240.425
23019638,2012-09-28T00:00:00,Health Status,N01.224.425
23019638,2012-09-28T00:00:00,Health Status,N06.850.505.400.425
23019638,2012-09-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23019638,2012-09-28T00:00:00,Pesticides,D27.720.031.700
23019638,2012-09-28T00:00:00,Pesticides,D27.720.723
23019638,2012-09-28T00:00:00,Pesticides,D27.888.723
23019638,2012-09-28T00:00:00,"Stress, Physiological",G07.700.830
23084792,2012-09-28T00:00:00,Adolescent,M01.060.057
23084792,2012-09-28T00:00:00,Adult,M01.060.116
23084792,2012-09-28T00:00:00,Brain,A08.186.211
23084792,2012-09-28T00:00:00,Child,M01.060.406
23084792,2012-09-28T00:00:00,"Child, Preschool",M01.060.406.448
23084792,2012-09-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23084792,2012-09-28T00:00:00,Middle Aged,M01.060.116.630
23084792,2012-09-28T00:00:00,Mitochondrial Diseases,C18.452.660
23084792,2012-09-28T00:00:00,Technetium Tc 99m Exametazime,D01.632.825.562
23084792,2012-09-28T00:00:00,Technetium Tc 99m Exametazime,D02.092.570.665.810
23084792,2012-09-28T00:00:00,Technetium Tc 99m Exametazime,D02.691.825.562
23084792,2012-09-28T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.350.800.800
23084792,2012-09-28T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.600.350.800.800
23084792,2012-09-28T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.710.800.800
23084792,2012-09-28T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.825.800.800
23084792,2012-09-28T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.384.730.800.800
23084792,2012-09-28T00:00:00,Treatment Outcome,E01.789.800
23084792,2012-09-28T00:00:00,Treatment Outcome,N04.761.559.590.800
23084792,2012-09-28T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23084792,2012-09-28T00:00:00,Young Adult,M01.060.116.815
23108091,2012-09-28T00:00:00,Animals,B01.050
23108091,2012-09-28T00:00:00,Binding Sites,G02.111.570.120
23108091,2012-09-28T00:00:00,DNA,D13.444.308
23108091,2012-09-28T00:00:00,"Disease Models, Animal",C22.232
23108091,2012-09-28T00:00:00,"Disease Models, Animal",E05.598.500
23108091,2012-09-28T00:00:00,"Disease Models, Animal",E05.599.395.080
23108091,2012-09-28T00:00:00,Endothelial Cells,A11.436.275
23108091,2012-09-28T00:00:00,Gene Expression,G05.355.310
23108091,2012-09-28T00:00:00,Glomerulonephritis,C12.777.419.570.363
23108091,2012-09-28T00:00:00,Glomerulonephritis,C13.351.968.419.570.363
23108091,2012-09-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23108091,2012-09-28T00:00:00,Kidney,A05.810.453
23108091,2012-09-28T00:00:00,Lupus Nephritis,C12.777.419.570.363.680
23108091,2012-09-28T00:00:00,Lupus Nephritis,C13.351.968.419.570.363.680
23108091,2012-09-28T00:00:00,Lupus Nephritis,C17.300.480.680
23108091,2012-09-28T00:00:00,Lupus Nephritis,C20.111.590.560
23108091,2012-09-28T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
23108091,2012-09-28T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
23108091,2012-09-28T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
23108091,2012-09-28T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.260.665.400
23108091,2012-09-28T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.624.664.700.175.400
23108091,2012-09-28T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.930.635.400
23053794,2012-09-29T00:00:00,Adult,M01.060.116
23053794,2012-09-29T00:00:00,Aged,M01.060.116.100
23053794,2012-09-29T00:00:00,Breast Neoplasms,C04.588.180
23053794,2012-09-29T00:00:00,Breast Neoplasms,C17.800.090.500
23053794,2012-09-29T00:00:00,Case-Control Studies,E05.318.760.500.500
23053794,2012-09-29T00:00:00,Case-Control Studies,N05.715.360.775.175.200
23053794,2012-09-29T00:00:00,Case-Control Studies,N06.850.520.450.500.500
23053794,2012-09-29T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
23053794,2012-09-29T00:00:00,Genetic Predisposition to Disease,G05.380.355
23053794,2012-09-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23053794,2012-09-29T00:00:00,Middle Aged,M01.060.116.630
23053794,2012-09-29T00:00:00,Motor Activity,F01.145.632
23053794,2012-09-29T00:00:00,Motor Activity,G11.427.590.530.698
23053794,2012-09-29T00:00:00,Oxidative Stress,G03.495.710
23053794,2012-09-29T00:00:00,Oxidative Stress,G07.700.830.750
23053794,2012-09-29T00:00:00,"Polymorphism, Genetic",G05.365.795
23053794,2012-09-29T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
23053794,2012-09-29T00:00:00,Risk Factors,E05.318.740.600.800.725
23053794,2012-09-29T00:00:00,Risk Factors,N05.715.350.200.700
23053794,2012-09-29T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23053794,2012-09-29T00:00:00,Risk Factors,N06.850.490.625.750
23053794,2012-09-29T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23053794,2012-09-29T00:00:00,Young Adult,M01.060.116.815
23023332,2012-09-30T00:00:00,Animals,B01.050
23023332,2012-09-30T00:00:00,Craniosynostoses,C05.116.099.370.894.232
23023332,2012-09-30T00:00:00,Craniosynostoses,C05.660.207.240
23023332,2012-09-30T00:00:00,Craniosynostoses,C05.660.906.364
23023332,2012-09-30T00:00:00,Craniosynostoses,C16.131.621.207.240
23023332,2012-09-30T00:00:00,Craniosynostoses,C16.131.621.906.364
23023332,2012-09-30T00:00:00,DNA-Binding Proteins,D12.776.260
23023332,2012-09-30T00:00:00,Fibroblasts,A11.329.228
23023332,2012-09-30T00:00:00,Fibroblasts,A11.872.228
23023332,2012-09-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23023332,2012-09-30T00:00:00,Mutation,G05.365.590
23023332,2012-09-30T00:00:00,Phenotype,G05.695
23023332,2012-09-30T00:00:00,Phosphorylation,G02.111.087.677
23023332,2012-09-30T00:00:00,Phosphorylation,G02.149.115.677
23023332,2012-09-30T00:00:00,Phosphorylation,G02.149.465.700
23023332,2012-09-30T00:00:00,Phosphorylation,G02.607.750.700
23023332,2012-09-30T00:00:00,Phosphorylation,G03.495.790
23023332,2012-09-30T00:00:00,Proto-Oncogene Proteins,D12.776.624.664.700
23023332,2012-09-30T00:00:00,Signal Transduction,G02.111.087.800
23023332,2012-09-30T00:00:00,Signal Transduction,G02.149.115.800
23023332,2012-09-30T00:00:00,Signal Transduction,G04.299.880
23023332,2012-09-30T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
23023332,2012-09-30T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
23023332,2012-09-30T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
23023332,2012-09-30T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
23023332,2012-09-30T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
23023332,2012-09-30T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
23023332,2012-09-30T00:00:00,Transforming Growth Factor beta,D23.529.374.687
23023332,2012-09-30T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
23023332,2012-09-30T00:00:00,Transforming Growth Factor beta,D23.529.960.720
23023332,2012-09-30T00:00:00,Zebrafish,B01.050.150.900.493.200.244.828
23052882,2012-09-30T00:00:00,Animals,B01.050
23052882,2012-09-30T00:00:00,Cell Line,A11.251.210
23052882,2012-09-30T00:00:00,Cell Survival,G04.299.316
23052882,2012-09-30T00:00:00,Dextrans,D05.750.078.562.272
23052882,2012-09-30T00:00:00,Dextrans,D09.698.365.272
23052882,2012-09-30T00:00:00,Fluorenes,D02.455.426.559.847.389
23052882,2012-09-30T00:00:00,Fluorenes,D04.615.389
23052882,2012-09-30T00:00:00,Fluorescent Dyes,D27.720.233.348
23052882,2012-09-30T00:00:00,Fluorescent Dyes,D27.720.470.330.348
23052882,2012-09-30T00:00:00,Fluorescent Dyes,D27.720.470.410.505.500
23052882,2012-09-30T00:00:00,Macrophages,A11.329.372
23052882,2012-09-30T00:00:00,Macrophages,A11.627.482
23052882,2012-09-30T00:00:00,Macrophages,A11.733.397
23052882,2012-09-30T00:00:00,Macrophages,A15.382.680.397
23052882,2012-09-30T00:00:00,Macrophages,A15.382.812.522
23052882,2012-09-30T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
23052882,2012-09-30T00:00:00,"Microscopy, Fluorescence",E05.595.458
23052882,2012-09-30T00:00:00,Nanoparticles,J01.637.512.600
23052882,2012-09-30T00:00:00,Polyethylene Glycols,D02.033.455.250.700
23052882,2012-09-30T00:00:00,Polyethylene Glycols,D05.750.741
23052882,2012-09-30T00:00:00,Polyethylene Glycols,D25.720.741
23052882,2012-09-30T00:00:00,Polyethylene Glycols,J01.637.051.720.741
23052882,2012-09-30T00:00:00,Polymers,D05.750
23052882,2012-09-30T00:00:00,Polymers,D25.720
23052882,2012-09-30T00:00:00,Polymers,J01.637.051.720
23052882,2012-09-30T00:00:00,Quantum Dots,E07.595.650
23052882,2012-09-30T00:00:00,Quantum Dots,J01.637.512.600.650
23260612,2012-09-30T00:00:00,Adult,M01.060.116
23260612,2012-09-30T00:00:00,African Americans,M01.686.508.100.100
23260612,2012-09-30T00:00:00,African Americans,M01.686.754.100
23260612,2012-09-30T00:00:00,Aged,M01.060.116.100
23260612,2012-09-30T00:00:00,Exercise,G11.427.590.237
23260612,2012-09-30T00:00:00,Exercise,I03.350
23260612,2012-09-30T00:00:00,Exercise Therapy,E02.779.483
23260612,2012-09-30T00:00:00,Exercise Therapy,E02.831.387
23260612,2012-09-30T00:00:00,Fatigue,C23.888.369
23260612,2012-09-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23260612,2012-09-30T00:00:00,Interviews as Topic,E05.318.308.420
23260612,2012-09-30T00:00:00,Interviews as Topic,L01.280.520
23260612,2012-09-30T00:00:00,Interviews as Topic,N05.715.360.300.400
23260612,2012-09-30T00:00:00,Interviews as Topic,N06.850.520.308.420
23260612,2012-09-30T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
23260612,2012-09-30T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
23260612,2012-09-30T00:00:00,Middle Aged,M01.060.116.630
23260612,2012-09-30T00:00:00,Motivation,F01.658
23260612,2012-09-30T00:00:00,Motivation,F01.752.543.500.750
23260612,2012-09-30T00:00:00,Patient Compliance,F01.145.488.500
23260612,2012-09-30T00:00:00,Patient Compliance,N05.300.150.600.600
23260612,2012-09-30T00:00:00,Sedentary Lifestyle,F01.829.458.705
23260612,2012-09-30T00:00:00,Video Games,I03.450.642.693.930
23260612,2012-09-30T00:00:00,Video Games,L01.224.900.930
21297431,2012-10-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
21297431,2012-10-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
21297431,2012-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21297431,2012-10-01T00:00:00,Organ Transplantation,E04.936.450
21297431,2012-10-01T00:00:00,Skin Neoplasms,C04.588.805
21297431,2012-10-01T00:00:00,Skin Neoplasms,C17.800.882
22222338,2012-10-01T00:00:00,African Americans,M01.686.508.100.100
22222338,2012-10-01T00:00:00,African Americans,M01.686.754.100
22222338,2012-10-01T00:00:00,Angiotensin-Converting Enzyme Inhibitors,D27.505.519.389.745.085
22222338,2012-10-01T00:00:00,Biological Markers,D23.101
22222338,2012-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22222338,2012-10-01T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
22222338,2012-10-01T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
22222338,2012-10-01T00:00:00,Risk Factors,E05.318.740.600.800.725
22222338,2012-10-01T00:00:00,Risk Factors,N05.715.350.200.700
22222338,2012-10-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22222338,2012-10-01T00:00:00,Risk Factors,N06.850.490.625.750
22222338,2012-10-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22222338,2012-10-01T00:00:00,Vitamin D,D04.808.812.768
22222338,2012-10-01T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
22581266,2012-10-01T00:00:00,Animals,B01.050
22581266,2012-10-01T00:00:00,Cell Line,A11.251.210
22581266,2012-10-01T00:00:00,Endotoxemia,C01.539.757.100.275
22581266,2012-10-01T00:00:00,Endotoxemia,C01.539.861.375
22581266,2012-10-01T00:00:00,Endotoxemia,C23.550.470.790.500.100.275
22581266,2012-10-01T00:00:00,Fibroblasts,A11.329.228
22581266,2012-10-01T00:00:00,Fibroblasts,A11.872.228
22581266,2012-10-01T00:00:00,Interleukin-6,D12.644.276.374.465.506
22581266,2012-10-01T00:00:00,Interleukin-6,D12.776.467.374.465.506
22581266,2012-10-01T00:00:00,Interleukin-6,D23.529.374.465.506
22581266,2012-10-01T00:00:00,Lipopolysaccharides,D09.400.500
22581266,2012-10-01T00:00:00,Lipopolysaccharides,D09.698.718.450
22581266,2012-10-01T00:00:00,Lipopolysaccharides,D10.494
22581266,2012-10-01T00:00:00,Lipopolysaccharides,D23.050.161.616.525
22581266,2012-10-01T00:00:00,Lipopolysaccharides,D23.946.123.329.500
22581266,2012-10-01T00:00:00,Poly I-C,D13.695.578.550.560.600
22581266,2012-10-01T00:00:00,Poly I-C,D13.695.578.550.650.600
22581266,2012-10-01T00:00:00,Toll-Like Receptor 4,D12.776.543.750.705.910.500.400
22581266,2012-10-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
22581266,2012-10-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
22581266,2012-10-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
22581266,2012-10-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
22581266,2012-10-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
22581266,2012-10-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
22581266,2012-10-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
22581266,2012-10-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
22581266,2012-10-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
22581266,2012-10-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
22581266,2012-10-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
22644587,2012-10-01T00:00:00,Adolescent,M01.060.057
22644587,2012-10-01T00:00:00,Behavior Therapy,F04.754.137
22644587,2012-10-01T00:00:00,Blood Glucose,D09.546.359.448.500
22644587,2012-10-01T00:00:00,Child,M01.060.406
22644587,2012-10-01T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
22644587,2012-10-01T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
22644587,2012-10-01T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
22644587,2012-10-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
22644587,2012-10-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
22644587,2012-10-01T00:00:00,Family Therapy,F04.754.864.581.273
22644587,2012-10-01T00:00:00,"Hemoglobin A, Glycosylated",D09.408.375
22644587,2012-10-01T00:00:00,"Hemoglobin A, Glycosylated",D12.776.124.400.405.440
22644587,2012-10-01T00:00:00,"Hemoglobin A, Glycosylated",D12.776.422.316.762.380.440
22644587,2012-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22644587,2012-10-01T00:00:00,Hypoglycemic Agents,D27.505.696.422
22644587,2012-10-01T00:00:00,Insulin,D06.472.699.587.740.625
22644587,2012-10-01T00:00:00,Insulin,D12.644.548.586.740.625
22644587,2012-10-01T00:00:00,Patient Compliance,F01.145.488.500
22644587,2012-10-01T00:00:00,Patient Compliance,N05.300.150.600.600
22644587,2012-10-01T00:00:00,Treatment Outcome,E01.789.800
22644587,2012-10-01T00:00:00,Treatment Outcome,N04.761.559.590.800
22644587,2012-10-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22847295,2012-10-01T00:00:00,Animals,B01.050
22847295,2012-10-01T00:00:00,Antigen Presentation,G12.425.107
22847295,2012-10-01T00:00:00,Antigen Presentation,G12.450.050.400.070
22847295,2012-10-01T00:00:00,Antineoplastic Agents,D27.505.954.248
22847295,2012-10-01T00:00:00,Apoptosis,G04.299.139.160
22847295,2012-10-01T00:00:00,CD4-Positive T-Lymphocytes,A11.118.637.555.567.569.200
22847295,2012-10-01T00:00:00,CD4-Positive T-Lymphocytes,A15.145.229.637.555.567.569.200
22847295,2012-10-01T00:00:00,CD4-Positive T-Lymphocytes,A15.382.490.555.567.569.200
22847295,2012-10-01T00:00:00,HLA-D Antigens,D23.050.301.500.410.400
22847295,2012-10-01T00:00:00,HLA-D Antigens,D23.050.301.500.450.400
22847295,2012-10-01T00:00:00,HLA-D Antigens,D23.050.705.552.410.400
22847295,2012-10-01T00:00:00,HLA-D Antigens,D23.050.705.552.450.400
22847295,2012-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22847295,2012-10-01T00:00:00,Melanoma,C04.557.465.625.650.510
22847295,2012-10-01T00:00:00,Melanoma,C04.557.580.625.650.510
22847295,2012-10-01T00:00:00,Melanoma,C04.557.665.510
22885623,2012-10-01T00:00:00,Dengue,C02.081.270
22885623,2012-10-01T00:00:00,Dengue,C02.782.350.250.214
22885623,2012-10-01T00:00:00,Dengue,C02.782.417.214
22885623,2012-10-01T00:00:00,Dengue Virus,B04.820.250.350.270
22885623,2012-10-01T00:00:00,Dengue Virus,B04.909.777.310.350.270
22885623,2012-10-01T00:00:00,Hepatitis,C06.552.380
22885623,2012-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22885623,2012-10-01T00:00:00,Middle Aged,M01.060.116.630
22885623,2012-10-01T00:00:00,Travel,I03.883
22885623,2012-10-01T00:00:00,United States,Z01.107.567.875
22914073,2012-10-01T00:00:00,Animals,B01.050
22914073,2012-10-01T00:00:00,"Conditioning, Operant",F02.463.425.179.509
22914073,2012-10-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.150.800
22914073,2012-10-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.600.220
22914073,2012-10-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.150.800
22914073,2012-10-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.600.220
22914073,2012-10-01T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
22914073,2012-10-01T00:00:00,Methylphenidate,D02.241.223.601.600
22914073,2012-10-01T00:00:00,Methylphenidate,D03.383.621.460
22914073,2012-10-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22914073,2012-10-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
22914073,2012-10-01T00:00:00,Self Administration,E02.319.890
22914073,2012-10-01T00:00:00,Self Administration,E02.900.890
22914073,2012-10-01T00:00:00,Social Environment,I01.880.656
22914073,2012-10-01T00:00:00,Social Isolation,F01.145.813.781
22914073,2012-10-01T00:00:00,Social Isolation,I01.880.683
22922758,2012-10-01T00:00:00,Cell Death,G04.299.139
22922758,2012-10-01T00:00:00,Ceramides,D02.065.313
22922758,2012-10-01T00:00:00,Ceramides,D09.400.410.420.525.200
22922758,2012-10-01T00:00:00,Ceramides,D10.390.470.675.200
22922758,2012-10-01T00:00:00,Ceramides,D10.570.877.360.612.200
22922758,2012-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22922758,2012-10-01T00:00:00,Lipids,D10
22922758,2012-10-01T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
22922758,2012-10-01T00:00:00,"Microscopy, Confocal",E05.595.395
22996139,2012-10-01T00:00:00,Adolescent,M01.060.057
22996139,2012-10-01T00:00:00,Child,M01.060.406
22996139,2012-10-01T00:00:00,Cognitive Therapy,F04.754.137.428
22996139,2012-10-01T00:00:00,Health Education,I02.233.332
22996139,2012-10-01T00:00:00,Health Education,N02.421.143.827.407
22996139,2012-10-01T00:00:00,Health Education,N02.421.726.407
22996139,2012-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22996139,2012-10-01T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
22996139,2012-10-01T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
22996139,2012-10-01T00:00:00,Pain,C10.597.617
22996139,2012-10-01T00:00:00,Pain,C23.888.592.612
22996139,2012-10-01T00:00:00,Pain,C23.888.646
22996139,2012-10-01T00:00:00,Pain,F02.830.816.444
22996139,2012-10-01T00:00:00,Pain,G11.561.600.810.444
22996139,2012-10-01T00:00:00,Quality of Life,I01.800
22996139,2012-10-01T00:00:00,Quality of Life,K01.752.400.750
22996139,2012-10-01T00:00:00,Social Adjustment,F01.145.813.621
22996139,2012-10-01T00:00:00,Treatment Outcome,E01.789.800
22996139,2012-10-01T00:00:00,Treatment Outcome,N04.761.559.590.800
22996139,2012-10-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22997371,2012-10-01T00:00:00,Adolescent,M01.060.057
22997371,2012-10-01T00:00:00,Adult,M01.060.116
22997371,2012-10-01T00:00:00,Aged,M01.060.116.100
22997371,2012-10-01T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.500.150
22997371,2012-10-01T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.825.500.150
22997371,2012-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22997371,2012-10-01T00:00:00,Iron,D01.268.556.412
22997371,2012-10-01T00:00:00,Iron,D01.268.956.287
22997371,2012-10-01T00:00:00,Iron,D01.552.544.412
22997371,2012-10-01T00:00:00,Liver,A03.620
22997371,2012-10-01T00:00:00,Liver Cirrhosis,C06.552.630
22997371,2012-10-01T00:00:00,Middle Aged,M01.060.116.630
22997371,2012-10-01T00:00:00,"Phantoms, Imaging",E07.671
22997371,2012-10-01T00:00:00,Young Adult,M01.060.116.815
23025512,2012-10-01T00:00:00,Antioxidants,D27.505.519.217
23025512,2012-10-01T00:00:00,Antioxidants,D27.505.696.706.125
23025512,2012-10-01T00:00:00,Antioxidants,D27.720.799.047
23025512,2012-10-01T00:00:00,Enzyme Inhibitors,D27.505.519.389
23025512,2012-10-01T00:00:00,Peroxidases,D08.811.682.732
23025512,2012-10-01T00:00:00,Plant Leaves,A18.024.812
23027618,2012-10-01T00:00:00,Adult,M01.060.116
23027618,2012-10-01T00:00:00,DNA Repair,G02.111.087.219
23027618,2012-10-01T00:00:00,DNA Repair,G02.149.115.219
23027618,2012-10-01T00:00:00,DNA Repair,G05.355.195
23027618,2012-10-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
23027618,2012-10-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
23027618,2012-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23027618,2012-10-01T00:00:00,Neoplasms,C04
23027618,2012-10-01T00:00:00,Population Surveillance,E05.318.308.250.700
23027618,2012-10-01T00:00:00,Population Surveillance,N05.715.360.300.375.625
23027618,2012-10-01T00:00:00,Population Surveillance,N06.850.520.308.250.700
23027618,2012-10-01T00:00:00,Population Surveillance,N06.850.780.675
23027618,2012-10-01T00:00:00,Risk Factors,E05.318.740.600.800.725
23027618,2012-10-01T00:00:00,Risk Factors,N05.715.350.200.700
23027618,2012-10-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23027618,2012-10-01T00:00:00,Risk Factors,N06.850.490.625.750
23027618,2012-10-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23028031,2012-10-01T00:00:00,Alleles,G05.360.340.024.340.030
23028031,2012-10-01T00:00:00,Autoimmune Diseases,C20.111
23028031,2012-10-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
23028031,2012-10-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
23028031,2012-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23028031,2012-10-01T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
23028031,2012-10-01T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
23028031,2012-10-01T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
23028031,2012-10-01T00:00:00,Risk Factors,E05.318.740.600.800.725
23028031,2012-10-01T00:00:00,Risk Factors,N05.715.350.200.700
23028031,2012-10-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23028031,2012-10-01T00:00:00,Risk Factors,N06.850.490.625.750
23028031,2012-10-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23028050,2012-10-01T00:00:00,Animals,B01.050
23028050,2012-10-01T00:00:00,Brain Ischemia,C10.228.140.300.150
23028050,2012-10-01T00:00:00,Brain Ischemia,C14.907.253.092
23028050,2012-10-01T00:00:00,"Complement Pathway, Alternative",G12.425.255.695
23028050,2012-10-01T00:00:00,Reperfusion Injury,C14.907.725
23028050,2012-10-01T00:00:00,Reperfusion Injury,C23.550.767.877
23028050,2012-10-01T00:00:00,Stroke,C10.228.140.300.775
23028050,2012-10-01T00:00:00,Stroke,C14.907.253.855
23035033,2012-10-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
23035033,2012-10-01T00:00:00,Risk Assessment,N04.452.871.715
23035033,2012-10-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
23035033,2012-10-01T00:00:00,Risk Assessment,N06.850.505.715
23035033,2012-10-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
23035034,2012-10-01T00:00:00,Bayes Theorem,E05.318.740.600.200
23035034,2012-10-01T00:00:00,Bayes Theorem,N05.715.360.750.625.150
23035034,2012-10-01T00:00:00,Bayes Theorem,N06.850.520.830.600.200
23035034,2012-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23035034,2012-10-01T00:00:00,"Models, Statistical",E05.318.740.500
23035034,2012-10-01T00:00:00,"Models, Statistical",E05.599.835
23035034,2012-10-01T00:00:00,"Models, Statistical",N05.715.360.750.530
23035034,2012-10-01T00:00:00,"Models, Statistical",N06.850.520.830.500
23036585,2012-10-01T00:00:00,Aged,M01.060.116.100
23036585,2012-10-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
23036585,2012-10-01T00:00:00,Alzheimer Disease,C10.574.945.249
23036585,2012-10-01T00:00:00,Alzheimer Disease,F03.087.400.100
23036585,2012-10-01T00:00:00,Disease Progression,C23.550.291.656
23036585,2012-10-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
23036585,2012-10-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
23036585,2012-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23036585,2012-10-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
23036585,2012-10-01T00:00:00,Risk Factors,E05.318.740.600.800.725
23036585,2012-10-01T00:00:00,Risk Factors,N05.715.350.200.700
23036585,2012-10-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23036585,2012-10-01T00:00:00,Risk Factors,N06.850.490.625.750
23036585,2012-10-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23070008,2012-10-01T00:00:00,Amidohydrolases,D08.811.277.087
23070008,2012-10-01T00:00:00,Apoptosis,G04.299.139.160
23070008,2012-10-01T00:00:00,Ceramides,D02.065.313
23070008,2012-10-01T00:00:00,Ceramides,D09.400.410.420.525.200
23070008,2012-10-01T00:00:00,Ceramides,D10.390.470.675.200
23070008,2012-10-01T00:00:00,Ceramides,D10.570.877.360.612.200
23070008,2012-10-01T00:00:00,Endoplasmic Reticulum,A11.284.430.214.190.875.248
23070008,2012-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23070008,2012-10-01T00:00:00,Mitochondria,A11.284.430.214.190.875.564
23070008,2012-10-01T00:00:00,Mitochondria,A11.284.835.626
23070008,2012-10-01T00:00:00,Neoplasms,C04
23070008,2012-10-01T00:00:00,Signal Transduction,G02.111.087.800
23070008,2012-10-01T00:00:00,Signal Transduction,G02.149.115.800
23070008,2012-10-01T00:00:00,Signal Transduction,G04.299.880
23070008,2012-10-01T00:00:00,Sphingolipids,D10.570.877
23070008,2012-10-01T00:00:00,Sphingolipids,D10.808
23079770,2012-10-01T00:00:00,Aged,M01.060.116.100
23079770,2012-10-01T00:00:00,Antipsychotic Agents,D27.505.696.277.950.040
23079770,2012-10-01T00:00:00,Antipsychotic Agents,D27.505.954.427.210.950.040
23079770,2012-10-01T00:00:00,Antipsychotic Agents,D27.505.954.427.700.872.331
23079770,2012-10-01T00:00:00,Creatine,D02.078.370.280
23079770,2012-10-01T00:00:00,Creatine,D12.125.373
23079770,2012-10-01T00:00:00,Double-Blind Method,E05.318.780.300
23079770,2012-10-01T00:00:00,Double-Blind Method,E05.581.500.300
23079770,2012-10-01T00:00:00,Double-Blind Method,N05.715.360.780.320
23079770,2012-10-01T00:00:00,Double-Blind Method,N06.850.520.445.300
23079770,2012-10-01T00:00:00,Evidence-Based Medicine,H02.249.750
23079770,2012-10-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
23079770,2012-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23079770,2012-10-01T00:00:00,Middle Aged,M01.060.116.630
23079770,2012-10-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
23079770,2012-10-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
23079770,2012-10-01T00:00:00,Parkinson Disease,C10.228.140.079.862.500
23079770,2012-10-01T00:00:00,Parkinson Disease,C10.228.662.600.400
23079770,2012-10-01T00:00:00,Parkinson Disease,C10.574.812
23079770,2012-10-01T00:00:00,Quality of Life,I01.800
23079770,2012-10-01T00:00:00,Quality of Life,K01.752.400.750
23079770,2012-10-01T00:00:00,United States,Z01.107.567.875
23090679,2012-10-01T00:00:00,Adult,M01.060.116
23090679,2012-10-01T00:00:00,Animals,B01.050
23090679,2012-10-01T00:00:00,Bone Marrow,A15.382.216
23090679,2012-10-01T00:00:00,Cell Proliferation,G04.299.233.750
23090679,2012-10-01T00:00:00,Cell Proliferation,G07.700.320.249.410.750
23090679,2012-10-01T00:00:00,"Disease Models, Animal",C22.232
23090679,2012-10-01T00:00:00,"Disease Models, Animal",E05.598.500
23090679,2012-10-01T00:00:00,"Disease Models, Animal",E05.599.395.080
23090679,2012-10-01T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
23090679,2012-10-01T00:00:00,Flow Cytometry,E05.200.500.386.350
23090679,2012-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23090679,2012-10-01T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
23090679,2012-10-01T00:00:00,Pyrimidines,D03.383.742
23090679,2012-10-01T00:00:00,Treatment Outcome,E01.789.800
23090679,2012-10-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23090679,2012-10-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23180490,2012-10-01T00:00:00,Cerebral Arterial Diseases,C10.228.140.300.510.200
23180490,2012-10-01T00:00:00,Cerebral Arterial Diseases,C14.907.253.560.200
23180490,2012-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23180490,2012-10-01T00:00:00,Stents,E07.695.750
23180490,2012-10-01T00:00:00,Stroke,C10.228.140.300.775
23180490,2012-10-01T00:00:00,Stroke,C14.907.253.855
23222402,2012-10-01T00:00:00,Adult,M01.060.116
23222402,2012-10-01T00:00:00,Automobile Driving,I03.125
23222402,2012-10-01T00:00:00,Child,M01.060.406
23222402,2012-10-01T00:00:00,Data Collection,E05.318.308
23222402,2012-10-01T00:00:00,Data Collection,L01.280
23222402,2012-10-01T00:00:00,Data Collection,N05.715.360.300
23222402,2012-10-01T00:00:00,Data Collection,N06.850.520.308
23222402,2012-10-01T00:00:00,Health Personnel,M01.526.485
23222402,2012-10-01T00:00:00,Health Personnel,N02.360
23222402,2012-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23222402,2012-10-01T00:00:00,Staff Development,I02.574.700
23222402,2012-10-01T00:00:00,Staff Development,N04.452.677.822
23222402,2012-10-01T00:00:00,Trauma Centers,N02.278.354.422.336.500
23222402,2012-10-01T00:00:00,Trauma Centers,N02.421.297.195.480
23222402,2012-10-01T00:00:00,Trauma Centers,N04.452.442.422.336.400
23431914,2012-10-01T00:00:00,Capsule Endoscopy,E01.370.388.250.250.250.140
23431914,2012-10-01T00:00:00,"Diagnosis, Differential",E01.171
23431914,2012-10-01T00:00:00,Gastrointestinal Hemorrhage,C06.405.227
23431914,2012-10-01T00:00:00,Gastrointestinal Hemorrhage,C23.550.414.788
23431914,2012-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23431916,2012-10-01T00:00:00,Diagnostic Imaging,E01.370.350
23431916,2012-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23431916,2012-10-01T00:00:00,Incidence,E05.318.308.985.525.375
23431916,2012-10-01T00:00:00,Incidence,L01.280.975.525.375
23431916,2012-10-01T00:00:00,Incidence,N01.224.935.597.500
23431916,2012-10-01T00:00:00,Incidence,N06.850.505.400.975.525.375
23431916,2012-10-01T00:00:00,Incidence,N06.850.520.308.985.525.375
23431916,2012-10-01T00:00:00,Mass Screening,E01.370.500
23431916,2012-10-01T00:00:00,Mass Screening,E05.318.308.250.580
23431916,2012-10-01T00:00:00,Mass Screening,N02.421.143.827.233.443
23431916,2012-10-01T00:00:00,Mass Screening,N02.421.726.233.443
23431916,2012-10-01T00:00:00,Mass Screening,N05.715.360.300.375.500
23431916,2012-10-01T00:00:00,Mass Screening,N06.850.520.308.250.580
23431916,2012-10-01T00:00:00,Mass Screening,N06.850.780.500
23431916,2012-10-01T00:00:00,Risk Factors,E05.318.740.600.800.725
23431916,2012-10-01T00:00:00,Risk Factors,N05.715.350.200.700
23431916,2012-10-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23431916,2012-10-01T00:00:00,Risk Factors,N06.850.490.625.750
23431916,2012-10-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23431916,2012-10-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23431916,2012-10-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23431916,2012-10-01T00:00:00,Stroke,C10.228.140.300.775
23431916,2012-10-01T00:00:00,Stroke,C14.907.253.855
23461074,2012-10-01T00:00:00,Adult,M01.060.116
23461074,2012-10-01T00:00:00,African Americans,M01.686.508.100.100
23461074,2012-10-01T00:00:00,African Americans,M01.686.754.100
23461074,2012-10-01T00:00:00,"Diagnosis, Differential",E01.171
23461074,2012-10-01T00:00:00,Disease Progression,C23.550.291.656
23461074,2012-10-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
23461074,2012-10-01T00:00:00,Glucocorticoids,D06.472.040.543
23461074,2012-10-01T00:00:00,Glucocorticoids,D27.505.696.399.472.488
23461074,2012-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23461074,2012-10-01T00:00:00,Lung,A04.411
23461074,2012-10-01T00:00:00,Middle Aged,M01.060.116.630
23461074,2012-10-01T00:00:00,"Radiography, Thoracic",E01.370.350.700.730
23461074,2012-10-01T00:00:00,"Sarcoidosis, Pulmonary",C08.381.483.725
23461074,2012-10-01T00:00:00,"Sarcoidosis, Pulmonary",C15.604.515.827.725
23461074,2012-10-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23461074,2012-10-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23461074,2012-10-01T00:00:00,Time Factors,G01.910.857
23026864,2012-10-02T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
23026864,2012-10-02T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
23026864,2012-10-02T00:00:00,"Defibrillators, Implantable",E07.695.175
23026864,2012-10-02T00:00:00,Electric Countershock,E02.342.287
23026864,2012-10-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23026864,2012-10-02T00:00:00,"Tachycardia, Ventricular",C14.280.067.845.940
23026864,2012-10-02T00:00:00,"Tachycardia, Ventricular",C23.550.073.845.940
23026864,2012-10-02T00:00:00,United States,Z01.107.567.875
23030769,2012-10-02T00:00:00,Adolescent,M01.060.057
23030769,2012-10-02T00:00:00,Adult,M01.060.116
23030769,2012-10-02T00:00:00,Decision Making,F02.463.785.373
23030769,2012-10-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23030769,2012-10-02T00:00:00,"Models, Theoretical",E05.599
23030769,2012-10-02T00:00:00,Personality,F01.752
23030769,2012-10-02T00:00:00,Personality Inventory,F04.711.647.513
23030769,2012-10-02T00:00:00,Psychometrics,F04.711.780
23030769,2012-10-02T00:00:00,Self Concept,F01.752.747.792
23030769,2012-10-02T00:00:00,Self Efficacy,F01.752.747.792.700
23032917,2012-10-02T00:00:00,Adenoidectomy,E04.580.068
23032917,2012-10-02T00:00:00,Child,M01.060.406
23032917,2012-10-02T00:00:00,"Child, Preschool",M01.060.406.448
23032917,2012-10-02T00:00:00,Chronic Disease,C23.550.291.500
23032917,2012-10-02T00:00:00,"Hospitals, Pediatric",N02.278.421.556.437
23032917,2012-10-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23032917,2012-10-02T00:00:00,Otitis Media,C09.218.705.663
23032917,2012-10-02T00:00:00,Otitis Media with Effusion,C09.218.705.663.683
23032917,2012-10-02T00:00:00,Physical Stimulation,E05.723
23032917,2012-10-02T00:00:00,Risk Assessment,E05.318.740.600.800.715
23032917,2012-10-02T00:00:00,Risk Assessment,N04.452.871.715
23032917,2012-10-02T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
23032917,2012-10-02T00:00:00,Risk Assessment,N06.850.505.715
23032917,2012-10-02T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
23032917,2012-10-02T00:00:00,Treatment Outcome,E01.789.800
23032917,2012-10-02T00:00:00,Treatment Outcome,N04.761.559.590.800
23032917,2012-10-02T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23036945,2012-10-02T00:00:00,Animals,B01.050
23036945,2012-10-02T00:00:00,Aortic Valve,A07.541.510.110
23036945,2012-10-02T00:00:00,Finite Element Analysis,E05.355
23036945,2012-10-02T00:00:00,Glycosaminoglycans,D09.698.373
23036945,2012-10-02T00:00:00,Heart Valve Prosthesis,E07.695.310
23036945,2012-10-02T00:00:00,Swine,B01.050.150.900.649.077.880
23032071,2012-10-03T00:00:00,Adult,M01.060.116
23032071,2012-10-03T00:00:00,Alcohol Drinking,F01.145.317.269
23032071,2012-10-03T00:00:00,Alcoholism,C21.739.100.250
23032071,2012-10-03T00:00:00,Alcoholism,F03.900.100.350
23032071,2012-10-03T00:00:00,Cues,F02.463.425.234
23032071,2012-10-03T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.157.530.450.625.124
23032071,2012-10-03T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.157.530.562.374.500.500
23032071,2012-10-03T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.543.585.450.625.124
23032071,2012-10-03T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.543.585.562.374.500.500
23032071,2012-10-03T00:00:00,Genetic Variation,G05.365
23032071,2012-10-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23032071,2012-10-03T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
23032071,2012-10-03T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
23032071,2012-10-03T00:00:00,Naltrexone,D03.132.577.249.706.550
23032071,2012-10-03T00:00:00,Naltrexone,D03.549.686.750.550
23032071,2012-10-03T00:00:00,Naltrexone,D03.605.497.750.550
23032071,2012-10-03T00:00:00,Naltrexone,D04.615.723.795.706.550
23032071,2012-10-03T00:00:00,Narcotic Antagonists,D27.505.696.543
23032071,2012-10-03T00:00:00,Narcotic Antagonists,D27.505.696.663.850.512
23032071,2012-10-03T00:00:00,Narcotic Antagonists,D27.505.954.427.550
23032071,2012-10-03T00:00:00,"Polymorphism, Genetic",G05.365.795
23032071,2012-10-03T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
23032071,2012-10-03T00:00:00,Treatment Outcome,E01.789.800
23032071,2012-10-03T00:00:00,Treatment Outcome,N04.761.559.590.800
23032071,2012-10-03T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23032071,2012-10-03T00:00:00,Young Adult,M01.060.116.815
23034866,2012-10-03T00:00:00,Adult,M01.060.116
23034866,2012-10-03T00:00:00,Algorithms,G17.035
23034866,2012-10-03T00:00:00,Algorithms,L01.224.050
23034866,2012-10-03T00:00:00,Artifacts,E05.047
23034866,2012-10-03T00:00:00,Brain,A08.186.211
23034866,2012-10-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23034866,2012-10-03T00:00:00,Image Enhancement,E01.370.350.600.350
23034866,2012-10-03T00:00:00,Image Enhancement,L01.224.308.380
23034866,2012-10-03T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
23034866,2012-10-03T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
23034866,2012-10-03T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
23034866,2012-10-03T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
23034866,2012-10-03T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
23034866,2012-10-03T00:00:00,Middle Aged,M01.060.116.630
23034866,2012-10-03T00:00:00,Subtraction Technique,E01.370.350.760
23034866,2012-10-03T00:00:00,Young Adult,M01.060.116.815
23089596,2012-10-03T00:00:00,Adsorption,G02.149.047
23089596,2012-10-03T00:00:00,Adsorption,G02.149.767.029
23089596,2012-10-03T00:00:00,Adsorption,G02.842.750.029
23089596,2012-10-03T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
23089596,2012-10-03T00:00:00,"Spectrometry, Fluorescence",E05.196.712.516.600.676
23089596,2012-10-03T00:00:00,"Spectrometry, Fluorescence",E05.196.867.726
23042700,2012-10-05T00:00:00,Adsorption,G02.149.047
23042700,2012-10-05T00:00:00,Adsorption,G02.149.767.029
23042700,2012-10-05T00:00:00,Adsorption,G02.842.750.029
23042700,2012-10-05T00:00:00,Peptides,D12.644
23042700,2012-10-05T00:00:00,Surface Plasmon Resonance,E05.196.890
23042700,2012-10-05T00:00:00,Surface Plasmon Resonance,E05.601.123.700
23042700,2012-10-05T00:00:00,Surface Properties,G02.842.850
23042700,2012-10-05T00:00:00,Water,D01.455.900
23042700,2012-10-05T00:00:00,Water,D01.650.550.925
23044243,2012-10-06T00:00:00,Adult,M01.060.116
23044243,2012-10-06T00:00:00,Aged,M01.060.116.100
23044243,2012-10-06T00:00:00,Anxiety Disorders,F03.080
23044243,2012-10-06T00:00:00,Depressive Disorder,F03.600.300
23044243,2012-10-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23044243,2012-10-06T00:00:00,Mental Disorders,F03
23044243,2012-10-06T00:00:00,Middle Aged,M01.060.116.630
23044243,2012-10-06T00:00:00,Obsessive-Compulsive Disorder,F03.080.600
23044243,2012-10-06T00:00:00,Primary Health Care,N04.590.233.727
23044243,2012-10-06T00:00:00,Quality of Life,I01.800
23044243,2012-10-06T00:00:00,Quality of Life,K01.752.400.750
23044243,2012-10-06T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
23044243,2012-10-06T00:00:00,Substance-Related Disorders,C21.739
23044243,2012-10-06T00:00:00,Substance-Related Disorders,F03.900
23044243,2012-10-06T00:00:00,United States,Z01.107.567.875
23044243,2012-10-06T00:00:00,United States Department of Veterans Affairs,I01.409.137.500.700
23044243,2012-10-06T00:00:00,United States Department of Veterans Affairs,N03.540.348.500.500.700
23044243,2012-10-06T00:00:00,Veterans,M01.930
23043501,2012-10-08T00:00:00,Angiogenesis Inhibitors,D27.505.696.377.077.099
23043501,2012-10-08T00:00:00,Angiogenesis Inhibitors,D27.505.696.377.450.100
23043501,2012-10-08T00:00:00,Angiogenesis Inhibitors,D27.505.954.248.025
23043501,2012-10-08T00:00:00,Animals,B01.050
23043501,2012-10-08T00:00:00,"Carcinoma, Hepatocellular",C04.557.470.200.025.255
23043501,2012-10-08T00:00:00,"Carcinoma, Hepatocellular",C04.588.274.623.160
23043501,2012-10-08T00:00:00,"Carcinoma, Hepatocellular",C06.301.623.160
23043501,2012-10-08T00:00:00,"Carcinoma, Hepatocellular",C06.552.697.160
23043501,2012-10-08T00:00:00,Catheter Ablation,E01.370.370.380.410.200
23043501,2012-10-08T00:00:00,Catheter Ablation,E02.148.110
23043501,2012-10-08T00:00:00,Catheter Ablation,E02.148.442.110
23043501,2012-10-08T00:00:00,Catheter Ablation,E02.154.402.110
23043501,2012-10-08T00:00:00,Catheter Ablation,E04.014.170.402.110
23043501,2012-10-08T00:00:00,Combined Modality Therapy,E02.186
23043501,2012-10-08T00:00:00,"Disease Models, Animal",C22.232
23043501,2012-10-08T00:00:00,"Disease Models, Animal",E05.598.500
23043501,2012-10-08T00:00:00,"Disease Models, Animal",E05.599.395.080
23043501,2012-10-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23043501,2012-10-08T00:00:00,Liver Neoplasms,C04.588.274.623
23043501,2012-10-08T00:00:00,Liver Neoplasms,C06.301.623
23043501,2012-10-08T00:00:00,Liver Neoplasms,C06.552.697
23044832,2012-10-08T00:00:00,Adrenal Cortex Hormones,D06.472.040
23044832,2012-10-08T00:00:00,Adult,M01.060.116
23044832,2012-10-08T00:00:00,Animals,B01.050
23044832,2012-10-08T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
23044832,2012-10-08T00:00:00,Antifungal Agents,D27.505.954.122.136
23044832,2012-10-08T00:00:00,Chronic Disease,C23.550.291.500
23044832,2012-10-08T00:00:00,Complementary Therapies,E02.190
23044832,2012-10-08T00:00:00,Evidence-Based Medicine,H02.249.750
23044832,2012-10-08T00:00:00,Evidence-Based Medicine,H02.403.200.400
23044832,2012-10-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23044832,2012-10-08T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
23044832,2012-10-08T00:00:00,Practice Guidelines as Topic,N05.700.350.650
23044832,2012-10-08T00:00:00,Rhinitis,C08.460.799
23044832,2012-10-08T00:00:00,Rhinitis,C08.730.674
23044832,2012-10-08T00:00:00,Rhinitis,C09.603.799
23044832,2012-10-08T00:00:00,Sinusitis,C08.460.692.752
23044832,2012-10-08T00:00:00,Sinusitis,C08.730.749
23044832,2012-10-08T00:00:00,Sinusitis,C09.603.692.752
23050802,2012-10-10T00:00:00,Adult,M01.060.116
23050802,2012-10-10T00:00:00,Aged,M01.060.116.100
23050802,2012-10-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23050802,2012-10-10T00:00:00,Mental Disorders,F03
23050802,2012-10-10T00:00:00,Middle Aged,M01.060.116.630
23050802,2012-10-10T00:00:00,Pilot Projects,E05.318.760.750
23050802,2012-10-10T00:00:00,Pilot Projects,E05.337.737
23050802,2012-10-10T00:00:00,Pilot Projects,N05.715.360.775.625
23050802,2012-10-10T00:00:00,Pilot Projects,N06.850.520.450.720
23050802,2012-10-10T00:00:00,Rural Health Services,N02.421.816
23050802,2012-10-10T00:00:00,Telemedicine,H02.403.840
23050802,2012-10-10T00:00:00,Telemedicine,L01.178.847.652
23050802,2012-10-10T00:00:00,Telemedicine,N04.590.374.800
23050802,2012-10-10T00:00:00,United States,Z01.107.567.875
23050802,2012-10-10T00:00:00,United States Department of Veterans Affairs,I01.409.137.500.700
23050802,2012-10-10T00:00:00,United States Department of Veterans Affairs,N03.540.348.500.500.700
23050802,2012-10-10T00:00:00,Young Adult,M01.060.116.815
23052303,2012-10-10T00:00:00,Hematopoietic Stem Cell Transplantation,E04.936.225.687.500
23052303,2012-10-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23052303,2012-10-10T00:00:00,Middle Aged,M01.060.116.630
23052303,2012-10-10T00:00:00,"Sequence Analysis, DNA",E05.393.760.700
23055478,2012-10-10T00:00:00,Animals,B01.050
23055478,2012-10-10T00:00:00,Corpus Striatum,A08.186.211.730.885.287.249.487
23055478,2012-10-10T00:00:00,Dopamine,D02.092.211.215.311.342
23055478,2012-10-10T00:00:00,Dopamine,D02.092.311.342
23055478,2012-10-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23055478,2012-10-10T00:00:00,Substantia Nigra,A08.186.211.132.659.822.731
23055478,2012-10-10T00:00:00,Substantia Nigra,A08.186.211.653.822.731
23055478,2012-10-10T00:00:00,Ventral Tegmental Area,A08.186.211.132.659.822.820
23055478,2012-10-10T00:00:00,Ventral Tegmental Area,A08.186.211.653.822.820
23055478,2012-10-10T00:00:00,gamma-Aminobutyric Acid,D02.241.081.160.050.350
23055478,2012-10-10T00:00:00,gamma-Aminobutyric Acid,D12.125.190.350
22951992,2012-10-11T00:00:00,Adsorption,G02.149.047
22951992,2012-10-11T00:00:00,Adsorption,G02.149.767.029
22951992,2012-10-11T00:00:00,Adsorption,G02.842.750.029
22951992,2012-10-11T00:00:00,Animals,B01.050
22951992,2012-10-11T00:00:00,Anion Exchange Resins,D27.720.470.420.050
22951992,2012-10-11T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
22951992,2012-10-11T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
22951992,2012-10-11T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
22951992,2012-10-11T00:00:00,CHO Cells,A11.251.210.200
22951992,2012-10-11T00:00:00,CHO Cells,A11.436.155
22951992,2012-10-11T00:00:00,"Chromatography, Ion Exchange",E05.196.181.400.383
22951992,2012-10-11T00:00:00,Cricetinae,B01.050.150.900.649.865.635.150
22951992,2012-10-11T00:00:00,DNA,D13.444.308
22951992,2012-10-11T00:00:00,"Membranes, Artificial",D25.479
22951992,2012-10-11T00:00:00,"Membranes, Artificial",J01.637.051.479
22951992,2012-10-11T00:00:00,"Membranes, Artificial",J01.637.087.500
22951992,2012-10-11T00:00:00,Proteins,D12.776
23063666,2012-10-11T00:00:00,Animals,B01.050
23063666,2012-10-11T00:00:00,Eye Proteins,D12.776.306
23063666,2012-10-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23063666,2012-10-11T00:00:00,Retina,A09.371.729
23063666,2012-10-11T00:00:00,Retinal Cone Photoreceptor Cells,A08.663.650.850.625.670.100
23063666,2012-10-11T00:00:00,Retinal Cone Photoreceptor Cells,A08.663.650.915.937.670.100
23063666,2012-10-11T00:00:00,Retinal Cone Photoreceptor Cells,A08.800.950.937.670.100
23063666,2012-10-11T00:00:00,Retinal Cone Photoreceptor Cells,A09.371.729.831.625.670.100
23063666,2012-10-11T00:00:00,Retinal Cone Photoreceptor Cells,A11.671.650.850.625.670.100
23063666,2012-10-11T00:00:00,Retinal Cone Photoreceptor Cells,A11.671.650.915.937.670.100
23063666,2012-10-11T00:00:00,Retinoids,D02.455.326.271.665.202.495
23063666,2012-10-11T00:00:00,Retinoids,D02.455.426.392.368.367.379.249.700
23063666,2012-10-11T00:00:00,Retinoids,D02.455.849.131.495
23063666,2012-10-11T00:00:00,Retinoids,D23.767.261.700
23064897,2012-10-11T00:00:00,Adolescent,M01.060.057
23064897,2012-10-11T00:00:00,Child,M01.060.406
23064897,2012-10-11T00:00:00,"Child, Preschool",M01.060.406.448
23064897,2012-10-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23064897,2012-10-11T00:00:00,Image Enhancement,E01.370.350.600.350
23064897,2012-10-11T00:00:00,Image Enhancement,L01.224.308.380
23064897,2012-10-11T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
23064897,2012-10-11T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
23064897,2012-10-11T00:00:00,"Lateral Ligament, Ankle",A02.513.514.162.500
23064897,2012-10-11T00:00:00,"Lateral Ligament, Ankle",A02.835.583.512.162.500
23064897,2012-10-11T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
23064897,2012-10-11T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
23064897,2012-10-11T00:00:00,Protons,D01.248.497.300.459.700
23064897,2012-10-11T00:00:00,Protons,D01.435.550
23064897,2012-10-11T00:00:00,Protons,G01.249.765
23064897,2012-10-11T00:00:00,Tarsal Bones,A02.835.232.043.300.710
23064897,2012-10-11T00:00:00,Young Adult,M01.060.116.815
23065594,2012-10-12T00:00:00,Adult,M01.060.116
23065594,2012-10-12T00:00:00,Contrast Media,D27.720.259
23065594,2012-10-12T00:00:00,Crohn Disease,C06.405.205.731.500
23065594,2012-10-12T00:00:00,Crohn Disease,C06.405.469.432.500
23065594,2012-10-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23065594,2012-10-12T00:00:00,Radiation Dosage,E05.799.513
23065594,2012-10-12T00:00:00,Radiation Dosage,G01.201.875.740
23065594,2012-10-12T00:00:00,Radiation Dosage,N06.850.810.250
23065594,2012-10-12T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
23065594,2012-10-12T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
23065594,2012-10-12T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
23065594,2012-10-12T00:00:00,Time Factors,G01.910.857
23065594,2012-10-12T00:00:00,"Tomography Scanners, X-Ray Computed",E07.913
23065594,2012-10-12T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23065594,2012-10-12T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23065594,2012-10-12T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23065594,2012-10-12T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23065594,2012-10-12T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23065968,2012-10-12T00:00:00,Ambulatory Care,E02.760.106
23065968,2012-10-12T00:00:00,Ambulatory Care,N02.421.585.106
23065968,2012-10-12T00:00:00,Continuity of Patient Care,N04.590.233.727.210
23065968,2012-10-12T00:00:00,Dietary Supplements,J02.500.456
23065968,2012-10-12T00:00:00,Enteral Nutrition,E02.421.360
23065968,2012-10-12T00:00:00,Enteral Nutrition,E02.642.500.360
23065968,2012-10-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23065968,2012-10-12T00:00:00,Inpatients,M01.643.470
23065968,2012-10-12T00:00:00,Malnutrition,C18.654.521
23065968,2012-10-12T00:00:00,Parenteral Nutrition,E02.421.505
23065968,2012-10-12T00:00:00,Parenteral Nutrition,E02.642.500.505
23065968,2012-10-12T00:00:00,Risk Factors,E05.318.740.600.800.725
23065968,2012-10-12T00:00:00,Risk Factors,N05.715.350.200.700
23065968,2012-10-12T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23065968,2012-10-12T00:00:00,Risk Factors,N06.850.490.625.750
23065968,2012-10-12T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23129840,2012-10-12T00:00:00,"Education, Graduate",I02.358.337
23129840,2012-10-12T00:00:00,"Education, Pharmacy",I02.358.525
23129840,2012-10-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23129840,2012-10-12T00:00:00,"Internship, Nonmedical",I02.358.750
23123087,2012-10-13T00:00:00,Bacteria,B03
23123087,2012-10-13T00:00:00,"Biodegradation, Environmental",N06.850.460.375.500
23123087,2012-10-13T00:00:00,"Biodegradation, Environmental",N06.850.860.510.900.299
23123087,2012-10-13T00:00:00,Electric Stimulation,E05.723.402
23123087,2012-10-13T00:00:00,Geologic Sediments,G01.311.500
23123087,2012-10-13T00:00:00,Geologic Sediments,G16.500.320
23123087,2012-10-13T00:00:00,Polychlorinated Biphenyls,D02.455.426.559.389.185.698
23123087,2012-10-13T00:00:00,Polychlorinated Biphenyls,D02.455.526.439.773
23123087,2012-10-13T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
22938635,2012-10-15T00:00:00,Animals,B01.050
22938635,2012-10-15T00:00:00,Autoimmune Diseases,C20.111
22938635,2012-10-15T00:00:00,Cardiovascular Diseases,C14
22938635,2012-10-15T00:00:00,Gene Expression Regulation,G05.355.315
22938635,2012-10-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22938635,2012-10-15T00:00:00,Inflammation,C23.550.470
22938635,2012-10-15T00:00:00,MAP Kinase Signaling System,G02.111.087.800.560
22938635,2012-10-15T00:00:00,MAP Kinase Signaling System,G02.149.115.800.560
22938635,2012-10-15T00:00:00,MAP Kinase Signaling System,G03.495.553.560
22938635,2012-10-15T00:00:00,MAP Kinase Signaling System,G04.299.880.560
22938635,2012-10-15T00:00:00,Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567
22938635,2012-10-15T00:00:00,Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750
22938635,2012-10-15T00:00:00,Mitogen-Activated Protein Kinases,D12.644.360.450
22938635,2012-10-15T00:00:00,Mitogen-Activated Protein Kinases,D12.776.476.450
22938635,2012-10-15T00:00:00,Neoplasms,C04
22938635,2012-10-15T00:00:00,Oxidative Stress,G03.495.710
22938635,2012-10-15T00:00:00,Oxidative Stress,G07.700.830.750
22938635,2012-10-15T00:00:00,Parkinson Disease,C10.228.140.079.862.500
22938635,2012-10-15T00:00:00,Parkinson Disease,C10.228.662.600.400
22938635,2012-10-15T00:00:00,Parkinson Disease,C10.574.812
22938635,2012-10-15T00:00:00,Skin Diseases,C17.800
22938635,2012-10-15T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
22938635,2012-10-15T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
22938635,2012-10-15T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
22938635,2012-10-15T00:00:00,Transcription Factors,D12.776.930
23072542,2012-10-16T00:00:00,Animals,B01.050
23072542,2012-10-16T00:00:00,Bronchoalveolar Lavage Fluid,E05.510.100.500
23072542,2012-10-16T00:00:00,Lung,A04.411
23072542,2012-10-16T00:00:00,"Nanotubes, Carbon",D01.268.150.250.500
23072542,2012-10-16T00:00:00,"Nanotubes, Carbon",J01.637.512.850.500
23072542,2012-10-16T00:00:00,Nitrogen,D01.268.604
23072542,2012-10-16T00:00:00,Nitrogen,D01.362.625
23074234,2012-10-16T00:00:00,Adult,M01.060.116
23074234,2012-10-16T00:00:00,Aged,M01.060.116.100
23074234,2012-10-16T00:00:00,Blood Glucose,D09.546.359.448.500
23074234,2012-10-16T00:00:00,Diabetes Mellitus,C18.452.394.750
23074234,2012-10-16T00:00:00,Diabetes Mellitus,C19.246
23074234,2012-10-16T00:00:00,Diabetic Nephropathies,C12.777.419.192
23074234,2012-10-16T00:00:00,Diabetic Nephropathies,C13.351.968.419.192
23074234,2012-10-16T00:00:00,Diabetic Nephropathies,C19.246.099.875
23074234,2012-10-16T00:00:00,Graft Survival,G12.425.901.545.340
23074234,2012-10-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23074234,2012-10-16T00:00:00,Hypoglycemic Agents,D27.505.696.422
23074234,2012-10-16T00:00:00,Insulin,D06.472.699.587.740.625
23074234,2012-10-16T00:00:00,Insulin,D12.644.548.586.740.625
23074234,2012-10-16T00:00:00,Kidney Transplantation,E02.870.500
23074234,2012-10-16T00:00:00,Kidney Transplantation,E04.936.450.485
23074234,2012-10-16T00:00:00,Kidney Transplantation,E04.950.774.400
23074234,2012-10-16T00:00:00,Middle Aged,M01.060.116.630
23074234,2012-10-16T00:00:00,Pilot Projects,E05.318.760.750
23074234,2012-10-16T00:00:00,Pilot Projects,E05.337.737
23074234,2012-10-16T00:00:00,Pilot Projects,N05.715.360.775.625
23074234,2012-10-16T00:00:00,Pilot Projects,N06.850.520.450.720
23074234,2012-10-16T00:00:00,Treatment Outcome,E01.789.800
23074234,2012-10-16T00:00:00,Treatment Outcome,N04.761.559.590.800
23074234,2012-10-16T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23074234,2012-10-16T00:00:00,Young Adult,M01.060.116.815
23079547,2012-10-16T00:00:00,Animals,B01.050
23079547,2012-10-16T00:00:00,"Complement Pathway, Alternative",G12.425.255.695
23079547,2012-10-16T00:00:00,"Disease Models, Animal",C22.232
23079547,2012-10-16T00:00:00,"Disease Models, Animal",E05.598.500
23079547,2012-10-16T00:00:00,"Disease Models, Animal",E05.599.395.080
23079547,2012-10-16T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.114.703.300
23079547,2012-10-16T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.314.350.250
23079547,2012-10-16T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C20.111.258.625.300
23079547,2012-10-16T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",E05.598.500.500.500
23079547,2012-10-16T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
23091600,2012-10-16T00:00:00,Case-Control Studies,E05.318.760.500.500
23091600,2012-10-16T00:00:00,Case-Control Studies,N05.715.360.775.175.200
23091600,2012-10-16T00:00:00,Case-Control Studies,N06.850.520.450.500.500
23091600,2012-10-16T00:00:00,Disease Progression,C23.550.291.656
23091600,2012-10-16T00:00:00,Early Detection of Cancer,E01.390.500
23091600,2012-10-16T00:00:00,Exosomes,A11.284.430.214.190.875.190.880.495
23091600,2012-10-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23091600,2012-10-16T00:00:00,Neoplasm Proteins,D12.776.624
23091600,2012-10-16T00:00:00,Prostate-Specific Antigen,D08.811.277.656.300.760.442.750
23091600,2012-10-16T00:00:00,Prostate-Specific Antigen,D08.811.277.656.959.350.442.750
23091600,2012-10-16T00:00:00,Prostate-Specific Antigen,D12.776.866.249.500
23091600,2012-10-16T00:00:00,Prostate-Specific Antigen,D23.050.285.625
23091600,2012-10-16T00:00:00,Prostate-Specific Antigen,D23.101.840.625
23091600,2012-10-16T00:00:00,Prostatic Hyperplasia,C12.294.565.500
23091600,2012-10-16T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
23091600,2012-10-16T00:00:00,Prostatic Neoplasms,C12.294.260.750
23091600,2012-10-16T00:00:00,Prostatic Neoplasms,C12.294.565.625
23091600,2012-10-16T00:00:00,Prostatic Neoplasms,C12.758.409.750
23091600,2012-10-16T00:00:00,"Tumor Markers, Biological",D23.101.840
23082168,2012-10-17T00:00:00,Animals,B01.050
23082168,2012-10-17T00:00:00,Antineoplastic Agents,D27.505.954.248
23082168,2012-10-17T00:00:00,Biological Availability,G03.787.151
23082168,2012-10-17T00:00:00,Biological Availability,G07.690.725.129
23082168,2012-10-17T00:00:00,Biological Transport,G03.495.166
23082168,2012-10-17T00:00:00,Doxorubicin,D02.455.426.559.847.562.050.200.175
23082168,2012-10-17T00:00:00,Doxorubicin,D04.615.562.050.200.175
23082168,2012-10-17T00:00:00,Doxorubicin,D09.408.051.059.200.175
23082168,2012-10-17T00:00:00,Liposomes,D25.479.517
23082168,2012-10-17T00:00:00,Liposomes,D26.255.260.517
23082168,2012-10-17T00:00:00,Liposomes,D27.720.280.260.517
23082168,2012-10-17T00:00:00,Liposomes,J01.637.051.479.517
23082168,2012-10-17T00:00:00,Liposomes,J01.637.087.500.517
23082168,2012-10-17T00:00:00,"Models, Biological",E05.599.395
23082168,2012-10-17T00:00:00,Temperature,G01.906.595
23082168,2012-10-17T00:00:00,Temperature,G16.500.275.063.725.710
23082168,2012-10-17T00:00:00,Temperature,G16.500.750.775.710
23082168,2012-10-17T00:00:00,Temperature,N06.230.150.450
23082168,2012-10-17T00:00:00,Temperature,N06.230.300.100.725.710
23082168,2012-10-17T00:00:00,Time Factors,G01.910.857
23083788,2012-10-17T00:00:00,Coronary Artery Disease,C14.280.647.250.260
23083788,2012-10-17T00:00:00,Coronary Artery Disease,C14.907.137.126.339
23083788,2012-10-17T00:00:00,Coronary Artery Disease,C14.907.585.250.260
23083788,2012-10-17T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
23083788,2012-10-17T00:00:00,Genetic Predisposition to Disease,G05.380.355
23083788,2012-10-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23083788,2012-10-17T00:00:00,"Polymorphism, Genetic",G05.365.795
23083788,2012-10-17T00:00:00,Risk Assessment,E05.318.740.600.800.715
23083788,2012-10-17T00:00:00,Risk Assessment,N04.452.871.715
23083788,2012-10-17T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
23083788,2012-10-17T00:00:00,Risk Assessment,N06.850.505.715
23083788,2012-10-17T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
23084430,2012-10-17T00:00:00,Adolescent,M01.060.057
23084430,2012-10-17T00:00:00,Child,M01.060.406
23084430,2012-10-17T00:00:00,"Child, Preschool",M01.060.406.448
23084430,2012-10-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23084430,2012-10-17T00:00:00,Infant,M01.060.703
23084430,2012-10-17T00:00:00,Otitis Media with Effusion,C09.218.705.663.683
23075176,2012-10-18T00:00:00,Aged,M01.060.116.100
23075176,2012-10-18T00:00:00,Aggression,F01.145.126.125
23075176,2012-10-18T00:00:00,Aggression,F01.145.813.045
23075176,2012-10-18T00:00:00,Alzheimer Disease,C10.228.140.380.100
23075176,2012-10-18T00:00:00,Alzheimer Disease,C10.574.945.249
23075176,2012-10-18T00:00:00,Alzheimer Disease,F03.087.400.100
23075176,2012-10-18T00:00:00,Antipsychotic Agents,D27.505.696.277.950.040
23075176,2012-10-18T00:00:00,Antipsychotic Agents,D27.505.954.427.210.950.040
23075176,2012-10-18T00:00:00,Antipsychotic Agents,D27.505.954.427.700.872.331
23075176,2012-10-18T00:00:00,Double-Blind Method,E05.318.780.300
23075176,2012-10-18T00:00:00,Double-Blind Method,E05.581.500.300
23075176,2012-10-18T00:00:00,Double-Blind Method,N05.715.360.780.320
23075176,2012-10-18T00:00:00,Double-Blind Method,N06.850.520.445.300
23075176,2012-10-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23075176,2012-10-18T00:00:00,Psychomotor Agitation,C10.597.350.600
23075176,2012-10-18T00:00:00,Psychomotor Agitation,C10.597.606.881.700
23075176,2012-10-18T00:00:00,Psychomotor Agitation,C23.888.592.350.600
23075176,2012-10-18T00:00:00,Psychomotor Agitation,C23.888.592.604.882.700
23075176,2012-10-18T00:00:00,Psychomotor Agitation,F01.700.875.700
23075176,2012-10-18T00:00:00,Psychotic Disorders,F03.700.675
23075176,2012-10-18T00:00:00,Risperidone,D03.383.742.698.685
23075176,2012-10-18T00:00:00,Substance Withdrawal Syndrome,C21.739.835
23075176,2012-10-18T00:00:00,Substance Withdrawal Syndrome,F03.900.825
23078479,2012-10-18T00:00:00,Health Services Accessibility,N04.590.374.350
23078479,2012-10-18T00:00:00,Health Services Accessibility,N05.300.430
23078479,2012-10-18T00:00:00,Healthcare Disparities,N04.590.374.380
23078479,2012-10-18T00:00:00,Healthcare Disparities,N05.300.493
23078479,2012-10-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23078479,2012-10-18T00:00:00,Primary Health Care,N04.590.233.727
23078479,2012-10-18T00:00:00,United States,Z01.107.567.875
23086228,2012-10-18T00:00:00,Animals,B01.050
23086228,2012-10-18T00:00:00,"Antimetabolites, Antineoplastic",D27.505.519.186.144
23086228,2012-10-18T00:00:00,"Antimetabolites, Antineoplastic",D27.505.954.248.144
23086228,2012-10-18T00:00:00,"Antimetabolites, Antineoplastic",D27.888.569.042.030
23086228,2012-10-18T00:00:00,Antineoplastic Agents,D27.505.954.248
23086228,2012-10-18T00:00:00,Apoptosis,G04.299.139.160
23086228,2012-10-18T00:00:00,Cell Death,G04.299.139
23086228,2012-10-18T00:00:00,Ceramides,D02.065.313
23086228,2012-10-18T00:00:00,Ceramides,D09.400.410.420.525.200
23086228,2012-10-18T00:00:00,Ceramides,D10.390.470.675.200
23086228,2012-10-18T00:00:00,Ceramides,D10.570.877.360.612.200
23086228,2012-10-18T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
23086228,2012-10-18T00:00:00,Coloring Agents,D27.720.233
23086228,2012-10-18T00:00:00,Coloring Agents,D27.720.470.330
23086228,2012-10-18T00:00:00,Deoxycytidine,D03.383.742.680.245.500
23086228,2012-10-18T00:00:00,Deoxycytidine,D13.570.230.329
23086228,2012-10-18T00:00:00,Deoxycytidine,D13.570.685.245.500
23086228,2012-10-18T00:00:00,Mitochondria,A11.284.430.214.190.875.564
23086228,2012-10-18T00:00:00,Mitochondria,A11.284.835.626
23086228,2012-10-18T00:00:00,Oxygen Consumption,G03.730
23086228,2012-10-18T00:00:00,Pancreatic Neoplasms,C04.588.274.761
23086228,2012-10-18T00:00:00,Pancreatic Neoplasms,C04.588.322.421
23086228,2012-10-18T00:00:00,Pancreatic Neoplasms,C06.301.761
23086228,2012-10-18T00:00:00,Pancreatic Neoplasms,C06.689.667
23086228,2012-10-18T00:00:00,Pancreatic Neoplasms,C19.344.421
23086228,2012-10-18T00:00:00,"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",E05.196.566.755
23125519,2012-10-18T00:00:00,Adolescent,M01.060.057
23125519,2012-10-18T00:00:00,Adult,M01.060.116
23125519,2012-10-18T00:00:00,African Americans,M01.686.508.100.100
23125519,2012-10-18T00:00:00,African Americans,M01.686.754.100
23125519,2012-10-18T00:00:00,"Circumcision, Male",E02.218.085.170
23125519,2012-10-18T00:00:00,"Circumcision, Male",E04.085.170
23125519,2012-10-18T00:00:00,"Circumcision, Male",E04.950.774.860.226
23125519,2012-10-18T00:00:00,Cost-Benefit Analysis,N03.219.151.125
23125519,2012-10-18T00:00:00,HIV Infections,C02.782.815.616.400
23125519,2012-10-18T00:00:00,HIV Infections,C02.800.801.400
23125519,2012-10-18T00:00:00,HIV Infections,C20.673.480
23125519,2012-10-18T00:00:00,Health Care Costs,N03.219.151.400
23125519,2012-10-18T00:00:00,Health Care Costs,N05.300.375
23125519,2012-10-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23125519,2012-10-18T00:00:00,Middle Aged,M01.060.116.630
23125519,2012-10-18T00:00:00,"Models, Statistical",E05.318.740.500
23125519,2012-10-18T00:00:00,"Models, Statistical",E05.599.835
23125519,2012-10-18T00:00:00,"Models, Statistical",N05.715.360.750.530
23125519,2012-10-18T00:00:00,"Models, Statistical",N06.850.520.830.500
23125519,2012-10-18T00:00:00,South Carolina,Z01.107.567.875.075.662
23125519,2012-10-18T00:00:00,South Carolina,Z01.107.567.875.750.700
23125519,2012-10-18T00:00:00,United States,Z01.107.567.875
23080405,2012-10-19T00:00:00,Animals,B01.050
23080405,2012-10-19T00:00:00,Calcium,D01.268.552.100
23080405,2012-10-19T00:00:00,Calcium,D01.552.539.288
23080405,2012-10-19T00:00:00,Calcium,D23.119.100
23080405,2012-10-19T00:00:00,Kidney,A05.810.453
23080405,2012-10-19T00:00:00,Mitochondria,A11.284.430.214.190.875.564
23080405,2012-10-19T00:00:00,Mitochondria,A11.284.835.626
23080405,2012-10-19T00:00:00,Rabbits,B01.050.150.900.649.521.700
23080405,2012-10-19T00:00:00,"Stress, Physiological",G07.700.830
23086231,2012-10-19T00:00:00,Cell Line,A11.251.210
23086231,2012-10-19T00:00:00,Cyclic AMP,D03.438.759.646.138.395
23086231,2012-10-19T00:00:00,Cyclic AMP,D13.695.462.200
23086231,2012-10-19T00:00:00,Cyclic AMP,D13.695.667.138.395
23086231,2012-10-19T00:00:00,Cyclic AMP,D13.695.827.068.395
23086231,2012-10-19T00:00:00,"Glycosylation End Products, Advanced",D02.415
23086231,2012-10-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23086231,2012-10-19T00:00:00,Retinal Pigment Epithelium,A09.371.670.500
23086231,2012-10-19T00:00:00,Retinal Pigment Epithelium,A09.371.729.887
23086231,2012-10-19T00:00:00,Serum Albumin,D12.776.034.841
23086231,2012-10-19T00:00:00,Serum Albumin,D12.776.124.050.700
23086231,2012-10-19T00:00:00,Serum Albumin,D12.776.124.727
23086231,2012-10-19T00:00:00,Signal Transduction,G02.111.087.800
23086231,2012-10-19T00:00:00,Signal Transduction,G02.149.115.800
23086231,2012-10-19T00:00:00,Signal Transduction,G04.299.880
22962667,2012-10-21T00:00:00,Animals,B01.050
22962667,2012-10-21T00:00:00,Contrast Media,D27.720.259
22962667,2012-10-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22962667,2012-10-21T00:00:00,Luminescence,G01.201.875.770.578.665
22962667,2012-10-21T00:00:00,Luminescence,G01.590.540.665
22962667,2012-10-21T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
22962667,2012-10-21T00:00:00,"Microscopy, Fluorescence",E05.595.458
22962667,2012-10-21T00:00:00,Neoplasms,C04
22962667,2012-10-21T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
22962667,2012-10-21T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
22962667,2012-10-21T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
22962667,2012-10-21T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
22962667,2012-10-21T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
22962667,2012-10-21T00:00:00,X-Rays,G01.201.875.750.918
23046143,2012-10-22T00:00:00,"Adaptation, Physiological",G07.700.062
23046143,2012-10-22T00:00:00,"Adaptation, Physiological",G16.100.057.500
23046143,2012-10-22T00:00:00,Adsorption,G02.149.047
23046143,2012-10-22T00:00:00,Adsorption,G02.149.767.029
23046143,2012-10-22T00:00:00,Adsorption,G02.842.750.029
23046143,2012-10-22T00:00:00,Chlorella,B01.040.080.469
23046143,2012-10-22T00:00:00,Metal Nanoparticles,J01.637.512.600.500
23046143,2012-10-22T00:00:00,Zinc Oxide,D01.650.550.975
23046143,2012-10-22T00:00:00,Zinc Oxide,D01.975.975
23088967,2012-10-22T00:00:00,Adolescent,M01.060.057
23088967,2012-10-22T00:00:00,Adult,M01.060.116
23088967,2012-10-22T00:00:00,Age Factors,N05.715.350.075
23088967,2012-10-22T00:00:00,Age Factors,N06.850.490.250
23088967,2012-10-22T00:00:00,Bladder Exstrophy,C12.706.132
23088967,2012-10-22T00:00:00,Bladder Exstrophy,C12.777.829.132
23088967,2012-10-22T00:00:00,Bladder Exstrophy,C13.351.875.132
23088967,2012-10-22T00:00:00,Bladder Exstrophy,C13.351.968.829.132
23088967,2012-10-22T00:00:00,Bladder Exstrophy,C16.131.939.132
23088967,2012-10-22T00:00:00,"Databases, Factual",L01.470.750.750
23088967,2012-10-22T00:00:00,"Databases, Factual",L01.700.508.300.188.400
23088967,2012-10-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23088967,2012-10-22T00:00:00,Incidence,E05.318.308.985.525.375
23088967,2012-10-22T00:00:00,Incidence,L01.280.975.525.375
23088967,2012-10-22T00:00:00,Incidence,N01.224.935.597.500
23088967,2012-10-22T00:00:00,Incidence,N06.850.505.400.975.525.375
23088967,2012-10-22T00:00:00,Incidence,N06.850.520.308.985.525.375
23088967,2012-10-22T00:00:00,Middle Aged,M01.060.116.630
23088967,2012-10-22T00:00:00,Pelvic Bones,A02.835.232.043.825
23088967,2012-10-22T00:00:00,Pelvic Organ Prolapse,C23.300.842.500
23088967,2012-10-22T00:00:00,Pregnancy,G08.686.785.760.769
23088967,2012-10-22T00:00:00,Reconstructive Surgical Procedures,E04.680
23088967,2012-10-22T00:00:00,Risk Assessment,E05.318.740.600.800.715
23088967,2012-10-22T00:00:00,Risk Assessment,N04.452.871.715
23088967,2012-10-22T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
23088967,2012-10-22T00:00:00,Risk Assessment,N06.850.505.715
23088967,2012-10-22T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
23088967,2012-10-22T00:00:00,Time Factors,G01.910.857
23088967,2012-10-22T00:00:00,Treatment Outcome,E01.789.800
23088967,2012-10-22T00:00:00,Treatment Outcome,N04.761.559.590.800
23088967,2012-10-22T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23088967,2012-10-22T00:00:00,Young Adult,M01.060.116.815
23088977,2012-10-22T00:00:00,Age Factors,N05.715.350.075
23088977,2012-10-22T00:00:00,Age Factors,N06.850.490.250
23088977,2012-10-22T00:00:00,Bladder Exstrophy,C12.706.132
23088977,2012-10-22T00:00:00,Bladder Exstrophy,C12.777.829.132
23088977,2012-10-22T00:00:00,Bladder Exstrophy,C13.351.875.132
23088977,2012-10-22T00:00:00,Bladder Exstrophy,C13.351.968.829.132
23088977,2012-10-22T00:00:00,Bladder Exstrophy,C16.131.939.132
23088977,2012-10-22T00:00:00,"Databases, Factual",L01.470.750.750
23088977,2012-10-22T00:00:00,"Databases, Factual",L01.700.508.300.188.400
23088977,2012-10-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23088977,2012-10-22T00:00:00,Infant,M01.060.703
23088977,2012-10-22T00:00:00,"Infant, Newborn",M01.060.703.520
23088977,2012-10-22T00:00:00,Reconstructive Surgical Procedures,E04.680
23088977,2012-10-22T00:00:00,Risk Assessment,E05.318.740.600.800.715
23088977,2012-10-22T00:00:00,Risk Assessment,N04.452.871.715
23088977,2012-10-22T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
23088977,2012-10-22T00:00:00,Risk Assessment,N06.850.505.715
23088977,2012-10-22T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
23088977,2012-10-22T00:00:00,Time Factors,G01.910.857
23088977,2012-10-22T00:00:00,Treatment Outcome,E01.789.800
23088977,2012-10-22T00:00:00,Treatment Outcome,N04.761.559.590.800
23088977,2012-10-22T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23088977,2012-10-22T00:00:00,Urinary Bladder,A05.810.890
23088977,2012-10-22T00:00:00,Urologic Surgical Procedures,E04.950.774
23090653,2012-10-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23289652,2012-10-22T00:00:00,Adolescent,M01.060.057
23289652,2012-10-22T00:00:00,Adult,M01.060.116
23289652,2012-10-22T00:00:00,Aged,M01.060.116.100
23289652,2012-10-22T00:00:00,Health Services Research,N03.349.380
23289652,2012-10-22T00:00:00,Health Services Research,N05.425
23289652,2012-10-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23289652,2012-10-22T00:00:00,Middle Aged,M01.060.116.630
23289652,2012-10-22T00:00:00,Oral Health,N01.400.535
23289652,2012-10-22T00:00:00,Rural Population,N01.600.725
23289652,2012-10-22T00:00:00,United States,Z01.107.567.875
23289652,2012-10-22T00:00:00,Urban Population,N01.600.900
23289652,2012-10-22T00:00:00,Young Adult,M01.060.116.815
23079123,2012-10-23T00:00:00,Adult,M01.060.116
23079123,2012-10-23T00:00:00,Coronary Angiography,E01.370.350.700.060.200
23079123,2012-10-23T00:00:00,Coronary Angiography,E01.370.370.050.200
23079123,2012-10-23T00:00:00,Coronary Angiography,E01.370.370.380.200
23079123,2012-10-23T00:00:00,Coronary Circulation,G09.330.190.163.324
23079123,2012-10-23T00:00:00,Coronary Vessel Anomalies,C14.240.400.210
23079123,2012-10-23T00:00:00,Coronary Vessel Anomalies,C14.280.400.210
23079123,2012-10-23T00:00:00,Coronary Vessel Anomalies,C16.131.240.400.210
23079123,2012-10-23T00:00:00,Coronary Vessels,A07.231.114.269
23079123,2012-10-23T00:00:00,Coronary Vessels,A07.231.908.194
23079123,2012-10-23T00:00:00,"Diagnosis, Differential",E01.171
23079123,2012-10-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23079123,2012-10-23T00:00:00,Pulmonary Artery,A07.231.114.715
23079123,2012-10-23T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23079123,2012-10-23T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23079123,2012-10-23T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23079123,2012-10-23T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23079123,2012-10-23T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23088451,2012-10-23T00:00:00,Aged,M01.060.116.100
23088451,2012-10-23T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
23088451,2012-10-23T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
23088451,2012-10-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23088451,2012-10-23T00:00:00,Knee Joint,A02.835.583.475
23088451,2012-10-23T00:00:00,Knee Prosthesis,E07.695.400.410
23088451,2012-10-23T00:00:00,Middle Aged,M01.060.116.630
23088451,2012-10-23T00:00:00,Polyethylene,D02.455.326.271.665.550.500
23088451,2012-10-23T00:00:00,Polyethylene,D05.750.716.507.500
23088451,2012-10-23T00:00:00,Polyethylene,D25.720.716.507.500
23088451,2012-10-23T00:00:00,Polyethylene,J01.637.051.720.716.507.500
23088451,2012-10-23T00:00:00,Prosthesis Design,E05.320.550
23088451,2012-10-23T00:00:00,Prosthesis Design,E07.695.680
23088451,2012-10-23T00:00:00,Recovery of Function,G16.757
23088451,2012-10-23T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23088451,2012-10-23T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23088451,2012-10-23T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23088451,2012-10-23T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23088451,2012-10-23T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23088451,2012-10-23T00:00:00,Treatment Outcome,E01.789.800
23088451,2012-10-23T00:00:00,Treatment Outcome,N04.761.559.590.800
23088451,2012-10-23T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23090843,2012-10-23T00:00:00,Adenosine Triphosphate,D03.438.759.646.138.236
23090843,2012-10-23T00:00:00,Adenosine Triphosphate,D13.695.667.138.236
23090843,2012-10-23T00:00:00,Adenosine Triphosphate,D13.695.827.068.236
23090843,2012-10-23T00:00:00,Animals,B01.050
23090843,2012-10-23T00:00:00,Calcium,D01.268.552.100
23090843,2012-10-23T00:00:00,Calcium,D01.552.539.288
23090843,2012-10-23T00:00:00,Calcium,D23.119.100
23090843,2012-10-23T00:00:00,Cell Death,G04.299.139
23090843,2012-10-23T00:00:00,Cell Line,A11.251.210
23090843,2012-10-23T00:00:00,Mitochondria,A11.284.430.214.190.875.564
23090843,2012-10-23T00:00:00,Mitochondria,A11.284.835.626
23090843,2012-10-23T00:00:00,Oxidative Stress,G03.495.710
23090843,2012-10-23T00:00:00,Oxidative Stress,G07.700.830.750
23090843,2012-10-23T00:00:00,Oxygen Consumption,G03.730
23090843,2012-10-23T00:00:00,Retinal Cone Photoreceptor Cells,A08.663.650.850.625.670.100
23090843,2012-10-23T00:00:00,Retinal Cone Photoreceptor Cells,A08.663.650.915.937.670.100
23090843,2012-10-23T00:00:00,Retinal Cone Photoreceptor Cells,A08.800.950.937.670.100
23090843,2012-10-23T00:00:00,Retinal Cone Photoreceptor Cells,A09.371.729.831.625.670.100
23090843,2012-10-23T00:00:00,Retinal Cone Photoreceptor Cells,A11.671.650.850.625.670.100
23090843,2012-10-23T00:00:00,Retinal Cone Photoreceptor Cells,A11.671.650.915.937.670.100
23102490,2012-10-23T00:00:00,Bacteria,B03
23102490,2012-10-23T00:00:00,"Biodegradation, Environmental",N06.850.460.375.500
23102490,2012-10-23T00:00:00,"Biodegradation, Environmental",N06.850.860.510.900.299
23102490,2012-10-23T00:00:00,Geologic Sediments,G01.311.500
23102490,2012-10-23T00:00:00,Geologic Sediments,G16.500.320
23102490,2012-10-23T00:00:00,Polychlorinated Biphenyls,D02.455.426.559.389.185.698
23102490,2012-10-23T00:00:00,Polychlorinated Biphenyls,D02.455.526.439.773
23102490,2012-10-23T00:00:00,Soil Pollutants,D27.888.284.756
23102682,2012-10-23T00:00:00,Attitude of Health Personnel,F01.100.050
23102682,2012-10-23T00:00:00,Attitude of Health Personnel,N05.300.100
23102682,2012-10-23T00:00:00,Cardiac Surgical Procedures,E04.100.376
23102682,2012-10-23T00:00:00,Cardiac Surgical Procedures,E04.928.220
23102682,2012-10-23T00:00:00,Conflict of Interest,K01.316.130
23102682,2012-10-23T00:00:00,Conflict of Interest,N05.350.225
23102682,2012-10-23T00:00:00,Government Regulation,I01.880.604.394
23102682,2012-10-23T00:00:00,Government Regulation,N03.706.358
23102682,2012-10-23T00:00:00,Health Policy,I01.880.604.825.608.400
23102682,2012-10-23T00:00:00,Health Policy,N03.706.825.608.428
23102682,2012-10-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23102682,2012-10-23T00:00:00,Income,N01.824.417
23102682,2012-10-23T00:00:00,"Insurance, Health, Reimbursement",N03.219.521.576.343.480
23102682,2012-10-23T00:00:00,"Insurance, Health, Reimbursement",N03.219.521.710
23102682,2012-10-23T00:00:00,Medicare,N03.219.521.346.506.564.663
23102682,2012-10-23T00:00:00,Medicare,N03.219.521.576.343.840
23102682,2012-10-23T00:00:00,Medicare,N03.706.615.696
23102682,2012-10-23T00:00:00,Physicians,M01.526.485.810
23102682,2012-10-23T00:00:00,Physicians,N02.360.810
23102682,2012-10-23T00:00:00,United States,Z01.107.567.875
23095280,2012-10-24T00:00:00,"Adaptation, Physiological",G07.700.062
23095280,2012-10-24T00:00:00,"Adaptation, Physiological",G16.100.057.500
23095280,2012-10-24T00:00:00,Animals,B01.050
23095280,2012-10-24T00:00:00,Cardiomegaly,C14.280.195
23095280,2012-10-24T00:00:00,Cardiomegaly,C23.300.775.250
23095280,2012-10-24T00:00:00,"Disease Models, Animal",C22.232
23095280,2012-10-24T00:00:00,"Disease Models, Animal",E05.598.500
23095280,2012-10-24T00:00:00,"Disease Models, Animal",E05.599.395.080
23095280,2012-10-24T00:00:00,Disease Progression,C23.550.291.656
23095280,2012-10-24T00:00:00,Heart Failure,C14.280.434
23095280,2012-10-24T00:00:00,Myocardial Contraction,G09.330.190.541
23095280,2012-10-24T00:00:00,Myocardial Contraction,G11.427.590.540.570
23095280,2012-10-24T00:00:00,Phosphorylation,G02.111.087.677
23095280,2012-10-24T00:00:00,Phosphorylation,G02.149.115.677
23095280,2012-10-24T00:00:00,Phosphorylation,G02.149.465.700
23095280,2012-10-24T00:00:00,Phosphorylation,G02.607.750.700
23095280,2012-10-24T00:00:00,Phosphorylation,G03.495.790
23095280,2012-10-24T00:00:00,Proteasome Endopeptidase Complex,D05.500.562.500
23095280,2012-10-24T00:00:00,Proteasome Endopeptidase Complex,D08.811.277.656.918
23095280,2012-10-24T00:00:00,Proteasome Endopeptidase Complex,D08.811.600.730
23095280,2012-10-24T00:00:00,"Stress, Physiological",G07.700.830
23095280,2012-10-24T00:00:00,Ventricular Pressure,G09.330.190.962.950
23095280,2012-10-24T00:00:00,Ventricular Pressure,G09.330.380.937
23095325,2012-10-24T00:00:00,Biometry,E05.318.740.225
23095325,2012-10-24T00:00:00,Biometry,N06.850.505.200
23095325,2012-10-24T00:00:00,Data Collection,E05.318.308
23095325,2012-10-24T00:00:00,Data Collection,L01.280
23095325,2012-10-24T00:00:00,Data Collection,N05.715.360.300
23095325,2012-10-24T00:00:00,Data Collection,N06.850.520.308
23095325,2012-10-24T00:00:00,"Data Interpretation, Statistical",E05.245.380
23095325,2012-10-24T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
23095325,2012-10-24T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
23095325,2012-10-24T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
23095325,2012-10-24T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
23095325,2012-10-24T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
23095325,2012-10-24T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
23095325,2012-10-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23095325,2012-10-24T00:00:00,Individualized Medicine,E02.574
23095325,2012-10-24T00:00:00,Individualized Medicine,H02.403.200.700
23095325,2012-10-24T00:00:00,"Models, Theoretical",E05.599
23095325,2012-10-24T00:00:00,Veterans,M01.930
23097457,2012-10-24T00:00:00,Cell Line,A11.251.210
23097457,2012-10-24T00:00:00,Down-Regulation,G02.111.087.225
23097457,2012-10-24T00:00:00,Down-Regulation,G02.149.115.225
23097457,2012-10-24T00:00:00,Down-Regulation,G05.355.315.200
23097457,2012-10-24T00:00:00,Down-Regulation,G07.690.812.230
23097457,2012-10-24T00:00:00,Down-Regulation,G07.700.680.230
23097457,2012-10-24T00:00:00,Dual Specificity Phosphatase 1,D08.811.277.352.650.587.200
23097457,2012-10-24T00:00:00,Dual Specificity Phosphatase 1,D08.811.277.352.650.625.225.200
23097457,2012-10-24T00:00:00,Dual Specificity Phosphatase 1,D08.811.277.352.650.775.250.200
23097457,2012-10-24T00:00:00,Dual Specificity Phosphatase 1,D12.644.360.268.200
23097457,2012-10-24T00:00:00,Dual Specificity Phosphatase 1,D12.644.360.445.100
23097457,2012-10-24T00:00:00,Dual Specificity Phosphatase 1,D12.776.476.268.200
23097457,2012-10-24T00:00:00,Dual Specificity Phosphatase 1,D12.776.476.445.200
23097457,2012-10-24T00:00:00,Gene Expression Profiling,E05.393.332
23097457,2012-10-24T00:00:00,Gene Expression Regulation,G05.355.315
23097457,2012-10-24T00:00:00,Host-Pathogen Interactions,G06.590.470
23097457,2012-10-24T00:00:00,Host-Pathogen Interactions,G16.100.380
23097457,2012-10-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23097457,2012-10-24T00:00:00,MicroRNAs,D13.150.650.319
23097457,2012-10-24T00:00:00,MicroRNAs,D13.444.735.150.319
23097457,2012-10-24T00:00:00,MicroRNAs,D13.444.735.790.099
23097457,2012-10-24T00:00:00,"RNA, Viral",D13.444.735.828
23098783,2012-10-24T00:00:00,Adult,M01.060.116
23098783,2012-10-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23098783,2012-10-24T00:00:00,Urodynamics,G08.852.898
23103157,2012-10-24T00:00:00,Animals,B01.050
23103157,2012-10-24T00:00:00,Antioxidants,D27.505.519.217
23103157,2012-10-24T00:00:00,Antioxidants,D27.505.696.706.125
23103157,2012-10-24T00:00:00,Antioxidants,D27.720.799.047
23103157,2012-10-24T00:00:00,Biocompatible Materials,D25.130
23103157,2012-10-24T00:00:00,Biocompatible Materials,D27.720.102.130
23103157,2012-10-24T00:00:00,Biocompatible Materials,J01.637.051.130
23103157,2012-10-24T00:00:00,Blood Vessel Prosthesis,E07.695.110
23103157,2012-10-24T00:00:00,Collagen,D05.750.078.280
23103157,2012-10-24T00:00:00,Collagen,D12.776.860.300.250
23103157,2012-10-24T00:00:00,"Diabetes Mellitus, Experimental",C18.452.394.750.074
23103157,2012-10-24T00:00:00,"Diabetes Mellitus, Experimental",C19.246.240
23103157,2012-10-24T00:00:00,"Diabetes Mellitus, Experimental",E05.598.500.374
23103157,2012-10-24T00:00:00,Elastin,D05.750.078.421
23103157,2012-10-24T00:00:00,Elastin,D12.776.860.300.350
23103157,2012-10-24T00:00:00,"Glycosylation End Products, Advanced",D02.415
23103157,2012-10-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23103157,2012-10-24T00:00:00,Hydrolyzable Tannins,D02.241.223.100.380.350.299
23103157,2012-10-24T00:00:00,Hydrolyzable Tannins,D02.241.511.390.350.299
23103157,2012-10-24T00:00:00,Hydrolyzable Tannins,D02.755.410.350.299
23103157,2012-10-24T00:00:00,Hydrolyzable Tannins,D05.750.078.937.214
23103157,2012-10-24T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23103157,2012-10-24T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
23103157,2012-10-24T00:00:00,Tissue Engineering,E05.200.249.750
23103157,2012-10-24T00:00:00,Tissue Scaffolds,E07.206.627
23103157,2012-10-24T00:00:00,Tissue Scaffolds,E07.695.825
23103584,2012-10-24T00:00:00,Animals,B01.050
23103584,2012-10-24T00:00:00,Cell Line,A11.251.210
23103584,2012-10-24T00:00:00,Cell Lineage,G04.172
23103584,2012-10-24T00:00:00,Cell Lineage,G07.700.320.500.325.180.500
23103584,2012-10-24T00:00:00,Cell Lineage,G08.686.155
23103584,2012-10-24T00:00:00,Cell Lineage,G08.686.785.760.170.104.249
23103584,2012-10-24T00:00:00,Cell Proliferation,G04.299.233.750
23103584,2012-10-24T00:00:00,Cell Proliferation,G07.700.320.249.410.750
23103584,2012-10-24T00:00:00,Endothelial Cells,A11.436.275
23103584,2012-10-24T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
23103584,2012-10-24T00:00:00,Flow Cytometry,E05.200.500.386.350
23103584,2012-10-24T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
23103584,2012-10-24T00:00:00,"Microscopy, Fluorescence",E05.595.458
23103584,2012-10-24T00:00:00,"Neovascularization, Physiologic",G09.330.190.751
23103584,2012-10-24T00:00:00,Nitric Oxide Synthase Type III,D08.811.682.664.500.772.750
23103584,2012-10-24T00:00:00,Phosphorylation,G02.111.087.677
23103584,2012-10-24T00:00:00,Phosphorylation,G02.149.115.677
23103584,2012-10-24T00:00:00,Phosphorylation,G02.149.465.700
23103584,2012-10-24T00:00:00,Phosphorylation,G02.607.750.700
23103584,2012-10-24T00:00:00,Phosphorylation,G03.495.790
23103584,2012-10-24T00:00:00,Signal Transduction,G02.111.087.800
23103584,2012-10-24T00:00:00,Signal Transduction,G02.149.115.800
23103584,2012-10-24T00:00:00,Signal Transduction,G04.299.880
23103584,2012-10-24T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
23103584,2012-10-24T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
23103584,2012-10-24T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
23102697,2012-10-25T00:00:00,"Biodegradation, Environmental",N06.850.460.375.500
23102697,2012-10-25T00:00:00,"Biodegradation, Environmental",N06.850.860.510.900.299
23102697,2012-10-25T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
23102905,2012-10-25T00:00:00,Animals,B01.050
23102905,2012-10-25T00:00:00,"Disease Models, Animal",C22.232
23102905,2012-10-25T00:00:00,"Disease Models, Animal",E05.598.500
23102905,2012-10-25T00:00:00,"Disease Models, Animal",E05.599.395.080
23102905,2012-10-25T00:00:00,Fibroblasts,A11.329.228
23102905,2012-10-25T00:00:00,Fibroblasts,A11.872.228
23102905,2012-10-25T00:00:00,Hemodynamics,G09.330.190.400
23102905,2012-10-25T00:00:00,Hemodynamics,G09.330.380
23102905,2012-10-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23102905,2012-10-25T00:00:00,Matrix Metalloproteinase 14,D08.811.277.656.300.480.525.300.500
23102905,2012-10-25T00:00:00,Matrix Metalloproteinase 14,D08.811.277.656.675.374.525.300.500
23102905,2012-10-25T00:00:00,MicroRNAs,D13.150.650.319
23102905,2012-10-25T00:00:00,MicroRNAs,D13.444.735.150.319
23102905,2012-10-25T00:00:00,MicroRNAs,D13.444.735.790.099
23102905,2012-10-25T00:00:00,Myocardial Contraction,G09.330.190.541
23102905,2012-10-25T00:00:00,Myocardial Contraction,G11.427.590.540.570
23102905,2012-10-25T00:00:00,Myocardium,A02.633.580
23102905,2012-10-25T00:00:00,Myocardium,A07.541.704
23102905,2012-10-25T00:00:00,Myocardium,A10.690.552.750
23102905,2012-10-25T00:00:00,Phosphorylation,G02.111.087.677
23102905,2012-10-25T00:00:00,Phosphorylation,G02.149.115.677
23102905,2012-10-25T00:00:00,Phosphorylation,G02.149.465.700
23102905,2012-10-25T00:00:00,Phosphorylation,G02.607.750.700
23102905,2012-10-25T00:00:00,Phosphorylation,G03.495.790
23102905,2012-10-25T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
23102905,2012-10-25T00:00:00,Signal Transduction,G02.111.087.800
23102905,2012-10-25T00:00:00,Signal Transduction,G02.149.115.800
23102905,2012-10-25T00:00:00,Signal Transduction,G04.299.880
23102905,2012-10-25T00:00:00,Swine,B01.050.150.900.649.077.880
23102905,2012-10-25T00:00:00,Time Factors,G01.910.857
23102905,2012-10-25T00:00:00,"Transduction, Genetic",E05.393.350.800
23102905,2012-10-25T00:00:00,"Transduction, Genetic",G05.355.760.850
23102905,2012-10-25T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
23104969,2012-10-25T00:00:00,Adult,M01.060.116
23104969,2012-10-25T00:00:00,Ethanol,D02.033.375
23104969,2012-10-25T00:00:00,Hemodynamics,G09.330.190.400
23104969,2012-10-25T00:00:00,Hemodynamics,G09.330.380
23104969,2012-10-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23104969,2012-10-25T00:00:00,Methylphenidate,D02.241.223.601.600
23104969,2012-10-25T00:00:00,Methylphenidate,D03.383.621.460
23104969,2012-10-25T00:00:00,Young Adult,M01.060.116.815
23107600,2012-10-26T00:00:00,Adult,M01.060.116
23107600,2012-10-26T00:00:00,Cellular Phone,L01.178.847.698.300
23107600,2012-10-26T00:00:00,Communication,F01.145.209
23107600,2012-10-26T00:00:00,Communication,L01.143
23107600,2012-10-26T00:00:00,Data Collection,E05.318.308
23107600,2012-10-26T00:00:00,Data Collection,L01.280
23107600,2012-10-26T00:00:00,Data Collection,N05.715.360.300
23107600,2012-10-26T00:00:00,Data Collection,N06.850.520.308
23107600,2012-10-26T00:00:00,Ethnic Groups,M01.686.754
23107600,2012-10-26T00:00:00,Ethnic Groups,N01.224.317
23107600,2012-10-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23107600,2012-10-26T00:00:00,Internet,L01.224.230.110.500
23107600,2012-10-26T00:00:00,Middle Aged,M01.060.116.630
23107600,2012-10-26T00:00:00,Social Support,I01.880.656.600
23107600,2012-10-26T00:00:00,Substance-Related Disorders,C21.739
23107600,2012-10-26T00:00:00,Substance-Related Disorders,F03.900
23282118,2012-10-26T00:00:00,Antihypertensive Agents,D27.505.954.411.162
23282118,2012-10-26T00:00:00,Blood Pressure,E01.370.600.875.249
23282118,2012-10-26T00:00:00,Blood Pressure,G09.330.380.076
23282118,2012-10-26T00:00:00,Cardiovascular System,A07
23282118,2012-10-26T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
23282118,2012-10-26T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
23282118,2012-10-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23282118,2012-10-26T00:00:00,Hypertension,C14.907.489
23282118,2012-10-26T00:00:00,"Renal Insufficiency, Chronic",C12.777.419.780.750
23282118,2012-10-26T00:00:00,"Renal Insufficiency, Chronic",C13.351.968.419.780.750
23106536,2012-10-29T00:00:00,Animals,B01.050
23106536,2012-10-29T00:00:00,Cocaine,D02.145.074.722.388
23106536,2012-10-29T00:00:00,Cocaine,D03.132.889.354
23106536,2012-10-29T00:00:00,Cocaine,D03.605.869.388
23106536,2012-10-29T00:00:00,Cocaine,D04.075.080.875.099.722.388
23106536,2012-10-29T00:00:00,Motor Activity,F01.145.632
23106536,2012-10-29T00:00:00,Motor Activity,G11.427.590.530.698
23106536,2012-10-29T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
23109248,2012-10-29T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
23109248,2012-10-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23109248,2012-10-29T00:00:00,Polypropylenes,D02.455.326.271.665.590
23109248,2012-10-29T00:00:00,Polypropylenes,D05.750.716.550
23109248,2012-10-29T00:00:00,Polypropylenes,D25.720.716.550
23109248,2012-10-29T00:00:00,Polypropylenes,J01.637.051.720.716.550
23109248,2012-10-29T00:00:00,Transferrin,D12.776.124.050.800
23109248,2012-10-29T00:00:00,Transferrin,D12.776.124.790.223.839
23109248,2012-10-29T00:00:00,Transferrin,D12.776.157.427.500
23109248,2012-10-29T00:00:00,Transferrin,D12.776.377.715.182.839
23109248,2012-10-29T00:00:00,Transferrin,D12.776.556.579.500
23112272,2012-10-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23112272,2012-10-30T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
23112272,2012-10-30T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
23112272,2012-10-30T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
23112272,2012-10-30T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
23118131,2012-10-31T00:00:00,Animals,B01.050
23118131,2012-10-31T00:00:00,"Animals, Newborn",B01.050.050.282
23118131,2012-10-31T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
23118131,2012-10-31T00:00:00,"Microscopy, Confocal",E05.595.395
23118131,2012-10-31T00:00:00,Muscle Development,G07.700.320.500.325.377.625.590
23118131,2012-10-31T00:00:00,Muscle Development,G11.427.590.560.590
23118131,2012-10-31T00:00:00,"Myocytes, Cardiac",A07.541.704.570
23118131,2012-10-31T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
23118131,2012-10-31T00:00:00,"Myocytes, Cardiac",A11.620.500
23118131,2012-10-31T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23118131,2012-10-31T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
22669523,2012-11-01T00:00:00,Bariatric Surgery,E02.065.062
22669523,2012-11-01T00:00:00,Bariatric Surgery,E04.062
22669523,2012-11-01T00:00:00,Depression,F01.145.126.350
22669523,2012-11-01T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
22669523,2012-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22669523,2012-11-01T00:00:00,Middle Aged,M01.060.116.630
22669523,2012-11-01T00:00:00,Mood Disorders,F03.600
22669523,2012-11-01T00:00:00,"Obesity, Morbid",C18.654.726.500.700
22669523,2012-11-01T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
22669523,2012-11-01T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
22669523,2012-11-01T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
22669523,2012-11-01T00:00:00,Patient Selection,E05.581.500.653
22669523,2012-11-01T00:00:00,Patient Selection,N04.590.731
22669523,2012-11-01T00:00:00,Personality Inventory,F04.711.647.513
22669523,2012-11-01T00:00:00,Questionnaires,E05.318.308.750
22669523,2012-11-01T00:00:00,Questionnaires,L01.280.800
22669523,2012-11-01T00:00:00,Questionnaires,N05.715.360.300.695
22669523,2012-11-01T00:00:00,Questionnaires,N06.850.520.308.750
22751335,2012-11-01T00:00:00,Abdominal Pain,C23.888.646.100
22751335,2012-11-01T00:00:00,Abdominal Pain,C23.888.821.030
22751335,2012-11-01T00:00:00,Adult,M01.060.116
22751335,2012-11-01T00:00:00,Aged,M01.060.116.100
22751335,2012-11-01T00:00:00,Chest Pain,C23.888.646.215
22751335,2012-11-01T00:00:00,Deglutition Disorders,C06.405.117.119
22751335,2012-11-01T00:00:00,Deglutition Disorders,C09.775.174
22751335,2012-11-01T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
22751335,2012-11-01T00:00:00,Health Status,I01.240.425
22751335,2012-11-01T00:00:00,Health Status,N01.224.425
22751335,2012-11-01T00:00:00,Health Status,N06.850.505.400.425
22751335,2012-11-01T00:00:00,Heartburn,C23.888.821.525
22751335,2012-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22751335,2012-11-01T00:00:00,Lymphocytes,A11.118.637.555.567
22751335,2012-11-01T00:00:00,Lymphocytes,A15.145.229.637.555.567
22751335,2012-11-01T00:00:00,Lymphocytes,A15.382.490.555.567
22751335,2012-11-01T00:00:00,Middle Aged,M01.060.116.630
22751335,2012-11-01T00:00:00,Proton Pump Inhibitors,D27.505.519.389.848
22751335,2012-11-01T00:00:00,Quality of Life,I01.800
22751335,2012-11-01T00:00:00,Quality of Life,K01.752.400.750
22751335,2012-11-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
22751335,2012-11-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
22751335,2012-11-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
22751335,2012-11-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
22751335,2012-11-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
22751335,2012-11-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
22751335,2012-11-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
22751335,2012-11-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
22751335,2012-11-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
22751335,2012-11-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
22751335,2012-11-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
22751335,2012-11-01T00:00:00,Young Adult,M01.060.116.815
22833143,2012-11-01T00:00:00,"Adaptor Proteins, Signal Transducing",D12.644.360.024
22833143,2012-11-01T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.157.057
22833143,2012-11-01T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.476.024
22833143,2012-11-01T00:00:00,African Americans,M01.686.508.100.100
22833143,2012-11-01T00:00:00,African Americans,M01.686.754.100
22833143,2012-11-01T00:00:00,B-Lymphocytes,A11.063.438
22833143,2012-11-01T00:00:00,B-Lymphocytes,A11.118.637.555.567.562
22833143,2012-11-01T00:00:00,B-Lymphocytes,A15.145.229.637.555.567.562
22833143,2012-11-01T00:00:00,B-Lymphocytes,A15.382.032.438
22833143,2012-11-01T00:00:00,B-Lymphocytes,A15.382.490.555.567.562
22833143,2012-11-01T00:00:00,DNA-Binding Proteins,D12.776.260
22833143,2012-11-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
22833143,2012-11-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
22833143,2012-11-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
22833143,2012-11-01T00:00:00,Hispanic Americans,M01.686.754.441
22833143,2012-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22833143,2012-11-01T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
22833143,2012-11-01T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
22833143,2012-11-01T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
22833143,2012-11-01T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
22833143,2012-11-01T00:00:00,Neoplasm Proteins,D12.776.624
22833143,2012-11-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
22833143,2012-11-01T00:00:00,Risk Factors,E05.318.740.600.800.725
22833143,2012-11-01T00:00:00,Risk Factors,N05.715.350.200.700
22833143,2012-11-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22833143,2012-11-01T00:00:00,Risk Factors,N06.850.490.625.750
22833143,2012-11-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22833143,2012-11-01T00:00:00,United States,Z01.107.567.875
22863686,2012-11-01T00:00:00,Adolescent,M01.060.057
22863686,2012-11-01T00:00:00,Child,M01.060.406
22863686,2012-11-01T00:00:00,"Child, Preschool",M01.060.406.448
22863686,2012-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22863686,2012-11-01T00:00:00,Infant,M01.060.703
22863686,2012-11-01T00:00:00,Kyphosis,C05.116.900.800.500
22863686,2012-11-01T00:00:00,Neural Tube Defects,C10.500.680
22863686,2012-11-01T00:00:00,Neural Tube Defects,C16.131.666.680
22863686,2012-11-01T00:00:00,Neurosurgical Procedures,E04.525
22863686,2012-11-01T00:00:00,Orthopedic Procedures,E02.718
22863686,2012-11-01T00:00:00,Orthopedic Procedures,E04.555
22863686,2012-11-01T00:00:00,Postoperative Complications,C23.550.767
22863686,2012-11-01T00:00:00,Scoliosis,C05.116.900.800.875
22863686,2012-11-01T00:00:00,Treatment Outcome,E01.789.800
22863686,2012-11-01T00:00:00,Treatment Outcome,N04.761.559.590.800
22863686,2012-11-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22886787,2012-11-01T00:00:00,Adolescent,M01.060.057
22886787,2012-11-01T00:00:00,Adult,M01.060.116
22886787,2012-11-01T00:00:00,Child,M01.060.406
22886787,2012-11-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
22886787,2012-11-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
22886787,2012-11-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
22886787,2012-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22886787,2012-11-01T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
22886787,2012-11-01T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
22886787,2012-11-01T00:00:00,Lupus Nephritis,C12.777.419.570.363.680
22886787,2012-11-01T00:00:00,Lupus Nephritis,C13.351.968.419.570.363.680
22886787,2012-11-01T00:00:00,Lupus Nephritis,C17.300.480.680
22886787,2012-11-01T00:00:00,Lupus Nephritis,C20.111.590.560
22886787,2012-11-01T00:00:00,Middle Aged,M01.060.116.630
22886787,2012-11-01T00:00:00,Risk Factors,E05.318.740.600.800.725
22886787,2012-11-01T00:00:00,Risk Factors,N05.715.350.200.700
22886787,2012-11-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22886787,2012-11-01T00:00:00,Risk Factors,N06.850.490.625.750
22886787,2012-11-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22886787,2012-11-01T00:00:00,Young Adult,M01.060.116.815
22928175,2012-11-01T00:00:00,Adolescent,M01.060.057
22928175,2012-11-01T00:00:00,Adult,M01.060.116
22928175,2012-11-01T00:00:00,Aged,M01.060.116.100
22928175,2012-11-01T00:00:00,Biocompatible Materials,D25.130
22928175,2012-11-01T00:00:00,Biocompatible Materials,D27.720.102.130
22928175,2012-11-01T00:00:00,Biocompatible Materials,J01.637.051.130
22928175,2012-11-01T00:00:00,Child,M01.060.406
22928175,2012-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22928175,2012-11-01T00:00:00,Incidence,E05.318.308.985.525.375
22928175,2012-11-01T00:00:00,Incidence,L01.280.975.525.375
22928175,2012-11-01T00:00:00,Incidence,N01.224.935.597.500
22928175,2012-11-01T00:00:00,Incidence,N06.850.505.400.975.525.375
22928175,2012-11-01T00:00:00,Incidence,N06.850.520.308.985.525.375
22928175,2012-11-01T00:00:00,Middle Aged,M01.060.116.630
22928175,2012-11-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
22928175,2012-11-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
22928175,2012-11-01T00:00:00,Polyethylenes,D02.455.326.271.665.550
22928175,2012-11-01T00:00:00,Polyethylenes,D05.750.716.507
22928175,2012-11-01T00:00:00,Polyethylenes,D25.720.716.507
22928175,2012-11-01T00:00:00,Polyethylenes,J01.637.051.720.716.507
22928175,2012-11-01T00:00:00,Polytetrafluoroethylene,D05.750.395.616
22928175,2012-11-01T00:00:00,Polytetrafluoroethylene,D25.720.395.616
22928175,2012-11-01T00:00:00,Polytetrafluoroethylene,J01.637.051.720.395.616
22928175,2012-11-01T00:00:00,Prostheses and Implants,E07.695
22928175,2012-11-01T00:00:00,Prosthesis Failure,C23.550.767.865
22928175,2012-11-01T00:00:00,Prosthesis Failure,E05.325.771
22928175,2012-11-01T00:00:00,Prosthesis-Related Infections,C01.539.685
22928175,2012-11-01T00:00:00,Prosthesis-Related Infections,C23.550.767.868
22928175,2012-11-01T00:00:00,Rhinoplasty,E02.218.755
22928175,2012-11-01T00:00:00,Rhinoplasty,E04.580.677
22928175,2012-11-01T00:00:00,Rhinoplasty,E04.680.650
22928175,2012-11-01T00:00:00,Young Adult,M01.060.116.815
22955018,2012-11-01T00:00:00,African Americans,M01.686.508.100.100
22955018,2012-11-01T00:00:00,African Americans,M01.686.754.100
22955018,2012-11-01T00:00:00,Caveolin 1,D12.644.360.024.264
22955018,2012-11-01T00:00:00,Caveolin 1,D12.776.157.057.010
22955018,2012-11-01T00:00:00,Caveolin 1,D12.776.476.024.280
22955018,2012-11-01T00:00:00,Caveolin 1,D12.776.543.990.100.500
22955018,2012-11-01T00:00:00,Caveolin 1,D12.776.744.287
22955018,2012-11-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
22955018,2012-11-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
22955018,2012-11-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
22955018,2012-11-01T00:00:00,Hepatocyte Growth Factor,D12.644.276.374.420
22955018,2012-11-01T00:00:00,Hepatocyte Growth Factor,D12.776.467.374.420
22955018,2012-11-01T00:00:00,Hepatocyte Growth Factor,D23.529.374.420
22955018,2012-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22955018,2012-11-01T00:00:00,"Scleroderma, Systemic",C17.300.799
22955018,2012-11-01T00:00:00,"Scleroderma, Systemic",C17.800.784
22955018,2012-11-01T00:00:00,Transforming Growth Factor beta1,D12.644.276.374.687.100
22955018,2012-11-01T00:00:00,Transforming Growth Factor beta1,D12.644.276.954.800.720.100
22955018,2012-11-01T00:00:00,Transforming Growth Factor beta1,D12.644.276.963.720.100
22955018,2012-11-01T00:00:00,Transforming Growth Factor beta1,D12.776.467.374.687.100
22955018,2012-11-01T00:00:00,Transforming Growth Factor beta1,D12.776.467.942.800.720.100
22955018,2012-11-01T00:00:00,Transforming Growth Factor beta1,D12.776.467.960.720.100
22955018,2012-11-01T00:00:00,Transforming Growth Factor beta1,D23.529.374.687.100
22955018,2012-11-01T00:00:00,Transforming Growth Factor beta1,D23.529.942.800.720.100
22955018,2012-11-01T00:00:00,Transforming Growth Factor beta1,D23.529.960.720.100
23018331,2012-11-01T00:00:00,Cultural Diversity,I01.076.201.450.350
23018331,2012-11-01T00:00:00,Cultural Diversity,I01.880.143.450
23018331,2012-11-01T00:00:00,Curriculum,I02.158
23018331,2012-11-01T00:00:00,"Faculty, Medical",I02.463.373
23018331,2012-11-01T00:00:00,"Faculty, Medical",M01.526.339.373
23018331,2012-11-01T00:00:00,"Faculty, Medical",M01.526.485.375
23018331,2012-11-01T00:00:00,"Faculty, Medical",N02.360.375
23018331,2012-11-01T00:00:00,Fellowships and Scholarships,N03.219.483.838.276
23018331,2012-11-01T00:00:00,Healthcare Disparities,N04.590.374.380
23018331,2012-11-01T00:00:00,Healthcare Disparities,N05.300.493
23018331,2012-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23018331,2012-11-01T00:00:00,Internship and Residency,I02.358.399.644
23018331,2012-11-01T00:00:00,Minority Groups,I01.880.371
23018331,2012-11-01T00:00:00,Organizational Objectives,N04.452.615
23018331,2012-11-01T00:00:00,School Admission Criteria,I02.399.750
23018331,2012-11-01T00:00:00,"Schools, Medical",I02.783.660.552
23018331,2012-11-01T00:00:00,"Schools, Medical",N02.278.020.578
23018331,2012-11-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23018331,2012-11-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23023704,2012-11-01T00:00:00,Animals,B01.050
23023704,2012-11-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
23023704,2012-11-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
23023704,2012-11-01T00:00:00,Dietary Fats,D10.212.302
23023704,2012-11-01T00:00:00,Dietary Fats,J02.500.375
23023704,2012-11-01T00:00:00,"Myocytes, Cardiac",A07.541.704.570
23023704,2012-11-01T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
23023704,2012-11-01T00:00:00,"Myocytes, Cardiac",A11.620.500
23023704,2012-11-01T00:00:00,Sphingolipids,D10.570.877
23023704,2012-11-01T00:00:00,Sphingolipids,D10.808
23023704,2012-11-01T00:00:00,Sphingosine N-Acyltransferase,D08.811.913.050.712
23050646,2012-11-01T00:00:00,Animals,B01.050
23050646,2012-11-01T00:00:00,Blood-Brain Barrier,A07.035
23050646,2012-11-01T00:00:00,Blood-Brain Barrier,A08.186.211.035
23050646,2012-11-01T00:00:00,Brain,A08.186.211
23050646,2012-11-01T00:00:00,Carrier Proteins,D12.776.157
23050646,2012-11-01T00:00:00,"Disease Models, Animal",C22.232
23050646,2012-11-01T00:00:00,"Disease Models, Animal",E05.598.500
23050646,2012-11-01T00:00:00,"Disease Models, Animal",E05.599.395.080
23050646,2012-11-01T00:00:00,Endothelial Cells,A11.436.275
23050646,2012-11-01T00:00:00,Functional Laterality,F02.830.297.425
23050646,2012-11-01T00:00:00,Functional Laterality,G11.561.225.425
23050646,2012-11-01T00:00:00,"Infarction, Middle Cerebral Artery",C10.228.140.300.150.477.200.450
23050646,2012-11-01T00:00:00,"Infarction, Middle Cerebral Artery",C10.228.140.300.510.200.387
23050646,2012-11-01T00:00:00,"Infarction, Middle Cerebral Artery",C10.228.140.300.775.200.200.450
23050646,2012-11-01T00:00:00,"Infarction, Middle Cerebral Artery",C14.907.253.092.477.200.450
23050646,2012-11-01T00:00:00,"Infarction, Middle Cerebral Artery",C14.907.253.560.200.387
23050646,2012-11-01T00:00:00,"Infarction, Middle Cerebral Artery",C14.907.253.855.200.200.450
23050646,2012-11-01T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.205.360
23050646,2012-11-01T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.252.445
23050646,2012-11-01T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.525.700.350
23050646,2012-11-01T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.205.360
23050646,2012-11-01T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.252.445
23050646,2012-11-01T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.525.700.350
23050646,2012-11-01T00:00:00,Neoplasm Proteins,D12.776.624
23050646,2012-11-01T00:00:00,Neurons,A08.663
23050646,2012-11-01T00:00:00,Neurons,A11.671
23050646,2012-11-01T00:00:00,Neuroprotective Agents,D27.505.696.706.548
23050646,2012-11-01T00:00:00,Neuroprotective Agents,D27.505.954.427.575
23050646,2012-11-01T00:00:00,Nitric Oxide,D01.339.387
23050646,2012-11-01T00:00:00,Nitric Oxide,D01.625.550.500
23050646,2012-11-01T00:00:00,Nitric Oxide,D01.625.700.500
23050646,2012-11-01T00:00:00,Nitric Oxide,D01.650.550.587.600
23050646,2012-11-01T00:00:00,Peroxynitrous Acid,D01.625.600.800
23050646,2012-11-01T00:00:00,Peroxynitrous Acid,D01.625.700.750
23050646,2012-11-01T00:00:00,Protein Transport,G03.495.166.700
23050646,2012-11-01T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
23050646,2012-11-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23050646,2012-11-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
23050646,2012-11-01T00:00:00,S-Nitrosoglutathione,D02.654.846.500.249
23050646,2012-11-01T00:00:00,S-Nitrosoglutathione,D02.886.489.650.750
23050646,2012-11-01T00:00:00,S-Nitrosoglutathione,D12.644.456.448.750
23050646,2012-11-01T00:00:00,Time Factors,G01.910.857
23050646,2012-11-01T00:00:00,Tyrosine,D12.125.072.050.875
23078690,2012-11-01T00:00:00,Curriculum,I02.158
23078690,2012-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23078690,2012-11-01T00:00:00,"Schools, Medical",I02.783.660.552
23078690,2012-11-01T00:00:00,"Schools, Medical",N02.278.020.578
23078690,2012-11-01T00:00:00,"Students, Medical",I02.851.686.602
23078690,2012-11-01T00:00:00,"Students, Medical",M01.848.769.602
23078690,2012-11-01T00:00:00,Teaching,I02.903
23079312,2012-11-01T00:00:00,Adult,M01.060.116
23079312,2012-11-01T00:00:00,Clinical Competence,I02.399.630.210
23079312,2012-11-01T00:00:00,Clinical Competence,N04.761.210
23079312,2012-11-01T00:00:00,"Education, Medical, Graduate",I02.358.337.350
23079312,2012-11-01T00:00:00,"Education, Medical, Graduate",I02.358.399.350
23079312,2012-11-01T00:00:00,Educational Measurement,I02.399
23079312,2012-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23079312,2012-11-01T00:00:00,Internship and Residency,I02.358.399.644
23079312,2012-11-01T00:00:00,"Keratomileusis, Laser In Situ",E02.594.480.750
23079312,2012-11-01T00:00:00,"Keratomileusis, Laser In Situ",E04.014.520.480.750
23079312,2012-11-01T00:00:00,"Keratomileusis, Laser In Situ",E04.540.825.437.374
23079312,2012-11-01T00:00:00,Middle Aged,M01.060.116.630
23079312,2012-11-01T00:00:00,Military Personnel,M01.526.625
23079312,2012-11-01T00:00:00,Ophthalmology,H02.403.810.468
23079312,2012-11-01T00:00:00,Photorefractive Keratectomy,E02.594.480.875
23079312,2012-11-01T00:00:00,Photorefractive Keratectomy,E04.014.520.480.875
23079312,2012-11-01T00:00:00,Photorefractive Keratectomy,E04.540.825.437.500
23079312,2012-11-01T00:00:00,"Refraction, Ocular",E01.370.380.850.700
23079312,2012-11-01T00:00:00,"Refraction, Ocular",G01.590.770.760
23079312,2012-11-01T00:00:00,"Refraction, Ocular",G01.595.640.760
23079312,2012-11-01T00:00:00,"Refraction, Ocular",G14.760
23079312,2012-11-01T00:00:00,Treatment Outcome,E01.789.800
23079312,2012-11-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23079312,2012-11-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23079312,2012-11-01T00:00:00,United States,Z01.107.567.875
23079312,2012-11-01T00:00:00,Visual Acuity,E01.370.380.850.950
23079312,2012-11-01T00:00:00,Visual Acuity,F02.463.593.932.901
23079312,2012-11-01T00:00:00,Visual Acuity,G14.940
23079312,2012-11-01T00:00:00,Young Adult,M01.060.116.815
23089416,2012-11-01T00:00:00,Adenocarcinoma,C04.557.470.200.025
23089416,2012-11-01T00:00:00,Colonic Neoplasms,C04.588.274.476.411.307.180
23089416,2012-11-01T00:00:00,Colonic Neoplasms,C06.301.371.411.307.180
23089416,2012-11-01T00:00:00,Colonic Neoplasms,C06.405.249.411.307.180
23089416,2012-11-01T00:00:00,Colonic Neoplasms,C06.405.469.158.356.180
23089416,2012-11-01T00:00:00,Colonic Neoplasms,C06.405.469.491.307.180
23089416,2012-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23089416,2012-11-01T00:00:00,Middle Aged,M01.060.116.630
23089416,2012-11-01T00:00:00,Skin Neoplasms,C04.588.805
23089416,2012-11-01T00:00:00,Skin Neoplasms,C17.800.882
23097174,2012-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23097174,2012-11-01T00:00:00,Neoplasms,C04
23097174,2012-11-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.158.600.680
23097174,2012-11-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.350.700
23097174,2012-11-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.700.705
23097174,2012-11-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",L01.700.508.100.158.600.680
23097174,2012-11-01T00:00:00,"Radiography, Dual-Energy Scanned Projection",E01.370.350.600.350.700.700
23097174,2012-11-01T00:00:00,"Radiography, Dual-Energy Scanned Projection",E01.370.350.700.700.700
23097174,2012-11-01T00:00:00,"Radiography, Dual-Energy Scanned Projection",E01.370.350.760.700
23097174,2012-11-01T00:00:00,"Radiography, Dual-Energy Scanned Projection",L01.224.308.380.800
23097174,2012-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23097174,2012-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23097174,2012-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23097174,2012-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23097174,2012-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23098940,2012-11-01T00:00:00,Extracorporeal Membrane Oxygenation,E02.880.301
23098940,2012-11-01T00:00:00,Extracorporeal Membrane Oxygenation,E04.292.451
23098940,2012-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23107239,2012-11-01T00:00:00,Crowns,E06.323.428.100
23107239,2012-11-01T00:00:00,Crowns,E06.323.528.250
23107239,2012-11-01T00:00:00,Crowns,E06.780.345.250
23107239,2012-11-01T00:00:00,Crowns,E06.780.345.737.100
23107239,2012-11-01T00:00:00,Crowns,E07.695.190.190.150
23107239,2012-11-01T00:00:00,Dental Marginal Adaptation,E06.323.764
23107239,2012-11-01T00:00:00,Dental Marginal Adaptation,E06.658.224
23107239,2012-11-01T00:00:00,Dental Marginal Adaptation,E06.780.620
23107239,2012-11-01T00:00:00,Dental Porcelain,D25.264.377
23107239,2012-11-01T00:00:00,Dental Porcelain,D25.339.376
23107239,2012-11-01T00:00:00,Dental Porcelain,J01.637.051.264.377
23107239,2012-11-01T00:00:00,Dental Porcelain,J01.637.051.339.376
23107239,2012-11-01T00:00:00,Dental Prosthesis Design,E06.780.345.625
23107239,2012-11-01T00:00:00,Dental Prosthesis Design,E06.912.145
23107239,2012-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23107239,2012-11-01T00:00:00,"Tooth Preparation, Prosthodontic",E06.931.750
23112091,2012-11-01T00:00:00,Adult,M01.060.116
23112091,2012-11-01T00:00:00,African Americans,M01.686.508.100.100
23112091,2012-11-01T00:00:00,African Americans,M01.686.754.100
23112091,2012-11-01T00:00:00,Aged,M01.060.116.100
23112091,2012-11-01T00:00:00,"Antibodies, Antinuclear",D12.776.124.486.485.114.323.204
23112091,2012-11-01T00:00:00,"Antibodies, Antinuclear",D12.776.124.790.651.114.323.204
23112091,2012-11-01T00:00:00,"Antibodies, Antinuclear",D12.776.377.715.548.114.323.204
23112091,2012-11-01T00:00:00,Autoantibodies,D12.776.124.486.485.114.323
23112091,2012-11-01T00:00:00,Autoantibodies,D12.776.124.790.651.114.323
23112091,2012-11-01T00:00:00,Autoantibodies,D12.776.377.715.548.114.323
23112091,2012-11-01T00:00:00,Ethnic Groups,M01.686.754
23112091,2012-11-01T00:00:00,Ethnic Groups,N01.224.317
23112091,2012-11-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
23112091,2012-11-01T00:00:00,Hispanic Americans,M01.686.754.441
23112091,2012-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23112091,2012-11-01T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
23112091,2012-11-01T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
23112091,2012-11-01T00:00:00,Middle Aged,M01.060.116.630
23112091,2012-11-01T00:00:00,United States,Z01.107.567.875
23114241,2012-11-01T00:00:00,Adolescent,M01.060.057
23114241,2012-11-01T00:00:00,Child,M01.060.406
23114241,2012-11-01T00:00:00,"Child, Preschool",M01.060.406.448
23114241,2012-11-01T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
23114241,2012-11-01T00:00:00,"Emergency Service, Hospital",N02.421.297.195
23114241,2012-11-01T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
23114241,2012-11-01T00:00:00,Health Care Costs,N03.219.151.400
23114241,2012-11-01T00:00:00,Health Care Costs,N05.300.375
23114241,2012-11-01T00:00:00,"Hospitals, Pediatric",N02.278.421.556.437
23114241,2012-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23114241,2012-11-01T00:00:00,Infant,M01.060.703
23114241,2012-11-01T00:00:00,Length of Stay,E02.760.400.480
23114241,2012-11-01T00:00:00,Length of Stay,N02.421.585.400.480
23114241,2012-11-01T00:00:00,Quality of Health Care,N04.761
23114241,2012-11-01T00:00:00,Quality of Health Care,N05.715
23114669,2012-11-01T00:00:00,Adult,M01.060.116
23114669,2012-11-01T00:00:00,Age of Onset,N05.715.350.075.100
23114669,2012-11-01T00:00:00,Age of Onset,N06.850.490.250.100
23114669,2012-11-01T00:00:00,Aged,M01.060.116.100
23114669,2012-11-01T00:00:00,Central Nervous System Diseases,C10.228
23114669,2012-11-01T00:00:00,Cranial Nerve Diseases,C10.292
23114669,2012-11-01T00:00:00,Headache,C10.597.617.470
23114669,2012-11-01T00:00:00,Headache,C23.888.592.612.441
23114669,2012-11-01T00:00:00,Headache,C23.888.646.487
23114669,2012-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23114669,2012-11-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
23114669,2012-11-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
23114669,2012-11-01T00:00:00,Middle Aged,M01.060.116.630
23114669,2012-11-01T00:00:00,Sarcoidosis,C15.604.515.827
23114669,2012-11-01T00:00:00,Treatment Outcome,E01.789.800
23114669,2012-11-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23114669,2012-11-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23114687,2012-11-01T00:00:00,Adult,M01.060.116
23114687,2012-11-01T00:00:00,African Americans,M01.686.508.100.100
23114687,2012-11-01T00:00:00,African Americans,M01.686.754.100
23114687,2012-11-01T00:00:00,Aged,M01.060.116.100
23114687,2012-11-01T00:00:00,Alleles,G05.360.340.024.340.030
23114687,2012-11-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
23114687,2012-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23114687,2012-11-01T00:00:00,"Immunity, Humoral",G12.450.050.420
23114687,2012-11-01T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
23114687,2012-11-01T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
23114687,2012-11-01T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
23114687,2012-11-01T00:00:00,Middle Aged,M01.060.116.630
23114687,2012-11-01T00:00:00,Neoplasm Staging,E01.370.550
23114687,2012-11-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
23114687,2012-11-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
23114687,2012-11-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
23114687,2012-11-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
23114687,2012-11-01T00:00:00,"Receptors, IgG",D12.776.543.750.705.871.300
23114687,2012-11-01T00:00:00,"Receptors, IgG",D23.050.301.264.035.695
23114687,2012-11-01T00:00:00,"Receptors, IgG",D23.101.100.110.695
23114687,2012-11-01T00:00:00,Young Adult,M01.060.116.815
23124181,2012-11-01T00:00:00,Adult,M01.060.116
23124181,2012-11-01T00:00:00,Aged,M01.060.116.100
23124181,2012-11-01T00:00:00,Anxiety Disorders,F03.080
23124181,2012-11-01T00:00:00,Checklist,N05.715.360.300.179
23124181,2012-11-01T00:00:00,Depressive Disorder,F03.600.300
23124181,2012-11-01T00:00:00,Fear,F01.470.361
23124181,2012-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23124181,2012-11-01T00:00:00,"Interview, Psychological",F04.669.599
23124181,2012-11-01T00:00:00,Life Change Events,F01.829.458.410
23124181,2012-11-01T00:00:00,Middle Aged,M01.060.116.630
23124181,2012-11-01T00:00:00,Neuropsychological Tests,F04.711.513
23124181,2012-11-01T00:00:00,Primary Health Care,N04.590.233.727
23124181,2012-11-01T00:00:00,Sex Factors,N05.715.350.675
23124181,2012-11-01T00:00:00,Sex Factors,N06.850.490.875
23124181,2012-11-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
23124181,2012-11-01T00:00:00,Veterans,M01.930
23141856,2012-11-01T00:00:00,Aged,M01.060.116.100
23141856,2012-11-01T00:00:00,Heart Failure,C14.280.434
23141856,2012-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23141856,2012-11-01T00:00:00,Kidney,A05.810.453
23141856,2012-11-01T00:00:00,Middle Aged,M01.060.116.630
23141856,2012-11-01T00:00:00,Obesity,C18.654.726.500
23141856,2012-11-01T00:00:00,Obesity,C23.888.144.699.500
23141856,2012-11-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
23141856,2012-11-01T00:00:00,Obesity,G07.100.100.160.120.699.500
23141856,2012-11-01T00:00:00,Treatment Outcome,E01.789.800
23141856,2012-11-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23141856,2012-11-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23148005,2012-11-01T00:00:00,Curriculum,I02.158
23148005,2012-11-01T00:00:00,"Education, Medical, Graduate",I02.358.337.350
23148005,2012-11-01T00:00:00,"Education, Medical, Graduate",I02.358.399.350
23148005,2012-11-01T00:00:00,Family Practice,H02.403.280
23148005,2012-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23148005,2012-11-01T00:00:00,Internship and Residency,I02.358.399.644
23148005,2012-11-01T00:00:00,Oral Health,N01.400.535
23170020,2012-11-01T00:00:00,Heart Failure,C14.280.434
23170020,2012-11-01T00:00:00,Heart Ventricles,A07.541.560
23170020,2012-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23170020,2012-11-01T00:00:00,Stroke Volume,E01.370.370.380.150.700
23170020,2012-11-01T00:00:00,Stroke Volume,G09.330.380.124.882
23193907,2012-11-01T00:00:00,Adult,M01.060.116
23193907,2012-11-01T00:00:00,Aged,M01.060.116.100
23193907,2012-11-01T00:00:00,Deglutition Disorders,C06.405.117.119
23193907,2012-11-01T00:00:00,Deglutition Disorders,C09.775.174
23193907,2012-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23193907,2012-11-01T00:00:00,Manometry,E05.559
23193907,2012-11-01T00:00:00,Middle Aged,M01.060.116.630
23193907,2012-11-01T00:00:00,Young Adult,M01.060.116.815
23125280,2012-11-02T00:00:00,Chronic Disease,C23.550.291.500
23125280,2012-11-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23125280,2012-11-02T00:00:00,Interviews as Topic,E05.318.308.420
23125280,2012-11-02T00:00:00,Interviews as Topic,L01.280.520
23125280,2012-11-02T00:00:00,Interviews as Topic,N05.715.360.300.400
23125280,2012-11-02T00:00:00,Interviews as Topic,N06.850.520.308.420
23125280,2012-11-02T00:00:00,Middle Aged,M01.060.116.630
23125280,2012-11-02T00:00:00,Patient Satisfaction,N04.452.822.360.600
23125280,2012-11-02T00:00:00,Patient Satisfaction,N05.300.150.600.630
23125280,2012-11-02T00:00:00,Patient Satisfaction,N05.715.360.600
23125280,2012-11-02T00:00:00,Physical Therapy Modalities,E02.779
23125280,2012-11-02T00:00:00,Postural Balance,G11.427.690
23125280,2012-11-02T00:00:00,Postural Balance,G11.561.600.810.541.595
23125280,2012-11-02T00:00:00,Qualitative Research,H01.770.644.241.850
23125280,2012-11-02T00:00:00,Stroke,C10.228.140.300.775
23125280,2012-11-02T00:00:00,Stroke,C14.907.253.855
23125280,2012-11-02T00:00:00,Treatment Outcome,E01.789.800
23125280,2012-11-02T00:00:00,Treatment Outcome,N04.761.559.590.800
23125280,2012-11-02T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23127574,2012-11-02T00:00:00,Colonic Neoplasms,C04.588.274.476.411.307.180
23127574,2012-11-02T00:00:00,Colonic Neoplasms,C06.301.371.411.307.180
23127574,2012-11-02T00:00:00,Colonic Neoplasms,C06.405.249.411.307.180
23127574,2012-11-02T00:00:00,Colonic Neoplasms,C06.405.469.158.356.180
23127574,2012-11-02T00:00:00,Colonic Neoplasms,C06.405.469.491.307.180
23127574,2012-11-02T00:00:00,Colonic Polyps,C23.300.825.411.235
23127574,2012-11-02T00:00:00,Colonoscopy,E01.370.372.250.250.200
23127574,2012-11-02T00:00:00,Colonoscopy,E01.370.388.250.250.250.160
23127574,2012-11-02T00:00:00,Colonoscopy,E04.210.240.250.160
23127574,2012-11-02T00:00:00,Colonoscopy,E04.800.250.250.250.160
23127574,2012-11-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23127802,2012-11-02T00:00:00,Alligators and Crocodiles,B01.050.150.900.833.100
23127802,2012-11-02T00:00:00,Amino Acid Sequence,G02.111.570.060
23127802,2012-11-02T00:00:00,Amino Acid Sequence,L01.453.245.667.060
23127802,2012-11-02T00:00:00,Animals,B01.050
23127802,2012-11-02T00:00:00,Cell Line,A11.251.210
23127802,2012-11-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23127802,2012-11-02T00:00:00,Hydrocortisone,D04.808.745.745.654.600
23127802,2012-11-02T00:00:00,Hydrocortisone,D06.472.040.585.353.476
23127802,2012-11-02T00:00:00,Hydrocortisone,D06.472.040.585.478.392
23127802,2012-11-02T00:00:00,Molecular Sequence Data,L01.453.245.667
23127802,2012-11-02T00:00:00,Phylogeny,G05.697
23127802,2012-11-02T00:00:00,Phylogeny,G16.100.275.605
23127802,2012-11-02T00:00:00,Phylogeny,L01.100.697
23127802,2012-11-02T00:00:00,Xenopus laevis,B01.050.150.900.090.180.610.500.562
23127802,2012-11-02T00:00:00,Zebrafish,B01.050.150.900.493.200.244.828
23215271,2012-11-02T00:00:00,"Data Interpretation, Statistical",E05.245.380
23215271,2012-11-02T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
23215271,2012-11-02T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
23215271,2012-11-02T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
23215271,2012-11-02T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
23215271,2012-11-02T00:00:00,"Models, Theoretical",E05.599
23215271,2012-11-02T00:00:00,Monte Carlo Method,E05.318.740.525
23215271,2012-11-02T00:00:00,Monte Carlo Method,L01.906.575.422
23215271,2012-11-02T00:00:00,Monte Carlo Method,N05.715.360.750.540
23215271,2012-11-02T00:00:00,Monte Carlo Method,N06.850.520.830.525
23215271,2012-11-02T00:00:00,Nuclear Energy,G01.595.630
23215271,2012-11-02T00:00:00,Nuclear Energy,N06.230.132.580
23215271,2012-11-02T00:00:00,Protons,D01.248.497.300.459.700
23215271,2012-11-02T00:00:00,Protons,D01.435.550
23215271,2012-11-02T00:00:00,Protons,G01.249.765
23131462,2012-11-03T00:00:00,Adult,M01.060.116
23131462,2012-11-03T00:00:00,Calcium,D01.268.552.100
23131462,2012-11-03T00:00:00,Calcium,D01.552.539.288
23131462,2012-11-03T00:00:00,Calcium,D23.119.100
23131462,2012-11-03T00:00:00,Dietary Supplements,J02.500.456
23131462,2012-11-03T00:00:00,Double-Blind Method,E05.318.780.300
23131462,2012-11-03T00:00:00,Double-Blind Method,E05.581.500.300
23131462,2012-11-03T00:00:00,Double-Blind Method,N05.715.360.780.320
23131462,2012-11-03T00:00:00,Double-Blind Method,N06.850.520.445.300
23131462,2012-11-03T00:00:00,Fetal Blood,A12.207.152.200
23131462,2012-11-03T00:00:00,Fetal Blood,A15.145.300
23131462,2012-11-03T00:00:00,Fetal Blood,A16.378.200
23131462,2012-11-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23131462,2012-11-03T00:00:00,Pregnancy,G08.686.785.760.769
23131462,2012-11-03T00:00:00,Pregnancy Outcome,E01.789.700
23131462,2012-11-03T00:00:00,Pregnancy Outcome,G08.686.785.760.769.530
23131462,2012-11-03T00:00:00,Questionnaires,E05.318.308.750
23131462,2012-11-03T00:00:00,Questionnaires,L01.280.800
23131462,2012-11-03T00:00:00,Questionnaires,N05.715.360.300.695
23131462,2012-11-03T00:00:00,Questionnaires,N06.850.520.308.750
23131462,2012-11-03T00:00:00,South Carolina,Z01.107.567.875.075.662
23131462,2012-11-03T00:00:00,South Carolina,Z01.107.567.875.750.700
23131462,2012-11-03T00:00:00,Vitamin D,D04.808.812.768
23131462,2012-11-03T00:00:00,Young Adult,M01.060.116.815
23127129,2012-11-05T00:00:00,Alcohol Drinking,F01.145.317.269
23127129,2012-11-05T00:00:00,Ethanol,D02.033.375
23127129,2012-11-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23127129,2012-11-05T00:00:00,Motivation,F01.658
23127129,2012-11-05T00:00:00,Motivation,F01.752.543.500.750
23127129,2012-11-05T00:00:00,Students,I02.233.748
23127129,2012-11-05T00:00:00,Students,I02.851
23127129,2012-11-05T00:00:00,Students,M01.848
23129107,2012-11-06T00:00:00,Adolescent,M01.060.057
23129107,2012-11-06T00:00:00,Child,M01.060.406
23129107,2012-11-06T00:00:00,Cognition Disorders,F03.087.250
23129107,2012-11-06T00:00:00,Emotions,F01.470
23129107,2012-11-06T00:00:00,Heart Atria,A07.541.358
23129107,2012-11-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23129107,2012-11-06T00:00:00,Neuropsychological Tests,F04.711.513
23129107,2012-11-06T00:00:00,Sex Factors,N05.715.350.675
23129107,2012-11-06T00:00:00,Sex Factors,N06.850.490.875
23129107,2012-11-06T00:00:00,"Tachycardia, Supraventricular",C14.280.067.845.880
23129107,2012-11-06T00:00:00,"Tachycardia, Supraventricular",C23.550.073.845.880
23129107,2012-11-06T00:00:00,Wolff-Parkinson-White Syndrome,C14.280.067.780.977
23129107,2012-11-06T00:00:00,Wolff-Parkinson-White Syndrome,C16.131.240.400.980
23137712,2012-11-06T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
23137712,2012-11-06T00:00:00,Cystic Fibrosis,C06.689.202
23137712,2012-11-06T00:00:00,Cystic Fibrosis,C08.381.187
23137712,2012-11-06T00:00:00,Cystic Fibrosis,C16.320.190
23137712,2012-11-06T00:00:00,Cystic Fibrosis,C16.614.213
23137712,2012-11-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23137712,2012-11-06T00:00:00,Pseudomonas Infections,C01.252.400.739
23137712,2012-11-06T00:00:00,Pseudomonas aeruginosa,B03.440.400.425.625.625.100
23137712,2012-11-06T00:00:00,Pseudomonas aeruginosa,B03.660.250.580.590.050
23142420,2012-11-06T00:00:00,Alleles,G05.360.340.024.340.030
23142420,2012-11-06T00:00:00,Apoptosis,G04.299.139.160
23142420,2012-11-06T00:00:00,Cell Membrane,A11.284.149
23142420,2012-11-06T00:00:00,Glutathione Transferase,D08.811.913.225.500
23142420,2012-11-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23142420,2012-11-06T00:00:00,Mutation,G05.365.590
23142420,2012-11-06T00:00:00,Oxidative Stress,G03.495.710
23142420,2012-11-06T00:00:00,Oxidative Stress,G07.700.830.750
23142420,2012-11-06T00:00:00,Peroxiredoxin VI,D08.811.277.352.100.680.750.937.300.500
23142420,2012-11-06T00:00:00,Peroxiredoxin VI,D08.811.277.352.100.680.750.937.625.624
23142420,2012-11-06T00:00:00,Peroxiredoxin VI,D08.811.682.732.850.500
23142420,2012-11-06T00:00:00,"Polymorphism, Genetic",G05.365.795
23135267,2012-11-07T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
23135267,2012-11-07T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
23135267,2012-11-07T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
23135267,2012-11-07T00:00:00,Head and Neck Neoplasms,C04.588.443
23135267,2012-11-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23135267,2012-11-07T00:00:00,Iron,D01.268.556.412
23135267,2012-11-07T00:00:00,Iron,D01.268.956.287
23135267,2012-11-07T00:00:00,Iron,D01.552.544.412
23135267,2012-11-07T00:00:00,Lysosomes,A11.284.430.214.190.875.190.550
23135267,2012-11-07T00:00:00,Macrolides,D02.540.505
23135267,2012-11-07T00:00:00,Macrolides,D04.345.349
23135267,2012-11-07T00:00:00,Macrolides,D09.408.477
23135267,2012-11-07T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
23135267,2012-11-07T00:00:00,"Microscopy, Confocal",E05.595.395
23135267,2012-11-07T00:00:00,Mitochondria,A11.284.430.214.190.875.564
23135267,2012-11-07T00:00:00,Mitochondria,A11.284.835.626
23135267,2012-11-07T00:00:00,"Models, Biological",E05.599.395
23135267,2012-11-07T00:00:00,Photochemotherapy,E02.186.500
23135267,2012-11-07T00:00:00,Photochemotherapy,E02.319.685
23135267,2012-11-07T00:00:00,Photochemotherapy,E02.774.722
23135267,2012-11-07T00:00:00,Reactive Oxygen Species,D01.339.431
23135267,2012-11-07T00:00:00,Reactive Oxygen Species,D01.650.775
23135267,2012-11-07T00:00:00,Time Factors,G01.910.857
23135269,2012-11-07T00:00:00,"Endothelium, Vascular",A07.231.330
23135269,2012-11-07T00:00:00,"Endothelium, Vascular",A10.272.491.355
23135269,2012-11-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23135269,2012-11-07T00:00:00,"Lipoproteins, HDL",D10.532.432
23135269,2012-11-07T00:00:00,"Lipoproteins, HDL",D12.776.521.479
23135269,2012-11-07T00:00:00,Lysophospholipids,D10.570.755.375.760.550
23135269,2012-11-07T00:00:00,Protein Transport,G03.495.166.700
23135269,2012-11-07T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
23135269,2012-11-07T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
23135269,2012-11-07T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
23135269,2012-11-07T00:00:00,"Receptors, Lysosphingolipid",D12.776.543.750.100.420.500
23135269,2012-11-07T00:00:00,Serum Albumin,D12.776.034.841
23135269,2012-11-07T00:00:00,Serum Albumin,D12.776.124.050.700
23135269,2012-11-07T00:00:00,Serum Albumin,D12.776.124.727
23135269,2012-11-07T00:00:00,Signal Transduction,G02.111.087.800
23135269,2012-11-07T00:00:00,Signal Transduction,G02.149.115.800
23135269,2012-11-07T00:00:00,Signal Transduction,G04.299.880
23135269,2012-11-07T00:00:00,Sphingosine,D02.033.100.700
23135269,2012-11-07T00:00:00,Sphingosine,D02.033.455.843
23135269,2012-11-07T00:00:00,Sphingosine,D02.092.063.700
23141166,2012-11-07T00:00:00,Animals,B01.050
23141166,2012-11-07T00:00:00,Brain,A08.186.211
23141166,2012-11-07T00:00:00,Cytokines,D12.644.276.374
23141166,2012-11-07T00:00:00,Cytokines,D12.776.467.374
23141166,2012-11-07T00:00:00,Cytokines,D23.529.374
23141166,2012-11-07T00:00:00,Dendritic Cells,A11.066.270
23141166,2012-11-07T00:00:00,Dendritic Cells,A11.436.270
23141166,2012-11-07T00:00:00,Dendritic Cells,A15.382.066.270
23141166,2012-11-07T00:00:00,Dendritic Cells,A15.382.812.260
23141166,2012-11-07T00:00:00,"Disease Models, Animal",C22.232
23141166,2012-11-07T00:00:00,"Disease Models, Animal",E05.598.500
23141166,2012-11-07T00:00:00,"Disease Models, Animal",E05.599.395.080
23141166,2012-11-07T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.114.703.300
23141166,2012-11-07T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.314.350.250
23141166,2012-11-07T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C20.111.258.625.300
23141166,2012-11-07T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",E05.598.500.500.500
23141166,2012-11-07T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
23141166,2012-11-07T00:00:00,Flow Cytometry,E05.200.500.386.350
23141166,2012-11-07T00:00:00,Gene Expression Regulation,G05.355.315
23141166,2012-11-07T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
23141166,2012-11-07T00:00:00,Interleukin-10,D12.644.276.374.465.510
23141166,2012-11-07T00:00:00,Interleukin-10,D12.776.467.374.465.510
23141166,2012-11-07T00:00:00,Interleukin-10,D23.529.374.465.510
23141166,2012-11-07T00:00:00,Lymph Nodes,A10.549.400
23141166,2012-11-07T00:00:00,Lymph Nodes,A15.382.520.604.412
23141166,2012-11-07T00:00:00,Peptides,D12.644
23141166,2012-11-07T00:00:00,Spleen,A10.549.700
23141166,2012-11-07T00:00:00,Spleen,A15.382.520.604.700
23141166,2012-11-07T00:00:00,Toll-Like Receptors,D12.776.543.750.705.910.500
23215374,2012-11-07T00:00:00,"Models, Theoretical",E05.599
23215374,2012-11-07T00:00:00,Nuclear Energy,G01.595.630
23215374,2012-11-07T00:00:00,Nuclear Energy,N06.230.132.580
23215374,2012-11-07T00:00:00,Protons,D01.248.497.300.459.700
23215374,2012-11-07T00:00:00,Protons,D01.435.550
23215374,2012-11-07T00:00:00,Protons,G01.249.765
23139430,2012-11-08T00:00:00,Animals,B01.050
23139430,2012-11-08T00:00:00,Cell Line,A11.251.210
23139430,2012-11-08T00:00:00,Ceramides,D02.065.313
23139430,2012-11-08T00:00:00,Ceramides,D09.400.410.420.525.200
23139430,2012-11-08T00:00:00,Ceramides,D10.390.470.675.200
23139430,2012-11-08T00:00:00,Ceramides,D10.570.877.360.612.200
23139430,2012-11-08T00:00:00,Cytokines,D12.644.276.374
23139430,2012-11-08T00:00:00,Cytokines,D12.776.467.374
23139430,2012-11-08T00:00:00,Cytokines,D23.529.374
23139430,2012-11-08T00:00:00,Fenretinide,D02.455.326.271.665.202.495.270
23139430,2012-11-08T00:00:00,Fenretinide,D02.455.426.392.368.367.379.249.700.270
23139430,2012-11-08T00:00:00,Fenretinide,D02.455.849.131.495.270
23139430,2012-11-08T00:00:00,Fenretinide,D23.767.261.700.270
23139430,2012-11-08T00:00:00,Gene Expression Regulation,G05.355.315
23139430,2012-11-08T00:00:00,Macrophages,A11.329.372
23139430,2012-11-08T00:00:00,Macrophages,A11.627.482
23139430,2012-11-08T00:00:00,Macrophages,A11.733.397
23139430,2012-11-08T00:00:00,Macrophages,A15.382.680.397
23139430,2012-11-08T00:00:00,Macrophages,A15.382.812.522
23139430,2012-11-08T00:00:00,NF-kappa B,D12.776.260.600
23139430,2012-11-08T00:00:00,NF-kappa B,D12.776.660.600
23139430,2012-11-08T00:00:00,NF-kappa B,D12.776.930.600
23139430,2012-11-08T00:00:00,Pasteurellaceae,B03.440.450.600
23139430,2012-11-08T00:00:00,Pasteurellaceae,B03.660.250.550
23139430,2012-11-08T00:00:00,Protein Kinase C,D08.811.913.696.620.682.700.725
23139430,2012-11-08T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
23139430,2012-11-08T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
23139430,2012-11-08T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
23139430,2012-11-08T00:00:00,Signal Transduction,G02.111.087.800
23139430,2012-11-08T00:00:00,Signal Transduction,G02.149.115.800
23139430,2012-11-08T00:00:00,Signal Transduction,G04.299.880
23142925,2012-11-08T00:00:00,Adolescent,M01.060.057
23142925,2012-11-08T00:00:00,Adult,M01.060.116
23142925,2012-11-08T00:00:00,Aged,M01.060.116.100
23142925,2012-11-08T00:00:00,Employment,N01.824.245
23142925,2012-11-08T00:00:00,Health Status,I01.240.425
23142925,2012-11-08T00:00:00,Health Status,N01.224.425
23142925,2012-11-08T00:00:00,Health Status,N06.850.505.400.425
23142925,2012-11-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23142925,2012-11-08T00:00:00,Middle Aged,M01.060.116.630
23142925,2012-11-08T00:00:00,Quality of Life,I01.800
23142925,2012-11-08T00:00:00,Quality of Life,K01.752.400.750
23142925,2012-11-08T00:00:00,Risk Factors,E05.318.740.600.800.725
23142925,2012-11-08T00:00:00,Risk Factors,N05.715.350.200.700
23142925,2012-11-08T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23142925,2012-11-08T00:00:00,Risk Factors,N06.850.490.625.750
23142925,2012-11-08T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23142925,2012-11-08T00:00:00,Time Factors,G01.910.857
23142925,2012-11-08T00:00:00,Young Adult,M01.060.116.815
23143503,2012-11-08T00:00:00,Adolescent,M01.060.057
23143503,2012-11-08T00:00:00,Adult,M01.060.116
23143503,2012-11-08T00:00:00,Child,M01.060.406
23143503,2012-11-08T00:00:00,"Child, Preschool",M01.060.406.448
23143503,2012-11-08T00:00:00,Cyclosporine,D04.345.566.235.300
23143503,2012-11-08T00:00:00,Cyclosporine,D12.644.641.235.300
23143503,2012-11-08T00:00:00,Dexamethasone,D04.808.745.432.769.344
23143503,2012-11-08T00:00:00,Dexamethasone,D04.808.908.238
23143503,2012-11-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23143503,2012-11-08T00:00:00,Immunosuppression,E02.095.465.425.450
23143503,2012-11-08T00:00:00,Immunosuppression,E05.478.610
23143503,2012-11-08T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
23143503,2012-11-08T00:00:00,Proteinuria,C12.777.934.734
23143503,2012-11-08T00:00:00,Proteinuria,C13.351.968.934.734
23143503,2012-11-08T00:00:00,Proteinuria,C23.888.942.750
23143503,2012-11-08T00:00:00,Young Adult,M01.060.116.815
23143504,2012-11-08T00:00:00,Aged,M01.060.116.100
23143504,2012-11-08T00:00:00,Angiotensinogen,D12.644.456.073.070
23143504,2012-11-08T00:00:00,Angiotensinogen,D12.644.822.750.020
23143504,2012-11-08T00:00:00,Angiotensinogen,D12.644.861.020
23143504,2012-11-08T00:00:00,Angiotensinogen,D12.776.645.750.020
23143504,2012-11-08T00:00:00,Angiotensinogen,D12.776.811.070
23143504,2012-11-08T00:00:00,Angiotensinogen,D12.776.872.020
23143504,2012-11-08T00:00:00,Biological Markers,D23.101
23143504,2012-11-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23143504,2012-11-08T00:00:00,Middle Aged,M01.060.116.630
23144812,2012-11-08T00:00:00,Algorithms,G17.035
23144812,2012-11-08T00:00:00,Algorithms,L01.224.050
23144812,2012-11-08T00:00:00,Breast Neoplasms,C04.588.180
23144812,2012-11-08T00:00:00,Breast Neoplasms,C17.800.090.500
23144812,2012-11-08T00:00:00,Computer Simulation,L01.224.160
23144812,2012-11-08T00:00:00,"Epistasis, Genetic",G05.355.315.207
23144812,2012-11-08T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
23144812,2012-11-08T00:00:00,Genetic Predisposition to Disease,G05.380.355
23144812,2012-11-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23144812,2012-11-08T00:00:00,"Models, Genetic",E05.599.395.397
23144812,2012-11-08T00:00:00,Peroxiredoxins,D08.811.682.732.850
23144812,2012-11-08T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
23139102,2012-11-09T00:00:00,Adult,M01.060.116
23139102,2012-11-09T00:00:00,African Continental Ancestry Group,M01.686.508.100
23139102,2012-11-09T00:00:00,European Continental Ancestry Group,M01.686.508.400
23139102,2012-11-09T00:00:00,Fetal Blood,A12.207.152.200
23139102,2012-11-09T00:00:00,Fetal Blood,A15.145.300
23139102,2012-11-09T00:00:00,Fetal Blood,A16.378.200
23139102,2012-11-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23139102,2012-11-09T00:00:00,"Infant, Newborn",M01.060.703.520
23139102,2012-11-09T00:00:00,Pregnancy,G08.686.785.760.769
23139102,2012-11-09T00:00:00,United States,Z01.107.567.875
23139102,2012-11-09T00:00:00,Vitamin D,D04.808.812.768
23139102,2012-11-09T00:00:00,Young Adult,M01.060.116.815
23149171,2012-11-10T00:00:00,Cardiac Surgical Procedures,E04.100.376
23149171,2012-11-10T00:00:00,Cardiac Surgical Procedures,E04.928.220
23149171,2012-11-10T00:00:00,Cardiopulmonary Bypass,E04.292.413
23149171,2012-11-10T00:00:00,Ethnic Groups,M01.686.754
23149171,2012-11-10T00:00:00,Ethnic Groups,N01.224.317
23149171,2012-11-10T00:00:00,"Heart Defects, Congenital",C14.240.400
23149171,2012-11-10T00:00:00,"Heart Defects, Congenital",C14.280.400
23149171,2012-11-10T00:00:00,"Heart Defects, Congenital",C16.131.240.400
23149171,2012-11-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23149171,2012-11-10T00:00:00,"Infant, Newborn",M01.060.703.520
23149171,2012-11-10T00:00:00,Myocardium,A02.633.580
23149171,2012-11-10T00:00:00,Myocardium,A07.541.704
23149171,2012-11-10T00:00:00,Myocardium,A10.690.552.750
23149171,2012-11-10T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
23149171,2012-11-10T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
23149171,2012-11-10T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
23149171,2012-11-10T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
23149171,2012-11-10T00:00:00,Research Design,E05.581.500
23149171,2012-11-10T00:00:00,Research Design,H01.770.644.728
23149171,2012-11-10T00:00:00,Treatment Outcome,E01.789.800
23149171,2012-11-10T00:00:00,Treatment Outcome,N04.761.559.590.800
23149171,2012-11-10T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23149171,2012-11-10T00:00:00,Vitamin D,D04.808.812.768
23149171,2012-11-10T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
23143602,2012-11-11T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
23143602,2012-11-11T00:00:00,Genetic Predisposition to Disease,G05.380.355
23143602,2012-11-11T00:00:00,Genetic Variation,G05.365
23143602,2012-11-11T00:00:00,Genome-Wide Association Study,E05.318.416.249
23143602,2012-11-11T00:00:00,Genome-Wide Association Study,E05.318.780.392
23143602,2012-11-11T00:00:00,Genome-Wide Association Study,E05.393.385.500
23143602,2012-11-11T00:00:00,Genome-Wide Association Study,E05.393.522.500
23143602,2012-11-11T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
23143602,2012-11-11T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
23143602,2012-11-11T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
23143602,2012-11-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23143602,2012-11-11T00:00:00,Mutation,G05.365.590
23143602,2012-11-11T00:00:00,"Pancreatitis, Alcoholic",C06.689.750.660
23143602,2012-11-11T00:00:00,"Pancreatitis, Alcoholic",C21.739.100.087.730
23143602,2012-11-11T00:00:00,Sex Factors,N05.715.350.675
23143602,2012-11-11T00:00:00,Sex Factors,N06.850.490.875
23149595,2012-11-12T00:00:00,African Americans,M01.686.508.100.100
23149595,2012-11-12T00:00:00,African Americans,M01.686.754.100
23149595,2012-11-12T00:00:00,Blood Pressure,E01.370.600.875.249
23149595,2012-11-12T00:00:00,Blood Pressure,G09.330.380.076
23149595,2012-11-12T00:00:00,European Continental Ancestry Group,M01.686.508.400
23149595,2012-11-12T00:00:00,Genetic Variation,G05.365
23149595,2012-11-12T00:00:00,Hispanic Americans,M01.686.754.441
23149595,2012-11-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23149595,2012-11-12T00:00:00,Hypertension,C14.907.489
23149595,2012-11-12T00:00:00,Middle Aged,M01.060.116.630
23149595,2012-11-12T00:00:00,Population Surveillance,E05.318.308.250.700
23149595,2012-11-12T00:00:00,Population Surveillance,N05.715.360.300.375.625
23149595,2012-11-12T00:00:00,Population Surveillance,N06.850.520.308.250.700
23149595,2012-11-12T00:00:00,Population Surveillance,N06.850.780.675
23149595,2012-11-12T00:00:00,United States,Z01.107.567.875
23153713,2012-11-13T00:00:00,Adolescent,M01.060.057
23153713,2012-11-13T00:00:00,Child,M01.060.406
23153713,2012-11-13T00:00:00,Child Psychology,F04.096.628.193
23153713,2012-11-13T00:00:00,Epilepsy,C10.228.140.490
23153713,2012-11-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23153713,2012-11-13T00:00:00,Mental Disorders,F03
23153713,2012-11-13T00:00:00,Psychiatric Status Rating Scales,F04.586
23153713,2012-11-13T00:00:00,Risk Factors,E05.318.740.600.800.725
23153713,2012-11-13T00:00:00,Risk Factors,N05.715.350.200.700
23153713,2012-11-13T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23153713,2012-11-13T00:00:00,Risk Factors,N06.850.490.625.750
23153713,2012-11-13T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23153713,2012-11-13T00:00:00,South Carolina,Z01.107.567.875.075.662
23153713,2012-11-13T00:00:00,South Carolina,Z01.107.567.875.750.700
23153940,2012-11-13T00:00:00,Animals,B01.050
23153940,2012-11-13T00:00:00,Cyclophosphamide,D02.455.526.728.650.730.243
23153940,2012-11-13T00:00:00,Cyclophosphamide,D02.705.670.243
23153940,2012-11-13T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370
23153940,2012-11-13T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370
23153940,2012-11-13T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.230.202.370
23153940,2012-11-13T00:00:00,Muscle Contraction,G11.427.590.540
23153940,2012-11-13T00:00:00,Pressure,G01.374.715
23153940,2012-11-13T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23153940,2012-11-13T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
23153940,2012-11-13T00:00:00,Simvastatin,D02.455.426.559.847.638.400.900
23153940,2012-11-13T00:00:00,Simvastatin,D04.615.638.400.900
23153940,2012-11-13T00:00:00,Urinary Bladder,A05.810.890
23153940,2012-11-13T00:00:00,Urodynamics,G08.852.898
23153950,2012-11-13T00:00:00,Age Factors,N05.715.350.075
23153950,2012-11-13T00:00:00,Age Factors,N06.850.490.250
23153950,2012-11-13T00:00:00,Aged,M01.060.116.100
23153950,2012-11-13T00:00:00,Case-Control Studies,E05.318.760.500.500
23153950,2012-11-13T00:00:00,Case-Control Studies,N05.715.360.775.175.200
23153950,2012-11-13T00:00:00,Case-Control Studies,N06.850.520.450.500.500
23153950,2012-11-13T00:00:00,Delirium,C10.597.606.337.500
23153950,2012-11-13T00:00:00,Delirium,C23.888.592.604.339.500
23153950,2012-11-13T00:00:00,Delirium,F01.700.250.500
23153950,2012-11-13T00:00:00,Delirium,F03.087.350
23153950,2012-11-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23153950,2012-11-13T00:00:00,Pilot Projects,E05.318.760.750
23153950,2012-11-13T00:00:00,Pilot Projects,E05.337.737
23153950,2012-11-13T00:00:00,Pilot Projects,N05.715.360.775.625
23153950,2012-11-13T00:00:00,Pilot Projects,N06.850.520.450.720
23153950,2012-11-13T00:00:00,Reoperation,E04.690
23153950,2012-11-13T00:00:00,Risk Factors,E05.318.740.600.800.725
23153950,2012-11-13T00:00:00,Risk Factors,N05.715.350.200.700
23153950,2012-11-13T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23153950,2012-11-13T00:00:00,Risk Factors,N06.850.490.625.750
23153950,2012-11-13T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23153950,2012-11-13T00:00:00,Urinary Bladder Neoplasms,C04.588.945.947.960
23153950,2012-11-13T00:00:00,Urinary Bladder Neoplasms,C12.758.820.968
23153950,2012-11-13T00:00:00,Urinary Bladder Neoplasms,C12.777.829.813
23153950,2012-11-13T00:00:00,Urinary Bladder Neoplasms,C13.351.937.820.945
23153950,2012-11-13T00:00:00,Urinary Bladder Neoplasms,C13.351.968.829.707
23155194,2012-11-14T00:00:00,Child,M01.060.406
23155194,2012-11-14T00:00:00,"Child, Preschool",M01.060.406.448
23155194,2012-11-14T00:00:00,Environmental Exposure,N06.850.460.350
23155194,2012-11-14T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
23155194,2012-11-14T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
23155194,2012-11-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23155194,2012-11-14T00:00:00,Infant,M01.060.703
23155194,2012-11-14T00:00:00,Lead Poisoning,C21.613.589
23155194,2012-11-14T00:00:00,Mass Screening,E01.370.500
23155194,2012-11-14T00:00:00,Mass Screening,E05.318.308.250.580
23155194,2012-11-14T00:00:00,Mass Screening,N02.421.143.827.233.443
23155194,2012-11-14T00:00:00,Mass Screening,N02.421.726.233.443
23155194,2012-11-14T00:00:00,Mass Screening,N05.715.360.300.375.500
23155194,2012-11-14T00:00:00,Mass Screening,N06.850.520.308.250.580
23155194,2012-11-14T00:00:00,Mass Screening,N06.850.780.500
23155194,2012-11-14T00:00:00,Questionnaires,E05.318.308.750
23155194,2012-11-14T00:00:00,Questionnaires,L01.280.800
23155194,2012-11-14T00:00:00,Questionnaires,N05.715.360.300.695
23155194,2012-11-14T00:00:00,Questionnaires,N06.850.520.308.750
23155194,2012-11-14T00:00:00,Risk Factors,E05.318.740.600.800.725
23155194,2012-11-14T00:00:00,Risk Factors,N05.715.350.200.700
23155194,2012-11-14T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23155194,2012-11-14T00:00:00,Risk Factors,N06.850.490.625.750
23155194,2012-11-14T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23155194,2012-11-14T00:00:00,South Carolina,Z01.107.567.875.075.662
23155194,2012-11-14T00:00:00,South Carolina,Z01.107.567.875.750.700
23135566,2012-11-15T00:00:00,Adult,M01.060.116
23135566,2012-11-15T00:00:00,Aged,M01.060.116.100
23135566,2012-11-15T00:00:00,Cooperative Behavior,F01.145.813.115
23135566,2012-11-15T00:00:00,Drug Monitoring,E01.370.520.200
23135566,2012-11-15T00:00:00,Hemorrhage,C23.550.414
23135566,2012-11-15T00:00:00,Heparin,D09.698.373.400
23135566,2012-11-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23135566,2012-11-15T00:00:00,Inpatients,M01.643.470
23135566,2012-11-15T00:00:00,Medication Errors,E02.319.529
23135566,2012-11-15T00:00:00,Medication Errors,N02.421.450.500
23135566,2012-11-15T00:00:00,Middle Aged,M01.060.116.630
23135566,2012-11-15T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
23135566,2012-11-15T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
23135566,2012-11-15T00:00:00,Peptide Fragments,D12.644.541
23135566,2012-11-15T00:00:00,Pharmacists,M01.526.485.780
23135566,2012-11-15T00:00:00,Pharmacists,N02.360.780
23135566,2012-11-15T00:00:00,Recombinant Proteins,D12.776.828
23135566,2012-11-15T00:00:00,Thrombocytopenia,C15.378.140.855
23135566,2012-11-15T00:00:00,Time Factors,G01.910.857
23154976,2012-11-15T00:00:00,Animals,B01.050
23154976,2012-11-15T00:00:00,Cell Membrane,A11.284.149
23154976,2012-11-15T00:00:00,Fluorescence Resonance Energy Transfer,E05.196.712.516.600.676.500
23154976,2012-11-15T00:00:00,Fluorescence Resonance Energy Transfer,G01.154.100.240.280
23154976,2012-11-15T00:00:00,Fluorescence Resonance Energy Transfer,G01.595.100.240.280
23154976,2012-11-15T00:00:00,Fluorescence Resonance Energy Transfer,G02.111.087.242.280
23154976,2012-11-15T00:00:00,Fluorescence Resonance Energy Transfer,G02.149.115.242.280
23154976,2012-11-15T00:00:00,Gastric Acid,A12.200.307.603
23154976,2012-11-15T00:00:00,H(+)-K(+)-Exchanging ATPase,D08.811.277.040.025.325.625
23154976,2012-11-15T00:00:00,H(+)-K(+)-Exchanging ATPase,D12.776.157.530.450.250.875.500.625
23154976,2012-11-15T00:00:00,H(+)-K(+)-Exchanging ATPase,D12.776.543.585.450.250.875.500.625
23154976,2012-11-15T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
23154976,2012-11-15T00:00:00,"Microscopy, Fluorescence",E05.595.458
23154976,2012-11-15T00:00:00,"Parietal Cells, Gastric",A03.556.875.875.440.708
23154976,2012-11-15T00:00:00,"Parietal Cells, Gastric",A10.615.550.291.650
23154976,2012-11-15T00:00:00,"Parietal Cells, Gastric",A11.436.708
23154976,2012-11-15T00:00:00,Protein Transport,G03.495.166.700
23154976,2012-11-15T00:00:00,Time Factors,G01.910.857
23154976,2012-11-15T00:00:00,rab GTP-Binding Proteins,D08.811.277.040.330.300.400.400
23154976,2012-11-15T00:00:00,rab GTP-Binding Proteins,D12.644.360.525.400
23154976,2012-11-15T00:00:00,rab GTP-Binding Proteins,D12.776.157.325.515.400
23154976,2012-11-15T00:00:00,rab GTP-Binding Proteins,D12.776.476.525.400
23157603,2012-11-15T00:00:00,Aged,M01.060.116.100
23157603,2012-11-15T00:00:00,Hearing,F02.830.816.263
23157603,2012-11-15T00:00:00,Hearing,G11.561.600.810.263
23157603,2012-11-15T00:00:00,Hearing Loss,C09.218.458.341
23157603,2012-11-15T00:00:00,Hearing Loss,C10.597.751.418.341
23157603,2012-11-15T00:00:00,Hearing Loss,C23.888.592.763.393.341
23157603,2012-11-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23157603,2012-11-15T00:00:00,Middle Aged,M01.060.116.630
23157603,2012-11-15T00:00:00,Reaction Time,F02.830.650
23157603,2012-11-15T00:00:00,Reaction Time,F04.669.817
23157603,2012-11-15T00:00:00,Reaction Time,G11.561.677
23157603,2012-11-15T00:00:00,Speech Perception,F02.463.593.071.875
23160882,2012-11-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23160882,2012-11-15T00:00:00,Incidence,E05.318.308.985.525.375
23160882,2012-11-15T00:00:00,Incidence,L01.280.975.525.375
23160882,2012-11-15T00:00:00,Incidence,N01.224.935.597.500
23160882,2012-11-15T00:00:00,Incidence,N06.850.505.400.975.525.375
23160882,2012-11-15T00:00:00,Incidence,N06.850.520.308.985.525.375
23160882,2012-11-15T00:00:00,Intracranial Hemorrhages,C10.228.140.300.535
23160882,2012-11-15T00:00:00,Intracranial Hemorrhages,C14.907.253.573
23160882,2012-11-15T00:00:00,Intracranial Hemorrhages,C23.550.414.913
23160882,2012-11-15T00:00:00,Lactones,D02.540
23160882,2012-11-15T00:00:00,Pyridines,D03.383.725
23160882,2012-11-15T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
23160882,2012-11-15T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
23160882,2012-11-15T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
23160882,2012-11-15T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
23160882,2012-11-15T00:00:00,Risk Factors,E05.318.740.600.800.725
23160882,2012-11-15T00:00:00,Risk Factors,N05.715.350.200.700
23160882,2012-11-15T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23160882,2012-11-15T00:00:00,Risk Factors,N06.850.490.625.750
23160882,2012-11-15T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23160882,2012-11-15T00:00:00,Thrombosis,C14.907.355.830
23159552,2012-11-16T00:00:00,Aged,M01.060.116.100
23159552,2012-11-16T00:00:00,Carotid Stenosis,C10.228.140.300.200.360
23159552,2012-11-16T00:00:00,Carotid Stenosis,C14.907.137.230
23159552,2012-11-16T00:00:00,Carotid Stenosis,C14.907.253.123.360
23159552,2012-11-16T00:00:00,"Endarterectomy, Carotid",E04.100.814.456.250
23159552,2012-11-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23159552,2012-11-16T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
23159552,2012-11-16T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
23159552,2012-11-16T00:00:00,Middle Aged,M01.060.116.630
23159552,2012-11-16T00:00:00,Stents,E07.695.750
23159552,2012-11-16T00:00:00,Stroke,C10.228.140.300.775
23159552,2012-11-16T00:00:00,Stroke,C14.907.253.855
23160178,2012-11-16T00:00:00,Bridged Compounds,D02.455.426.100
23160178,2012-11-16T00:00:00,Bridged Compounds,D04.075
23160178,2012-11-16T00:00:00,Cell Line,A11.251.210
23160178,2012-11-16T00:00:00,Ceramides,D02.065.313
23160178,2012-11-16T00:00:00,Ceramides,D09.400.410.420.525.200
23160178,2012-11-16T00:00:00,Ceramides,D10.390.470.675.200
23160178,2012-11-16T00:00:00,Ceramides,D10.570.877.360.612.200
23160178,2012-11-16T00:00:00,"Genes, abl",G05.360.340.024.340.375.500.791.100
23160178,2012-11-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23160178,2012-11-16T00:00:00,Membrane Proteins,D12.776.543
23160178,2012-11-16T00:00:00,Nerve Tissue Proteins,D12.776.641
23160178,2012-11-16T00:00:00,Piperazines,D03.383.606
23160178,2012-11-16T00:00:00,Pyrimidines,D03.383.742
23160178,2012-11-16T00:00:00,Transferases (Other Substituted Phosphate Groups),D08.811.913.696.900
23161217,2012-11-16T00:00:00,Animals,B01.050
23161217,2012-11-16T00:00:00,Ethanol,D02.033.375
23161217,2012-11-16T00:00:00,Graft Survival,G12.425.901.545.340
23161217,2012-11-16T00:00:00,Liver,A03.620
23161217,2012-11-16T00:00:00,Liver Regeneration,G10.261.326.520
23161217,2012-11-16T00:00:00,Liver Regeneration,G16.100.856.468
23161217,2012-11-16T00:00:00,Liver Transplantation,E04.210.650
23161217,2012-11-16T00:00:00,Liver Transplantation,E04.936.450.490
23161217,2012-11-16T00:00:00,Liver Transplantation,E04.936.580.490
23161217,2012-11-16T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23165217,2012-11-16T00:00:00,Algorithms,G17.035
23165217,2012-11-16T00:00:00,Algorithms,L01.224.050
23165217,2012-11-16T00:00:00,Carcinoma,C04.557.470.200
23165217,2012-11-16T00:00:00,Gene Expression,G05.355.310
23165217,2012-11-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23165217,2012-11-16T00:00:00,Neoplasm Proteins,D12.776.624
23165217,2012-11-16T00:00:00,Ovarian Neoplasms,C04.588.322.455
23165217,2012-11-16T00:00:00,Ovarian Neoplasms,C13.351.500.056.630.705
23165217,2012-11-16T00:00:00,Ovarian Neoplasms,C13.351.937.418.685
23165217,2012-11-16T00:00:00,Ovarian Neoplasms,C19.344.410
23165217,2012-11-16T00:00:00,Ovarian Neoplasms,C19.391.630.705
23165217,2012-11-16T00:00:00,Proteins,D12.776
23165217,2012-11-16T00:00:00,"Tumor Markers, Biological",D23.101.840
23165887,2012-11-16T00:00:00,Academic Medical Centers,N02.278.020
23165887,2012-11-16T00:00:00,Adult,M01.060.116
23165887,2012-11-16T00:00:00,African Americans,M01.686.508.100.100
23165887,2012-11-16T00:00:00,African Americans,M01.686.754.100
23165887,2012-11-16T00:00:00,Aged,M01.060.116.100
23165887,2012-11-16T00:00:00,Graft Survival,G12.425.901.545.340
23165887,2012-11-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23165887,2012-11-16T00:00:00,Incidence,E05.318.308.985.525.375
23165887,2012-11-16T00:00:00,Incidence,L01.280.975.525.375
23165887,2012-11-16T00:00:00,Incidence,N01.224.935.597.500
23165887,2012-11-16T00:00:00,Incidence,N06.850.505.400.975.525.375
23165887,2012-11-16T00:00:00,Incidence,N06.850.520.308.985.525.375
23165887,2012-11-16T00:00:00,Kidney Transplantation,E02.870.500
23165887,2012-11-16T00:00:00,Kidney Transplantation,E04.936.450.485
23165887,2012-11-16T00:00:00,Kidney Transplantation,E04.950.774.400
23165887,2012-11-16T00:00:00,Medication Errors,E02.319.529
23165887,2012-11-16T00:00:00,Medication Errors,N02.421.450.500
23165887,2012-11-16T00:00:00,Middle Aged,M01.060.116.630
23165887,2012-11-16T00:00:00,Pharmaceutical Preparations,D26
23165887,2012-11-16T00:00:00,Risk Factors,E05.318.740.600.800.725
23165887,2012-11-16T00:00:00,Risk Factors,N05.715.350.200.700
23165887,2012-11-16T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23165887,2012-11-16T00:00:00,Risk Factors,N06.850.490.625.750
23165887,2012-11-16T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23165887,2012-11-16T00:00:00,Sex Factors,N05.715.350.675
23165887,2012-11-16T00:00:00,Sex Factors,N06.850.490.875
23165887,2012-11-16T00:00:00,Treatment Outcome,E01.789.800
23165887,2012-11-16T00:00:00,Treatment Outcome,N04.761.559.590.800
23165887,2012-11-16T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23261493,2012-11-16T00:00:00,Acetylcysteine,D02.886.030.230.259
23261493,2012-11-16T00:00:00,Acetylcysteine,D12.125.166.230.259
23261493,2012-11-16T00:00:00,Adolescent,M01.060.057
23261493,2012-11-16T00:00:00,Combined Modality Therapy,E02.186
23261493,2012-11-16T00:00:00,Counseling,F02.784.176
23261493,2012-11-16T00:00:00,Counseling,F04.408.413
23261493,2012-11-16T00:00:00,Counseling,N02.421.143.303
23261493,2012-11-16T00:00:00,Counseling,N02.421.461.363
23261493,2012-11-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23261493,2012-11-16T00:00:00,Marijuana Abuse,C21.739.635
23261493,2012-11-16T00:00:00,Marijuana Abuse,F03.900.635
23261493,2012-11-16T00:00:00,Substance Withdrawal Syndrome,C21.739.835
23261493,2012-11-16T00:00:00,Substance Withdrawal Syndrome,F03.900.825
23261493,2012-11-16T00:00:00,Young Adult,M01.060.116.815
23481250,2012-11-17T00:00:00,African Americans,M01.686.508.100.100
23481250,2012-11-17T00:00:00,African Americans,M01.686.754.100
23481250,2012-11-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23481250,2012-11-17T00:00:00,Middle Aged,M01.060.116.630
23481250,2012-11-17T00:00:00,"Models, Statistical",E05.318.740.500
23481250,2012-11-17T00:00:00,"Models, Statistical",E05.599.835
23481250,2012-11-17T00:00:00,"Models, Statistical",N05.715.360.750.530
23481250,2012-11-17T00:00:00,"Models, Statistical",N06.850.520.830.500
23481250,2012-11-17T00:00:00,Motor Activity,F01.145.632
23481250,2012-11-17T00:00:00,Motor Activity,G11.427.590.530.698
23481250,2012-11-17T00:00:00,Social Environment,I01.880.656
23481250,2012-11-17T00:00:00,Walking,G11.427.590.530.568.900
23481250,2012-11-17T00:00:00,Walking,G11.427.590.530.698.940
23481250,2012-11-17T00:00:00,Walking,I03.450.642.845.940
23179150,2012-11-18T00:00:00,Adult,M01.060.116
23179150,2012-11-18T00:00:00,Aged,M01.060.116.100
23179150,2012-11-18T00:00:00,Deglutition,G10.261.326.215
23179150,2012-11-18T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
23179150,2012-11-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23179150,2012-11-18T00:00:00,Middle Aged,M01.060.116.630
23179150,2012-11-18T00:00:00,Sleep,F02.830.855
23179150,2012-11-18T00:00:00,Sleep,G11.561.600.815
23179150,2012-11-18T00:00:00,Sleep Disorders,C10.886
23179150,2012-11-18T00:00:00,Sleep Disorders,C23.888.592.796
23179150,2012-11-18T00:00:00,Sleep Disorders,F03.870
23174094,2012-11-19T00:00:00,Algorithms,G17.035
23174094,2012-11-19T00:00:00,Algorithms,L01.224.050
23174094,2012-11-19T00:00:00,Artificial Intelligence,L01.224.065
23174094,2012-11-19T00:00:00,Electroencephalography,E01.370.376.300
23174094,2012-11-19T00:00:00,Electroencephalography,E01.370.405.245
23174094,2012-11-19T00:00:00,Epilepsy,C10.228.140.490
23174094,2012-11-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23174094,2012-11-19T00:00:00,"Signal Processing, Computer-Assisted",L01.224.800
23174094,2012-11-19T00:00:00,Software,L01.224.900
23187491,2012-11-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23187491,2012-11-19T00:00:00,Light,G01.201.875.770.578
23187491,2012-11-19T00:00:00,Light,G01.590.540
23187491,2012-11-19T00:00:00,Optical Fibers,E07.632.750
23187491,2012-11-19T00:00:00,Photons,G01.201.875.770.578.782
23187491,2012-11-19T00:00:00,Photons,G01.249.705
23187491,2012-11-19T00:00:00,Photons,G01.590.540.782
23187491,2012-11-19T00:00:00,"Scattering, Radiation",E05.196.822
23187491,2012-11-19T00:00:00,"Scattering, Radiation",G01.595.861
23187491,2012-11-19T00:00:00,Surface Plasmon Resonance,E05.196.890
23187491,2012-11-19T00:00:00,Surface Plasmon Resonance,E05.601.123.700
23182424,2012-11-20T00:00:00,Adenosine Triphosphate,D03.438.759.646.138.236
23182424,2012-11-20T00:00:00,Adenosine Triphosphate,D13.695.667.138.236
23182424,2012-11-20T00:00:00,Adenosine Triphosphate,D13.695.827.068.236
23182424,2012-11-20T00:00:00,Amino Acid Sequence,G02.111.570.060
23182424,2012-11-20T00:00:00,Amino Acid Sequence,L01.453.245.667.060
23182424,2012-11-20T00:00:00,Binding Sites,G02.111.570.120
23182424,2012-11-20T00:00:00,Calcium,D01.268.552.100
23182424,2012-11-20T00:00:00,Calcium,D01.552.539.288
23182424,2012-11-20T00:00:00,Calcium,D23.119.100
23182424,2012-11-20T00:00:00,Cell Cycle Proteins,D12.776.167
23182424,2012-11-20T00:00:00,"DNA, Single-Stranded",D13.444.308.497
23182424,2012-11-20T00:00:00,DNA-Binding Proteins,D12.776.260
23182424,2012-11-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23182424,2012-11-20T00:00:00,Lysine,D12.125.068.555
23182424,2012-11-20T00:00:00,Lysine,D12.125.095.647
23182424,2012-11-20T00:00:00,Lysine,D12.125.142.497
23182424,2012-11-20T00:00:00,Molecular Sequence Data,L01.453.245.667
23182424,2012-11-20T00:00:00,"Mutation, Missense",G05.365.590.650
23174564,2012-11-21T00:00:00,Animals,B01.050
23174564,2012-11-21T00:00:00,Extracellular Matrix,A11.284.295.310
23174564,2012-11-21T00:00:00,Fibrillar Collagens,D05.750.078.280.300
23174564,2012-11-21T00:00:00,Fibrillar Collagens,D12.776.860.300.250.300
23174564,2012-11-21T00:00:00,Fibroblasts,A11.329.228
23174564,2012-11-21T00:00:00,Fibroblasts,A11.872.228
23174564,2012-11-21T00:00:00,Fibrosis,C23.550.355
23174564,2012-11-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23174564,2012-11-21T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
23174564,2012-11-21T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
23174564,2012-11-21T00:00:00,Myocardium,A02.633.580
23174564,2012-11-21T00:00:00,Myocardium,A07.541.704
23174564,2012-11-21T00:00:00,Myocardium,A10.690.552.750
23174564,2012-11-21T00:00:00,Ventricular Remodeling,C23.300.985
23174564,2012-11-21T00:00:00,Ventricular Remodeling,G09.330.190.962.975
23174857,2012-11-21T00:00:00,Adult,M01.060.116
23174857,2012-11-21T00:00:00,Aged,M01.060.116.100
23174857,2012-11-21T00:00:00,Electric Stimulation,E05.723.402
23174857,2012-11-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23174857,2012-11-21T00:00:00,Middle Aged,M01.060.116.630
23174857,2012-11-21T00:00:00,Muscle Contraction,G11.427.590.540
23174857,2012-11-21T00:00:00,"Muscle, Smooth",A02.633.570
23174857,2012-11-21T00:00:00,"Muscle, Smooth",A10.690.467
23174857,2012-11-21T00:00:00,Urinary Bladder,A05.810.890
23174857,2012-11-21T00:00:00,"Urinary Bladder, Overactive",C12.777.829.866
23174857,2012-11-21T00:00:00,"Urinary Bladder, Overactive",C13.351.968.829.813
23174857,2012-11-21T00:00:00,"Urinary Bladder, Overactive",C23.888.942.775
23175723,2012-11-21T00:00:00,Age Factors,N05.715.350.075
23175723,2012-11-21T00:00:00,Age Factors,N06.850.490.250
23175723,2012-11-21T00:00:00,Aged,M01.060.116.100
23175723,2012-11-21T00:00:00,Cerebral Hemorrhage,C10.228.140.300.535.200
23175723,2012-11-21T00:00:00,Cerebral Hemorrhage,C14.907.253.573.200
23175723,2012-11-21T00:00:00,Cerebral Hemorrhage,C23.550.414.913.100
23175723,2012-11-21T00:00:00,Double-Blind Method,E05.318.780.300
23175723,2012-11-21T00:00:00,Double-Blind Method,E05.581.500.300
23175723,2012-11-21T00:00:00,Double-Blind Method,N05.715.360.780.320
23175723,2012-11-21T00:00:00,Double-Blind Method,N06.850.520.445.300
23175723,2012-11-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23175723,2012-11-21T00:00:00,Middle Aged,M01.060.116.630
23175723,2012-11-21T00:00:00,Stroke,C10.228.140.300.775
23175723,2012-11-21T00:00:00,Stroke,C14.907.253.855
23175723,2012-11-21T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
23175723,2012-11-21T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
23175723,2012-11-21T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
23175723,2012-11-21T00:00:00,Tissue Plasminogen Activator,D23.119.970
23178125,2012-11-21T00:00:00,Animals,B01.050
23178125,2012-11-21T00:00:00,Cell Differentiation,G04.299.151
23178125,2012-11-21T00:00:00,Coronary Vessels,A07.231.114.269
23178125,2012-11-21T00:00:00,Coronary Vessels,A07.231.908.194
23178125,2012-11-21T00:00:00,Endothelial Cells,A11.436.275
23178125,2012-11-21T00:00:00,Myocardium,A02.633.580
23178125,2012-11-21T00:00:00,Myocardium,A07.541.704
23178125,2012-11-21T00:00:00,Myocardium,A10.690.552.750
23178125,2012-11-21T00:00:00,"Neovascularization, Physiologic",G09.330.190.751
23178125,2012-11-21T00:00:00,Signal Transduction,G02.111.087.800
23178125,2012-11-21T00:00:00,Signal Transduction,G02.149.115.800
23178125,2012-11-21T00:00:00,Signal Transduction,G04.299.880
23178125,2012-11-21T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
23178125,2012-11-21T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
23178125,2012-11-21T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
23179658,2012-11-21T00:00:00,Adult,M01.060.116
23179658,2012-11-21T00:00:00,African Americans,M01.686.508.100.100
23179658,2012-11-21T00:00:00,African Americans,M01.686.754.100
23179658,2012-11-21T00:00:00,Age Factors,N05.715.350.075
23179658,2012-11-21T00:00:00,Age Factors,N06.850.490.250
23179658,2012-11-21T00:00:00,Carcinoma,C04.557.470.200
23179658,2012-11-21T00:00:00,European Continental Ancestry Group,M01.686.508.400
23179658,2012-11-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23179658,2012-11-21T00:00:00,Incidence,E05.318.308.985.525.375
23179658,2012-11-21T00:00:00,Incidence,L01.280.975.525.375
23179658,2012-11-21T00:00:00,Incidence,N01.224.935.597.500
23179658,2012-11-21T00:00:00,Incidence,N06.850.505.400.975.525.375
23179658,2012-11-21T00:00:00,Incidence,N06.850.520.308.985.525.375
23179658,2012-11-21T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
23179658,2012-11-21T00:00:00,Prostatic Neoplasms,C12.294.260.750
23179658,2012-11-21T00:00:00,Prostatic Neoplasms,C12.294.565.625
23179658,2012-11-21T00:00:00,Prostatic Neoplasms,C12.758.409.750
23106593,2012-11-22T00:00:00,Animals,B01.050
23106593,2012-11-22T00:00:00,Apoptosis,G04.299.139.160
23106593,2012-11-22T00:00:00,Calcium,D01.268.552.100
23106593,2012-11-22T00:00:00,Calcium,D01.552.539.288
23106593,2012-11-22T00:00:00,Calcium,D23.119.100
23106593,2012-11-22T00:00:00,Calpain,D08.811.277.656.262.500.120
23106593,2012-11-22T00:00:00,Calpain,D08.811.277.656.300.200.120
23106593,2012-11-22T00:00:00,Cyclooxygenase 2,D08.811.600.720.750
23106593,2012-11-22T00:00:00,Cytokines,D12.644.276.374
23106593,2012-11-22T00:00:00,Cytokines,D12.776.467.374
23106593,2012-11-22T00:00:00,Cytokines,D23.529.374
23106593,2012-11-22T00:00:00,"Disease Models, Animal",C22.232
23106593,2012-11-22T00:00:00,"Disease Models, Animal",E05.598.500
23106593,2012-11-22T00:00:00,"Disease Models, Animal",E05.599.395.080
23106593,2012-11-22T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.114.703.300
23106593,2012-11-22T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.314.350.250
23106593,2012-11-22T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C20.111.258.625.300
23106593,2012-11-22T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",E05.598.500.500.500
23106593,2012-11-22T00:00:00,Gene Expression Regulation,G05.355.315
23106593,2012-11-22T00:00:00,Glycoproteins,D09.400.430
23106593,2012-11-22T00:00:00,Glycoproteins,D12.776.395
23106593,2012-11-22T00:00:00,Molecular Weight,G02.842.580
23106593,2012-11-22T00:00:00,NF-kappa B,D12.776.260.600
23106593,2012-11-22T00:00:00,NF-kappa B,D12.776.660.600
23106593,2012-11-22T00:00:00,NF-kappa B,D12.776.930.600
23106593,2012-11-22T00:00:00,Nitric Oxide Synthase Type II,D08.811.682.664.500.772.500
23106593,2012-11-22T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23106593,2012-11-22T00:00:00,Signal Transduction,G02.111.087.800
23106593,2012-11-22T00:00:00,Signal Transduction,G02.149.115.800
23106593,2012-11-22T00:00:00,Signal Transduction,G04.299.880
23178078,2012-11-22T00:00:00,Animals,B01.050
23178078,2012-11-22T00:00:00,"Antigens, CD147",D12.776.395.550.045
23178078,2012-11-22T00:00:00,"Antigens, CD147",D12.776.543.550.188
23178078,2012-11-22T00:00:00,"Antigens, CD147",D23.050.285.040
23178078,2012-11-22T00:00:00,"Antigens, CD147",D23.050.301.264.035.247
23178078,2012-11-22T00:00:00,"Antigens, CD147",D23.101.100.110.247
23178078,2012-11-22T00:00:00,"Antigens, CD44",D12.776.395.550.200.625.144
23178078,2012-11-22T00:00:00,"Antigens, CD44",D12.776.543.550.200.625.144
23178078,2012-11-22T00:00:00,"Antigens, CD44",D12.776.543.750.705.877.144
23178078,2012-11-22T00:00:00,"Antigens, CD44",D23.050.301.264.035.850.144
23178078,2012-11-22T00:00:00,"Antigens, CD44",D23.050.301.350.625.144
23178078,2012-11-22T00:00:00,"Antigens, CD44",D23.101.100.110.850.144
23178078,2012-11-22T00:00:00,Cell Adhesion,G04.299.117
23178078,2012-11-22T00:00:00,Cell Membrane,A11.284.149
23178078,2012-11-22T00:00:00,Cell Proliferation,G04.299.233.750
23178078,2012-11-22T00:00:00,Cell Proliferation,G07.700.320.249.410.750
23178078,2012-11-22T00:00:00,"Cell Transformation, Neoplastic",C04.697.152
23178078,2012-11-22T00:00:00,"Cell Transformation, Neoplastic",C23.550.727.152
23178078,2012-11-22T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
23178078,2012-11-22T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
23178078,2012-11-22T00:00:00,Flow Cytometry,E05.200.500.386.350
23178078,2012-11-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23178078,2012-11-22T00:00:00,"Mammary Neoplasms, Animal",C04.588.531
23178078,2012-11-22T00:00:00,"Mammary Neoplasms, Animal",C22.520
23178078,2012-11-22T00:00:00,Neoplasm Invasiveness,C04.697.645
23178078,2012-11-22T00:00:00,Neoplasm Invasiveness,C23.550.727.645
23178078,2012-11-22T00:00:00,Neoplasms,C04
23178078,2012-11-22T00:00:00,"Receptor, Epidermal Growth Factor",D08.811.913.696.620.682.725.400.100
23178078,2012-11-22T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.060.249
23178078,2012-11-22T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.360.300
23178078,2012-11-22T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.400.340
23178078,2012-11-22T00:00:00,"Spheroids, Cellular",A11.251.800
23179649,2012-11-22T00:00:00,Adolescent,M01.060.057
23179649,2012-11-22T00:00:00,Adult,M01.060.116
23179649,2012-11-22T00:00:00,Brain Injuries,C10.228.140.199
23179649,2012-11-22T00:00:00,Brain Injuries,C10.900.300.087
23179649,2012-11-22T00:00:00,Brain Injuries,C21.866.260.118
23179649,2012-11-22T00:00:00,Brain Injuries,C21.866.915.300.200
23179649,2012-11-22T00:00:00,Cognition Disorders,F03.087.250
23179649,2012-11-22T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.500.150
23179649,2012-11-22T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.825.500.150
23179649,2012-11-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23179649,2012-11-22T00:00:00,Image Enhancement,E01.370.350.600.350
23179649,2012-11-22T00:00:00,Image Enhancement,L01.224.308.380
23179649,2012-11-22T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
23179649,2012-11-22T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
23179649,2012-11-22T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
23179649,2012-11-22T00:00:00,Magnetic Resonance Angiography,E01.370.350.500.500
23179649,2012-11-22T00:00:00,Magnetic Resonance Angiography,E01.370.350.825.500.500
23179649,2012-11-22T00:00:00,Magnetic Resonance Angiography,E01.370.370.050.500
23179649,2012-11-22T00:00:00,Middle Aged,M01.060.116.630
23179649,2012-11-22T00:00:00,"Nerve Fibers, Myelinated",A08.663.542.512
23179649,2012-11-22T00:00:00,"Nerve Fibers, Myelinated",A11.671.514
23179649,2012-11-22T00:00:00,Young Adult,M01.060.116.815
23180027,2012-11-22T00:00:00,Algorithms,G17.035
23180027,2012-11-22T00:00:00,Algorithms,L01.224.050
23180027,2012-11-22T00:00:00,Animals,B01.050
23180027,2012-11-22T00:00:00,Computer Simulation,L01.224.160
23180027,2012-11-22T00:00:00,Finite Element Analysis,E05.355
23180027,2012-11-22T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
23180027,2012-11-22T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
23180027,2012-11-22T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
23180027,2012-11-22T00:00:00,"Microscopy, Confocal",E05.595.395
23180027,2012-11-22T00:00:00,"Models, Biological",E05.599.395
23180027,2012-11-22T00:00:00,"Myocytes, Smooth Muscle",A11.620.520
23180027,2012-11-22T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23180027,2012-11-22T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
23173749,2012-11-23T00:00:00,Animals,B01.050
23173749,2012-11-23T00:00:00,"Disease Models, Animal",C22.232
23173749,2012-11-23T00:00:00,"Disease Models, Animal",E05.598.500
23173749,2012-11-23T00:00:00,"Disease Models, Animal",E05.599.395.080
23173749,2012-11-23T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
23173749,2012-11-23T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
23173749,2012-11-23T00:00:00,Treatment Outcome,E01.789.800
23173749,2012-11-23T00:00:00,Treatment Outcome,N04.761.559.590.800
23173749,2012-11-23T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23207934,2012-11-23T00:00:00,Colonic Neoplasms,C04.588.274.476.411.307.180
23207934,2012-11-23T00:00:00,Colonic Neoplasms,C06.301.371.411.307.180
23207934,2012-11-23T00:00:00,Colonic Neoplasms,C06.405.249.411.307.180
23207934,2012-11-23T00:00:00,Colonic Neoplasms,C06.405.469.158.356.180
23207934,2012-11-23T00:00:00,Colonic Neoplasms,C06.405.469.491.307.180
23207934,2012-11-23T00:00:00,Colonic Polyps,C23.300.825.411.235
23207934,2012-11-23T00:00:00,Colonoscopy,E01.370.372.250.250.200
23207934,2012-11-23T00:00:00,Colonoscopy,E01.370.388.250.250.250.160
23207934,2012-11-23T00:00:00,Colonoscopy,E04.210.240.250.160
23207934,2012-11-23T00:00:00,Colonoscopy,E04.800.250.250.250.160
23207934,2012-11-23T00:00:00,Early Detection of Cancer,E01.390.500
23207934,2012-11-23T00:00:00,"Education, Medical, Continuing",I02.358.212.350
23207934,2012-11-23T00:00:00,"Education, Medical, Continuing",I02.358.399.250
23207934,2012-11-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23207934,2012-11-23T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
23207934,2012-11-23T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
23207934,2012-11-23T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
23237238,2012-11-23T00:00:00,Disinfectants,D27.505.954.122.425
23237238,2012-11-23T00:00:00,Disinfectants,D27.720.274
23237238,2012-11-23T00:00:00,Humic Substances,D02.241.444
23237238,2012-11-23T00:00:00,Humic Substances,D02.755.377
23237238,2012-11-23T00:00:00,Humic Substances,D20.721.500
23237238,2012-11-23T00:00:00,Molecular Structure,G02.111.570
23237238,2012-11-23T00:00:00,Molecular Structure,G02.575
23237238,2012-11-23T00:00:00,Molecular Structure,G02.842.575
23237238,2012-11-23T00:00:00,South Carolina,Z01.107.567.875.075.662
23237238,2012-11-23T00:00:00,South Carolina,Z01.107.567.875.750.700
23237238,2012-11-23T00:00:00,United States,Z01.107.567.875
23237238,2012-11-23T00:00:00,Water Purification,N06.850.780.200.800.800.900.900
23237238,2012-11-23T00:00:00,Water Purification,N06.850.860.510.900.900
23237238,2012-11-23T00:00:00,Water Purification,N06.850.860.510.915.900
23180565,2012-11-25T00:00:00,Animals,B01.050
23180565,2012-11-25T00:00:00,Antineoplastic Agents,D27.505.954.248
23180565,2012-11-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23180565,2012-11-25T00:00:00,Lung Neoplasms,C04.588.894.797.520
23180565,2012-11-25T00:00:00,Lung Neoplasms,C08.381.540
23180565,2012-11-25T00:00:00,Lung Neoplasms,C08.785.520
23180565,2012-11-25T00:00:00,"Models, Molecular",E05.599.595
23180565,2012-11-25T00:00:00,Phosphorylation,G02.111.087.677
23180565,2012-11-25T00:00:00,Phosphorylation,G02.149.115.677
23180565,2012-11-25T00:00:00,Phosphorylation,G02.149.465.700
23180565,2012-11-25T00:00:00,Phosphorylation,G02.607.750.700
23180565,2012-11-25T00:00:00,Phosphorylation,G03.495.790
23180565,2012-11-25T00:00:00,Propylene Glycols,D02.033.455.706
23180565,2012-11-25T00:00:00,Protein Phosphatase 2,D08.811.277.352.650.625.706
23180565,2012-11-25T00:00:00,Protein Phosphatase 2,D12.644.360.583
23180565,2012-11-25T00:00:00,Protein Phosphatase 2,D12.776.476.561
23180565,2012-11-25T00:00:00,Sphingosine,D02.033.100.700
23180565,2012-11-25T00:00:00,Sphingosine,D02.033.455.843
23180565,2012-11-25T00:00:00,Sphingosine,D02.092.063.700
23180565,2012-11-25T00:00:00,Transcription Factors,D12.776.930
23184105,2012-11-26T00:00:00,Attention Deficit Disorder with Hyperactivity,F03.550.150.150
23184105,2012-11-26T00:00:00,Child,M01.060.406
23184105,2012-11-26T00:00:00,Curriculum,I02.158
23184105,2012-11-26T00:00:00,Developmental Disabilities,F03.550.362
23184105,2012-11-26T00:00:00,Environmental Exposure,N06.850.460.350
23184105,2012-11-26T00:00:00,Environmental Monitoring,N06.850.460.350.080
23184105,2012-11-26T00:00:00,Environmental Monitoring,N06.850.780.375
23184105,2012-11-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23184105,2012-11-26T00:00:00,"Infant, Newborn",M01.060.703.520
23184105,2012-11-26T00:00:00,Leukemia,C04.557.337
23184105,2012-11-26T00:00:00,Neoplasms,C04
23184105,2012-11-26T00:00:00,Occupational Exposure,N06.850.460.350.600
23184105,2012-11-26T00:00:00,Pediatrics,H02.403.670
23184105,2012-11-26T00:00:00,Pesticides,D27.720.031.700
23184105,2012-11-26T00:00:00,Pesticides,D27.720.723
23184105,2012-11-26T00:00:00,Pesticides,D27.888.723
23184105,2012-11-26T00:00:00,Poisoning,C21.613
23184105,2012-11-26T00:00:00,Pregnancy,G08.686.785.760.769
23184105,2012-11-26T00:00:00,Prenatal Exposure Delayed Effects,C13.703.824.500
23184105,2012-11-26T00:00:00,Risk Factors,E05.318.740.600.800.725
23184105,2012-11-26T00:00:00,Risk Factors,N05.715.350.200.700
23184105,2012-11-26T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23184105,2012-11-26T00:00:00,Risk Factors,N06.850.490.625.750
23184105,2012-11-26T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23184105,2012-11-26T00:00:00,United States,Z01.107.567.875
23190873,2012-11-26T00:00:00,Adolescent,M01.060.057
23190873,2012-11-26T00:00:00,African Americans,M01.686.508.100.100
23190873,2012-11-26T00:00:00,African Americans,M01.686.754.100
23190873,2012-11-26T00:00:00,Antioxidants,D27.505.519.217
23190873,2012-11-26T00:00:00,Antioxidants,D27.505.696.706.125
23190873,2012-11-26T00:00:00,Antioxidants,D27.720.799.047
23190873,2012-11-26T00:00:00,Cardiovascular Diseases,C14
23190873,2012-11-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23190873,2012-11-26T00:00:00,Metabolic Diseases,C18.452
23190873,2012-11-26T00:00:00,Obesity,C18.654.726.500
23190873,2012-11-26T00:00:00,Obesity,C23.888.144.699.500
23190873,2012-11-26T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
23190873,2012-11-26T00:00:00,Obesity,G07.100.100.160.120.699.500
23190873,2012-11-26T00:00:00,Risk Factors,E05.318.740.600.800.725
23190873,2012-11-26T00:00:00,Risk Factors,N05.715.350.200.700
23190873,2012-11-26T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23190873,2012-11-26T00:00:00,Risk Factors,N06.850.490.625.750
23190873,2012-11-26T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23190873,2012-11-26T00:00:00,Serpins,D12.644.822.750
23190873,2012-11-26T00:00:00,Serpins,D12.644.861
23190873,2012-11-26T00:00:00,Serpins,D12.776.645.750
23190873,2012-11-26T00:00:00,Serpins,D12.776.872
23190873,2012-11-26T00:00:00,Young Adult,M01.060.116.815
23188683,2012-11-27T00:00:00,Angiography,E01.370.350.700.060
23188683,2012-11-27T00:00:00,Angiography,E01.370.370.050
23188683,2012-11-27T00:00:00,Diagnostic Imaging,E01.370.350
23188683,2012-11-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23188683,2012-11-27T00:00:00,Klippel-Trenaunay-Weber Syndrome,C14.907.077.410
23188683,2012-11-27T00:00:00,Magnetic Resonance Angiography,E01.370.350.500.500
23188683,2012-11-27T00:00:00,Magnetic Resonance Angiography,E01.370.350.825.500.500
23188683,2012-11-27T00:00:00,Magnetic Resonance Angiography,E01.370.370.050.500
23188683,2012-11-27T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23188683,2012-11-27T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23188683,2012-11-27T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23188683,2012-11-27T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23188683,2012-11-27T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23188683,2012-11-27T00:00:00,Ultrasonography,E01.370.350.850
23188683,2012-11-27T00:00:00,Vascular Malformations,C14.240.850
23188683,2012-11-27T00:00:00,Vascular Malformations,C16.131.240.850
23188686,2012-11-27T00:00:00,Adult,M01.060.116
23188686,2012-11-27T00:00:00,Child,M01.060.406
23188686,2012-11-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23188686,2012-11-27T00:00:00,Laryngoscopy,E01.370.386.460
23188686,2012-11-27T00:00:00,Laryngoscopy,E01.370.388.250.525
23188686,2012-11-27T00:00:00,Laryngoscopy,E04.580.373
23188686,2012-11-27T00:00:00,Laryngoscopy,E04.800.250.525
23188686,2012-11-27T00:00:00,Magnetic Resonance Angiography,E01.370.350.500.500
23188686,2012-11-27T00:00:00,Magnetic Resonance Angiography,E01.370.350.825.500.500
23188686,2012-11-27T00:00:00,Magnetic Resonance Angiography,E01.370.370.050.500
23188686,2012-11-27T00:00:00,Vascular Malformations,C14.240.850
23188686,2012-11-27T00:00:00,Vascular Malformations,C16.131.240.850
23188686,2012-11-27T00:00:00,Vascular Neoplasms,C04.588.839.750
23188686,2012-11-27T00:00:00,Vascular Neoplasms,C14.907.936
23274197,2012-11-27T00:00:00,Biosensing Techniques,E05.601.123
23274197,2012-11-27T00:00:00,Crystallization,E05.196.300
23274197,2012-11-27T00:00:00,Crystallization,G02.149.767.505
23274197,2012-11-27T00:00:00,Crystallization,G02.842.750.505
23274197,2012-11-27T00:00:00,Equipment Failure Analysis,E05.325.192
23274197,2012-11-27T00:00:00,Homeodomain Proteins,D12.776.260.400
23274197,2012-11-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23274197,2012-11-27T00:00:00,Lung Neoplasms,C04.588.894.797.520
23274197,2012-11-27T00:00:00,Lung Neoplasms,C08.381.540
23274197,2012-11-27T00:00:00,Lung Neoplasms,C08.785.520
23274197,2012-11-27T00:00:00,Miniaturization,J01.897.520
23274197,2012-11-27T00:00:00,Refractometry,E05.196.808
23274197,2012-11-27T00:00:00,Refractometry,H01.671.617.755
23274197,2012-11-27T00:00:00,Transcription Factors,D12.776.930
23274197,2012-11-27T00:00:00,"Tumor Markers, Biological",D23.101.840
23373686,2012-11-27T00:00:00,Aged,M01.060.116.100
23373686,2012-11-27T00:00:00,Dementia,C10.228.140.380
23373686,2012-11-27T00:00:00,Dementia,F03.087.400
23373686,2012-11-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23373686,2012-11-27T00:00:00,Middle Aged,M01.060.116.630
23373686,2012-11-27T00:00:00,Neuropsychological Tests,F04.711.513
23373686,2012-11-27T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
23373686,2012-11-27T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
23373686,2012-11-27T00:00:00,Parkinson Disease,C10.228.140.079.862.500
23373686,2012-11-27T00:00:00,Parkinson Disease,C10.228.662.600.400
23373686,2012-11-27T00:00:00,Parkinson Disease,C10.574.812
23373686,2012-11-27T00:00:00,Psychiatric Status Rating Scales,F04.586
23188522,2012-11-28T00:00:00,Analgesics,D27.505.696.663.850.014
23188522,2012-11-28T00:00:00,Analgesics,D27.505.954.427.040
23188522,2012-11-28T00:00:00,Animals,B01.050
23188522,2012-11-28T00:00:00,Cauda Equina,A08.800.800.720.725.150
23188522,2012-11-28T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370
23188522,2012-11-28T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370
23188522,2012-11-28T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.230.202.370
23188522,2012-11-28T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
23188522,2012-11-28T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
23188522,2012-11-28T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
23188522,2012-11-28T00:00:00,"Microscopy, Electron, Transmission",E01.370.350.515.402.580
23188522,2012-11-28T00:00:00,"Microscopy, Electron, Transmission",E05.595.402.580
23188522,2012-11-28T00:00:00,Neuroprotective Agents,D27.505.696.706.548
23188522,2012-11-28T00:00:00,Neuroprotective Agents,D27.505.954.427.575
23188522,2012-11-28T00:00:00,Pain Measurement,E01.370.376.550.600
23188522,2012-11-28T00:00:00,Physical Stimulation,E05.723
23188522,2012-11-28T00:00:00,Postural Balance,G11.427.690
23188522,2012-11-28T00:00:00,Postural Balance,G11.561.600.810.541.595
23188522,2012-11-28T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23188522,2012-11-28T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
23188522,2012-11-28T00:00:00,Simvastatin,D02.455.426.559.847.638.400.900
23188522,2012-11-28T00:00:00,Simvastatin,D04.615.638.400.900
23188522,2012-11-28T00:00:00,Spinal Cord Compression,C10.228.854.761
23188522,2012-11-28T00:00:00,Spinal Cord Compression,C21.866.819.678
23188522,2012-11-28T00:00:00,Spinal Stenosis,C05.116.900.825
23079871,2012-11-29T00:00:00,Animals,B01.050
23079871,2012-11-29T00:00:00,"Antigens, CD44",D12.776.395.550.200.625.144
23079871,2012-11-29T00:00:00,"Antigens, CD44",D12.776.543.550.200.625.144
23079871,2012-11-29T00:00:00,"Antigens, CD44",D12.776.543.750.705.877.144
23079871,2012-11-29T00:00:00,"Antigens, CD44",D23.050.301.264.035.850.144
23079871,2012-11-29T00:00:00,"Antigens, CD44",D23.050.301.350.625.144
23079871,2012-11-29T00:00:00,"Antigens, CD44",D23.101.100.110.850.144
23079871,2012-11-29T00:00:00,CD4-Positive T-Lymphocytes,A11.118.637.555.567.569.200
23079871,2012-11-29T00:00:00,CD4-Positive T-Lymphocytes,A15.145.229.637.555.567.569.200
23079871,2012-11-29T00:00:00,CD4-Positive T-Lymphocytes,A15.382.490.555.567.569.200
23079871,2012-11-29T00:00:00,Disease Progression,C23.550.291.656
23079871,2012-11-29T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.114.703.300
23079871,2012-11-29T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.314.350.250
23079871,2012-11-29T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C20.111.258.625.300
23079871,2012-11-29T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",E05.598.500.500.500
23079871,2012-11-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23079871,2012-11-29T00:00:00,MicroRNAs,D13.150.650.319
23079871,2012-11-29T00:00:00,MicroRNAs,D13.444.735.150.319
23079871,2012-11-29T00:00:00,MicroRNAs,D13.444.735.790.099
23079871,2012-11-29T00:00:00,Multiple Sclerosis,C10.114.375.500
23079871,2012-11-29T00:00:00,Multiple Sclerosis,C10.314.350.500
23079871,2012-11-29T00:00:00,Multiple Sclerosis,C20.111.258.250.500
23204050,2012-11-29T00:00:00,Animals,B01.050
23204050,2012-11-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23204050,2012-11-29T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
23204050,2012-11-29T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
23192662,2012-11-30T00:00:00,Apoptosis,G04.299.139.160
23192662,2012-11-30T00:00:00,Cell Survival,G04.299.316
23192662,2012-11-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23192662,2012-11-30T00:00:00,MicroRNAs,D13.150.650.319
23192662,2012-11-30T00:00:00,MicroRNAs,D13.444.735.150.319
23192662,2012-11-30T00:00:00,MicroRNAs,D13.444.735.790.099
23192662,2012-11-30T00:00:00,Neuroblastoma,C04.557.465.625.600.590.650.550
23192662,2012-11-30T00:00:00,Neuroblastoma,C04.557.470.670.590.650.550
23192662,2012-11-30T00:00:00,Neuroblastoma,C04.557.580.625.600.590.650.550
23192662,2012-11-30T00:00:00,Treatment Outcome,E01.789.800
23192662,2012-11-30T00:00:00,Treatment Outcome,N04.761.559.590.800
23192662,2012-11-30T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23197224,2012-11-30T00:00:00,Adult,M01.060.116
23197224,2012-11-30T00:00:00,African Americans,M01.686.508.100.100
23197224,2012-11-30T00:00:00,African Americans,M01.686.754.100
23197224,2012-11-30T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
23197224,2012-11-30T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
23197224,2012-11-30T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
23197224,2012-11-30T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
23197224,2012-11-30T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
23197224,2012-11-30T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
23197224,2012-11-30T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
23197224,2012-11-30T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
23197224,2012-11-30T00:00:00,European Continental Ancestry Group,M01.686.508.400
23197224,2012-11-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23197224,2012-11-30T00:00:00,Incidence,E05.318.308.985.525.375
23197224,2012-11-30T00:00:00,Incidence,L01.280.975.525.375
23197224,2012-11-30T00:00:00,Incidence,N01.224.935.597.500
23197224,2012-11-30T00:00:00,Incidence,N06.850.505.400.975.525.375
23197224,2012-11-30T00:00:00,Incidence,N06.850.520.308.985.525.375
23197224,2012-11-30T00:00:00,Middle Aged,M01.060.116.630
23197224,2012-11-30T00:00:00,Risk Factors,E05.318.740.600.800.725
23197224,2012-11-30T00:00:00,Risk Factors,N05.715.350.200.700
23197224,2012-11-30T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23197224,2012-11-30T00:00:00,Risk Factors,N06.850.490.625.750
23197224,2012-11-30T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23197224,2012-11-30T00:00:00,South Carolina,Z01.107.567.875.075.662
23197224,2012-11-30T00:00:00,South Carolina,Z01.107.567.875.750.700
23245540,2012-11-30T00:00:00,Chlorine,D01.268.380.150
23245540,2012-11-30T00:00:00,Chlorine,D01.362.225
23245540,2012-11-30T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
23245540,2012-11-30T00:00:00,Water Purification,N06.850.780.200.800.800.900.900
23245540,2012-11-30T00:00:00,Water Purification,N06.850.860.510.900.900
23245540,2012-11-30T00:00:00,Water Purification,N06.850.860.510.915.900
22888069,2012-12-01T00:00:00,Adult,M01.060.116
22888069,2012-12-01T00:00:00,Aged,M01.060.116.100
22888069,2012-12-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.350.700.715.200.200
22888069,2012-12-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.200.200
22888069,2012-12-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.250.200
22888069,2012-12-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.388.250.250.160
22888069,2012-12-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.210.240.160
22888069,2012-12-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.800.250.250.160
22888069,2012-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22888069,2012-12-01T00:00:00,Liver Transplantation,E04.210.650
22888069,2012-12-01T00:00:00,Liver Transplantation,E04.936.450.490
22888069,2012-12-01T00:00:00,Liver Transplantation,E04.936.580.490
22888069,2012-12-01T00:00:00,Middle Aged,M01.060.116.630
22888069,2012-12-01T00:00:00,Patient Selection,E05.581.500.653
22888069,2012-12-01T00:00:00,Patient Selection,N04.590.731
22888069,2012-12-01T00:00:00,Physician's Practice Patterns,N04.590.748
22888069,2012-12-01T00:00:00,Physician's Practice Patterns,N05.300.625
22888069,2012-12-01T00:00:00,Questionnaires,E05.318.308.750
22888069,2012-12-01T00:00:00,Questionnaires,L01.280.800
22888069,2012-12-01T00:00:00,Questionnaires,N05.715.360.300.695
22888069,2012-12-01T00:00:00,Questionnaires,N06.850.520.308.750
22888069,2012-12-01T00:00:00,Risk Factors,E05.318.740.600.800.725
22888069,2012-12-01T00:00:00,Risk Factors,N05.715.350.200.700
22888069,2012-12-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22888069,2012-12-01T00:00:00,Risk Factors,N06.850.490.625.750
22888069,2012-12-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22949135,2012-12-01T00:00:00,Counseling,F02.784.176
22949135,2012-12-01T00:00:00,Counseling,F04.408.413
22949135,2012-12-01T00:00:00,Counseling,N02.421.143.303
22949135,2012-12-01T00:00:00,Counseling,N02.421.461.363
22949135,2012-12-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
22949135,2012-12-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
22949135,2012-12-01T00:00:00,Health Care Costs,N03.219.151.400
22949135,2012-12-01T00:00:00,Health Care Costs,N05.300.375
22949135,2012-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22949135,2012-12-01T00:00:00,Interpersonal Relations,F01.829.401
22949135,2012-12-01T00:00:00,Self Care,E02.900
22949135,2012-12-01T00:00:00,Self Care,N02.421.784.680
22949135,2012-12-01T00:00:00,Social Support,I01.880.656.600
22949135,2012-12-01T00:00:00,Treatment Outcome,E01.789.800
22949135,2012-12-01T00:00:00,Treatment Outcome,N04.761.559.590.800
22949135,2012-12-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22949135,2012-12-01T00:00:00,United States,Z01.107.567.875
23032478,2012-12-01T00:00:00,Aged,M01.060.116.100
23032478,2012-12-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
23032478,2012-12-01T00:00:00,Alzheimer Disease,C10.574.945.249
23032478,2012-12-01T00:00:00,Alzheimer Disease,F03.087.400.100
23032478,2012-12-01T00:00:00,Antidepressive Agents,D27.505.954.427.700.122
23032478,2012-12-01T00:00:00,Cognition,F02.463.188
23032478,2012-12-01T00:00:00,Depressive Disorder,F03.600.300
23032478,2012-12-01T00:00:00,Double-Blind Method,E05.318.780.300
23032478,2012-12-01T00:00:00,Double-Blind Method,E05.581.500.300
23032478,2012-12-01T00:00:00,Double-Blind Method,N05.715.360.780.320
23032478,2012-12-01T00:00:00,Double-Blind Method,N06.850.520.445.300
23032478,2012-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23032478,2012-12-01T00:00:00,Neuropsychological Tests,F04.711.513
23032478,2012-12-01T00:00:00,Sertraline,D02.092.705.800
23032478,2012-12-01T00:00:00,Sertraline,D02.455.426.559.847.638.845.800
23032478,2012-12-01T00:00:00,Sertraline,D04.615.638.845.800
23032478,2012-12-01T00:00:00,Treatment Outcome,E01.789.800
23032478,2012-12-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23032478,2012-12-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23054662,2012-12-01T00:00:00,Bariatric Surgery,E02.065.062
23054662,2012-12-01T00:00:00,Bariatric Surgery,E04.062
23054662,2012-12-01T00:00:00,Cardiovascular Diseases,C14
23054662,2012-12-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
23054662,2012-12-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
23054662,2012-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23054662,2012-12-01T00:00:00,Obesity,C18.654.726.500
23054662,2012-12-01T00:00:00,Obesity,C23.888.144.699.500
23054662,2012-12-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
23054662,2012-12-01T00:00:00,Obesity,G07.100.100.160.120.699.500
23054662,2012-12-01T00:00:00,Risk Factors,E05.318.740.600.800.725
23054662,2012-12-01T00:00:00,Risk Factors,N05.715.350.200.700
23054662,2012-12-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23054662,2012-12-01T00:00:00,Risk Factors,N06.850.490.625.750
23054662,2012-12-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23054662,2012-12-01T00:00:00,Weight Loss,C23.888.144.243.963
23054662,2012-12-01T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
23090453,2012-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23090453,2012-12-01T00:00:00,Pregnancy,G08.686.785.760.769
23090453,2012-12-01T00:00:00,"Pregnancy Complications, Infectious",C01.539.674
23090453,2012-12-01T00:00:00,"Pregnancy Complications, Infectious",C13.703.700
23090454,2012-12-01T00:00:00,Antibiotic Prophylaxis,E02.319.162.150
23090454,2012-12-01T00:00:00,Antibiotic Prophylaxis,E02.319.703.150
23090454,2012-12-01T00:00:00,Bacteremia,C01.252.100
23090454,2012-12-01T00:00:00,Bacteremia,C01.539.757.100
23090454,2012-12-01T00:00:00,Bacteremia,C23.550.470.790.500.100
23090454,2012-12-01T00:00:00,Diabetes Complications,C19.246.099
23090454,2012-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23090454,2012-12-01T00:00:00,Pregnancy,G08.686.785.760.769
23090454,2012-12-01T00:00:00,"Pregnancy Complications, Infectious",C01.539.674
23090454,2012-12-01T00:00:00,"Pregnancy Complications, Infectious",C13.703.700
23090454,2012-12-01T00:00:00,Sepsis,C01.539.757
23090454,2012-12-01T00:00:00,Sepsis,C23.550.470.790.500
23090454,2012-12-01T00:00:00,Surgical Wound Infection,C01.539.947.692
23090454,2012-12-01T00:00:00,Surgical Wound Infection,C23.550.767.925
23090455,2012-12-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
23090455,2012-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23090455,2012-12-01T00:00:00,Pregnancy,G08.686.785.760.769
23090455,2012-12-01T00:00:00,"Pregnancy Complications, Infectious",C01.539.674
23090455,2012-12-01T00:00:00,"Pregnancy Complications, Infectious",C13.703.700
23090455,2012-12-01T00:00:00,"Shock, Septic",C01.539.757.800
23090455,2012-12-01T00:00:00,"Shock, Septic",C23.550.470.790.500.800
23090455,2012-12-01T00:00:00,"Shock, Septic",C23.550.835.900.712
23090455,2012-12-01T00:00:00,Streptococcal Infections,C01.252.410.890
23090455,2012-12-01T00:00:00,Streptococcus pyogenes,B03.510.400.800.872.575
23090455,2012-12-01T00:00:00,Surgical Wound Infection,C01.539.947.692
23090455,2012-12-01T00:00:00,Surgical Wound Infection,C23.550.767.925
23090457,2012-12-01T00:00:00,"Abortion, Induced",E04.520.050
23090457,2012-12-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
23090457,2012-12-01T00:00:00,Clostridium Infections,C01.252.410.222
23090457,2012-12-01T00:00:00,Clostridium perfringens,B03.300.390.400.200.575
23090457,2012-12-01T00:00:00,Clostridium perfringens,B03.510.415.400.200.575
23090457,2012-12-01T00:00:00,Clostridium sordellii,B03.300.390.400.200.700
23090457,2012-12-01T00:00:00,Clostridium sordellii,B03.510.415.400.200.700
23090457,2012-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23090457,2012-12-01T00:00:00,United States,Z01.107.567.875
23090461,2012-12-01T00:00:00,AIDS-Related Opportunistic Infections,C01.539.597.050
23090461,2012-12-01T00:00:00,AIDS-Related Opportunistic Infections,C02.597.050
23090461,2012-12-01T00:00:00,AIDS-Related Opportunistic Infections,C02.782.815.616.400.100
23090461,2012-12-01T00:00:00,AIDS-Related Opportunistic Infections,C03.684.050
23090461,2012-12-01T00:00:00,AIDS-Related Opportunistic Infections,C20.673.480.100
23090461,2012-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23090461,2012-12-01T00:00:00,"Infectious Disease Transmission, Vertical",N06.850.310.425
23090461,2012-12-01T00:00:00,Pregnancy,G08.686.785.760.769
23090461,2012-12-01T00:00:00,"Pregnancy Complications, Infectious",C01.539.674
23090461,2012-12-01T00:00:00,"Pregnancy Complications, Infectious",C13.703.700
23090461,2012-12-01T00:00:00,Risk Factors,E05.318.740.600.800.725
23090461,2012-12-01T00:00:00,Risk Factors,N05.715.350.200.700
23090461,2012-12-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23090461,2012-12-01T00:00:00,Risk Factors,N06.850.490.625.750
23090461,2012-12-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23090461,2012-12-01T00:00:00,United States,Z01.107.567.875
23136997,2012-12-01T00:00:00,Animals,B01.050
23136997,2012-12-01T00:00:00,Cochlea,A09.246.631.246
23136997,2012-12-01T00:00:00,"Ear, Inner",A09.246.631
23136997,2012-12-01T00:00:00,Gene Expression Regulation,G05.355.315
23136997,2012-12-01T00:00:00,MicroRNAs,D13.150.650.319
23136997,2012-12-01T00:00:00,MicroRNAs,D13.444.735.150.319
23136997,2012-12-01T00:00:00,MicroRNAs,D13.444.735.790.099
23136997,2012-12-01T00:00:00,Neurons,A08.663
23136997,2012-12-01T00:00:00,Neurons,A11.671
23159253,2012-12-01T00:00:00,Adult,M01.060.116
23159253,2012-12-01T00:00:00,Breast Neoplasms,C04.588.180
23159253,2012-12-01T00:00:00,Breast Neoplasms,C17.800.090.500
23159253,2012-12-01T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
23159253,2012-12-01T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
23159253,2012-12-01T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
23159253,2012-12-01T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
23159253,2012-12-01T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
23159253,2012-12-01T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
23159253,2012-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23159253,2012-12-01T00:00:00,Mammography,E01.370.350.700.500
23159253,2012-12-01T00:00:00,Mass Screening,E01.370.500
23159253,2012-12-01T00:00:00,Mass Screening,E05.318.308.250.580
23159253,2012-12-01T00:00:00,Mass Screening,N02.421.143.827.233.443
23159253,2012-12-01T00:00:00,Mass Screening,N02.421.726.233.443
23159253,2012-12-01T00:00:00,Mass Screening,N05.715.360.300.375.500
23159253,2012-12-01T00:00:00,Mass Screening,N06.850.520.308.250.580
23159253,2012-12-01T00:00:00,Mass Screening,N06.850.780.500
23159253,2012-12-01T00:00:00,Middle Aged,M01.060.116.630
23159253,2012-12-01T00:00:00,Physician's Practice Patterns,N04.590.748
23159253,2012-12-01T00:00:00,Physician's Practice Patterns,N05.300.625
23159253,2012-12-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
23159253,2012-12-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
23159253,2012-12-01T00:00:00,Primary Health Care,N04.590.233.727
23159253,2012-12-01T00:00:00,United States,Z01.107.567.875
23159254,2012-12-01T00:00:00,Adolescent,M01.060.057
23159254,2012-12-01T00:00:00,Adult,M01.060.116
23159254,2012-12-01T00:00:00,Health Literacy,I02.233.332.186.500
23159254,2012-12-01T00:00:00,Health Literacy,N02.421.143.827.407.228.500
23159254,2012-12-01T00:00:00,Health Literacy,N02.421.726.407.228.500
23159254,2012-12-01T00:00:00,Health Policy,I01.880.604.825.608.400
23159254,2012-12-01T00:00:00,Health Policy,N03.706.825.608.428
23159254,2012-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23159254,2012-12-01T00:00:00,Middle Aged,M01.060.116.630
23159254,2012-12-01T00:00:00,Smoking,F01.145.466.753
23159254,2012-12-01T00:00:00,United States,Z01.107.567.875
23159254,2012-12-01T00:00:00,Young Adult,M01.060.116.815
23174689,2012-12-01T00:00:00,Aged,M01.060.116.100
23174689,2012-12-01T00:00:00,Antioxidants,D27.505.519.217
23174689,2012-12-01T00:00:00,Antioxidants,D27.505.696.706.125
23174689,2012-12-01T00:00:00,Antioxidants,D27.720.799.047
23174689,2012-12-01T00:00:00,Case-Control Studies,E05.318.760.500.500
23174689,2012-12-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
23174689,2012-12-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
23174689,2012-12-01T00:00:00,Depression,F01.145.126.350
23174689,2012-12-01T00:00:00,Diet,E05.272
23174689,2012-12-01T00:00:00,Diet,G07.610.240
23174689,2012-12-01T00:00:00,Dietary Supplements,J02.500.456
23174689,2012-12-01T00:00:00,Fruit,A18.024.500
23174689,2012-12-01T00:00:00,Fruit,J02.500.562
23174689,2012-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23174689,2012-12-01T00:00:00,Middle Aged,M01.060.116.630
23176901,2012-12-01T00:00:00,Aortic Valve Stenosis,C14.280.484.150
23176901,2012-12-01T00:00:00,Aortic Valve Stenosis,C14.280.955.249
23176901,2012-12-01T00:00:00,"Ethics, Medical",K01.316.333.132.750
23176901,2012-12-01T00:00:00,"Ethics, Medical",N05.350.340.162.500
23176901,2012-12-01T00:00:00,Heart Valve Prosthesis Implantation,E04.100.376.485
23176901,2012-12-01T00:00:00,Heart Valve Prosthesis Implantation,E04.650.410
23176901,2012-12-01T00:00:00,Heart Valve Prosthesis Implantation,E04.928.220.410
23176901,2012-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23176920,2012-12-01T00:00:00,"Biopsy, Fine-Needle",E01.370.388.100.100.500
23176920,2012-12-01T00:00:00,"Biopsy, Fine-Needle",E01.450.230.100.100.500
23176920,2012-12-01T00:00:00,"Biopsy, Fine-Needle",E01.450.865.100.100.500
23176920,2012-12-01T00:00:00,"Biopsy, Fine-Needle",E04.074.119.500
23176920,2012-12-01T00:00:00,Bronchoscopy,E01.370.386.105
23176920,2012-12-01T00:00:00,Bronchoscopy,E01.370.388.250.100
23176920,2012-12-01T00:00:00,Bronchoscopy,E04.800.250.100
23176920,2012-12-01T00:00:00,Bronchoscopy,E04.928.600.080
23176920,2012-12-01T00:00:00,Endosonography,E01.370.350.850.280
23176920,2012-12-01T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
23176920,2012-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23176920,2012-12-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
23176920,2012-12-01T00:00:00,Lung Neoplasms,C08.381.540
23176920,2012-12-01T00:00:00,Lung Neoplasms,C08.785.520
23176920,2012-12-01T00:00:00,Lymph Nodes,A10.549.400
23176920,2012-12-01T00:00:00,Lymph Nodes,A15.382.520.604.412
23176920,2012-12-01T00:00:00,"RNA, Messenger",D13.444.735.544
23176932,2012-12-01T00:00:00,Aged,M01.060.116.100
23176932,2012-12-01T00:00:00,Atrial Fibrillation,C14.280.067.198
23176932,2012-12-01T00:00:00,Atrial Fibrillation,C23.550.073.198
23176932,2012-12-01T00:00:00,Device Removal,E04.199
23176932,2012-12-01T00:00:00,"Diagnosis, Differential",E01.171
23176932,2012-12-01T00:00:00,Echocardiography,E01.370.350.850.220
23176932,2012-12-01T00:00:00,Echocardiography,E01.370.370.380.220
23176932,2012-12-01T00:00:00,"Foramen Ovale, Patent",C14.240.400.560.375.258
23176932,2012-12-01T00:00:00,"Foramen Ovale, Patent",C14.280.400.560.375.258
23176932,2012-12-01T00:00:00,"Foramen Ovale, Patent",C16.131.240.400.560.375.258
23176932,2012-12-01T00:00:00,Foreign-Body Migration,C21.866.392.500
23176932,2012-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23176932,2012-12-01T00:00:00,Mitral Valve,A07.541.510.507
23176932,2012-12-01T00:00:00,"Pacemaker, Artificial",E07.858.082.748
23176932,2012-12-01T00:00:00,"Radiography, Thoracic",E01.370.350.700.730
23176959,2012-12-01T00:00:00,"Abnormalities, Multiple",C16.131.077
23176959,2012-12-01T00:00:00,Blood Vessel Prosthesis,E07.695.110
23176959,2012-12-01T00:00:00,Cardiac Surgical Procedures,E04.100.376
23176959,2012-12-01T00:00:00,Cardiac Surgical Procedures,E04.928.220
23176959,2012-12-01T00:00:00,"Diagnosis, Differential",E01.171
23176959,2012-12-01T00:00:00,Echocardiography,E01.370.350.850.220
23176959,2012-12-01T00:00:00,Echocardiography,E01.370.370.380.220
23176959,2012-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23176959,2012-12-01T00:00:00,"Infant, Newborn",M01.060.703.520
23176959,2012-12-01T00:00:00,Prosthesis Design,E05.320.550
23176959,2012-12-01T00:00:00,Prosthesis Design,E07.695.680
23176959,2012-12-01T00:00:00,Pulmonary Artery,A07.231.114.715
23176959,2012-12-01T00:00:00,Suture Techniques,E04.901
23187056,2012-12-01T00:00:00,Activities of Daily Living,E02.831.067
23187056,2012-12-01T00:00:00,Activities of Daily Living,I03.050
23187056,2012-12-01T00:00:00,Activities of Daily Living,N02.421.784.110
23187056,2012-12-01T00:00:00,Analgesics,D27.505.696.663.850.014
23187056,2012-12-01T00:00:00,Analgesics,D27.505.954.427.040
23187056,2012-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23187056,2012-12-01T00:00:00,Liver Transplantation,E04.210.650
23187056,2012-12-01T00:00:00,Liver Transplantation,E04.936.450.490
23187056,2012-12-01T00:00:00,Liver Transplantation,E04.936.580.490
23187056,2012-12-01T00:00:00,Middle Aged,M01.060.116.630
23187056,2012-12-01T00:00:00,Pain Measurement,E01.370.376.550.600
23187995,2012-12-01T00:00:00,"Child, Preschool",M01.060.406.448
23187995,2012-12-01T00:00:00,Emergencies,C23.550.291.781
23187995,2012-12-01T00:00:00,Emergencies,N06.230.100.083
23187995,2012-12-01T00:00:00,Emergencies,N06.850.376
23187995,2012-12-01T00:00:00,Emergency Medical Services,N02.421.297
23187995,2012-12-01T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
23187995,2012-12-01T00:00:00,"Emergency Service, Hospital",N02.421.297.195
23187995,2012-12-01T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
23187995,2012-12-01T00:00:00,"Hospitals, Pediatric",N02.278.421.556.437
23187995,2012-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23187995,2012-12-01T00:00:00,Infant,M01.060.703
23187995,2012-12-01T00:00:00,Physicians,M01.526.485.810
23187995,2012-12-01T00:00:00,Physicians,N02.360.810
23187995,2012-12-01T00:00:00,Poison Control Centers,N02.278.726
23187995,2012-12-01T00:00:00,Poison Control Centers,N02.421.297.695
23187995,2012-12-01T00:00:00,Poisoning,C21.613
23187995,2012-12-01T00:00:00,Referral and Consultation,N04.452.758.849
23187995,2012-12-01T00:00:00,Transportation of Patients,E02.365.839
23187995,2012-12-01T00:00:00,Transportation of Patients,N02.421.297.879
23187995,2012-12-01T00:00:00,Triage,N02.421.297.900
23208335,2012-12-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
23208335,2012-12-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
23208335,2012-12-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
23208335,2012-12-01T00:00:00,Catheter Ablation,E01.370.370.380.410.200
23208335,2012-12-01T00:00:00,Catheter Ablation,E02.148.110
23208335,2012-12-01T00:00:00,Catheter Ablation,E02.148.442.110
23208335,2012-12-01T00:00:00,Catheter Ablation,E02.154.402.110
23208335,2012-12-01T00:00:00,Catheter Ablation,E04.014.170.402.110
23208335,2012-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23208335,2012-12-01T00:00:00,Neoplasm Staging,E01.370.550
23208335,2012-12-01T00:00:00,Pneumonectomy,E04.928.600.600
23208335,2012-12-01T00:00:00,Radiosurgery,E02.815.530
23208335,2012-12-01T00:00:00,Radiosurgery,E04.525.800.650
23208335,2012-12-01T00:00:00,Radiosurgery,E05.873.500
23208335,2012-12-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
23208335,2012-12-01T00:00:00,Risk Assessment,N04.452.871.715
23208335,2012-12-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
23208335,2012-12-01T00:00:00,Risk Assessment,N06.850.505.715
23208335,2012-12-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
23208335,2012-12-01T00:00:00,United States,Z01.107.567.875
23208336,2012-12-01T00:00:00,Bronchoscopy,E01.370.386.105
23208336,2012-12-01T00:00:00,Bronchoscopy,E01.370.388.250.100
23208336,2012-12-01T00:00:00,Bronchoscopy,E04.800.250.100
23208336,2012-12-01T00:00:00,Bronchoscopy,E04.928.600.080
23208336,2012-12-01T00:00:00,Endoscopy,E01.370.388.250
23208336,2012-12-01T00:00:00,Endoscopy,E04.800.250
23208336,2012-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23208336,2012-12-01T00:00:00,Lung Diseases,C08.381
23208336,2012-12-01T00:00:00,Pneumonectomy,E04.928.600.600
23208336,2012-12-01T00:00:00,Ultrasonography,E01.370.350.850
23208348,2012-12-01T00:00:00,Asthma,C08.127.108
23208348,2012-12-01T00:00:00,Asthma,C08.381.495.108
23208348,2012-12-01T00:00:00,Asthma,C08.674.095
23208348,2012-12-01T00:00:00,Asthma,C20.543.480.680.095
23208348,2012-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23208348,2012-12-01T00:00:00,Patient Satisfaction,N04.452.822.360.600
23208348,2012-12-01T00:00:00,Patient Satisfaction,N05.300.150.600.630
23208348,2012-12-01T00:00:00,Patient Satisfaction,N05.715.360.600
23208348,2012-12-01T00:00:00,Self Care,E02.900
23208348,2012-12-01T00:00:00,Self Care,N02.421.784.680
23228870,2012-12-01T00:00:00,Cardiac Output,E01.370.370.380.150
23228870,2012-12-01T00:00:00,Cardiac Output,G09.330.380.124
23228870,2012-12-01T00:00:00,"Cardiac Pacing, Artificial",E02.145
23228870,2012-12-01T00:00:00,Decision Making,F02.463.785.373
23228870,2012-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23228870,2012-12-01T00:00:00,Intracranial Aneurysm,C10.228.140.300.510.600
23228870,2012-12-01T00:00:00,Intracranial Aneurysm,C14.907.055.635
23228870,2012-12-01T00:00:00,Intracranial Aneurysm,C14.907.253.560.300
23228870,2012-12-01T00:00:00,Middle Aged,M01.060.116.630
23228873,2012-12-01T00:00:00,Aged,M01.060.116.100
23228873,2012-12-01T00:00:00,"Anesthesia, General",E03.155.197
23228873,2012-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23228873,2012-12-01T00:00:00,"Intubation, Intratracheal",E05.497.578
23228873,2012-12-01T00:00:00,Laryngoscopes,E07.230.220.525
23228873,2012-12-01T00:00:00,Laryngoscopes,E07.858.240.525
23228873,2012-12-01T00:00:00,Laryngoscopy,E01.370.386.460
23228873,2012-12-01T00:00:00,Laryngoscopy,E01.370.388.250.525
23228873,2012-12-01T00:00:00,Laryngoscopy,E04.580.373
23228873,2012-12-01T00:00:00,Laryngoscopy,E04.800.250.525
23228873,2012-12-01T00:00:00,Video Recording,L01.240.960
23250889,2012-12-01T00:00:00,Acoustic Stimulation,E02.037
23250889,2012-12-01T00:00:00,Acoustic Stimulation,E02.190.888.030
23250889,2012-12-01T00:00:00,Acoustic Stimulation,E05.723.136
23250889,2012-12-01T00:00:00,Aged,M01.060.116.100
23250889,2012-12-01T00:00:00,Brain Mapping,E01.370.350.086
23250889,2012-12-01T00:00:00,Brain Mapping,E01.370.376.149
23250889,2012-12-01T00:00:00,Brain Mapping,E05.132
23250889,2012-12-01T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
23250889,2012-12-01T00:00:00,Functional Laterality,F02.830.297.425
23250889,2012-12-01T00:00:00,Functional Laterality,G11.561.225.425
23250889,2012-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23250889,2012-12-01T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
23250889,2012-12-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
23250889,2012-12-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
23250889,2012-12-01T00:00:00,Middle Aged,M01.060.116.630
23250889,2012-12-01T00:00:00,Oxygen,D01.268.185.550
23250889,2012-12-01T00:00:00,Oxygen,D01.362.670
23250889,2012-12-01T00:00:00,Photic Stimulation,E05.723.729
23250889,2012-12-01T00:00:00,Stroke,C10.228.140.300.775
23250889,2012-12-01T00:00:00,Stroke,C14.907.253.855
23254618,2012-12-01T00:00:00,Child,M01.060.406
23254618,2012-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23254618,2012-12-01T00:00:00,Laryngomalacia,C05.182.310
23254618,2012-12-01T00:00:00,Laryngomalacia,C08.360.563
23254618,2012-12-01T00:00:00,Laryngomalacia,C09.400.563
23254618,2012-12-01T00:00:00,Laryngomalacia,C16.131.621.568
23254618,2012-12-01T00:00:00,Laryngomalacia,C17.300.182.310
23254618,2012-12-01T00:00:00,Treatment Outcome,E01.789.800
23254618,2012-12-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23254618,2012-12-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23331602,2012-12-01T00:00:00,Child,M01.060.406
23331602,2012-12-01T00:00:00,"Child, Preschool",M01.060.406.448
23331602,2012-12-01T00:00:00,Extracorporeal Membrane Oxygenation,E02.880.301
23331602,2012-12-01T00:00:00,Extracorporeal Membrane Oxygenation,E04.292.451
23331602,2012-12-01T00:00:00,"Heart Defects, Congenital",C14.240.400
23331602,2012-12-01T00:00:00,"Heart Defects, Congenital",C14.280.400
23331602,2012-12-01T00:00:00,"Heart Defects, Congenital",C16.131.240.400
23331602,2012-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23331602,2012-12-01T00:00:00,Infant,M01.060.703
23331602,2012-12-01T00:00:00,"Infant, Newborn",M01.060.703.520
23331602,2012-12-01T00:00:00,Patient Selection,E05.581.500.653
23331602,2012-12-01T00:00:00,Patient Selection,N04.590.731
23408212,2012-12-01T00:00:00,"Adaptation, Physiological",G07.700.062
23408212,2012-12-01T00:00:00,"Adaptation, Physiological",G16.100.057.500
23408212,2012-12-01T00:00:00,Aged,M01.060.116.100
23408212,2012-12-01T00:00:00,Case-Control Studies,E05.318.760.500.500
23408212,2012-12-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
23408212,2012-12-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
23408212,2012-12-01T00:00:00,"Gait Disorders, Neurologic",C10.597.404
23408212,2012-12-01T00:00:00,"Gait Disorders, Neurologic",C23.888.592.413
23408212,2012-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23408212,2012-12-01T00:00:00,Lower Extremity,A01.378.610
23408212,2012-12-01T00:00:00,Middle Aged,M01.060.116.630
23408212,2012-12-01T00:00:00,Paresis,C10.597.636
23408212,2012-12-01T00:00:00,Paresis,C23.888.592.643
23408212,2012-12-01T00:00:00,Stroke,C10.228.140.300.775
23408212,2012-12-01T00:00:00,Stroke,C14.907.253.855
23408212,2012-12-01T00:00:00,Video Recording,L01.240.960
23408212,2012-12-01T00:00:00,Walking,G11.427.590.530.568.900
23408212,2012-12-01T00:00:00,Walking,G11.427.590.530.698.940
23408212,2012-12-01T00:00:00,Walking,I03.450.642.845.940
23408212,2012-12-01T00:00:00,Weight-Bearing,G01.374.676.965
23408212,2012-12-01T00:00:00,Weight-Bearing,G01.595.540.965
23441563,2012-12-01T00:00:00,Child,M01.060.406
23441563,2012-12-01T00:00:00,"Child, Preschool",M01.060.406.448
23441563,2012-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23441563,2012-12-01T00:00:00,Hypoplastic Left Heart Syndrome,C14.240.400.625
23441563,2012-12-01T00:00:00,Hypoplastic Left Heart Syndrome,C14.280.400.625
23441563,2012-12-01T00:00:00,Hypoplastic Left Heart Syndrome,C16.131.240.400.625
23441563,2012-12-01T00:00:00,Infant,M01.060.703
23441563,2012-12-01T00:00:00,Treatment Outcome,E01.789.800
23441563,2012-12-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23441563,2012-12-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23205743,2012-12-03T00:00:00,Aged,M01.060.116.100
23205743,2012-12-03T00:00:00,Chronic Disease,C23.550.291.500
23205743,2012-12-03T00:00:00,Hospital Mortality,E05.318.308.985.550.400
23205743,2012-12-03T00:00:00,Hospital Mortality,L01.280.975.550.400
23205743,2012-12-03T00:00:00,Hospital Mortality,N01.224.935.698.400
23205743,2012-12-03T00:00:00,Hospital Mortality,N06.850.505.400.975.550.400
23205743,2012-12-03T00:00:00,Hospital Mortality,N06.850.520.308.985.550.400
23205743,2012-12-03T00:00:00,Hospitals,N02.278.421
23205743,2012-12-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23205743,2012-12-03T00:00:00,Length of Stay,E02.760.400.480
23205743,2012-12-03T00:00:00,Length of Stay,N02.421.585.400.480
23205743,2012-12-03T00:00:00,Medicare,N03.219.521.346.506.564.663
23205743,2012-12-03T00:00:00,Medicare,N03.219.521.576.343.840
23205743,2012-12-03T00:00:00,Medicare,N03.706.615.696
23205743,2012-12-03T00:00:00,Nutrition Surveys,E05.318.308.250.600
23205743,2012-12-03T00:00:00,Nutrition Surveys,E05.318.308.585.550
23205743,2012-12-03T00:00:00,Nutrition Surveys,N05.715.360.300.375.560
23205743,2012-12-03T00:00:00,Nutrition Surveys,N05.715.360.300.560.565
23205743,2012-12-03T00:00:00,Nutrition Surveys,N06.850.520.308.250.600
23205743,2012-12-03T00:00:00,Nutrition Surveys,N06.850.520.308.585.550
23205743,2012-12-03T00:00:00,Transferrin,D12.776.124.050.800
23205743,2012-12-03T00:00:00,Transferrin,D12.776.124.790.223.839
23205743,2012-12-03T00:00:00,Transferrin,D12.776.157.427.500
23205743,2012-12-03T00:00:00,Transferrin,D12.776.377.715.182.839
23205743,2012-12-03T00:00:00,Transferrin,D12.776.556.579.500
23205743,2012-12-03T00:00:00,United States,Z01.107.567.875
23262726,2012-12-03T00:00:00,Fiber Optic Technology,H01.671.617.249
23262726,2012-12-03T00:00:00,"Models, Theoretical",E05.599
23262726,2012-12-03T00:00:00,Optical Fibers,E07.632.750
23262726,2012-12-03T00:00:00,Photons,G01.201.875.770.578.782
23262726,2012-12-03T00:00:00,Photons,G01.249.705
23262726,2012-12-03T00:00:00,Photons,G01.590.540.782
23262726,2012-12-03T00:00:00,"Scattering, Radiation",E05.196.822
23262726,2012-12-03T00:00:00,"Scattering, Radiation",G01.595.861
23210764,2012-12-04T00:00:00,Aged,M01.060.116.100
23210764,2012-12-04T00:00:00,Algorithms,G17.035
23210764,2012-12-04T00:00:00,Algorithms,L01.224.050
23210764,2012-12-04T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
23210764,2012-12-04T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
23210764,2012-12-04T00:00:00,"Defibrillators, Implantable",E07.695.175
23210764,2012-12-04T00:00:00,Electric Countershock,E02.342.287
23210764,2012-12-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23210764,2012-12-04T00:00:00,Materials Testing,E05.570
23210764,2012-12-04T00:00:00,Middle Aged,M01.060.116.630
23210764,2012-12-04T00:00:00,"Signal Processing, Computer-Assisted",L01.224.800
23210764,2012-12-04T00:00:00,Stroke Volume,E01.370.370.380.150.700
23210764,2012-12-04T00:00:00,Stroke Volume,G09.330.380.124.882
23210764,2012-12-04T00:00:00,Time Factors,G01.910.857
23210764,2012-12-04T00:00:00,Treatment Outcome,E01.789.800
23210764,2012-12-04T00:00:00,Treatment Outcome,N04.761.559.590.800
23210764,2012-12-04T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23210764,2012-12-04T00:00:00,United States,Z01.107.567.875
23210764,2012-12-04T00:00:00,Ventricular Fibrillation,C14.280.067.922
23210764,2012-12-04T00:00:00,Ventricular Fibrillation,C23.550.073.922
23210764,2012-12-04T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
23212907,2012-12-04T00:00:00,Animals,B01.050
23212907,2012-12-04T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D08.811.277.040.330.300.200.100.200
23212907,2012-12-04T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.644.360.375.100.200
23212907,2012-12-04T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.776.157.325.332.100.200
23212907,2012-12-04T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.776.476.375.100.200
23212907,2012-12-04T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.776.543.325.100.200
23212907,2012-12-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23212907,2012-12-04T00:00:00,Neurons,A08.663
23212907,2012-12-04T00:00:00,Neurons,A11.671
23212907,2012-12-04T00:00:00,RGS Proteins,D12.644.360.325.150.750
23212907,2012-12-04T00:00:00,RGS Proteins,D12.776.402.150.750
23212907,2012-12-04T00:00:00,RGS Proteins,D12.776.476.325.150.750
23212907,2012-12-04T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
23212907,2012-12-04T00:00:00,Signal Transduction,G02.111.087.800
23212907,2012-12-04T00:00:00,Signal Transduction,G02.149.115.800
23212907,2012-12-04T00:00:00,Signal Transduction,G04.299.880
23212907,2012-12-04T00:00:00,Vesicular Transport Proteins,D12.776.543.990
23226108,2012-12-04T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
23226108,2012-12-04T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
23226108,2012-12-04T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
23226108,2012-12-04T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
23226108,2012-12-04T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
23226108,2012-12-04T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
23226108,2012-12-04T00:00:00,Early Detection of Cancer,E01.390.500
23226108,2012-12-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23226108,2012-12-04T00:00:00,Incidence,E05.318.308.985.525.375
23226108,2012-12-04T00:00:00,Incidence,L01.280.975.525.375
23226108,2012-12-04T00:00:00,Incidence,N01.224.935.597.500
23226108,2012-12-04T00:00:00,Incidence,N06.850.505.400.975.525.375
23226108,2012-12-04T00:00:00,Incidence,N06.850.520.308.985.525.375
23226108,2012-12-04T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
23226108,2012-12-04T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
23226108,2012-12-04T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
23226108,2012-12-04T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
23226108,2012-12-04T00:00:00,Sigmoidoscopy,E01.370.372.250.250.200.700
23226108,2012-12-04T00:00:00,Sigmoidoscopy,E01.370.388.250.250.250.160.800
23226108,2012-12-04T00:00:00,Sigmoidoscopy,E04.210.240.250.160.800
23226108,2012-12-04T00:00:00,Sigmoidoscopy,E04.800.250.250.250.160.800
23217202,2012-12-05T00:00:00,Computational Biology,H01.158.273.180
23217202,2012-12-05T00:00:00,"Models, Molecular",E05.599.595
23217202,2012-12-05T00:00:00,Nanotechnology,H01.603
23217202,2012-12-05T00:00:00,Nanotechnology,J01.897.520.600
23217202,2012-12-05T00:00:00,Proteins,D12.776
23217202,2012-12-05T00:00:00,Software,L01.224.900
23217202,2012-12-05T00:00:00,Solvents,D27.720.844
23217202,2012-12-05T00:00:00,Static Electricity,G01.201.249.820
23217260,2012-12-05T00:00:00,Animals,B01.050
23217260,2012-12-05T00:00:00,Cell Differentiation,G04.299.151
23217260,2012-12-05T00:00:00,DNA-Binding Proteins,D12.776.260
23217260,2012-12-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23217260,2012-12-05T00:00:00,Insulin,D06.472.699.587.740.625
23217260,2012-12-05T00:00:00,Insulin,D12.644.548.586.740.625
23217260,2012-12-05T00:00:00,Obesity,C18.654.726.500
23217260,2012-12-05T00:00:00,Obesity,C23.888.144.699.500
23217260,2012-12-05T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
23217260,2012-12-05T00:00:00,Obesity,G07.100.100.160.120.699.500
23217260,2012-12-05T00:00:00,Transcription Factors,D12.776.930
23217260,2012-12-05T00:00:00,Weight Loss,C23.888.144.243.963
23217260,2012-12-05T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
23220082,2012-12-05T00:00:00,Age Factors,N05.715.350.075
23220082,2012-12-05T00:00:00,Age Factors,N06.850.490.250
23220082,2012-12-05T00:00:00,Aged,M01.060.116.100
23220082,2012-12-05T00:00:00,Chronic Disease,C23.550.291.500
23220082,2012-12-05T00:00:00,"Gait Disorders, Neurologic",C10.597.404
23220082,2012-12-05T00:00:00,"Gait Disorders, Neurologic",C23.888.592.413
23220082,2012-12-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23220082,2012-12-05T00:00:00,Lower Extremity,A01.378.610
23220082,2012-12-05T00:00:00,Middle Aged,M01.060.116.630
23220082,2012-12-05T00:00:00,Physical Endurance,G11.427.680
23220082,2012-12-05T00:00:00,Physical Endurance,I03.450.642.845.054.600
23220082,2012-12-05T00:00:00,Postural Balance,G11.427.690
23220082,2012-12-05T00:00:00,Postural Balance,G11.561.600.810.541.595
23220082,2012-12-05T00:00:00,Stroke,C10.228.140.300.775
23220082,2012-12-05T00:00:00,Stroke,C14.907.253.855
23220082,2012-12-05T00:00:00,Task Performance and Analysis,F02.784.412.846
23220082,2012-12-05T00:00:00,Task Performance and Analysis,F02.784.692.746
23220082,2012-12-05T00:00:00,Task Performance and Analysis,F02.808.600
23220082,2012-12-05T00:00:00,Time Factors,G01.910.857
23220082,2012-12-05T00:00:00,Walking,G11.427.590.530.568.900
23220082,2012-12-05T00:00:00,Walking,G11.427.590.530.698.940
23220082,2012-12-05T00:00:00,Walking,I03.450.642.845.940
23220430,2012-12-05T00:00:00,Adult,M01.060.116
23220430,2012-12-05T00:00:00,Artifacts,E05.047
23220430,2012-12-05T00:00:00,Brain,A08.186.211
23220430,2012-12-05T00:00:00,Brain Mapping,E01.370.350.086
23220430,2012-12-05T00:00:00,Brain Mapping,E01.370.376.149
23220430,2012-12-05T00:00:00,Brain Mapping,E05.132
23220430,2012-12-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23220430,2012-12-05T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
23220430,2012-12-05T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
23220430,2012-12-05T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
23220430,2012-12-05T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
23220430,2012-12-05T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
23220430,2012-12-05T00:00:00,Young Adult,M01.060.116.815
23223297,2012-12-05T00:00:00,Animals,B01.050
23223297,2012-12-05T00:00:00,Astrocytes,A08.637.200
23223297,2012-12-05T00:00:00,Astrocytes,A11.650.200
23223297,2012-12-05T00:00:00,Cell Survival,G04.299.316
23223297,2012-12-05T00:00:00,Central Nervous System,A08.186
23223297,2012-12-05T00:00:00,"Disease Models, Animal",C22.232
23223297,2012-12-05T00:00:00,"Disease Models, Animal",E05.598.500
23223297,2012-12-05T00:00:00,"Disease Models, Animal",E05.599.395.080
23223297,2012-12-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23223297,2012-12-05T00:00:00,Motor Neurons,A08.663.655.500
23223297,2012-12-05T00:00:00,Motor Neurons,A11.671.655.500
23223297,2012-12-05T00:00:00,NF-E2-Related Factor 2,D12.776.260.108.737
23223297,2012-12-05T00:00:00,NF-E2-Related Factor 2,D12.776.930.127.737
23223297,2012-12-05T00:00:00,Neuroprotective Agents,D27.505.696.706.548
23223297,2012-12-05T00:00:00,Neuroprotective Agents,D27.505.954.427.575
23223297,2012-12-05T00:00:00,Oxidative Stress,G03.495.710
23223297,2012-12-05T00:00:00,Oxidative Stress,G07.700.830.750
23223297,2012-12-05T00:00:00,Parkinson Disease,C10.228.140.079.862.500
23223297,2012-12-05T00:00:00,Parkinson Disease,C10.228.662.600.400
23223297,2012-12-05T00:00:00,Parkinson Disease,C10.574.812
23223297,2012-12-05T00:00:00,Phosphorylation,G02.111.087.677
23223297,2012-12-05T00:00:00,Phosphorylation,G02.149.115.677
23223297,2012-12-05T00:00:00,Phosphorylation,G02.149.465.700
23223297,2012-12-05T00:00:00,Phosphorylation,G02.607.750.700
23223297,2012-12-05T00:00:00,Phosphorylation,G03.495.790
23223297,2012-12-05T00:00:00,alpha-Synuclein,D12.776.641.860.500
23227162,2012-12-05T00:00:00,Animals,B01.050
23227162,2012-12-05T00:00:00,Blood Glucose,D09.546.359.448.500
23227162,2012-12-05T00:00:00,Major Histocompatibility Complex,G05.360.340.024.340.610
23227162,2012-12-05T00:00:00,Major Histocompatibility Complex,G05.360.340.024.380.500
23227162,2012-12-05T00:00:00,Major Histocompatibility Complex,G12.500.500
23227162,2012-12-05T00:00:00,"Mice, Inbred DBA",B01.050.050.157.520.460
23227162,2012-12-05T00:00:00,"Mice, Inbred DBA",B01.050.050.199.520.520.460
23227162,2012-12-05T00:00:00,"Mice, Inbred DBA",B01.050.150.900.649.865.635.505.500.400.460
23227162,2012-12-05T00:00:00,Nanomedicine,H01.603.600
23227162,2012-12-05T00:00:00,Nanomedicine,J01.897.115.625
23227162,2012-12-05T00:00:00,Nanomedicine,J01.897.520.600.600
23227162,2012-12-05T00:00:00,Pancreas Transplantation,E04.210.725
23227162,2012-12-05T00:00:00,Pancreas Transplantation,E04.936.450.650
23227162,2012-12-05T00:00:00,Polyethylene Glycols,D02.033.455.250.700
23227162,2012-12-05T00:00:00,Polyethylene Glycols,D05.750.741
23227162,2012-12-05T00:00:00,Polyethylene Glycols,D25.720.741
23227162,2012-12-05T00:00:00,Polyethylene Glycols,J01.637.051.720.741
23220550,2012-12-07T00:00:00,African Americans,M01.686.508.100.100
23220550,2012-12-07T00:00:00,African Americans,M01.686.754.100
23220550,2012-12-07T00:00:00,Cholecalciferol,D04.808.247.222.159
23220550,2012-12-07T00:00:00,Cholecalciferol,D04.808.247.808.146
23220550,2012-12-07T00:00:00,Cholecalciferol,D04.808.812.768.196
23220550,2012-12-07T00:00:00,Cholecalciferol,D10.570.938.146
23220550,2012-12-07T00:00:00,Clinical Trials as Topic,E05.318.760.535
23220550,2012-12-07T00:00:00,Clinical Trials as Topic,E05.337.250
23220550,2012-12-07T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
23220550,2012-12-07T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
23220550,2012-12-07T00:00:00,Dietary Supplements,J02.500.456
23220550,2012-12-07T00:00:00,Healthcare Disparities,N04.590.374.380
23220550,2012-12-07T00:00:00,Healthcare Disparities,N05.300.493
23220550,2012-12-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23220550,2012-12-07T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
23220550,2012-12-07T00:00:00,Prostatic Neoplasms,C12.294.260.750
23220550,2012-12-07T00:00:00,Prostatic Neoplasms,C12.294.565.625
23220550,2012-12-07T00:00:00,Prostatic Neoplasms,C12.758.409.750
23220550,2012-12-07T00:00:00,Vitamin D,D04.808.812.768
23220550,2012-12-07T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
23236364,2012-12-07T00:00:00,African Continental Ancestry Group,M01.686.508.100
23236364,2012-12-07T00:00:00,Alleles,G05.360.340.024.340.030
23236364,2012-12-07T00:00:00,Cholesterol,D04.808.247.222.284
23236364,2012-12-07T00:00:00,Cholesterol,D04.808.247.808.197
23236364,2012-12-07T00:00:00,Cholesterol,D10.570.938.208
23236364,2012-12-07T00:00:00,Cholesterol,D10.851.208
23236364,2012-12-07T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
23236364,2012-12-07T00:00:00,Genetic Predisposition to Disease,G05.380.355
23236364,2012-12-07T00:00:00,Hispanic Americans,M01.686.754.441
23236364,2012-12-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23236364,2012-12-07T00:00:00,"Lipoproteins, HDL",D10.532.432
23236364,2012-12-07T00:00:00,"Lipoproteins, HDL",D12.776.521.479
23236364,2012-12-07T00:00:00,"Lipoproteins, LDL",D10.532.515
23236364,2012-12-07T00:00:00,"Lipoproteins, LDL",D12.776.521.550
23236364,2012-12-07T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
23228466,2012-12-08T00:00:00,Adult,M01.060.116
23228466,2012-12-08T00:00:00,Age Factors,N05.715.350.075
23228466,2012-12-08T00:00:00,Age Factors,N06.850.490.250
23228466,2012-12-08T00:00:00,Aged,M01.060.116.100
23228466,2012-12-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23228466,2012-12-08T00:00:00,Mental Disorders,F03
23228466,2012-12-08T00:00:00,Middle Aged,M01.060.116.630
23228466,2012-12-08T00:00:00,Needs Assessment,I02.594
23228466,2012-12-08T00:00:00,Needs Assessment,N03.349.380.565
23228466,2012-12-08T00:00:00,Needs Assessment,N05.300.537
23228466,2012-12-08T00:00:00,Psychometrics,F04.711.780
23228466,2012-12-08T00:00:00,Questionnaires,E05.318.308.750
23228466,2012-12-08T00:00:00,Questionnaires,L01.280.800
23228466,2012-12-08T00:00:00,Questionnaires,N05.715.360.300.695
23228466,2012-12-08T00:00:00,Questionnaires,N06.850.520.308.750
23228466,2012-12-08T00:00:00,Sex Factors,N05.715.350.675
23228466,2012-12-08T00:00:00,Sex Factors,N06.850.490.875
23234802,2012-12-09T00:00:00,Adolescent,M01.060.057
23234802,2012-12-09T00:00:00,Adult,M01.060.116
23234802,2012-12-09T00:00:00,Child,M01.060.406
23234802,2012-12-09T00:00:00,Cystic Fibrosis,C06.689.202
23234802,2012-12-09T00:00:00,Cystic Fibrosis,C08.381.187
23234802,2012-12-09T00:00:00,Cystic Fibrosis,C16.320.190
23234802,2012-12-09T00:00:00,Cystic Fibrosis,C16.614.213
23234802,2012-12-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23234802,2012-12-09T00:00:00,Middle Aged,M01.060.116.630
23234802,2012-12-09T00:00:00,Young Adult,M01.060.116.815
23216131,2012-12-10T00:00:00,Animals,B01.050
23216131,2012-12-10T00:00:00,Dogs,B01.050.150.900.649.147.153.200
23216131,2012-12-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23216131,2012-12-10T00:00:00,"Models, Animal",E05.598
23216131,2012-12-10T00:00:00,Swine,B01.050.150.900.649.077.880
23216131,2012-12-10T00:00:00,"Swine, Miniature",B01.050.150.900.649.077.880.399.800
23216131,2012-12-10T00:00:00,Toxicity Tests,E05.940
23217217,2012-12-10T00:00:00,Bacteremia,C01.252.100
23217217,2012-12-10T00:00:00,Bacteremia,C01.539.757.100
23217217,2012-12-10T00:00:00,Bacteremia,C23.550.470.790.500.100
23217217,2012-12-10T00:00:00,Bacterial Proteins,D12.776.097
23217217,2012-12-10T00:00:00,Child,M01.060.406
23217217,2012-12-10T00:00:00,"Child, Preschool",M01.060.406.448
23217217,2012-12-10T00:00:00,China,Z01.252.474.164
23217217,2012-12-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23217217,2012-12-10T00:00:00,Infant,M01.060.703
23217217,2012-12-10T00:00:00,Staphylococcal Infections,C01.252.410.868
23217217,2012-12-10T00:00:00,Staphylococcus aureus,B03.300.390.400.800.750.100
23217217,2012-12-10T00:00:00,Staphylococcus aureus,B03.510.100.750.750.100
23217217,2012-12-10T00:00:00,Staphylococcus aureus,B03.510.400.790.750.100
23236168,2012-12-10T00:00:00,Animals,B01.050
23236168,2012-12-10T00:00:00,Carrier Proteins,D12.776.157
23236168,2012-12-10T00:00:00,"Disease Models, Animal",C22.232
23236168,2012-12-10T00:00:00,"Disease Models, Animal",E05.598.500
23236168,2012-12-10T00:00:00,"Disease Models, Animal",E05.599.395.080
23236168,2012-12-10T00:00:00,Disease Progression,C23.550.291.656
23236168,2012-12-10T00:00:00,Kidney,A05.810.453
23236168,2012-12-10T00:00:00,Protein Transport,G03.495.166.700
23233387,2012-12-11T00:00:00,Aged,M01.060.116.100
23233387,2012-12-11T00:00:00,Cerebral Hemorrhage,C10.228.140.300.535.200
23233387,2012-12-11T00:00:00,Cerebral Hemorrhage,C14.907.253.573.200
23233387,2012-12-11T00:00:00,Cerebral Hemorrhage,C23.550.414.913.100
23233387,2012-12-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23233387,2012-12-11T00:00:00,Middle Aged,M01.060.116.630
23233387,2012-12-11T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23233387,2012-12-11T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23233387,2012-12-11T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23233387,2012-12-11T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23233387,2012-12-11T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23238350,2012-12-11T00:00:00,Adult,M01.060.116
23238350,2012-12-11T00:00:00,African Americans,M01.686.508.100.100
23238350,2012-12-11T00:00:00,African Americans,M01.686.754.100
23238350,2012-12-11T00:00:00,Aged,M01.060.116.100
23238350,2012-12-11T00:00:00,Blood Glucose,D09.546.359.448.500
23238350,2012-12-11T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
23238350,2012-12-11T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
23238350,2012-12-11T00:00:00,European Continental Ancestry Group,M01.686.508.400
23238350,2012-12-11T00:00:00,"Hemoglobin A, Glycosylated",D09.408.375
23238350,2012-12-11T00:00:00,"Hemoglobin A, Glycosylated",D12.776.124.400.405.440
23238350,2012-12-11T00:00:00,"Hemoglobin A, Glycosylated",D12.776.422.316.762.380.440
23238350,2012-12-11T00:00:00,Hispanic Americans,M01.686.754.441
23238350,2012-12-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23238350,2012-12-11T00:00:00,Hypoglycemic Agents,D27.505.696.422
23238350,2012-12-11T00:00:00,Medication Adherence,F01.145.488.500.500
23238350,2012-12-11T00:00:00,Medication Adherence,N05.300.150.600.600.500
23238350,2012-12-11T00:00:00,Middle Aged,M01.060.116.630
23238350,2012-12-11T00:00:00,United States,Z01.107.567.875
23238350,2012-12-11T00:00:00,Veterans,M01.930
23205763,2012-12-12T00:00:00,Materials Testing,E05.570
23205763,2012-12-12T00:00:00,Proteins,D12.776
23205763,2012-12-12T00:00:00,"Spectroscopy, Near-Infrared",E01.370.350.750
23205763,2012-12-12T00:00:00,"Spectroscopy, Near-Infrared",E05.196.867.851
23238907,2012-12-12T00:00:00,Adult,M01.060.116
23238907,2012-12-12T00:00:00,Double-Blind Method,E05.318.780.300
23238907,2012-12-12T00:00:00,Double-Blind Method,E05.581.500.300
23238907,2012-12-12T00:00:00,Double-Blind Method,N05.715.360.780.320
23238907,2012-12-12T00:00:00,Double-Blind Method,N06.850.520.445.300
23238907,2012-12-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23238907,2012-12-12T00:00:00,Treatment Outcome,E01.789.800
23238907,2012-12-12T00:00:00,Treatment Outcome,N04.761.559.590.800
23238907,2012-12-12T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23238907,2012-12-12T00:00:00,gamma-Aminobutyric Acid,D02.241.081.160.050.350
23238907,2012-12-12T00:00:00,gamma-Aminobutyric Acid,D12.125.190.350
23239837,2012-12-12T00:00:00,Heart Diseases,C14.280
23239837,2012-12-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23239837,2012-12-12T00:00:00,Risk Factors,E05.318.740.600.800.725
23239837,2012-12-12T00:00:00,Risk Factors,N05.715.350.200.700
23239837,2012-12-12T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23239837,2012-12-12T00:00:00,Risk Factors,N06.850.490.625.750
23239837,2012-12-12T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23239837,2012-12-12T00:00:00,Stroke,C10.228.140.300.775
23239837,2012-12-12T00:00:00,Stroke,C14.907.253.855
23239837,2012-12-12T00:00:00,United States,Z01.107.567.875
23247043,2012-12-12T00:00:00,Adolescent,M01.060.057
23247043,2012-12-12T00:00:00,Adult,M01.060.116
23247043,2012-12-12T00:00:00,Aggression,F01.145.126.125
23247043,2012-12-12T00:00:00,Aggression,F01.145.813.045
23247043,2012-12-12T00:00:00,Body Weight,C23.888.144
23247043,2012-12-12T00:00:00,Body Weight,E01.370.600.115.100.160.120
23247043,2012-12-12T00:00:00,Body Weight,E05.041.124.160.750
23247043,2012-12-12T00:00:00,Body Weight,G07.100.100.160.120
23247043,2012-12-12T00:00:00,Body Weight,G07.700.320.249.314.120
23247043,2012-12-12T00:00:00,Caregivers,M01.085
23247043,2012-12-12T00:00:00,Caregivers,M01.526.485.200
23247043,2012-12-12T00:00:00,Caregivers,N02.360.200
23247043,2012-12-12T00:00:00,Child,M01.060.406
23247043,2012-12-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23247043,2012-12-12T00:00:00,Juvenile Delinquency,I01.880.735.479
23247043,2012-12-12T00:00:00,Middle Aged,M01.060.116.630
23247043,2012-12-12T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
23247043,2012-12-12T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
23247043,2012-12-12T00:00:00,Peer Group,F01.829.316.483
23247043,2012-12-12T00:00:00,Questionnaires,E05.318.308.750
23247043,2012-12-12T00:00:00,Questionnaires,L01.280.800
23247043,2012-12-12T00:00:00,Questionnaires,N05.715.360.300.695
23247043,2012-12-12T00:00:00,Questionnaires,N06.850.520.308.750
23247043,2012-12-12T00:00:00,Saliva,A12.200.666
23247043,2012-12-12T00:00:00,Testosterone,D04.808.054.079.429.824
23247043,2012-12-12T00:00:00,Testosterone,D06.472.334.851.968.984
23247043,2012-12-12T00:00:00,Time Factors,G01.910.857
23271035,2012-12-12T00:00:00,Animals,B01.050
23271035,2012-12-12T00:00:00,Fluorescent Dyes,D27.720.233.348
23271035,2012-12-12T00:00:00,Fluorescent Dyes,D27.720.470.330.348
23271035,2012-12-12T00:00:00,Fluorescent Dyes,D27.720.470.410.505.500
23271035,2012-12-12T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
23271035,2012-12-12T00:00:00,"Microscopy, Fluorescence, Multiphoton",E01.370.350.515.458.500
23271035,2012-12-12T00:00:00,"Microscopy, Fluorescence, Multiphoton",E05.595.458.500
23271035,2012-12-12T00:00:00,Neocortex,A08.186.211.730.885.287.500.420
23271035,2012-12-12T00:00:00,Neurons,A08.663
23271035,2012-12-12T00:00:00,Neurons,A11.671
23236966,2012-12-13T00:00:00,Adolescent,M01.060.057
23236966,2012-12-13T00:00:00,Adolescent Behavior,F01.145.022
23236966,2012-12-13T00:00:00,Health Surveys,E05.318.308.250
23236966,2012-12-13T00:00:00,Health Surveys,N05.715.360.300.375
23236966,2012-12-13T00:00:00,Health Surveys,N06.850.520.308.250
23236966,2012-12-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23236966,2012-12-13T00:00:00,Juvenile Delinquency,I01.880.735.479
23236966,2012-12-13T00:00:00,Life Change Events,F01.829.458.410
23236966,2012-12-13T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
23236966,2012-12-13T00:00:00,Substance-Related Disorders,C21.739
23236966,2012-12-13T00:00:00,Substance-Related Disorders,F03.900
23236966,2012-12-13T00:00:00,Violence,I01.198.240.856
23236966,2012-12-13T00:00:00,Violence,I01.880.735.900
23239148,2012-12-13T00:00:00,African Americans,M01.686.508.100.100
23239148,2012-12-13T00:00:00,African Americans,M01.686.754.100
23239148,2012-12-13T00:00:00,Breast Neoplasms,C04.588.180
23239148,2012-12-13T00:00:00,Breast Neoplasms,C17.800.090.500
23239148,2012-12-13T00:00:00,European Continental Ancestry Group,M01.686.508.400
23239148,2012-12-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23239148,2012-12-13T00:00:00,Mass Screening,E01.370.500
23239148,2012-12-13T00:00:00,Mass Screening,E05.318.308.250.580
23239148,2012-12-13T00:00:00,Mass Screening,N02.421.143.827.233.443
23239148,2012-12-13T00:00:00,Mass Screening,N02.421.726.233.443
23239148,2012-12-13T00:00:00,Mass Screening,N05.715.360.300.375.500
23239148,2012-12-13T00:00:00,Mass Screening,N06.850.520.308.250.580
23239148,2012-12-13T00:00:00,Mass Screening,N06.850.780.500
23239148,2012-12-13T00:00:00,Middle Aged,M01.060.116.630
23239148,2012-12-13T00:00:00,"Receptors, Estrogen",D12.776.260.698.750.350
23239148,2012-12-13T00:00:00,"Receptors, Estrogen",D12.776.826.750.350
23239148,2012-12-13T00:00:00,"Receptors, Estrogen",D12.776.930.669.750.350
23239148,2012-12-13T00:00:00,South Carolina,Z01.107.567.875.075.662
23239148,2012-12-13T00:00:00,South Carolina,Z01.107.567.875.750.700
23239807,2012-12-13T00:00:00,Adult,M01.060.116
23239807,2012-12-13T00:00:00,Aged,M01.060.116.100
23239807,2012-12-13T00:00:00,Endoscopy,E01.370.388.250
23239807,2012-12-13T00:00:00,Endoscopy,E04.800.250
23239807,2012-12-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23239807,2012-12-13T00:00:00,Middle Aged,M01.060.116.630
23239807,2012-12-13T00:00:00,Treatment Outcome,E01.789.800
23239807,2012-12-13T00:00:00,Treatment Outcome,N04.761.559.590.800
23239807,2012-12-13T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23239807,2012-12-13T00:00:00,"Ultrasonography, Interventional",E01.370.350.850.855
23239823,2012-12-13T00:00:00,Animals,B01.050
23239823,2012-12-13T00:00:00,Demyelinating Diseases,C10.314
23239823,2012-12-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23239823,2012-12-13T00:00:00,Hyaluronic Acid,D09.698.373.475
23239823,2012-12-13T00:00:00,Hydrogels,D20.280.320.375
23239823,2012-12-13T00:00:00,Hydrogels,D26.255.165.320.375
23239823,2012-12-13T00:00:00,Oligodendroglia,A08.637.600
23239823,2012-12-13T00:00:00,Oligodendroglia,A11.650.600
23239823,2012-12-13T00:00:00,Polyethylene Glycols,D02.033.455.250.700
23239823,2012-12-13T00:00:00,Polyethylene Glycols,D05.750.741
23239823,2012-12-13T00:00:00,Polyethylene Glycols,D25.720.741
23239823,2012-12-13T00:00:00,Polyethylene Glycols,J01.637.051.720.741
23239823,2012-12-13T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23239823,2012-12-13T00:00:00,Spinal Cord Injuries,C10.228.854.770
23239823,2012-12-13T00:00:00,Spinal Cord Injuries,C10.900.850
23239823,2012-12-13T00:00:00,Spinal Cord Injuries,C21.866.819
23246236,2012-12-13T00:00:00,Aged,M01.060.116.100
23246236,2012-12-13T00:00:00,Body Mass Index,E01.370.600.115.100.125
23246236,2012-12-13T00:00:00,Body Mass Index,E05.041.124.125
23246236,2012-12-13T00:00:00,Body Mass Index,G07.100.100.125
23246236,2012-12-13T00:00:00,Body Mass Index,N06.850.505.200.100.175
23246236,2012-12-13T00:00:00,Eating,G07.610.593.260
23246236,2012-12-13T00:00:00,Eating,G07.700.620.260
23246236,2012-12-13T00:00:00,Eating,G10.261.326.240
23246236,2012-12-13T00:00:00,Energy Intake,G07.610.240.340
23246236,2012-12-13T00:00:00,Geriatric Assessment,E05.318.308.225
23246236,2012-12-13T00:00:00,Geriatric Assessment,I01.240.425.350
23246236,2012-12-13T00:00:00,Geriatric Assessment,L01.280.360
23246236,2012-12-13T00:00:00,Geriatric Assessment,N01.224.425.350
23246236,2012-12-13T00:00:00,Geriatric Assessment,N05.715.360.300.360
23246236,2012-12-13T00:00:00,Geriatric Assessment,N06.850.505.400.425.350
23246236,2012-12-13T00:00:00,Geriatric Assessment,N06.850.520.308.225
23246236,2012-12-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23246236,2012-12-13T00:00:00,Nursing Homes,N02.278.825.610
23246236,2012-12-13T00:00:00,Risk Factors,E05.318.740.600.800.725
23246236,2012-12-13T00:00:00,Risk Factors,N05.715.350.200.700
23246236,2012-12-13T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23246236,2012-12-13T00:00:00,Risk Factors,N06.850.490.625.750
23246236,2012-12-13T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23246236,2012-12-13T00:00:00,Weight Loss,C23.888.144.243.963
23246236,2012-12-13T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
23247107,2012-12-13T00:00:00,Animals,B01.050
23247107,2012-12-13T00:00:00,Endoplasmic Reticulum,A11.284.430.214.190.875.248
23247107,2012-12-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23247107,2012-12-13T00:00:00,Lysine,D12.125.068.555
23247107,2012-12-13T00:00:00,Lysine,D12.125.095.647
23247107,2012-12-13T00:00:00,Lysine,D12.125.142.497
23247107,2012-12-13T00:00:00,"Protein Processing, Post-Translational",G02.111.087.675.871.790.600
23247107,2012-12-13T00:00:00,"Protein Processing, Post-Translational",G02.111.087.693.600
23247107,2012-12-13T00:00:00,"Protein Processing, Post-Translational",G02.149.115.675.871.790.600
23247107,2012-12-13T00:00:00,"Protein Processing, Post-Translational",G02.149.115.693.600
23247107,2012-12-13T00:00:00,"Protein Processing, Post-Translational",G03.495.770.871.790.600
23247107,2012-12-13T00:00:00,"Protein Processing, Post-Translational",G05.355.315.670.600
23380490,2012-12-13T00:00:00,Adolescent,M01.060.057
23380490,2012-12-13T00:00:00,Adult,M01.060.116
23380490,2012-12-13T00:00:00,Alcohol Drinking,F01.145.317.269
23380490,2012-12-13T00:00:00,Crime Victims,M01.135
23380490,2012-12-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23380490,2012-12-13T00:00:00,Mental Health Services,F04.408
23380490,2012-12-13T00:00:00,Mental Health Services,N02.421.461
23380490,2012-12-13T00:00:00,Middle Aged,M01.060.116.630
23380490,2012-12-13T00:00:00,Rape,I01.198.240.748.640
23380490,2012-12-13T00:00:00,Substance-Related Disorders,C21.739
23380490,2012-12-13T00:00:00,Substance-Related Disorders,F03.900
23380490,2012-12-13T00:00:00,United States,Z01.107.567.875
23380490,2012-12-13T00:00:00,Young Adult,M01.060.116.815
23240586,2012-12-14T00:00:00,Adult,M01.060.116
23240586,2012-12-14T00:00:00,Alcohol Drinking,F01.145.317.269
23240586,2012-12-14T00:00:00,Benzazepines,D03.438.079
23240586,2012-12-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23240586,2012-12-14T00:00:00,Middle Aged,M01.060.116.630
23240586,2012-12-14T00:00:00,Nicotinic Agonists,D27.505.519.625.120.140.700
23240586,2012-12-14T00:00:00,Nicotinic Agonists,D27.505.696.577.120.140.700
23240586,2012-12-14T00:00:00,Smoking Cessation,F01.145.940.700
23286988,2012-12-14T00:00:00,Disinfection,N06.850.780.200.450.850.375
23286988,2012-12-14T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
23380491,2012-12-16T00:00:00,Adolescent,M01.060.057
23380491,2012-12-16T00:00:00,Adult,M01.060.116
23380491,2012-12-16T00:00:00,Age Factors,N05.715.350.075
23380491,2012-12-16T00:00:00,Age Factors,N06.850.490.250
23380491,2012-12-16T00:00:00,Attitude to Health,F01.100.150
23380491,2012-12-16T00:00:00,Attitude to Health,N05.300.150
23380491,2012-12-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23380491,2012-12-16T00:00:00,Income,N01.824.417
23380491,2012-12-16T00:00:00,Middle Aged,M01.060.116.630
23380491,2012-12-16T00:00:00,Risk Reduction Behavior,F01.145.699
23380491,2012-12-16T00:00:00,Smoking,F01.145.466.753
23380491,2012-12-16T00:00:00,Smoking Cessation,F01.145.940.700
23380491,2012-12-16T00:00:00,Tobacco Use Disorder,C21.739.912
23380491,2012-12-16T00:00:00,Tobacco Use Disorder,F03.900.912
23380491,2012-12-16T00:00:00,Young Adult,M01.060.116.815
23244786,2012-12-17T00:00:00,Aged,M01.060.116.100
23244786,2012-12-17T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
23244786,2012-12-17T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
23244786,2012-12-17T00:00:00,Bone Cements,D05.750.716.822.300
23244786,2012-12-17T00:00:00,Bone Cements,D25.720.716.822.300
23244786,2012-12-17T00:00:00,Bone Cements,D27.720.102.158
23244786,2012-12-17T00:00:00,Bone Cements,J01.637.051.720.716.822.300
23244786,2012-12-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23244786,2012-12-17T00:00:00,Knee Joint,A02.835.583.475
23244786,2012-12-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23244786,2012-12-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23244786,2012-12-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23244786,2012-12-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23244786,2012-12-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23245214,2012-12-17T00:00:00,Fluorides,D01.248.497.158.380
23245214,2012-12-17T00:00:00,Fluorides,D01.303.350.300
23245214,2012-12-17T00:00:00,Hafnium,D01.268.556.337
23245214,2012-12-17T00:00:00,Hafnium,D01.268.956.249
23245214,2012-12-17T00:00:00,Hafnium,D01.552.544.337
23245214,2012-12-17T00:00:00,Luminescence,G01.201.875.770.578.665
23245214,2012-12-17T00:00:00,Luminescence,G01.590.540.665
23245214,2012-12-17T00:00:00,"Metals, Alkali",D01.268.549
23245214,2012-12-17T00:00:00,"Metals, Alkali",D01.552.528
23245214,2012-12-17T00:00:00,Molecular Structure,G02.111.570
23245214,2012-12-17T00:00:00,Molecular Structure,G02.575
23245214,2012-12-17T00:00:00,Molecular Structure,G02.842.575
23245214,2012-12-17T00:00:00,"Spectrometry, Fluorescence",E05.196.712.516.600.676
23245214,2012-12-17T00:00:00,"Spectrometry, Fluorescence",E05.196.867.726
23245214,2012-12-17T00:00:00,Temperature,G01.906.595
23245214,2012-12-17T00:00:00,Temperature,G16.500.275.063.725.710
23245214,2012-12-17T00:00:00,Temperature,G16.500.750.775.710
23245214,2012-12-17T00:00:00,Temperature,N06.230.150.450
23245214,2012-12-17T00:00:00,Temperature,N06.230.300.100.725.710
23250758,2012-12-17T00:00:00,Animals,B01.050
23250758,2012-12-17T00:00:00,Cell Membrane,A11.284.149
23250758,2012-12-17T00:00:00,Cell Survival,G04.299.316
23250758,2012-12-17T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D08.811.277.040.330.300.200.100.200
23250758,2012-12-17T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.644.360.375.100.200
23250758,2012-12-17T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.776.157.325.332.100.200
23250758,2012-12-17T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.776.476.375.100.200
23250758,2012-12-17T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.776.543.325.100.200
23250758,2012-12-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23250758,2012-12-17T00:00:00,"Models, Biological",E05.599.395
23250758,2012-12-17T00:00:00,Protein Transport,G03.495.166.700
23250758,2012-12-17T00:00:00,RGS Proteins,D12.644.360.325.150.750
23250758,2012-12-17T00:00:00,RGS Proteins,D12.776.402.150.750
23250758,2012-12-17T00:00:00,RGS Proteins,D12.776.476.325.150.750
23250758,2012-12-17T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23250758,2012-12-17T00:00:00,"Receptors, Adrenergic, beta-2",D12.776.543.750.070.300.300.340.725
23250758,2012-12-17T00:00:00,"Receptors, Adrenergic, beta-2",D12.776.543.750.100.150.300.340.725
23250758,2012-12-17T00:00:00,"Receptors, Adrenergic, beta-2",D12.776.543.750.720.300.300.300.340.200
23250758,2012-12-17T00:00:00,Signal Transduction,G02.111.087.800
23250758,2012-12-17T00:00:00,Signal Transduction,G02.149.115.800
23250758,2012-12-17T00:00:00,Signal Transduction,G04.299.880
23282411,2012-12-17T00:00:00,Algorithms,G17.035
23282411,2012-12-17T00:00:00,Algorithms,L01.224.050
23282411,2012-12-17T00:00:00,Animals,B01.050
23282411,2012-12-17T00:00:00,Biomedical Research,H01.770.644.145
23282411,2012-12-17T00:00:00,Computational Biology,H01.158.273.180
23282411,2012-12-17T00:00:00,"Databases, Genetic",L01.470.750.750.325
23282411,2012-12-17T00:00:00,"Databases, Genetic",L01.700.508.300.188.400.325
23282411,2012-12-17T00:00:00,Gene Expression,G05.355.310
23282411,2012-12-17T00:00:00,Gene Regulatory Networks,G05.360.080.689.360
23282411,2012-12-17T00:00:00,Genomics,H01.158.273.180.350
23282411,2012-12-17T00:00:00,Genomics,H01.158.273.343.350
23282411,2012-12-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23282411,2012-12-17T00:00:00,Microarray Analysis,E05.196.630.570
23282411,2012-12-17T00:00:00,Microarray Analysis,E05.588.570
23282411,2012-12-17T00:00:00,"Models, Statistical",E05.318.740.500
23282411,2012-12-17T00:00:00,"Models, Statistical",E05.599.835
23282411,2012-12-17T00:00:00,"Models, Statistical",N05.715.360.750.530
23282411,2012-12-17T00:00:00,"Models, Statistical",N06.850.520.830.500
23282411,2012-12-17T00:00:00,Saccharomyces cerevisiae,B01.300.107.795.785.800
23282411,2012-12-17T00:00:00,Saccharomyces cerevisiae,B01.300.930.705.655
23282411,2012-12-17T00:00:00,Transcription Factors,D12.776.930
23257556,2012-12-18T00:00:00,Cerebrospinal Fluid Rhinorrhea,C10.597.267
23257556,2012-12-18T00:00:00,Cerebrospinal Fluid Rhinorrhea,C10.900.300.153
23257556,2012-12-18T00:00:00,Cerebrospinal Fluid Rhinorrhea,C21.866.260.207
23257556,2012-12-18T00:00:00,Cerebrospinal Fluid Rhinorrhea,C21.866.915.300.300
23257556,2012-12-18T00:00:00,Cerebrospinal Fluid Rhinorrhea,C23.888.592.264
23257556,2012-12-18T00:00:00,Endoscopy,E01.370.388.250
23257556,2012-12-18T00:00:00,Endoscopy,E04.800.250
23257556,2012-12-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23257556,2012-12-18T00:00:00,Intracranial Pressure,G11.561.170.505
23257556,2012-12-18T00:00:00,Ventriculoperitoneal Shunt,E04.035.188.850
23257556,2012-12-18T00:00:00,Ventriculoperitoneal Shunt,E04.525.170.850
23255299,2012-12-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23255299,2012-12-19T00:00:00,Incidence,E05.318.308.985.525.375
23255299,2012-12-19T00:00:00,Incidence,L01.280.975.525.375
23255299,2012-12-19T00:00:00,Incidence,N01.224.935.597.500
23255299,2012-12-19T00:00:00,Incidence,N06.850.505.400.975.525.375
23255299,2012-12-19T00:00:00,Incidence,N06.850.520.308.985.525.375
23255299,2012-12-19T00:00:00,Neoplasms,C04
23255299,2012-12-19T00:00:00,Occupational Exposure,N06.850.460.350.600
23255299,2012-12-19T00:00:00,Risk Factors,E05.318.740.600.800.725
23255299,2012-12-19T00:00:00,Risk Factors,N05.715.350.200.700
23255299,2012-12-19T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23255299,2012-12-19T00:00:00,Risk Factors,N06.850.490.625.750
23255299,2012-12-19T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23255780,2012-12-19T00:00:00,Biological Markers,D23.101
23255780,2012-12-19T00:00:00,Blood Glucose,D09.546.359.448.500
23255780,2012-12-19T00:00:00,Carbohydrate Metabolism,G02.111.087.160
23255780,2012-12-19T00:00:00,Carbohydrate Metabolism,G02.149.115.160
23255780,2012-12-19T00:00:00,Carbohydrate Metabolism,G03.495.256
23255780,2012-12-19T00:00:00,Diet,E05.272
23255780,2012-12-19T00:00:00,Diet,G07.610.240
23255780,2012-12-19T00:00:00,Genome-Wide Association Study,E05.318.416.249
23255780,2012-12-19T00:00:00,Genome-Wide Association Study,E05.318.780.392
23255780,2012-12-19T00:00:00,Genome-Wide Association Study,E05.393.385.500
23255780,2012-12-19T00:00:00,Genome-Wide Association Study,E05.393.522.500
23255780,2012-12-19T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
23255780,2012-12-19T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
23255780,2012-12-19T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
23255780,2012-12-19T00:00:00,Homeostasis,G07.700.360
23255780,2012-12-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23255780,2012-12-19T00:00:00,Insulin,D06.472.699.587.740.625
23255780,2012-12-19T00:00:00,Insulin,D12.644.548.586.740.625
23255780,2012-12-19T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
23261934,2012-12-19T00:00:00,Amides,D02.065
23261934,2012-12-19T00:00:00,Animals,B01.050
23261934,2012-12-19T00:00:00,Avian Proteins,D12.776.093
23261934,2012-12-19T00:00:00,Chick Embryo,A13.350.150
23261934,2012-12-19T00:00:00,Chick Embryo,A16.331.200
23261934,2012-12-19T00:00:00,Extracellular Matrix,A11.284.295.310
23261934,2012-12-19T00:00:00,Extracellular Matrix Proteins,D12.776.860.300
23261934,2012-12-19T00:00:00,Gene Expression Profiling,E05.393.332
23261934,2012-12-19T00:00:00,Heart Valves,A07.541.510
23261934,2012-12-19T00:00:00,Lysophospholipids,D10.570.755.375.760.550
23261934,2012-12-19T00:00:00,"Mechanotransduction, Cellular",G01.154.100.440
23261934,2012-12-19T00:00:00,"Mechanotransduction, Cellular",G01.595.100.440
23261934,2012-12-19T00:00:00,"Mechanotransduction, Cellular",G02.111.087.800.580
23261934,2012-12-19T00:00:00,"Mechanotransduction, Cellular",G02.149.115.800.580
23261934,2012-12-19T00:00:00,"Mechanotransduction, Cellular",G04.299.880.580
23261934,2012-12-19T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
23261934,2012-12-19T00:00:00,"Microscopy, Confocal",E05.595.395
23261934,2012-12-19T00:00:00,Pyridines,D03.383.725
23261934,2012-12-19T00:00:00,"Stress, Mechanical",G01.374.676.830
23261934,2012-12-19T00:00:00,"Stress, Mechanical",G01.595.540.830
23261934,2012-12-19T00:00:00,Time Factors,G01.910.857
23258931,2012-12-20T00:00:00,Academic Medical Centers,N02.278.020
23258931,2012-12-20T00:00:00,Cardiovascular Diseases,C14
23258931,2012-12-20T00:00:00,Diabetes Mellitus,C18.452.394.750
23258931,2012-12-20T00:00:00,Diabetes Mellitus,C19.246
23258931,2012-12-20T00:00:00,Graft Rejection,G12.425.901.545.328
23258931,2012-12-20T00:00:00,Graft Survival,G12.425.901.545.340
23258931,2012-12-20T00:00:00,Healthcare Disparities,N04.590.374.380
23258931,2012-12-20T00:00:00,Healthcare Disparities,N05.300.493
23258931,2012-12-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23258931,2012-12-20T00:00:00,Hypertension,C14.907.489
23258931,2012-12-20T00:00:00,Incidence,E05.318.308.985.525.375
23258931,2012-12-20T00:00:00,Incidence,L01.280.975.525.375
23258931,2012-12-20T00:00:00,Incidence,N01.224.935.597.500
23258931,2012-12-20T00:00:00,Incidence,N06.850.505.400.975.525.375
23258931,2012-12-20T00:00:00,Incidence,N06.850.520.308.985.525.375
23258931,2012-12-20T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
23258931,2012-12-20T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
23258931,2012-12-20T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
23258931,2012-12-20T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
23258931,2012-12-20T00:00:00,Kidney Transplantation,E02.870.500
23258931,2012-12-20T00:00:00,Kidney Transplantation,E04.936.450.485
23258931,2012-12-20T00:00:00,Kidney Transplantation,E04.950.774.400
23258931,2012-12-20T00:00:00,Middle Aged,M01.060.116.630
23258931,2012-12-20T00:00:00,Risk Factors,E05.318.740.600.800.725
23258931,2012-12-20T00:00:00,Risk Factors,N05.715.350.200.700
23258931,2012-12-20T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23258931,2012-12-20T00:00:00,Risk Factors,N06.850.490.625.750
23258931,2012-12-20T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23258931,2012-12-20T00:00:00,South Carolina,Z01.107.567.875.075.662
23258931,2012-12-20T00:00:00,South Carolina,Z01.107.567.875.750.700
23261250,2012-12-20T00:00:00,Animals,B01.050
23261250,2012-12-20T00:00:00,Apolipoproteins E,D10.532.091.500
23261250,2012-12-20T00:00:00,Apolipoproteins E,D12.776.070.400.500
23261250,2012-12-20T00:00:00,Apolipoproteins E,D12.776.521.120.500
23261250,2012-12-20T00:00:00,Collagen,D05.750.078.280
23261250,2012-12-20T00:00:00,Collagen,D12.776.860.300.250
23261250,2012-12-20T00:00:00,"Disease Models, Animal",C22.232
23261250,2012-12-20T00:00:00,"Disease Models, Animal",E05.598.500
23261250,2012-12-20T00:00:00,"Disease Models, Animal",E05.599.395.080
23261250,2012-12-20T00:00:00,Elastin,D05.750.078.421
23261250,2012-12-20T00:00:00,Elastin,D12.776.860.300.350
23261250,2012-12-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23261250,2012-12-20T00:00:00,Macrophages,A11.329.372
23261250,2012-12-20T00:00:00,Macrophages,A11.627.482
23261250,2012-12-20T00:00:00,Macrophages,A11.733.397
23261250,2012-12-20T00:00:00,Macrophages,A15.382.680.397
23261250,2012-12-20T00:00:00,Macrophages,A15.382.812.522
23265585,2012-12-20T00:00:00,Aged,M01.060.116.100
23265585,2012-12-20T00:00:00,Angioplasty,E02.148.050
23265585,2012-12-20T00:00:00,Angioplasty,E04.100.814.050
23265585,2012-12-20T00:00:00,Carotid Stenosis,C10.228.140.300.200.360
23265585,2012-12-20T00:00:00,Carotid Stenosis,C14.907.137.230
23265585,2012-12-20T00:00:00,Carotid Stenosis,C14.907.253.123.360
23265585,2012-12-20T00:00:00,Clinical Competence,I02.399.630.210
23265585,2012-12-20T00:00:00,Clinical Competence,N04.761.210
23265585,2012-12-20T00:00:00,"Endarterectomy, Carotid",E04.100.814.456.250
23265585,2012-12-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23265585,2012-12-20T00:00:00,Middle Aged,M01.060.116.630
23265585,2012-12-20T00:00:00,Myocardial Infarction,C14.280.647.500
23265585,2012-12-20T00:00:00,Myocardial Infarction,C14.907.585.500
23265585,2012-12-20T00:00:00,Risk Assessment,E05.318.740.600.800.715
23265585,2012-12-20T00:00:00,Risk Assessment,N04.452.871.715
23265585,2012-12-20T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
23265585,2012-12-20T00:00:00,Risk Assessment,N06.850.505.715
23265585,2012-12-20T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
23265585,2012-12-20T00:00:00,Risk Factors,E05.318.740.600.800.725
23265585,2012-12-20T00:00:00,Risk Factors,N05.715.350.200.700
23265585,2012-12-20T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23265585,2012-12-20T00:00:00,Risk Factors,N06.850.490.625.750
23265585,2012-12-20T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23265585,2012-12-20T00:00:00,Stents,E07.695.750
23265585,2012-12-20T00:00:00,Stroke,C10.228.140.300.775
23265585,2012-12-20T00:00:00,Stroke,C14.907.253.855
23265585,2012-12-20T00:00:00,Time Factors,G01.910.857
23265585,2012-12-20T00:00:00,Treatment Outcome,E01.789.800
23265585,2012-12-20T00:00:00,Treatment Outcome,N04.761.559.590.800
23265585,2012-12-20T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23265585,2012-12-20T00:00:00,United States,Z01.107.567.875
23266092,2012-12-20T00:00:00,Adolescent,M01.060.057
23266092,2012-12-20T00:00:00,Adult,M01.060.116
23266092,2012-12-20T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
23266092,2012-12-20T00:00:00,Cystic Fibrosis,C06.689.202
23266092,2012-12-20T00:00:00,Cystic Fibrosis,C08.381.187
23266092,2012-12-20T00:00:00,Cystic Fibrosis,C16.320.190
23266092,2012-12-20T00:00:00,Cystic Fibrosis,C16.614.213
23266092,2012-12-20T00:00:00,Drug Monitoring,E01.370.520.200
23266092,2012-12-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23266092,2012-12-20T00:00:00,Young Adult,M01.060.116.815
23280333,2012-12-20T00:00:00,Aged,M01.060.116.100
23280333,2012-12-20T00:00:00,Colonic Neoplasms,C04.588.274.476.411.307.180
23280333,2012-12-20T00:00:00,Colonic Neoplasms,C06.301.371.411.307.180
23280333,2012-12-20T00:00:00,Colonic Neoplasms,C06.405.249.411.307.180
23280333,2012-12-20T00:00:00,Colonic Neoplasms,C06.405.469.158.356.180
23280333,2012-12-20T00:00:00,Colonic Neoplasms,C06.405.469.491.307.180
23280333,2012-12-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23280333,2012-12-20T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
23280333,2012-12-20T00:00:00,Metabolic Syndrome X,C18.452.625
23280333,2012-12-20T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
23280333,2012-12-20T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
23280333,2012-12-20T00:00:00,Risk Factors,E05.318.740.600.800.725
23280333,2012-12-20T00:00:00,Risk Factors,N05.715.350.200.700
23280333,2012-12-20T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23280333,2012-12-20T00:00:00,Risk Factors,N06.850.490.625.750
23280333,2012-12-20T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23280333,2012-12-20T00:00:00,SEER Program,E05.318.308.970.725
23280333,2012-12-20T00:00:00,SEER Program,L01.280.950.725
23280333,2012-12-20T00:00:00,SEER Program,N04.452.859.819.725
23280333,2012-12-20T00:00:00,SEER Program,N05.715.360.300.715.700.725
23280333,2012-12-20T00:00:00,SEER Program,N06.850.520.308.970.725
23280333,2012-12-20T00:00:00,Treatment Outcome,E01.789.800
23280333,2012-12-20T00:00:00,Treatment Outcome,N04.761.559.590.800
23280333,2012-12-20T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23280333,2012-12-20T00:00:00,United States,Z01.107.567.875
23285117,2012-12-20T00:00:00,Animals,B01.050
23285117,2012-12-20T00:00:00,Gene Expression Profiling,E05.393.332
23285117,2012-12-20T00:00:00,Gene Expression Regulation,G05.355.315
23285117,2012-12-20T00:00:00,Heterogeneous-Nuclear Ribonucleoproteins,D12.776.157.725.500.500
23285117,2012-12-20T00:00:00,Heterogeneous-Nuclear Ribonucleoproteins,D12.776.664.962.500.500
23285117,2012-12-20T00:00:00,Nucleic Acid Conformation,G02.111.570.790.486
23285117,2012-12-20T00:00:00,Nucleic Acid Conformation,G05.360.580
23285117,2012-12-20T00:00:00,Protein Biosynthesis,G02.111.087.675.871
23285117,2012-12-20T00:00:00,Protein Biosynthesis,G02.149.115.675.871
23285117,2012-12-20T00:00:00,Protein Biosynthesis,G03.495.770.871
23285117,2012-12-20T00:00:00,Protein Biosynthesis,G05.355.310.670
23285117,2012-12-20T00:00:00,"RNA Processing, Post-Transcriptional",G02.111.087.750
23285117,2012-12-20T00:00:00,"RNA Processing, Post-Transcriptional",G02.149.115.750
23285117,2012-12-20T00:00:00,"RNA Processing, Post-Transcriptional",G03.495.839
23285117,2012-12-20T00:00:00,"RNA Processing, Post-Transcriptional",G05.355.315.700
23285117,2012-12-20T00:00:00,"RNA, Messenger",D13.444.735.544
23285117,2012-12-20T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
23285117,2012-12-20T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
23285117,2012-12-20T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
23285117,2012-12-20T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
23285117,2012-12-20T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
23285117,2012-12-20T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
23285117,2012-12-20T00:00:00,Transforming Growth Factor beta,D23.529.374.687
23285117,2012-12-20T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
23285117,2012-12-20T00:00:00,Transforming Growth Factor beta,D23.529.960.720
23263950,2012-12-21T00:00:00,Environmental Microbiology,H01.158.273.540.274
23263950,2012-12-21T00:00:00,Environmental Microbiology,N06.850.425
23263950,2012-12-21T00:00:00,Ethylene Dibromide,D02.455.526.368.225
23263950,2012-12-21T00:00:00,Ethylene Dichlorides,D02.455.326.146.379.350
23263950,2012-12-21T00:00:00,Ethylene Dichlorides,D02.455.526.439.458
23263950,2012-12-21T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
23264005,2012-12-21T00:00:00,African Americans,M01.686.508.100.100
23264005,2012-12-21T00:00:00,African Americans,M01.686.754.100
23264005,2012-12-21T00:00:00,Age Factors,N05.715.350.075
23264005,2012-12-21T00:00:00,Age Factors,N06.850.490.250
23264005,2012-12-21T00:00:00,Aged,M01.060.116.100
23264005,2012-12-21T00:00:00,Aging,G07.700.320.124
23264005,2012-12-21T00:00:00,Brain Ischemia,C10.228.140.300.150
23264005,2012-12-21T00:00:00,Brain Ischemia,C14.907.253.092
23264005,2012-12-21T00:00:00,Depression,F01.145.126.350
23264005,2012-12-21T00:00:00,European Continental Ancestry Group,M01.686.508.400
23264005,2012-12-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23264005,2012-12-21T00:00:00,Incidence,E05.318.308.985.525.375
23264005,2012-12-21T00:00:00,Incidence,L01.280.975.525.375
23264005,2012-12-21T00:00:00,Incidence,N01.224.935.597.500
23264005,2012-12-21T00:00:00,Incidence,N06.850.505.400.975.525.375
23264005,2012-12-21T00:00:00,Incidence,N06.850.520.308.985.525.375
23264005,2012-12-21T00:00:00,Middle Aged,M01.060.116.630
23264005,2012-12-21T00:00:00,Risk Assessment,E05.318.740.600.800.715
23264005,2012-12-21T00:00:00,Risk Assessment,N04.452.871.715
23264005,2012-12-21T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
23264005,2012-12-21T00:00:00,Risk Assessment,N06.850.505.715
23264005,2012-12-21T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
23264005,2012-12-21T00:00:00,Risk Factors,E05.318.740.600.800.725
23264005,2012-12-21T00:00:00,Risk Factors,N05.715.350.200.700
23264005,2012-12-21T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23264005,2012-12-21T00:00:00,Risk Factors,N06.850.490.625.750
23264005,2012-12-21T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23264005,2012-12-21T00:00:00,Social Support,I01.880.656.600
23264005,2012-12-21T00:00:00,Stroke,C10.228.140.300.775
23264005,2012-12-21T00:00:00,Stroke,C14.907.253.855
23264005,2012-12-21T00:00:00,Time Factors,G01.910.857
23264005,2012-12-21T00:00:00,United States,Z01.107.567.875
23264446,2012-12-21T00:00:00,Anticoagulants,D27.505.954.502.119
23264446,2012-12-21T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
23264446,2012-12-21T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
23264446,2012-12-21T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
23264446,2012-12-21T00:00:00,Heart Failure,C14.280.434
23264446,2012-12-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23264446,2012-12-21T00:00:00,Intracranial Hemorrhages,C10.228.140.300.535
23264446,2012-12-21T00:00:00,Intracranial Hemorrhages,C14.907.253.573
23264446,2012-12-21T00:00:00,Intracranial Hemorrhages,C23.550.414.913
23264446,2012-12-21T00:00:00,Middle Aged,M01.060.116.630
23264446,2012-12-21T00:00:00,Patient Selection,E05.581.500.653
23264446,2012-12-21T00:00:00,Patient Selection,N04.590.731
23264446,2012-12-21T00:00:00,Risk Assessment,E05.318.740.600.800.715
23264446,2012-12-21T00:00:00,Risk Assessment,N04.452.871.715
23264446,2012-12-21T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
23264446,2012-12-21T00:00:00,Risk Assessment,N06.850.505.715
23264446,2012-12-21T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
23264446,2012-12-21T00:00:00,Risk Factors,E05.318.740.600.800.725
23264446,2012-12-21T00:00:00,Risk Factors,N05.715.350.200.700
23264446,2012-12-21T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23264446,2012-12-21T00:00:00,Risk Factors,N06.850.490.625.750
23264446,2012-12-21T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23264446,2012-12-21T00:00:00,Stroke,C10.228.140.300.775
23264446,2012-12-21T00:00:00,Stroke,C14.907.253.855
23264446,2012-12-21T00:00:00,Treatment Outcome,E01.789.800
23264446,2012-12-21T00:00:00,Treatment Outcome,N04.761.559.590.800
23264446,2012-12-21T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23264446,2012-12-21T00:00:00,Warfarin,D03.438.150.446.520.914
23264446,2012-12-21T00:00:00,Warfarin,D03.830.219.446.520.914
23264628,2012-12-21T00:00:00,Animals,B01.050
23264628,2012-12-21T00:00:00,Astrocytes,A08.637.200
23264628,2012-12-21T00:00:00,Astrocytes,A11.650.200
23264628,2012-12-21T00:00:00,Cell Differentiation,G04.299.151
23264628,2012-12-21T00:00:00,Central Nervous System,A08.186
23264628,2012-12-21T00:00:00,Gene Expression Regulation,G05.355.315
23264628,2012-12-21T00:00:00,Nitric Oxide,D01.339.387
23264628,2012-12-21T00:00:00,Nitric Oxide,D01.625.550.500
23264628,2012-12-21T00:00:00,Nitric Oxide,D01.625.700.500
23264628,2012-12-21T00:00:00,Nitric Oxide,D01.650.550.587.600
23264628,2012-12-21T00:00:00,Oligodendroglia,A08.637.600
23264628,2012-12-21T00:00:00,Oligodendroglia,A11.650.600
23264628,2012-12-21T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23264628,2012-12-21T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
23264628,2012-12-21T00:00:00,S-Nitrosoglutathione,D02.654.846.500.249
23264628,2012-12-21T00:00:00,S-Nitrosoglutathione,D02.886.489.650.750
23264628,2012-12-21T00:00:00,S-Nitrosoglutathione,D12.644.456.448.750
23264628,2012-12-21T00:00:00,Signal Transduction,G02.111.087.800
23264628,2012-12-21T00:00:00,Signal Transduction,G02.149.115.800
23264628,2012-12-21T00:00:00,Signal Transduction,G04.299.880
23264628,2012-12-21T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567.878
23264628,2012-12-21T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750.843
23264628,2012-12-21T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.644.360.450.835
23264628,2012-12-21T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.776.476.450.835
23396174,2012-12-21T00:00:00,Adolescent,M01.060.057
23396174,2012-12-21T00:00:00,Adult,M01.060.116
23396174,2012-12-21T00:00:00,Alcoholism,C21.739.100.250
23396174,2012-12-21T00:00:00,Alcoholism,F03.900.100.350
23396174,2012-12-21T00:00:00,Crime Victims,M01.135
23396174,2012-12-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23396174,2012-12-21T00:00:00,Marijuana Abuse,C21.739.635
23396174,2012-12-21T00:00:00,Marijuana Abuse,F03.900.635
23396174,2012-12-21T00:00:00,Rape,I01.198.240.748.640
23396174,2012-12-21T00:00:00,Referral and Consultation,N04.452.758.849
23396174,2012-12-21T00:00:00,Substance-Related Disorders,C21.739
23396174,2012-12-21T00:00:00,Substance-Related Disorders,F03.900
23396174,2012-12-21T00:00:00,Young Adult,M01.060.116.815
23266769,2012-12-22T00:00:00,25-Hydroxyvitamin D 2,D04.808.247.222.474.400
23266769,2012-12-22T00:00:00,25-Hydroxyvitamin D 2,D04.808.247.808.412.400
23266769,2012-12-22T00:00:00,25-Hydroxyvitamin D 2,D04.808.812.768.462.400
23266769,2012-12-22T00:00:00,25-Hydroxyvitamin D 2,D10.570.938.439.500
23266769,2012-12-22T00:00:00,Blood Chemical Analysis,E01.450.150.100
23266769,2012-12-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23267721,2012-12-23T00:00:00,Adolescent,M01.060.057
23267721,2012-12-23T00:00:00,Adult,M01.060.116
23267721,2012-12-23T00:00:00,Child,M01.060.406
23267721,2012-12-23T00:00:00,"Child, Preschool",M01.060.406.448
23267721,2012-12-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23267721,2012-12-23T00:00:00,Melanocytes,A11.436.613
23267721,2012-12-23T00:00:00,"Nevus, Pigmented",C04.557.665.560.615
23266995,2012-12-24T00:00:00,Adolescent,M01.060.057
23266995,2012-12-24T00:00:00,Adolescent Behavior,F01.145.022
23266995,2012-12-24T00:00:00,Crime Victims,M01.135
23266995,2012-12-24T00:00:00,Ethnic Groups,M01.686.754
23266995,2012-12-24T00:00:00,Ethnic Groups,N01.224.317
23266995,2012-12-24T00:00:00,Health Status,I01.240.425
23266995,2012-12-24T00:00:00,Health Status,N01.224.425
23266995,2012-12-24T00:00:00,Health Status,N06.850.505.400.425
23266995,2012-12-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23266995,2012-12-24T00:00:00,Juvenile Delinquency,I01.880.735.479
23266995,2012-12-24T00:00:00,Peer Group,F01.829.316.483
23266995,2012-12-24T00:00:00,Risk Factors,E05.318.740.600.800.725
23266995,2012-12-24T00:00:00,Risk Factors,N05.715.350.200.700
23266995,2012-12-24T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23266995,2012-12-24T00:00:00,Risk Factors,N06.850.490.625.750
23266995,2012-12-24T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23266995,2012-12-24T00:00:00,Risk-Taking,F01.145.722
23266995,2012-12-24T00:00:00,United States,Z01.107.567.875
23266995,2012-12-24T00:00:00,Violence,I01.198.240.856
23266995,2012-12-24T00:00:00,Violence,I01.880.735.900
23272824,2012-12-25T00:00:00,"Ethics, Medical",K01.316.333.132.750
23272824,2012-12-25T00:00:00,"Ethics, Medical",N05.350.340.162.500
23272824,2012-12-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23272824,2012-12-25T00:00:00,Thoracic Surgery,H02.403.810.803
23275571,2012-12-28T00:00:00,Molecular Sequence Data,L01.453.245.667
23275571,2012-12-28T00:00:00,Mutation,G05.365.590
23275571,2012-12-28T00:00:00,"Nuclear Magnetic Resonance, Biomolecular",E05.196.867.519.550
23275571,2012-12-28T00:00:00,Nucleic Acid Conformation,G02.111.570.790.486
23275571,2012-12-28T00:00:00,Nucleic Acid Conformation,G05.360.580
23275571,2012-12-28T00:00:00,"RNA, Viral",D13.444.735.828
23275571,2012-12-28T00:00:00,Temperature,G01.906.595
23275571,2012-12-28T00:00:00,Temperature,G16.500.275.063.725.710
23275571,2012-12-28T00:00:00,Temperature,G16.500.750.775.710
23275571,2012-12-28T00:00:00,Temperature,N06.230.150.450
23275571,2012-12-28T00:00:00,Temperature,N06.230.300.100.725.710
23313232,2012-12-28T00:00:00,Adsorption,G02.149.047
23313232,2012-12-28T00:00:00,Adsorption,G02.149.767.029
23313232,2012-12-28T00:00:00,Adsorption,G02.842.750.029
23313232,2012-12-28T00:00:00,Biphenyl Compounds,D02.455.426.559.389.185
23313232,2012-12-28T00:00:00,Carbon,D01.268.150
23313232,2012-12-28T00:00:00,Graphite,D01.268.150.300
23313232,2012-12-28T00:00:00,Graphite,D01.578.300
23313232,2012-12-28T00:00:00,Nanostructures,J01.637.512
23313232,2012-12-28T00:00:00,"Nanotubes, Carbon",D01.268.150.250.500
23313232,2012-12-28T00:00:00,"Nanotubes, Carbon",J01.637.512.850.500
23313232,2012-12-28T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
23313232,2012-12-28T00:00:00,Water Purification,N06.850.780.200.800.800.900.900
23313232,2012-12-28T00:00:00,Water Purification,N06.850.860.510.900.900
23313232,2012-12-28T00:00:00,Water Purification,N06.850.860.510.915.900
22322428,2013-01-01T00:00:00,Adolescent,M01.060.057
22322428,2013-01-01T00:00:00,Adult,M01.060.116
22322428,2013-01-01T00:00:00,African Continental Ancestry Group,M01.686.508.100
22322428,2013-01-01T00:00:00,Birth Weight,C23.888.144.186
22322428,2013-01-01T00:00:00,Birth Weight,E01.370.600.115.100.160.120.186
22322428,2013-01-01T00:00:00,Birth Weight,E05.041.124.160.750.149
22322428,2013-01-01T00:00:00,Birth Weight,G07.100.100.160.120.186
22322428,2013-01-01T00:00:00,Birth Weight,G07.700.320.249.314.120.186
22322428,2013-01-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
22322428,2013-01-01T00:00:00,Body Mass Index,E05.041.124.125
22322428,2013-01-01T00:00:00,Body Mass Index,G07.100.100.125
22322428,2013-01-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
22322428,2013-01-01T00:00:00,Body Weight,C23.888.144
22322428,2013-01-01T00:00:00,Body Weight,E01.370.600.115.100.160.120
22322428,2013-01-01T00:00:00,Body Weight,E05.041.124.160.750
22322428,2013-01-01T00:00:00,Body Weight,G07.100.100.160.120
22322428,2013-01-01T00:00:00,Body Weight,G07.700.320.249.314.120
22322428,2013-01-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
22322428,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22322428,2013-01-01T00:00:00,"Infant, Newborn",M01.060.703.520
22322428,2013-01-01T00:00:00,Pregnancy,G08.686.785.760.769
22322428,2013-01-01T00:00:00,Regression Analysis,E05.318.740.750
22322428,2013-01-01T00:00:00,Regression Analysis,N05.715.360.750.695
22322428,2013-01-01T00:00:00,Regression Analysis,N06.850.520.830.750
22322428,2013-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
22322428,2013-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
22322428,2013-01-01T00:00:00,Weight Gain,C23.888.144.243.926
22322428,2013-01-01T00:00:00,Weight Gain,G07.700.320.249.314.120.200.926
22322428,2013-01-01T00:00:00,Young Adult,M01.060.116.815
22371267,2013-01-01T00:00:00,Alcohol Drinking,F01.145.317.269
22371267,2013-01-01T00:00:00,Animals,B01.050
22371267,2013-01-01T00:00:00,Central Nervous System Depressants,D27.505.696.277
22371267,2013-01-01T00:00:00,Central Nervous System Depressants,D27.505.954.427.210
22371267,2013-01-01T00:00:00,"Disease Models, Animal",C22.232
22371267,2013-01-01T00:00:00,"Disease Models, Animal",E05.598.500
22371267,2013-01-01T00:00:00,"Disease Models, Animal",E05.599.395.080
22371267,2013-01-01T00:00:00,Ethanol,D02.033.375
22371267,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22415358,2013-01-01T00:00:00,Aged,M01.060.116.100
22415358,2013-01-01T00:00:00,Aging,G07.700.320.124
22415358,2013-01-01T00:00:00,Gait,E01.370.600.250
22415358,2013-01-01T00:00:00,Gait,G11.427.590.530.389
22415358,2013-01-01T00:00:00,Geriatric Assessment,E05.318.308.225
22415358,2013-01-01T00:00:00,Geriatric Assessment,I01.240.425.350
22415358,2013-01-01T00:00:00,Geriatric Assessment,L01.280.360
22415358,2013-01-01T00:00:00,Geriatric Assessment,N01.224.425.350
22415358,2013-01-01T00:00:00,Geriatric Assessment,N05.715.360.300.360
22415358,2013-01-01T00:00:00,Geriatric Assessment,N06.850.505.400.425.350
22415358,2013-01-01T00:00:00,Geriatric Assessment,N06.850.520.308.225
22415358,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22415358,2013-01-01T00:00:00,Walking,G11.427.590.530.568.900
22415358,2013-01-01T00:00:00,Walking,G11.427.590.530.698.940
22415358,2013-01-01T00:00:00,Walking,I03.450.642.845.940
22488969,2013-01-01T00:00:00,Adolescent,M01.060.057
22488969,2013-01-01T00:00:00,Adult,M01.060.116
22488969,2013-01-01T00:00:00,Case-Control Studies,E05.318.760.500.500
22488969,2013-01-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
22488969,2013-01-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
22488969,2013-01-01T00:00:00,Child,M01.060.406
22488969,2013-01-01T00:00:00,"Child, Preschool",M01.060.406.448
22488969,2013-01-01T00:00:00,Crohn Disease,C06.405.205.731.500
22488969,2013-01-01T00:00:00,Crohn Disease,C06.405.469.432.500
22488969,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22488969,2013-01-01T00:00:00,Parathyroid Hormone,D06.472.699.590
22488969,2013-01-01T00:00:00,Parathyroid Hormone,D12.644.548.587
22488969,2013-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
22488969,2013-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
22488969,2013-01-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
22488969,2013-01-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
22488969,2013-01-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
22488969,2013-01-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
22488969,2013-01-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
22488969,2013-01-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
22488969,2013-01-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
22488969,2013-01-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
22488969,2013-01-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
22488969,2013-01-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
22488969,2013-01-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
22488969,2013-01-01T00:00:00,Vitamin D,D04.808.812.768
22488969,2013-01-01T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
22488969,2013-01-01T00:00:00,Young Adult,M01.060.116.815
23070097,2013-01-01T00:00:00,Adult,M01.060.116
23070097,2013-01-01T00:00:00,Aged,M01.060.116.100
23070097,2013-01-01T00:00:00,Artifacts,E05.047
23070097,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23070097,2013-01-01T00:00:00,Liver Diseases,C06.552
23070097,2013-01-01T00:00:00,Middle Aged,M01.060.116.630
23070097,2013-01-01T00:00:00,Radiation Dosage,E05.799.513
23070097,2013-01-01T00:00:00,Radiation Dosage,G01.201.875.740
23070097,2013-01-01T00:00:00,Radiation Dosage,N06.850.810.250
23070097,2013-01-01T00:00:00,"Radiography, Abdominal",E01.370.350.700.715
23070097,2013-01-01T00:00:00,"Radiography, Dual-Energy Scanned Projection",E01.370.350.600.350.700.700
23070097,2013-01-01T00:00:00,"Radiography, Dual-Energy Scanned Projection",E01.370.350.700.700.700
23070097,2013-01-01T00:00:00,"Radiography, Dual-Energy Scanned Projection",E01.370.350.760.700
23070097,2013-01-01T00:00:00,"Radiography, Dual-Energy Scanned Projection",L01.224.308.380.800
23070097,2013-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23070097,2013-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23070097,2013-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23070097,2013-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23070097,2013-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23070097,2013-01-01T00:00:00,Young Adult,M01.060.116.815
23096416,2013-01-01T00:00:00,Adult,M01.060.116
23096416,2013-01-01T00:00:00,Aged,M01.060.116.100
23096416,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23096416,2013-01-01T00:00:00,Intracranial Aneurysm,C10.228.140.300.510.600
23096416,2013-01-01T00:00:00,Intracranial Aneurysm,C14.907.055.635
23096416,2013-01-01T00:00:00,Intracranial Aneurysm,C14.907.253.560.300
23096416,2013-01-01T00:00:00,Middle Aged,M01.060.116.630
23096416,2013-01-01T00:00:00,Neurosurgical Procedures,E04.525
23111406,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23150372,2013-01-01T00:00:00,Animals,B01.050
23150372,2013-01-01T00:00:00,DNA Damage,C21.111
23150372,2013-01-01T00:00:00,DNA Damage,G05.355.180
23150372,2013-01-01T00:00:00,"DNA, Mitochondrial",D13.444.308.283.225
23150372,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23150372,2013-01-01T00:00:00,Mitochondria,A11.284.430.214.190.875.564
23150372,2013-01-01T00:00:00,Mitochondria,A11.284.835.626
23150372,2013-01-01T00:00:00,Oxidative Stress,G03.495.710
23150372,2013-01-01T00:00:00,Oxidative Stress,G07.700.830.750
23150372,2013-01-01T00:00:00,Oxygen,D01.268.185.550
23150372,2013-01-01T00:00:00,Oxygen,D01.362.670
23150372,2013-01-01T00:00:00,Retina,A09.371.729
23154644,2013-01-01T00:00:00,Depressive Disorder,F03.600.300
23154644,2013-01-01T00:00:00,Evidence-Based Medicine,H02.249.750
23154644,2013-01-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
23154644,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23154644,2013-01-01T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
23154644,2013-01-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
23154644,2013-01-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
23154644,2013-01-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
23154644,2013-01-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
23154644,2013-01-01T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
23154644,2013-01-01T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
23159848,2013-01-01T00:00:00,Cell Cycle,G04.299.134
23159848,2013-01-01T00:00:00,Cell Cycle Proteins,D12.776.167
23159848,2013-01-01T00:00:00,"Cell Transformation, Neoplastic",C04.697.152
23159848,2013-01-01T00:00:00,"Cell Transformation, Neoplastic",C23.550.727.152
23159848,2013-01-01T00:00:00,Cyclin-Dependent Kinase Inhibitor p21,D12.644.360.225.500
23159848,2013-01-01T00:00:00,Cyclin-Dependent Kinase Inhibitor p21,D12.776.167.187.500
23159848,2013-01-01T00:00:00,Cyclin-Dependent Kinase Inhibitor p21,D12.776.476.225.500
23159848,2013-01-01T00:00:00,Cyclin-Dependent Kinase Inhibitor p21,D12.776.624.776.355.500
23159848,2013-01-01T00:00:00,Gene Expression Regulation,G05.355.315
23159848,2013-01-01T00:00:00,"Genes, p53",G05.360.340.024.340.375.249.385
23159848,2013-01-01T00:00:00,"Genes, p53",G05.360.340.024.340.415.400.385
23159848,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23159848,2013-01-01T00:00:00,Neoplasms,C04
23172611,2013-01-01T00:00:00,Antiviral Agents,D27.505.954.122.388
23172611,2013-01-01T00:00:00,Glomerulonephritis,C12.777.419.570.363
23172611,2013-01-01T00:00:00,Glomerulonephritis,C13.351.968.419.570.363
23172611,2013-01-01T00:00:00,Hepatitis C,C02.440.440
23172611,2013-01-01T00:00:00,Hepatitis C,C02.782.350.350
23172611,2013-01-01T00:00:00,Hepatitis C,C06.552.380.705.440
23172611,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23172611,2013-01-01T00:00:00,Middle Aged,M01.060.116.630
23172611,2013-01-01T00:00:00,Oligopeptides,D12.644.456
23172611,2013-01-01T00:00:00,Stroke,C10.228.140.300.775
23172611,2013-01-01T00:00:00,Stroke,C14.907.253.855
23192083,2013-01-01T00:00:00,Bayes Theorem,E05.318.740.600.200
23192083,2013-01-01T00:00:00,Bayes Theorem,N05.715.360.750.625.150
23192083,2013-01-01T00:00:00,Bayes Theorem,N06.850.520.830.600.200
23192083,2013-01-01T00:00:00,"Data Interpretation, Statistical",E05.245.380
23192083,2013-01-01T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
23192083,2013-01-01T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
23192083,2013-01-01T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
23192083,2013-01-01T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
23192083,2013-01-01T00:00:00,Radiation Monitoring,E05.799.638
23192083,2013-01-01T00:00:00,Radiation Monitoring,N06.850.780.375.700
23192083,2013-01-01T00:00:00,Radiation Monitoring,N06.850.810.370
23197285,2013-01-01T00:00:00,Contrast Media,D27.720.259
23197285,2013-01-01T00:00:00,Diagnostic Imaging,E01.370.350
23197285,2013-01-01T00:00:00,Evidence-Based Medicine,H02.249.750
23197285,2013-01-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
23197285,2013-01-01T00:00:00,Fluorodeoxyglucose F18,D09.254.229.500
23197285,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23197285,2013-01-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
23197285,2013-01-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
23197285,2013-01-01T00:00:00,Positron-Emission Tomography,E01.370.350.350.800.700
23197285,2013-01-01T00:00:00,Positron-Emission Tomography,E01.370.350.600.350.800.399
23197285,2013-01-01T00:00:00,Positron-Emission Tomography,E01.370.350.710.800.399
23197285,2013-01-01T00:00:00,Positron-Emission Tomography,E01.370.350.825.800.399
23197285,2013-01-01T00:00:00,Positron-Emission Tomography,E01.370.384.730.800.399
23197285,2013-01-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
23197285,2013-01-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
23197285,2013-01-01T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
23197285,2013-01-01T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
23197285,2013-01-01T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
23197285,2013-01-01T00:00:00,Radiology,H02.403.740
23197285,2013-01-01T00:00:00,Radiopharmaceuticals,D27.720.470.410.650
23197285,2013-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23197285,2013-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23197285,2013-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23197285,2013-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23197285,2013-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23202287,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23202287,2013-01-01T00:00:00,Kidney Neoplasms,C04.588.945.947.535
23202287,2013-01-01T00:00:00,Kidney Neoplasms,C12.758.820.750
23202287,2013-01-01T00:00:00,Kidney Neoplasms,C12.777.419.473
23202287,2013-01-01T00:00:00,Kidney Neoplasms,C13.351.937.820.535
23202287,2013-01-01T00:00:00,Kidney Neoplasms,C13.351.968.419.473
23202287,2013-01-01T00:00:00,Lymph Node Excision,E04.446
23202287,2013-01-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
23202287,2013-01-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
23202287,2013-01-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
23202287,2013-01-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
23202287,2013-01-01T00:00:00,"Surgical Procedures, Minimally Invasive",E04.800
23202287,2013-01-01T00:00:00,Treatment Outcome,E01.789.800
23202287,2013-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23202287,2013-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23224875,2013-01-01T00:00:00,Animals,B01.050
23224875,2013-01-01T00:00:00,Calcium,D01.268.552.100
23224875,2013-01-01T00:00:00,Calcium,D01.552.539.288
23224875,2013-01-01T00:00:00,Calcium,D23.119.100
23224875,2013-01-01T00:00:00,Cardiomegaly,C14.280.195
23224875,2013-01-01T00:00:00,Cardiomegaly,C23.300.775.250
23224875,2013-01-01T00:00:00,Gene Expression Regulation,G05.355.315
23224875,2013-01-01T00:00:00,Heart Failure,C14.280.434
23224875,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23224875,2013-01-01T00:00:00,Myocardial Contraction,G09.330.190.541
23224875,2013-01-01T00:00:00,Myocardial Contraction,G11.427.590.540.570
23224875,2013-01-01T00:00:00,Sodium-Calcium Exchanger,D12.776.157.530.450.162.442
23224875,2013-01-01T00:00:00,Sodium-Calcium Exchanger,D12.776.543.585.450.162.442
23224875,2013-01-01T00:00:00,"Transcription, Genetic",G02.111.087.847
23224875,2013-01-01T00:00:00,"Transcription, Genetic",G02.149.115.847
23224875,2013-01-01T00:00:00,"Transcription, Genetic",G05.355.310.700
23232986,2013-01-01T00:00:00,Age Factors,N05.715.350.075
23232986,2013-01-01T00:00:00,Age Factors,N06.850.490.250
23232986,2013-01-01T00:00:00,Anticholesteremic Agents,D27.505.519.186.071.202
23232986,2013-01-01T00:00:00,Anticholesteremic Agents,D27.505.954.230.202
23232986,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23232986,2013-01-01T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370
23232986,2013-01-01T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370
23232986,2013-01-01T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.230.202.370
23232986,2013-01-01T00:00:00,Hypercholesterolemia,C18.452.584.500.500.396
23232986,2013-01-01T00:00:00,Incidence,E05.318.308.985.525.375
23232986,2013-01-01T00:00:00,Incidence,L01.280.975.525.375
23232986,2013-01-01T00:00:00,Incidence,N01.224.935.597.500
23232986,2013-01-01T00:00:00,Incidence,N06.850.505.400.975.525.375
23232986,2013-01-01T00:00:00,Incidence,N06.850.520.308.985.525.375
23232986,2013-01-01T00:00:00,"Lipoproteins, LDL",D10.532.515
23232986,2013-01-01T00:00:00,"Lipoproteins, LDL",D12.776.521.550
23232986,2013-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
23232986,2013-01-01T00:00:00,Risk Factors,N05.715.350.200.700
23232986,2013-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23232986,2013-01-01T00:00:00,Risk Factors,N06.850.490.625.750
23232986,2013-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23232986,2013-01-01T00:00:00,Young Adult,M01.060.116.815
23235396,2013-01-01T00:00:00,Adult,M01.060.116
23235396,2013-01-01T00:00:00,Device Removal,E04.199
23235396,2013-01-01T00:00:00,Gastroplasty,E02.065.062.750
23235396,2013-01-01T00:00:00,Gastroplasty,E04.062.750
23235396,2013-01-01T00:00:00,Gastroplasty,E04.210.485
23235396,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23235396,2013-01-01T00:00:00,Laparoscopy,E01.370.388.250.520
23235396,2013-01-01T00:00:00,Laparoscopy,E04.800.250.520
23235396,2013-01-01T00:00:00,Middle Aged,M01.060.116.630
23235396,2013-01-01T00:00:00,Obesity,C18.654.726.500
23235396,2013-01-01T00:00:00,Obesity,C23.888.144.699.500
23235396,2013-01-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
23235396,2013-01-01T00:00:00,Obesity,G07.100.100.160.120.699.500
23235396,2013-01-01T00:00:00,Reoperation,E04.690
23235396,2013-01-01T00:00:00,Treatment Outcome,E01.789.800
23235396,2013-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23235396,2013-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23235396,2013-01-01T00:00:00,Weight Loss,C23.888.144.243.963
23235396,2013-01-01T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
23245789,2013-01-01T00:00:00,Aged,M01.060.116.100
23245789,2013-01-01T00:00:00,Automobile Driving,I03.125
23245789,2013-01-01T00:00:00,Caregivers,M01.085
23245789,2013-01-01T00:00:00,Caregivers,M01.526.485.200
23245789,2013-01-01T00:00:00,Caregivers,N02.360.200
23245789,2013-01-01T00:00:00,Geriatric Assessment,E05.318.308.225
23245789,2013-01-01T00:00:00,Geriatric Assessment,I01.240.425.350
23245789,2013-01-01T00:00:00,Geriatric Assessment,L01.280.360
23245789,2013-01-01T00:00:00,Geriatric Assessment,N01.224.425.350
23245789,2013-01-01T00:00:00,Geriatric Assessment,N05.715.360.300.360
23245789,2013-01-01T00:00:00,Geriatric Assessment,N06.850.505.400.425.350
23245789,2013-01-01T00:00:00,Geriatric Assessment,N06.850.520.308.225
23245789,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23245789,2013-01-01T00:00:00,Life Style,F01.829.458
23245789,2013-01-01T00:00:00,Psychometrics,F04.711.780
23254638,2013-01-01T00:00:00,Animals,B01.050
23254638,2013-01-01T00:00:00,Brain,A08.186.211
23254638,2013-01-01T00:00:00,Cell Line,A11.251.210
23254638,2013-01-01T00:00:00,Chronic Disease,C23.550.291.500
23254638,2013-01-01T00:00:00,Cognition Disorders,F03.087.250
23254638,2013-01-01T00:00:00,"Disease Models, Animal",C22.232
23254638,2013-01-01T00:00:00,"Disease Models, Animal",E05.598.500
23254638,2013-01-01T00:00:00,"Disease Models, Animal",E05.599.395.080
23254638,2013-01-01T00:00:00,Maze Learning,F02.463.425.507
23254638,2013-01-01T00:00:00,Neuroprotective Agents,D27.505.696.706.548
23254638,2013-01-01T00:00:00,Neuroprotective Agents,D27.505.954.427.575
23254638,2013-01-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23254638,2013-01-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
23254638,2013-01-01T00:00:00,S-Nitrosoglutathione,D02.654.846.500.249
23254638,2013-01-01T00:00:00,S-Nitrosoglutathione,D02.886.489.650.750
23254638,2013-01-01T00:00:00,S-Nitrosoglutathione,D12.644.456.448.750
23257926,2013-01-01T00:00:00,Animals,B01.050
23257926,2013-01-01T00:00:00,Cocaine,D02.145.074.722.388
23257926,2013-01-01T00:00:00,Cocaine,D03.132.889.354
23257926,2013-01-01T00:00:00,Cocaine,D03.605.869.388
23257926,2013-01-01T00:00:00,Cocaine,D04.075.080.875.099.722.388
23257926,2013-01-01T00:00:00,"Conditioning, Operant",F02.463.425.179.509
23257926,2013-01-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.150.800
23257926,2013-01-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.600.220
23257926,2013-01-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.150.800
23257926,2013-01-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.600.220
23257926,2013-01-01T00:00:00,Phenotype,G05.695
23262812,2013-01-01T00:00:00,Aged,M01.060.116.100
23262812,2013-01-01T00:00:00,Bacteremia,C01.252.100
23262812,2013-01-01T00:00:00,Bacteremia,C01.539.757.100
23262812,2013-01-01T00:00:00,Bacteremia,C23.550.470.790.500.100
23262812,2013-01-01T00:00:00,Endophthalmitis,C01.252.354.900.350
23262812,2013-01-01T00:00:00,Endophthalmitis,C01.539.375.354.900.350
23262812,2013-01-01T00:00:00,Endophthalmitis,C01.539.375.450.900.350
23262812,2013-01-01T00:00:00,Endophthalmitis,C01.703.343.900.350
23262812,2013-01-01T00:00:00,Endophthalmitis,C11.294.354.900.350
23262812,2013-01-01T00:00:00,Endophthalmitis,C11.294.450.900.350
23262812,2013-01-01T00:00:00,Endophthalmitis,C11.941.879.960.380
23262812,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23262812,2013-01-01T00:00:00,Methicillin-Resistant Staphylococcus aureus,B03.300.390.400.800.750.100.500
23262812,2013-01-01T00:00:00,Methicillin-Resistant Staphylococcus aureus,B03.510.100.750.750.100.500
23262812,2013-01-01T00:00:00,Methicillin-Resistant Staphylococcus aureus,B03.510.400.790.750.100.500
23262812,2013-01-01T00:00:00,"Pacemaker, Artificial",E07.858.082.748
23262812,2013-01-01T00:00:00,Staphylococcal Infections,C01.252.410.868
23263313,2013-01-01T00:00:00,Competency-Based Education,I02.158.210
23263313,2013-01-01T00:00:00,Disaster Planning,N06.230.100.035
23263313,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23263313,2013-01-01T00:00:00,Inservice Training,I02.574
23263313,2013-01-01T00:00:00,Needs Assessment,I02.594
23263313,2013-01-01T00:00:00,Needs Assessment,N03.349.380.565
23263313,2013-01-01T00:00:00,Needs Assessment,N05.300.537
23263313,2013-01-01T00:00:00,Program Development,N04.452.760
23263318,2013-01-01T00:00:00,Adolescent,M01.060.057
23263318,2013-01-01T00:00:00,Adult,M01.060.116
23263318,2013-01-01T00:00:00,Case-Control Studies,E05.318.760.500.500
23263318,2013-01-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
23263318,2013-01-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
23263318,2013-01-01T00:00:00,Chlorine,D01.268.380.150
23263318,2013-01-01T00:00:00,Chlorine,D01.362.225
23263318,2013-01-01T00:00:00,Disaster Planning,N06.230.100.035
23263318,2013-01-01T00:00:00,Disasters,N06.230.100
23263318,2013-01-01T00:00:00,Health Services Accessibility,N04.590.374.350
23263318,2013-01-01T00:00:00,Health Services Accessibility,N05.300.430
23263318,2013-01-01T00:00:00,Healthcare Disparities,N04.590.374.380
23263318,2013-01-01T00:00:00,Healthcare Disparities,N05.300.493
23263318,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23263318,2013-01-01T00:00:00,Middle Aged,M01.060.116.630
23263318,2013-01-01T00:00:00,Primary Health Care,N04.590.233.727
23263318,2013-01-01T00:00:00,Regression Analysis,E05.318.740.750
23263318,2013-01-01T00:00:00,Regression Analysis,N05.715.360.750.695
23263318,2013-01-01T00:00:00,Regression Analysis,N06.850.520.830.750
23263318,2013-01-01T00:00:00,United States,Z01.107.567.875
23267130,2013-01-01T00:00:00,Apoptosis,G04.299.139.160
23267130,2013-01-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
23267130,2013-01-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
23267130,2013-01-01T00:00:00,Ceramides,D02.065.313
23267130,2013-01-01T00:00:00,Ceramides,D09.400.410.420.525.200
23267130,2013-01-01T00:00:00,Ceramides,D10.390.470.675.200
23267130,2013-01-01T00:00:00,Ceramides,D10.570.877.360.612.200
23267130,2013-01-01T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
23267130,2013-01-01T00:00:00,Head and Neck Neoplasms,C04.588.443
23267130,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23267130,2013-01-01T00:00:00,Oxidoreductases,D08.811.682
23267130,2013-01-01T00:00:00,Photochemotherapy,E02.186.500
23267130,2013-01-01T00:00:00,Photochemotherapy,E02.319.685
23267130,2013-01-01T00:00:00,Photochemotherapy,E02.774.722
23267130,2013-01-01T00:00:00,Sphingolipids,D10.570.877
23267130,2013-01-01T00:00:00,Sphingolipids,D10.808
23273083,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23273083,2013-01-01T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
23273083,2013-01-01T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
23273083,2013-01-01T00:00:00,Peptide Fragments,D12.644.541
23273083,2013-01-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
23273083,2013-01-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
23273083,2013-01-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
23273083,2013-01-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
23276939,2013-01-01T00:00:00,Alternative Splicing,G02.111.087.750.700.100
23276939,2013-01-01T00:00:00,Alternative Splicing,G02.149.115.750.700.100
23276939,2013-01-01T00:00:00,Alternative Splicing,G03.495.839.700.100
23276939,2013-01-01T00:00:00,Alternative Splicing,G05.355.315.700.700.100
23276939,2013-01-01T00:00:00,Animals,B01.050
23276939,2013-01-01T00:00:00,Autoimmunity,G12.450.192
23276939,2013-01-01T00:00:00,Calcium,D01.268.552.100
23276939,2013-01-01T00:00:00,Calcium,D01.552.539.288
23276939,2013-01-01T00:00:00,Calcium,D23.119.100
23276939,2013-01-01T00:00:00,Cell Adhesion,G04.299.117
23276939,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23276939,2013-01-01T00:00:00,"Models, Molecular",E05.599.595
23276939,2013-01-01T00:00:00,Neurodegenerative Diseases,C10.574
23276939,2013-01-01T00:00:00,Transglutaminases,D08.811.913.050.200.800
23276939,2013-01-01T00:00:00,Wound Healing,G16.100.856.891
23279681,2013-01-01T00:00:00,Aged,M01.060.116.100
23279681,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23279681,2013-01-01T00:00:00,Kidney Transplantation,E02.870.500
23279681,2013-01-01T00:00:00,Kidney Transplantation,E04.936.450.485
23279681,2013-01-01T00:00:00,Kidney Transplantation,E04.950.774.400
23279681,2013-01-01T00:00:00,Middle Aged,M01.060.116.630
23279681,2013-01-01T00:00:00,United States,Z01.107.567.875
23282724,2013-01-01T00:00:00,Cross Infection,C01.539.248
23282724,2013-01-01T00:00:00,Health Personnel,M01.526.485
23282724,2013-01-01T00:00:00,Health Personnel,N02.360
23282724,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23282724,2013-01-01T00:00:00,Hygiene,E02.547
23282724,2013-01-01T00:00:00,Hygiene,N06.850.670
23282724,2013-01-01T00:00:00,Operating Rooms,N02.278.388.700
23283859,2013-01-01T00:00:00,Heart Diseases,C14.280
23283859,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23283859,2013-01-01T00:00:00,Obesity,C18.654.726.500
23283859,2013-01-01T00:00:00,Obesity,C23.888.144.699.500
23283859,2013-01-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
23283859,2013-01-01T00:00:00,Obesity,G07.100.100.160.120.699.500
23283859,2013-01-01T00:00:00,Stroke,C10.228.140.300.775
23283859,2013-01-01T00:00:00,Stroke,C14.907.253.855
23283859,2013-01-01T00:00:00,United States,Z01.107.567.875
23288636,2013-01-01T00:00:00,"Carcinoma, Hepatocellular",C04.557.470.200.025.255
23288636,2013-01-01T00:00:00,"Carcinoma, Hepatocellular",C04.588.274.623.160
23288636,2013-01-01T00:00:00,"Carcinoma, Hepatocellular",C06.301.623.160
23288636,2013-01-01T00:00:00,"Carcinoma, Hepatocellular",C06.552.697.160
23288636,2013-01-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
23288636,2013-01-01T00:00:00,Clinical Trials as Topic,E05.337.250
23288636,2013-01-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
23288636,2013-01-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
23288636,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23288636,2013-01-01T00:00:00,Liver Neoplasms,C04.588.274.623
23288636,2013-01-01T00:00:00,Liver Neoplasms,C06.301.623
23288636,2013-01-01T00:00:00,Liver Neoplasms,C06.552.697
23288641,2013-01-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
23288641,2013-01-01T00:00:00,Clinical Trials as Topic,E05.337.250
23288641,2013-01-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
23288641,2013-01-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
23288641,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23288641,2013-01-01T00:00:00,Multiple Myeloma,C04.557.595.500
23288641,2013-01-01T00:00:00,Multiple Myeloma,C14.907.454.460
23288641,2013-01-01T00:00:00,Multiple Myeloma,C15.378.147.780.650
23288641,2013-01-01T00:00:00,Multiple Myeloma,C15.378.463.835.460
23288641,2013-01-01T00:00:00,Multiple Myeloma,C20.683.515.845
23288641,2013-01-01T00:00:00,Multiple Myeloma,C20.683.780.650
23288641,2013-01-01T00:00:00,Neoplastic Stem Cells,A11.872.650
23288641,2013-01-01T00:00:00,Signal Transduction,G02.111.087.800
23288641,2013-01-01T00:00:00,Signal Transduction,G02.149.115.800
23288641,2013-01-01T00:00:00,Signal Transduction,G04.299.880
23288969,2013-01-01T00:00:00,Animals,B01.050
23288969,2013-01-01T00:00:00,Cataplexy,C10.886.425.800.200.750.500
23288969,2013-01-01T00:00:00,Cataplexy,F03.870.400.800.200.750.500
23288969,2013-01-01T00:00:00,"Disease Models, Animal",C22.232
23288969,2013-01-01T00:00:00,"Disease Models, Animal",E05.598.500
23288969,2013-01-01T00:00:00,"Disease Models, Animal",E05.599.395.080
23288969,2013-01-01T00:00:00,Electroencephalography,E01.370.376.300
23288969,2013-01-01T00:00:00,Electroencephalography,E01.370.405.245
23288969,2013-01-01T00:00:00,Electromyography,E01.370.405.255
23288969,2013-01-01T00:00:00,Electromyography,E01.370.530.255
23288969,2013-01-01T00:00:00,Gene Transfer Techniques,E05.393.350
23288969,2013-01-01T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
23288969,2013-01-01T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
23288969,2013-01-01T00:00:00,Narcolepsy,C10.886.425.800.200.750
23288969,2013-01-01T00:00:00,Narcolepsy,F03.870.400.800.200.750
23288969,2013-01-01T00:00:00,Neurons,A08.663
23288969,2013-01-01T00:00:00,Neurons,A11.671
23288969,2013-01-01T00:00:00,Neuropeptides,D12.644.400
23288969,2013-01-01T00:00:00,Neuropeptides,D12.776.641.650
23290775,2013-01-01T00:00:00,Animals,B01.050
23290775,2013-01-01T00:00:00,Antineoplastic Agents,D27.505.954.248
23290775,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23290775,2013-01-01T00:00:00,Neoplasms,C04
23290775,2013-01-01T00:00:00,Sphingolipids,D10.570.877
23290775,2013-01-01T00:00:00,Sphingolipids,D10.808
23290783,2013-01-01T00:00:00,Animals,B01.050
23290783,2013-01-01T00:00:00,Antineoplastic Agents,D27.505.954.248
23290783,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23290783,2013-01-01T00:00:00,Neoplasms,C04
23290783,2013-01-01T00:00:00,Sphingolipids,D10.570.877
23290783,2013-01-01T00:00:00,Sphingolipids,D10.808
23305002,2013-01-01T00:00:00,Adult,M01.060.116
23305002,2013-01-01T00:00:00,Altitude,G16.500.275.058
23305002,2013-01-01T00:00:00,Altitude,N06.230.058
23305002,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23305002,2013-01-01T00:00:00,"Hypertension, Pulmonary",C08.381.423
23305002,2013-01-01T00:00:00,Oxygen,D01.268.185.550
23305002,2013-01-01T00:00:00,Oxygen,D01.362.670
23305002,2013-01-01T00:00:00,Travel,I03.883
23305541,2013-01-01T00:00:00,Adolescent,M01.060.057
23305541,2013-01-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
23305541,2013-01-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
23305541,2013-01-01T00:00:00,Health Surveys,E05.318.308.250
23305541,2013-01-01T00:00:00,Health Surveys,N05.715.360.300.375
23305541,2013-01-01T00:00:00,Health Surveys,N06.850.520.308.250
23305541,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23305541,2013-01-01T00:00:00,Papillomavirus Infections,C02.256.650
23305541,2013-01-01T00:00:00,Papillomavirus Infections,C02.928.725
23305541,2013-01-01T00:00:00,Papillomavirus Vaccines,D20.215.894.899.498
23305541,2013-01-01T00:00:00,Sexual Behavior,F01.145.802
23305541,2013-01-01T00:00:00,Students,I02.233.748
23305541,2013-01-01T00:00:00,Students,I02.851
23305541,2013-01-01T00:00:00,Students,M01.848
23305541,2013-01-01T00:00:00,United States,Z01.107.567.875
23305541,2013-01-01T00:00:00,Young Adult,M01.060.116.815
23312630,2013-01-01T00:00:00,Evidence-Based Medicine,H02.249.750
23312630,2013-01-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
23312630,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23312630,2013-01-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
23312630,2013-01-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
23312630,2013-01-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
23312630,2013-01-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
23312630,2013-01-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
23312630,2013-01-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
23319023,2013-01-01T00:00:00,Bone Nails,E07.695.120
23319023,2013-01-01T00:00:00,Bone Nails,E07.858.442.660.100
23319023,2013-01-01T00:00:00,Bone Nails,E07.858.690.650.100
23319023,2013-01-01T00:00:00,Femoral Fractures,C21.866.404.061
23319023,2013-01-01T00:00:00,Femoral Fractures,C21.866.558.276
23319023,2013-01-01T00:00:00,"Fracture Fixation, Intramedullary",E04.555.300.300.300
23319023,2013-01-01T00:00:00,"Fractures, Stress",C21.866.404.437
23319023,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23319023,2013-01-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
23319023,2013-01-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
23319023,2013-01-01T00:00:00,Middle Aged,M01.060.116.630
23319023,2013-01-01T00:00:00,"Neoplasms, Connective Tissue",C04.557.450.565
23319023,2013-01-01T00:00:00,"Neoplasms, Connective Tissue",C17.300.680
23319023,2013-01-01T00:00:00,Treatment Outcome,E01.789.800
23319023,2013-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23319023,2013-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23321408,2013-01-01T00:00:00,Antihypertensive Agents,D27.505.954.411.162
23321408,2013-01-01T00:00:00,Drug Resistance,G07.690.320
23321408,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23321408,2013-01-01T00:00:00,Hypertension,C14.907.489
23321408,2013-01-01T00:00:00,Qualitative Research,H01.770.644.241.850
23323982,2013-01-01T00:00:00,Antigen-Antibody Complex,D12.776.124.486.485.114.257
23323982,2013-01-01T00:00:00,Antigen-Antibody Complex,D12.776.124.790.651.114.257
23323982,2013-01-01T00:00:00,Antigen-Antibody Complex,D12.776.377.715.548.114.257
23323982,2013-01-01T00:00:00,Antigen-Antibody Complex,D23.050.101
23323982,2013-01-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
23323982,2013-01-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
23323982,2013-01-01T00:00:00,"Glycosylation End Products, Advanced",D02.415
23323982,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23323982,2013-01-01T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
23323982,2013-01-01T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
23323982,2013-01-01T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
23323982,2013-01-01T00:00:00,"Lipoproteins, LDL",D10.532.515
23323982,2013-01-01T00:00:00,"Lipoproteins, LDL",D12.776.521.550
23340073,2013-01-01T00:00:00,Brain,A08.186.211
23340073,2013-01-01T00:00:00,Functional Laterality,F02.830.297.425
23340073,2013-01-01T00:00:00,Functional Laterality,G11.561.225.425
23340073,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23340073,2013-01-01T00:00:00,Recovery of Function,G16.757
23340073,2013-01-01T00:00:00,Stroke,C10.228.140.300.775
23340073,2013-01-01T00:00:00,Stroke,C14.907.253.855
23340073,2013-01-01T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
23340073,2013-01-01T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
23351737,2013-01-01T00:00:00,Animals,B01.050
23351737,2013-01-01T00:00:00,Cell Membrane,A11.284.149
23351737,2013-01-01T00:00:00,Gene Expression Regulation,G05.355.315
23351737,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23351737,2013-01-01T00:00:00,Protein Transport,G03.495.166.700
23351737,2013-01-01T00:00:00,"RNA, Messenger",D13.444.735.544
23351737,2013-01-01T00:00:00,RNA-Binding Proteins,D12.776.157.725
23351737,2013-01-01T00:00:00,RNA-Binding Proteins,D12.776.664.962
23351737,2013-01-01T00:00:00,"Receptors, Adrenergic, beta-2",D12.776.543.750.070.300.300.340.725
23351737,2013-01-01T00:00:00,"Receptors, Adrenergic, beta-2",D12.776.543.750.100.150.300.340.725
23351737,2013-01-01T00:00:00,"Receptors, Adrenergic, beta-2",D12.776.543.750.720.300.300.300.340.200
23374185,2013-01-01T00:00:00,Binding Sites,G02.111.570.120
23374185,2013-01-01T00:00:00,GTP-Binding Protein Regulators,D12.644.360.325
23374185,2013-01-01T00:00:00,GTP-Binding Protein Regulators,D12.776.402
23374185,2013-01-01T00:00:00,GTP-Binding Protein Regulators,D12.776.476.325
23374185,2013-01-01T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D08.811.277.040.330.300.200.100.200
23374185,2013-01-01T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.644.360.375.100.200
23374185,2013-01-01T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.776.157.325.332.100.200
23374185,2013-01-01T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.776.476.375.100.200
23374185,2013-01-01T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.776.543.325.100.200
23374185,2013-01-01T00:00:00,Gene Expression,G05.355.310
23374185,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23374185,2013-01-01T00:00:00,Signal Transduction,G02.111.087.800
23374185,2013-01-01T00:00:00,Signal Transduction,G02.149.115.800
23374185,2013-01-01T00:00:00,Signal Transduction,G04.299.880
23374189,2013-01-01T00:00:00,Animals,B01.050
23374189,2013-01-01T00:00:00,Arrestins,D12.776.306.090
23374189,2013-01-01T00:00:00,Arrestins,D12.776.543.090
23374189,2013-01-01T00:00:00,Bias (Epidemiology),N05.715.350.150
23374189,2013-01-01T00:00:00,Bias (Epidemiology),N06.850.490.500
23374189,2013-01-01T00:00:00,Biological Assay,E05.091
23374189,2013-01-01T00:00:00,Calcium,D01.268.552.100
23374189,2013-01-01T00:00:00,Calcium,D01.552.539.288
23374189,2013-01-01T00:00:00,Calcium,D23.119.100
23374189,2013-01-01T00:00:00,Cyclic AMP,D03.438.759.646.138.395
23374189,2013-01-01T00:00:00,Cyclic AMP,D13.695.462.200
23374189,2013-01-01T00:00:00,Cyclic AMP,D13.695.667.138.395
23374189,2013-01-01T00:00:00,Cyclic AMP,D13.695.827.068.395
23374189,2013-01-01T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.567.342
23374189,2013-01-01T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.646.750.249
23374189,2013-01-01T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.644.360.450.169
23374189,2013-01-01T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.776.476.450.169
23374189,2013-01-01T00:00:00,Gene Expression Regulation,G05.355.315
23374189,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23374189,2013-01-01T00:00:00,Peptide Fragments,D12.644.541
23374189,2013-01-01T00:00:00,"Receptor, Parathyroid Hormone, Type 1",D12.776.543.750.100.650.100
23374189,2013-01-01T00:00:00,"Receptor, Parathyroid Hormone, Type 1",D12.776.543.750.750.600.100
23374189,2013-01-01T00:00:00,Signal Transduction,G02.111.087.800
23374189,2013-01-01T00:00:00,Signal Transduction,G02.149.115.800
23374189,2013-01-01T00:00:00,Signal Transduction,G04.299.880
23374892,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23374892,2013-01-01T00:00:00,Kidney Transplantation,E02.870.500
23374892,2013-01-01T00:00:00,Kidney Transplantation,E04.936.450.485
23374892,2013-01-01T00:00:00,Kidney Transplantation,E04.950.774.400
23374892,2013-01-01T00:00:00,Obesity,C18.654.726.500
23374892,2013-01-01T00:00:00,Obesity,C23.888.144.699.500
23374892,2013-01-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
23374892,2013-01-01T00:00:00,Obesity,G07.100.100.160.120.699.500
23374892,2013-01-01T00:00:00,Postoperative Complications,C23.550.767
23378332,2013-01-01T00:00:00,Genetic Loci,G05.360.340.024.380
23378332,2013-01-01T00:00:00,Genetic Variation,G05.365
23378332,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23378332,2013-01-01T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
23378332,2013-01-01T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
23378332,2013-01-01T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
23378332,2013-01-01T00:00:00,Multiple Sclerosis,C10.114.375.500
23378332,2013-01-01T00:00:00,Multiple Sclerosis,C10.314.350.500
23378332,2013-01-01T00:00:00,Multiple Sclerosis,C20.111.258.250.500
23402024,2013-01-01T00:00:00,Animals,B01.050
23402024,2013-01-01T00:00:00,Complement Activation,G12.425.255
23402024,2013-01-01T00:00:00,Complement System Proteins,D12.776.124.486.274
23402024,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23402024,2013-01-01T00:00:00,Macular Degeneration,C11.768.585.439
23462610,2013-01-01T00:00:00,Adult,M01.060.116
23462610,2013-01-01T00:00:00,Bone Marrow,A15.382.216
23462610,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23462610,2013-01-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
23462610,2013-01-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
23462610,2013-01-01T00:00:00,Neuroblastoma,C04.557.465.625.600.590.650.550
23462610,2013-01-01T00:00:00,Neuroblastoma,C04.557.470.670.590.650.550
23462610,2013-01-01T00:00:00,Neuroblastoma,C04.557.580.625.600.590.650.550
23471287,2013-01-01T00:00:00,Adult,M01.060.116
23471287,2013-01-01T00:00:00,Allied Health Personnel,M01.526.485.067
23471287,2013-01-01T00:00:00,Allied Health Personnel,N02.360.067
23471287,2013-01-01T00:00:00,Cooperative Behavior,F01.145.813.115
23471287,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23471287,2013-01-01T00:00:00,Interprofessional Relations,F01.829.401.205
23471287,2013-01-01T00:00:00,Patient Care Team,N04.590.715
23471287,2013-01-01T00:00:00,Patient Simulation,I02.903.525
23471287,2013-01-01T00:00:00,Questionnaires,E05.318.308.750
23471287,2013-01-01T00:00:00,Questionnaires,L01.280.800
23471287,2013-01-01T00:00:00,Questionnaires,N05.715.360.300.695
23471287,2013-01-01T00:00:00,Questionnaires,N06.850.520.308.750
23471287,2013-01-01T00:00:00,Treatment Outcome,E01.789.800
23471287,2013-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23471287,2013-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23471287,2013-01-01T00:00:00,Young Adult,M01.060.116.815
23516953,2013-01-01T00:00:00,Anterior Cruciate Ligament,A02.513.514.100
23516953,2013-01-01T00:00:00,Anterior Cruciate Ligament,A02.835.583.512.100
23516953,2013-01-01T00:00:00,Computer Simulation,L01.224.160
23516953,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23516953,2013-01-01T00:00:00,Knee Joint,A02.835.583.475
23516953,2013-01-01T00:00:00,Knee Prosthesis,E07.695.400.410
23516953,2013-01-01T00:00:00,"Models, Biological",E05.599.395
23516953,2013-01-01T00:00:00,Posterior Cruciate Ligament,A02.513.514.600
23516953,2013-01-01T00:00:00,Posterior Cruciate Ligament,A02.835.583.512.600
23516953,2013-01-01T00:00:00,Treatment Outcome,E01.789.800
23516953,2013-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23516953,2013-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23524621,2013-01-01T00:00:00,Adult,M01.060.116
23524621,2013-01-01T00:00:00,Circadian Rhythm,G07.180.562.190
23524621,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23524621,2013-01-01T00:00:00,Hydrocortisone,D04.808.745.745.654.600
23524621,2013-01-01T00:00:00,Hydrocortisone,D06.472.040.585.353.476
23524621,2013-01-01T00:00:00,Hydrocortisone,D06.472.040.585.478.392
23524621,2013-01-01T00:00:00,Life Change Events,F01.829.458.410
23524621,2013-01-01T00:00:00,Middle Aged,M01.060.116.630
23524621,2013-01-01T00:00:00,"Polymorphism, Genetic",G05.365.795
23524621,2013-01-01T00:00:00,"Stress, Psychological",F01.145.126.990
23524621,2013-01-01T00:00:00,"Stress, Psychological",F02.830.900
23530307,2013-01-01T00:00:00,African Americans,M01.686.508.100.100
23530307,2013-01-01T00:00:00,African Americans,M01.686.754.100
23530307,2013-01-01T00:00:00,Aged,M01.060.116.100
23530307,2013-01-01T00:00:00,Diabetic Nephropathies,C12.777.419.192
23530307,2013-01-01T00:00:00,Diabetic Nephropathies,C13.351.968.419.192
23530307,2013-01-01T00:00:00,Diabetic Nephropathies,C19.246.099.875
23530307,2013-01-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
23530307,2013-01-01T00:00:00,Graft Rejection,G12.425.901.545.328
23530307,2013-01-01T00:00:00,Healthcare Disparities,N04.590.374.380
23530307,2013-01-01T00:00:00,Healthcare Disparities,N05.300.493
23530307,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23530307,2013-01-01T00:00:00,Kidney Transplantation,E02.870.500
23530307,2013-01-01T00:00:00,Kidney Transplantation,E04.936.450.485
23530307,2013-01-01T00:00:00,Kidney Transplantation,E04.950.774.400
23530307,2013-01-01T00:00:00,Middle Aged,M01.060.116.630
23530307,2013-01-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
23530307,2013-01-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
23530307,2013-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
23530307,2013-01-01T00:00:00,Risk Factors,N05.715.350.200.700
23530307,2013-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23530307,2013-01-01T00:00:00,Risk Factors,N06.850.490.625.750
23530307,2013-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23530633,2013-01-01T00:00:00,Aged,M01.060.116.100
23530633,2013-01-01T00:00:00,Blood Glucose,D09.546.359.448.500
23530633,2013-01-01T00:00:00,Breast Neoplasms,C04.588.180
23530633,2013-01-01T00:00:00,Breast Neoplasms,C17.800.090.500
23530633,2013-01-01T00:00:00,Diet,E05.272
23530633,2013-01-01T00:00:00,Diet,G07.610.240
23530633,2013-01-01T00:00:00,Dietary Carbohydrates,D09.301
23530633,2013-01-01T00:00:00,Dietary Carbohydrates,J02.500.362
23530633,2013-01-01T00:00:00,Dietary Supplements,J02.500.456
23530633,2013-01-01T00:00:00,Folic Acid,D03.438.733.631.400
23530633,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23530633,2013-01-01T00:00:00,Middle Aged,M01.060.116.630
23530633,2013-01-01T00:00:00,New York,Z01.107.567.875.075.437
23530633,2013-01-01T00:00:00,New York,Z01.107.567.875.350.530
23530633,2013-01-01T00:00:00,New York,Z01.107.567.875.500.530
23530633,2013-01-01T00:00:00,Oxidative Stress,G03.495.710
23530633,2013-01-01T00:00:00,Oxidative Stress,G07.700.830.750
23530633,2013-01-01T00:00:00,Questionnaires,E05.318.308.750
23530633,2013-01-01T00:00:00,Questionnaires,L01.280.800
23530633,2013-01-01T00:00:00,Questionnaires,N05.715.360.300.695
23530633,2013-01-01T00:00:00,Questionnaires,N06.850.520.308.750
23530633,2013-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
23530633,2013-01-01T00:00:00,Risk Factors,N05.715.350.200.700
23530633,2013-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23530633,2013-01-01T00:00:00,Risk Factors,N06.850.490.625.750
23530633,2013-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23530674,2013-01-01T00:00:00,Consumer Satisfaction,N04.452.822.360
23530674,2013-01-01T00:00:00,Curriculum,I02.158
23530674,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23530674,2013-01-01T00:00:00,Questionnaires,E05.318.308.750
23530674,2013-01-01T00:00:00,Questionnaires,L01.280.800
23530674,2013-01-01T00:00:00,Questionnaires,N05.715.360.300.695
23530674,2013-01-01T00:00:00,Questionnaires,N06.850.520.308.750
23530674,2013-01-01T00:00:00,"Schools, Medical",I02.783.660.552
23530674,2013-01-01T00:00:00,"Schools, Medical",N02.278.020.578
23530674,2013-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23530674,2013-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23530674,2013-01-01T00:00:00,"Students, Medical",I02.851.686.602
23530674,2013-01-01T00:00:00,"Students, Medical",M01.848.769.602
23530674,2013-01-01T00:00:00,Writing,L01.143.506.423.906
23563667,2013-01-01T00:00:00,Animals,B01.050
23563667,2013-01-01T00:00:00,Biological Markers,D23.101
23563667,2013-01-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
23563667,2013-01-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
23563667,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23563667,2013-01-01T00:00:00,Insulin Resistance,C18.452.394.968.500
23563667,2013-01-01T00:00:00,Insulin Resistance,G07.690.320.617
23563667,2013-01-01T00:00:00,Metabolic Diseases,C18.452
23563667,2013-01-01T00:00:00,"Muscle, Skeletal",A02.633.567
23563667,2013-01-01T00:00:00,"Muscle, Skeletal",A10.690.552.500
23563667,2013-01-01T00:00:00,Myocardium,A02.633.580
23563667,2013-01-01T00:00:00,Myocardium,A07.541.704
23563667,2013-01-01T00:00:00,Myocardium,A10.690.552.750
23563667,2013-01-01T00:00:00,Obesity,C18.654.726.500
23563667,2013-01-01T00:00:00,Obesity,C23.888.144.699.500
23563667,2013-01-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
23563667,2013-01-01T00:00:00,Obesity,G07.100.100.160.120.699.500
23563667,2013-01-01T00:00:00,Signal Transduction,G02.111.087.800
23563667,2013-01-01T00:00:00,Signal Transduction,G02.149.115.800
23563667,2013-01-01T00:00:00,Signal Transduction,G04.299.880
23563667,2013-01-01T00:00:00,Sphingolipids,D10.570.877
23563667,2013-01-01T00:00:00,Sphingolipids,D10.808
23590215,2013-01-01T00:00:00,Adrenal Cortex Hormones,D06.472.040
23590215,2013-01-01T00:00:00,Anti-Asthmatic Agents,D27.505.954.796.050
23590215,2013-01-01T00:00:00,Asthma,C08.127.108
23590215,2013-01-01T00:00:00,Asthma,C08.381.495.108
23590215,2013-01-01T00:00:00,Asthma,C08.674.095
23590215,2013-01-01T00:00:00,Asthma,C20.543.480.680.095
23590215,2013-01-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
23590215,2013-01-01T00:00:00,Clinical Trials as Topic,E05.337.250
23590215,2013-01-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
23590215,2013-01-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
23590215,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23590215,2013-01-01T00:00:00,Quality of Life,I01.800
23590215,2013-01-01T00:00:00,Quality of Life,K01.752.400.750
23590215,2013-01-01T00:00:00,Treatment Outcome,E01.789.800
23590215,2013-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23590215,2013-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23628577,2013-01-01T00:00:00,Acromioclavicular Joint,A02.835.583.032
23628577,2013-01-01T00:00:00,Adult,M01.060.116
23628577,2013-01-01T00:00:00,Clavicle,A02.835.232.087.227
23628577,2013-01-01T00:00:00,Dislocations,C21.866.289
23628577,2013-01-01T00:00:00,"Fracture Fixation, Internal",E04.555.300.300
23628577,2013-01-01T00:00:00,"Fractures, Bone",C21.866.404
23628577,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23743392,2013-01-01T00:00:00,Adult,M01.060.116
23743392,2013-01-01T00:00:00,"Cerclage, Cervical",E04.520.100
23743392,2013-01-01T00:00:00,Device Removal,E04.199
23743392,2013-01-01T00:00:00,"Fetal Membranes, Premature Rupture",C13.703.420.339
23743392,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23743392,2013-01-01T00:00:00,Laparoscopy,E01.370.388.250.520
23743392,2013-01-01T00:00:00,Laparoscopy,E04.800.250.520
23743392,2013-01-01T00:00:00,Pregnancy,G08.686.785.760.769
23752242,2013-01-01T00:00:00,Adult,M01.060.116
23752242,2013-01-01T00:00:00,Clinical Competence,I02.399.630.210
23752242,2013-01-01T00:00:00,Clinical Competence,N04.761.210
23752242,2013-01-01T00:00:00,Communication,F01.145.209
23752242,2013-01-01T00:00:00,Communication,L01.143
23752242,2013-01-01T00:00:00,Curriculum,I02.158
23752242,2013-01-01T00:00:00,Educational Measurement,I02.399
23752242,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23752242,2013-01-01T00:00:00,Learning,F02.463.425
23752242,2013-01-01T00:00:00,Learning,F02.784.629.529
23752242,2013-01-01T00:00:00,"Models, Educational",E05.599.545
23752242,2013-01-01T00:00:00,"Models, Educational",I02.903.302
23752242,2013-01-01T00:00:00,Patient Simulation,I02.903.525
23752242,2013-01-01T00:00:00,Peer Group,F01.829.316.483
23752242,2013-01-01T00:00:00,Pilot Projects,E05.318.760.750
23752242,2013-01-01T00:00:00,Pilot Projects,E05.337.737
23752242,2013-01-01T00:00:00,Pilot Projects,N05.715.360.775.625
23752242,2013-01-01T00:00:00,Pilot Projects,N06.850.520.450.720
23752242,2013-01-01T00:00:00,Professional-Patient Relations,F01.829.401.650
23752242,2013-01-01T00:00:00,Professional-Patient Relations,N05.300.660
23752242,2013-01-01T00:00:00,Teaching,I02.903
23752242,2013-01-01T00:00:00,Video Recording,L01.240.960
23793251,2013-01-01T00:00:00,Adult,M01.060.116
23793251,2013-01-01T00:00:00,African Americans,M01.686.508.100.100
23793251,2013-01-01T00:00:00,African Americans,M01.686.754.100
23793251,2013-01-01T00:00:00,Aged,M01.060.116.100
23793251,2013-01-01T00:00:00,Community-Based Participatory Research,N05.425.104
23793251,2013-01-01T00:00:00,Cultural Competency,I01.880.143.364
23793251,2013-01-01T00:00:00,Fear,F01.470.361
23793251,2013-01-01T00:00:00,Health Promotion,N02.370
23793251,2013-01-01T00:00:00,Health Promotion,N02.421.726.507
23793251,2013-01-01T00:00:00,Health Services Accessibility,N04.590.374.350
23793251,2013-01-01T00:00:00,Health Services Accessibility,N05.300.430
23793251,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23793251,2013-01-01T00:00:00,Middle Aged,M01.060.116.630
23793251,2013-01-01T00:00:00,Needs Assessment,I02.594
23793251,2013-01-01T00:00:00,Needs Assessment,N03.349.380.565
23793251,2013-01-01T00:00:00,Needs Assessment,N05.300.537
23793251,2013-01-01T00:00:00,Oral Health,N01.400.535
23793251,2013-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23793251,2013-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23909060,2013-01-01T00:00:00,Aged,M01.060.116.100
23909060,2013-01-01T00:00:00,Cognitive Therapy,F04.754.137.428
23909060,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23909060,2013-01-01T00:00:00,Implosive Therapy,F04.754.137.506.325
23909060,2013-01-01T00:00:00,Sleep Initiation and Maintenance Disorders,C10.886.425.800.800
23909060,2013-01-01T00:00:00,Sleep Initiation and Maintenance Disorders,F03.870.400.800.800
23909060,2013-01-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
23909060,2013-01-01T00:00:00,Time Factors,G01.910.857
23909060,2013-01-01T00:00:00,Treatment Outcome,E01.789.800
23909060,2013-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23909060,2013-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23909060,2013-01-01T00:00:00,United States,Z01.107.567.875
23909060,2013-01-01T00:00:00,Veterans,M01.930
23977816,2013-01-01T00:00:00,Age Factors,N05.715.350.075
23977816,2013-01-01T00:00:00,Age Factors,N06.850.490.250
23977816,2013-01-01T00:00:00,Aged,M01.060.116.100
23977816,2013-01-01T00:00:00,Combat Disorders,F03.080.931.249
23977816,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23977816,2013-01-01T00:00:00,Implosive Therapy,F04.754.137.506.325
23977816,2013-01-01T00:00:00,Middle Aged,M01.060.116.630
23977816,2013-01-01T00:00:00,Personality Inventory,F04.711.647.513
23977816,2013-01-01T00:00:00,Psychometrics,F04.711.780
23977816,2013-01-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
23977816,2013-01-01T00:00:00,Treatment Outcome,E01.789.800
23977816,2013-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23977816,2013-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23977816,2013-01-01T00:00:00,Veterans,M01.930
23977819,2013-01-01T00:00:00,"Adaptation, Psychological",F01.058
23977819,2013-01-01T00:00:00,Adult,M01.060.116
23977819,2013-01-01T00:00:00,Community Mental Health Services,F04.408.307
23977819,2013-01-01T00:00:00,Community Mental Health Services,N02.421.143.183
23977819,2013-01-01T00:00:00,Community Mental Health Services,N02.421.461.232
23977819,2013-01-01T00:00:00,Disasters,N06.230.100
23977819,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23977819,2013-01-01T00:00:00,Inservice Training,I02.574
23977819,2013-01-01T00:00:00,Life Change Events,F01.829.458.410
23977819,2013-01-01T00:00:00,Mass Screening,E01.370.500
23977819,2013-01-01T00:00:00,Mass Screening,E05.318.308.250.580
23977819,2013-01-01T00:00:00,Mass Screening,N02.421.143.827.233.443
23977819,2013-01-01T00:00:00,Mass Screening,N02.421.726.233.443
23977819,2013-01-01T00:00:00,Mass Screening,N05.715.360.300.375.500
23977819,2013-01-01T00:00:00,Mass Screening,N06.850.520.308.250.580
23977819,2013-01-01T00:00:00,Mass Screening,N06.850.780.500
23977819,2013-01-01T00:00:00,Middle Aged,M01.060.116.630
23977819,2013-01-01T00:00:00,Questionnaires,E05.318.308.750
23977819,2013-01-01T00:00:00,Questionnaires,L01.280.800
23977819,2013-01-01T00:00:00,Questionnaires,N05.715.360.300.695
23977819,2013-01-01T00:00:00,Questionnaires,N06.850.520.308.750
23977819,2013-01-01T00:00:00,"Resilience, Psychological",F02.940
23977819,2013-01-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
23977819,2013-01-01T00:00:00,Survivors,M01.643.836
23977819,2013-01-01T00:00:00,Survivors,M01.860
24013249,2013-01-01T00:00:00,Adult,M01.060.116
24013249,2013-01-01T00:00:00,Cooperative Behavior,F01.145.813.115
24013249,2013-01-01T00:00:00,Curriculum,I02.158
24013249,2013-01-01T00:00:00,Educational Measurement,I02.399
24013249,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24013249,2013-01-01T00:00:00,Interprofessional Relations,F01.829.401.205
24013249,2013-01-01T00:00:00,"Models, Educational",E05.599.545
24013249,2013-01-01T00:00:00,"Models, Educational",I02.903.302
24013249,2013-01-01T00:00:00,Occupational Therapy,E02.831.489
24013249,2013-01-01T00:00:00,Occupational Therapy,H02.010.500
24013249,2013-01-01T00:00:00,Patient Care Team,N04.590.715
24013249,2013-01-01T00:00:00,Patient Discharge,E02.760.400.610
24013249,2013-01-01T00:00:00,Patient Discharge,N02.421.585.400.610
24013249,2013-01-01T00:00:00,Patient Simulation,I02.903.525
24013249,2013-01-01T00:00:00,Physician Assistants,M01.526.485.067.740
24013249,2013-01-01T00:00:00,Physician Assistants,N02.360.067.740
24063796,2013-01-01T00:00:00,Adolescent,M01.060.057
24063796,2013-01-01T00:00:00,Adult,M01.060.116
24063796,2013-01-01T00:00:00,Aged,M01.060.116.100
24063796,2013-01-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
24063796,2013-01-01T00:00:00,"Arthroplasty, Replacement, Hip",E04.555.110.110.110
24063796,2013-01-01T00:00:00,"Arthroplasty, Replacement, Hip",E04.650.110.110
24063796,2013-01-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
24063796,2013-01-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
24063796,2013-01-01T00:00:00,Child,M01.060.406
24063796,2013-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24063796,2013-01-01T00:00:00,Incidence,E05.318.308.985.525.375
24063796,2013-01-01T00:00:00,Incidence,L01.280.975.525.375
24063796,2013-01-01T00:00:00,Incidence,N01.224.935.597.500
24063796,2013-01-01T00:00:00,Incidence,N06.850.505.400.975.525.375
24063796,2013-01-01T00:00:00,Incidence,N06.850.520.308.985.525.375
24063796,2013-01-01T00:00:00,Middle Aged,M01.060.116.630
24063796,2013-01-01T00:00:00,Organ Transplantation,E04.936.450
24063796,2013-01-01T00:00:00,Prosthesis-Related Infections,C01.539.685
24063796,2013-01-01T00:00:00,Prosthesis-Related Infections,C23.550.767.868
24063796,2013-01-01T00:00:00,Reoperation,E04.690
24063796,2013-01-01T00:00:00,Time Factors,G01.910.857
24063796,2013-01-01T00:00:00,United States,Z01.107.567.875
24063796,2013-01-01T00:00:00,Young Adult,M01.060.116.815
